{"meta":{"query_hash":"af509f147c9a","filters":{"venue":"Journal of the European Academy of Dermatology and Venereology"},"cohort_total":401,"direct_labels_cover":2,"predictions_cover":401,"exported":401,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/af509f147c9a","api":"https://metacan.xera.ac/api/v1/cohort?venue=Journal+of+the+European+Academy+of+Dermatology+and+Venereology"},"results":[{"id":"W1480504814","doi":"10.1111/j.1468-3083.2010.03685.x","title":"Development and evaluation of a Global Acne Severity Scale (GEA Scale) suitable for France and Europe","year":2010,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Acne and Rosacea Treatments and Effects","field":"Medicine","cited_by":235,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"","keywords":"Medicine; Scale (ratio); Acne; Dermatology; Cartography","score_opus":0.0186248839202601,"score_gpt":0.3029074759377921,"score_spread":0.28428259201753203,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1480504814","genre_codex":"empirical","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8939198,0.0034728113,0.06259351,0.0016562445,0.00036682014,0.0051651555,0.003219618,0.0005661812,0.029039802],"genre_scores_gemma":[0.9007273,0.00077832467,0.089886926,0.000355034,0.0001252646,0.0026158253,0.0031849274,0.00009307632,0.0022333225],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9935812,0.0035334365,0.0007579428,0.00031005807,0.0016657204,0.00015178963],"domain_scores_gemma":[0.99014753,0.0021712496,0.0016095737,0.0005368288,0.0050544683,0.00048037025],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.012625265,0.00053160236,0.00057483086,0.0023385845,0.00036416177,0.00086348975,0.00058767345,0.00068077457,0.0020356015],"category_scores_gemma":[0.01449097,0.00016222932,0.0008661741,0.0010317311,0.00054304017,0.0008640429,0.0010147102,0.0006022123,0.00051812246],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009074048,0.0008053994,0.5384722,0.00058418466,0.00037610435,0.0004727457,0.0016951389,0.0027817725,0.010930764,0.0024027135,0.011448574,0.42912304],"study_design_scores_gemma":[0.00034106075,0.0026750288,0.96120113,0.00033726543,0.000107263666,0.0013617851,0.000735203,0.0038328324,0.0029435323,0.00071608374,0.025682475,0.00006644913],"about_ca_topic_score_codex":0.003212507,"about_ca_topic_score_gemma":0.0032536048,"teacher_disagreement_score":0.012625265,"about_ca_system_score_codex":0.00084986445,"about_ca_system_score_gemma":0.0015368646,"threshold_uncertainty_score":0.06676954},"labels":[],"label_agreement":null},{"id":"W1485937383","doi":"10.1111/j.1468-3083.2011.04412.x","title":"Effective and sustainable biologic treatment of psoriasis: what can we learn from new clinical data?","year":2012,"lang":"en","type":"review","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; Dalhousie University","funders":"Astellas Pharma; Celgene; Pfizer; Genentech; Amgen","keywords":"Medicine; Adalimumab; Ustekinumab; Infliximab; Etanercept; Psoriasis; Psoriasis Area and Severity Index; Adverse effect; Clinical trial; Methotrexate; Randomized controlled trial; Intensive care medicine; Dermatology; Disease; Internal medicine; Tumor necrosis factor alpha","score_opus":0.0945180806812629,"score_gpt":0.34455574239945885,"score_spread":0.25003766171819597,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1485937383","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00068508764,0.8618018,0.0012789909,0.12974106,0.004970676,0.000046980986,0.00023991158,0.00007477629,0.0011606994],"genre_scores_gemma":[0.009803383,0.90722924,0.005003808,0.061040934,0.015857924,0.00015706818,0.00033201365,0.00006222386,0.0005135175],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.982787,0.008127853,0.0028601983,0.0014659088,0.003957393,0.00080177654],"domain_scores_gemma":[0.8060019,0.14206013,0.009238776,0.0074265464,0.027249115,0.008023573],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.062561244,0.0024244194,0.008961589,0.0040361295,0.0018791122,0.01396257,0.0054749288,0.012329357,0.010496518],"category_scores_gemma":[0.11200065,0.0013407838,0.0045362497,0.00516842,0.00874942,0.03792716,0.0049420167,0.01759078,0.0037103945],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016460601,0.00061013905,0.0023717568,0.036533188,0.001115492,0.00044121174,0.0006208814,0.0008715821,0.0005833726,0.020720106,0.15694368,0.7775425],"study_design_scores_gemma":[0.0009751724,0.0025357134,0.004491958,0.0611728,0.0021477735,0.0010203363,0.0031956462,0.0012848213,0.0006135871,0.14038329,0.78176504,0.00041391383],"about_ca_topic_score_codex":0.0034878417,"about_ca_topic_score_gemma":0.0048946757,"teacher_disagreement_score":0.062561244,"about_ca_system_score_codex":0.0044978736,"about_ca_system_score_gemma":0.0132363485,"threshold_uncertainty_score":0.33085942},"labels":[],"label_agreement":null},{"id":"W1489599371","doi":"10.1111/j.1468-3083.2009.03531.x","title":"Genital verrucous carcinoma is associated with lichen sclerosus: a retrospective study and review of the literature","year":2009,"lang":"en","type":"review","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Genital Health and Disease","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital","funders":"","keywords":"Verrucous carcinoma; Lichen sclerosus; Medicine; Sex organ; Dermatology; Carcinoma; Histopathology; Anal Carcinoma; Penile Carcinoma; Basal cell carcinoma; Pathology; Basal cell; Anal canal; Penis; Surgery; Rectum; Penile cancer","score_opus":0.02943462111530235,"score_gpt":0.31670863183713666,"score_spread":0.2872740107218343,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1489599371","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7850628,0.21077074,0.00044536142,0.00022123625,0.000103178005,0.00014898126,0.0006762147,0.00004320281,0.0025283436],"genre_scores_gemma":[0.9072848,0.09035203,0.00056341296,0.00032169282,0.00029529232,0.000087013475,0.0007017049,0.0000127588355,0.00038133282],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99888355,0.00015232546,0.00044923802,0.00022168805,0.00020094866,0.000092194314],"domain_scores_gemma":[0.996585,0.0009928619,0.0017656854,0.00014848022,0.00032711864,0.00018096385],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00065864285,0.00046837897,0.0010019691,0.0069164163,0.0006782367,0.0010369705,0.0006232493,0.0009885795,0.0017760271],"category_scores_gemma":[0.0022900747,0.00060075306,0.0007432908,0.006580242,0.000667749,0.0011630899,0.0005686168,0.00038371823,0.00061331433],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023096998,0.00019520607,0.8408162,0.005333651,0.00052326557,0.11208647,0.00079389045,0.00012458207,0.0020978625,0.00015341552,0.0013342458,0.036310323],"study_design_scores_gemma":[0.000042627777,0.00047818787,0.46854264,0.0021452548,0.0015701307,0.51433635,0.0022047614,0.0002350559,0.00072017155,0.0001297451,0.0095248725,0.00007020642],"about_ca_topic_score_codex":0.0010778444,"about_ca_topic_score_gemma":0.001402202,"teacher_disagreement_score":0.0069164163,"about_ca_system_score_codex":0.0003565496,"about_ca_system_score_gemma":0.0007375442,"threshold_uncertainty_score":0.0059414506},"labels":[],"label_agreement":null},{"id":"W1508119413","doi":"10.1111/jdv.13198","title":"Management and treatment of chronic urticaria (<scp>CU</scp>)","year":2015,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Urticaria and Related Conditions","field":"Medicine","cited_by":71,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"Novartis Pharma; European Academy of Allergy and Clinical Immunology; Novartis","keywords":"Omalizumab; Medicine; Chronic urticaria; Immunoglobulin E; Dermatology; Mast cell; Pharmacotherapy; Intensive care medicine; Immunology; Antibody; Internal medicine","score_opus":0.024091147831914614,"score_gpt":0.2701843375442187,"score_spread":0.2460931897123041,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1508119413","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.16179988,0.7221572,0.0138305435,0.016169239,0.0022171794,0.00038185238,0.000218265,0.00047861232,0.082747236],"genre_scores_gemma":[0.70928854,0.25270736,0.014877153,0.0057365694,0.0042760535,0.00021639677,0.0003287374,0.000049821836,0.01251938],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997658,0.000055553923,0.000029871562,0.00002259146,0.00008012088,0.000046070403],"domain_scores_gemma":[0.9998758,0.000019427443,0.000046564295,0.0000059008216,0.000020661362,0.00003161681],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029538345,0.00025560378,0.00032132104,0.0004684685,0.0005614076,0.00040106618,0.00026153744,0.0007606384,0.0020745962],"category_scores_gemma":[0.000517506,0.00006643116,0.00032707656,0.0002805831,0.00023075541,0.00031758082,0.00046492933,0.0007484251,0.0006471629],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024980228,0.00043043576,0.009410086,0.0028497183,0.000089398745,0.011239779,0.00032530978,0.00030469478,0.015121828,0.0024960404,0.044326235,0.91315657],"study_design_scores_gemma":[0.00037447576,0.0025771298,0.0860961,0.0046123085,0.00022002352,0.26567918,0.00083234854,0.0013037456,0.010936446,0.0047190352,0.622576,0.000073148694],"about_ca_topic_score_codex":0.0005198747,"about_ca_topic_score_gemma":0.0012156334,"teacher_disagreement_score":0.0020745962,"about_ca_system_score_codex":0.00024513915,"about_ca_system_score_gemma":0.0003066097,"threshold_uncertainty_score":0.0069402456},"labels":[],"label_agreement":null},{"id":"W1515460825","doi":"10.1111/j.1468-3083.2009.03491.x","title":"Ineffectiveness of sun awareness posters in dermatology clinics","year":2009,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Skin Protection and Aging","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Sun protection; Appeal; Slogan; Notice; Skin cancer; Population; Family medicine; Dermatology; Cancer; Environmental health","score_opus":0.022310917568841997,"score_gpt":0.3188563871022523,"score_spread":0.29654546953341027,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1515460825","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9904101,0.0016046094,0.00081906124,0.0014487518,0.00016338973,0.00040528807,0.000069498274,0.0001343842,0.0049449448],"genre_scores_gemma":[0.9955454,0.0006269063,0.0023059065,0.00044696472,0.00013239314,0.00017942232,0.000050270228,0.000019967036,0.00069272664],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.980809,0.013652694,0.0011387258,0.00086067175,0.0028699595,0.0006689961],"domain_scores_gemma":[0.90748656,0.06799709,0.012702754,0.0033760858,0.0029808301,0.0054567265],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.018445263,0.00052831596,0.00057148584,0.00069428,0.0010619153,0.0012247651,0.0008605628,0.001197932,0.008249843],"category_scores_gemma":[0.05122751,0.0004076143,0.00071876677,0.00043506015,0.00084402895,0.0008707452,0.0014840347,0.00094732974,0.0009795383],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004978831,0.006018746,0.41056538,0.007116789,0.00046188734,0.0018044807,0.024838502,0.0012416298,0.020287335,0.0004179001,0.0070820805,0.5151864],"study_design_scores_gemma":[0.0009957176,0.037162565,0.88312924,0.0028785127,0.0007283685,0.0035951447,0.02551202,0.0031043037,0.009798803,0.00045935766,0.03245825,0.0001776991],"about_ca_topic_score_codex":0.0007146346,"about_ca_topic_score_gemma":0.0007085206,"teacher_disagreement_score":0.018445263,"about_ca_system_score_codex":0.0009123342,"about_ca_system_score_gemma":0.0013933557,"threshold_uncertainty_score":0.09754908},"labels":[],"label_agreement":null},{"id":"W1516980019","doi":"10.1111/j.1468-3083.2012.04673.x","title":"Preliminary exploration of the clinical features of Chinese patients with skin malignancies and premalignancies: a retrospective study of 1420 cases from Peking University First Hospital","year":2012,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Nonmelanoma Skin Cancer Studies","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Basal cell carcinoma; Trunk; Epidemiology; Retrospective cohort study; Dermatology; Head and neck; Melanoma; Population; Acral lentiginous melanoma; Histology; Skin cancer; Tongue; Basal cell; Internal medicine; Pathology; Cancer; Surgery","score_opus":0.01987544341107099,"score_gpt":0.26942049562447823,"score_spread":0.24954505221340723,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1516980019","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99917185,0.00020118174,0.000041513984,0.000011949769,0.0000024793658,0.000020629259,0.00021878262,0.000001899122,0.0003297897],"genre_scores_gemma":[0.99903715,0.0002009121,0.00006404863,0.000025229901,0.000010289538,0.000028328215,0.0005039255,0.0000015849015,0.00012866555],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99960047,0.000039113078,0.000070082664,0.00012283023,0.00007602876,0.000091544076],"domain_scores_gemma":[0.9993123,0.00009505939,0.00020967315,0.00007160823,0.000116035706,0.00019536214],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043338872,0.00036375062,0.00041688656,0.0016562231,0.00093986234,0.00041271962,0.00034673093,0.00034397093,0.0021881922],"category_scores_gemma":[0.0009737191,0.0004541594,0.00035128114,0.0015625338,0.00042615505,0.0005342491,0.00059534155,0.00022543549,0.00030190224],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000028114157,0.000010524466,0.9982938,0.000014874808,0.000010184974,0.00051198225,0.00015565097,0.000009185453,0.0002300462,0.0000072548937,0.000046902867,0.00068148517],"study_design_scores_gemma":[0.000003891677,0.000068762645,0.99757344,0.0000057342845,0.00001567715,0.0015647812,0.00040577006,0.000036861456,0.000068744936,0.0000103467555,0.00024236765,0.000003548302],"about_ca_topic_score_codex":0.013030311,"about_ca_topic_score_gemma":0.011850222,"teacher_disagreement_score":0.013030311,"about_ca_system_score_codex":0.0007236307,"about_ca_system_score_gemma":0.00097026676,"threshold_uncertainty_score":0.025908947},"labels":[],"label_agreement":null},{"id":"W1524666011","doi":"10.1111/j.1468-3083.2012.04584.x","title":"Terbinafine in the treatment of dermatophyte toenail onychomycosis: a meta‐analysis of efficacy for continuous and intermittent regimens","year":2012,"lang":"en","type":"review","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Nail Diseases and Treatments","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mediprobe Research (Canada); University of Toronto","funders":"","keywords":"Terbinafine; Medicine; Regimen; Dermatophyte; Internal medicine; Surgery; Dermatology; Itraconazole; Antifungal","score_opus":0.12266566769689088,"score_gpt":0.37796785656385773,"score_spread":0.2553021888669669,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1524666011","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0168077,0.98139864,0.00048077383,0.00017563174,0.00023348513,0.00019685867,0.0002783543,0.000025591567,0.0004029251],"genre_scores_gemma":[0.48022127,0.5146759,0.0017992026,0.00090392405,0.00042151904,0.0005922863,0.0006151688,0.00004593987,0.0007247112],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99383235,0.0037159575,0.0011491252,0.0005989258,0.0005241722,0.00017949456],"domain_scores_gemma":[0.9881968,0.008747517,0.001849211,0.0003742707,0.00060544244,0.00022679403],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010001334,0.0023060816,0.015460713,0.002994457,0.00043194863,0.0028339913,0.0012605487,0.0020458933,0.0035288217],"category_scores_gemma":[0.015648525,0.0009898461,0.032159723,0.002856204,0.00054047606,0.0013431618,0.00091467774,0.0020595784,0.0003067872],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.022748016,0.00008463176,0.0016146334,0.12891637,0.82901984,0.00010010783,0.000058053232,0.00063759583,0.00054188323,0.00009384854,0.00030460925,0.015880356],"study_design_scores_gemma":[0.003864344,0.0014320302,0.0029886463,0.0073033893,0.98257667,0.000080793245,0.00004025869,0.00023227847,0.00017955322,0.00015126963,0.0011303332,0.00002042296],"about_ca_topic_score_codex":0.002608085,"about_ca_topic_score_gemma":0.004440415,"teacher_disagreement_score":0.015460713,"about_ca_system_score_codex":0.0014566177,"about_ca_system_score_gemma":0.00108448,"threshold_uncertainty_score":0.052892745},"labels":[],"label_agreement":null},{"id":"W1538494537","doi":"10.1111/j.1468-3083.2011.04123.x","title":"Experience with ustekinumab for the treatment of moderate to severe Hidradenitis suppurativa","year":2011,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Hidradenitis Suppurativa and Treatments","field":"Medicine","cited_by":121,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"","keywords":"Medicine; Hidradenitis suppurativa; Ustekinumab; Dermatology; Adalimumab; Internal medicine; Disease","score_opus":0.05073594249532849,"score_gpt":0.2911861156631689,"score_spread":0.2404501731678404,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1538494537","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9558098,0.032206748,0.0024220527,0.0021807903,0.00017078289,0.00027544764,0.00014274861,0.00007572297,0.0067159142],"genre_scores_gemma":[0.98338014,0.011772974,0.0015929646,0.0013855579,0.00035023072,0.00007780986,0.00017916787,0.000017225664,0.001243904],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9994174,0.00027237047,0.00007006261,0.00006457433,0.00008414989,0.000091520335],"domain_scores_gemma":[0.9989004,0.0005131326,0.00013780275,0.00006481707,0.00007383151,0.00030997192],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013970415,0.0005826601,0.0005186336,0.00012935634,0.00050599047,0.00045836336,0.00042453298,0.0006380107,0.0020907521],"category_scores_gemma":[0.0017371841,0.00017563635,0.0007313518,0.00024519596,0.00038935695,0.0003757768,0.00028247002,0.0011376055,0.00048675205],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01553489,0.01672051,0.09864525,0.00189645,0.0012827526,0.01986564,0.007038749,0.002488091,0.06256594,0.0012107869,0.009333697,0.7634172],"study_design_scores_gemma":[0.0150654735,0.23489146,0.43550724,0.0007732834,0.0016663154,0.13883276,0.0017597305,0.0032108857,0.03038037,0.0013662032,0.13636893,0.0001773308],"about_ca_topic_score_codex":0.00069469167,"about_ca_topic_score_gemma":0.0010660737,"teacher_disagreement_score":0.0020907521,"about_ca_system_score_codex":0.00028197787,"about_ca_system_score_gemma":0.0003700469,"threshold_uncertainty_score":0.0073883533},"labels":[],"label_agreement":null},{"id":"W1540837383","doi":"10.1111/j.1468-3083.2010.03637.x","title":"Gene expression profiling in psoriatic scalp hair follicles: clobetasol propionate shampoo 0.05% normalizes psoriasis disease markers","year":2010,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lynde Centre for Dermatology; University of British Columbia; Centre de Recherche Dermatologique du Québec Métropolitain","funders":"Galderma","keywords":"Psoriasis; Clobetasol propionate; Scalp; Medicine; Shampoo; Dermatology; Hair follicle; Gene expression; Transcriptome; Gene expression profiling; Gene; Internal medicine; Pathology; Biology; Genetics","score_opus":0.012421193648398362,"score_gpt":0.23837578959684205,"score_spread":0.2259545959484437,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1540837383","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99395823,0.0008827573,0.003177046,0.000067461086,0.00004613953,0.00018383613,0.0005576862,0.00006747942,0.0010594375],"genre_scores_gemma":[0.98804605,0.00066137273,0.007460474,0.00015168967,0.00004287365,0.00043352626,0.0012027464,0.000042526946,0.0019586026],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997445,0.000047720267,0.000013606618,0.000065952896,0.00008926064,0.000038951974],"domain_scores_gemma":[0.9997782,0.000065311986,0.000043534426,0.000025473082,0.00005506638,0.0000324581],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026149803,0.00017750243,0.0002450611,0.00034179975,0.00018564657,0.00026178441,0.00011416952,0.00024618238,0.0019219321],"category_scores_gemma":[0.00027677655,0.00011480346,0.00022131993,0.00031237272,0.00028287966,0.00010313418,0.0000976977,0.00034064785,0.00033921044],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046490235,0.000047184643,0.0006814436,0.000022385799,0.000003352544,0.000014006338,0.000018891858,0.000015690737,0.99764913,0.000004672554,0.000021425905,0.0010568869],"study_design_scores_gemma":[0.00014880327,0.004939332,0.10496842,0.000017369353,0.000071080205,0.0006041549,0.00021172073,0.0011990936,0.88514936,0.000061027462,0.0026150942,0.0000145544955],"about_ca_topic_score_codex":0.00038644212,"about_ca_topic_score_gemma":0.0007953729,"teacher_disagreement_score":0.0019219321,"about_ca_system_score_codex":0.0001501038,"about_ca_system_score_gemma":0.00018643524,"threshold_uncertainty_score":0.0064294934},"labels":[],"label_agreement":null},{"id":"W1548178271","doi":"10.1111/j.1468-3083.2011.04033.x","title":"Strategies for improving the quality of care in psoriasis with the use of treatment goals – a report on an implementation meeting","year":2011,"lang":"en","type":"review","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":53,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Universität Hamburg; Abbott Laboratories","keywords":"Medicine; Psoriasis; Quality (philosophy); Intensive care medicine; Medical physics; Dermatology","score_opus":0.12007054824233551,"score_gpt":0.3672513233067706,"score_spread":0.24718077506443512,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1548178271","genre_codex":"commentary","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008354239,0.115772165,0.030371549,0.77912873,0.016417008,0.0074960156,0.0016404883,0.0011324843,0.039687257],"genre_scores_gemma":[0.1291558,0.29054257,0.2943668,0.2193906,0.007493973,0.01614689,0.009406168,0.00073609204,0.03276111],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9642987,0.016801193,0.004480049,0.0011590392,0.009538761,0.0037222682],"domain_scores_gemma":[0.97049195,0.006716687,0.0029552989,0.0014267713,0.0127536515,0.005655683],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.057031922,0.0016510048,0.001015182,0.0026972317,0.0019568857,0.0067908997,0.003640275,0.006989778,0.005229712],"category_scores_gemma":[0.035010535,0.0006534608,0.0034942497,0.0027071058,0.0011562807,0.0059618317,0.009578954,0.00822709,0.0019989384],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016318659,0.0013135549,0.006199367,0.010668046,0.00032728782,0.00046041977,0.0026630475,0.0018209096,0.0017113124,0.029885635,0.28206253,0.66272455],"study_design_scores_gemma":[0.00020122809,0.00083489815,0.022789316,0.017054418,0.00033190355,0.000370152,0.0035019498,0.0011659381,0.0023018918,0.0067475555,0.94456404,0.0001366595],"about_ca_topic_score_codex":0.018909255,"about_ca_topic_score_gemma":0.014585012,"teacher_disagreement_score":0.057031922,"about_ca_system_score_codex":0.008973747,"about_ca_system_score_gemma":0.064487696,"threshold_uncertainty_score":0.3016172},"labels":[],"label_agreement":null},{"id":"W1552498041","doi":"10.1111/j.1468-3083.2011.04082.x","title":"Impact of ustekinumab on health‐related quality of life and sexual difficulties associated with psoriasis: results from two phase III clinical trials","year":2011,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":71,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Moncton Hospital; Centre de Recherche Dermatologique du Québec Métropolitain; Guenther Dermatology Research Centre","funders":"","keywords":"Ustekinumab; Psoriasis; Medicine; Dermatology Life Quality Index; Sexual function; Psoriasis Area and Severity Index; Placebo; Quality of life (healthcare); Internal medicine; Severity of illness; Dermatology; Disease; Physical therapy; Pathology; Alternative medicine; Adalimumab","score_opus":0.1610515970460512,"score_gpt":0.3920532647250895,"score_spread":0.2310016676790383,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1552498041","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8742903,0.10909935,0.0014251788,0.0023845844,0.00049006316,0.0042407494,0.0024527991,0.00020670313,0.0054103183],"genre_scores_gemma":[0.94560325,0.042076215,0.0015183346,0.0025729896,0.00049986446,0.004035119,0.0020628162,0.000042203,0.0015893297],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9981078,0.0011570203,0.00018841594,0.00014737126,0.00022407254,0.00017530234],"domain_scores_gemma":[0.9965759,0.001426338,0.0010309966,0.0002458845,0.00025723863,0.00046372332],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006612448,0.0011709009,0.002785863,0.00034936515,0.0004021606,0.0013218669,0.0009282562,0.0015994156,0.0034425636],"category_scores_gemma":[0.0042730523,0.00040601034,0.0033646147,0.00073551014,0.00089817384,0.00077350985,0.00035655248,0.00245528,0.00048813276],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7458264,0.01986352,0.00511977,0.0065048626,0.010603205,0.00017007731,0.00028456456,0.0012416991,0.007771759,0.0002538271,0.0046010236,0.19775935],"study_design_scores_gemma":[0.86108595,0.11039193,0.017642085,0.00052177085,0.0043340046,0.00026624376,0.00007459955,0.00050384575,0.0012867065,0.00022906557,0.0036241917,0.000039557603],"about_ca_topic_score_codex":0.0008717573,"about_ca_topic_score_gemma":0.0019449216,"teacher_disagreement_score":0.006612448,"about_ca_system_score_codex":0.0008373616,"about_ca_system_score_gemma":0.0012206754,"threshold_uncertainty_score":0.034970403},"labels":[],"label_agreement":null},{"id":"W1555982523","doi":"10.1111/jdv.13199","title":"Treatment dilemmas in chronic urticaria","year":2015,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Urticaria and Related Conditions","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"Novartis Pharma; Novartis","keywords":"Medicine; Chronic urticaria; Allergy; Clinical immunology; Asthma; Dermatology; Variety (cybernetics); European community; Intensive care medicine; Immunology; Artificial intelligence","score_opus":0.035138819861152824,"score_gpt":0.29472063759619443,"score_spread":0.25958181773504163,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1555982523","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0505644,0.2898136,0.029087974,0.52524275,0.013755027,0.00036538354,0.0001345687,0.000328442,0.090707906],"genre_scores_gemma":[0.6384647,0.13060579,0.035623223,0.14264765,0.042844065,0.0006336996,0.00021856363,0.00019093706,0.008771403],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9970921,0.0014229815,0.00039113336,0.00022763426,0.0005397167,0.00032626698],"domain_scores_gemma":[0.9958877,0.0023317554,0.00051412464,0.000112155634,0.0004979898,0.00065616216],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003119114,0.0007483788,0.00085341727,0.0014388025,0.0044814358,0.0024094412,0.0011101321,0.0059349136,0.0029242518],"category_scores_gemma":[0.015474018,0.00033189094,0.0007589792,0.0008493011,0.0032387653,0.0032784222,0.0025497589,0.0075681037,0.0010289983],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036423127,0.00040360584,0.015588738,0.0027113627,0.00013364645,0.32506484,0.0075398604,0.002618,0.0019612624,0.044924196,0.12738103,0.47130924],"study_design_scores_gemma":[0.00018426824,0.00027445884,0.004780293,0.005083146,0.000079050704,0.6802878,0.008590011,0.0018389666,0.00072106445,0.06712164,0.2309186,0.000120773475],"about_ca_topic_score_codex":0.0009948565,"about_ca_topic_score_gemma":0.0018538957,"teacher_disagreement_score":0.0059349136,"about_ca_system_score_codex":0.001760484,"about_ca_system_score_gemma":0.002037216,"threshold_uncertainty_score":0.016495645},"labels":[],"label_agreement":null},{"id":"W1561358013","doi":"10.1111/j.1468-3083.2011.04409.x","title":"Exploring new concepts in the successful management of psoriasis","year":2012,"lang":"en","type":"editorial","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Psoriasis; Medicine; Disease; Immunology; Pathogenesis; Immune system; Acquired immune system; Systemic inflammation; Inflammation; Dermatology; Intensive care medicine; Pathology","score_opus":0.05146601797081459,"score_gpt":0.28629176813823803,"score_spread":0.23482575016742344,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1561358013","genre_codex":"review","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0027653617,0.70865375,0.007977118,0.23749645,0.013100327,0.00007442763,0.000047774713,0.000093842405,0.02979095],"genre_scores_gemma":[0.058260627,0.80805343,0.019143883,0.0725539,0.03247288,0.0002220112,0.000084975625,0.00007206233,0.009136133],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9967049,0.0016851568,0.00022981942,0.00028409995,0.0008469655,0.0002491618],"domain_scores_gemma":[0.99503016,0.0029226486,0.000339758,0.00020374577,0.000744719,0.000758974],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008072065,0.0006916285,0.0008707133,0.0013670556,0.0013878597,0.0054082926,0.0015593101,0.0042300345,0.008650208],"category_scores_gemma":[0.007855191,0.00024561945,0.0009902607,0.00085768575,0.0074012238,0.009739337,0.003688405,0.0109849945,0.002573021],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022855571,0.0004228918,0.0006391574,0.0038273013,0.00007579972,0.0010694333,0.0020292506,0.00079266436,0.0012861133,0.18978857,0.08835963,0.7114807],"study_design_scores_gemma":[0.000100024765,0.00040959727,0.0005957131,0.0055085258,0.000041256873,0.0015258822,0.0020980663,0.00044152656,0.0004408378,0.15651971,0.83225626,0.00006270138],"about_ca_topic_score_codex":0.0010961692,"about_ca_topic_score_gemma":0.0027152863,"teacher_disagreement_score":0.008650208,"about_ca_system_score_codex":0.0024900935,"about_ca_system_score_gemma":0.0042253737,"threshold_uncertainty_score":0.04268968},"labels":[],"label_agreement":null},{"id":"W1565124901","doi":"10.1111/j.1468-3083.2011.04226.x","title":"Oral prednisone use and risk of keratinocyte carcinoma in non‐transplant population. The VATTC trial","year":2011,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Nonmelanoma Skin Cancer Studies","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Prednisone; Hazard ratio; Internal medicine; Basal cell carcinoma; Veterans Affairs; Proportional hazards model; Confidence interval; Population; Retrospective cohort study; Odds ratio; Gastroenterology; Surgery; Basal cell","score_opus":0.04572885224419065,"score_gpt":0.26852201049973334,"score_spread":0.2227931582555427,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1565124901","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9816783,0.014653602,0.000096660704,0.00037826638,0.00011799251,0.00012511198,0.0014007569,0.00001437561,0.0015349236],"genre_scores_gemma":[0.99598,0.0019679153,0.00007345351,0.00019182457,0.0001198239,0.00009023355,0.0010561718,0.0000040988816,0.00051647425],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99930096,0.0003826967,0.000053210715,0.00010587443,0.000072886105,0.00008432453],"domain_scores_gemma":[0.99859506,0.00035804327,0.00059398025,0.00011009872,0.00006461515,0.00027811909],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016545525,0.000399176,0.00073398126,0.00021248442,0.00028279363,0.0009803744,0.00043483815,0.0006350006,0.0018128633],"category_scores_gemma":[0.00186885,0.00017870562,0.001239659,0.0006107545,0.00031936492,0.00039896712,0.00034205464,0.0011217133,0.00016518762],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5422683,0.001715463,0.381745,0.0028359503,0.011515257,0.00047608028,0.00013588267,0.0018672247,0.0018561928,0.0004557987,0.0063627255,0.0487662],"study_design_scores_gemma":[0.17756766,0.04147824,0.7475681,0.0008434545,0.017149037,0.0012278507,0.00024668884,0.003914763,0.0009945619,0.0011419435,0.0077865655,0.00008107208],"about_ca_topic_score_codex":0.002011214,"about_ca_topic_score_gemma":0.0035811549,"teacher_disagreement_score":0.002011214,"about_ca_system_score_codex":0.0004732968,"about_ca_system_score_gemma":0.0006803446,"threshold_uncertainty_score":0.0087502},"labels":[],"label_agreement":null},{"id":"W1575784630","doi":"10.1111/j.1468-3083.2012.04515.x","title":"Long‐term outcomes of interruption and retreatment vs. continuous therapy with adalimumab for psoriasis: subanalysis of REVEAL and the open‐label extension study","year":2012,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":59,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre de Recherche Dermatologique du Québec Métropolitain; Probity Medical Research","funders":"Abbott Laboratories; Abbott Fund","keywords":"Adalimumab; Medicine; Psoriasis; Adverse effect; Placebo; Randomized controlled trial; Open label; Internal medicine; Surgery; Dermatology","score_opus":0.057498941496831484,"score_gpt":0.31670504011991774,"score_spread":0.25920609862308625,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1575784630","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930414,0.0049153925,0.00029590045,0.0000706867,0.00005459641,0.00022721512,0.0008623155,0.000014086509,0.00051835674],"genre_scores_gemma":[0.99598193,0.0011928874,0.00018125128,0.00014031348,0.00017596099,0.0003049108,0.0013745695,0.000011369745,0.00063677],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99383885,0.0038704528,0.00047594376,0.00053987844,0.0007785296,0.00049645704],"domain_scores_gemma":[0.9842131,0.006598845,0.0045673833,0.0023511478,0.00079034193,0.0014790737],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011208404,0.0012527895,0.003360144,0.0004981226,0.00036838363,0.0015368221,0.000898087,0.0014178642,0.0022962987],"category_scores_gemma":[0.008372255,0.00056612684,0.0065360535,0.0006754665,0.0008614501,0.001015733,0.0010091369,0.00238306,0.0004186019],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.95021456,0.0024773327,0.02081032,0.00060530804,0.01069339,0.00004910662,0.00016338135,0.00038699686,0.0013314174,0.00006178542,0.00037548586,0.012830849],"study_design_scores_gemma":[0.22190924,0.29217863,0.45005503,0.0003656847,0.028083399,0.00034735407,0.00036010044,0.0017522676,0.0016290393,0.00032026562,0.0028632986,0.00013560304],"about_ca_topic_score_codex":0.00083343603,"about_ca_topic_score_gemma":0.0012490983,"teacher_disagreement_score":0.011208404,"about_ca_system_score_codex":0.00084769906,"about_ca_system_score_gemma":0.00088651717,"threshold_uncertainty_score":0.059276402},"labels":[],"label_agreement":null},{"id":"W1590700846","doi":"10.1111/j.1468-3083.2007.02424.x","title":"Scalp psoriasis: a review of current topical treatment options","year":2007,"lang":"en","type":"review","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Nail Diseases and Treatments","field":"Medicine","cited_by":90,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research","funders":"LEO Pharma","keywords":"Scalp; Medicine; Psoriasis; Dermatology; Disease; Dithranol; Pathology","score_opus":0.11425145155830968,"score_gpt":0.427176742084144,"score_spread":0.31292529052583434,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1590700846","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00014809152,0.9985708,0.000100722435,0.00012861531,0.00012143885,0.000006868762,0.000020806292,0.000008803145,0.0008938994],"genre_scores_gemma":[0.00053944776,0.9987085,0.00023573832,0.000094148905,0.00013994513,0.0000060033863,0.000027291919,0.0000012521747,0.00024776373],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997129,0.00005072413,0.000057078338,0.000047084664,0.00011360794,0.000018596604],"domain_scores_gemma":[0.9995105,0.00026923773,0.00008042881,0.000012611681,0.00008758434,0.00003963723],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004914723,0.0010685073,0.0018141847,0.0045432984,0.00043007673,0.001023332,0.0010786277,0.00086001557,0.0064101685],"category_scores_gemma":[0.00086739525,0.0003568735,0.0006222996,0.004135048,0.00042492268,0.0014512886,0.0005368607,0.0013423043,0.0024589885],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000065978435,0.00010365174,0.00021248535,0.020872977,0.00007925979,0.0006253534,0.00007980551,0.00029463499,0.0008386957,0.0008991351,0.026891598,0.9490364],"study_design_scores_gemma":[0.000040399056,0.00015922158,0.0019577746,0.01557758,0.0002796956,0.009875212,0.00019501187,0.00015109139,0.0005003853,0.0017020312,0.9695253,0.000036432404],"about_ca_topic_score_codex":0.0012909824,"about_ca_topic_score_gemma":0.0025150317,"teacher_disagreement_score":0.0064101685,"about_ca_system_score_codex":0.0004832731,"about_ca_system_score_gemma":0.00082906015,"threshold_uncertainty_score":0.021444201},"labels":[],"label_agreement":null},{"id":"W1597178328","doi":"10.1111/jdv.12066","title":"Evaluation of risk factors for body weight increment in psoriatic patients on infliximab: a multicentre, cross‐sectional study","year":2012,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ste. Anne's Hospital","funders":"","keywords":"Medicine; Psoriasis; Infliximab; Weight gain; Internal medicine; Body mass index; Weight change; Weight loss; Methotrexate; Psoriatic arthritis; Risk factor; Cross-sectional study; Gastroenterology; Surgery; Body weight; Obesity; Disease; Dermatology","score_opus":0.03690896554661592,"score_gpt":0.3025646443894252,"score_spread":0.2656556788428093,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1597178328","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9994492,0.00021776784,0.000064764725,0.000013474546,0.000003391384,0.000015247809,0.000105981475,0.0000019221663,0.00012830927],"genre_scores_gemma":[0.9993869,0.00011132751,0.00013534035,0.000033827764,0.000013848994,0.00001752653,0.00023749459,0.0000010893866,0.00006268787],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992398,0.00032102744,0.00007588269,0.00015598907,0.00013144255,0.0000759438],"domain_scores_gemma":[0.99827063,0.00035877142,0.0007068945,0.00014235504,0.00019232681,0.00032904794],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014868475,0.00040318124,0.00054132723,0.0008452455,0.0004563509,0.0005550867,0.00027974517,0.00064315303,0.0011366344],"category_scores_gemma":[0.0020693236,0.0004206161,0.00051492325,0.0009315689,0.00027074516,0.0004741609,0.0003250219,0.0004816263,0.00028706118],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002012429,0.00007827418,0.99866664,0.000009520879,0.000059870377,0.000065806125,0.00006412559,0.000014238264,0.00016054646,0.0000030390304,0.000034384073,0.0006422143],"study_design_scores_gemma":[0.000024694298,0.0004346972,0.9988992,0.0000036963088,0.000033780027,0.00036645427,0.00007400716,0.000057890844,0.000026629215,0.000002824765,0.00007338607,0.000002690443],"about_ca_topic_score_codex":0.0020492696,"about_ca_topic_score_gemma":0.0019872284,"teacher_disagreement_score":0.0020492696,"about_ca_system_score_codex":0.0002423294,"about_ca_system_score_gemma":0.00023082606,"threshold_uncertainty_score":0.007863343},"labels":[],"label_agreement":null},{"id":"W1608594180","doi":"10.1111/j.1468-3083.2011.04225.x","title":"Efficacy and safety of adalimumab when added to inadequate therapy for the treatment of psoriasis: results of PRIDE, an open‐label, multicentre, phase IIIb study","year":2011,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Lynde Centre for Dermatology; University of British Columbia; Abbott (Canada); Probity Medical Research","funders":"Abbott Laboratories","keywords":"Medicine; Adalimumab; Psoriasis; Psoriasis Area and Severity Index; Adverse effect; Internal medicine; Plaque psoriasis; Dermatology","score_opus":0.08825053625924434,"score_gpt":0.3294644849332314,"score_spread":0.24121394867398704,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1608594180","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99301517,0.0034822486,0.0004719498,0.00024604678,0.00009502545,0.0010589276,0.00073575747,0.000050904124,0.0008439432],"genre_scores_gemma":[0.9914357,0.0022549897,0.0014210701,0.00073078676,0.00023258897,0.0010289387,0.0017933814,0.00003566245,0.0010668201],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99815637,0.0009861778,0.0000970677,0.00019141371,0.00037132326,0.00019754749],"domain_scores_gemma":[0.99712306,0.00067856297,0.00067006284,0.00028502478,0.00033994997,0.0009033082],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00667072,0.0012960747,0.0024435648,0.00039639356,0.00061870157,0.0012084696,0.0009963628,0.00151964,0.0016971923],"category_scores_gemma":[0.0028378803,0.00063268177,0.0020044777,0.00045677004,0.0009613805,0.0007607355,0.00031798682,0.0038385342,0.00055329787],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8068007,0.07557488,0.010146179,0.00082983315,0.002834002,0.00015257852,0.00031017608,0.001037434,0.023080703,0.00007989874,0.0029016305,0.07625193],"study_design_scores_gemma":[0.5049669,0.45677617,0.031199291,0.00006150643,0.0010980682,0.00024579075,0.00004888643,0.0009023632,0.0028656132,0.000056856003,0.001740255,0.000038368544],"about_ca_topic_score_codex":0.002552347,"about_ca_topic_score_gemma":0.0038086257,"teacher_disagreement_score":0.00667072,"about_ca_system_score_codex":0.0013591503,"about_ca_system_score_gemma":0.0020240683,"threshold_uncertainty_score":0.0352785},"labels":[],"label_agreement":null},{"id":"W1654452971","doi":"10.1111/j.1468-3083.2011.04305.x","title":"Cost‐effectiveness evaluation of clobetasol propionate shampoo (CPS) maintenance in patients with moderate scalp psoriasis: a Pan‐European analysis","year":2011,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lynde Centre for Dermatology; Centre de Recherche Dermatologique du Québec Métropolitain; Probity Medical Research","funders":"","keywords":"Medicine; Psoriasis; Scalp; Clobetasol propionate; Population; Dermatology; Surgery; Physical therapy; Environmental health","score_opus":0.043413423672481556,"score_gpt":0.26313708424653115,"score_spread":0.2197236605740496,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1654452971","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9753669,0.0060738744,0.01302006,0.00072539353,0.00004877417,0.00027055255,0.0018821872,0.000051039096,0.0025612556],"genre_scores_gemma":[0.99646336,0.00076162757,0.0018212862,0.00006802582,0.000009477342,0.00008252859,0.00056011544,0.000008512904,0.0002249429],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.9979335,0.001591661,0.0000778534,0.00014112522,0.000100189354,0.00015573375],"domain_scores_gemma":[0.9914329,0.007224878,0.0006246433,0.00014168244,0.00032653022,0.00024933578],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005537039,0.0010331549,0.001715801,0.0010941223,0.0002501803,0.00094269146,0.0010170382,0.0012036964,0.0029515785],"category_scores_gemma":[0.00782414,0.0005846229,0.0056958064,0.0012187092,0.00038577884,0.0006589288,0.0006561583,0.0008411967,0.000112325644],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031080553,0.0004445728,0.013433639,0.0004097872,0.0021236138,0.0001676431,0.000022492863,0.9726723,0.00021403225,0.0008236269,0.00043076221,0.006149424],"study_design_scores_gemma":[0.0011101314,0.002992602,0.011906111,0.00015935327,0.002789412,0.0002194127,0.00010732389,0.9784113,0.00035396643,0.0012819405,0.0006273953,0.00004098416],"about_ca_topic_score_codex":0.017111627,"about_ca_topic_score_gemma":0.005167716,"teacher_disagreement_score":0.017111627,"about_ca_system_score_codex":0.0028080961,"about_ca_system_score_gemma":0.0017142793,"threshold_uncertainty_score":0.03402406},"labels":[],"label_agreement":null},{"id":"W1693800702","doi":"10.1111/j.1468-3083.2011.04374.x","title":"European Evidence‐based (S3) Guidelines for the Treatment of Acne","year":2012,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Acne and Rosacea Treatments and Effects","field":"Medicine","cited_by":422,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"","keywords":"Medicine; Acne; Dermatology; MEDLINE; Family medicine","score_opus":0.17655058195789403,"score_gpt":0.3958956970660321,"score_spread":0.2193451151081381,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1693800702","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0019402966,0.6118854,0.038320944,0.09220511,0.027396305,0.0122214025,0.049956795,0.0026179284,0.16345578],"genre_scores_gemma":[0.018454403,0.5436097,0.17430733,0.055787906,0.0049141864,0.015498118,0.11086704,0.0009865259,0.07557485],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98665863,0.0041987966,0.0037975316,0.0004990533,0.0042042183,0.0006417735],"domain_scores_gemma":[0.96759987,0.011342245,0.0037879788,0.0009207967,0.015339261,0.0010097534],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.012555427,0.0014663363,0.002925146,0.011624526,0.00096871954,0.0031517565,0.0052728034,0.0076605664,0.05172058],"category_scores_gemma":[0.040872186,0.00087657705,0.004911487,0.007917446,0.0010444949,0.0019170638,0.0022222416,0.005296463,0.02253642],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002443026,0.00022647064,0.00040375377,0.035718266,0.00032806137,0.0004058012,0.00023359877,0.0006776877,0.00083159574,0.0065844744,0.6877086,0.2666374],"study_design_scores_gemma":[0.00026719488,0.00008081828,0.00159512,0.054307908,0.00033933416,0.00048386317,0.000094047435,0.00023462012,0.00027114153,0.0039449716,0.93833786,0.000043143922],"about_ca_topic_score_codex":0.011015108,"about_ca_topic_score_gemma":0.015186717,"teacher_disagreement_score":0.05172058,"about_ca_system_score_codex":0.0041042715,"about_ca_system_score_gemma":0.016196556,"threshold_uncertainty_score":0.17302257},"labels":[],"label_agreement":null},{"id":"W1842567347","doi":"10.1111/jdv.13180","title":"Evidence‐ and consensus‐based (S3) Guidelines for the Treatment of Actinic Keratosis – International League of Dermatological Societies in cooperation with the European Dermatology Forum – Short version","year":2015,"lang":"en","type":"review","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Nonmelanoma Skin Cancer Studies","field":"Medicine","cited_by":299,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mediprobe Research (Canada); University of Toronto","funders":"","keywords":"Medicine; Systematic review; Actinic keratosis; Guideline; Grading (engineering); Psychological intervention; Evidence-based medicine; MEDLINE; Evidence-based practice; Alternative medicine; Dermatology; Family medicine; Medical physics; Pathology; Nursing","score_opus":0.21153437611990286,"score_gpt":0.41418633935475274,"score_spread":0.20265196323484988,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1842567347","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00332031,0.5002353,0.08507102,0.18527363,0.054912932,0.058454067,0.053864025,0.003312179,0.055556536],"genre_scores_gemma":[0.025180766,0.30534515,0.43837503,0.032540977,0.0068290276,0.08301285,0.08466188,0.0009103902,0.023144012],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9211338,0.031178918,0.029158449,0.0023299668,0.014550779,0.001648155],"domain_scores_gemma":[0.84472454,0.051385216,0.0281844,0.0046288804,0.06744277,0.0036341243],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.062989324,0.0027789315,0.0068833996,0.018408604,0.0021653057,0.007912781,0.0111591,0.013730602,0.020335957],"category_scores_gemma":[0.17492002,0.0022647488,0.013403458,0.012997396,0.0023430712,0.004359504,0.005838358,0.0095784245,0.012100756],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00057597394,0.00027870893,0.0010587121,0.20474151,0.0020868373,0.0005000182,0.001060527,0.0017599264,0.0012603779,0.009662515,0.52438885,0.25262606],"study_design_scores_gemma":[0.00097105367,0.00017859753,0.0030379726,0.3672497,0.004092146,0.00057425856,0.00045001224,0.001309982,0.00091376074,0.010218099,0.61081994,0.00018446676],"about_ca_topic_score_codex":0.011690789,"about_ca_topic_score_gemma":0.013545503,"teacher_disagreement_score":0.062989324,"about_ca_system_score_codex":0.009984202,"about_ca_system_score_gemma":0.05019407,"threshold_uncertainty_score":0.3331234},"labels":[],"label_agreement":null},{"id":"W1892481070","doi":"10.1111/j.1468-3083.2010.03804.x","title":"Resurgence of bedbugs in southern France: a local problem or the tip of the iceberg?","year":2010,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Dermatological diseases and infestations","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Iceberg; Medicine; Oceanography; Geology","score_opus":0.015278828781239559,"score_gpt":0.2786790289018549,"score_spread":0.2634002001206154,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1892481070","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99378806,0.0017630227,0.0001421384,0.0028570748,0.000030693765,0.000009290241,0.0000540528,0.000014815213,0.0013408341],"genre_scores_gemma":[0.99799865,0.0007263644,0.00015498395,0.0004724502,0.000058709993,0.000005003482,0.00006723461,0.0000021217418,0.00051458005],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994842,0.00017851031,0.00002220905,0.00007460887,0.00007285033,0.00016776673],"domain_scores_gemma":[0.99903226,0.00014858558,0.0004380049,0.00002616236,0.00016652352,0.00018852427],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010185199,0.00031141227,0.00026566887,0.00071744533,0.0012057774,0.000835265,0.00045775028,0.0011934424,0.0027281607],"category_scores_gemma":[0.0012413232,0.000114901704,0.00020683286,0.00058135315,0.0010982298,0.000667889,0.00045688672,0.00031586937,0.00023927813],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015177048,0.00010588912,0.936783,0.000262448,0.000044431643,0.0073847165,0.01396205,0.00021380157,0.003100631,0.00032610734,0.0027721848,0.03489293],"study_design_scores_gemma":[0.0000087007575,0.00034583753,0.96134686,0.00012106394,0.000018336601,0.0055901115,0.022980047,0.00017010751,0.00019869118,0.00010014305,0.009100272,0.000019806732],"about_ca_topic_score_codex":0.08147011,"about_ca_topic_score_gemma":0.11331914,"teacher_disagreement_score":0.08147011,"about_ca_system_score_codex":0.0017014593,"about_ca_system_score_gemma":0.0010908492,"threshold_uncertainty_score":0.16199178},"labels":[],"label_agreement":null},{"id":"W1922614056","doi":"10.1111/j.1468-3083.2012.04638.x","title":"Phospholipase activity after β‐endorphin exposure discriminates <i>Malassezia</i> strains isolated from healthy and seborrhoeic dermatitis skin","year":2012,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Nail Diseases and Treatments","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health","funders":"","keywords":"Malassezia; Seborrhoeic dermatitis; Medicine; Phospholipase; Atopic dermatitis; Microbiology; Enzyme; Dermatology; Biology; Biochemistry","score_opus":0.013124488588326462,"score_gpt":0.26444011579187376,"score_spread":0.2513156272035473,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1922614056","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99966884,0.00009882257,0.0000640311,0.000005052928,0.000001290834,0.0000051099555,0.00006320827,0.0000019595102,0.00009158404],"genre_scores_gemma":[0.9993942,0.00008670118,0.00016439943,0.000008962172,0.0000028648342,0.0000069303114,0.00018664783,0.0000017236273,0.0001474983],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998273,0.00002760968,0.000022763534,0.000054089407,0.000031934458,0.000036240257],"domain_scores_gemma":[0.9997081,0.000049521706,0.00013076929,0.000019825437,0.000041084273,0.000050656836],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015620397,0.00028460016,0.00021927369,0.00033710815,0.00012747856,0.0002871214,0.00008417822,0.00021131137,0.001292418],"category_scores_gemma":[0.0003945946,0.00011826332,0.00017710244,0.00025679922,0.00019983388,0.00018753117,0.00023885079,0.00022840059,0.00019153154],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018385114,0.00016004339,0.30993122,0.000099363155,0.000046143337,0.0002669665,0.00023367463,0.000032576678,0.68121606,0.0000152566645,0.000045711517,0.0061145476],"study_design_scores_gemma":[0.000009542593,0.0014158566,0.9566108,0.000004947512,0.000030392743,0.0010573281,0.00021554201,0.000074951655,0.040393144,0.000010202084,0.00017358577,0.0000037601162],"about_ca_topic_score_codex":0.00045681422,"about_ca_topic_score_gemma":0.0004279177,"teacher_disagreement_score":0.001292418,"about_ca_system_score_codex":0.00010538936,"about_ca_system_score_gemma":0.000054298995,"threshold_uncertainty_score":0.004323542},"labels":[],"label_agreement":null},{"id":"W1924457352","doi":"10.1111/j.1468-3083.2012.04705.x","title":"Safety results from a pooled analysis of randomized, controlled phase II and III clinical trials and interim data from an open‐label extension trial of the interleukin‐12/23 monoclonal antibody, briakinumab, in moderate to severe psoriasis","year":2012,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":69,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; Dalhousie University","funders":"","keywords":"Medicine; Mace; Adverse effect; Internal medicine; Interim analysis; Clinical trial; Incidence (geometry); Population; Surgery; Myocardial infarction","score_opus":0.12957312501059454,"score_gpt":0.414242384369461,"score_spread":0.28466925935886644,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1924457352","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7020846,0.23066239,0.031138793,0.0010361555,0.0014427527,0.009527864,0.017395925,0.0010335204,0.0056780726],"genre_scores_gemma":[0.97192615,0.010176337,0.005083689,0.00072726654,0.0005013724,0.0036868784,0.007207799,0.00012624667,0.0005643051],"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","domain_scores_codex":[0.93553233,0.04508773,0.008623056,0.0052161464,0.0047058156,0.00083498773],"domain_scores_gemma":[0.9204361,0.04346647,0.022435876,0.0076382905,0.0048577636,0.0011654841],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.08219039,0.0032367278,0.00923821,0.002962488,0.0005283298,0.0027103247,0.0012266051,0.00209176,0.0035471593],"category_scores_gemma":[0.07569802,0.0013906963,0.027121719,0.0023221956,0.0012769009,0.0020683312,0.0013880691,0.0022691728,0.00048572524],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.471785,0.00076585886,0.023078563,0.010421152,0.45363352,0.00013007555,0.00014290228,0.0028770326,0.0022079537,0.00018563167,0.0018897591,0.03288256],"study_design_scores_gemma":[0.20420425,0.043092404,0.08649094,0.0012303686,0.65300196,0.00052922266,0.00012643074,0.003413658,0.0025042817,0.0012613551,0.0039458117,0.00019927524],"about_ca_topic_score_codex":0.00030302108,"about_ca_topic_score_gemma":0.00046505392,"teacher_disagreement_score":0.08219039,"about_ca_system_score_codex":0.0009002202,"about_ca_system_score_gemma":0.0013628263,"threshold_uncertainty_score":0.4346695},"labels":[],"label_agreement":null},{"id":"W1925087877","doi":"10.1111/j.1468-3083.2011.04332.x","title":"Efficacy and safety of topical WBI‐1001 in patients with mild to moderate psoriasis: results from a randomized double‐blind placebo‐controlled, phase II trial","year":2011,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":71,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Welichem Biotech (Canada); Innovaderm (Canada)","funders":"","keywords":"Medicine; Psoriasis; Placebo; Randomized controlled trial; Adverse effect; Psoriasis Area and Severity Index; Body surface area; Clinical endpoint; Internal medicine; Dermatology; Pathology","score_opus":0.03312076175434684,"score_gpt":0.264419496675059,"score_spread":0.23129873492071215,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1925087877","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97176796,0.017168727,0.001104891,0.0010439574,0.0005236575,0.0046817414,0.0010846732,0.0001990055,0.0024253856],"genre_scores_gemma":[0.9753338,0.0094951,0.002137338,0.0020197756,0.0006261324,0.006408664,0.0012430797,0.000039046787,0.0026970538],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99928916,0.00039686073,0.000054299424,0.00010733265,0.00007575238,0.00007658615],"domain_scores_gemma":[0.9988556,0.00038426212,0.00030622422,0.000073116025,0.0000716887,0.00030906659],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022813233,0.0012482799,0.0030835879,0.0003498908,0.00042493545,0.0009470017,0.00079462054,0.0017709706,0.0060994145],"category_scores_gemma":[0.0019354728,0.0005763873,0.0013889378,0.00042040966,0.0009768272,0.0007005933,0.0002549245,0.002208271,0.0009240003],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9504148,0.008845711,0.00083239854,0.0015110073,0.001120331,0.000047383724,0.00005535446,0.0001856824,0.00699802,0.00007236982,0.0009960863,0.028920967],"study_design_scores_gemma":[0.9545558,0.042476982,0.0018072767,0.00004554293,0.00028167773,0.000034132758,0.000009156033,0.00012366068,0.00024823882,0.000048292382,0.00036043953,0.00000876814],"about_ca_topic_score_codex":0.0003926507,"about_ca_topic_score_gemma":0.0009122764,"teacher_disagreement_score":0.0060994145,"about_ca_system_score_codex":0.00042571776,"about_ca_system_score_gemma":0.0008803445,"threshold_uncertainty_score":0.020404518},"labels":[],"label_agreement":null},{"id":"W1931293371","doi":"10.1111/j.1468-3083.2011.03984.x","title":"Treatment of palmoplantar psoriasis with infliximab: a randomized, double‐blind placebo‐controlled study","year":2011,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":67,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lynde Centre for Dermatology; Guenther Dermatology Research Centre; Centre de Recherche Dermatologique du Québec Métropolitain; Innovaderm (Canada)","funders":"","keywords":"Medicine; Infliximab; Psoriasis; Placebo; Randomized controlled trial; Internal medicine; Clinical endpoint; Psoriasis Area and Severity Index; Surgery; Gastroenterology; Dermatology; Pathology; Tumor necrosis factor alpha","score_opus":0.03670318478321744,"score_gpt":0.2581723549905103,"score_spread":0.22146917020729284,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1931293371","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9655926,0.012776946,0.0015322103,0.0011401329,0.001654193,0.013295029,0.0013493767,0.00026318483,0.0023963265],"genre_scores_gemma":[0.95981026,0.0099707665,0.0038585085,0.0025290533,0.0020242047,0.016723493,0.001223123,0.00004299591,0.0038176314],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.998317,0.0009114617,0.0001608143,0.00024459357,0.00019877867,0.00016744525],"domain_scores_gemma":[0.9981622,0.0006159173,0.0004565556,0.00017717454,0.00018123692,0.00040686593],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0033971372,0.0017632507,0.0052440525,0.0007337634,0.0006612785,0.0014335363,0.0013535408,0.0032705772,0.009187619],"category_scores_gemma":[0.0031143776,0.0009843482,0.0021108696,0.0006977282,0.0017273278,0.0011793729,0.0004587382,0.002483961,0.0012568742],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9772126,0.009745488,0.00029290424,0.0011961564,0.0008962177,0.000036955604,0.000036818165,0.0000883296,0.0019326437,0.000051730603,0.00037006603,0.008140113],"study_design_scores_gemma":[0.98042196,0.018528342,0.00044653154,0.00002146487,0.00022383554,0.000011981435,0.0000056922045,0.000062622225,0.000084306805,0.000019067615,0.00016952501,0.0000046426576],"about_ca_topic_score_codex":0.00062950683,"about_ca_topic_score_gemma":0.0011452716,"teacher_disagreement_score":0.009187619,"about_ca_system_score_codex":0.00056678464,"about_ca_system_score_gemma":0.0012392104,"threshold_uncertainty_score":0.030735612},"labels":[],"label_agreement":null},{"id":"W1941648032","doi":"10.1111/j.1468-3083.2010.03852.x","title":"Expert Opinion: Efficacy of superficial chemical peels in active acne management – what can we learn from the literature today? Evidence‐based recommendations","year":2010,"lang":"en","type":"review","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Acne and Rosacea Treatments and Effects","field":"Medicine","cited_by":79,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Acne; Medicine; Acne treatment; Dermatology; Clinical trial; Randomized controlled trial; Concomitant; Surgery; Pathology","score_opus":0.06711342368617096,"score_gpt":0.36845234886596906,"score_spread":0.3013389251797981,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1941648032","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00054547365,0.63114935,0.0016158152,0.32685086,0.029451171,0.00044571795,0.0012956859,0.00009840025,0.008547527],"genre_scores_gemma":[0.012062743,0.7481081,0.008774703,0.19760844,0.02719495,0.0008453717,0.0015176634,0.00007891149,0.0038091028],"study_design_codex":"not_applicable","study_design_gemma":"systematic_review","domain_scores_codex":[0.9868961,0.0047271857,0.0038247777,0.00083500316,0.0031328541,0.00058402406],"domain_scores_gemma":[0.87495404,0.07355636,0.0102332,0.0013974572,0.03721896,0.002639957],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.020653138,0.0012514073,0.006110531,0.0032293978,0.001253082,0.004647154,0.0064214244,0.014727796,0.017563572],"category_scores_gemma":[0.11598259,0.00083500915,0.0049764034,0.0026729258,0.0019542146,0.007254655,0.002030271,0.009295884,0.008488654],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041394006,0.00008511666,0.00051746704,0.10583537,0.0011737352,0.00037637804,0.0002215969,0.00044740413,0.00036443546,0.002748176,0.48344755,0.40436894],"study_design_scores_gemma":[0.00046965329,0.00015391211,0.0011720422,0.2970233,0.002501776,0.00063118554,0.00051351567,0.00037379478,0.00025342611,0.012719317,0.6840598,0.00012833558],"about_ca_topic_score_codex":0.0036487284,"about_ca_topic_score_gemma":0.0048808805,"teacher_disagreement_score":0.020653138,"about_ca_system_score_codex":0.0034433817,"about_ca_system_score_gemma":0.008563604,"threshold_uncertainty_score":0.10922557},"labels":[],"label_agreement":null},{"id":"W1942178163","doi":"10.1111/j.1468-3083.2011.04351.x","title":"Antibiotic‐resistant <i>Propionibacterium acnes</i> among acne patients in a regional skin centre in Hong Kong","year":2011,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Acne and Rosacea Treatments and Effects","field":"Medicine","cited_by":72,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Guenther Dermatology Research Centre","funders":"Chinese University of Hong Kong; University of Hong Kong","keywords":"Propionibacterium acnes; Minocycline; Clindamycin; Erythromycin; Antibiotics; Tetracycline; Medicine; Doxycycline; Microbiology; Antibiotic resistance; Minimum inhibitory concentration; Acne; Biology; Dermatology","score_opus":0.015587904439886193,"score_gpt":0.22760691869097135,"score_spread":0.21201901425108516,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1942178163","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9996074,0.00009680591,0.000020887965,0.000022492308,0.0000026362047,0.000011761318,0.000049662183,0.0000016977041,0.00018668389],"genre_scores_gemma":[0.99967825,0.000091301314,0.000031068477,0.000033948818,0.0000047835133,0.0000043942987,0.000047452857,8.590192e-7,0.000108016255],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999622,0.000071619565,0.00005166515,0.00009570495,0.00004648877,0.000112415146],"domain_scores_gemma":[0.99904674,0.00013761764,0.0003468862,0.000048188245,0.00011963409,0.00030080654],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003279718,0.00040414985,0.0003217815,0.00048036227,0.00075032114,0.0006030279,0.00036430135,0.00028017812,0.0018632412],"category_scores_gemma":[0.00067585247,0.00037872,0.00026795093,0.00056220463,0.0007467385,0.0003824038,0.00046740848,0.00035212343,0.00024904963],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000062809486,0.000045366087,0.9946226,0.000058390033,0.000017268558,0.0024050497,0.00056954153,0.000028741744,0.00083542924,0.0000083162995,0.0001319105,0.0012146953],"study_design_scores_gemma":[0.000008068304,0.00020168627,0.99431,0.000022710532,0.000016917013,0.0031433145,0.0018729053,0.000057466328,0.00015524821,0.00000431113,0.00020089767,0.000006342561],"about_ca_topic_score_codex":0.04625399,"about_ca_topic_score_gemma":0.030771758,"teacher_disagreement_score":0.04625399,"about_ca_system_score_codex":0.0011955496,"about_ca_system_score_gemma":0.0010392235,"threshold_uncertainty_score":0.09196949},"labels":[],"label_agreement":null},{"id":"W1958642174","doi":"10.1111/j.1468-3083.2011.04349.x","title":"Recommendations for the treatment of nail psoriasis in patients with moderate to severe psoriasis: a dermatology expert group consensus","year":2011,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Dalhousie University","funders":"","keywords":"Medicine; Psoriasis; Nail (fastener); Dermatology; Acitretin; Onycholysis; Nail disease; Delphi method; Clinical Practice; Disease; Severity of illness; Physical therapy; Internal medicine","score_opus":0.03883756735476328,"score_gpt":0.25454460723101613,"score_spread":0.21570703987625284,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1958642174","genre_codex":"commentary","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0072130812,0.048151135,0.030276436,0.8439307,0.01855566,0.0064470116,0.0014015445,0.0004550344,0.04356949],"genre_scores_gemma":[0.13248189,0.1376249,0.43304375,0.23601985,0.009519509,0.014396097,0.008547091,0.0003914614,0.027975487],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9440984,0.03043149,0.011804578,0.0013133652,0.010226329,0.0021259054],"domain_scores_gemma":[0.8906577,0.02825753,0.0076002087,0.0022966964,0.062191267,0.008996639],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.06105121,0.0011281961,0.0016497234,0.0038694039,0.0026730644,0.0036464997,0.0052834437,0.010637676,0.0069541507],"category_scores_gemma":[0.09194434,0.0009412868,0.0037258554,0.002392697,0.0015280342,0.0034798477,0.0048831827,0.009034493,0.004770726],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001210631,0.00038254214,0.0038311377,0.007927298,0.00019733881,0.0010963383,0.003551125,0.000953154,0.0012073847,0.0047228737,0.6929664,0.28304332],"study_design_scores_gemma":[0.0004609795,0.0002671777,0.009575468,0.05729954,0.0005091937,0.002633151,0.007816383,0.001660527,0.0007144531,0.019068062,0.89975476,0.00024029108],"about_ca_topic_score_codex":0.006230683,"about_ca_topic_score_gemma":0.00985047,"teacher_disagreement_score":0.06105121,"about_ca_system_score_codex":0.0050904974,"about_ca_system_score_gemma":0.033511117,"threshold_uncertainty_score":0.32287347},"labels":[],"label_agreement":null},{"id":"W1960538084","doi":"10.1111/j.1468-3083.2011.04373.x","title":"Efficacy, safety and tolerability of topical terbinafine nail solution in patients with mild‐to‐moderate toenail onychomycosis: results from three randomized studies using double‐blind vehicle‐controlled and open‐label active‐controlled designs","year":2011,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Nail Diseases and Treatments","field":"Medicine","cited_by":72,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Novartis Pharma; Novartis","keywords":"Medicine; Tolerability; Double blind; Terbinafine; Open label; Dermatology; Nail (fastener); Randomized controlled trial; Nail disease; Adverse effect; Surgery; Pharmacology; Placebo; Antifungal","score_opus":0.1166435695795924,"score_gpt":0.33586545337156914,"score_spread":0.21922188379197674,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1960538084","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9924447,0.004797876,0.00064713287,0.00012618906,0.000084090985,0.0013283218,0.0001921936,0.00003502971,0.00034450286],"genre_scores_gemma":[0.99584526,0.001592039,0.0008701453,0.00015525884,0.000118895514,0.00096692855,0.00018444231,0.000007544852,0.00025949633],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9968252,0.001958921,0.00042318483,0.0002870113,0.00029175606,0.00021393303],"domain_scores_gemma":[0.99611086,0.0018111828,0.0010953149,0.0002831381,0.00026706717,0.00043251415],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005286813,0.001110432,0.0033720087,0.00047699033,0.00042724045,0.00088825973,0.00085501425,0.0015619991,0.0030598685],"category_scores_gemma":[0.0037471168,0.0005904321,0.00257012,0.0005297326,0.0013497826,0.0010209087,0.00035434007,0.0013620004,0.00036272165],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9232314,0.017784756,0.001938154,0.0016940151,0.0024736892,0.000052569325,0.00014401872,0.00037309722,0.013928011,0.000071022725,0.0001909549,0.038118277],"study_design_scores_gemma":[0.62774575,0.3600525,0.007450205,0.00005669976,0.0018876387,0.00006412828,0.000049595437,0.0003086042,0.0019222136,0.00007659166,0.00035429158,0.00003174308],"about_ca_topic_score_codex":0.0005424949,"about_ca_topic_score_gemma":0.0012836728,"teacher_disagreement_score":0.005286813,"about_ca_system_score_codex":0.0007658971,"about_ca_system_score_gemma":0.0009954543,"threshold_uncertainty_score":0.027959645},"labels":[],"label_agreement":null},{"id":"W1966163121","doi":"10.1111/jdv.12943","title":"Etanercept for patients with psoriasis who did not respond or who lost their response to adalimumab or infliximab","year":2015,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dermatrials Research; Lynde Centre for Dermatology; Merck Canada Inc. (Canada); Innovaderm (Canada)","funders":"Janssen Biotech; LEO Pharma; AbbVie; Celgene; Novartis; Pfizer; Amgen","keywords":"Adalimumab; Medicine; Infliximab; Etanercept; Psoriasis; Internal medicine; Tumor necrosis factor alpha; Gastroenterology; Surgery; Dermatology","score_opus":0.03392926498281086,"score_gpt":0.26605132690787525,"score_spread":0.2321220619250644,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1966163121","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.980644,0.014937469,0.00042307994,0.00045684678,0.00010102243,0.00022500334,0.00022351822,0.000021499236,0.002967619],"genre_scores_gemma":[0.995911,0.0020483718,0.00031614082,0.0005822605,0.00008834075,0.00012139523,0.00019068923,0.00000280086,0.0007390898],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995491,0.00018096938,0.000064292406,0.000058662965,0.00007110286,0.0000757997],"domain_scores_gemma":[0.9992847,0.000253048,0.00023356515,0.0000299597,0.000052611205,0.00014609472],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00093832205,0.0001950821,0.0007315344,0.00032070468,0.0003755297,0.00046172075,0.00018087385,0.00036378027,0.0017984847],"category_scores_gemma":[0.0011243209,0.00011498621,0.00067948696,0.000398394,0.00017304363,0.0002576033,0.0001828768,0.00048063227,0.00025880194],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.041160263,0.0017410018,0.7158932,0.0019013344,0.0015100719,0.0077761463,0.0005425768,0.0005745282,0.009419768,0.00036221807,0.003907276,0.21521167],"study_design_scores_gemma":[0.0147818215,0.02932649,0.86833286,0.00080274726,0.001731846,0.049989834,0.0005387136,0.0021834848,0.0036638067,0.00064545684,0.02794214,0.00006082845],"about_ca_topic_score_codex":0.00026428798,"about_ca_topic_score_gemma":0.00062075706,"teacher_disagreement_score":0.0017984847,"about_ca_system_score_codex":0.00025873582,"about_ca_system_score_gemma":0.00038227826,"threshold_uncertainty_score":0.006016493},"labels":[],"label_agreement":null},{"id":"W1966230877","doi":"10.1111/j.1468-3083.2009.03255.x","title":"Alexithymia in patients with alopecia areata: educational background much more important than traumatic events","year":2009,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Psychosomatic Disorders and Their Treatments","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Alexithymia; Toronto Alexithymia Scale; Medicine; Dysfunctional family; Clinical psychology; Alopecia areata; Population; Psychiatry; Dermatology","score_opus":0.015735323988733126,"score_gpt":0.2785568901401588,"score_spread":0.26282156615142566,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1966230877","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9989435,0.00034673177,0.000028703436,0.000039468054,0.000005749777,0.0000058169985,0.000033077584,0.0000018481473,0.00059521745],"genre_scores_gemma":[0.9997824,0.00010226815,0.000019223957,0.0000137198485,0.000007280353,0.000001978206,0.000031385014,2.8400922e-7,0.000041438612],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998078,0.000040823434,0.000024188514,0.00003302444,0.000049280185,0.0000450219],"domain_scores_gemma":[0.9992493,0.00013492943,0.0004145131,0.000016281148,0.000042709624,0.0001421283],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001618937,0.00021793037,0.00028792376,0.00057674974,0.00044245948,0.00037541424,0.00011287141,0.00023915156,0.0023657682],"category_scores_gemma":[0.0012606676,0.00009966719,0.0002181601,0.00063521514,0.0002640583,0.00024982446,0.00032853853,0.0003563625,0.00015215731],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011344472,0.000045571327,0.99416757,0.000027094655,0.00002483852,0.0011802944,0.00016773511,0.000017407187,0.0007620183,0.00001578965,0.00007585286,0.0034023942],"study_design_scores_gemma":[0.000005247224,0.0000883674,0.9958895,0.0000069997322,0.000012392346,0.0036327075,0.00020475755,0.00003391556,0.00003590152,0.000014479956,0.000073646945,0.000002096702],"about_ca_topic_score_codex":0.0015735833,"about_ca_topic_score_gemma":0.0022226814,"teacher_disagreement_score":0.0023657682,"about_ca_system_score_codex":0.00022143307,"about_ca_system_score_gemma":0.00022305369,"threshold_uncertainty_score":0.007914305},"labels":[],"label_agreement":null},{"id":"W1973632883","doi":"10.1111/j.1468-3083.2008.03036.x","title":"The use of an intermittent terbinafine regimen for the treatment of dermatophyte toenail onychomycosis","year":2009,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Nail Diseases and Treatments","field":"Medicine","cited_by":64,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; Mediprobe Research (Canada); Sunnybrook Health Science Centre","funders":"","keywords":"Terbinafine; Medicine; Dermatophyte; Regimen; Itraconazole; Adverse effect; Dermatology; Surgery; Internal medicine; Antifungal","score_opus":0.04576219408455422,"score_gpt":0.30792544093164215,"score_spread":0.2621632468470879,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1973632883","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99468553,0.0039731013,0.000215445,0.00005555806,0.000017125976,0.00017889556,0.00006836248,0.000011657691,0.0007944679],"genre_scores_gemma":[0.997361,0.0015455221,0.0005750746,0.00008107388,0.000034941408,0.00007820935,0.00013392507,0.0000019290858,0.00018838399],"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99971694,0.000088310546,0.000019212379,0.000035176086,0.00009501847,0.000045425528],"domain_scores_gemma":[0.9992692,0.00018810702,0.00023206462,0.000056420213,0.00006999726,0.00018415987],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005416514,0.00023809385,0.0005914566,0.00015317954,0.00023392876,0.00023065203,0.0004903196,0.00029562943,0.0014018713],"category_scores_gemma":[0.0012430275,0.00009131531,0.00029231858,0.00027003005,0.0004369059,0.00013632409,0.00012151604,0.00049546984,0.00008611554],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.20451963,0.015085444,0.047097098,0.0030225394,0.0013614327,0.00045038693,0.00036573847,0.0017283743,0.039828997,0.00021606461,0.0012737836,0.68505055],"study_design_scores_gemma":[0.091413245,0.44739443,0.43532693,0.0005098182,0.0019525419,0.0023332566,0.00024170782,0.0019225528,0.009859331,0.00017428318,0.008817127,0.00005478794],"about_ca_topic_score_codex":0.015933352,"about_ca_topic_score_gemma":0.031944357,"teacher_disagreement_score":0.015933352,"about_ca_system_score_codex":0.0008970504,"about_ca_system_score_gemma":0.001460249,"threshold_uncertainty_score":0.03168124},"labels":[],"label_agreement":null},{"id":"W1975941816","doi":"10.1111/jdv.12198","title":"Efficacy of adalimumab across subgroups of patients with moderate‐to‐severe chronic plaque psoriasis of the hands and/or feet: post hoc analysis of REACH","year":2013,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; Centre de Recherche Dermatologique du Québec Métropolitain","funders":"Celgene; Pfizer; Eli Lilly and Company; Incyte; Amgen","keywords":"Adalimumab; Medicine; Psoriasis; Clinical endpoint; Placebo; Dermatology Life Quality Index; Post-hoc analysis; Dermatology; Plaque psoriasis; Erythema; Psoriasis Area and Severity Index; Internal medicine; Randomized controlled trial; Disease; Pathology","score_opus":0.01061239310158144,"score_gpt":0.2340154822033418,"score_spread":0.22340308910176038,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1975941816","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99669826,0.0009592143,0.00061050674,0.000085651336,0.00009059759,0.0005954812,0.0003221077,0.00002843218,0.0006098111],"genre_scores_gemma":[0.99709916,0.00021474845,0.0006601848,0.00009285585,0.00009341864,0.0009085822,0.00046248114,0.000012559341,0.0004560461],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9940415,0.003841394,0.00039043048,0.00071538216,0.0005115559,0.0004997427],"domain_scores_gemma":[0.9949641,0.0028082158,0.0009149544,0.00061933947,0.00027076766,0.0004226458],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00766363,0.0010825199,0.0035341512,0.0004325463,0.0003689994,0.0007161999,0.0006312182,0.0007251059,0.004279757],"category_scores_gemma":[0.0060946615,0.0003430633,0.004665986,0.0003258062,0.00069487246,0.0007145978,0.0006142184,0.0011623334,0.0002898158],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9699755,0.00195875,0.0064697284,0.0003876199,0.005106397,0.00006543819,0.00008964006,0.0004327876,0.0036850974,0.00007544348,0.00030436824,0.011449301],"study_design_scores_gemma":[0.3244318,0.4896856,0.15609027,0.00012263456,0.015861608,0.00027557067,0.0002696457,0.004307893,0.0057037063,0.0006119239,0.0025418242,0.00009739673],"about_ca_topic_score_codex":0.00033951533,"about_ca_topic_score_gemma":0.0006580248,"teacher_disagreement_score":0.00766363,"about_ca_system_score_codex":0.00043521362,"about_ca_system_score_gemma":0.00089792564,"threshold_uncertainty_score":0.04052961},"labels":[],"label_agreement":null},{"id":"W1976865991","doi":"10.1111/jdv.12934","title":"Improvements in patient‐reported outcomes in patients with psoriasis receiving etanercept plus topical therapies: results from REFINE","year":2015,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Merck Canada Inc. (Canada); Lynde Centre for Dermatology; Moncton Hospital; Amgen (Canada); Centre de Recherche Dermatologique du Québec Métropolitain; Innovaderm (Canada); Probity Medical Research","funders":"Pfizer; Amgen","keywords":"Etanercept; Medicine; Dermatology Life Quality Index; Psoriasis; Internal medicine; Randomized controlled trial; Dermatology; Rheumatoid arthritis","score_opus":0.02378567879713218,"score_gpt":0.24451367082407646,"score_spread":0.2207279920269443,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1976865991","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967775,0.0018714304,0.00012632017,0.000064185515,0.000007813873,0.00008217027,0.00039016161,0.0000071389445,0.00067321234],"genre_scores_gemma":[0.9981578,0.0007813062,0.0002773107,0.000084470994,0.000026780937,0.000054423126,0.00043916382,0.000002524391,0.00017619344],"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9986933,0.0006420603,0.00015290345,0.00011912438,0.00030673735,0.00008599622],"domain_scores_gemma":[0.99584323,0.0017368324,0.0014442573,0.0003619369,0.0003680063,0.00024572155],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026665044,0.00026069672,0.00095612986,0.00029619393,0.00011993628,0.00036361086,0.00024909855,0.0002856576,0.0017075097],"category_scores_gemma":[0.0043328204,0.00015829428,0.0014444875,0.0004285149,0.0002596383,0.00031435644,0.00030470916,0.00046891326,0.00019702151],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.29391253,0.005826778,0.42349178,0.0023284196,0.008205855,0.00016209668,0.00069100165,0.002233339,0.011196165,0.00017286594,0.0015265299,0.25025254],"study_design_scores_gemma":[0.027180785,0.06583186,0.8944709,0.00016807127,0.0048813163,0.0004156017,0.000236976,0.00087823346,0.0022148278,0.00009813426,0.003574181,0.000049152157],"about_ca_topic_score_codex":0.00085643906,"about_ca_topic_score_gemma":0.0017475105,"teacher_disagreement_score":0.0026665044,"about_ca_system_score_codex":0.00035032604,"about_ca_system_score_gemma":0.00034733323,"threshold_uncertainty_score":0.014101982},"labels":[],"label_agreement":null},{"id":"W1978855446","doi":"10.1111/jdv.12372","title":"Changes in C‐reactive protein in patients with moderate‐to‐severe psoriasis switched to adalimumab therapy after suboptimal response to etanercept, methotrexate or phototherapy","year":2014,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre de Recherche Dermatologique du Québec Métropolitain; Université Laval; Probity Medical Research","funders":"AbbVie","keywords":"Medicine; Etanercept; Adalimumab; Psoriasis; C-reactive protein; Internal medicine; Methotrexate; Psoriasis Area and Severity Index; Psoriatic arthritis; Gastroenterology; Infliximab; Discontinuation; Rheumatoid arthritis; Inflammation; Tumor necrosis factor alpha; Dermatology","score_opus":0.015510631042594309,"score_gpt":0.2466818735983513,"score_spread":0.231171242555757,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1978855446","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99904305,0.00051187497,0.000022066797,0.00003857086,0.0000056873355,0.000015801306,0.00007918499,0.00000247141,0.00028132054],"genre_scores_gemma":[0.9997186,0.0000642683,0.000031291773,0.000048626665,0.0000060684433,0.000009220572,0.00007655726,4.9755556e-7,0.00004482673],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993042,0.00025179225,0.00008449361,0.00014715121,0.000109268316,0.000103138525],"domain_scores_gemma":[0.9986914,0.00032296212,0.0005734218,0.00005700397,0.000113549664,0.00024163545],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010476221,0.0002517039,0.00086187857,0.00033023205,0.0004834722,0.0005786783,0.00023118351,0.0006272326,0.0010326038],"category_scores_gemma":[0.0021780108,0.00022712802,0.0006891297,0.00051611976,0.00019985848,0.0002751655,0.00021292755,0.00059586344,0.00017571541],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005337157,0.00024697455,0.9855304,0.000076314725,0.00032266742,0.00034794633,0.00015576875,0.00007464379,0.0016644128,0.000011275041,0.00022146618,0.006011036],"study_design_scores_gemma":[0.00027025305,0.0020078716,0.99615884,0.000015219497,0.0001500228,0.00081118103,0.00009064489,0.00014032997,0.00015775603,0.000017392835,0.00017350879,0.000006942264],"about_ca_topic_score_codex":0.0021477698,"about_ca_topic_score_gemma":0.004452404,"teacher_disagreement_score":0.0021477698,"about_ca_system_score_codex":0.000545366,"about_ca_system_score_gemma":0.0002936216,"threshold_uncertainty_score":0.0055404305},"labels":[],"label_agreement":null},{"id":"W1981581559","doi":"10.1111/jdv.12946","title":"Are baths desirable in atopic dermatitis?","year":2015,"lang":"en","type":"review","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Bathing; Medicine; Atopic dermatitis; Hydrotherapy; Confidence interval; Balneotherapy; Observational study; Meta-analysis; Sensitive skin; Dermatology; Tap water; Surgery; Internal medicine; Pathology; Alternative medicine","score_opus":0.07525347339608372,"score_gpt":0.3467981715744355,"score_spread":0.27154469817835175,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1981581559","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.013762825,0.9778153,0.00026079593,0.0058981753,0.00055606174,0.000049901435,0.00035825022,0.000010537907,0.0012881956],"genre_scores_gemma":[0.33987603,0.64559025,0.0016400078,0.009278938,0.0027134286,0.00018318156,0.00041385615,0.00001980237,0.00028452734],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.9869376,0.007609788,0.0029596577,0.000995602,0.0012506787,0.00024673215],"domain_scores_gemma":[0.91090983,0.06995475,0.016039068,0.000784419,0.0017846494,0.000527318],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01950809,0.00075683877,0.00411815,0.0018963163,0.00038447,0.0027379014,0.0012850239,0.0036422526,0.0088517135],"category_scores_gemma":[0.06575762,0.00074986153,0.0056736404,0.0032693024,0.0018981961,0.0026960557,0.000788196,0.002618884,0.0005868123],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01630836,0.00034057218,0.041867632,0.6505423,0.06485843,0.00059344183,0.0010265711,0.0005240431,0.0010804812,0.0022592077,0.008093477,0.21250552],"study_design_scores_gemma":[0.019932978,0.0059758783,0.21911386,0.38757393,0.27709457,0.003588327,0.003027453,0.0006863912,0.0015751407,0.015272523,0.06590379,0.00025523096],"about_ca_topic_score_codex":0.002147455,"about_ca_topic_score_gemma":0.003884364,"teacher_disagreement_score":0.01950809,"about_ca_system_score_codex":0.0011514686,"about_ca_system_score_gemma":0.0015118379,"threshold_uncertainty_score":0.10316992},"labels":[],"label_agreement":null},{"id":"W1982881053","doi":"10.1111/jdv.12242","title":"Comparative effect of topical silicone gel and topical tretinoin cream for the prevention of hypertrophic scar and keloid formation and the improvement of scars","year":2013,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Dermatologic Treatments and Research","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Wonkwang University","keywords":"Medicine; Keloid; Dermatology; Hypertrophic scars; Tretinoin; Silicone; Hypertrophic scar; Scars; Surgery; Retinoic acid","score_opus":0.023586038058781057,"score_gpt":0.31308353915566745,"score_spread":0.2894975010968864,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1982881053","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9916923,0.007266478,0.00024526715,0.000030007013,0.000044273962,0.00006024136,0.00002071196,0.000008932935,0.0006317917],"genre_scores_gemma":[0.9958823,0.002707997,0.000804177,0.000046501842,0.000061474115,0.00005377876,0.0000441412,0.0000035754117,0.0003959889],"study_design_codex":"bench_or_experimental","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9996892,0.00009685179,0.000030826657,0.000041780364,0.00009770958,0.00004364054],"domain_scores_gemma":[0.9996865,0.0001300413,0.000054088443,0.00002253003,0.000033775515,0.000073105766],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040821935,0.0003649049,0.0007002852,0.00035188918,0.00018962265,0.00016249903,0.0001551215,0.00025602034,0.001611533],"category_scores_gemma":[0.0005610385,0.00012459324,0.0005311126,0.00017089088,0.00021213117,0.00023001584,0.00014120855,0.00030868425,0.00014660886],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.13248911,0.023520678,0.016021932,0.0038836736,0.0009729601,0.0019150437,0.00060567696,0.0009985459,0.4617393,0.0003553681,0.00076520804,0.35673258],"study_design_scores_gemma":[0.01310666,0.70100313,0.096976414,0.0002433248,0.00226445,0.0047997306,0.00068981876,0.0026293155,0.1716037,0.00022212467,0.006392711,0.000068704656],"about_ca_topic_score_codex":0.00020799234,"about_ca_topic_score_gemma":0.00040503536,"teacher_disagreement_score":0.001611533,"about_ca_system_score_codex":0.00010400356,"about_ca_system_score_gemma":0.00024466653,"threshold_uncertainty_score":0.005391121},"labels":[],"label_agreement":null},{"id":"W1986000961","doi":"10.1111/j.1468-3083.2005.01212.x","title":"A phase I/II randomized, double‐blind, placebo‐controlled, dose‐ranging study evaluating the efficacy, safety and pharmacokinetics of ravuconazole in the treatment of onychomycosis","year":2005,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Nail Diseases and Treatments","field":"Medicine","cited_by":71,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; Mediprobe Research (Canada); Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Placebo; Adverse effect; Dosing; Dose-ranging study; Pharmacokinetics; Randomized controlled trial; Surgery; Nail disease; Double blind; Clinical trial; Internal medicine; Complication; Pathology","score_opus":0.048453893681914474,"score_gpt":0.38669375212267715,"score_spread":0.33823985844076265,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1986000961","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9840146,0.0029076121,0.0012266752,0.00038470278,0.0003309897,0.009004262,0.00068057934,0.00015059346,0.0012999815],"genre_scores_gemma":[0.9758597,0.0032062356,0.004503464,0.0015346182,0.00064147986,0.010219024,0.0010916145,0.000041784206,0.0029020715],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99906164,0.00052960333,0.000065928965,0.00014171332,0.00009108433,0.00010991751],"domain_scores_gemma":[0.99865204,0.00043179316,0.0003131871,0.00012226184,0.00012915877,0.0003515871],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022280621,0.0017697419,0.0027093596,0.0005832915,0.00052829,0.0007919272,0.0012195684,0.0020948648,0.004975518],"category_scores_gemma":[0.0019390963,0.00091197615,0.00087669486,0.00046831107,0.0015049888,0.001003937,0.00025942203,0.0022143975,0.0008735154],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.89077944,0.050868917,0.0009951734,0.0011199273,0.0005614813,0.00008857238,0.00010246765,0.00051637925,0.025216088,0.0001254202,0.0010235202,0.0286026],"study_design_scores_gemma":[0.86007893,0.13718793,0.0011101173,0.000019244817,0.00013404069,0.000029836727,0.000010346011,0.00017829388,0.00083884725,0.000041253967,0.0003610009,0.000010091937],"about_ca_topic_score_codex":0.00046453287,"about_ca_topic_score_gemma":0.00087979186,"teacher_disagreement_score":0.004975518,"about_ca_system_score_codex":0.0004752077,"about_ca_system_score_gemma":0.0013354841,"threshold_uncertainty_score":0.016644776},"labels":[],"label_agreement":null},{"id":"W1992270897","doi":"10.1111/j.1468-3083.2007.02216.x","title":"Quality of clinical practice guidelines in dermatological oncology","year":2007,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Clinical practice guidelines implementation","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; MEDLINE; Guideline; Critical appraisal; Evidence-based medicine; CLARITY; Family medicine; Medical physics; Alternative medicine; Pathology","score_opus":0.430461132646136,"score_gpt":0.6106730590765326,"score_spread":0.18021192643039657,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1992270897","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.032218646,0.7537659,0.027944978,0.12470025,0.0052743196,0.006754825,0.0045213155,0.0003320424,0.04448769],"genre_scores_gemma":[0.5318625,0.26708478,0.16441262,0.016270528,0.0030304233,0.010379575,0.004877454,0.00019498813,0.0018872063],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.5991037,0.2346967,0.09335916,0.0062006484,0.0640696,0.0025702077],"domain_scores_gemma":[0.25827774,0.47195727,0.12849334,0.014260378,0.11868149,0.008329705],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.18257435,0.0007562357,0.0028550527,0.020368407,0.0014758026,0.009416263,0.002919959,0.0032678533,0.004509159],"category_scores_gemma":[0.5662543,0.0008429712,0.0020172372,0.022324963,0.004390258,0.005457185,0.0046779555,0.0036934637,0.00066867814],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000353158,0.0003191682,0.05921033,0.12954397,0.0018693444,0.00030966426,0.0055050454,0.0017148949,0.0005522932,0.023204405,0.06548457,0.7119332],"study_design_scores_gemma":[0.0008839386,0.0010897118,0.18677703,0.42791778,0.0027469324,0.0020479208,0.0094391005,0.0039582206,0.0013948291,0.06695527,0.29645443,0.00033499688],"about_ca_topic_score_codex":0.0059223464,"about_ca_topic_score_gemma":0.005899796,"teacher_disagreement_score":0.18257435,"about_ca_system_score_codex":0.010289117,"about_ca_system_score_gemma":0.029391112,"threshold_uncertainty_score":0.965557},"labels":[],"label_agreement":null},{"id":"W1995705126","doi":"10.1111/j.1468-3083.2005.01216.x","title":"Rosacea and its management: an overview","year":2005,"lang":"en","type":"review","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Acne and Rosacea Treatments and Effects","field":"Medicine","cited_by":134,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mediprobe Research (Canada); Sunnybrook Health Science Centre","funders":"","keywords":"Rosacea; Rhinophyma; Medicine; Metronidazole; Dermatology; Telangiectasia; Isotretinoin; Papulopustular; Erythema; Demodex; Population; Acne; Antibiotics; Mite","score_opus":0.08959379741148042,"score_gpt":0.38464605610132124,"score_spread":0.2950522586898408,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1995705126","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00033216752,0.9968725,0.00020208806,0.0008528136,0.0003467693,0.000010216463,0.00001872603,0.0000113731085,0.0013533732],"genre_scores_gemma":[0.0017984837,0.9963218,0.0004348991,0.0004525121,0.000588095,0.000013220198,0.000047507438,0.0000023068717,0.0003412592],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99967945,0.000071677656,0.00007219067,0.00004474843,0.00010243819,0.00002945317],"domain_scores_gemma":[0.999585,0.00018299429,0.000084794105,0.000008242533,0.00009329531,0.000045634537],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00049868366,0.00082760304,0.000906396,0.0026837054,0.00044065542,0.0011371033,0.00062762067,0.0012231679,0.00366456],"category_scores_gemma":[0.0008627894,0.00020473263,0.0006642121,0.0014938277,0.0004130195,0.001492133,0.00068864773,0.0019085157,0.0010544248],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000095850555,0.00014233477,0.0010140674,0.02239276,0.00010410107,0.0012228133,0.0001732327,0.00032649864,0.0006832824,0.002008773,0.044612084,0.92722416],"study_design_scores_gemma":[0.00003178273,0.0003289312,0.004210115,0.034568433,0.00030980603,0.022540923,0.0004366412,0.00027025887,0.00030331966,0.0028618267,0.9340905,0.00004742763],"about_ca_topic_score_codex":0.0010619588,"about_ca_topic_score_gemma":0.0017806744,"teacher_disagreement_score":0.00366456,"about_ca_system_score_codex":0.00055005454,"about_ca_system_score_gemma":0.0010930112,"threshold_uncertainty_score":0.012259126},"labels":[],"label_agreement":null},{"id":"W1996190935","doi":"10.1046/j.1468-3083.17.s2.3.x","title":"Clinical response to alefacept: results of a phase 3 study of intramuscular administration of alefacept in patients with chronic plaque psoriasis","year":2003,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":68,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Placebo; Psoriasis; Adverse effect; Internal medicine; Psoriasis Area and Severity Index; Clinical trial; Gastroenterology; Dermatology; Pathology","score_opus":0.01923045553152288,"score_gpt":0.2943934389556732,"score_spread":0.27516298342415035,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1996190935","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956785,0.0024379261,0.00031096986,0.00018194864,0.000047170415,0.0005140014,0.00021732519,0.000038568018,0.0005736578],"genre_scores_gemma":[0.9962935,0.00088094384,0.00072697975,0.00037116153,0.00015876189,0.000491173,0.0006218235,0.000011367153,0.00044420548],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99897707,0.0005255703,0.00007247867,0.00014494856,0.000129039,0.00015079671],"domain_scores_gemma":[0.99834347,0.000492852,0.00034274958,0.00011847335,0.00011372866,0.00058872637],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031574504,0.0011193462,0.0025055252,0.00028906466,0.00041507336,0.0007812719,0.00048660615,0.0011217635,0.0015963705],"category_scores_gemma":[0.0019701219,0.00045480882,0.0014539944,0.00033519254,0.0009033466,0.00051712256,0.0002523031,0.001830102,0.0004771079],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.79501,0.03401798,0.036810435,0.00048407153,0.001762853,0.00036602165,0.00034097585,0.0010219228,0.031308144,0.000057563222,0.0015269277,0.09729324],"study_design_scores_gemma":[0.49563426,0.38941416,0.107524075,0.00004487548,0.0010572263,0.0006565,0.00007023727,0.0011816329,0.0030094665,0.00008045827,0.0012872923,0.00003982578],"about_ca_topic_score_codex":0.0006088089,"about_ca_topic_score_gemma":0.0006462313,"teacher_disagreement_score":0.0031574504,"about_ca_system_score_codex":0.00061152154,"about_ca_system_score_gemma":0.000950461,"threshold_uncertainty_score":0.01669842},"labels":[],"label_agreement":null},{"id":"W1997237519","doi":"10.1111/jdv.12909","title":"Effect of biologics on depressive symptoms in patients with psoriasis: a systematic review","year":2014,"lang":"en","type":"review","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":104,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland; Centre Hospitalier de l’Université de Montréal; Innovaderm (Canada); Centre hospitalier universitaire de Québec; University of British Columbia; University of Toronto; Western University; Hôpital du Sacré-Cœur de Montréal; Lynde Centre for Dermatology; University of Alberta; Université de Montréal; Hôpital Saint-Luc","funders":"Sanofi","keywords":"Medicine; Adalimumab; Ustekinumab; Etanercept; Psoriasis; Placebo; Randomized controlled trial; Depression (economics); Internal medicine; Beck Depression Inventory; Physical therapy; Clinical trial; Dermatology; Anxiety; Psychiatry; Tumor necrosis factor alpha; Alternative medicine","score_opus":0.011939223124890748,"score_gpt":0.2652383911809469,"score_spread":0.2532991680560561,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1997237519","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0012343114,0.99804866,0.000049503622,0.00012519048,0.000054922857,0.00013738252,0.00017700256,0.00000384305,0.00016908575],"genre_scores_gemma":[0.02589977,0.97273207,0.00032540405,0.0004487468,0.00007787957,0.00027942355,0.0001595013,0.000002918951,0.000074248106],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9948667,0.0018549501,0.0018788016,0.00040469164,0.0008585476,0.00013621914],"domain_scores_gemma":[0.98142886,0.012912195,0.0041695507,0.00021415776,0.0010794919,0.00019568157],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0050647035,0.0010347659,0.007908324,0.004539707,0.00046804667,0.0017976313,0.0011954745,0.0016273081,0.00334445],"category_scores_gemma":[0.020768967,0.0008497123,0.007620864,0.004771745,0.0007099203,0.0011423983,0.0008113849,0.0009911469,0.00023026027],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006720357,0.000030289373,0.0011527283,0.94255126,0.021150235,0.00008743832,0.0000945385,0.000092629096,0.00015089297,0.00011199862,0.0010638012,0.032842238],"study_design_scores_gemma":[0.0019282161,0.0007492781,0.010083542,0.7436543,0.2256461,0.00069968926,0.00022385016,0.00014008865,0.0002894166,0.00032887215,0.016209267,0.00004739195],"about_ca_topic_score_codex":0.005236166,"about_ca_topic_score_gemma":0.0133580575,"teacher_disagreement_score":0.007908324,"about_ca_system_score_codex":0.0020234152,"about_ca_system_score_gemma":0.0043298304,"threshold_uncertainty_score":0.026785076},"labels":[],"label_agreement":null},{"id":"W1998679145","doi":"10.1046/j.1468-3083.2003.00691.x","title":"The efficacy and safety of terbinafine in children","year":2003,"lang":"en","type":"review","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Nail Diseases and Treatments","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mediprobe Research (Canada); Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Terbinafine; Intensive care medicine; Dermatology","score_opus":0.02146016045992034,"score_gpt":0.31759497259198227,"score_spread":0.29613481213206194,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1998679145","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00049442204,0.9987601,0.00002761005,0.00008060745,0.000030982534,0.0000025393097,0.000008814651,0.0000019465383,0.000593073],"genre_scores_gemma":[0.003591381,0.9958332,0.000090195215,0.00007678604,0.000052440788,0.0000046698037,0.000014854794,8.174276e-7,0.00033566586],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9997117,0.000063241605,0.000055039036,0.00004206428,0.0001045109,0.000023386234],"domain_scores_gemma":[0.99962485,0.00017471745,0.00010285332,0.000008664162,0.000066996006,0.000021929853],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006402236,0.0005330731,0.001544922,0.0013755824,0.0002738702,0.0006883328,0.00055975094,0.0009281213,0.0028724242],"category_scores_gemma":[0.0009444827,0.00023721739,0.00044296315,0.0015231349,0.0003468,0.0006906244,0.00037126243,0.00073525147,0.0010682249],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024002844,0.00006111034,0.0009089481,0.021378895,0.00010668673,0.000852919,0.000114315786,0.00016046978,0.0020676428,0.00081697427,0.006579063,0.9667131],"study_design_scores_gemma":[0.00015369817,0.00068337435,0.012731817,0.012144575,0.0006208567,0.016811864,0.0002696075,0.00014175511,0.004706341,0.0013352885,0.95036215,0.000038665905],"about_ca_topic_score_codex":0.0019471121,"about_ca_topic_score_gemma":0.0025182397,"teacher_disagreement_score":0.0028724242,"about_ca_system_score_codex":0.00053571875,"about_ca_system_score_gemma":0.00092573016,"threshold_uncertainty_score":0.009609282},"labels":[],"label_agreement":null},{"id":"W1999836286","doi":"10.1111/jdv.12530","title":"Physician perceptions and experience of current treatment in actinic keratosis","year":2014,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Nonmelanoma Skin Cancer Studies","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Valeant Pharmaceuticals International; Celgene; Eli Lilly and Company; LEO Pharma; Galderma; Amgen","keywords":"Actinic keratosis; Medicine; Dermatology; Intensive care medicine; Basal cell; Internal medicine","score_opus":0.030680032593310386,"score_gpt":0.32714390511078173,"score_spread":0.29646387251747136,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1999836286","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99594903,0.0010396213,0.0001320988,0.00094818516,0.00002006253,0.000014302346,0.0000337267,0.0000036805413,0.0018592362],"genre_scores_gemma":[0.999015,0.0004003108,0.0001461867,0.00024406578,0.000011514177,0.0000055076707,0.000018011899,0.0000012277701,0.00015816261],"study_design_codex":"observational","study_design_gemma":"qualitative","domain_scores_codex":[0.9954136,0.0029211773,0.00040438195,0.00018189778,0.00081780547,0.00026115883],"domain_scores_gemma":[0.9791393,0.010708102,0.0060566133,0.00024673252,0.0017211802,0.0021280327],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0038032439,0.00010992226,0.00022056597,0.0004206656,0.0007206945,0.0009825217,0.0002506956,0.000564527,0.00228332],"category_scores_gemma":[0.020871246,0.00015175075,0.0002624239,0.00036799276,0.00062095234,0.0006588472,0.0005898794,0.0006060621,0.00014096385],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040119697,0.00045734918,0.87127465,0.0006558042,0.00014888096,0.0012491731,0.081766404,0.00037310706,0.0014596488,0.00023547641,0.0023850359,0.039593153],"study_design_scores_gemma":[0.00005774481,0.0017530388,0.8430693,0.00049446,0.00009192672,0.0051405905,0.1380587,0.0009390476,0.00044884405,0.0002091956,0.009670515,0.00006669881],"about_ca_topic_score_codex":0.0045705526,"about_ca_topic_score_gemma":0.005655021,"teacher_disagreement_score":0.0045705526,"about_ca_system_score_codex":0.0008274604,"about_ca_system_score_gemma":0.00095533626,"threshold_uncertainty_score":0.020113707},"labels":[],"label_agreement":null},{"id":"W2001467013","doi":"10.1111/j.1468-3083.2009.03221.x","title":"Quality of life in patients with scalp psoriasis treated with calcipotriol/betamethasone dipropionate scalp formulation: a randomized controlled trial","year":2009,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Windsor Clinical Research; Western University","funders":"University of California, San Francisco; LEO Pharma; University of Sheffield","keywords":"Calcipotriol; Scalp; Medicine; Betamethasone dipropionate; Betamethasone; Psoriasis; Dermatology; Quality of life (healthcare); Randomized controlled trial; Surgery; Internal medicine","score_opus":0.015627777923780686,"score_gpt":0.25255241881348667,"score_spread":0.236924640889706,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2001467013","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9700429,0.016817747,0.0007010433,0.00080994354,0.0009479889,0.007376776,0.0012672765,0.00011217548,0.0019242112],"genre_scores_gemma":[0.9797661,0.005788425,0.0013290771,0.0008092086,0.0007073885,0.009456394,0.00083031046,0.0000129247655,0.001300137],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99862635,0.0007669357,0.00013356419,0.0002275208,0.00011873509,0.00012698486],"domain_scores_gemma":[0.9985745,0.00056535064,0.0003659226,0.00007908674,0.00011051649,0.00030461492],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020459762,0.0011854961,0.0039740363,0.0005366888,0.0005268212,0.0010482641,0.0008448992,0.0018956683,0.0065061892],"category_scores_gemma":[0.0022541229,0.00061002054,0.0026735757,0.00078411394,0.00092519843,0.00074049324,0.00036372963,0.0019864957,0.00046960165],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.98480785,0.0032166722,0.00063422235,0.0011151816,0.0011267066,0.000028086133,0.000020078609,0.00008838735,0.00071844156,0.00003423519,0.00024553353,0.007964537],"study_design_scores_gemma":[0.9749323,0.02282285,0.0011856157,0.000035060017,0.000573045,0.000011768548,0.000010752442,0.00013256786,0.000087999186,0.00003125257,0.00017141608,0.000005362965],"about_ca_topic_score_codex":0.0011649106,"about_ca_topic_score_gemma":0.0013866858,"teacher_disagreement_score":0.0065061892,"about_ca_system_score_codex":0.00065470376,"about_ca_system_score_gemma":0.0011500978,"threshold_uncertainty_score":0.021765351},"labels":[],"label_agreement":null},{"id":"W2003059802","doi":"10.1111/jdv.12677","title":"Adalimumab retreatment successfully restores clinical response and health‐related quality of life in patients with moderate to severe psoriasis who undergo therapy interruption","year":2014,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"AbbVie","keywords":"Medicine; Adalimumab; Psoriasis; Regimen; Psoriasis Area and Severity Index; Quality of life (healthcare); Dosing; Severity of illness; Dermatology Life Quality Index; Internal medicine; Surgery; Drug withdrawal; Drug; Disease; Dermatology; Pharmacology","score_opus":0.056016352291885306,"score_gpt":0.3229741263617203,"score_spread":0.266957774069835,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2003059802","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.999342,0.0003224503,0.000050488274,0.000014399534,0.000005498975,0.000031628308,0.000021102778,0.0000048675033,0.00020750829],"genre_scores_gemma":[0.9995196,0.00011904821,0.00009168135,0.000044437827,0.00001904457,0.00002410933,0.00006997389,0.0000013296108,0.0001106576],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995869,0.00017614996,0.000035259363,0.00005334572,0.00007597191,0.00007232158],"domain_scores_gemma":[0.9995043,0.0001675931,0.00013503506,0.000047585796,0.000024282323,0.00012118211],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00105599,0.0002986931,0.0010756672,0.00017344802,0.00028624348,0.0003973608,0.00016275566,0.00022250798,0.00087312766],"category_scores_gemma":[0.0011918702,0.00016502515,0.0006171474,0.00018218221,0.00020399781,0.00022902492,0.00014467741,0.00047801397,0.00020962191],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.17245825,0.022019103,0.46661383,0.0007736137,0.0020684416,0.0018916023,0.0010643348,0.0012605259,0.050742958,0.00009275413,0.002427432,0.27858716],"study_design_scores_gemma":[0.009180076,0.11965379,0.86171556,0.000045214147,0.0004853989,0.0021373576,0.00018383068,0.001551525,0.0029036242,0.000058265778,0.002062063,0.00002328997],"about_ca_topic_score_codex":0.00039481322,"about_ca_topic_score_gemma":0.00077437237,"teacher_disagreement_score":0.0010756672,"about_ca_system_score_codex":0.0002406151,"about_ca_system_score_gemma":0.0003412799,"threshold_uncertainty_score":0.005584657},"labels":[],"label_agreement":null},{"id":"W2017296296","doi":"10.1111/j.1468-3083.2008.02708.x","title":"Schnitzler syndrome: a dramatic improvement with anakinra","year":2008,"lang":"en","type":"letter","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Inflammasome and immune disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"","keywords":"Medicine; Humanities; Philosophy","score_opus":0.007054060283025894,"score_gpt":0.20767689814571766,"score_spread":0.20062283786269178,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2017296296","genre_codex":"commentary","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.23492774,0.016630566,0.008286206,0.59578735,0.028682664,0.0003849508,0.00085136225,0.0018754144,0.112573735],"genre_scores_gemma":[0.85124236,0.008007268,0.00519224,0.080685936,0.030956874,0.00018307203,0.00033126073,0.00016188361,0.023238994],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9992982,0.00019359856,0.00006189564,0.00013421464,0.00018313066,0.00012897133],"domain_scores_gemma":[0.99849844,0.0009374465,0.00009209147,0.00011330642,0.00010226011,0.00025640536],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00060983276,0.0017276026,0.001255005,0.0007472293,0.0012024129,0.0010309332,0.0011052449,0.013239139,0.0022850153],"category_scores_gemma":[0.0066540577,0.00051911804,0.0010252183,0.00047963866,0.0013303687,0.0020376996,0.00057584746,0.0070181526,0.001035883],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025278275,0.00006296912,0.0022132637,0.00006423502,0.00003429346,0.96860665,0.00008254181,0.0001889736,0.0012165493,0.001750212,0.019097533,0.0064299754],"study_design_scores_gemma":[0.00034574416,0.0002443232,0.006738306,0.000080102735,0.00005993396,0.9638115,0.00010299677,0.0019542128,0.0010191397,0.0049672457,0.020626524,0.00005000893],"about_ca_topic_score_codex":0.0014581626,"about_ca_topic_score_gemma":0.0016212257,"teacher_disagreement_score":0.013239139,"about_ca_system_score_codex":0.001398376,"about_ca_system_score_gemma":0.00073097897,"threshold_uncertainty_score":0.010145903},"labels":[],"label_agreement":null},{"id":"W2017480010","doi":"10.1111/jdv.12177","title":"Effects of briakinumab treatment for moderate to severe psoriasis on health‐related quality of life and work productivity and activity impairment: results from a randomized phase III study","year":2013,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research","funders":"AbbVie","keywords":"Medicine; Quality of life (healthcare); Dermatology Life Quality Index; Psoriasis; Placebo; Physical therapy; Psoriatic arthritis; Work productivity; Randomized controlled trial; Severity of illness; Internal medicine; Productivity; Alternative medicine; Dermatology; Nursing","score_opus":0.028383320793183855,"score_gpt":0.29311438830241565,"score_spread":0.2647310675092318,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2017480010","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98270744,0.007946056,0.0010140425,0.000697504,0.00037058626,0.0043287333,0.0009417611,0.00018863904,0.0018051954],"genre_scores_gemma":[0.9839595,0.004562363,0.0016612028,0.0014815652,0.0004840576,0.0047489,0.0010906664,0.00004308984,0.0019686078],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99881065,0.0007456133,0.00008032835,0.000103275925,0.00011162201,0.00014857274],"domain_scores_gemma":[0.99829096,0.00057150045,0.0004100724,0.00013865817,0.0000981684,0.00049063656],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0037948885,0.001184382,0.0030871741,0.00040212242,0.00050689245,0.0011738165,0.0011236207,0.0017037472,0.005798292],"category_scores_gemma":[0.0021360505,0.000621868,0.0020104933,0.00048653802,0.0011228267,0.0006804574,0.0003072397,0.0025133467,0.00092744676],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.93072575,0.023594767,0.0011098962,0.0009875897,0.0013095152,0.00006650499,0.00007332836,0.00028853037,0.008020517,0.000061231396,0.0011587724,0.03260351],"study_design_scores_gemma":[0.9024861,0.09271496,0.0033734275,0.000039836923,0.00037631026,0.000045048768,0.0000139000695,0.00015151418,0.00034807506,0.000052122752,0.00038927165,0.000009529437],"about_ca_topic_score_codex":0.0006012729,"about_ca_topic_score_gemma":0.0012936144,"teacher_disagreement_score":0.005798292,"about_ca_system_score_codex":0.0005597144,"about_ca_system_score_gemma":0.0012275284,"threshold_uncertainty_score":0.02006954},"labels":[],"label_agreement":null},{"id":"W2024105484","doi":"10.1046/j.1468-3083.2001.00206.x","title":"Itraconazole pulse therapy for the treatment of <i>Candida</i> onychomycosis","year":2001,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Nail Diseases and Treatments","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Itraconazole; Medicine; Candida albicans; Candida glabrata; Dermatology; Nail (fastener); Adverse effect; Nail disease; Terbinafine; Fluconazole; Clinical trial; Mycosis; Cure rate; Antifungal; Surgery; Internal medicine; Paronychia; Microbiology","score_opus":0.027971757526540953,"score_gpt":0.3043991934224572,"score_spread":0.27642743589591623,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2024105484","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98987514,0.006836022,0.0005406135,0.00018579901,0.00016103091,0.0012348111,0.00019142964,0.000060930066,0.000914193],"genre_scores_gemma":[0.9910342,0.0047156787,0.0013577284,0.00042811464,0.00026232318,0.0011712228,0.00040799784,0.000008643256,0.00061406265],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9995865,0.000235045,0.000040527764,0.000047302932,0.00003797625,0.00005256836],"domain_scores_gemma":[0.9995703,0.00014624606,0.000099481134,0.0000359482,0.00003215671,0.0001158001],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009539974,0.0007400516,0.0016098046,0.00035452878,0.00028102752,0.00057815044,0.00045933944,0.00095503055,0.0016682491],"category_scores_gemma":[0.00079469854,0.0002720921,0.001085283,0.000347522,0.00047477058,0.00048800456,0.00021348373,0.0013283595,0.0002712097],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7326839,0.020039832,0.0036630295,0.0025266625,0.001357511,0.00034944853,0.00015616803,0.0009884898,0.024616709,0.00020383969,0.0011117924,0.21230257],"study_design_scores_gemma":[0.6579403,0.3262061,0.010551735,0.00011556111,0.00051922246,0.00043912214,0.000036638507,0.0006040838,0.002242533,0.000075873024,0.00123789,0.000030981297],"about_ca_topic_score_codex":0.00042684074,"about_ca_topic_score_gemma":0.00085119205,"teacher_disagreement_score":0.0016682491,"about_ca_system_score_codex":0.00027227294,"about_ca_system_score_gemma":0.00057476404,"threshold_uncertainty_score":0.0055808425},"labels":[],"label_agreement":null},{"id":"W2029325865","doi":"10.1046/j.1468-3083.2000.00124.x","title":"The epidemiology of onychomycosis: possible role of smoking and peripheral arterial disease","year":2000,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Nail Diseases and Treatments","field":"Medicine","cited_by":134,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ministry of Health and Long Term Care; University of Toronto; Western University; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Arterial disease; Epidemiology; Peripheral; Disease; Etiology; Odds ratio; Vascular disease; Internal medicine; Young adult; Surgery","score_opus":0.01603390867579008,"score_gpt":0.283071681337145,"score_spread":0.2670377726613549,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2029325865","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99614465,0.002935516,0.00020993144,0.00017128942,0.000009044236,0.0000075479848,0.00006356274,0.000005785977,0.00045271777],"genre_scores_gemma":[0.9990748,0.0006613747,0.000116885,0.000022543294,0.000025481346,0.0000028755173,0.00004408996,0.0000014377332,0.000050386905],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986777,0.00066133274,0.00015064674,0.00016746405,0.00019914616,0.0001437421],"domain_scores_gemma":[0.9957711,0.0012801135,0.0019636992,0.00014560852,0.00029309792,0.00054635684],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008417303,0.00020739014,0.00036191838,0.0011003426,0.00031286298,0.0007889429,0.00042328855,0.00070487364,0.001843676],"category_scores_gemma":[0.0036257177,0.00024994859,0.00024623284,0.0017155152,0.0006188204,0.0005652323,0.0005383121,0.0004695891,0.00018236591],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003635655,0.000016672231,0.99745244,0.00001902669,0.000030339017,0.000118213175,0.000043284952,0.000031864223,0.00017716578,0.000029915576,0.000032274133,0.002012423],"study_design_scores_gemma":[0.0000016023042,0.000057117537,0.99859124,0.00001666464,0.000016054208,0.0009027074,0.00010172314,0.0001805406,0.00002015466,0.000037080208,0.00007206079,0.0000029734251],"about_ca_topic_score_codex":0.00334746,"about_ca_topic_score_gemma":0.0030670888,"teacher_disagreement_score":0.00334746,"about_ca_system_score_codex":0.00021608308,"about_ca_system_score_gemma":0.00035176007,"threshold_uncertainty_score":0.0066559315},"labels":[],"label_agreement":null},{"id":"W2029548961","doi":"10.1111/jdv.12174","title":"Identifying individual psychosocial and adherence support needs in patients with psoriasis: a multinational two‐stage qualitative and quantitative study","year":2013,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":96,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"LEO Pharma; University of Pennsylvania","keywords":"Psychosocial; Medicine; Medical prescription; Feeling; Thematic analysis; Psoriasis; Social support; Qualitative research; Family medicine; Clinical psychology; Psychiatry; Nursing; Psychology","score_opus":0.04022761123985095,"score_gpt":0.32076705672190114,"score_spread":0.2805394454820502,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2029548961","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975872,0.00011316395,0.0006667835,0.00036923203,0.000008572793,0.00044266114,0.00017574074,0.00000496398,0.0006316816],"genre_scores_gemma":[0.9954122,0.00028787684,0.0015743098,0.0003822677,0.0000070794904,0.0012788329,0.00013876359,0.00000789065,0.00091070886],"study_design_codex":"qualitative","study_design_gemma":"qualitative","domain_scores_codex":[0.9943585,0.00385955,0.00034161107,0.00029215615,0.00044908727,0.0006989992],"domain_scores_gemma":[0.98645186,0.00983068,0.0011267485,0.0003369936,0.0012933495,0.0009603987],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.012783451,0.0003298463,0.00058415387,0.0016409016,0.00405848,0.001836873,0.00094195653,0.0010328789,0.002558508],"category_scores_gemma":[0.015363292,0.00053257664,0.00042949087,0.0018294688,0.0028036307,0.0017601657,0.0034226715,0.0015110414,0.00030128114],"study_design_candidate":"qualitative","study_design_consensus":"qualitative","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012750686,0.00030718857,0.035500184,0.00041420085,0.000013422077,0.00054030836,0.9463028,0.00008874426,0.0021715076,0.00035295886,0.0004974671,0.013683719],"study_design_scores_gemma":[0.000016936443,0.00027220687,0.024566595,0.00013882351,0.000009524913,0.0001732559,0.97198063,0.00022392666,0.0003535177,0.00013545579,0.0021108028,0.000018337074],"about_ca_topic_score_codex":0.009319249,"about_ca_topic_score_gemma":0.015318447,"teacher_disagreement_score":0.012783451,"about_ca_system_score_codex":0.0037242537,"about_ca_system_score_gemma":0.004488506,"threshold_uncertainty_score":0.06760615},"labels":[],"label_agreement":null},{"id":"W2031009350","doi":"10.1046/j.1468-3083.2003.00692.x","title":"Pimecrolimus: A review","year":2003,"lang":"en","type":"review","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":186,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mediprobe Research (Canada); Sunnybrook Health Science Centre","funders":"","keywords":"Pimecrolimus; Calcineurin; Medicine; Atopic dermatitis; Allergic contact dermatitis; Tacrolimus; Pharmacology; Dermatology; Immunology; Allergy; Internal medicine; Transplantation","score_opus":0.04798298555150113,"score_gpt":0.3536054557671963,"score_spread":0.3056224702156952,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2031009350","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002988845,0.9956962,0.00015847874,0.00040844423,0.0005290417,0.0000112429225,0.000075641285,0.0000232508,0.0027988388],"genre_scores_gemma":[0.001630897,0.9949439,0.00034657566,0.00051988236,0.00069000607,0.000017100392,0.00017317194,0.0000050157205,0.0016733473],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998252,0.000021262504,0.000044301432,0.00003236134,0.000060937884,0.000015984237],"domain_scores_gemma":[0.99979,0.00007795807,0.000043687498,0.000008073756,0.000047871174,0.00003237733],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000291091,0.0007181858,0.0011603887,0.0021679662,0.00032055977,0.0011713326,0.0007553905,0.0008080051,0.01093],"category_scores_gemma":[0.00049447734,0.00020133812,0.00056124385,0.0018825058,0.00018266682,0.0011269088,0.0005036065,0.001497764,0.004920514],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000088240115,0.00008622876,0.00014290816,0.011352608,0.00006810953,0.0003260639,0.00002351884,0.00013469852,0.0009202288,0.00096209854,0.033430226,0.9524651],"study_design_scores_gemma":[0.000025737492,0.000085885054,0.00086157734,0.0028436936,0.00016283436,0.002926759,0.000026383444,0.0000775247,0.00041555124,0.0005715413,0.99198747,0.000014956242],"about_ca_topic_score_codex":0.0006098685,"about_ca_topic_score_gemma":0.0010059936,"teacher_disagreement_score":0.01093,"about_ca_system_score_codex":0.00035552995,"about_ca_system_score_gemma":0.0008040323,"threshold_uncertainty_score":0.03656447},"labels":[],"label_agreement":null},{"id":"W2032132548","doi":"10.1046/j.1468-3083.17.s2.4.x","title":"Clinical response to alefacept: results of a phase 3 study of intravenous administration of alefacept in patients with chronic plaque psoriasis","year":2003,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Plaque psoriasis; Psoriasis; Psoriasis Area and Severity Index; Placebo; Clinical trial; Body surface area; Dermatology; Internal medicine; Randomized controlled trial; Surgery; Pathology","score_opus":0.02010016712135707,"score_gpt":0.29285495982258564,"score_spread":0.27275479270122854,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2032132548","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99693054,0.001554347,0.00024771734,0.00013610903,0.000031273084,0.00043601054,0.00019034272,0.00003036021,0.00044340288],"genre_scores_gemma":[0.9971105,0.00055180077,0.00056368846,0.00028943288,0.000119425684,0.00036943785,0.0006458077,0.0000104602295,0.00033942913],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9987778,0.000634612,0.0000696772,0.00018929262,0.00014086526,0.00018775613],"domain_scores_gemma":[0.9980307,0.0005077779,0.0004521407,0.00015672456,0.0001433736,0.0007093472],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0032523212,0.0012050982,0.0021700468,0.0002758595,0.00049382995,0.00078559184,0.00055139756,0.0011887221,0.0012782594],"category_scores_gemma":[0.0021378014,0.0004839512,0.0012824018,0.00036238824,0.00090723933,0.00047240773,0.0002525171,0.0020065324,0.0004386272],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7523208,0.054236937,0.059995346,0.0003824715,0.00176986,0.00036258728,0.0004241863,0.0013535375,0.033263408,0.0000548881,0.0019719622,0.0938641],"study_design_scores_gemma":[0.44107065,0.39088878,0.16003715,0.000036650064,0.0010026072,0.0006159847,0.00006641174,0.0013878663,0.0033207028,0.00007617238,0.001452713,0.0000442864],"about_ca_topic_score_codex":0.001063562,"about_ca_topic_score_gemma":0.00093555293,"teacher_disagreement_score":0.0032523212,"about_ca_system_score_codex":0.0008554693,"about_ca_system_score_gemma":0.0011674806,"threshold_uncertainty_score":0.017200172},"labels":[],"label_agreement":null},{"id":"W2032397829","doi":"10.1111/jdv.12873","title":"The prevalence of culture‐confirmed toenail onychomycosis in at‐risk patient populations","year":2014,"lang":"en","type":"review","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Nail Diseases and Treatments","field":"Medicine","cited_by":93,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mediprobe Research (Canada); University of Toronto","funders":"","keywords":"Dermatology; Medicine","score_opus":0.03682509605801688,"score_gpt":0.3371707578711909,"score_spread":0.300345661813174,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2032397829","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.11844476,0.87579143,0.00046979543,0.00026573444,0.00012981604,0.00014111219,0.0037755102,0.00001513088,0.0009666946],"genre_scores_gemma":[0.71673745,0.27888963,0.00097051344,0.0006007043,0.00014575427,0.0002782346,0.0022351418,0.0000121615185,0.00013033047],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9875843,0.004407482,0.0045133857,0.0016652502,0.0016216749,0.00020782712],"domain_scores_gemma":[0.97857684,0.011941788,0.006869616,0.0006229737,0.0018101857,0.0001786222],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0066901604,0.00053164014,0.0034638317,0.0054402347,0.00027932247,0.0015469593,0.00084341754,0.0010044781,0.0010633927],"category_scores_gemma":[0.025324037,0.00059503346,0.0054388084,0.0060337796,0.0005152846,0.001031452,0.0009383426,0.00066717237,0.0001424047],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016149097,0.00008029144,0.45413455,0.31445333,0.12668216,0.0006577223,0.0010501165,0.00046290355,0.0009755405,0.00032154963,0.0025331168,0.09703383],"study_design_scores_gemma":[0.00047618969,0.0007790065,0.73097384,0.085604616,0.16533393,0.0045603956,0.0014241319,0.00038921606,0.00090956484,0.0007052876,0.0086954,0.0001484581],"about_ca_topic_score_codex":0.0049486174,"about_ca_topic_score_gemma":0.0071508083,"teacher_disagreement_score":0.0066901604,"about_ca_system_score_codex":0.00069229456,"about_ca_system_score_gemma":0.0012788939,"threshold_uncertainty_score":0.035381377},"labels":[],"label_agreement":null},{"id":"W2034350610","doi":"10.1111/jdv.13150","title":"Physician perspectives in the management of psoriasis and psoriatic arthritis: results from the population‐based Multinational Assessment of Psoriasis and Psoriatic Arthritis survey","year":2015,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":169,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Dalhousie University","funders":"Celgene","keywords":"Medicine; Psoriatic arthritis; Psoriasis; Tolerability; Dermatology; Apremilast; Population; Systemic therapy; Disease; Internal medicine; Adverse effect","score_opus":0.03936081271656534,"score_gpt":0.314312860066395,"score_spread":0.27495204734982964,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2034350610","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965389,0.00066168257,0.00005126533,0.00045018876,0.000011896624,0.000021015227,0.0014083091,0.0000038262156,0.00085297786],"genre_scores_gemma":[0.99819833,0.00038199543,0.00010260571,0.00014781705,0.000018664552,0.000023680133,0.00099272,0.0000018877782,0.0001323701],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978612,0.0010275154,0.0002793789,0.00018095899,0.0004975763,0.00015330398],"domain_scores_gemma":[0.9921713,0.0014239851,0.0045099827,0.00016912782,0.0007263446,0.000999306],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025206916,0.00015556838,0.00021095929,0.00073527923,0.00035142837,0.00058562227,0.00033066745,0.00048198522,0.0009631541],"category_scores_gemma":[0.0069067096,0.00019127622,0.00049804046,0.0013171417,0.00025553894,0.000603046,0.0007663786,0.0005720393,0.00022507894],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000034745834,0.00003219836,0.99780756,0.000020521245,0.000037200378,0.000019668989,0.00032918554,0.000029389303,0.000028510825,0.000005086083,0.0002686283,0.0013873789],"study_design_scores_gemma":[0.0000041894286,0.000036432928,0.9990715,0.000009354421,0.000007972795,0.00004766177,0.0005355092,0.000063045314,0.000008185188,0.0000037911482,0.00020996715,0.0000023551002],"about_ca_topic_score_codex":0.01251845,"about_ca_topic_score_gemma":0.018565005,"teacher_disagreement_score":0.01251845,"about_ca_system_score_codex":0.0005194905,"about_ca_system_score_gemma":0.00045768006,"threshold_uncertainty_score":0.024891138},"labels":[],"label_agreement":null},{"id":"W2036181769","doi":"10.1111/jdv.12150","title":"Consensus recommendations for the treatment of basal cell carcinomas in <scp>G</scp>orlin syndrome with topical methylaminolaevulinate‐photodynamic therapy","year":2013,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Hedgehog Signaling Pathway Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Innovaderm (Canada)","funders":"Galderma","keywords":"Medicine; Basal cell carcinoma; Basal Cell Nevus Syndrome; Photodynamic therapy; Dermatology; Basal cell; Population; Surgery; Pathology","score_opus":0.02439417055306216,"score_gpt":0.2628485709735768,"score_spread":0.23845440042051463,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2036181769","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.006260339,0.34387314,0.046021912,0.5015341,0.04423478,0.007428915,0.003108962,0.0009000726,0.04663777],"genre_scores_gemma":[0.052451238,0.33110243,0.41312853,0.14671308,0.010346528,0.013860949,0.01143881,0.0004064096,0.020551976],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9674557,0.011653404,0.011848291,0.0012041121,0.0063866833,0.001451739],"domain_scores_gemma":[0.8941368,0.026658067,0.008208573,0.0020681517,0.064380355,0.004548127],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.03711173,0.0016503541,0.0028243957,0.0059871934,0.002764518,0.0031200957,0.0093649505,0.01324729,0.00591282],"category_scores_gemma":[0.06414709,0.0011785794,0.008369416,0.003446117,0.0017701599,0.003746515,0.003819023,0.0101072565,0.004807334],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003505192,0.0004482418,0.0024897347,0.044556092,0.00070133427,0.0022858314,0.002445943,0.0015920958,0.004323052,0.007919966,0.49967977,0.43320742],"study_design_scores_gemma":[0.00055325485,0.00029296908,0.005033676,0.09539843,0.0017478667,0.0027049514,0.0022734397,0.0010123134,0.0018221405,0.013427163,0.87551683,0.00021693189],"about_ca_topic_score_codex":0.008298651,"about_ca_topic_score_gemma":0.009537595,"teacher_disagreement_score":0.03711173,"about_ca_system_score_codex":0.0053036935,"about_ca_system_score_gemma":0.024971934,"threshold_uncertainty_score":0.1962679},"labels":[],"label_agreement":null},{"id":"W2039572636","doi":"10.1111/j.1468-3083.2007.02152.x","title":"A pragmatic randomized controlled trial on the effectiveness of low concentrated saline spa water baths followed by ultraviolet B (UVB) compared to UVB only in moderate to severe psoriasis","year":2007,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Therapeutic Uses of Natural Elements","field":"Health Professions","cited_by":59,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Brock University","funders":"","keywords":"Medicine; Psoriasis; Randomized controlled trial; Body surface area; Ultraviolet b; Psoriasis Area and Severity Index; Ultraviolet a; Dermatology; Saline; Surgery; Internal medicine","score_opus":0.01993755468573249,"score_gpt":0.3504801004896524,"score_spread":0.3305425458039199,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2039572636","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.896372,0.015021128,0.002927192,0.0027917374,0.0054014367,0.070903786,0.0018317305,0.00028454707,0.004466332],"genre_scores_gemma":[0.91611356,0.0043272316,0.008674076,0.0029181752,0.0014683151,0.06293819,0.0009307149,0.000034142962,0.0025955406],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99061346,0.007068304,0.00071094686,0.0007187074,0.00047311146,0.00041558317],"domain_scores_gemma":[0.99245036,0.0034304443,0.0017917558,0.0003841184,0.00052715995,0.001416097],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0080752075,0.0024961971,0.0072335135,0.0011292009,0.0010703023,0.0014811546,0.0013494695,0.0037574393,0.013633872],"category_scores_gemma":[0.013914838,0.001137612,0.0038493925,0.00096903613,0.0021541426,0.001582104,0.0012230899,0.0028632148,0.0009198126],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.98819643,0.0034469622,0.00012877057,0.0015054977,0.000878418,0.000024591956,0.000029974095,0.00010586602,0.0003782593,0.00008086556,0.00023484581,0.004989481],"study_design_scores_gemma":[0.97696805,0.022140529,0.00023537595,0.00005824341,0.0002699283,0.0000055374285,0.00001125987,0.00008059466,0.000034746838,0.000062237465,0.0001278068,0.0000056713725],"about_ca_topic_score_codex":0.0017718803,"about_ca_topic_score_gemma":0.0027934401,"teacher_disagreement_score":0.013633872,"about_ca_system_score_codex":0.0016412117,"about_ca_system_score_gemma":0.0032382617,"threshold_uncertainty_score":0.04560989},"labels":[],"label_agreement":null},{"id":"W2041325459","doi":"10.1111/jdv.12555","title":"A Randomized, blinded assessor study to Evaluate the efFIcacy and safety of etanercept 50 mg once weekly plus as Needed topical agent vs. Etanercept 50 mg twice weekly in patients with moderate to severe plaque psoriasis (<scp>REFINE</scp>)","year":2014,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Merck Canada Inc. (Canada); Lynde Centre for Dermatology; Moncton Hospital; Amgen (Canada); Centre de Recherche Dermatologique du Québec Métropolitain; Innovaderm (Canada); Probity Medical Research","funders":"Astellas Pharma; Pfizer; Eli Lilly and Company; Incyte; Amgen","keywords":"Etanercept; Medicine; Clinical endpoint; Randomized controlled trial; Psoriasis Area and Severity Index; Psoriasis; Internal medicine; Body surface area; Confidence interval; Surgery; Gastroenterology; Dermatology; Rheumatoid arthritis","score_opus":0.020609265804763396,"score_gpt":0.26908514774791686,"score_spread":0.24847588194315345,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2041325459","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95162696,0.0027046495,0.0040316824,0.0008632189,0.0018070667,0.032643396,0.002874814,0.0003173345,0.0031309458],"genre_scores_gemma":[0.92156035,0.0013591192,0.011605412,0.0023216868,0.0018508555,0.054578885,0.0014797238,0.00007563476,0.005168284],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99307257,0.004583474,0.00045080285,0.00092929957,0.0004862133,0.00047772282],"domain_scores_gemma":[0.99117017,0.003439661,0.0022663614,0.0010731764,0.0006686095,0.0013819912],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.012732685,0.0026780078,0.0064175585,0.0007004577,0.0010695521,0.0016754046,0.0018502584,0.003048174,0.012718354],"category_scores_gemma":[0.00972876,0.0014963691,0.0021958211,0.0006681466,0.00236913,0.0019546193,0.00085227104,0.003541923,0.0021520425],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9884918,0.0066477414,0.00022014335,0.0001357229,0.00034279036,0.000009351618,0.000024979254,0.00008511438,0.0008338064,0.000052604635,0.0002476586,0.0029083018],"study_design_scores_gemma":[0.96317226,0.0356857,0.00041009343,0.000009654872,0.00016035998,0.000009773974,0.0000057308066,0.00018657105,0.000114481,0.00007645099,0.0001626886,0.0000062398635],"about_ca_topic_score_codex":0.00067403214,"about_ca_topic_score_gemma":0.0013811259,"teacher_disagreement_score":0.012732685,"about_ca_system_score_codex":0.0011908965,"about_ca_system_score_gemma":0.0030555266,"threshold_uncertainty_score":0.06733769},"labels":[],"label_agreement":null},{"id":"W2050501917","doi":"10.1111/jdv.12996","title":"Improvement of scalp and nail lesions with ixekizumab in a phase 2 trial in patients with chronic plaque psoriasis","year":2015,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":80,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"Eli Lilly and Company","keywords":"Medicine; Ixekizumab; Plaque psoriasis; Dermatology; Scalp; Psoriasis; Nail (fastener); Psoriatic arthritis; Secukinumab","score_opus":0.017956625286759696,"score_gpt":0.24744523857170717,"score_spread":0.22948861328494746,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2050501917","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948895,0.0021754962,0.0002026528,0.00025617052,0.000102830265,0.0013289021,0.00028083706,0.00004198657,0.0007215771],"genre_scores_gemma":[0.99142295,0.002126231,0.001073957,0.0004795668,0.00029596777,0.0025129518,0.0007470495,0.000013952257,0.0013273619],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99908555,0.0005582557,0.00004919169,0.00011405104,0.00006942488,0.00012346497],"domain_scores_gemma":[0.9989454,0.0003411611,0.0002426186,0.00009242178,0.00007789564,0.0003005429],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030977053,0.0013892105,0.0024009896,0.00038039242,0.00032916965,0.00088723877,0.0005778601,0.0011473857,0.0032123195],"category_scores_gemma":[0.001958118,0.0005911568,0.0016800466,0.00031915278,0.0007702745,0.0007387411,0.00035289247,0.0020614963,0.00046987797],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9566158,0.010471162,0.0019314274,0.00046775478,0.0006504607,0.00007325707,0.000095876014,0.00034039264,0.005457133,0.000056338413,0.0004727561,0.023367617],"study_design_scores_gemma":[0.8885025,0.10530593,0.0048487037,0.000023171027,0.0002741589,0.00004963124,0.000020276075,0.00025014472,0.00035065037,0.000052131483,0.000314023,0.000008640958],"about_ca_topic_score_codex":0.0006516268,"about_ca_topic_score_gemma":0.0013004434,"teacher_disagreement_score":0.0032123195,"about_ca_system_score_codex":0.0005326749,"about_ca_system_score_gemma":0.0010546689,"threshold_uncertainty_score":0.016382396},"labels":[],"label_agreement":null},{"id":"W2051116895","doi":"10.1046/j.1468-3083.2003.00760.x","title":"Stressful life events, anxiety, depression and coping mechanisms in patients with Behçet's disease","year":2003,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Ocular Diseases and Behçet’s Syndrome","field":"Medicine","cited_by":69,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Behcet's disease; Alexithymia; Anxiety; Psychosocial; Disease; Sadness; Coping (psychology); Anger; Internal medicine; Behcet disease; Depression (economics); Clinical psychology; Psychiatry","score_opus":0.007055292083619947,"score_gpt":0.22676768725205323,"score_spread":0.2197123951684333,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2051116895","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99882835,0.0007910146,0.00001744638,0.000069666756,0.0000062191684,0.000005610824,0.00003818454,8.2468847e-7,0.00024281816],"genre_scores_gemma":[0.99962425,0.00025115738,0.00002905265,0.000023960429,0.000008390231,0.0000041209114,0.000035873694,1.3087214e-7,0.000023142591],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998172,0.00006732725,0.000020752648,0.000016631959,0.00004222552,0.00003599942],"domain_scores_gemma":[0.9994723,0.0001367429,0.00021424291,0.000009041831,0.000037483383,0.00013016479],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030514027,0.00021210933,0.00029660735,0.0004509135,0.00042266963,0.00032025797,0.00009253974,0.00025862458,0.0008893209],"category_scores_gemma":[0.0016146024,0.000102202546,0.00021020592,0.00044936108,0.00021333418,0.00021735825,0.00024660994,0.00032155364,0.00006808208],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012958625,0.000051654057,0.99605906,0.000028131297,0.000038704595,0.0003264631,0.00036029873,0.000029174777,0.00017589726,0.000014115456,0.000078203324,0.0027086756],"study_design_scores_gemma":[0.00001291249,0.00022258448,0.9974324,0.000016265994,0.000019723513,0.0014088704,0.0006185648,0.00007136216,0.000024390107,0.000030384359,0.00013877696,0.0000037104048],"about_ca_topic_score_codex":0.0012012714,"about_ca_topic_score_gemma":0.0018021873,"teacher_disagreement_score":0.0012012714,"about_ca_system_score_codex":0.00016949866,"about_ca_system_score_gemma":0.00017160068,"threshold_uncertainty_score":0.0029751062},"labels":[],"label_agreement":null},{"id":"W2053528201","doi":"10.1111/jdv.12272","title":"Increased expression of <scp>IL</scp>‐17A and limited involvement of <scp>IL</scp>‐23 in patients with palmo‐plantar (<scp>PP</scp>) pustular psoriasis or <scp>PP</scp> pustulosis; results from a randomised controlled trial","year":2013,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":117,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lynde Centre for Dermatology; Windsor Clinical Research; Dalhousie University; Innovaderm (Canada)","funders":"National Center for Advancing Translational Sciences","keywords":"Medicine; Ustekinumab; Placebo; Psoriasis; Internal medicine; Pustulosis; Dermatology; Gastroenterology; Disease; Pathology","score_opus":0.014113659528431454,"score_gpt":0.21441690747392753,"score_spread":0.20030324794549606,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2053528201","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9881455,0.008700246,0.00027878975,0.00027905125,0.0002656207,0.0011710135,0.00031982825,0.00003654252,0.0008033676],"genre_scores_gemma":[0.9954543,0.0021678202,0.00035338456,0.00028094882,0.00026150348,0.00086979783,0.00018632114,0.000005771026,0.00042005477],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9989417,0.0005907278,0.00011800913,0.00013203494,0.00010518173,0.00011232472],"domain_scores_gemma":[0.9980248,0.00077010127,0.0005912407,0.000098501536,0.00010135634,0.00041391831],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023565758,0.0008448705,0.0028161458,0.0003550767,0.00037765322,0.0009888343,0.0006440523,0.0014343447,0.004446093],"category_scores_gemma":[0.0021709742,0.00061104266,0.0019035954,0.00047999466,0.0010861777,0.00072196824,0.00033843564,0.0020982986,0.00050116616],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9745934,0.0033394115,0.0018857943,0.0011137897,0.0017375386,0.000053391585,0.000042425316,0.00014226463,0.0031432936,0.000037219095,0.0002210847,0.013690384],"study_design_scores_gemma":[0.85858285,0.13081808,0.007180284,0.000087986504,0.0017569499,0.00011038096,0.000035018078,0.00022271511,0.00069913606,0.00008225589,0.00040840587,0.000015884243],"about_ca_topic_score_codex":0.00040181243,"about_ca_topic_score_gemma":0.00077809155,"teacher_disagreement_score":0.004446093,"about_ca_system_score_codex":0.0004327897,"about_ca_system_score_gemma":0.000696775,"threshold_uncertainty_score":0.014873624},"labels":[],"label_agreement":null},{"id":"W2054496321","doi":"10.1046/j.1468-3083.2000.00134.x","title":"Quality of life of psoriasis patients","year":2000,"lang":"en","type":"letter","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Psoriasis; Medicine; Quality of life (healthcare); Context (archaeology); Disease; Gerontology; Socialization; Dermatology; Psychology; Developmental psychology; Nursing","score_opus":0.0279421862173735,"score_gpt":0.25686378712024344,"score_spread":0.22892160090286995,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2054496321","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93030196,0.018779503,0.00051434315,0.0065360973,0.00031011627,0.000118590106,0.00393785,0.000036305137,0.039465215],"genre_scores_gemma":[0.99409664,0.002489884,0.0002156621,0.00095709006,0.00007506482,0.000043863078,0.0010098739,0.000005520749,0.0011063163],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990609,0.00031019092,0.00010816483,0.000071431525,0.00030600923,0.00014333175],"domain_scores_gemma":[0.9982773,0.0002566098,0.000652363,0.00004379822,0.00030039204,0.00046959583],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008233838,0.00014967333,0.00039783912,0.0008976639,0.00048602972,0.0010265465,0.00020459312,0.00038617864,0.006336339],"category_scores_gemma":[0.0052644294,0.000075447955,0.0006532469,0.0010700846,0.00023488441,0.00071270746,0.00059933134,0.0009361187,0.0006825384],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005603175,0.00042848015,0.8405513,0.00056719995,0.00048265132,0.0006383855,0.003189387,0.00041779873,0.00058810326,0.0011928079,0.016846515,0.13453707],"study_design_scores_gemma":[0.0000562833,0.0006989553,0.96517086,0.00043220198,0.00014075947,0.002433044,0.003140704,0.00040767953,0.000158905,0.00089013047,0.026427098,0.000043347933],"about_ca_topic_score_codex":0.0012408822,"about_ca_topic_score_gemma":0.0010991194,"teacher_disagreement_score":0.006336339,"about_ca_system_score_codex":0.00054735877,"about_ca_system_score_gemma":0.00033364564,"threshold_uncertainty_score":0.02119714},"labels":[],"label_agreement":null},{"id":"W2055136319","doi":"10.1111/j.1468-3083.2009.03295.x","title":"A global survey of the role of ultraviolet radiation and hormonal influences in the development of melasma","year":2009,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Dermatologic Treatments and Research","field":"Medicine","cited_by":270,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Coastal Health Research Institute; University of British Columbia","funders":"Galderma","keywords":"Melasma; Medicine; Pregnancy; Family history; Dermatology; Pediatrics; Internal medicine","score_opus":0.024780523465410285,"score_gpt":0.3145255929134245,"score_spread":0.28974506944801426,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2055136319","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979373,0.000388463,0.00009171045,0.00006487826,0.0000041006433,0.000016456504,0.00082500407,0.00000633775,0.00066578016],"genre_scores_gemma":[0.9987349,0.00030170596,0.000141359,0.000054359636,0.0000078136345,0.000013316423,0.00055937935,0.0000018744141,0.00018527587],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996253,0.00016704686,0.00004443486,0.000051399496,0.000054459448,0.0000572433],"domain_scores_gemma":[0.9987638,0.00030092127,0.000498328,0.00006682769,0.00017196892,0.0001983059],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007833111,0.00022825236,0.000222965,0.00083398016,0.00019019812,0.0002685361,0.0001585591,0.00034622406,0.0012849261],"category_scores_gemma":[0.0014614821,0.00021107214,0.00025261389,0.0009478096,0.00023750639,0.00044946838,0.0003334574,0.00030884173,0.00024361788],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002691647,0.000016990987,0.99762315,0.000023373976,0.000021600947,0.00003363718,0.0001636118,0.000014929427,0.0002609171,0.000005691539,0.00010782268,0.0017012504],"study_design_scores_gemma":[0.0000013911764,0.00007486977,0.9993254,0.0000043912432,0.000006946449,0.000120096636,0.00023483887,0.00001772296,0.000018709537,0.0000025678441,0.0001920003,0.0000011339431],"about_ca_topic_score_codex":0.0033100087,"about_ca_topic_score_gemma":0.002910837,"teacher_disagreement_score":0.0033100087,"about_ca_system_score_codex":0.0001899665,"about_ca_system_score_gemma":0.00019200274,"threshold_uncertainty_score":0.0065814853},"labels":[],"label_agreement":null},{"id":"W2055578335","doi":"10.1111/j.1468-3083.2010.03615.x","title":"Redefining treatment options in chronic hand eczema (CHE)","year":2010,"lang":"en","type":"review","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Contact Dermatitis and Allergies","field":"Medicine","cited_by":65,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lynde Centre for Dermatology; Innovaderm (Canada)","funders":"","keywords":"Hand eczema; Medicine; Dermatology; Intensive care medicine; Allergy; Contact dermatitis; Immunology","score_opus":0.05262662468249588,"score_gpt":0.3424925210969857,"score_spread":0.2898658964144898,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2055578335","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00015740946,0.9993074,0.000056680594,0.00008032355,0.000096338445,0.000003312359,0.0000065315503,0.0000031366528,0.00028885758],"genre_scores_gemma":[0.0017491129,0.99710804,0.0002827121,0.0002464272,0.00018793879,0.000006039416,0.000022718103,0.0000011674504,0.00039584612],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99980265,0.000039063387,0.000039001818,0.00002998449,0.00006741912,0.000021839827],"domain_scores_gemma":[0.99966264,0.00018911554,0.000074104486,0.000008102861,0.000046947967,0.000019018109],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00065724173,0.0007759114,0.0017793196,0.0021788504,0.00022996121,0.0008586891,0.00089990796,0.0011236378,0.0028530238],"category_scores_gemma":[0.00064285,0.00030473093,0.0006746591,0.0014731999,0.00035423334,0.0011362999,0.000483601,0.0014908279,0.00093192945],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011406527,0.000114520226,0.00023122561,0.022567507,0.00015486298,0.0004005521,0.000049249375,0.00023378129,0.0011955454,0.0008986194,0.014684047,0.9593561],"study_design_scores_gemma":[0.00021998453,0.00039282852,0.004474061,0.016608886,0.0011812045,0.007826792,0.00019677432,0.00038745778,0.0011785345,0.0018876224,0.9655964,0.00004960698],"about_ca_topic_score_codex":0.0012977843,"about_ca_topic_score_gemma":0.003671935,"teacher_disagreement_score":0.0028530238,"about_ca_system_score_codex":0.00034738902,"about_ca_system_score_gemma":0.000508855,"threshold_uncertainty_score":0.009544373},"labels":[],"label_agreement":null},{"id":"W2064761712","doi":"10.1111/j.1468-3083.2009.03416.x","title":"Adenosine deaminase activity, trypsin inhibitory capacity and total antioxidant capacity in psoriasis","year":2009,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Children's Hospital Research Institute of Manitoba","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Antioxidant capacity; Psoriasis; Adenosine deaminase; Antioxidant; Trypsin; Internal medicine; Gastroenterology; Endocrinology; Enzyme; Immunology; Adenosine; Biochemistry; Oxidative stress; Chemistry","score_opus":0.02713003508645927,"score_gpt":0.23523032525060186,"score_spread":0.20810029016414258,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2064761712","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99345267,0.0057145013,0.0001993452,0.000032269232,0.0000069658845,0.000008372991,0.000095208314,0.000005523627,0.00048523003],"genre_scores_gemma":[0.9989184,0.00067635876,0.00018368677,0.000011071731,0.000011038563,0.0000053009835,0.000068885434,5.4564777e-7,0.00012468938],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998939,0.000028947772,0.000015199049,0.000021421627,0.000027523547,0.0000129244345],"domain_scores_gemma":[0.99969554,0.00005802945,0.00013542785,0.000011394031,0.000037551836,0.00006217896],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020336219,0.00017493972,0.00019837591,0.0005620316,0.00012315466,0.00025654276,0.00007427954,0.00018617924,0.0012146883],"category_scores_gemma":[0.00045227553,0.000093506715,0.00010525459,0.0003515197,0.00013907757,0.00012837087,0.00011589867,0.000258002,0.0001639039],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004666598,0.0007052551,0.84850526,0.0004908015,0.00027304614,0.000822497,0.00032577934,0.00023943082,0.08639304,0.00015792513,0.0004139409,0.05700646],"study_design_scores_gemma":[0.000069694615,0.0020808307,0.9855136,0.000027884638,0.00011296812,0.0049817073,0.00014710093,0.00030401463,0.0056482046,0.00018008339,0.0009252164,0.00000873211],"about_ca_topic_score_codex":0.00020904926,"about_ca_topic_score_gemma":0.0001522775,"teacher_disagreement_score":0.0012146883,"about_ca_system_score_codex":0.00009291776,"about_ca_system_score_gemma":0.000089315436,"threshold_uncertainty_score":0.0040635467},"labels":[],"label_agreement":null},{"id":"W2067188617","doi":"10.1111/j.1468-3083.2010.03593.x","title":"Efficacy and safety of 1064‐nm Q‐switched Nd:YAG laser with low fluence for keloids and hypertrophic scars","year":2010,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Dermatologic Treatments and Research","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Hypertrophic scars; Scars; Hypertrophic scar; Vascularity; Erythema; Laser; Dermatology; Treatment modality; Laser treatment; Fluence; Lesion; Surgery; Intense pulsed light; Optics","score_opus":0.013914258930783472,"score_gpt":0.2828253312397817,"score_spread":0.26891107230899824,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2067188617","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99713206,0.0017632548,0.00055299274,0.00004278945,0.0000074480117,0.000019046316,0.00001998925,0.000024046649,0.00043834635],"genre_scores_gemma":[0.99903727,0.00027269404,0.0003173907,0.000037980077,0.0000125638,0.00001677692,0.00003760844,0.0000051240745,0.0002625879],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99983144,0.000052883122,0.000019121278,0.000023846727,0.000050951967,0.00002189879],"domain_scores_gemma":[0.9997261,0.00010552526,0.00008457871,0.000021119587,0.000034006953,0.000028616634],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041232503,0.00017426413,0.0002617143,0.00014336249,0.00017542597,0.00016290936,0.00018499982,0.00024103899,0.0013111907],"category_scores_gemma":[0.0005243219,0.00007367454,0.00025561766,0.00007041175,0.00026192647,0.0001800752,0.00010747852,0.00029577207,0.00016567725],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012228867,0.0023763902,0.09845678,0.0010554171,0.00029761973,0.00089584995,0.00036326572,0.0013433341,0.66389585,0.00014381095,0.0006787871,0.218264],"study_design_scores_gemma":[0.0038557742,0.12515227,0.47640762,0.0001837729,0.0009933268,0.016284602,0.00090583746,0.0057187686,0.36327899,0.00025472438,0.006894193,0.0000701515],"about_ca_topic_score_codex":0.00033392347,"about_ca_topic_score_gemma":0.0003110746,"teacher_disagreement_score":0.0013111907,"about_ca_system_score_codex":0.00018957221,"about_ca_system_score_gemma":0.00015961837,"threshold_uncertainty_score":0.0043863654},"labels":[],"label_agreement":null},{"id":"W2069047101","doi":"10.1046/j.1468-3083.2001.00209.x","title":"The specific dermatoses of pregnancy: a re‐appraisal","year":2001,"lang":"en","type":"review","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Autoimmune Bullous Skin Diseases","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Medicine; Pregnancy; Endocrine system; Disease; Obstetrics; Dermatology; Intensive care medicine; Pathology; Internal medicine; Hormone","score_opus":0.052494963552746826,"score_gpt":0.3475453575750964,"score_spread":0.29505039402234956,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2069047101","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00029178048,0.99706656,0.00011806696,0.0006826167,0.00095263304,0.0000046004047,0.000009527552,0.0000056541926,0.0008684939],"genre_scores_gemma":[0.0017229347,0.9962619,0.00013658212,0.00036487292,0.0010173548,0.0000042285938,0.000018752437,0.0000011161433,0.0004721944],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995882,0.000084626095,0.00007932105,0.0000527349,0.00015635522,0.00003880519],"domain_scores_gemma":[0.9991691,0.00033512953,0.00015420259,0.000029360024,0.0002485166,0.00006375444],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00072427373,0.0012427174,0.0019006134,0.0023373542,0.00032691043,0.0010686045,0.0010024853,0.0011568173,0.0026110292],"category_scores_gemma":[0.00116743,0.00029131395,0.00052735326,0.0020757408,0.0005954856,0.0023150668,0.0005318305,0.0015266772,0.0011037881],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001443781,0.00007239846,0.0013996908,0.018726146,0.00012994949,0.0040992512,0.00015822661,0.00045868382,0.0013357815,0.0019486926,0.052586284,0.9189405],"study_design_scores_gemma":[0.000038635448,0.00014935056,0.008431027,0.014711625,0.00026049238,0.038355153,0.00055881083,0.00031183276,0.00054383406,0.0027599253,0.9338334,0.00004586603],"about_ca_topic_score_codex":0.0015263364,"about_ca_topic_score_gemma":0.0028382284,"teacher_disagreement_score":0.0026110292,"about_ca_system_score_codex":0.0006467344,"about_ca_system_score_gemma":0.001023274,"threshold_uncertainty_score":0.008734822},"labels":[],"label_agreement":null},{"id":"W2075940743","doi":"10.1046/j.1468-3083.2002.00589.x","title":"Onychomycosis: strategies to improve efficacy and reduce recurrence","year":2002,"lang":"en","type":"review","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Nail Diseases and Treatments","field":"Medicine","cited_by":69,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mediprobe Research (Canada); Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Onycholysis; Antifungal; Drug; Concomitant; Genetic predisposition; Disease; Dermatology; Intensive care medicine; Surgery; Internal medicine; Pharmacology; Paronychia","score_opus":0.05633573004033433,"score_gpt":0.3637918596431306,"score_spread":0.3074561296027963,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2075940743","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005223352,0.99522346,0.0004816872,0.0008912969,0.00030743217,0.000018265955,0.000019268165,0.000032193686,0.0025041061],"genre_scores_gemma":[0.0029883075,0.99278146,0.0013190362,0.00060201646,0.00047195778,0.000027492244,0.000042809486,0.000005130443,0.0017618812],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99978167,0.00005511138,0.000028812934,0.000027723188,0.0000844745,0.000022198972],"domain_scores_gemma":[0.99977225,0.00009685282,0.00003805862,0.0000108578415,0.000051207662,0.00003082978],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006764502,0.00088169146,0.0017760356,0.001958558,0.0002977486,0.0008401854,0.0012642028,0.0016106463,0.0061794785],"category_scores_gemma":[0.0007484986,0.00018190224,0.00046875302,0.0011539448,0.00040636348,0.0011930015,0.0004497071,0.0016711473,0.0029444979],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009067084,0.00029267787,0.00026512373,0.00867436,0.00008363518,0.0005115525,0.000044133838,0.00048278493,0.0014247753,0.0022559061,0.023287825,0.9625866],"study_design_scores_gemma":[0.00018023972,0.00043437543,0.0041423673,0.006111837,0.00018341484,0.0065123118,0.00017532404,0.00033722736,0.0010676075,0.004382294,0.97644174,0.000031248317],"about_ca_topic_score_codex":0.00085699745,"about_ca_topic_score_gemma":0.0019617782,"teacher_disagreement_score":0.0061794785,"about_ca_system_score_codex":0.0004999295,"about_ca_system_score_gemma":0.0006485003,"threshold_uncertainty_score":0.02067244},"labels":[],"label_agreement":null},{"id":"W2081251370","doi":"10.1111/jdv.12138","title":"Disease characteristics in patients with and without psoriatic arthritis treated with etanercept","year":2013,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Amgen (Canada); Centre de Recherche Dermatologique du Québec Métropolitain; Probity Medical Research","funders":"","keywords":"Medicine; Etanercept; Dermatology Life Quality Index; Psoriatic arthritis; Psoriasis; Quality of life (healthcare); Internal medicine; Psoriasis Area and Severity Index; Placebo; Physical therapy; Depression (economics); Arthritis; Disease; Dermatology; Rheumatoid arthritis; Pathology","score_opus":0.006849012346338562,"score_gpt":0.2175289543293556,"score_spread":0.21067994198301704,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2081251370","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981919,0.00072352844,0.000041396368,0.00005765939,0.000013154504,0.000022547421,0.00024182252,0.0000025222873,0.0007054511],"genre_scores_gemma":[0.9991366,0.0001462395,0.000051391224,0.00009520852,0.000031387724,0.000025468806,0.00036218448,0.0000012284958,0.00015035608],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99958235,0.00009567862,0.00006611398,0.00009770565,0.000083308834,0.00007489659],"domain_scores_gemma":[0.99904054,0.00022262933,0.00032312033,0.00003226829,0.00008101269,0.00030049385],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047103627,0.00025244872,0.00077887304,0.0006247191,0.00044625052,0.00058150745,0.00016428316,0.00053378544,0.0015810829],"category_scores_gemma":[0.0017512885,0.0001500128,0.0005381664,0.0006874563,0.0001936152,0.00043426067,0.00023927336,0.00041343176,0.00027659873],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032127695,0.00024451988,0.98855674,0.00005158609,0.000299194,0.0004939847,0.00010063482,0.00012258855,0.0011027645,0.000029647166,0.0002570626,0.005528577],"study_design_scores_gemma":[0.00027143047,0.0011354281,0.9960234,0.000010885117,0.00011869957,0.0016440044,0.00013729412,0.00016668388,0.00006957674,0.00004138167,0.00037315604,0.000008036094],"about_ca_topic_score_codex":0.00075719657,"about_ca_topic_score_gemma":0.0011059142,"teacher_disagreement_score":0.0015810829,"about_ca_system_score_codex":0.00025498623,"about_ca_system_score_gemma":0.00026763818,"threshold_uncertainty_score":0.005289197},"labels":[],"label_agreement":null},{"id":"W2083502021","doi":"10.1111/jdv.12118","title":"A consensus report on appropriate treatment optimization and transitioning in the management of moderate‐to‐severe plaque psoriasis","year":2013,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":146,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"National Institute for Health and Care Research","keywords":"Medicine; Plaque psoriasis; Dermatology; Psoriasis; Consensus conference; MEDLINE; Intensive care medicine; Internal medicine","score_opus":0.018976310717006735,"score_gpt":0.24011096736160484,"score_spread":0.2211346566445981,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2083502021","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.013404386,0.24323165,0.093436725,0.482695,0.06910777,0.027938312,0.011398997,0.0010374528,0.05774973],"genre_scores_gemma":[0.13580818,0.26503167,0.40233517,0.09334947,0.010691332,0.050880883,0.026049133,0.0006059493,0.015248243],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.74916226,0.11191343,0.08726978,0.008178893,0.037441526,0.00603416],"domain_scores_gemma":[0.71483195,0.11432866,0.028900072,0.008964786,0.117912486,0.015061994],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.21804881,0.0022388902,0.0049283463,0.010292808,0.003769799,0.0071154092,0.009267563,0.015274269,0.008652428],"category_scores_gemma":[0.23165865,0.00201521,0.011551739,0.006191379,0.0033937548,0.0074372273,0.015429484,0.010422655,0.004456627],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000655783,0.00037145673,0.0038328192,0.17310467,0.0021727022,0.0014096932,0.013286596,0.0025208222,0.0028768315,0.019377446,0.35460943,0.4257817],"study_design_scores_gemma":[0.0008209033,0.0005567981,0.0059914207,0.3212101,0.0028686791,0.0021046833,0.008163538,0.0015169394,0.0015238136,0.02261587,0.632249,0.000378328],"about_ca_topic_score_codex":0.004739477,"about_ca_topic_score_gemma":0.0039037073,"teacher_disagreement_score":0.21804881,"about_ca_system_score_codex":0.009788954,"about_ca_system_score_gemma":0.071663335,"threshold_uncertainty_score":0.964285},"labels":[],"label_agreement":null},{"id":"W2093598521","doi":"10.1046/j.1468-3083.2001.00278.x","title":"The use of antidepressant drugs in dermatology","year":2001,"lang":"en","type":"review","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":140,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Western University","funders":"","keywords":"Medicine; Antidepressant; Doxepin; Psychiatry; Trazodone; Tricyclic antidepressant; Dermatology; Anxiety; Pharmacology","score_opus":0.06740521826130111,"score_gpt":0.3372424054885133,"score_spread":0.26983718722721217,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2093598521","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00033413435,0.99660504,0.000093607356,0.00043634712,0.00039512533,0.0000055414607,0.000048292637,0.000010686132,0.0020711026],"genre_scores_gemma":[0.001835167,0.99562967,0.00025475209,0.000565324,0.0005907898,0.000006028736,0.00008852398,0.0000034984346,0.0010262174],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9994654,0.00009745396,0.00015593073,0.00006845452,0.00017780118,0.000035029163],"domain_scores_gemma":[0.999233,0.00039364133,0.00016391503,0.000022135684,0.00015014387,0.0000372096],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039262898,0.0005058328,0.0009225994,0.002759262,0.0002371136,0.0009974355,0.0005018208,0.0008218963,0.0057210904],"category_scores_gemma":[0.0012302441,0.00024316748,0.0006582243,0.0025185295,0.00024584672,0.0011469705,0.0005690899,0.0011183588,0.0019661963],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007067334,0.00004525911,0.00088266016,0.011638521,0.0001213229,0.00041801168,0.000087935936,0.00015525428,0.00063741,0.0008843499,0.04215165,0.9429069],"study_design_scores_gemma":[0.000017857034,0.000100681216,0.004299712,0.0083027445,0.00022579035,0.007026531,0.00010035758,0.00008708514,0.00023687124,0.00082207716,0.9787579,0.000022492884],"about_ca_topic_score_codex":0.0011062518,"about_ca_topic_score_gemma":0.002563392,"teacher_disagreement_score":0.0057210904,"about_ca_system_score_codex":0.0005105219,"about_ca_system_score_gemma":0.00079766277,"threshold_uncertainty_score":0.019138932},"labels":[],"label_agreement":null},{"id":"W2094598110","doi":"10.1111/jdv.12587","title":"Treatment of facial erythema in patients with rosacea with topical brimonidine tartrate: correlation of patient satisfaction with standard clinical endpoints of improvement of facial erythema","year":2014,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Acne and Rosacea Treatments and Effects","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Galderma","keywords":"Medicine; Erythema; Rosacea; Dermatology; Brimonidine; Patient satisfaction; Internal medicine; Surgery","score_opus":0.009165477755679604,"score_gpt":0.2563354839994701,"score_spread":0.24717000624379049,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2094598110","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970289,0.0012976173,0.0006171572,0.00007969333,0.000009892986,0.00008232828,0.00019255582,0.0000113220985,0.00068054115],"genre_scores_gemma":[0.9992842,0.00013217748,0.0002975083,0.000042095446,0.00001076013,0.00003014227,0.00012369933,0.0000018526289,0.00007752757],"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9980458,0.0010945995,0.00020898886,0.00013370477,0.00043234462,0.00008447376],"domain_scores_gemma":[0.99084735,0.004794658,0.0033485498,0.0001939376,0.0005557839,0.00025971103],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0035173716,0.00017146001,0.00069234637,0.00027022063,0.00012904698,0.0003003153,0.0001374681,0.0002923788,0.0015683306],"category_scores_gemma":[0.006080184,0.00011920555,0.00051831163,0.00034066392,0.00017931806,0.00027486187,0.00022706739,0.0005161684,0.00015209871],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012092681,0.0005373114,0.93483245,0.00038305225,0.00083485973,0.0001416205,0.00020672545,0.0005298858,0.0065632216,0.000041869454,0.0003682903,0.043468032],"study_design_scores_gemma":[0.00035566353,0.008447525,0.98797894,0.000017074772,0.0002063032,0.000591054,0.00007441059,0.0010281787,0.0008581335,0.000023936966,0.00040543027,0.000013331926],"about_ca_topic_score_codex":0.00016554115,"about_ca_topic_score_gemma":0.00027636098,"teacher_disagreement_score":0.0035173716,"about_ca_system_score_codex":0.0001912226,"about_ca_system_score_gemma":0.00014779984,"threshold_uncertainty_score":0.018601894},"labels":[],"label_agreement":null},{"id":"W2095273564","doi":"10.1111/jdv.12210","title":"Factors influencing seasonal patterns of relapse in anti‐<scp>TNF</scp> psoriatic responders after temporary drug discontinuation","year":2013,"lang":"en","type":"letter","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canada's Michael Smith Genome Sciences Centre","keywords":"Medicine; Discontinuation; Drug; Tumor necrosis factor alpha; Psoriasis; Internal medicine; Pharmacology; Immunology","score_opus":0.017700943385415537,"score_gpt":0.22878811725361556,"score_spread":0.21108717386820003,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2095273564","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974477,0.0002711625,0.00007287898,0.00093472423,0.000047562397,0.000008440941,0.00012272043,0.000006264812,0.0010886223],"genre_scores_gemma":[0.9991725,0.0001115392,0.000058671576,0.00029121237,0.00007763861,0.000004485916,0.000053929685,0.00000372607,0.0002263688],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99974245,0.000072552255,0.00002790177,0.00003217783,0.000039947092,0.00008500884],"domain_scores_gemma":[0.9987357,0.00040112206,0.00042768667,0.00008875434,0.00013350089,0.00021325934],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030511525,0.000098434306,0.0002264916,0.00032407852,0.00036528884,0.00036253824,0.00016635796,0.0005151427,0.0017401569],"category_scores_gemma":[0.0023091885,0.00008877344,0.00026668655,0.0005859419,0.00016715807,0.0002369816,0.00013396346,0.00057085574,0.0002766127],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011878475,0.00012690706,0.98217356,0.000024418916,0.000039334565,0.0022836041,0.0003323404,0.000051104274,0.0022067449,0.000054144843,0.0012688021,0.010251201],"study_design_scores_gemma":[0.000011940537,0.00012647426,0.9959825,0.000009362614,0.00001558185,0.002540106,0.0004975022,0.00014249329,0.00012204369,0.000046496945,0.0005004841,0.0000049980436],"about_ca_topic_score_codex":0.0027019843,"about_ca_topic_score_gemma":0.004105326,"teacher_disagreement_score":0.0027019843,"about_ca_system_score_codex":0.0002422056,"about_ca_system_score_gemma":0.00018440104,"threshold_uncertainty_score":0.005821407},"labels":[],"label_agreement":null},{"id":"W2097558212","doi":"10.1111/j.1468-3083.2012.04692.x","title":"Correlation of photographic images from the Leeds revised acne grading system with a six‐category global acne severity scale","year":2012,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Acne and Rosacea Treatments and Effects","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Windsor Clinical Research; University of Windsor; Western University","funders":"","keywords":"Medicine; Acne; Grading (engineering); Grading scale; Dermatology; Surgery","score_opus":0.011377450055930577,"score_gpt":0.2472276166380265,"score_spread":0.23585016658209593,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2097558212","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98719144,0.00044863642,0.0050254674,0.000053258835,0.000076472155,0.0003298099,0.0007954675,0.00011337541,0.0059660156],"genre_scores_gemma":[0.9956755,0.00010397446,0.0029569897,0.0000228321,0.000018340632,0.00008956982,0.0005679342,0.00001827115,0.00054641743],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99663216,0.00093229,0.00045812156,0.00052724744,0.0013366899,0.00011343252],"domain_scores_gemma":[0.9837796,0.004817792,0.003192089,0.0014400446,0.0063730674,0.0003973227],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034556412,0.0003202027,0.00043473305,0.0024889815,0.00022271855,0.00059748685,0.0003224067,0.00033782207,0.003537821],"category_scores_gemma":[0.021722302,0.00018888604,0.00039768065,0.00081804197,0.00029164908,0.000593707,0.0007042761,0.00042988308,0.00051247986],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010788172,0.00011740547,0.94466794,0.0002206178,0.00038998644,0.00020864877,0.0008745948,0.0009261056,0.006642585,0.00014469559,0.0013115357,0.04341705],"study_design_scores_gemma":[0.000023265986,0.0002499596,0.9934536,0.000031082007,0.00006603704,0.0007399703,0.0004698615,0.0025632475,0.0014162929,0.000101346595,0.00086710684,0.000018199926],"about_ca_topic_score_codex":0.0010034259,"about_ca_topic_score_gemma":0.0013627808,"teacher_disagreement_score":0.003537821,"about_ca_system_score_codex":0.00032080893,"about_ca_system_score_gemma":0.0001977908,"threshold_uncertainty_score":0.01827538},"labels":[],"label_agreement":null},{"id":"W2103750969","doi":"10.1111/jdv.12751","title":"Efficacy, safety and usability of secukinumab administration by autoinjector/pen in psoriasis: a randomized, controlled trial (<scp>JUNCTURE</scp>)","year":2014,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":277,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Secukinumab; Medicine; Placebo; Psoriasis Area and Severity Index; Adverse effect; Randomized controlled trial; Psoriasis; Internal medicine; Dermatology; Alternative medicine; Pathology","score_opus":0.009028260821662588,"score_gpt":0.2390158899966629,"score_spread":0.22998762917500032,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2103750969","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9857282,0.003917242,0.00082195876,0.00038293467,0.0003618095,0.00608035,0.00082940666,0.00016488407,0.0017132359],"genre_scores_gemma":[0.9845793,0.0025362717,0.0020054665,0.00072738406,0.00041353106,0.006647374,0.0006994864,0.000029351733,0.0023618443],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9991654,0.00047312118,0.0000646832,0.00013389613,0.00007337078,0.00008947785],"domain_scores_gemma":[0.9988148,0.00034011048,0.00040449598,0.000089515495,0.00009102276,0.00026008778],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019799806,0.0012444912,0.0020912974,0.0003822407,0.00037260394,0.0010012802,0.0006599671,0.0014153854,0.0068814927],"category_scores_gemma":[0.0014310041,0.00052008283,0.0015651105,0.00039724304,0.00087272754,0.0006926605,0.00026710107,0.0020455448,0.0009006573],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9720918,0.009152968,0.00032854764,0.0006350179,0.0005368502,0.000024171464,0.000034016466,0.00013706165,0.0030853732,0.000054191332,0.000457338,0.013462655],"study_design_scores_gemma":[0.92410904,0.073598154,0.001023048,0.000032496526,0.00025871763,0.000024631987,0.00001173531,0.00021030042,0.0004358108,0.000044324555,0.00024476866,0.000006979475],"about_ca_topic_score_codex":0.00064237043,"about_ca_topic_score_gemma":0.0013151172,"teacher_disagreement_score":0.0068814927,"about_ca_system_score_codex":0.0004689966,"about_ca_system_score_gemma":0.0009743148,"threshold_uncertainty_score":0.023020923},"labels":[],"label_agreement":null},{"id":"W2104763740","doi":"10.1111/j.1468-3083.2011.04347.x","title":"Aesthetic evaluation after non‐invasive treatment for superficial basal cell carcinoma","year":2011,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Nonmelanoma Skin Cancer Studies","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Vascularity; Scars; Basal cell carcinoma; Reproducibility; Basal cell; Surgery; Dermatology; Pathology","score_opus":0.050446701983362166,"score_gpt":0.2879771208231179,"score_spread":0.23753041883975573,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2104763740","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979371,0.00061530614,0.0005757251,0.000016966309,0.000012129704,0.000039962742,0.000038268092,0.000010003947,0.00075456325],"genre_scores_gemma":[0.9991591,0.00018825552,0.00038208277,0.000012339489,0.000010368569,0.00001513864,0.000062822044,0.000003980883,0.00016593144],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99871194,0.00045448032,0.00015489252,0.00010394441,0.0005041909,0.00007058287],"domain_scores_gemma":[0.99601954,0.0012870242,0.001383956,0.00031155173,0.000783876,0.00021398427],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020537963,0.00034208954,0.00046415397,0.00086199684,0.00032619873,0.00036970523,0.00029704347,0.0002314623,0.0016773487],"category_scores_gemma":[0.004632219,0.00015823134,0.00049988827,0.0004889966,0.0004570187,0.00023732056,0.00047934358,0.00038431204,0.00027451618],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030589798,0.00040903233,0.86949396,0.00047689443,0.0002539731,0.0030387891,0.001443157,0.0006662614,0.018212745,0.000051228802,0.0005641059,0.102330945],"study_design_scores_gemma":[0.000036894973,0.0013991932,0.98656076,0.000020806372,0.00010190759,0.0075360294,0.00045204727,0.0004961689,0.0029479773,0.000058453228,0.00037465565,0.000014896485],"about_ca_topic_score_codex":0.00038327134,"about_ca_topic_score_gemma":0.000573945,"teacher_disagreement_score":0.0020537963,"about_ca_system_score_codex":0.00033149947,"about_ca_system_score_gemma":0.0001840306,"threshold_uncertainty_score":0.010861635},"labels":[],"label_agreement":null},{"id":"W2112239594","doi":"10.1111/j.1468-3083.2011.04386.x","title":"Daylight photodynamic therapy for actinic keratosis: an international consensus","year":2011,"lang":"en","type":"review","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Nonmelanoma Skin Cancer Studies","field":"Medicine","cited_by":217,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Innovaderm (Canada)","funders":"","keywords":"Daylight; Actinic keratosis; Medicine; Photodynamic therapy; Cosmesis; Dermatology; Keratosis; Actinic keratoses; Sunlight; Surgery; Internal medicine; Optics; Basal cell","score_opus":0.07704072548087271,"score_gpt":0.3729178681691493,"score_spread":0.2958771426882766,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2112239594","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00012670315,0.99394906,0.00044784916,0.0032520178,0.00086659414,0.00002113754,0.00003730861,0.00001180836,0.0012875756],"genre_scores_gemma":[0.00063607865,0.9963624,0.00088377035,0.0011241244,0.0003256817,0.000024448851,0.000072722665,0.0000037738505,0.0005669907],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9991708,0.0001347455,0.00024461513,0.000102299986,0.00030141277,0.000046070127],"domain_scores_gemma":[0.9978927,0.00079466455,0.00026456767,0.000063845204,0.0008386673,0.00014558919],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031096307,0.0008225486,0.0017805506,0.003186581,0.00044986574,0.0014228534,0.0022155219,0.0026986354,0.0032666372],"category_scores_gemma":[0.0027255595,0.00031465778,0.0013955568,0.0032653878,0.0007926766,0.0026719854,0.0011735338,0.0031061764,0.0019697852],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006162495,0.00009230732,0.00026473528,0.02604956,0.00012633421,0.00026608567,0.000105688036,0.00026454648,0.0009497642,0.0033634405,0.058243323,0.91021264],"study_design_scores_gemma":[0.000035037807,0.00007296986,0.0009825873,0.020543098,0.0003175811,0.001314826,0.00013563794,0.00012093561,0.00045493324,0.0028438305,0.9731529,0.00002573034],"about_ca_topic_score_codex":0.0017628832,"about_ca_topic_score_gemma":0.00290016,"teacher_disagreement_score":0.0032666372,"about_ca_system_score_codex":0.0010118706,"about_ca_system_score_gemma":0.0044891154,"threshold_uncertainty_score":0.016445518},"labels":[],"label_agreement":null},{"id":"W2112873380","doi":"10.1111/jdv.13228","title":"Daylight photodynamic therapy with methyl aminolevulinate cream is effective and nearly painless in treating actinic keratoses: a randomised, investigator‐blinded, controlled, phase <scp>III</scp> study throughout Europe","year":2015,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Nonmelanoma Skin Cancer Studies","field":"Medicine","cited_by":146,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"","keywords":"Medicine; Actinic keratosis; Photodynamic therapy; Adverse effect; Dermatology; Actinic keratoses; Incidence (geometry); Scalp; Target lesion; Clinical endpoint; Randomized controlled trial; Surgery; Internal medicine","score_opus":0.03183953925032114,"score_gpt":0.3296307222586962,"score_spread":0.2977911830083751,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2112873380","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98988837,0.0042173085,0.0008177773,0.00016605007,0.000174367,0.0036046277,0.00023895502,0.000057402387,0.0008350828],"genre_scores_gemma":[0.991646,0.0029057765,0.0017700241,0.000321387,0.00021116086,0.0019556463,0.00029070248,0.000022764541,0.00087666593],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9975172,0.0016875535,0.00017266048,0.00025656167,0.00022269301,0.000143312],"domain_scores_gemma":[0.998412,0.00057157193,0.00042011583,0.00014381326,0.00015439466,0.00029806787],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005564809,0.0009585219,0.0026551585,0.0005043114,0.000428226,0.0008554999,0.0010631847,0.0014140374,0.00303128],"category_scores_gemma":[0.0020363533,0.0006241624,0.00141396,0.00062869355,0.0011631475,0.00085289817,0.000359587,0.0013955196,0.00036226754],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9051844,0.03069551,0.0011742263,0.0016882152,0.00169176,0.000053602063,0.00018297034,0.0003039519,0.022547526,0.00010590965,0.00047862396,0.035893284],"study_design_scores_gemma":[0.7188681,0.2732438,0.004618777,0.000060154183,0.0006895612,0.000048539274,0.000033127882,0.00024169165,0.0015240017,0.00005295693,0.0006037007,0.000015534843],"about_ca_topic_score_codex":0.00076200045,"about_ca_topic_score_gemma":0.0020252785,"teacher_disagreement_score":0.005564809,"about_ca_system_score_codex":0.0005801362,"about_ca_system_score_gemma":0.0009136865,"threshold_uncertainty_score":0.029429853},"labels":[],"label_agreement":null},{"id":"W2114797203","doi":"10.1111/j.1468-3083.2007.02304.x","title":"1% topical cidofovir used as last alternative to treat viral infections","year":2007,"lang":"en","type":"letter","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Polyomavirus and related diseases","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"","keywords":"Medicine; Cidofovir; Pharmacy; Dermatology; Family medicine; Pediatrics; Virology; Virus","score_opus":0.02141723193309927,"score_gpt":0.3067943194311044,"score_spread":0.28537708749800517,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2114797203","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.26636958,0.1148068,0.005325245,0.40803218,0.055024993,0.00017805307,0.0003545036,0.00084750296,0.14906107],"genre_scores_gemma":[0.8118775,0.01851912,0.0024474068,0.106083505,0.024503397,0.00007295146,0.00012426551,0.000074558346,0.03629733],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99950933,0.00013930486,0.000061905885,0.00006536888,0.00011755596,0.000106416475],"domain_scores_gemma":[0.9994898,0.00028702637,0.000049868573,0.000027199365,0.00006134588,0.000084653446],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035491533,0.000595333,0.0011525226,0.000507027,0.0012487955,0.0007752273,0.0008018215,0.006249359,0.0032196702],"category_scores_gemma":[0.002801047,0.00018444729,0.00080850575,0.00030095846,0.0005917244,0.0008422257,0.0003113526,0.0046345023,0.0012130805],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020217304,0.0007437484,0.009407759,0.0009621768,0.0002109844,0.6673382,0.00043392828,0.00049459044,0.011594264,0.004333623,0.16367911,0.13877988],"study_design_scores_gemma":[0.0006537778,0.0013956354,0.009103673,0.00042883895,0.0001671136,0.73550653,0.000318664,0.001256091,0.0057499623,0.0024948535,0.242853,0.00007191011],"about_ca_topic_score_codex":0.0010563366,"about_ca_topic_score_gemma":0.002626751,"teacher_disagreement_score":0.006249359,"about_ca_system_score_codex":0.0011012554,"about_ca_system_score_gemma":0.00033528972,"threshold_uncertainty_score":0.010770857},"labels":[],"label_agreement":null},{"id":"W2121881520","doi":"10.1111/jdv.12197","title":"Systematic Review of Oral Treatments for Seborrheic Dermatitis","year":2013,"lang":"en","type":"review","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Nail Diseases and Treatments","field":"Medicine","cited_by":78,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mediprobe Research (Canada); University of Toronto","funders":"","keywords":"Medicine; Ketoconazole; Itraconazole; Regimen; Terbinafine; Fluconazole; Dosing; Randomized controlled trial; Clinical trial; Dermatology; Seborrheic dermatitis; Internal medicine; Antifungal","score_opus":0.045029536252832666,"score_gpt":0.35903027420260447,"score_spread":0.3140007379497718,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2121881520","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0008469284,0.9976821,0.00010003448,0.00015428472,0.00011691078,0.00030867226,0.00042591573,0.000007638845,0.00035761425],"genre_scores_gemma":[0.008970307,0.98915064,0.0005020689,0.0003790073,0.000088036366,0.000460522,0.000290277,0.0000053145704,0.00015382776],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99200094,0.0030620168,0.0028852478,0.000484808,0.001364703,0.00020230215],"domain_scores_gemma":[0.9811071,0.012413288,0.0040577175,0.00025681395,0.0019271427,0.00023804014],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006349536,0.0015279178,0.008908806,0.0100197885,0.0006360718,0.002359224,0.0020424693,0.0016073833,0.008436887],"category_scores_gemma":[0.025792722,0.00085930864,0.006814038,0.01019332,0.0008077225,0.0018868266,0.001245953,0.0010941791,0.0005300764],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018245021,0.00001428484,0.00022537286,0.9710183,0.0063457284,0.00008332516,0.00008061731,0.000040918887,0.00009645078,0.0000896067,0.0010873057,0.020735644],"study_design_scores_gemma":[0.00045503542,0.00030873017,0.0029345872,0.8947316,0.07660109,0.00041250678,0.00021643632,0.0000590269,0.00018232164,0.00019742231,0.023866398,0.00003485229],"about_ca_topic_score_codex":0.0057099666,"about_ca_topic_score_gemma":0.016688786,"teacher_disagreement_score":0.0100197885,"about_ca_system_score_codex":0.003119126,"about_ca_system_score_gemma":0.008641514,"threshold_uncertainty_score":0.033579946},"labels":[],"label_agreement":null},{"id":"W2124137477","doi":"10.1111/j.1468-3083.2004.00931.x","title":"Stressful major life events are associated with a higher frequency of cutaneous sensory symptoms: an empirical study of non‐clinical subjects","year":2004,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; Western University","funders":"","keywords":"Medicine; Dermatology; Audiology","score_opus":0.03300123175073792,"score_gpt":0.3324240930199173,"score_spread":0.2994228612691794,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2124137477","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9997336,0.00006240298,0.0000108462555,0.000009819364,0.0000016402702,0.000009851576,0.000017375512,3.4890377e-7,0.00015399321],"genre_scores_gemma":[0.99962246,0.00011007544,0.000023160033,0.000029170507,0.000008426969,0.000012349522,0.00007100778,5.2061347e-7,0.00012278747],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99957126,0.00013457793,0.000036972353,0.000067304405,0.000104162515,0.00008573913],"domain_scores_gemma":[0.99796677,0.0005217161,0.00065848086,0.00007606297,0.00028055153,0.00049652864],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047724845,0.00025173702,0.00027982733,0.0006043115,0.0007704892,0.00057604077,0.00024245719,0.00041737026,0.0027256839],"category_scores_gemma":[0.0031191497,0.000210238,0.00014647457,0.0005554728,0.00064692704,0.00034421333,0.00032179683,0.00031961774,0.00035732918],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012839785,0.00029026298,0.9959996,0.00002541263,0.00001874843,0.00032360954,0.0012113777,0.0000069304187,0.0002619388,0.000010024081,0.00011223553,0.0016115552],"study_design_scores_gemma":[0.000012726737,0.0003986078,0.99671173,0.0000067219057,0.0000070213573,0.00064362417,0.001987924,0.000021005626,0.000026267828,0.000009116465,0.00017284122,0.0000023739278],"about_ca_topic_score_codex":0.0054104375,"about_ca_topic_score_gemma":0.0067651714,"teacher_disagreement_score":0.0054104375,"about_ca_system_score_codex":0.0002786732,"about_ca_system_score_gemma":0.00038147607,"threshold_uncertainty_score":0.0107578635},"labels":[],"label_agreement":null},{"id":"W2129777700","doi":"10.1111/jdv.12046","title":"Long‐term efficacy of ustekinumab in patients with moderate‐to‐severe psoriasis treated for up to 5 years in the PHOENIX 1 study","year":2012,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":211,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Innovaderm (Canada); Probity Medical Research","funders":"","keywords":"Medicine; Ustekinumab; Psoriasis Area and Severity Index; Adverse effect; Psoriasis; Placebo; Population; Internal medicine; Randomized controlled trial; Clinical trial; Dermatology; Disease; Adalimumab","score_opus":0.02111987263224534,"score_gpt":0.26119187618601464,"score_spread":0.2400720035537693,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2129777700","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99212086,0.005745337,0.000106146865,0.00023328104,0.000043647167,0.00027969226,0.0003879286,0.000010396755,0.0010727479],"genre_scores_gemma":[0.9956381,0.0019793573,0.00016281368,0.00048361934,0.000112249385,0.00018967762,0.0006291802,0.0000027736003,0.0008022385],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9992157,0.0004131922,0.00003955803,0.000101186786,0.00011324884,0.000117091615],"domain_scores_gemma":[0.99905604,0.00014688658,0.0003470476,0.000060903494,0.000066323366,0.0003227413],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0038139995,0.00054896955,0.0010258807,0.00024319412,0.0005031473,0.0007849931,0.0004283148,0.0007482116,0.0014543218],"category_scores_gemma":[0.0011503444,0.0002667832,0.0012867453,0.0003191829,0.0002722745,0.00054508203,0.00040853547,0.0015181596,0.00024277063],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.52761555,0.021826236,0.28287742,0.0014535588,0.007827912,0.00047994484,0.00046585375,0.0011523527,0.010960076,0.00021889355,0.0050248075,0.14009742],"study_design_scores_gemma":[0.13953753,0.21943852,0.62376803,0.00037648686,0.006302708,0.0004841936,0.0001552501,0.0010451005,0.0020466328,0.00015389116,0.006639038,0.000052572428],"about_ca_topic_score_codex":0.00079160696,"about_ca_topic_score_gemma":0.0014745515,"teacher_disagreement_score":0.0038139995,"about_ca_system_score_codex":0.00047592894,"about_ca_system_score_gemma":0.00064606505,"threshold_uncertainty_score":0.02017057},"labels":[],"label_agreement":null},{"id":"W2135717941","doi":"10.1111/j.1468-3083.2011.04193.x","title":"Cultural and linguistic validation of acne‐QoL in French","year":2011,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Acne and Rosacea Treatments and Effects","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université Laval; Centre de Recherche Dermatologique du Québec Métropolitain; McMaster University; Windsor Clinical Research; University of Windsor; Western University","funders":"","keywords":"Medicine; Linguistics; MEDLINE","score_opus":0.04553297125672814,"score_gpt":0.2987348881926314,"score_spread":0.25320191693590327,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2135717941","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97894603,0.001209001,0.0047338144,0.00048638915,0.00009791643,0.0012361947,0.0017064027,0.000039583327,0.011544696],"genre_scores_gemma":[0.98885554,0.00045064502,0.00595241,0.00021070486,0.000039853057,0.0015462016,0.0018833547,0.0000258404,0.0010354575],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9921314,0.005220962,0.0006331188,0.00039980622,0.0012644402,0.00035029306],"domain_scores_gemma":[0.9891649,0.0040114443,0.0012625628,0.0007802585,0.0044925795,0.00028835202],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011594001,0.00049311423,0.00029655138,0.0015896093,0.0011692179,0.00083209854,0.000449066,0.00030785517,0.0032175744],"category_scores_gemma":[0.01925675,0.00011294667,0.00075173355,0.0009789006,0.00090770575,0.0003498793,0.0010780524,0.00046863192,0.00039048604],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011015973,0.0015673151,0.6492601,0.0013754964,0.0004225174,0.0016394125,0.045013443,0.0019335292,0.01202112,0.0032523782,0.010052781,0.27236032],"study_design_scores_gemma":[0.0002006865,0.0011402527,0.95214933,0.00068250555,0.00016361818,0.0018422247,0.008022585,0.0011117338,0.003399922,0.0003701702,0.030838868,0.000078097146],"about_ca_topic_score_codex":0.03567679,"about_ca_topic_score_gemma":0.035862725,"teacher_disagreement_score":0.03567679,"about_ca_system_score_codex":0.0025493647,"about_ca_system_score_gemma":0.0028529074,"threshold_uncertainty_score":0.07093823},"labels":[],"label_agreement":null},{"id":"W2140408800","doi":"10.1046/j.1468-3083.2002.00367.x","title":"Personality dimensions of sexually transmitted disease repeaters assessed with the Millon Clinical Multiaxial Inventory","year":2002,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Psychopathy, Forensic Psychiatry, Sexual Offending","field":"Psychology","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health","funders":"Science and Engineering Research Board","keywords":"Millon Clinical Multiaxial Inventory; Minnesota Multiphasic Personality Inventory; Medicine; Personality; Sexually transmitted disease; Clinical psychology; Psychiatry; Personality Assessment Inventory; Test (biology); Personality disorders; Psychology; Syphilis; Social psychology; Human immunodeficiency virus (HIV); Family medicine","score_opus":0.05467175663020175,"score_gpt":0.3259328662663068,"score_spread":0.27126110963610506,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2140408800","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9998084,0.00004540517,0.000013869416,0.0000061225287,0.000001702131,0.00000590611,0.0000417667,0.0000010715792,0.00007585291],"genre_scores_gemma":[0.99970514,0.000028044571,0.000053515247,0.0000053958506,0.0000036383076,0.000004856852,0.00010514624,5.9454266e-7,0.00009362314],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99967825,0.00008043156,0.000036597317,0.00006567639,0.00008510567,0.000053956774],"domain_scores_gemma":[0.9985018,0.00018027394,0.00081228523,0.00007963558,0.00011816251,0.0003079041],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047322598,0.00040851193,0.00045597742,0.0011302448,0.00045870585,0.000446813,0.00020968128,0.00039545432,0.0018524253],"category_scores_gemma":[0.0023569388,0.0002767127,0.0002856203,0.00047377008,0.00026989827,0.00026777294,0.00035456865,0.00053066225,0.00022207054],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012945793,0.0000855269,0.9981408,0.000004379802,0.000029455583,0.000189356,0.00012113319,0.000012971443,0.0004015872,0.000005120033,0.000029884908,0.0008503056],"study_design_scores_gemma":[0.000008307049,0.00027547972,0.9985726,0.0000024548378,0.000011169522,0.0008806401,0.00011061488,0.00005065371,0.000046466856,0.000005433637,0.00003408187,0.000002188527],"about_ca_topic_score_codex":0.0023229725,"about_ca_topic_score_gemma":0.0021749653,"teacher_disagreement_score":0.0023229725,"about_ca_system_score_codex":0.00028118325,"about_ca_system_score_gemma":0.00012947233,"threshold_uncertainty_score":0.0061969757},"labels":[],"label_agreement":null},{"id":"W2142040104","doi":"10.1046/j.1468-3083.2002.00380.x","title":"Tacrolimus: a review of its use for the management of dermatoses","year":2002,"lang":"en","type":"review","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":97,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Tacrolimus; Medicine; Atopic dermatitis; Pyoderma gangrenosum; Dermatology; Psoriasis; Calcineurin; Population; Pimecrolimus; Pharmacology; Surgery; Internal medicine; Transplantation; Disease","score_opus":0.08296957189220099,"score_gpt":0.35761478121636736,"score_spread":0.27464520932416636,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2142040104","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00016412216,0.9971085,0.00020128394,0.00018456782,0.0005385204,0.000011111274,0.000020642552,0.000012658182,0.0017587106],"genre_scores_gemma":[0.00060132187,0.997656,0.00032804563,0.00018491995,0.00048028873,0.000011519587,0.000032585755,0.0000028044622,0.0007025922],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996319,0.000062338106,0.00008006508,0.00006113937,0.00014154508,0.00002296547],"domain_scores_gemma":[0.99950135,0.00022596354,0.000072520714,0.000019856527,0.00012505174,0.000055098397],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005443266,0.0014208427,0.0019507488,0.0049732765,0.00053372944,0.0010985945,0.0013226785,0.0010700051,0.005569136],"category_scores_gemma":[0.0009653001,0.00030135844,0.00067123625,0.0051990394,0.00055340363,0.0017573393,0.00060687104,0.001620157,0.0037478146],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006845265,0.00011832059,0.00018420996,0.012268011,0.000078969126,0.0006591505,0.00009549881,0.0003319209,0.0011156336,0.0012166969,0.03895329,0.9449098],"study_design_scores_gemma":[0.000027084025,0.000115120005,0.0010900907,0.004537036,0.000114204966,0.0061277887,0.00006718913,0.00009703001,0.0002992097,0.0009781482,0.98652357,0.0000235798],"about_ca_topic_score_codex":0.0012407794,"about_ca_topic_score_gemma":0.002650362,"teacher_disagreement_score":0.005569136,"about_ca_system_score_codex":0.000495892,"about_ca_system_score_gemma":0.0008099635,"threshold_uncertainty_score":0.018630624},"labels":[],"label_agreement":null},{"id":"W2147039316","doi":"10.1111/j.1468-3083.2012.04470.x","title":"Neonatal intensive care practices and the influence on skin condition","year":2012,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Neonatal skin health care","field":"Health Professions","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health","funders":"Johnson and Johnson","keywords":"Medicine; Transepidermal water loss; Erythema; Gestational age; Rash; Irritation; Diaper Dermatitis; Dermatology; Pediatrics; Stratum corneum; Pregnancy; Immunology; Pathology","score_opus":0.03894538672755047,"score_gpt":0.4031856910818239,"score_spread":0.3642403043542734,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2147039316","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99082935,0.0056406823,0.000069334674,0.00036432547,0.000028117056,0.000013262192,0.00025643205,0.0000054860143,0.0027929223],"genre_scores_gemma":[0.99776626,0.001872492,0.00006730805,0.000045250676,0.000016852162,0.000007905842,0.00011247279,0.0000024746646,0.000109090164],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99895906,0.0004177966,0.00013084813,0.00010411331,0.00024325673,0.00014489701],"domain_scores_gemma":[0.99371606,0.0023281923,0.0025206204,0.00014841213,0.0004891761,0.00079765456],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00064280524,0.000144074,0.00022259839,0.00054907106,0.0003812803,0.0006123115,0.00034097634,0.00026702645,0.0028659839],"category_scores_gemma":[0.010330258,0.00010004053,0.00022692088,0.00086482946,0.00026087026,0.00027620108,0.0004676783,0.0005250571,0.00016903029],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005682297,0.000025896461,0.9936318,0.000037664617,0.000032777087,0.00048227582,0.00019202441,0.00003509737,0.000075888805,0.000041193583,0.00014609353,0.0052426136],"study_design_scores_gemma":[0.0000010501262,0.00005559866,0.99847573,0.000069355374,0.000015062166,0.0006965611,0.00030223985,0.00004782202,0.000048722082,0.000020975102,0.00026408103,0.0000027806461],"about_ca_topic_score_codex":0.0075422814,"about_ca_topic_score_gemma":0.0051458343,"teacher_disagreement_score":0.0075422814,"about_ca_system_score_codex":0.00064774725,"about_ca_system_score_gemma":0.00062115473,"threshold_uncertainty_score":0.014996767},"labels":[],"label_agreement":null},{"id":"W2156752733","doi":"10.1111/j.1468-3083.2011.04140.x","title":"Treatment of keloids and hypertrophic scars using topical and intralesional mitomycin C","year":2011,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Dermatologic Treatments and Research","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Mitomycin C; Hypertrophic scars; Dermatology; Scars; Surgery; Keloid; Adverse effect; Hypertrophic scar; Internal medicine","score_opus":0.07972781984046748,"score_gpt":0.31731605618742414,"score_spread":0.23758823634695667,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2156752733","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97997266,0.01532584,0.001980527,0.00013285963,0.000039758685,0.0000961946,0.000031538813,0.00005626435,0.0023645156],"genre_scores_gemma":[0.9951538,0.003282002,0.00086800783,0.000096544696,0.000053415934,0.000041001025,0.000044695127,0.0000058742985,0.0004546997],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99988055,0.000029320747,0.000009287218,0.000016468339,0.00003277217,0.000031527088],"domain_scores_gemma":[0.9998425,0.000051130104,0.000040898383,0.000019041314,0.000009693656,0.00003676072],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025126513,0.00028958102,0.0004196791,0.00021932596,0.0002898556,0.00011648168,0.00016614758,0.00024653637,0.0010401991],"category_scores_gemma":[0.00041442516,0.00009036109,0.00026932504,0.000104869876,0.00030014725,0.00012579683,0.00016626265,0.0004908733,0.00017536944],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008294424,0.0038867977,0.05594375,0.0025462944,0.00028765554,0.018120423,0.0006585079,0.0009903358,0.40404263,0.000392387,0.001626841,0.50321],"study_design_scores_gemma":[0.0041021556,0.119612016,0.3087014,0.0005264442,0.00080634304,0.24744461,0.00091340323,0.003139614,0.2942734,0.0005822798,0.019797405,0.00010091132],"about_ca_topic_score_codex":0.00022012921,"about_ca_topic_score_gemma":0.00054411654,"teacher_disagreement_score":0.0010401991,"about_ca_system_score_codex":0.00011078957,"about_ca_system_score_gemma":0.00019504491,"threshold_uncertainty_score":0.0034797788},"labels":[],"label_agreement":null},{"id":"W2157021107","doi":"10.1111/j.1468-3083.2006.01698.x","title":"Pulse itraconazole vs. continuous terbinafine for the treatment of dermatophyte toenail onychomycosis in patients with diabetes mellitus","year":2006,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Nail Diseases and Treatments","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; Sunnybrook Hospital; Toronto General Hospital; University of Toronto; Mediprobe Research (Canada); Sunnybrook Health Science Centre","funders":"","keywords":"Terbinafine; Itraconazole; Medicine; Dermatophyte; Population; Dermatology; Adverse effect; Nail (fastener); Internal medicine; Concomitant; Randomized controlled trial; Antifungal","score_opus":0.006744628919302417,"score_gpt":0.22714307767739778,"score_spread":0.22039844875809536,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2157021107","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99720615,0.0020323123,0.000106078245,0.000052309755,0.000049468857,0.00020351537,0.0000444103,0.0000074860664,0.00029820768],"genre_scores_gemma":[0.99786633,0.0010511295,0.00040728683,0.00012307931,0.00012310021,0.00019564529,0.000067211135,0.0000016260125,0.00016463315],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9994128,0.00027076964,0.00008062859,0.00007719666,0.0000850533,0.00007357795],"domain_scores_gemma":[0.99849105,0.0006658399,0.00035603734,0.00008542776,0.00006492528,0.0003367218],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001659823,0.00041321525,0.0014711939,0.00035474516,0.0002674132,0.00052399765,0.00047689644,0.0007320508,0.0020375242],"category_scores_gemma":[0.0015697978,0.0002672781,0.00091875286,0.00037269862,0.0004719167,0.00050600345,0.00026719377,0.0011967922,0.00017199431],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8679719,0.022417413,0.010663901,0.0008187634,0.0008712285,0.0001797843,0.00010567572,0.00060948654,0.013931271,0.00008324919,0.00024603566,0.08210131],"study_design_scores_gemma":[0.2936855,0.6586988,0.04023411,0.00012071831,0.0013110891,0.00030592148,0.000081778424,0.0010603464,0.003871435,0.00007727349,0.00052842003,0.000024653848],"about_ca_topic_score_codex":0.000288844,"about_ca_topic_score_gemma":0.00049945794,"teacher_disagreement_score":0.0020375242,"about_ca_system_score_codex":0.0002598421,"about_ca_system_score_gemma":0.00045253037,"threshold_uncertainty_score":0.008778095},"labels":[],"label_agreement":null},{"id":"W2158472585","doi":"10.1111/j.1468-3083.2007.02506.x","title":"Lack of association of iron metabolism and Dupuytren's disease","year":2008,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Dupuytren's Contracture and Treatments","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Nutrition, Metabolism and Diabetes","funders":"Univerzita Karlova v Praze","keywords":"Medicine; Internal medicine; Pathogenesis; Dupuytren's contracture; Chronic liver disease; Dyslipidemia; Diabetes mellitus; Gastroenterology; Incidence (geometry); Disease; Hereditary hemochromatosis; Fibrosis; Liver disease; Cirrhosis; Surgery; Hemochromatosis; Endocrinology","score_opus":0.02207643369068086,"score_gpt":0.2776691287881359,"score_spread":0.255592695097455,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2158472585","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988607,0.000380862,0.00009532612,0.00003602746,0.0000073946208,0.000003468226,0.000064383734,0.0000033012118,0.00054860866],"genre_scores_gemma":[0.9997291,0.00007048388,0.00004085403,0.000010125571,0.0000119535825,0.000001994863,0.000048993006,0.000001069522,0.00008543847],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999461,0.000104113176,0.00007735869,0.00016385959,0.00011011193,0.000083674364],"domain_scores_gemma":[0.99593556,0.0014184439,0.0015330266,0.00024123678,0.0002929007,0.00057885697],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00058351894,0.000378622,0.00044764837,0.0012131684,0.00043396832,0.0003901463,0.00034311335,0.00058622344,0.0051993],"category_scores_gemma":[0.0035801188,0.00020246312,0.00023088307,0.0006509294,0.0006104184,0.00028333094,0.00032738043,0.00039677296,0.00031144105],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035030872,0.000031964348,0.9945655,0.000026041957,0.000060530547,0.0016966687,0.000065493645,0.000032681695,0.0011608938,0.000058085167,0.00005355135,0.0018983105],"study_design_scores_gemma":[0.000017137532,0.00034916247,0.97670627,0.000012128861,0.00006322636,0.021826211,0.0001010207,0.00018173759,0.0003201061,0.00011540118,0.00029967175,0.00000783701],"about_ca_topic_score_codex":0.00076378055,"about_ca_topic_score_gemma":0.0006517671,"teacher_disagreement_score":0.0051993,"about_ca_system_score_codex":0.00015239777,"about_ca_system_score_gemma":0.00021390182,"threshold_uncertainty_score":0.01739341},"labels":[],"label_agreement":null},{"id":"W2161108378","doi":"10.1046/j.1468-3083.2001.00195.x","title":"Uncommon localization or presentation of tinea infection","year":2001,"lang":"en","type":"letter","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Nail Diseases and Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Tinea capitis; Medicine; Dermatology; Scalp; Dermatophyte; Seborrheic dermatitis; Microsporum canis; Differential diagnosis; Nail (fastener); Trichophyton; Trichophyton rubrum; Pathology; Antifungal","score_opus":0.03040885177046571,"score_gpt":0.30896397742106557,"score_spread":0.27855512565059987,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2161108378","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.79658824,0.052522816,0.009262729,0.0021542755,0.0014794341,0.0003321934,0.0011852257,0.0012897094,0.13518544],"genre_scores_gemma":[0.98834515,0.0055114655,0.00088424876,0.0009022215,0.0006516399,0.00003118394,0.00041579455,0.00006274614,0.0031955217],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9992285,0.000053464846,0.00007383604,0.0001679061,0.00013347506,0.0003427104],"domain_scores_gemma":[0.9989749,0.00012548377,0.00034423155,0.00010972386,0.00014061587,0.00030492488],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022216032,0.0010938279,0.00097259943,0.0015491622,0.0012787337,0.0013518461,0.0008610655,0.0019065003,0.011515404],"category_scores_gemma":[0.0028019634,0.00039851424,0.0006294442,0.0012471296,0.0006756486,0.0014237806,0.0011976338,0.0016607756,0.0033617748],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023503802,0.00027487564,0.20739469,0.00061522704,0.00009062128,0.7244016,0.0006478879,0.00039536288,0.0063394727,0.001852494,0.010666784,0.047086038],"study_design_scores_gemma":[0.000011102459,0.00007086615,0.0163086,0.0001809225,0.000028362996,0.9783458,0.00029263127,0.00024806813,0.00046011354,0.000801729,0.0032310449,0.00002071864],"about_ca_topic_score_codex":0.0016015772,"about_ca_topic_score_gemma":0.0011677898,"teacher_disagreement_score":0.011515404,"about_ca_system_score_codex":0.0004876746,"about_ca_system_score_gemma":0.0005834845,"threshold_uncertainty_score":0.0385229},"labels":[],"label_agreement":null},{"id":"W2164214226","doi":"10.1111/j.1468-3083.2007.02534.x","title":"Psoriasis: consensus on topical therapies","year":2008,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; Western University","funders":"","keywords":"Medicine; Consensus conference; Psoriasis; Family medicine; Alternative medicine; MEDLINE; Dermatology; Pathology; Internal medicine","score_opus":0.030575454888843716,"score_gpt":0.24952175534235474,"score_spread":0.21894630045351102,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2164214226","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0015005183,0.26423264,0.021349564,0.5491747,0.11236025,0.0018155787,0.0017938978,0.00039648323,0.04737632],"genre_scores_gemma":[0.05991432,0.42377895,0.12861834,0.25606197,0.058292642,0.0061994134,0.011369264,0.00071045756,0.055054605],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9434817,0.02084309,0.010153468,0.0026193142,0.020504534,0.0023978574],"domain_scores_gemma":[0.9349842,0.014368937,0.0055177896,0.0030828489,0.035989,0.0060572233],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.057968818,0.0017209952,0.0031593225,0.00704318,0.0026356543,0.0073590055,0.0071546445,0.013350192,0.012475352],"category_scores_gemma":[0.06313716,0.0012457015,0.0037174835,0.0047375425,0.0028449625,0.0053666676,0.008127284,0.016092392,0.009253655],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016935903,0.00008481639,0.00035614794,0.0093855085,0.00017861491,0.00033049466,0.00085308915,0.00040193967,0.0007885242,0.013500626,0.7685944,0.20535648],"study_design_scores_gemma":[0.00007481022,0.000048319027,0.0006243732,0.012878999,0.0001241278,0.00048216214,0.00041342858,0.00012053133,0.0003128463,0.011843357,0.97303873,0.00003826599],"about_ca_topic_score_codex":0.0030685312,"about_ca_topic_score_gemma":0.0031038842,"teacher_disagreement_score":0.057968818,"about_ca_system_score_codex":0.0062498236,"about_ca_system_score_gemma":0.035158608,"threshold_uncertainty_score":0.30657202},"labels":[],"label_agreement":null},{"id":"W2166708589","doi":"10.1111/j.1468-3083.2004.00781.x","title":"First case of <i>Mycobacterium haemophilum</i> infection in an AIDS patient in Italy**","year":2003,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Mycobacterium research and diagnosis","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Dermatology; Incidence (geometry); Mycobacterium avium complex; Disease; Acid-fast; Human immunodeficiency virus (HIV); Tuberculosis; Mycobacterium; Immunology; Pathology","score_opus":0.021531631159157922,"score_gpt":0.2895484124112846,"score_spread":0.2680167812521267,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2166708589","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9541851,0.0036295853,0.0009160162,0.0050680465,0.00068575534,0.00017961522,0.00028149263,0.00018379666,0.03487046],"genre_scores_gemma":[0.9937955,0.0008717159,0.0003842757,0.0019975519,0.00085679954,0.0000255311,0.000096116215,0.000024277524,0.0019482032],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99951196,0.00006635452,0.000041448035,0.00010513144,0.000048348997,0.00022669636],"domain_scores_gemma":[0.9991048,0.0002204947,0.00019783384,0.00006947139,0.00007006474,0.00033737763],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031149006,0.0014094079,0.0008990232,0.0011988019,0.0030767852,0.0013189436,0.0010597344,0.0041161817,0.0018047394],"category_scores_gemma":[0.0019831974,0.00078061403,0.0010368782,0.0009506064,0.0012851285,0.0009011642,0.0011646448,0.0023344674,0.0008751208],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000895317,0.00013407912,0.029140526,0.00007431412,0.000022599776,0.963959,0.00095378386,0.00006847869,0.001050372,0.00019977348,0.0019015918,0.0024059243],"study_design_scores_gemma":[0.000030281499,0.00034203738,0.048292633,0.00004380417,0.000034913202,0.94661343,0.00056466996,0.00018782755,0.00026134186,0.00009526211,0.0035040646,0.00002968],"about_ca_topic_score_codex":0.006344309,"about_ca_topic_score_gemma":0.0073103076,"teacher_disagreement_score":0.006344309,"about_ca_system_score_codex":0.0012145321,"about_ca_system_score_gemma":0.0006671711,"threshold_uncertainty_score":0.012614787},"labels":[],"label_agreement":null},{"id":"W2167552313","doi":"10.1111/j.1468-3083.2004.01180.x","title":"Hyaluronic acid: a unique topical vehicle for the localized delivery of drugs to the skin","year":2005,"lang":"en","type":"review","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Proteoglycans and glycosaminoglycans research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":371,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Hyaluronic acid; Transdermal; Drug delivery; Pharmacology; Dermatology; Surgery","score_opus":0.03020499803473864,"score_gpt":0.3339282385067472,"score_spread":0.30372324047200855,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2167552313","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.012004698,0.96834266,0.007874157,0.0004953409,0.00073593145,0.00006152882,0.00014853872,0.00010414034,0.010232999],"genre_scores_gemma":[0.060610425,0.9125891,0.0077782026,0.00056396046,0.0005385446,0.00006363974,0.00025383948,0.000025819623,0.017576555],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9999076,0.000013468416,0.000008791406,0.000018043886,0.000039504794,0.00001255926],"domain_scores_gemma":[0.9999672,0.000006292903,0.000009934023,0.0000014891693,0.000008440268,0.000006670787],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014725362,0.00045509805,0.00030576493,0.00076507573,0.00018428205,0.0005394927,0.00023353097,0.0005044768,0.0011932254],"category_scores_gemma":[0.00009211705,0.00012895989,0.00019583017,0.00066244387,0.0002239252,0.000711766,0.00029289522,0.0005840387,0.0010633077],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001493907,0.00010645595,0.00038275614,0.0072176037,0.00005574689,0.0011202946,0.00014756255,0.00042269178,0.38612857,0.005537928,0.011684752,0.58704627],"study_design_scores_gemma":[0.00001563316,0.00044371074,0.001994157,0.0004585898,0.00008305802,0.007462177,0.00008409561,0.0003440132,0.13651899,0.0007533485,0.8518078,0.000034524553],"about_ca_topic_score_codex":0.00032306605,"about_ca_topic_score_gemma":0.00043795435,"teacher_disagreement_score":0.0011932254,"about_ca_system_score_codex":0.00023458607,"about_ca_system_score_gemma":0.00023386051,"threshold_uncertainty_score":0.003991723},"labels":[],"label_agreement":null},{"id":"W2169158351","doi":"10.1111/j.1468-3083.2012.04453.x","title":"Unique features of PTCH1 mutation spectrum in Chinese sporadic basal cell carcinoma","year":2012,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Hedgehog Signaling Pathway Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Specialized Research Fund for the Doctoral Program of Higher Education of China","keywords":"PTCH1; Loss of heterozygosity; Mutation; Genetics; Basal cell carcinoma; Single-nucleotide polymorphism; Population; Biology; Medicine; Cancer research; Gene; Pathology; Allele; Genotype; Basal cell; Hedgehog signaling pathway","score_opus":0.009025741006305089,"score_gpt":0.24422592873861534,"score_spread":0.23520018773231025,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2169158351","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99940944,0.0001241763,0.000075667485,0.000018701852,0.0000024466817,0.0000075259177,0.00004741083,0.000005779535,0.00030877916],"genre_scores_gemma":[0.99964356,0.000057747922,0.00008922211,0.000011618409,0.0000043837736,0.000005554032,0.000073337455,0.0000020043103,0.000112519796],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99984014,0.000009149083,0.00001538551,0.000046207377,0.000053321848,0.00003587388],"domain_scores_gemma":[0.9997379,0.00005038151,0.000059033595,0.000022989143,0.0000508784,0.000078839585],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017542162,0.00031536986,0.00037234137,0.0018890377,0.00082013564,0.00023082802,0.00024227118,0.00030141877,0.0013801168],"category_scores_gemma":[0.00052401866,0.0001990865,0.0002698329,0.00087234343,0.0004068185,0.00011648034,0.00027403684,0.00018357196,0.0001961456],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046196545,0.00011450691,0.83531415,0.00011583281,0.000084675456,0.058022942,0.0014619874,0.00034850553,0.090013385,0.00018347321,0.00040329844,0.0134753715],"study_design_scores_gemma":[0.000031478365,0.00021846688,0.9169219,0.000013628097,0.00010356607,0.07363003,0.00049602654,0.00066733913,0.006735405,0.0002477571,0.00091399485,0.00002035451],"about_ca_topic_score_codex":0.006468872,"about_ca_topic_score_gemma":0.0071893893,"teacher_disagreement_score":0.006468872,"about_ca_system_score_codex":0.00043027478,"about_ca_system_score_gemma":0.000462466,"threshold_uncertainty_score":0.012862444},"labels":[],"label_agreement":null},{"id":"W2169913775","doi":"10.1111/j.1468-3083.2008.02785.x","title":"Effectiveness and safety of a prevention‐of‐flare‐progression strategy with pimecrolimus cream 1% in the management of paediatric atopic dermatitis","year":2008,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health","funders":"","keywords":"Pimecrolimus; Medicine; Atopic dermatitis; Dermatology; Randomization; Randomized controlled trial; Calcineurin; Surgery; Transplantation","score_opus":0.013590214088772609,"score_gpt":0.27752948685634954,"score_spread":0.26393927276757695,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2169913775","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99663687,0.002833752,0.00008532347,0.000055803604,0.000019895811,0.000107310676,0.000029785517,0.0000060516986,0.00022523344],"genre_scores_gemma":[0.9976708,0.0014691146,0.000458683,0.000062257954,0.000071003975,0.0001027169,0.00005750571,0.0000015978788,0.00010634033],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99921596,0.0004750631,0.00006719366,0.00007247817,0.00011810502,0.000051167015],"domain_scores_gemma":[0.9991078,0.00037240703,0.00032135993,0.000041158906,0.000036632286,0.00012062426],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001300034,0.00032032427,0.00092344324,0.00020642778,0.00017951822,0.00026442687,0.00037414805,0.00053207483,0.00091593264],"category_scores_gemma":[0.0018062245,0.00016621937,0.0006284482,0.00013780947,0.00032560623,0.00030984328,0.00015750158,0.0008451005,0.00012341069],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.50804883,0.03583738,0.039595027,0.0030422444,0.0020012066,0.00046715504,0.0002766047,0.002317093,0.026458642,0.00018091753,0.00070157176,0.3810733],"study_design_scores_gemma":[0.14683746,0.7303618,0.10793547,0.00031157178,0.0014790503,0.0008569438,0.00008948835,0.0016424231,0.008642289,0.00007644925,0.0017344203,0.000032692962],"about_ca_topic_score_codex":0.00033412056,"about_ca_topic_score_gemma":0.00064148393,"teacher_disagreement_score":0.001300034,"about_ca_system_score_codex":0.0002826761,"about_ca_system_score_gemma":0.0004521387,"threshold_uncertainty_score":0.006875336},"labels":[],"label_agreement":null},{"id":"W2171514322","doi":"10.1111/j.1468-3083.2011.04432.x","title":"Photodynamic therapy for skin field cancerization: an international consensus. International Society for Photodynamic Therapy in Dermatology","year":2012,"lang":"en","type":"review","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Nonmelanoma Skin Cancer Studies","field":"Medicine","cited_by":91,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Innovaderm (Canada)","funders":"","keywords":"Medicine; Photodynamic therapy; Field cancerization; Dermatology; Pathology; Basal cell","score_opus":0.046656333393848094,"score_gpt":0.36428724872466767,"score_spread":0.31763091533081955,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2171514322","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000054696604,0.99776936,0.00010191926,0.0009800909,0.0003101254,0.000006864925,0.000016351789,0.000004732705,0.000755859],"genre_scores_gemma":[0.0005850731,0.9977081,0.0003759207,0.00049253524,0.00019768957,0.000010527474,0.000040147836,0.0000020763994,0.00058787514],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9994814,0.00007069642,0.00014752103,0.00007204405,0.00019799903,0.000030407602],"domain_scores_gemma":[0.99898976,0.0003536767,0.0001884086,0.000028110693,0.000365288,0.000074835414],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017610933,0.00081369496,0.0013336944,0.0035917624,0.00037486723,0.0012502493,0.0013456374,0.0018207853,0.003431381],"category_scores_gemma":[0.0013182297,0.00030187573,0.00075927394,0.00392331,0.00074838736,0.002051251,0.0008694975,0.002460596,0.0024857125],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004026844,0.00006993186,0.00024346384,0.013360363,0.00003814176,0.00020914366,0.00007278042,0.00012426854,0.00073909876,0.0026199191,0.04865648,0.93382615],"study_design_scores_gemma":[0.00001876518,0.000061339066,0.0013561352,0.009656771,0.000102914426,0.002478599,0.00014699736,0.00006857469,0.00041092304,0.0016787082,0.98400116,0.000019219073],"about_ca_topic_score_codex":0.0017490559,"about_ca_topic_score_gemma":0.0031143553,"teacher_disagreement_score":0.0035917624,"about_ca_system_score_codex":0.00087687984,"about_ca_system_score_gemma":0.0025126964,"threshold_uncertainty_score":0.01147908},"labels":[],"label_agreement":null},{"id":"W2259724254","doi":"10.1111/jdv.13559","title":"Participation and health care provision of statutory skin cancer screening in Germany – a secondary data analysis","year":2016,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Cutaneous Melanoma Detection and Management","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"DAK-Gesundheit","keywords":"Medicine; Quarter (Canadian coin); Statutory law; Demography; Health insurance; German; Population; Health care; Family medicine; Gerontology; Environmental health; Law; Geography","score_opus":0.04137604867302665,"score_gpt":0.34865641377928913,"score_spread":0.3072803651062625,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2259724254","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9881058,0.0002061346,0.00019224157,0.00008497977,0.0000047276158,0.00006942438,0.010768945,0.000008156335,0.00055968086],"genre_scores_gemma":[0.99141616,0.00009210869,0.0002069116,0.0000388297,0.000007481898,0.00014001715,0.00785902,0.0000034398927,0.00023606014],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99602026,0.0013693873,0.00061782304,0.0007048649,0.00056569924,0.0007221034],"domain_scores_gemma":[0.99381846,0.0015393505,0.0032297943,0.00047783685,0.00051696325,0.00041753956],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0033917315,0.00037231226,0.0005461117,0.004367395,0.00030958228,0.0009589603,0.0006057382,0.00048893766,0.0029825268],"category_scores_gemma":[0.005900269,0.00031527365,0.0013888592,0.0056567183,0.0003689067,0.0007248893,0.001032505,0.00047201704,0.0004794887],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019491088,0.00009918457,0.9948319,0.00010725831,0.00030530847,0.00007997311,0.00025150416,0.0003279263,0.00010346379,0.00010507136,0.00088822,0.0027051538],"study_design_scores_gemma":[0.0000119146225,0.00007627158,0.9983493,0.000026693202,0.00007464201,0.000047551755,0.00023205981,0.0005257266,0.000084082814,0.000018051589,0.0005484232,0.0000052496707],"about_ca_topic_score_codex":0.025366424,"about_ca_topic_score_gemma":0.015372766,"teacher_disagreement_score":0.025366424,"about_ca_system_score_codex":0.0016955473,"about_ca_system_score_gemma":0.0011781304,"threshold_uncertainty_score":0.05043757},"labels":[],"label_agreement":null},{"id":"W2287025256","doi":"10.1111/jdv.13556","title":"Prevalence of rosacea in the general population of Germany and Russia – The <scp>RISE</scp> study","year":2016,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Acne and Rosacea Treatments and Effects","field":"Medicine","cited_by":145,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Windsor Clinical Research; Western University","funders":"","keywords":"Rosacea; Medicine; Epidemiology; Population; Phototype; Demography; Dermatology; Pediatrics; Internal medicine; Environmental health","score_opus":0.015102449670923626,"score_gpt":0.285933548558823,"score_spread":0.2708310988878994,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2287025256","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99897563,0.00022506356,0.000038968556,0.000022888078,0.0000045570564,0.000010215051,0.00038277608,0.0000029237483,0.00033715728],"genre_scores_gemma":[0.9993351,0.000109195964,0.000041413357,0.000018192473,0.0000057664156,0.000007900607,0.00038739332,7.934022e-7,0.00009437793],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994696,0.00014980121,0.000065864246,0.00012543592,0.00010799412,0.00008140164],"domain_scores_gemma":[0.9994832,0.000051986775,0.00023954296,0.000044281885,0.000060069924,0.00012097413],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007333328,0.00024356888,0.00034475804,0.0012372278,0.0002965921,0.0005439594,0.00030436454,0.00047088455,0.0009033934],"category_scores_gemma":[0.0007364682,0.00024113942,0.0005029785,0.00086405315,0.0002625488,0.00043716893,0.0005220857,0.00032943208,0.00024132687],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006986434,0.00003067759,0.9981862,0.000013436961,0.00007134986,0.000062627725,0.000116293355,0.000020775658,0.00019352131,0.000014680298,0.00011307844,0.0011075829],"study_design_scores_gemma":[0.0000031341751,0.00004842129,0.9995889,0.000003047162,0.000013437698,0.000092161106,0.00010031144,0.000028889086,0.00001842368,0.0000033254416,0.00009877019,0.0000011258459],"about_ca_topic_score_codex":0.011168253,"about_ca_topic_score_gemma":0.0074824686,"teacher_disagreement_score":0.011168253,"about_ca_system_score_codex":0.0004345541,"about_ca_system_score_gemma":0.00028636467,"threshold_uncertainty_score":0.022206485},"labels":[],"label_agreement":null},{"id":"W2301023649","doi":"10.1111/jdv.13614","title":"Identification of key research needs for topical therapy treatment of psoriasis – a consensus paper by the International Psoriasis Council","year":2016,"lang":"en","type":"review","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Innovaderm (Canada); University of Toronto","funders":"","keywords":"Psoriasis; Medicine; Dermatology; Systemic therapy; Topical agents; Internal medicine","score_opus":0.13021997312421185,"score_gpt":0.3547782450982474,"score_spread":0.22455827197403555,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2301023649","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00013801093,0.9818901,0.000447831,0.013085549,0.0027683277,0.000020861806,0.000034633314,0.000011991289,0.0016026567],"genre_scores_gemma":[0.0013602022,0.99117357,0.0012196286,0.003948907,0.0013434764,0.000021389682,0.000091678776,0.0000068793124,0.0008342844],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981704,0.00041029393,0.00037234742,0.00021894282,0.0006738471,0.00015416337],"domain_scores_gemma":[0.99445677,0.0027631316,0.00048081877,0.00014610415,0.001706391,0.00044672025],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0064578457,0.0007283089,0.0018301673,0.0032951224,0.0006940359,0.0026993707,0.0013614531,0.003927311,0.0038123692],"category_scores_gemma":[0.004616469,0.00045309955,0.0011693253,0.002714685,0.0013861557,0.004462419,0.002090944,0.007069483,0.002088812],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000098623925,0.00012203751,0.0002814085,0.020404974,0.00007628222,0.00044093866,0.00029362697,0.00027162,0.0019878503,0.014430941,0.13027702,0.8313147],"study_design_scores_gemma":[0.000017298067,0.00004799514,0.0004202128,0.008987665,0.00007180641,0.0008803701,0.00024815454,0.00005514048,0.00036245617,0.004089953,0.9847965,0.000022521013],"about_ca_topic_score_codex":0.0015461014,"about_ca_topic_score_gemma":0.0024893768,"teacher_disagreement_score":0.0064578457,"about_ca_system_score_codex":0.0015147582,"about_ca_system_score_gemma":0.008183392,"threshold_uncertainty_score":0.034152806},"labels":[],"label_agreement":null},{"id":"W2323054755","doi":"10.1111/jdv.13636","title":"Fragility of epidermis in newborns, children and adolescents","year":2016,"lang":"en","type":"review","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Neonatal skin health care","field":"Health Professions","cited_by":61,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Windsor Clinical Research; University of Windsor; Western University","funders":"","keywords":"Atopic dermatitis; Medicine; Dermatology; Acne; Dry skin; Rosacea; Pathological; Epidermis (zoology); Pathology; Anatomy","score_opus":0.05234042134235651,"score_gpt":0.41697344414858295,"score_spread":0.36463302280622645,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2323054755","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00044981198,0.9987772,0.000026114754,0.000110186134,0.00005618983,0.0000019483753,0.000009614818,0.0000021965245,0.0005667103],"genre_scores_gemma":[0.0039604963,0.9955382,0.000065711996,0.00008184067,0.0000714999,0.0000030765286,0.000014438423,6.2299523e-7,0.00026412297],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997856,0.000040566545,0.00004232526,0.00003885003,0.00006902971,0.000023725026],"domain_scores_gemma":[0.9996866,0.0001886913,0.000061182145,0.000005827025,0.000040761806,0.000017045593],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029337537,0.00046402897,0.00073658716,0.0021197733,0.0002948843,0.0008568533,0.0003632457,0.00080253277,0.0022569601],"category_scores_gemma":[0.000876971,0.00015900192,0.0004703839,0.001405464,0.00050769537,0.0009085762,0.0005058677,0.0007993844,0.00045748556],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000078584206,0.000052669104,0.0030332254,0.027460026,0.000098873126,0.0016708168,0.00036693594,0.00013330106,0.0009410893,0.0024539996,0.013722377,0.9499881],"study_design_scores_gemma":[0.000019697995,0.0001893486,0.025036432,0.037127536,0.00048058832,0.049941648,0.0016799957,0.00011560351,0.0014555785,0.0033706883,0.8805328,0.000050042312],"about_ca_topic_score_codex":0.0017894818,"about_ca_topic_score_gemma":0.0025207251,"teacher_disagreement_score":0.0022569601,"about_ca_system_score_codex":0.00037661902,"about_ca_system_score_gemma":0.0006158043,"threshold_uncertainty_score":0.007550299},"labels":[],"label_agreement":null},{"id":"W2323925800","doi":"10.1111/jdv.13611","title":"Drug survival of biologic therapy in a large, disease‐based registry of patients with psoriasis: results from the Psoriasis Longitudinal Assessment and Registry (PSOLAR)","year":2016,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":242,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research","funders":"","keywords":"Medicine; Ustekinumab; Adalimumab; Discontinuation; Etanercept; Psoriasis; Hazard ratio; Infliximab; Internal medicine; Proportional hazards model; Confidence interval; Disease; Dermatology; Rheumatoid arthritis","score_opus":0.02220654482873743,"score_gpt":0.25711842298768806,"score_spread":0.23491187815895062,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2323925800","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9888598,0.0009174012,0.00086848444,0.00020639303,0.000016172642,0.00008987849,0.008011,0.00003539174,0.0009955177],"genre_scores_gemma":[0.9871588,0.00038146597,0.00086289167,0.000089222325,0.00003569269,0.00013127169,0.011147242,0.000012571887,0.00018090806],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99235827,0.0042534936,0.00096564024,0.0009350786,0.0011704572,0.00031699147],"domain_scores_gemma":[0.9609503,0.010431831,0.020787451,0.0030083281,0.0032072433,0.0016147731],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011063126,0.00021943159,0.0006134924,0.0015042623,0.00032669387,0.0008707457,0.0005271813,0.00031667654,0.0011680519],"category_scores_gemma":[0.017588357,0.00020783475,0.0010414723,0.0021629734,0.00023787828,0.00119556,0.0010466464,0.00080590846,0.00032496615],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011717357,0.00008708809,0.9927636,0.000059668684,0.00028004756,0.00002053397,0.0000819438,0.00014425348,0.000097311415,0.000058790567,0.00075851067,0.0044766306],"study_design_scores_gemma":[0.00030839402,0.000800686,0.9954471,0.000042600586,0.00036712096,0.00022114228,0.00017439276,0.0010844688,0.00019051516,0.00005518664,0.0012907613,0.00001762741],"about_ca_topic_score_codex":0.003087183,"about_ca_topic_score_gemma":0.0037633465,"teacher_disagreement_score":0.011063126,"about_ca_system_score_codex":0.0005606368,"about_ca_system_score_gemma":0.0011594853,"threshold_uncertainty_score":0.058508098},"labels":[],"label_agreement":null},{"id":"W2360341433","doi":"10.1111/jdv.13677","title":"The prevalence of unsuspected onychomycosis and its causative organisms in a multicentre Canadian sample of 30 000 patients visiting physicians' offices","year":2016,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Nail Diseases and Treatments","field":"Medicine","cited_by":99,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Mediprobe Research (Canada); Lynde Centre for Dermatology; University of Toronto","funders":"","keywords":"Medicine; Dermatophyte; Population; Nail disease; Nail (fastener); Dermatology; Pediatrics; Environmental health","score_opus":0.009031369865292514,"score_gpt":0.2460838376625951,"score_spread":0.23705246779730257,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2360341433","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984363,0.00020563308,0.0000348351,0.000053457108,0.0000027400633,0.000025076237,0.0007368145,0.0000040522823,0.0005010821],"genre_scores_gemma":[0.99901223,0.00022727251,0.000099127355,0.00006254842,0.0000041981107,0.000009326057,0.00042327365,0.0000015855588,0.00016039891],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991714,0.000044163244,0.000047979545,0.00016032626,0.00035415348,0.00022206473],"domain_scores_gemma":[0.9988533,0.00008919894,0.00031500784,0.000030917363,0.00036480333,0.00034660843],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004615944,0.0004529333,0.00037388364,0.00118082,0.0018606031,0.0009680875,0.00094675587,0.00058636453,0.001611843],"category_scores_gemma":[0.0018260222,0.0005040056,0.00035955696,0.00218671,0.0008407884,0.00032395896,0.0006913877,0.00050794537,0.00020791341],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000035870886,0.000018894842,0.9978211,0.000025231702,0.000018030496,0.00014484795,0.0003983805,0.00002490492,0.0002457212,0.000012323094,0.00020049767,0.0010541944],"study_design_scores_gemma":[0.0000047965596,0.000035975776,0.998889,0.000011058225,0.000013245543,0.00023183723,0.00055890065,0.000072969044,0.000038490216,0.0000042442102,0.00013445133,0.000004989555],"about_ca_topic_score_codex":0.9419284,"about_ca_topic_score_gemma":0.9430845,"teacher_disagreement_score":0.058071613,"about_ca_system_score_codex":0.007776712,"about_ca_system_score_gemma":0.008113131,"threshold_uncertainty_score":0.11682719},"labels":[],"label_agreement":null},{"id":"W2400175744","doi":"10.1111/jdv.13723","title":"Tuberculids: cutaneous indicator diseases of <i>Mycobacterium tuberculosis</i> infection in young patients","year":2016,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Infectious Diseases and Tuberculosis","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"","keywords":"Medicine; Tuberculosis; Dermatology; Mycobacterium tuberculosis; Disease; Incidence (geometry); Cutaneous tuberculosis; Immunology; Pathology","score_opus":0.005857499863624775,"score_gpt":0.23344210382344543,"score_spread":0.22758460395982066,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2400175744","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98047274,0.0057225516,0.00063300895,0.0010621499,0.000104262515,0.00010759505,0.00024438117,0.000052512853,0.011600706],"genre_scores_gemma":[0.99753964,0.00094477524,0.00022602042,0.00046436125,0.00014272204,0.000019668301,0.000084872685,0.000004510308,0.00057352334],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99983,0.000026600754,0.000023214116,0.000028914634,0.000024063242,0.00006709167],"domain_scores_gemma":[0.99946517,0.00009612109,0.0001977818,0.000013310741,0.00003173748,0.00019590963],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021031722,0.00042652042,0.00036618736,0.0004784968,0.0007384972,0.0006269293,0.00017762723,0.00087503233,0.0041690567],"category_scores_gemma":[0.00085397647,0.00021156116,0.00022503539,0.0004962097,0.0004373936,0.00076237123,0.00043171548,0.000691026,0.00079814857],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001661358,0.00011569491,0.7288804,0.00019431784,0.000018282111,0.25725067,0.00073961995,0.00007018014,0.0028220764,0.00023217883,0.0016798303,0.007830636],"study_design_scores_gemma":[0.000019521829,0.00023367301,0.19654109,0.000117049014,0.000024045212,0.79905355,0.0008781741,0.00012720839,0.00052388164,0.000188332,0.0022793792,0.000014112284],"about_ca_topic_score_codex":0.00082118396,"about_ca_topic_score_gemma":0.0008044043,"teacher_disagreement_score":0.0041690567,"about_ca_system_score_codex":0.0002574204,"about_ca_system_score_gemma":0.00035389155,"threshold_uncertainty_score":0.013946831},"labels":[],"label_agreement":null},{"id":"W2411058141","doi":"10.1111/jdv.13742","title":"Chronic urticaria: new hope for an old disease","year":2016,"lang":"en","type":"editorial","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Urticaria and Related Conditions","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Omalizumab; Angioedema; Chronic urticaria; Disease; Dermatology; Population; Immunoglobulin E; Immunology; Antibody; Internal medicine","score_opus":0.014721355064582175,"score_gpt":0.29702255354488966,"score_spread":0.2823011984803075,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2411058141","genre_codex":"review","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00069853186,0.75528705,0.00095019175,0.21038277,0.027857678,0.000011373802,0.000053527838,0.0000725034,0.004686386],"genre_scores_gemma":[0.018994266,0.751614,0.0020906786,0.12746927,0.0895963,0.000052010164,0.0001404071,0.00006739698,0.009975771],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978154,0.0007771567,0.00021750454,0.00029143764,0.0006254142,0.00027304192],"domain_scores_gemma":[0.98880625,0.0055983383,0.00045345398,0.0005375776,0.0019073974,0.0026969265],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0057090325,0.0008337053,0.0023551132,0.0018272279,0.0021171356,0.005472925,0.0015581909,0.008231507,0.008486876],"category_scores_gemma":[0.010313253,0.0003528168,0.001093954,0.0008881531,0.0076570758,0.013882724,0.00341102,0.02173742,0.002754583],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034670724,0.00024263289,0.001432788,0.003484784,0.00013621795,0.0018276602,0.0013638114,0.00020090242,0.0008376876,0.075431466,0.5549251,0.35977033],"study_design_scores_gemma":[0.0000662343,0.0002489771,0.00085796736,0.004146179,0.000050509643,0.0046583638,0.0016774077,0.00019625455,0.00011851324,0.066250086,0.9216567,0.00007284294],"about_ca_topic_score_codex":0.0013479372,"about_ca_topic_score_gemma":0.0026778155,"teacher_disagreement_score":0.008486876,"about_ca_system_score_codex":0.0025870746,"about_ca_system_score_gemma":0.0033900104,"threshold_uncertainty_score":0.030192614},"labels":[],"label_agreement":null},{"id":"W2411190232","doi":"10.1111/jdv.13695","title":"Questions and answers in chronic urticaria: where do we stand and where do we go?","year":2016,"lang":"en","type":"review","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Urticaria and Related Conditions","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"Novartis Pharma; Novartis","keywords":"Medicine; Excellence; Chronic urticaria; Angioedema; MEDLINE; Disease; Chronic disease; Task force; Intensive care medicine; Dermatology; Pathology","score_opus":0.021354220919779694,"score_gpt":0.3113276296616351,"score_spread":0.2899734087418554,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2411190232","genre_codex":"commentary","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00042261876,0.24784742,0.00079931744,0.4777365,0.26483268,0.00006298025,0.00043332035,0.00008377461,0.0077813743],"genre_scores_gemma":[0.005864856,0.29156595,0.0020017656,0.24568115,0.44170418,0.00016980826,0.00079643715,0.00013762356,0.012078312],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9929947,0.0032176813,0.0009712493,0.0006320857,0.0014863856,0.0006978016],"domain_scores_gemma":[0.9379208,0.042388488,0.0028467667,0.0010137206,0.0107299425,0.0051003103],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008820885,0.0012070966,0.0028828047,0.0031175858,0.0031731892,0.010952369,0.002261453,0.009669262,0.034048103],"category_scores_gemma":[0.057808045,0.0006278705,0.0018399934,0.0022192905,0.0042815697,0.011456397,0.004279186,0.012629135,0.009127677],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000056202207,0.00003180926,0.00033313048,0.0020423147,0.00003185592,0.00014047438,0.0006480465,0.00003609019,0.00009778507,0.0034040676,0.92650044,0.066677794],"study_design_scores_gemma":[0.000022674785,0.0000365278,0.0006980917,0.0044050375,0.000033961587,0.00048138885,0.00136229,0.000037706945,0.00003975911,0.0062536355,0.986597,0.000031824067],"about_ca_topic_score_codex":0.0047402903,"about_ca_topic_score_gemma":0.008587381,"teacher_disagreement_score":0.034048103,"about_ca_system_score_codex":0.0048992694,"about_ca_system_score_gemma":0.009526809,"threshold_uncertainty_score":0.11390227},"labels":[],"label_agreement":null},{"id":"W2411635562","doi":"10.1111/jdv.13696","title":"Controversies and challenges in the management of chronic urticaria","year":2016,"lang":"en","type":"review","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Urticaria and Related Conditions","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"Novartis Pharma; Novartis","keywords":"Medicine; Chronic urticaria; Intensive care medicine; Dermatology","score_opus":0.056217667706589425,"score_gpt":0.3149547558859581,"score_spread":0.2587370881793687,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2411635562","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000537705,0.99720603,0.000057888254,0.0016377586,0.000514431,0.0000027262622,0.0000053765852,0.0000023486568,0.00051960145],"genre_scores_gemma":[0.00083031034,0.9961611,0.00024776658,0.0013556996,0.0011583153,0.000005763971,0.000015119076,0.0000016848518,0.00022421103],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99847764,0.00042609748,0.00037553642,0.00014805116,0.0004959951,0.00007670771],"domain_scores_gemma":[0.99662554,0.0021897487,0.0004127361,0.00005818289,0.0005951374,0.0001187206],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00245871,0.0007010297,0.0016369068,0.0028901994,0.00062538154,0.0022200497,0.0011623478,0.0022206837,0.0027862235],"category_scores_gemma":[0.004951795,0.00034625625,0.00094193814,0.0029732524,0.0012572363,0.0033486343,0.0009556809,0.0033596647,0.0010376613],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005740562,0.000060279166,0.00029558322,0.04285049,0.00014255421,0.0005499019,0.0003772035,0.0002135165,0.00045891464,0.006416378,0.06918841,0.8793894],"study_design_scores_gemma":[0.00002187714,0.00005770585,0.00096237485,0.026931956,0.00016616107,0.0043872613,0.0003936374,0.00007752097,0.00012700778,0.0038988898,0.96294236,0.000033170218],"about_ca_topic_score_codex":0.002009137,"about_ca_topic_score_gemma":0.003791733,"teacher_disagreement_score":0.0028901994,"about_ca_system_score_codex":0.0012056131,"about_ca_system_score_gemma":0.002824068,"threshold_uncertainty_score":0.013003051},"labels":[],"label_agreement":null},{"id":"W2420387358","doi":"10.1111/jdv.13598","title":"Efficacy of tofacitinib in treatment of alopecia universalis in two patients","year":2016,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Hair Growth and Disorders","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mediprobe Research (Canada); University of Toronto","funders":"","keywords":"Tofacitinib; Alopecia universalis; Medicine; Alopecia areata; Hair loss; Scalp; Dermatology; Adverse effect; Eyebrow; Hair growth; Hypertrichosis; Janus kinase inhibitor; Side effect (computer science); Surgery; Internal medicine; Rheumatoid arthritis; Physiology","score_opus":0.015926280555008596,"score_gpt":0.2839050210635051,"score_spread":0.2679787405084965,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2420387358","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944882,0.0024604637,0.00013742177,0.00036296013,0.000030090408,0.00007774363,0.000067791676,0.000018324072,0.002357062],"genre_scores_gemma":[0.9985417,0.00039430254,0.00020158016,0.00035324512,0.00004645913,0.000036203357,0.0001219178,0.0000026667187,0.0003018243],"study_design_codex":"design_other","study_design_gemma":"case_report","domain_scores_codex":[0.9998462,0.00002704448,0.000017351867,0.000026596059,0.000028088682,0.00005457105],"domain_scores_gemma":[0.999716,0.00006089417,0.000045117093,0.000013486076,0.000015701773,0.00014869336],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002520728,0.00031762506,0.0005653266,0.0003026261,0.00054813956,0.0005507106,0.00018318955,0.0009139868,0.0010366185],"category_scores_gemma":[0.0007215397,0.00011882762,0.00051303045,0.0001890527,0.00020175263,0.00023868935,0.00021930318,0.0007019379,0.00015410336],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.026723377,0.00947621,0.3826763,0.0006597293,0.00062300963,0.14050592,0.0021048533,0.001427271,0.043222133,0.0011374016,0.00390698,0.38753673],"study_design_scores_gemma":[0.014213784,0.057428036,0.60724396,0.00020777802,0.0006922001,0.28451416,0.00092744624,0.003304963,0.009996922,0.0006088867,0.020753553,0.00010839341],"about_ca_topic_score_codex":0.00059209764,"about_ca_topic_score_gemma":0.00073196396,"teacher_disagreement_score":0.0010366185,"about_ca_system_score_codex":0.0006745382,"about_ca_system_score_gemma":0.00032537783,"threshold_uncertainty_score":0.004894078},"labels":[],"label_agreement":null},{"id":"W2460537833","doi":"10.1111/jdv.13748","title":"Feelings of stigmatization in patients with rosacea","year":2016,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Acne and Rosacea Treatments and Effects","field":"Medicine","cited_by":101,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Windsor Clinical Research; Western University; University of Windsor","funders":"Galderma","keywords":"Rosacea; Feeling; Medicine; Depression (economics); Population; Clinical psychology; Disease; Dermatology; Psychiatry; Acne; Internal medicine; Psychology; Social psychology","score_opus":0.005847095919427014,"score_gpt":0.22003521158534703,"score_spread":0.21418811566592003,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2460537833","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956118,0.0009213155,0.000054934255,0.0007137236,0.000027777372,0.00001606114,0.000029522032,0.000002478948,0.0026224144],"genre_scores_gemma":[0.99938726,0.00028144725,0.000037849775,0.00015862678,0.000010773593,0.000004596615,0.000010040657,4.673404e-7,0.00010906875],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998698,0.0007306908,0.00009531314,0.000055036893,0.00028167272,0.00013926068],"domain_scores_gemma":[0.9958956,0.0012580374,0.0019189084,0.000109866145,0.00030274814,0.00051482837],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014204896,0.00015257036,0.00030571246,0.0004179872,0.001047949,0.0010108491,0.00015957348,0.0005108969,0.0037784744],"category_scores_gemma":[0.006277908,0.00012803737,0.00040852418,0.00034704493,0.0009167516,0.0006440378,0.0011121967,0.0008088875,0.00018760502],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035227052,0.00030448378,0.90191114,0.0005770128,0.0002775224,0.001882827,0.054764822,0.00012083297,0.0017515784,0.0005793617,0.0028412847,0.034636885],"study_design_scores_gemma":[0.000042929103,0.00051460305,0.8833888,0.0007908509,0.000102503414,0.0061421134,0.098984055,0.00036381258,0.00044384235,0.0005393284,0.008625818,0.00006128983],"about_ca_topic_score_codex":0.0009503455,"about_ca_topic_score_gemma":0.0010914692,"teacher_disagreement_score":0.0037784744,"about_ca_system_score_codex":0.0005187263,"about_ca_system_score_gemma":0.00044394808,"threshold_uncertainty_score":0.012640297},"labels":[],"label_agreement":null},{"id":"W2462271786","doi":"10.1111/jdv.13787","title":"Clinical and molecular investigation of Buschke‐Fischer‐Brauer in consanguineous Tunisian families","year":2016,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Skin and Cellular Biology Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Ministry of Higher Education and Scientific Research","keywords":"Genetics; Genetic heterogeneity; Mutation; Medicine; Founder effect; Pedigree chart; Anticipation (artificial intelligence); Palmoplantar keratoderma; Phenotype; Genotype; Biology; Gene; Haplotype","score_opus":0.019454462689324974,"score_gpt":0.29338747537195403,"score_spread":0.27393301268262904,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2462271786","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99926263,0.0001564512,0.000052317948,0.0000311725,0.0000020894315,0.000008456873,0.00006401638,0.0000045626757,0.00041820208],"genre_scores_gemma":[0.99947923,0.00012199608,0.00012931679,0.000022404865,0.0000049660575,0.000006680949,0.000068745154,0.0000021901258,0.00016460184],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99966884,0.00007955837,0.00003248719,0.00009038543,0.00005274182,0.000075887845],"domain_scores_gemma":[0.99958485,0.00009381197,0.0001298884,0.000021925443,0.000057986625,0.0001114592],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003976592,0.00073936087,0.0002740225,0.002157545,0.0010356426,0.0003658597,0.00039241737,0.00048722787,0.0018986941],"category_scores_gemma":[0.0013466849,0.00026764328,0.00022987835,0.0010810333,0.0005200724,0.00023284684,0.00042446863,0.00024333513,0.00017265881],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036169027,0.00012449596,0.9280069,0.000050882398,0.00007962317,0.05072704,0.002109609,0.00014726933,0.0102877,0.00018073712,0.0002594043,0.007664519],"study_design_scores_gemma":[0.00003972448,0.00028442446,0.9073683,0.000038199927,0.000074504365,0.087739795,0.0012786811,0.00035008223,0.0012855756,0.00010436763,0.0014180988,0.000018388158],"about_ca_topic_score_codex":0.015277848,"about_ca_topic_score_gemma":0.011109256,"teacher_disagreement_score":0.015277848,"about_ca_system_score_codex":0.00072987954,"about_ca_system_score_gemma":0.00040294437,"threshold_uncertainty_score":0.030377865},"labels":[],"label_agreement":null},{"id":"W2507392739","doi":"10.1111/jdv.13905","title":"Increased serum levels of vascular endothelial growth factor in pemphigus foliaceus patients with erythroderma","year":2016,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Autoimmune Bullous Skin Diseases","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Conselho Nacional de Desenvolvimento Científico e Tecnológico","keywords":"Medicine; Pemphigus foliaceus; Erythroderma; Dermatology; Immunology; Antibody; Autoantibody","score_opus":0.012460589834091878,"score_gpt":0.2358919172990648,"score_spread":0.22343132746497293,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2507392739","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9991155,0.00049003225,0.00004434761,0.000015456422,0.000002690148,0.000004805477,0.00007120356,0.0000031997524,0.00025275582],"genre_scores_gemma":[0.9997379,0.00011253042,0.000053184915,0.0000063842563,0.0000048306615,0.0000021563053,0.000052052023,3.8763093e-7,0.000030457264],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99980754,0.0000377208,0.000029456663,0.000050990122,0.000043663895,0.00003068821],"domain_scores_gemma":[0.99930704,0.00010371999,0.00044288966,0.000015923188,0.000048467504,0.00008188089],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020795644,0.0002489409,0.00026746496,0.001011364,0.00031193614,0.00032467904,0.00012280917,0.00031947243,0.00092227245],"category_scores_gemma":[0.0011261114,0.00014316633,0.00017397343,0.0006510495,0.00016697407,0.0002527953,0.00014058585,0.00023369957,0.00009381682],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000101797734,0.000024047888,0.9955433,0.000021531156,0.000017076429,0.0012173972,0.000067411755,0.00002300498,0.0013452854,0.0000103112925,0.00004161566,0.0015871894],"study_design_scores_gemma":[0.000004907162,0.00013692507,0.99037033,0.000010782457,0.00002114659,0.008815846,0.000115297305,0.00007189618,0.00027551161,0.000014748445,0.0001596173,0.0000030253516],"about_ca_topic_score_codex":0.000958473,"about_ca_topic_score_gemma":0.0008723189,"teacher_disagreement_score":0.001011364,"about_ca_system_score_codex":0.00020768616,"about_ca_system_score_gemma":0.00014399394,"threshold_uncertainty_score":0.0030852556},"labels":[],"label_agreement":null},{"id":"W2508182513","doi":"10.1111/jdv.13808","title":"Effect of tofacitinib withdrawal and re‐treatment on patient‐reported outcomes: results from a Phase 3 study in patients with moderate to severe chronic plaque psoriasis","year":2016,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dermatrials Research","funders":"National Institutes of Health; Pfizer","keywords":"Tofacitinib; Medicine; Dermatology Life Quality Index; Psoriasis Area and Severity Index; Psoriasis; Janus kinase inhibitor; Placebo; Internal medicine; Plaque psoriasis; Randomized controlled trial; Dermatology; Surgery","score_opus":0.014304655100352299,"score_gpt":0.26121729816183525,"score_spread":0.24691264306148294,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2508182513","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9896814,0.0061130333,0.00029261407,0.00042510955,0.00007970443,0.0012653364,0.0011691428,0.000043056076,0.00093044725],"genre_scores_gemma":[0.9903743,0.0027992416,0.0008290984,0.0007833925,0.00020622516,0.0020767776,0.0021720142,0.00001828585,0.00074065005],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99801093,0.0010256282,0.00016590698,0.00029255557,0.0002818101,0.0002231456],"domain_scores_gemma":[0.99653184,0.0009457823,0.0011733834,0.00028440548,0.00027803218,0.0007866073],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005198206,0.0011509362,0.003185397,0.00035541557,0.00070391945,0.0010151245,0.00079346215,0.0013445639,0.0033195047],"category_scores_gemma":[0.002910018,0.00039914745,0.005393124,0.00058824144,0.0006607462,0.00077119767,0.00045741885,0.0035076463,0.0004914988],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.83939505,0.0340069,0.013603295,0.0015524321,0.006360426,0.00015139267,0.00018079113,0.0007947246,0.008985036,0.000053597738,0.0020506794,0.09286562],"study_design_scores_gemma":[0.55831087,0.34100828,0.09318196,0.00012879049,0.0033987095,0.00036401502,0.00008056314,0.00069225545,0.0012873186,0.00012367331,0.0013569165,0.00006660296],"about_ca_topic_score_codex":0.00087647437,"about_ca_topic_score_gemma":0.0020400516,"teacher_disagreement_score":0.005198206,"about_ca_system_score_codex":0.0008248161,"about_ca_system_score_gemma":0.0015410769,"threshold_uncertainty_score":0.027491093},"labels":[],"label_agreement":null},{"id":"W2510680239","doi":"10.1111/jdv.13918","title":"Apremilast, an oral phosphodiesterase 4 inhibitor, improves patient‐reported outcomes in the treatment of moderate to severe psoriasis: results of two phase <scp>III</scp> randomized, controlled trials","year":2016,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre de Recherche Dermatologique du Québec Métropolitain","funders":"Baxalta; Celgene; Biogen; Amgen; Pfizer; Eli Lilly and Company","keywords":"Apremilast; Medicine; Psoriasis; Placebo; Dermatology Life Quality Index; Quality of life (healthcare); Internal medicine; Randomized controlled trial; Psoriasis Area and Severity Index; Psoriatic arthritis; Physical therapy; Dermatology; Alternative medicine; Pathology; Nursing","score_opus":0.032819225057326575,"score_gpt":0.30237584257435646,"score_spread":0.26955661751702986,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2510680239","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.81049776,0.17283262,0.0012549367,0.0024094048,0.0009986238,0.0054732882,0.0025557713,0.00019269841,0.0037848763],"genre_scores_gemma":[0.9284321,0.05923378,0.0024137115,0.0021260737,0.0010459004,0.003584449,0.0020315007,0.000031184223,0.0011012031],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9979231,0.0011576831,0.00033724573,0.00019390881,0.0002879506,0.00010015048],"domain_scores_gemma":[0.9962238,0.001702179,0.0012688328,0.00016450032,0.00029990566,0.00034083278],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0068464624,0.0009527149,0.0026035407,0.0004689568,0.00032132043,0.001064848,0.0007789877,0.0013641241,0.00297025],"category_scores_gemma":[0.0060476223,0.0004054932,0.003555888,0.0006994242,0.0006833848,0.000581513,0.00026397925,0.0017011944,0.0002508302],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8479302,0.00523911,0.004319884,0.012834512,0.01854994,0.0000627115,0.00010858923,0.00057179056,0.0040123514,0.00012723828,0.002839583,0.10340417],"study_design_scores_gemma":[0.9144924,0.050424892,0.019002205,0.00089445163,0.011969628,0.000106464744,0.000037787657,0.0003356488,0.00068605563,0.00011467787,0.0019045075,0.00003126859],"about_ca_topic_score_codex":0.0007964521,"about_ca_topic_score_gemma":0.0019815643,"teacher_disagreement_score":0.0068464624,"about_ca_system_score_codex":0.0005275905,"about_ca_system_score_gemma":0.0009575315,"threshold_uncertainty_score":0.036207974},"labels":[],"label_agreement":null},{"id":"W2510838450","doi":"10.1111/jdv.13824","title":"Sentinel lymph node biopsy plus wide local excision vs. wide location excision alone for primary cutaneous melanoma: a systematic review and meta‐analysis","year":2016,"lang":"en","type":"review","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Cutaneous Melanoma Detection and Management","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Meta-analysis; Sentinel lymph node; Publication bias; Confidence interval; Hazard ratio; Wide local excision; Biopsy; MEDLINE; Melanoma; Systematic review; Study heterogeneity; Relative risk; Subgroup analysis; Surgery; Internal medicine; Oncology; Cancer; Breast cancer","score_opus":0.031168256464496134,"score_gpt":0.30349978427188207,"score_spread":0.27233152780738595,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2510838450","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0075847614,0.9905494,0.00047417666,0.00018966931,0.00020040141,0.00036105866,0.00038773025,0.00002282127,0.00022993256],"genre_scores_gemma":[0.23061948,0.7621405,0.0024449446,0.0011125426,0.00041298536,0.0018609589,0.00080264726,0.00003611096,0.00056974264],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9929803,0.003603635,0.00164484,0.00076388946,0.000755902,0.00025147916],"domain_scores_gemma":[0.98633206,0.0099594295,0.0021361662,0.00030939275,0.0010241007,0.00023881198],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.012347609,0.0027758821,0.019078339,0.004486506,0.00058224646,0.0029759451,0.0022331276,0.0026328242,0.0038431645],"category_scores_gemma":[0.022230087,0.0013898463,0.04745327,0.004671943,0.0006459336,0.0016856687,0.0013054967,0.0021630432,0.00036562711],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004761978,0.00004720526,0.002558041,0.33406782,0.64814836,0.00010075527,0.000069793,0.0005579424,0.00020213096,0.00010189939,0.00042498147,0.00895904],"study_design_scores_gemma":[0.00100367,0.00031391002,0.0019981072,0.015966704,0.979479,0.000055291966,0.000034794935,0.00017426096,0.000080845355,0.00010609231,0.0007709456,0.000016353426],"about_ca_topic_score_codex":0.0068488843,"about_ca_topic_score_gemma":0.014830506,"teacher_disagreement_score":0.019078339,"about_ca_system_score_codex":0.0027301332,"about_ca_system_score_gemma":0.0032417374,"threshold_uncertainty_score":0.06530118},"labels":[],"label_agreement":null},{"id":"W2514982855","doi":"10.1111/jdv.14386","title":"European consensus statement on phenotypes of pustular psoriasis","year":2017,"lang":"en","type":"review","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":440,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"National Institute for Health and Care Research; European Academy of Dermatology and Venereology; Psoriasis Association","keywords":"Medicine; Psoriasis; Generalized pustular psoriasis; Dermatology; Phenotype; Pustular psoriasis; Clinical trial; Pathology; Genetics","score_opus":0.0838083635548977,"score_gpt":0.3311105540073089,"score_spread":0.2473021904524112,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2514982855","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0057497914,0.4388623,0.038965628,0.2551153,0.058248796,0.0028328146,0.016949968,0.0014649773,0.18181036],"genre_scores_gemma":[0.07422335,0.39104038,0.12284354,0.19299345,0.023037456,0.0079985615,0.071682334,0.0016406071,0.11454029],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98487675,0.0046195425,0.0033918347,0.0010540775,0.004732022,0.0013256862],"domain_scores_gemma":[0.9728434,0.007837768,0.0025044512,0.0012397388,0.013627188,0.0019474396],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.021307176,0.0013419642,0.0024490408,0.0046200813,0.001201168,0.004164146,0.0056155,0.008563147,0.0149119245],"category_scores_gemma":[0.03025558,0.00083605206,0.004405859,0.0033598726,0.0018361091,0.0027857586,0.004397849,0.008237656,0.011641055],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044337404,0.00015352742,0.0020072458,0.005775721,0.00019299194,0.0011786572,0.00046028433,0.00062975776,0.0017722296,0.019923016,0.6801522,0.2873111],"study_design_scores_gemma":[0.00013250062,0.000072043666,0.0032413856,0.009891081,0.00017580268,0.0019568845,0.0002833811,0.00018811332,0.0006269138,0.0070392773,0.9763456,0.000047045065],"about_ca_topic_score_codex":0.0058385907,"about_ca_topic_score_gemma":0.0038759306,"teacher_disagreement_score":0.021307176,"about_ca_system_score_codex":0.0030658469,"about_ca_system_score_gemma":0.009778186,"threshold_uncertainty_score":0.11268443},"labels":[],"label_agreement":null},{"id":"W2519503335","doi":"10.1111/jdv.13891","title":"The prevalence of anxiety in patients with psoriasis: a systematic review of observational studies and clinical trials","year":2016,"lang":"en","type":"review","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":152,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland; Lynde Centre for Dermatology; University of Toronto","funders":"","keywords":"Psoriasis; Medicine; Anxiety; Observational study; Psychological intervention; Internal medicine; MEDLINE; Systematic review; Psychiatry; Physical therapy; Dermatology","score_opus":0.13560397315939046,"score_gpt":0.39119430731098176,"score_spread":0.25559033415159127,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2519503335","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0018577167,0.9971842,0.00013811454,0.000119888246,0.00007059322,0.0002621041,0.00024263703,0.000006341519,0.000118391654],"genre_scores_gemma":[0.038467888,0.9591213,0.0008192039,0.00052029255,0.000113175374,0.0005874374,0.00029293651,0.000008241032,0.00006949304],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.983557,0.005924427,0.0069489414,0.0012158736,0.0020939696,0.00025984662],"domain_scores_gemma":[0.9421317,0.040544696,0.012501997,0.0010559805,0.0033403262,0.0004252576],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.015087353,0.0016109516,0.011731967,0.0073915645,0.00071153475,0.0029461372,0.0017754413,0.0016295314,0.0029732934],"category_scores_gemma":[0.056419857,0.0014607935,0.013612171,0.009138214,0.0010973143,0.0020972076,0.0014614188,0.0013649222,0.0002530275],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005915137,0.000020660342,0.0022301332,0.9129152,0.06682535,0.00010129894,0.00013022718,0.00008304279,0.00013366959,0.00008712974,0.0005412973,0.016340476],"study_design_scores_gemma":[0.0009642304,0.0005600056,0.012975275,0.45637614,0.5203127,0.0006403605,0.00025077263,0.00012507485,0.00024348439,0.00030769478,0.0071806153,0.00006357439],"about_ca_topic_score_codex":0.0059293825,"about_ca_topic_score_gemma":0.017748058,"teacher_disagreement_score":0.015087353,"about_ca_system_score_codex":0.003104891,"about_ca_system_score_gemma":0.006720583,"threshold_uncertainty_score":0.07979047},"labels":[],"label_agreement":null},{"id":"W2532238474","doi":"10.1111/jdv.14015","title":"The efficacy and safety of apremilast, etanercept and placebo in patients with moderate‐to‐severe plaque psoriasis: 52‐week results from a phase IIIb, randomized, placebo‐controlled trial (LIBERATE)","year":2016,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":198,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research","funders":"Cilag; Regeneron Pharmaceuticals; UCB Pharma; Medac; LEO Pharma; Eli Lilly and Company; Galderma; Biogen; Celgene; GlaxoSmithKline; Amgen; Pfizer","keywords":"Medicine; Apremilast; Placebo; Etanercept; Psoriasis; Randomized controlled trial; Dermatology; Internal medicine; Physical therapy; Psoriatic arthritis; Alternative medicine; Tumor necrosis factor alpha; Pathology","score_opus":0.011074629238026117,"score_gpt":0.2306057609492769,"score_spread":0.21953113171125077,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2532238474","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9852642,0.007215041,0.00070623803,0.0007045808,0.00038478896,0.0031713953,0.00083133794,0.00012239284,0.0016001131],"genre_scores_gemma":[0.9859773,0.003328184,0.0019252785,0.0012649932,0.0006201373,0.0039017578,0.00096246623,0.000028747198,0.0019911274],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9986045,0.0008122487,0.00012422759,0.00019538397,0.00014003481,0.00012360292],"domain_scores_gemma":[0.99812466,0.0005656033,0.0005143177,0.00013944898,0.000117222495,0.0005387644],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0045827613,0.0014515932,0.0031149047,0.0004073581,0.0005598462,0.0012031564,0.00082689483,0.0018916494,0.0061432286],"category_scores_gemma":[0.002634875,0.0008951644,0.0020206815,0.00036441875,0.0010204843,0.0011378694,0.0004355731,0.0035148486,0.00090465316],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.96710134,0.010796842,0.0007180265,0.0005105493,0.0006848271,0.000028116025,0.00005546957,0.00015138001,0.004057091,0.000042621108,0.00055612077,0.015297679],"study_design_scores_gemma":[0.9339675,0.062887356,0.002157995,0.000023884662,0.00023651612,0.00003196075,0.000010558299,0.00013329204,0.00029960577,0.000036402223,0.00020680892,0.000008156324],"about_ca_topic_score_codex":0.00040298892,"about_ca_topic_score_gemma":0.00084485445,"teacher_disagreement_score":0.0061432286,"about_ca_system_score_codex":0.0006078963,"about_ca_system_score_gemma":0.0010547965,"threshold_uncertainty_score":0.024236262},"labels":[],"label_agreement":null},{"id":"W2546600532","doi":"10.1111/jdv.14033","title":"Ixekizumab treatment improves fingernail psoriasis in patients with moderate‐to‐severe psoriasis: results from the randomized, controlled and open‐label phases of <scp>UNCOVER</scp>‐3","year":2016,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":82,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Guenther Dermatology Research Centre; Western University","funders":"Universidade Católica de Brasília; Regeneron Pharmaceuticals; Roche; American Society for Parenteral and Enteral Nutrition; Novartis; Merck; Celgene; Eli Lilly and Company; Bristol-Myers Squibb; AstraZeneca; Boehringer Ingelheim; Amgen; Pfizer; Baxalta; Schering-Plough; AbbVie; Biogen Idec","keywords":"Ixekizumab; Medicine; Etanercept; Placebo; Psoriasis; Plaque psoriasis; Dermatology; Internal medicine; Psoriatic arthritis; Secukinumab; Tumor necrosis factor alpha; Pathology","score_opus":0.01729171059612685,"score_gpt":0.23998958720637256,"score_spread":0.2226978766102457,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2546600532","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9879953,0.00876007,0.00030899254,0.00034060146,0.00016624731,0.00080812105,0.00056154985,0.000043561242,0.0010154817],"genre_scores_gemma":[0.9922415,0.004142562,0.0007433064,0.0005462165,0.0003054625,0.00059071486,0.0007477231,0.000012488873,0.00067022006],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9990742,0.0005464237,0.00009572442,0.00009749993,0.00010135381,0.000084708925],"domain_scores_gemma":[0.9986072,0.00054013537,0.00041015184,0.00009573151,0.000096041505,0.00025080354],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025368372,0.00076280657,0.001811691,0.00022923441,0.00025962145,0.000732725,0.0005120455,0.00078770873,0.0036576425],"category_scores_gemma":[0.0019754355,0.00032186127,0.0023138698,0.00033232188,0.0005974811,0.00050056103,0.00022878988,0.0013885576,0.00030102878],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9405222,0.007659666,0.002696003,0.0012373922,0.0023855304,0.00003373583,0.00007919951,0.00028106905,0.004742371,0.000062924955,0.00096224254,0.039337512],"study_design_scores_gemma":[0.88971436,0.09550599,0.011146051,0.000092484675,0.0015127124,0.00010215908,0.00004126726,0.0002632084,0.0007939183,0.000099625395,0.00071001274,0.000018156772],"about_ca_topic_score_codex":0.0006098403,"about_ca_topic_score_gemma":0.0017730049,"teacher_disagreement_score":0.0036576425,"about_ca_system_score_codex":0.0005016728,"about_ca_system_score_gemma":0.0007078333,"threshold_uncertainty_score":0.013416231},"labels":[],"label_agreement":null},{"id":"W2546692346","doi":"10.1111/jdv.14026","title":"Adapalene 0.1%/benzoyl peroxide 2.5% gel reduces the risk of atrophic scar formation in moderate inflammatory acne: a split‐face randomized controlled trial","year":2016,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Dermatologic Treatments and Research","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Windsor Clinical Research; Innovaderm (Canada); Western University","funders":"Galderma","keywords":"Medicine; Acne; Adapalene; Benzoyl peroxide; Dermatology; Acne scars; Randomized controlled trial; Scars; Lesion; Clinical trial; Surgery; Internal medicine","score_opus":0.01761102456958635,"score_gpt":0.28041098261753067,"score_spread":0.2627999580479443,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2546692346","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99123466,0.00405268,0.00040462558,0.00023477706,0.00027749425,0.0025065716,0.00041599196,0.00007062508,0.0008025547],"genre_scores_gemma":[0.9907979,0.0024400789,0.0011385451,0.0003753877,0.00037783862,0.0030330338,0.00032371093,0.000013067115,0.0015004487],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9993298,0.00032027686,0.00005337896,0.00012735774,0.0000843104,0.00008493107],"domain_scores_gemma":[0.9991572,0.00024512975,0.00019573778,0.0000771725,0.00007977454,0.0002449774],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017004642,0.00128828,0.0029730236,0.00045177116,0.00040332196,0.00081291876,0.00097227196,0.0015972941,0.005186688],"category_scores_gemma":[0.0012283442,0.0005921786,0.0014866104,0.00038798823,0.0008119464,0.00073416246,0.0003398175,0.0015978356,0.00061745424],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9708818,0.010775077,0.00042617615,0.000832263,0.00059949,0.000030954336,0.000032191958,0.00009897511,0.0044131973,0.000038083377,0.0002455371,0.011626222],"study_design_scores_gemma":[0.8786501,0.116593204,0.0029718434,0.00004096953,0.00050337426,0.000027539028,0.000020123307,0.0002949556,0.0005699236,0.00004354202,0.00027330362,0.000011065197],"about_ca_topic_score_codex":0.0008018264,"about_ca_topic_score_gemma":0.0015086347,"teacher_disagreement_score":0.005186688,"about_ca_system_score_codex":0.00041940634,"about_ca_system_score_gemma":0.00071694603,"threshold_uncertainty_score":0.01735115},"labels":[],"label_agreement":null},{"id":"W2575934766","doi":"10.1111/jdv.14128","title":"A randomized, double‐blind, placebo‐controlled, dose‐escalation first‐in‐man study (phase 0) to assess the safety and efficacy of topical cytosolic phospholipase A2 inhibitor, <scp>AVX</scp>001, in patients with mild to moderate plaque psoriasis","year":2017,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Placebo; Double blind; Phases of clinical research; Pharmacology; Clinical trial; Internal medicine; Pathology","score_opus":0.03017783277983754,"score_gpt":0.28746147086302093,"score_spread":0.2572836380831834,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2575934766","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9785186,0.0019285873,0.001972484,0.0004951728,0.00040255807,0.013842944,0.0013014056,0.00026279828,0.0012754201],"genre_scores_gemma":[0.9548035,0.0022984038,0.008042697,0.0016977722,0.000758839,0.022667713,0.0019262484,0.00008667688,0.0077180993],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9987413,0.00072844134,0.000056536446,0.000199175,0.00010218914,0.00017238078],"domain_scores_gemma":[0.9981736,0.00043514598,0.00045839627,0.00021884123,0.00016371906,0.0005503693],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0033960312,0.0025243931,0.0038627246,0.00064694835,0.00066941336,0.0009442411,0.0015534327,0.0019190301,0.008230997],"category_scores_gemma":[0.0023272464,0.0012813935,0.0013696189,0.0004604986,0.0017218358,0.0012363767,0.0004557719,0.0025599052,0.0014558634],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.95584613,0.023401218,0.00058939616,0.00033523186,0.00037437803,0.000035921286,0.00007910295,0.00020460121,0.008545088,0.000090925896,0.00073598477,0.009761895],"study_design_scores_gemma":[0.9013703,0.09626703,0.0011384545,0.000009622208,0.00010201935,0.000027566526,0.000007397626,0.00014993873,0.0005079112,0.000061591745,0.00034992336,0.000008320557],"about_ca_topic_score_codex":0.0005969529,"about_ca_topic_score_gemma":0.0013062092,"teacher_disagreement_score":0.008230997,"about_ca_system_score_codex":0.0006884847,"about_ca_system_score_gemma":0.0017898362,"threshold_uncertainty_score":0.027535379},"labels":[],"label_agreement":null},{"id":"W2587305350","doi":"10.1111/jdv.14163","title":"Continuous dosing versus interrupted therapy with ixekizumab: an integrated analysis of two phase 3 trials in psoriasis","year":2017,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":67,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre de Recherche Dermatologique du Québec Métropolitain; Hôtel-Dieu de Québec; Université Laval; Probity Medical Research","funders":"Eli Lilly and Company","keywords":"Ixekizumab; Medicine; Psoriasis; Placebo; Dosing; Maintenance therapy; Clinical trial; Phases of clinical research; Internal medicine; Chemotherapy; Dermatology; Pathology; Secukinumab","score_opus":0.07432504716928887,"score_gpt":0.3566753525540663,"score_spread":0.28235030538477746,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2587305350","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92795396,0.054413304,0.008474301,0.0006261326,0.00023429288,0.003969407,0.0026072147,0.00017553517,0.0015457816],"genre_scores_gemma":[0.9883159,0.004055819,0.0039649466,0.00031234432,0.00012378534,0.0016222557,0.0012771814,0.00003694567,0.00029075402],"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9751893,0.020112563,0.0013685809,0.0012415976,0.0015598711,0.00052804843],"domain_scores_gemma":[0.97601306,0.015115033,0.0054504513,0.0016201624,0.0009507382,0.0008505977],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.028664934,0.0010331293,0.003616991,0.0009809607,0.00026502303,0.0020271847,0.0007085817,0.0010318413,0.0019869155],"category_scores_gemma":[0.026728678,0.00054857624,0.009865979,0.0013507837,0.0005637224,0.0010986233,0.0009041973,0.0017017104,0.00015619012],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.72547174,0.0021209302,0.040942073,0.0036346023,0.14400537,0.00009887295,0.0001422747,0.0040405,0.0036576649,0.00027163367,0.0010184088,0.07459596],"study_design_scores_gemma":[0.3765146,0.16792327,0.1757606,0.0011165107,0.25485778,0.00034798184,0.00018031569,0.013489749,0.0026690606,0.001810993,0.005180891,0.00014816248],"about_ca_topic_score_codex":0.00059108215,"about_ca_topic_score_gemma":0.0011242138,"teacher_disagreement_score":0.028664934,"about_ca_system_score_codex":0.0010358178,"about_ca_system_score_gemma":0.0013268378,"threshold_uncertainty_score":0.15159649},"labels":[],"label_agreement":null},{"id":"W2593047881","doi":"10.1111/jdv.14211","title":"Rapid improvements in health‐related quality of life and itch with ixekizumab treatment in randomized phase 3 trials: results from <scp>UNCOVER</scp>‐2 and <scp>UNCOVER</scp>‐3","year":2017,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health; Queen's University","funders":"Eli Lilly and Company","keywords":"Medicine; Ixekizumab; Dermatology Life Quality Index; Post-hoc analysis; Minimal clinically important difference; Clinical endpoint; Placebo; Hazard ratio; Randomization; Randomized controlled trial; Quality of life (healthcare); Internal medicine; Confidence interval; Pathology; Disease","score_opus":0.055895265232394,"score_gpt":0.3162650381622829,"score_spread":0.2603697729298889,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2593047881","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9280074,0.059963126,0.0018536531,0.00095431576,0.00045897014,0.0035157942,0.0027789748,0.0001379113,0.0023298073],"genre_scores_gemma":[0.9758127,0.015287511,0.0018537969,0.00063041924,0.00041642468,0.0032985883,0.0018889299,0.00004250546,0.0007691462],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99641174,0.0022821086,0.00043907925,0.00033020336,0.00031854562,0.00021825962],"domain_scores_gemma":[0.99477684,0.0024263067,0.0018425111,0.00031513578,0.00030930998,0.00032989713],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008564698,0.0010445656,0.003080488,0.0003898998,0.00029669757,0.0014080871,0.00045816484,0.000715471,0.0032936695],"category_scores_gemma":[0.0071050082,0.00037303346,0.006553732,0.0006682306,0.0007425829,0.00080590846,0.00043760234,0.0016220494,0.00024606974],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9122178,0.001990196,0.0054750415,0.00526836,0.022602588,0.00005648746,0.000077250304,0.0010413318,0.002563972,0.00013992573,0.0014026596,0.04716428],"study_design_scores_gemma":[0.87174845,0.07807965,0.020297257,0.0006264194,0.024814805,0.00014474432,0.00006228952,0.0006202907,0.0012065198,0.00033613906,0.002021032,0.00004251869],"about_ca_topic_score_codex":0.00050090323,"about_ca_topic_score_gemma":0.0014266323,"teacher_disagreement_score":0.008564698,"about_ca_system_score_codex":0.0007155938,"about_ca_system_score_gemma":0.0014529314,"threshold_uncertainty_score":0.045295},"labels":[],"label_agreement":null},{"id":"W2594127289","doi":"10.1111/jdv.14109","title":"What lies beneath actinic keratosis? Looking beyond visible lesions to optimize patient outcomes","year":2017,"lang":"en","type":"editorial","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Nonmelanoma Skin Cancer Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Actinic keratosis; Medicine; Dermatology; Field cancerization; Keratosis; Venereology; Atypia; Actinic keratoses; Pathology; Basal cell","score_opus":0.019071879503127952,"score_gpt":0.3166914939644801,"score_spread":0.29761961446135216,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2594127289","genre_codex":"review","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.1401411,0.51909584,0.024357308,0.15697856,0.009206208,0.00038037772,0.0023767478,0.0010992297,0.14636463],"genre_scores_gemma":[0.65134305,0.26379278,0.02370948,0.027661953,0.011759962,0.00028836812,0.002457362,0.00044703964,0.018540021],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99943346,0.00015978956,0.00007769458,0.000059648275,0.0001605518,0.00010877483],"domain_scores_gemma":[0.99827206,0.0004199752,0.00035990725,0.000056831665,0.00040880227,0.00048251206],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001073988,0.00036421628,0.00095499324,0.0010582343,0.0007846787,0.0026662075,0.00049287954,0.0010966454,0.009152335],"category_scores_gemma":[0.005429636,0.00010356939,0.0007530736,0.0005711477,0.00031553043,0.0025756313,0.0012454885,0.0021159048,0.0025527754],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004156225,0.00022429149,0.049859527,0.0016642888,0.0001164857,0.0024901107,0.00056477345,0.0004737868,0.0011883557,0.003929054,0.07100314,0.8680706],"study_design_scores_gemma":[0.00027994844,0.0017895736,0.22663777,0.03088548,0.001182192,0.049963374,0.010466062,0.002466455,0.004409143,0.058317933,0.6132416,0.0003604595],"about_ca_topic_score_codex":0.00095888175,"about_ca_topic_score_gemma":0.0024165923,"teacher_disagreement_score":0.009152335,"about_ca_system_score_codex":0.0007366725,"about_ca_system_score_gemma":0.0011194961,"threshold_uncertainty_score":0.030617595},"labels":[],"label_agreement":null},{"id":"W2596478994","doi":"10.1111/jdv.14223","title":"Assessing finasteride‐associated sexual dysfunction using the<scp>FAERS</scp>database","year":2017,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Sexual function and dysfunction studies","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; Mediprobe Research (Canada); University of Toronto","funders":"","keywords":"Finasteride; Medicine; Adverse Event Reporting System; Sexual dysfunction; Odds ratio; Incidence (geometry); Confidence interval; Ambulatory; Erectile dysfunction; Adverse effect; Internal medicine; Prostate; Cancer","score_opus":0.0986043684382941,"score_gpt":0.35312224437626966,"score_spread":0.2545178759379756,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2596478994","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7409215,0.010100145,0.0010487195,0.0006602129,0.000048670066,0.0010821895,0.23607098,0.00012095953,0.009946729],"genre_scores_gemma":[0.91184795,0.0036046726,0.0019909807,0.00029978022,0.00008067421,0.0006291284,0.08065418,0.000015685042,0.00087695185],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9958521,0.001002821,0.0016094176,0.00044821348,0.000977519,0.00010993062],"domain_scores_gemma":[0.9789556,0.0048587034,0.012772504,0.0011370907,0.0017986635,0.0004773253],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003368504,0.00026185357,0.00050911406,0.0047568292,0.00026503616,0.0008895522,0.00061156903,0.00032002755,0.004119504],"category_scores_gemma":[0.012518804,0.00015951642,0.0009978728,0.00504909,0.00019001521,0.0005758376,0.00062624906,0.0003705081,0.00040804374],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000654754,0.000035911977,0.977029,0.0014732148,0.0011704059,0.00013743053,0.00012271528,0.00019174976,0.00025863133,0.00019637618,0.0054727485,0.013257037],"study_design_scores_gemma":[0.00010816862,0.00021549597,0.9897858,0.00044351202,0.0006152395,0.0006062712,0.00017377573,0.00040334542,0.00039032724,0.00010126896,0.00713674,0.000020042395],"about_ca_topic_score_codex":0.017201044,"about_ca_topic_score_gemma":0.018356552,"teacher_disagreement_score":0.017201044,"about_ca_system_score_codex":0.0007125322,"about_ca_system_score_gemma":0.0012111294,"threshold_uncertainty_score":0.0342018},"labels":[],"label_agreement":null},{"id":"W2597810631","doi":"10.1111/jdv.14212","title":"A critical review of improvement rates for laser therapy used to treat toenail onychomycosis","year":2017,"lang":"en","type":"review","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Nail Diseases and Treatments","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mediprobe Research (Canada); University of Toronto","funders":"","keywords":"Medicine; Cure rate; Nail (fastener); Dermatology; Nail plate; Clinical efficacy; Clinical trial; Surgery; Internal medicine; Paronychia","score_opus":0.15705176954980152,"score_gpt":0.45709884605656975,"score_spread":0.3000470765067682,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2597810631","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00040936278,0.9987375,0.00006428298,0.00015931917,0.00014235235,0.000106251384,0.00015728056,0.000005487903,0.00021827247],"genre_scores_gemma":[0.0037147664,0.99514765,0.00032702897,0.00031129617,0.00009101025,0.00018466833,0.00014865995,0.000005260495,0.000069645896],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99178773,0.0019057218,0.004246803,0.00046684395,0.0014397845,0.00015306749],"domain_scores_gemma":[0.96497446,0.024472442,0.0052858028,0.00040775133,0.004585339,0.00027412825],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008308495,0.0013965573,0.007116841,0.014260803,0.0006363422,0.0026014042,0.0019226017,0.0015584677,0.0044746674],"category_scores_gemma":[0.03012448,0.0008881925,0.0062031993,0.013324891,0.0009675901,0.0026723286,0.0010509769,0.0011965311,0.0005120433],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026482716,0.000023080105,0.00031975648,0.91431195,0.0027606667,0.00012774588,0.0001997528,0.000060229508,0.00030885212,0.00026349621,0.002744046,0.078615665],"study_design_scores_gemma":[0.00020357437,0.00048271648,0.004319718,0.8906893,0.03488148,0.0011613055,0.000391374,0.00006243718,0.00049049215,0.00036077385,0.06689835,0.000058454607],"about_ca_topic_score_codex":0.0030458374,"about_ca_topic_score_gemma":0.0063969498,"teacher_disagreement_score":0.014260803,"about_ca_system_score_codex":0.003281997,"about_ca_system_score_gemma":0.008242024,"threshold_uncertainty_score":0.043940067},"labels":[],"label_agreement":null},{"id":"W2598622099","doi":"10.1111/jdv.14237","title":"Efficacy of ixekizumab compared to etanercept and placebo in patients with moderate‐to‐severe plaque psoriasis and non‐pustular palmoplantar involvement: results from three phase 3 trials (<scp>UNCOVER</scp>‐1, <scp>UNCOVER</scp>‐2 and <scp>UNCOVER</scp>‐3)","year":2017,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":74,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"Celgene; Regeneron Pharmaceuticals; Novartis; Amgen; Pfizer; Allergan; Biogen Idec; Eli Lilly and Company; AbbVie; Merck","keywords":"Ixekizumab; Medicine; Placebo; Etanercept; Psoriasis; Palmoplantar pustulosis; Psoriasis Area and Severity Index; Internal medicine; Plaque psoriasis; Dermatology; Gastroenterology; Psoriatic arthritis; Pathology; Tumor necrosis factor alpha; Secukinumab","score_opus":0.029237971730965918,"score_gpt":0.2649287669594539,"score_spread":0.23569079522848796,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2598622099","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9807577,0.014640013,0.00038415534,0.0006321488,0.0005223535,0.0008062534,0.00051568437,0.000088161876,0.0016534271],"genre_scores_gemma":[0.9938797,0.0030074148,0.0004799851,0.00044704895,0.00031723263,0.00060563703,0.00035566997,0.0000093349645,0.0008979043],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9992872,0.00039530234,0.00007979633,0.000110802925,0.000052312,0.0000746469],"domain_scores_gemma":[0.9989195,0.0003963101,0.00031113348,0.000048955335,0.00004119788,0.0002828713],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019182604,0.00088053197,0.003173173,0.00030204098,0.00030912485,0.0008626834,0.0005942981,0.0015080143,0.004295642],"category_scores_gemma":[0.0018503766,0.0005382444,0.0023674367,0.00028668265,0.00069568877,0.00096673635,0.0002852888,0.0022220374,0.00053232897],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9700844,0.0028536096,0.0006404724,0.000511365,0.0007325489,0.00003221623,0.000041090017,0.0002272068,0.0025971648,0.00004998926,0.00039101852,0.021838952],"study_design_scores_gemma":[0.8465103,0.14603554,0.0047432506,0.0000605906,0.0008050858,0.000099681645,0.000027686348,0.00048397924,0.0005808654,0.00014619007,0.0004890796,0.000017792381],"about_ca_topic_score_codex":0.0003973612,"about_ca_topic_score_gemma":0.00060782384,"teacher_disagreement_score":0.004295642,"about_ca_system_score_codex":0.00050441694,"about_ca_system_score_gemma":0.00075651536,"threshold_uncertainty_score":0.014370382},"labels":[],"label_agreement":null},{"id":"W2604967271","doi":"10.1111/jdv.14250","title":"Topical treatment of psoriasis: questionnaire results on topical therapy accessibility and influence of body surface area on usage","year":2017,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Innovaderm (Canada)","funders":"Janssen Biotech; Merck Sharp and Dohme; Allergan; Astellas Pharma; Celgene; Regeneron Pharmaceuticals; Novartis; Amgen; Pfizer; LEO Pharma Research Foundation; Eli Lilly and Company; Johnson and Johnson; AbbVie; Merck; GlaxoSmithKline","keywords":"Medicine; Psoriasis; Dermatology; Body surface area; Surgery","score_opus":0.036488101955308855,"score_gpt":0.2993034730095933,"score_spread":0.26281537105428443,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2604967271","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99628013,0.00027114543,0.00022174144,0.0000987463,0.0000074556992,0.00009895586,0.0010237076,0.00000996517,0.001987975],"genre_scores_gemma":[0.99846244,0.00017561502,0.00039712354,0.0000717461,0.000009010273,0.00006403066,0.00044486037,0.000002950575,0.0003721887],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985422,0.00051947695,0.00026535106,0.0001276788,0.00039361196,0.00015167802],"domain_scores_gemma":[0.99364626,0.0019648273,0.0030974455,0.00018214108,0.000679392,0.00042989603],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002091826,0.0001914322,0.0003044774,0.0008260648,0.0001904865,0.00038369666,0.0001972029,0.00036113962,0.0036823489],"category_scores_gemma":[0.0046080365,0.00012878011,0.00051871984,0.0009168643,0.00020224608,0.00039703143,0.00040129776,0.0004218945,0.0006466805],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001089122,0.00019692809,0.99116546,0.00010334381,0.00006710872,0.00006414866,0.00056343764,0.00013033953,0.00056256785,0.000018904493,0.00051936693,0.006499356],"study_design_scores_gemma":[0.000009511905,0.00043554907,0.9972154,0.000025150124,0.000021631855,0.00031473278,0.0008021523,0.00014470467,0.00013963813,0.000013947476,0.0008706642,0.0000068106547],"about_ca_topic_score_codex":0.00093987497,"about_ca_topic_score_gemma":0.0008009097,"teacher_disagreement_score":0.0036823489,"about_ca_system_score_codex":0.00018715212,"about_ca_system_score_gemma":0.00018594737,"threshold_uncertainty_score":0.012318671},"labels":[],"label_agreement":null},{"id":"W2606429310","doi":"10.1111/jdv.14284","title":"Oral lichenoid reactions associated with anti‐<scp>PD</scp>‐1/<scp>PD</scp>‐L1 therapies: clinicopathological findings","year":2017,"lang":"en","type":"letter","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":74,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Integre de Sante et de Services Sociaux de Laval","funders":"National Cancer Institute; National Institutes of Health; Memorial Sloan-Kettering Cancer Center","keywords":"Medicine; Cancer; Library science; Family medicine; Gerontology; Internal medicine","score_opus":0.03939686956812237,"score_gpt":0.3004152909291787,"score_spread":0.2610184213610563,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2606429310","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.61609864,0.017195247,0.0027663822,0.22112624,0.008209208,0.00046322413,0.0006955549,0.00042198162,0.13302355],"genre_scores_gemma":[0.9538117,0.003749495,0.0011384198,0.021321338,0.011343299,0.00006713974,0.00018304895,0.000033593427,0.008351941],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.999418,0.00012584715,0.000060312483,0.00010356189,0.00013981303,0.00015243124],"domain_scores_gemma":[0.9983797,0.00070320076,0.00020511163,0.00016209441,0.00024563,0.00030424487],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007214002,0.0006445573,0.0005998356,0.00094633555,0.00110674,0.0013702842,0.00081719697,0.0059695086,0.0027187439],"category_scores_gemma":[0.003888726,0.0004705691,0.0007287011,0.0006152481,0.0011623839,0.0014957871,0.0005060893,0.003511904,0.0014636018],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017119313,0.00007315149,0.016203672,0.00008842784,0.000021360307,0.958282,0.00018767669,0.00012886681,0.0017468677,0.00096994627,0.015440684,0.0066860714],"study_design_scores_gemma":[0.00008010892,0.00011471298,0.012515248,0.000082272956,0.00005231473,0.9614576,0.00027464336,0.001127812,0.00082778226,0.0013860364,0.022060968,0.000020518846],"about_ca_topic_score_codex":0.0010291723,"about_ca_topic_score_gemma":0.0014786081,"teacher_disagreement_score":0.0059695086,"about_ca_system_score_codex":0.0013331528,"about_ca_system_score_gemma":0.0005928823,"threshold_uncertainty_score":0.009672701},"labels":[],"label_agreement":null},{"id":"W2612944846","doi":"10.1111/jdv.14325","title":"Development of an atrophic acne scar risk assessment tool","year":2017,"lang":"en","type":"review","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Dermatologic Treatments and Research","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Windsor Clinical Research; University of Windsor; Western University","funders":"Galderma","keywords":"Medicine; Acne; Acne scars; Dermatology; Population; Scars; Surgery; Environmental health","score_opus":0.1232259938683696,"score_gpt":0.44152694401355286,"score_spread":0.3183009501451832,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2612944846","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6379544,0.007990865,0.20830575,0.009005938,0.001228705,0.069493085,0.030979577,0.005019845,0.030021854],"genre_scores_gemma":[0.3710033,0.0023592107,0.58171827,0.0013044913,0.00017880455,0.030487766,0.009944511,0.00012294391,0.0028806983],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.987128,0.005742281,0.0035516697,0.00060681615,0.002557534,0.00041365583],"domain_scores_gemma":[0.932225,0.050499424,0.0058463453,0.0013663708,0.008982118,0.0010808022],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.022013152,0.000784238,0.0014147918,0.0060669146,0.0004940828,0.0019977952,0.0013979425,0.0012525879,0.0045245085],"category_scores_gemma":[0.06846781,0.00062587974,0.003583628,0.0022035355,0.0003169668,0.0021011294,0.0023320043,0.0014162429,0.0010793051],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011569774,0.0014781859,0.15756759,0.011246422,0.00095683726,0.0006248393,0.0047261436,0.0029039776,0.0021593736,0.002896533,0.03136226,0.7829208],"study_design_scores_gemma":[0.003233734,0.007928326,0.6538971,0.026346471,0.0038607419,0.006249757,0.011557714,0.046662793,0.0101376595,0.0183634,0.21075805,0.0010041923],"about_ca_topic_score_codex":0.0008531623,"about_ca_topic_score_gemma":0.0015383427,"teacher_disagreement_score":0.022013152,"about_ca_system_score_codex":0.0011480587,"about_ca_system_score_gemma":0.0034224812,"threshold_uncertainty_score":0.11641812},"labels":[],"label_agreement":null},{"id":"W2618864847","doi":"10.1111/jdv.14313","title":"Phase I randomized study of <scp>KHK</scp>4083, an anti‐<scp>OX</scp>40 monoclonal antibody, in patients with mild to moderate plaque psoriasis","year":2017,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; Probity Medical Research","funders":"Kyowa Hakko Kirin","keywords":"Medicine; Monoclonal antibody; Plaque psoriasis; Monoclonal; Antibody; Psoriasis; Immunology","score_opus":0.020971043833649877,"score_gpt":0.2840904797723824,"score_spread":0.2631194359387325,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2618864847","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9850065,0.002052309,0.001023541,0.0005594361,0.00044637223,0.007976851,0.0009492265,0.00017953504,0.0018061585],"genre_scores_gemma":[0.9819547,0.0021303694,0.0021423888,0.0013035539,0.0004881512,0.007557023,0.0009226325,0.000033415374,0.0034677023],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9993467,0.00035228764,0.000030224553,0.00009831965,0.000057830235,0.00011464132],"domain_scores_gemma":[0.99889475,0.00028243088,0.00022282728,0.00008862443,0.00007864159,0.00043279325],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020240229,0.0016115046,0.002877746,0.0004185093,0.00048415287,0.0008020178,0.00082990906,0.0013423024,0.004718136],"category_scores_gemma":[0.0016004256,0.0009014773,0.0010984767,0.00038777487,0.00135202,0.00074606447,0.0003668488,0.0024441832,0.00078137196],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9487579,0.02133344,0.00093080476,0.0004729291,0.00049366936,0.000055223343,0.00007891941,0.0005227036,0.010579909,0.00015364679,0.0013503812,0.015270473],"study_design_scores_gemma":[0.8468517,0.14962566,0.0018023237,0.0000145734775,0.00017200543,0.000030138859,0.000015321804,0.00034557751,0.0005212119,0.00010402594,0.00050561014,0.000011908407],"about_ca_topic_score_codex":0.0010554207,"about_ca_topic_score_gemma":0.0023166786,"teacher_disagreement_score":0.004718136,"about_ca_system_score_codex":0.00071360014,"about_ca_system_score_gemma":0.0019213513,"threshold_uncertainty_score":0.015783727},"labels":[],"label_agreement":null},{"id":"W2618882799","doi":"10.1111/jdv.14352","title":"Rosacea is associated with Helicobacter pylori: a systematic review and meta‐analysis","year":2017,"lang":"en","type":"review","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Acne and Rosacea Treatments and Effects","field":"Medicine","cited_by":87,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Lundbeckfonden","keywords":"Medicine; Rosacea; Helicobacter pylori; Meta-analysis; Helicobacter Infections; Dermatology; Gastroenterology; Internal medicine","score_opus":0.08943490696579805,"score_gpt":0.3603888535594337,"score_spread":0.27095394659363564,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2618882799","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0044507575,0.99410665,0.00029411708,0.00014765798,0.000100604724,0.0002304473,0.00046394035,0.000015711103,0.00019004554],"genre_scores_gemma":[0.1372934,0.85766685,0.0016669678,0.0007561397,0.00027185745,0.001089201,0.0009042923,0.000025537633,0.00032584774],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9933329,0.0026789194,0.0020603728,0.00075613864,0.000869999,0.00030165105],"domain_scores_gemma":[0.9860459,0.009392808,0.002709877,0.00039762814,0.0012273638,0.00022639407],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009324268,0.0026807755,0.016640514,0.006626985,0.0007312956,0.0030081258,0.0021104629,0.0022219021,0.0041988753],"category_scores_gemma":[0.021676244,0.0014263354,0.029627576,0.0076105245,0.00059205614,0.0014805603,0.0014627917,0.0014435147,0.0002926853],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016418465,0.000034770917,0.0049675833,0.5160876,0.46531278,0.00022538399,0.0000978128,0.0003713589,0.00028784253,0.00010311522,0.00067847123,0.010191507],"study_design_scores_gemma":[0.00039516846,0.00021836307,0.0049200454,0.03253014,0.95979166,0.0001610125,0.0000513563,0.00012881344,0.000098727025,0.00011702509,0.0015634075,0.000024282816],"about_ca_topic_score_codex":0.0050926185,"about_ca_topic_score_gemma":0.011378647,"teacher_disagreement_score":0.016640514,"about_ca_system_score_codex":0.0022405419,"about_ca_system_score_gemma":0.0031233795,"threshold_uncertainty_score":0.049312055},"labels":[],"label_agreement":null},{"id":"W2620586117","doi":"10.1111/jdv.14377","title":"Impact of ixekizumab treatment on skin‐related personal relationship difficulties in moderate‐to‐severe psoriasis patients: 12‐week results from two Phase 3 trials","year":2017,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre de Recherche Dermatologique du Québec Métropolitain; Université Laval; Guenther Dermatology Research Centre","funders":"Eli Lilly and Company","keywords":"Ixekizumab; Medicine; Psoriasis; Dermatology Life Quality Index; Placebo; Etanercept; Internal medicine; Quality of life (healthcare); Dermatology; Secukinumab; Tumor necrosis factor alpha; Pathology; Psoriatic arthritis","score_opus":0.06330163258511776,"score_gpt":0.32777521611422883,"score_spread":0.2644735835291111,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2620586117","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96402586,0.025960607,0.0013821514,0.00090286485,0.00026594082,0.0032750953,0.0021067213,0.00017427273,0.0019065104],"genre_scores_gemma":[0.97761077,0.010048988,0.0024358986,0.0011585695,0.00035871798,0.0043629943,0.002262298,0.000049942842,0.0017118653],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9972398,0.0016832153,0.00026604926,0.00026868682,0.00028115817,0.00026107888],"domain_scores_gemma":[0.99573237,0.0017250885,0.0011811126,0.00039510775,0.0003250483,0.0006413832],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008756776,0.00168196,0.004476299,0.00042518484,0.00057249336,0.0016172457,0.0009478954,0.0020227982,0.0030255974],"category_scores_gemma":[0.005642941,0.0006702959,0.006698915,0.0006631741,0.00084998517,0.00092846976,0.00053496717,0.00272572,0.0004964108],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9030251,0.013031261,0.005063905,0.0029466355,0.010837807,0.0000989351,0.00023791628,0.0010098311,0.0058430308,0.000079542544,0.0017688136,0.056057252],"study_design_scores_gemma":[0.80953896,0.15772916,0.02374238,0.00027659873,0.0055302945,0.00016029006,0.000063171225,0.00050362264,0.0008124197,0.00017147779,0.0014188945,0.000052744144],"about_ca_topic_score_codex":0.0010285185,"about_ca_topic_score_gemma":0.0023162444,"teacher_disagreement_score":0.008756776,"about_ca_system_score_codex":0.000829586,"about_ca_system_score_gemma":0.0014258993,"threshold_uncertainty_score":0.046310782},"labels":[],"label_agreement":null},{"id":"W2622966691","doi":"10.1111/jdv.14387","title":"Early relapse of psoriasis after stopping brodalumab: a retrospective cohort study in 77 patients","year":2017,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":71,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Moncton Hospital; Centre de Recherche Dermatologique du Québec Métropolitain","funders":"","keywords":"Medicine; Psoriasis; Discontinuation; Retrospective cohort study; Psoriatic arthritis; Cohort; Internal medicine; Dermatology","score_opus":0.013630829294167271,"score_gpt":0.24784718476585627,"score_spread":0.234216355471689,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2622966691","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9994203,0.00021276741,0.000049119837,0.00001032409,0.000003817175,0.00002306125,0.00010748288,0.0000023627308,0.00017085584],"genre_scores_gemma":[0.9993754,0.00015966909,0.000064351945,0.000034482455,0.000012926001,0.000021455651,0.0002446839,0.0000041324583,0.00008298317],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99898654,0.00013917357,0.00010676345,0.00037420372,0.000182895,0.00021030962],"domain_scores_gemma":[0.99843675,0.00021903655,0.00071078655,0.00020202315,0.00011759522,0.0003138209],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00078304356,0.0004569283,0.0009311506,0.00093830645,0.0009973068,0.0009864955,0.00054413005,0.00062393694,0.0017517597],"category_scores_gemma":[0.0017860144,0.00083552126,0.00093783584,0.0012268036,0.00046755903,0.0008105927,0.00063723105,0.00086150464,0.00054598914],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026376144,0.0000774458,0.9976546,0.000010454147,0.00004966927,0.00066796754,0.00013468329,0.000018340636,0.00017631265,0.000008851664,0.00006012224,0.000877766],"study_design_scores_gemma":[0.00005691643,0.0006481406,0.99457526,0.00001942801,0.00011844394,0.00337819,0.0005381311,0.0001693508,0.0001017786,0.00001653173,0.00036341205,0.000014463744],"about_ca_topic_score_codex":0.003783196,"about_ca_topic_score_gemma":0.0033480886,"teacher_disagreement_score":0.003783196,"about_ca_system_score_codex":0.0006952755,"about_ca_system_score_gemma":0.00057344086,"threshold_uncertainty_score":0.0075223446},"labels":[],"label_agreement":null},{"id":"W2625513611","doi":"10.1111/jdv.14414","title":"Observations from our evaluation of bodyweight changes after initiation of a biologic therapy in the Psoriasis Longitudinal Assessment and Registry (PSOLAR)","year":2017,"lang":"en","type":"letter","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Gerontology; Library science; Family medicine","score_opus":0.10927326327233622,"score_gpt":0.32794786725086755,"score_spread":0.21867460397853133,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2625513611","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9142087,0.0011758046,0.0025039436,0.05664414,0.0021147234,0.00010141557,0.0012132167,0.00012807433,0.021909976],"genre_scores_gemma":[0.9755897,0.0005394542,0.0011685457,0.016112164,0.0016415851,0.000034440665,0.0004722416,0.00002989841,0.004412031],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99900764,0.00026467186,0.00014765105,0.0001369015,0.00028634616,0.00015682126],"domain_scores_gemma":[0.9959229,0.0013603293,0.0009530089,0.0003014188,0.00097332685,0.0004889931],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010109483,0.00027166074,0.0001890318,0.00053959864,0.0005747955,0.00065087667,0.00033708406,0.0013349424,0.00084509404],"category_scores_gemma":[0.006425664,0.00011377403,0.00025604403,0.00051063014,0.00026739688,0.00044485784,0.00030558713,0.0023190372,0.00045250758],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008647126,0.0005084345,0.8422849,0.00009090132,0.0000965535,0.07437795,0.0029825259,0.00022353056,0.007336303,0.0010698497,0.03508716,0.03507718],"study_design_scores_gemma":[0.00008841572,0.0015242209,0.791404,0.00018106881,0.00013061377,0.12165174,0.0033330012,0.0015463294,0.007454075,0.0008641391,0.07173024,0.000092112095],"about_ca_topic_score_codex":0.003753473,"about_ca_topic_score_gemma":0.0050958497,"teacher_disagreement_score":0.003753473,"about_ca_system_score_codex":0.00043836076,"about_ca_system_score_gemma":0.00031769986,"threshold_uncertainty_score":0.0074632764},"labels":[],"label_agreement":null},{"id":"W2743435786","doi":"10.1111/jdv.14515","title":"Patients with psoriasis have different preferences for topical therapy, highlighting the importance of individualized treatment approaches: randomized phase IIIb PSO‐INSIGHTFUL study","year":2017,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Probity Medical Research; University of British Columbia","funders":"LEO Pharma; LEO Pharma Research Foundation","keywords":"Medicine; Psoriasis; Randomized controlled trial; Phase (matter); Dermatology; Physical therapy; Intensive care medicine; Surgery","score_opus":0.06585235734554229,"score_gpt":0.2942708366845995,"score_spread":0.22841847933905723,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2743435786","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.984751,0.0019655265,0.0010362286,0.00051970006,0.00017388872,0.0087986905,0.0011988166,0.0000905354,0.001465743],"genre_scores_gemma":[0.9792747,0.0016550745,0.003323108,0.0019836249,0.00029601637,0.00991022,0.0014195484,0.000032716485,0.00210502],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99917537,0.00042719807,0.000059794656,0.00011908463,0.00009129438,0.00012732662],"domain_scores_gemma":[0.9987068,0.00036459157,0.00037368602,0.00014593061,0.000101056,0.000307849],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030930762,0.0013289233,0.0020420135,0.00032713552,0.00040872613,0.0009999408,0.00079237757,0.001515015,0.0070180795],"category_scores_gemma":[0.0018257684,0.0006353117,0.0020037128,0.0005028668,0.0009202566,0.0009034876,0.00037794383,0.0020146929,0.0007802084],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9441815,0.027523404,0.0018013788,0.00052084617,0.000998697,0.000038803777,0.00007001813,0.00021805124,0.00609552,0.00009369569,0.000674627,0.017783435],"study_design_scores_gemma":[0.88165563,0.11399442,0.0029767356,0.000023869177,0.00040830445,0.00003178967,0.00001946981,0.00016282046,0.00029023946,0.0000778857,0.0003486225,0.000010071217],"about_ca_topic_score_codex":0.0008410456,"about_ca_topic_score_gemma":0.0020333002,"teacher_disagreement_score":0.0070180795,"about_ca_system_score_codex":0.00056446594,"about_ca_system_score_gemma":0.0014588166,"threshold_uncertainty_score":0.023477852},"labels":[],"label_agreement":null},{"id":"W2752688736","doi":"10.1111/jdv.14581","title":"Impact of ixekizumab on facial psoriasis and related quality of life measures in moderate‐to‐severe psoriasis patients: 12‐week results from two phase <scp>III</scp> trials","year":2017,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre de Recherche Dermatologique du Québec Métropolitain; Université Laval; Guenther Dermatology Research Centre; Western University","funders":"Eli Lilly and Company","keywords":"Psoriasis; Ixekizumab; Medicine; Placebo; Psoriasis Area and Severity Index; Dermatology; Dermatology Life Quality Index; Quality of life (healthcare); Internal medicine; Secukinumab; Pathology; Psoriatic arthritis","score_opus":0.07829322909685908,"score_gpt":0.33741251816149587,"score_spread":0.25911928906463677,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2752688736","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9563702,0.037703466,0.00061920227,0.0006229981,0.00015973032,0.001442351,0.0015989254,0.00007102341,0.0014121373],"genre_scores_gemma":[0.9838007,0.009756555,0.0011558273,0.0006007704,0.00025830782,0.0017611149,0.0020362912,0.00001848041,0.0006119828],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9967526,0.0020181765,0.00035676203,0.00028688912,0.00039531128,0.00019036484],"domain_scores_gemma":[0.9956209,0.0016588854,0.0016208012,0.0002591241,0.00031282427,0.0005274725],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00921788,0.0012591364,0.0037178686,0.00044108534,0.00035196551,0.001254214,0.00072934973,0.0013831669,0.0017345976],"category_scores_gemma":[0.0047316714,0.00052355183,0.005801679,0.0006716509,0.00060691766,0.00056276354,0.0004534372,0.0020212037,0.00023970421],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.86563283,0.0064036176,0.02076171,0.0042125713,0.022404829,0.00007363398,0.00014171207,0.0011823252,0.0045105917,0.00007149112,0.0020052523,0.072599374],"study_design_scores_gemma":[0.7786178,0.1126093,0.093261905,0.00044075656,0.01095199,0.00025406116,0.00005921592,0.0009170561,0.0011351223,0.00013013775,0.0015653486,0.000057277677],"about_ca_topic_score_codex":0.00067085994,"about_ca_topic_score_gemma":0.0015715798,"teacher_disagreement_score":0.00921788,"about_ca_system_score_codex":0.0006572943,"about_ca_system_score_gemma":0.00081385544,"threshold_uncertainty_score":0.048749328},"labels":[],"label_agreement":null},{"id":"W2756882238","doi":"10.1111/jdv.14609","title":"Clinical interpretation of the Uremic Pruritus in Dialysis Patients (<scp>UP</scp>‐Dial) scale: a novel instrument for the assessment of uremic pruritus","year":2017,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Clinical Evaluative Sciences; Ottawa Hospital; University of Ottawa","funders":"National Research Council of Thailand; Chiang Mai University","keywords":"Medicine; Dialysis; Visual analogue scale; Receiver operating characteristic; Quality of life (healthcare); Cohen's kappa; EQ-5D; Kidney disease; Hemodialysis; Severity of illness; Internal medicine; Surgery; Disease; Health related quality of life; Statistics","score_opus":0.028109130684692094,"score_gpt":0.34406067009448044,"score_spread":0.3159515394097883,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2756882238","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9771662,0.0021128769,0.009838758,0.00047205572,0.000102896774,0.0008101095,0.0021307974,0.00011846373,0.0072480026],"genre_scores_gemma":[0.9853703,0.00053842936,0.012222958,0.00012662241,0.00005791587,0.00033322533,0.00077836274,0.000008137665,0.00056401675],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99775475,0.0009974069,0.00037498938,0.00015653604,0.0006466828,0.000069652895],"domain_scores_gemma":[0.9942188,0.0015448513,0.002899587,0.00019526319,0.0008878948,0.0002535192],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028003452,0.00035200056,0.00039453103,0.0011653146,0.00020505048,0.0006222225,0.00040084866,0.000397784,0.0018486766],"category_scores_gemma":[0.007318769,0.00010380472,0.00047178625,0.00069617294,0.00030490907,0.00050212035,0.00090957753,0.0006455447,0.00033292818],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041363918,0.0002663462,0.9027851,0.0004901492,0.00019078249,0.00018280934,0.0007267369,0.00044626358,0.0042855404,0.00030545524,0.002348184,0.08755902],"study_design_scores_gemma":[0.00005869294,0.0005286583,0.99301094,0.00008958895,0.00004989482,0.0011748377,0.00027771355,0.0011744042,0.0009390118,0.00017887681,0.0024980423,0.000019301551],"about_ca_topic_score_codex":0.0004994553,"about_ca_topic_score_gemma":0.00088819163,"teacher_disagreement_score":0.0028003452,"about_ca_system_score_codex":0.00034511267,"about_ca_system_score_gemma":0.0003277358,"threshold_uncertainty_score":0.014809847},"labels":[],"label_agreement":null},{"id":"W2766291043","doi":"10.1111/jdv.14647","title":"Apremilast for the treatment of moderate‐to‐severe palmoplantar psoriasis: results from a double‐blind, placebo‐controlled, randomized study","year":2017,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Nexus Clinical Research (Canada); SKiN Health; Merck Canada Inc. (Canada); Lynde Centre for Dermatology; Recyc PHP (Canada); Innovation Initiatives Ontario North; Manitoba Beekeepers' Association; Centre de Recherche Dermatologique du Québec Métropolitain; Innovaderm (Canada)","funders":"Novo Nordisk; Valeant Pharmaceuticals International; Regeneron Pharmaceuticals; Celgene; Novartis; AbbVie; Sanofi; Merck; GlaxoSmithKline; LEO Pharma Research Foundation; Pfizer; Boehringer Ingelheim; Amgen; Eli Lilly and Company; DUSA Pharmaceuticals; Abbott Fund","keywords":"Medicine; Apremilast; Psoriasis; Dermatology; Placebo; Randomized controlled trial; Double blind; Palmoplantar pustulosis; Internal medicine; Alternative medicine; Psoriatic arthritis; Pathology","score_opus":0.0427613775513459,"score_gpt":0.2904193061054218,"score_spread":0.24765792855407592,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2766291043","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95266634,0.030633718,0.0019532254,0.0010384494,0.0011750957,0.008513538,0.0012562985,0.00024019078,0.0025232262],"genre_scores_gemma":[0.9692582,0.01585449,0.0032582162,0.0013129866,0.001170184,0.005784757,0.0010020126,0.000035736088,0.0023233702],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.997881,0.0013446824,0.00021754437,0.00021325571,0.00021951567,0.00012397456],"domain_scores_gemma":[0.9979419,0.000874433,0.00052473636,0.00014218039,0.0001650155,0.0003516948],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005207834,0.0012235321,0.0038368625,0.00060292846,0.00044877073,0.0011074091,0.0009882372,0.0019555003,0.0066215377],"category_scores_gemma":[0.0033467521,0.00079803687,0.0026171159,0.0005159678,0.0010451438,0.00096473226,0.00034799677,0.0015789631,0.00070628815],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9669799,0.0063240333,0.00033887918,0.0020778663,0.0015883463,0.000043765336,0.00003426196,0.00012808922,0.003658412,0.000064265754,0.00038299413,0.018379068],"study_design_scores_gemma":[0.962223,0.035240747,0.001142408,0.000053552394,0.00064698834,0.000037029127,0.0000089112455,0.00011071589,0.00020605029,0.000039918512,0.00028159414,0.00000918405],"about_ca_topic_score_codex":0.0003589472,"about_ca_topic_score_gemma":0.0007686445,"teacher_disagreement_score":0.0066215377,"about_ca_system_score_codex":0.0004526441,"about_ca_system_score_gemma":0.0009701082,"threshold_uncertainty_score":0.027541995},"labels":[],"label_agreement":null},{"id":"W2766928453","doi":"10.1111/jdv.14651","title":"A phase 2a randomized controlled study to evaluate the pharmacokinetic, safety, tolerability and clinical effect of topically applied Umeclidinium in subjects with primary axillary hyperhidrosis","year":2017,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Sympathectomy and Hyperhidrosis Treatments","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Innovaderm (Canada)","funders":"Dermira; GlaxoSmithKline","keywords":"Medicine; Tolerability; Clinical endpoint; Randomized controlled trial; Hyperhidrosis; Clinical trial; Adverse effect; Crossover study; Anesthesia; Randomization; Internal medicine; Placebo","score_opus":0.022282691191992818,"score_gpt":0.3575611563178448,"score_spread":0.33527846512585197,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2766928453","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96363825,0.0049299323,0.0021011522,0.0009900971,0.0008845644,0.023381284,0.0016872574,0.00024279376,0.002144601],"genre_scores_gemma":[0.94391835,0.003235014,0.0068041226,0.0025490823,0.0010742866,0.035189815,0.0015769794,0.000057586876,0.0055947923],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99857914,0.0008209947,0.00007622479,0.00023957086,0.0001365807,0.00014758068],"domain_scores_gemma":[0.9979771,0.0006487704,0.0004786526,0.00017515542,0.00021574317,0.0005047698],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00346386,0.0018246477,0.0039411834,0.000465278,0.00069380907,0.0010412064,0.0011745911,0.0021311722,0.009440454],"category_scores_gemma":[0.0029938207,0.00097584544,0.0012550607,0.00052883057,0.0013476298,0.0011787585,0.0003901058,0.0026501429,0.0012507758],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.96607757,0.01857623,0.00046823654,0.0005749922,0.0005034437,0.000052358722,0.0000569192,0.00013685234,0.00489846,0.000073810384,0.0006665848,0.007914637],"study_design_scores_gemma":[0.90685,0.09150561,0.00075636466,0.000013593273,0.00012831892,0.00002226493,0.000011462928,0.00015425697,0.00020881816,0.000043888245,0.00029914844,0.0000062267372],"about_ca_topic_score_codex":0.00076569937,"about_ca_topic_score_gemma":0.0018127987,"teacher_disagreement_score":0.009440454,"about_ca_system_score_codex":0.00070019613,"about_ca_system_score_gemma":0.0023325311,"threshold_uncertainty_score":0.03158146},"labels":[],"label_agreement":null},{"id":"W2772776690","doi":"10.1111/jdv.14738","title":"Safety and efficacy of apremilast through 104 weeks in patients with moderate to severe psoriasis who continued on apremilast or switched from etanercept treatment: findings from the LIBERATE study","year":2017,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":67,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; University of Toronto; Probity Medical Research; Queen's University","funders":"Galderma; Dermira; Celgene; GlaxoSmithKline; Biogen; Kyowa Hakko Kirin; Eli Lilly and Company; Astellas Pharma; Astellas Pharma US; Amgen","keywords":"Apremilast; Medicine; Psoriasis; Etanercept; Dermatology Life Quality Index; Placebo; Dermatology; Internal medicine; Visual analogue scale; Psoriasis Area and Severity Index; Adverse effect; Psoriatic arthritis; Surgery; Tumor necrosis factor alpha; Pathology","score_opus":0.02100902211503499,"score_gpt":0.25064626129932743,"score_spread":0.22963723918429244,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2772776690","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99760264,0.00140892,0.000087119544,0.00010488568,0.000018004523,0.000089362955,0.00017086777,0.000007289026,0.0005110421],"genre_scores_gemma":[0.99843186,0.0004962349,0.00017607734,0.0002399665,0.000050008755,0.00008540812,0.00028939964,0.0000021123274,0.0002288879],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99933136,0.00034009723,0.000058938895,0.00008765553,0.00012138957,0.000060507096],"domain_scores_gemma":[0.9984415,0.0004677568,0.0005347707,0.00010319927,0.000089584064,0.0003631589],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018245633,0.00026518982,0.0010541696,0.00014786328,0.00027505402,0.0005191752,0.00021189969,0.0004459862,0.0016311808],"category_scores_gemma":[0.0019122354,0.00020336703,0.0009996744,0.00021011296,0.00028399407,0.00043921903,0.00018711857,0.0010286317,0.00025566958],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.58980304,0.0099883685,0.227089,0.0007333496,0.0028072484,0.00041803712,0.000376809,0.00073709193,0.017545884,0.0001034935,0.0021276893,0.14827012],"study_design_scores_gemma":[0.21592812,0.22256486,0.5505452,0.00014256594,0.0019504695,0.0015083808,0.00017144956,0.001142225,0.0021252385,0.00020917499,0.0036560318,0.000056220408],"about_ca_topic_score_codex":0.00024659064,"about_ca_topic_score_gemma":0.0005640131,"teacher_disagreement_score":0.0018245633,"about_ca_system_score_codex":0.00033892872,"about_ca_system_score_gemma":0.00045523216,"threshold_uncertainty_score":0.009649277},"labels":[],"label_agreement":null},{"id":"W2774054421","doi":"10.1111/jdv.14728","title":"Assessing dutasteride‐associated sexual dysfunction using the U.S. Food and Drug Administration Adverse Event Reporting System","year":2017,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Sexual function and dysfunction studies","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; Western University; Mediprobe Research (Canada); University of Toronto","funders":"Foundation for Anesthesia Education and Research","keywords":"Dutasteride; Adverse Event Reporting System; Medicine; Sexual dysfunction; Adverse effect; Food and drug administration; Odds ratio; Confidence interval; Internal medicine; Pharmacology; Prostate cancer","score_opus":0.08335158688987766,"score_gpt":0.3524436751290392,"score_spread":0.26909208823916153,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2774054421","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9068495,0.01886792,0.015470284,0.001086376,0.00019319844,0.004818179,0.036641497,0.0002271353,0.015846059],"genre_scores_gemma":[0.9796234,0.0029777263,0.008011507,0.00031412073,0.00009761129,0.0013495955,0.0071229287,0.000012429806,0.0004906372],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9587777,0.018577103,0.013170972,0.0016953354,0.007333438,0.0004454936],"domain_scores_gemma":[0.8586248,0.03672343,0.08747148,0.0042327913,0.011965164,0.0009824635],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.030293865,0.00039203858,0.00077700085,0.007161982,0.00035645833,0.0010234577,0.00072037446,0.00037942486,0.0019426941],"category_scores_gemma":[0.04839166,0.00022987463,0.0016314004,0.0070375497,0.00036898867,0.00090457255,0.00089027465,0.0005383354,0.00030233918],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003581943,0.000054609747,0.97988796,0.0007213047,0.0008004429,0.00006508631,0.00012068054,0.00026304886,0.00033956004,0.00021215269,0.00085668324,0.016320277],"study_design_scores_gemma":[0.000043692708,0.0007578422,0.9920163,0.00034096037,0.00051122083,0.0006654815,0.0002414369,0.0010403236,0.0009865954,0.00017517884,0.0031903395,0.0000305329],"about_ca_topic_score_codex":0.004300511,"about_ca_topic_score_gemma":0.0041536395,"teacher_disagreement_score":0.030293865,"about_ca_system_score_codex":0.00090921845,"about_ca_system_score_gemma":0.0011621796,"threshold_uncertainty_score":0.1602112},"labels":[],"label_agreement":null},{"id":"W2790018949","doi":"10.1111/jdv.14879","title":"Is atopic dermatitis associated with obesity? A systematic review of observational studies","year":2018,"lang":"en","type":"review","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":78,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Atopic dermatitis; Observational study; Dermatology; Obesity; MEDLINE; Pediatrics; Internal medicine","score_opus":0.10802148936770264,"score_gpt":0.36892652969075757,"score_spread":0.26090504032305495,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2790018949","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0019227117,0.9968755,0.00015332103,0.00021651528,0.00010142855,0.000187304,0.00042160368,0.000004710646,0.0001168858],"genre_scores_gemma":[0.03145555,0.96584463,0.00075981906,0.00069323287,0.00013688616,0.0005664461,0.00046510634,0.000006388845,0.00007197232],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9838308,0.005179538,0.0075715943,0.0012880391,0.001826328,0.00030373613],"domain_scores_gemma":[0.93710387,0.043195464,0.014138318,0.0013508283,0.0038321295,0.00037934733],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.013759838,0.0014449209,0.0085540665,0.009518043,0.000655,0.0026585045,0.001604439,0.0017784161,0.0033000186],"category_scores_gemma":[0.06407827,0.0012834687,0.011543733,0.01148389,0.000948123,0.002035127,0.0015072403,0.0012993959,0.00024641416],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028037277,0.00001658177,0.0044728126,0.9427763,0.034516122,0.0001553548,0.00015146396,0.000075942255,0.000119525,0.00012575918,0.00079655525,0.016513117],"study_design_scores_gemma":[0.0003851225,0.00026625517,0.021247538,0.6908885,0.2758431,0.00087880006,0.00035451513,0.000107784144,0.00017514692,0.0003973256,0.009397112,0.0000587925],"about_ca_topic_score_codex":0.009067822,"about_ca_topic_score_gemma":0.023049615,"teacher_disagreement_score":0.013759838,"about_ca_system_score_codex":0.0028675976,"about_ca_system_score_gemma":0.007942682,"threshold_uncertainty_score":0.07276982},"labels":[],"label_agreement":null},{"id":"W2790684790","doi":"10.1111/jdv.14913","title":"Improvement in itch and other psoriasis symptoms with brodalumab in phase 3 randomized controlled trials","year":2018,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Valeant Pharmaceuticals International","keywords":"Medicine; Ustekinumab; Psoriasis; Randomized controlled trial; Placebo; Visual analogue scale; Dermatology Life Quality Index; Ixekizumab; Internal medicine; Dermatology; Physical therapy; Secukinumab; Adalimumab; Psoriatic arthritis; Disease","score_opus":0.020231432584534467,"score_gpt":0.28475968443126637,"score_spread":0.2645282518467319,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2790684790","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6438082,0.27905977,0.0063779233,0.005385097,0.0036667339,0.04285948,0.006838103,0.0010840303,0.0109207295],"genre_scores_gemma":[0.8596151,0.075467706,0.0071816533,0.006682036,0.0013417811,0.043153726,0.0032479248,0.000105454186,0.0032046132],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99658173,0.002072536,0.0004334691,0.0003405404,0.00030852068,0.0002632211],"domain_scores_gemma":[0.9968927,0.001140312,0.001143084,0.00018124047,0.00027470224,0.00036788327],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00694296,0.0015061055,0.0044164867,0.0008253558,0.00066663086,0.0017246233,0.0012830244,0.0023104139,0.0068441955],"category_scores_gemma":[0.006550234,0.000770549,0.0047972337,0.0011901724,0.0009276443,0.0010033977,0.00048539563,0.0024672952,0.0005712348],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.908878,0.0037012964,0.0013765834,0.01682279,0.013587751,0.00010626628,0.00010494955,0.0005546523,0.0027232668,0.00028179135,0.003961115,0.04790141],"study_design_scores_gemma":[0.980838,0.012645936,0.001873587,0.000474848,0.0023080078,0.00004285723,0.000016233034,0.00018243729,0.00017183945,0.0001418984,0.0012889797,0.000015313677],"about_ca_topic_score_codex":0.0009547926,"about_ca_topic_score_gemma":0.0030656997,"teacher_disagreement_score":0.00694296,"about_ca_system_score_codex":0.0009508219,"about_ca_system_score_gemma":0.0017351238,"threshold_uncertainty_score":0.03671831},"labels":[],"label_agreement":null},{"id":"W2791839805","doi":"10.1111/jdv.14910","title":"Patient‐reported symptoms and signs of moderate‐to‐severe psoriasis treated with guselkumab or adalimumab: results from the randomized <scp>VOYAGE</scp> 1 trial","year":2018,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research","funders":"National Institutes of Health; National Institute for Health and Care Research","keywords":"Medicine; Adalimumab; Psoriasis; Placebo; Randomized controlled trial; Internal medicine; Surgery; Dermatology; Disease","score_opus":0.021936845428191774,"score_gpt":0.24077548794487086,"score_spread":0.2188386425166791,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2791839805","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9826701,0.011275181,0.00039107635,0.00075614173,0.00037017147,0.0010314672,0.0013111284,0.0000717935,0.0021228637],"genre_scores_gemma":[0.990186,0.0038931246,0.00052532053,0.0009050655,0.0003854357,0.0012195893,0.0016298833,0.000020569054,0.0012351293],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9982174,0.0011908154,0.00010821996,0.0001874998,0.00014161086,0.00015446526],"domain_scores_gemma":[0.998097,0.0007376234,0.0005482496,0.00015149245,0.00009977199,0.00036577135],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0037234647,0.0011104335,0.0028291966,0.00030795732,0.0003434447,0.0011374544,0.00079149683,0.0017078349,0.004892932],"category_scores_gemma":[0.003314344,0.0004709128,0.0030064546,0.0003416981,0.0008748865,0.0007956321,0.00034638782,0.0025561494,0.00061457854],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.97952145,0.0022090268,0.0014152988,0.00062905165,0.0017538593,0.000019412997,0.000042251562,0.00017856271,0.00092093885,0.000056021545,0.0010073751,0.012246702],"study_design_scores_gemma":[0.96534306,0.02617283,0.005750292,0.00008564755,0.0014588654,0.00005054339,0.000023747727,0.00021854731,0.0001959081,0.00013313908,0.000553922,0.000013496868],"about_ca_topic_score_codex":0.0006290106,"about_ca_topic_score_gemma":0.0012684519,"teacher_disagreement_score":0.004892932,"about_ca_system_score_codex":0.00057975977,"about_ca_system_score_gemma":0.0007962692,"threshold_uncertainty_score":0.019691765},"labels":[],"label_agreement":null},{"id":"W2792561725","doi":"10.1111/jdv.14942","title":"Primary cutaneous peripheral T‐cell lymphoma not otherwise specified a rare and aggressive lymphoma","year":2018,"lang":"en","type":"letter","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Cutaneous lymphoproliferative disorders research","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Specialty; Dermatology; Lymphoma; Family medicine; Pathology","score_opus":0.020957724216252558,"score_gpt":0.26841564148761954,"score_spread":0.24745791727136698,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2792561725","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.571705,0.027363747,0.0078081377,0.18136676,0.014293416,0.00035591744,0.0009393918,0.00071162614,0.19545604],"genre_scores_gemma":[0.93352985,0.0050675715,0.0017375626,0.024691856,0.020357128,0.000056955098,0.0002453631,0.000058164962,0.014255536],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9995223,0.0001209024,0.00004685832,0.000094006435,0.0000762556,0.00013974536],"domain_scores_gemma":[0.99905497,0.00040734658,0.00012940461,0.000092093076,0.000114926916,0.00020118411],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038906123,0.000689905,0.0005982909,0.00051319064,0.0012310018,0.0013020273,0.00056423945,0.005311024,0.004400261],"category_scores_gemma":[0.0026775429,0.00034713905,0.00047870365,0.0005287744,0.00091321045,0.0018052532,0.00062129775,0.002853477,0.0017592082],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000073178744,0.00006150702,0.009625209,0.00010912339,0.000015707903,0.961658,0.0001382387,0.0001461011,0.0013954088,0.002542336,0.018115066,0.006120156],"study_design_scores_gemma":[0.00007594774,0.000084553256,0.008603106,0.00008049867,0.00003444874,0.966515,0.0002772643,0.0011996331,0.00046351054,0.002462962,0.020192474,0.000010604358],"about_ca_topic_score_codex":0.00052632653,"about_ca_topic_score_gemma":0.0008598288,"teacher_disagreement_score":0.005311024,"about_ca_system_score_codex":0.00089273846,"about_ca_system_score_gemma":0.00038018762,"threshold_uncertainty_score":0.014720321},"labels":[],"label_agreement":null},{"id":"W2792921896","doi":"10.1111/jdv.14878","title":"Secukinumab demonstrates high sustained efficacy and a favourable safety profile in patients with moderate‐to‐severe psoriasis through 5 years of treatment (<scp>SCULPTURE</scp> Extension Study)","year":2018,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":193,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"XLV Diagnostics (Canada); Probity Medical Research; Innovaderm (Canada)","funders":"Novartis Pharma; Novartis","keywords":"Secukinumab; Medicine; Psoriasis Area and Severity Index; Dermatology Life Quality Index; Psoriasis; Psoriatic arthritis; Adverse effect; Clinical trial; Internal medicine; Surgery; Dermatology","score_opus":0.011323670330450543,"score_gpt":0.2304250217205764,"score_spread":0.21910135139012588,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2792921896","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99666023,0.0018882898,0.00024827116,0.00006915668,0.00001285929,0.00011568274,0.00019960337,0.000029503191,0.00077644724],"genre_scores_gemma":[0.9982961,0.00039532877,0.0002927578,0.00008786939,0.000032709257,0.00006152552,0.00042363247,0.000004598445,0.0004054327],"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99958223,0.00019835998,0.00003615147,0.000050487743,0.000078584344,0.00005432856],"domain_scores_gemma":[0.99920887,0.00017433755,0.0002990241,0.0000738129,0.00006302736,0.00018101391],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002214504,0.00034375375,0.0007804515,0.00016010982,0.0002251004,0.00034460588,0.000151726,0.00030244008,0.0021154648],"category_scores_gemma":[0.0008254671,0.0001508738,0.0005017388,0.00017502146,0.00020608916,0.0002526158,0.00019585426,0.000686246,0.0004071634],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.22515665,0.017458314,0.1747916,0.0015831537,0.0022915336,0.00049982464,0.0005234072,0.002381396,0.12166929,0.00028163707,0.0055225412,0.4478407],"study_design_scores_gemma":[0.03684187,0.30407026,0.6359,0.00010518116,0.00080711715,0.0019297582,0.00007460176,0.0014689201,0.0121336,0.000115342664,0.0065075452,0.0000457804],"about_ca_topic_score_codex":0.00020432973,"about_ca_topic_score_gemma":0.0007312786,"teacher_disagreement_score":0.002214504,"about_ca_system_score_codex":0.00014427293,"about_ca_system_score_gemma":0.0002666507,"threshold_uncertainty_score":0.011711597},"labels":[],"label_agreement":null},{"id":"W2793134358","doi":"10.1111/jdv.14805","title":"T‐cell papulosis associated with B‐cell malignancy: a distinctive clinicopathologic entity","year":2018,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Eosinophilic Disorders and Syndromes","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Malignancy; Pathology; clone (Java method); Pathogenesis; Mycosis fungoides; Medicine; Immunohistochemistry; B cell; Lymphoma; Biology; Immunology; Antibody; Gene","score_opus":0.01666045752171911,"score_gpt":0.2574517097412249,"score_spread":0.24079125221950579,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2793134358","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962465,0.0016816123,0.0003558364,0.000050272876,0.000010514287,0.00002499925,0.000070626316,0.000021155693,0.0015384615],"genre_scores_gemma":[0.9993186,0.00031199068,0.00013945386,0.000025007632,0.000048432717,0.000009618231,0.00006785246,0.0000021374244,0.00007680447],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.99976104,0.000041381412,0.00002679767,0.000060828537,0.000036168283,0.00007384566],"domain_scores_gemma":[0.9989675,0.00021365554,0.0004376308,0.00010342857,0.000068170826,0.00020960101],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002947508,0.0005141765,0.00041179822,0.0011300079,0.0005623437,0.00052894984,0.00037366024,0.0007263024,0.0016983148],"category_scores_gemma":[0.0010905104,0.00023159101,0.00019913357,0.0012096664,0.00076337997,0.0003706144,0.0005866781,0.00033092228,0.0005211145],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030577785,0.00011667165,0.6083309,0.00018051511,0.00006463974,0.36325797,0.0005091456,0.00019921114,0.014544531,0.00035713371,0.00071428245,0.011419281],"study_design_scores_gemma":[0.00003188505,0.0001821416,0.20044245,0.00002237556,0.000041658463,0.796512,0.00024028662,0.00022425772,0.0006903113,0.00014746984,0.0014557077,0.00000948381],"about_ca_topic_score_codex":0.00042970138,"about_ca_topic_score_gemma":0.00048603435,"teacher_disagreement_score":0.0016983148,"about_ca_system_score_codex":0.00019259406,"about_ca_system_score_gemma":0.00030501085,"threshold_uncertainty_score":0.005681455},"labels":[],"label_agreement":null},{"id":"W2793539409","doi":"10.1111/jdv.14933","title":"Sinecatechins ointment 10% (Veregen®) for genital warts: percutaneous penetration of epigallocatechin gallate concentrations in the stratum corneum collected by adhesive tape stripping method","year":2018,"lang":"en","type":"letter","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"","keywords":"Stratum corneum; Medicine; Chromatography; Adhesive; Epigallocatechin gallate; Penetration (warfare); Composite material; Materials science; Chemistry; Biochemistry; Pathology","score_opus":0.020602860225596,"score_gpt":0.28943621433196315,"score_spread":0.26883335410636716,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2793539409","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.62600994,0.20894152,0.024912283,0.06449498,0.067254394,0.00049266685,0.0006916198,0.0006424692,0.006560239],"genre_scores_gemma":[0.83026135,0.06511324,0.015190663,0.020447854,0.04305004,0.00014633173,0.00030312745,0.00017334337,0.025314027],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.999777,0.0000540839,0.000028054157,0.0000425556,0.00007490582,0.00002347807],"domain_scores_gemma":[0.99936444,0.00029238852,0.00012632509,0.000043790093,0.00013060545,0.000042593],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007029172,0.00041003022,0.0005405775,0.00026969684,0.00013662665,0.0004831628,0.00040257693,0.0009933917,0.0016885005],"category_scores_gemma":[0.0010208781,0.00013003232,0.0002599013,0.00016848238,0.00034793027,0.000501368,0.00010593961,0.0011257436,0.00078425894],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008087164,0.00062316505,0.008193456,0.003790173,0.00022169226,0.022606937,0.00033454475,0.0001356774,0.5848969,0.0010227979,0.06909493,0.3009926],"study_design_scores_gemma":[0.0004374504,0.0057049417,0.038947463,0.0003043959,0.00058166654,0.077647455,0.00044359703,0.0054889293,0.45687923,0.000826271,0.41265127,0.00008721941],"about_ca_topic_score_codex":0.00018726474,"about_ca_topic_score_gemma":0.0003301049,"teacher_disagreement_score":0.0016885005,"about_ca_system_score_codex":0.00021332847,"about_ca_system_score_gemma":0.000106000036,"threshold_uncertainty_score":0.005648613},"labels":[],"label_agreement":null},{"id":"W2793564922","doi":"10.1111/jdv.14926","title":"Long‐term optimization of outcomes with flexible adalimumab dosing in patients with moderate to severe plaque psoriasis","year":2018,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Dosing; Adalimumab; Psoriasis; Psoriasis Area and Severity Index; Plaque psoriasis; Internal medicine; Population; Dermatology; Disease","score_opus":0.01301828960695399,"score_gpt":0.23493063478086915,"score_spread":0.22191234517391517,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2793564922","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969506,0.0019580673,0.00016154317,0.0001181217,0.000014773797,0.00006215323,0.000102806946,0.0000069795997,0.0006250616],"genre_scores_gemma":[0.99910057,0.00026581384,0.0001830089,0.000085909465,0.000030263309,0.00005058556,0.00016577684,0.000001300102,0.000116809446],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991048,0.00043064717,0.00008733681,0.000102329905,0.00014591514,0.000129024],"domain_scores_gemma":[0.997738,0.0006506949,0.0008329994,0.00016182996,0.00015382556,0.00046258242],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029653385,0.0002571459,0.00087561127,0.00017386413,0.0003754479,0.0006803235,0.00019487184,0.00037454866,0.0010068825],"category_scores_gemma":[0.0026532437,0.0001211218,0.0010609825,0.00031653166,0.00022075008,0.00050295907,0.00031445624,0.00095665484,0.00019852766],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.16625161,0.010416999,0.5403738,0.0006864229,0.001995219,0.00040297286,0.00045056807,0.002134711,0.011353653,0.00013751644,0.0019723484,0.2638243],"study_design_scores_gemma":[0.0076075424,0.13286506,0.852009,0.00012443881,0.00090078806,0.0007525218,0.00019301877,0.0016768109,0.0015493957,0.00025305533,0.0020301568,0.0000383412],"about_ca_topic_score_codex":0.00035096065,"about_ca_topic_score_gemma":0.00069195457,"teacher_disagreement_score":0.0029653385,"about_ca_system_score_codex":0.00036665073,"about_ca_system_score_gemma":0.00052122626,"threshold_uncertainty_score":0.015682459},"labels":[],"label_agreement":null},{"id":"W2793756714","doi":"10.1111/jdv.14868","title":"Shifting the focus – the primary role of <scp>IL</scp>‐23 in psoriasis and other inflammatory disorders","year":2018,"lang":"en","type":"review","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":110,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lynde Centre for Dermatology; University of Toronto; Probity Medical Research; Queen's University","funders":"","keywords":"Medicine; Psoriasis; Spondyloarthropathy; Context (archaeology); Immunology; Tumor necrosis factor alpha; Inflammatory bowel disease; Disease; Proinflammatory cytokine; Interleukin 23; Inflammation; Interleukin 17; Arthritis; Internal medicine","score_opus":0.01864517733715582,"score_gpt":0.25272203884677913,"score_spread":0.2340768615096233,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2793756714","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000110193876,0.99839216,0.00006574376,0.0004542176,0.00025243,0.000002257231,0.0000072248886,0.0000040501754,0.00071176246],"genre_scores_gemma":[0.0008132746,0.9979486,0.00009569922,0.00033129603,0.00029316903,0.0000031058307,0.000011787318,0.0000012483339,0.0005019565],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99980694,0.000037625712,0.00002523071,0.00003259114,0.00007623398,0.000021366537],"domain_scores_gemma":[0.99974424,0.00011357748,0.000033312106,0.000009335962,0.00006934197,0.000030098108],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005436831,0.0005095534,0.0009022712,0.0016258825,0.00032044674,0.0010577117,0.0006256713,0.001009459,0.0033259226],"category_scores_gemma":[0.00066122593,0.00018442953,0.00035031748,0.001292687,0.0005984711,0.0014138293,0.0007108858,0.0018455312,0.0018147368],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007055342,0.00004913731,0.00017977196,0.014660754,0.00006305541,0.00034383696,0.00014298006,0.00017321292,0.0024792224,0.0060313824,0.036494426,0.93931174],"study_design_scores_gemma":[0.000010037844,0.000054174772,0.0006345974,0.0029521454,0.000050302304,0.0018506607,0.00010170022,0.00002898611,0.0004071281,0.002361749,0.9915383,0.000010268127],"about_ca_topic_score_codex":0.00086906017,"about_ca_topic_score_gemma":0.0015374171,"teacher_disagreement_score":0.0033259226,"about_ca_system_score_codex":0.00048223638,"about_ca_system_score_gemma":0.0010539538,"threshold_uncertainty_score":0.01112628},"labels":[],"label_agreement":null},{"id":"W2794114508","doi":"10.1111/jdv.14903","title":"Exploring the <i>in situ</i> expression of vascular endothelial growth factor and endoglin in pemphigus foliaceus variants and pemphigus vulgaris","year":2018,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Autoimmune Bullous Skin Diseases","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Endoglin; Erythroderma; Pemphigus foliaceus; Desmoglein 1; Medicine; Psoriasis; Vascular endothelial growth factor; Angiogenesis; Desmoglein 3; Autoantibody; Pemphigus; Pathogenesis; Pemphigus vulgaris; Pathology; Immunology; Dermatology; VEGF receptors; Cancer research; Antibody; Biology; Stem cell","score_opus":0.03583895620357203,"score_gpt":0.26350818998607456,"score_spread":0.22766923378250253,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2794114508","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9990689,0.0001716447,0.00043242663,0.00000504461,0.0000013381159,0.000003755427,0.000016433816,0.0000044139997,0.00029610124],"genre_scores_gemma":[0.9992662,0.00005881366,0.00054476055,0.000006426964,0.0000020062228,0.0000036600707,0.00004307547,0.0000017392109,0.00007323751],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9998385,0.000037957398,0.000011578097,0.00004864669,0.0000321091,0.000031308748],"domain_scores_gemma":[0.99981385,0.000048913353,0.00006393463,0.000013628835,0.00003138256,0.000028361164],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032971048,0.00015325243,0.00008844736,0.000504776,0.00012100139,0.00023221564,0.000131563,0.00022918571,0.0008192136],"category_scores_gemma":[0.00038097778,0.000109263674,0.00010764827,0.00017350625,0.00023224043,0.00017809002,0.00015922906,0.00018681391,0.000108820925],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007951751,0.00007649754,0.20324716,0.00013310804,0.00007321121,0.0015104243,0.00034114224,0.00015412043,0.78435266,0.00013960528,0.00008379446,0.009093171],"study_design_scores_gemma":[0.000035849058,0.0006272394,0.88642716,0.00001598175,0.00008972267,0.012710493,0.00051994936,0.0015676701,0.096690804,0.0001469098,0.0011604046,0.00000788917],"about_ca_topic_score_codex":0.0004672029,"about_ca_topic_score_gemma":0.00054305076,"teacher_disagreement_score":0.0008192136,"about_ca_system_score_codex":0.00015916092,"about_ca_system_score_gemma":0.000057287314,"threshold_uncertainty_score":0.0027405024},"labels":[],"label_agreement":null},{"id":"W2796762777","doi":"10.1111/jdv.14993","title":"Psoriasis patients’ preference for an aerosol foam topical formulation","year":2018,"lang":"en","type":"letter","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Montreal Clinical Research Institute; Guenther Dermatology Research Centre; Thornhill Medical (Canada); Western University; SKiN Health; Queen's University; McMaster University; Dermatrials Research","funders":"","keywords":"Medicine; Psoriasis; Dermatology; Aerosol; Preference; Meteorology","score_opus":0.046562204864978335,"score_gpt":0.26312829806763816,"score_spread":0.21656609320265982,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2796762777","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.10430522,0.015519339,0.00088330504,0.7900721,0.012298776,0.000037882262,0.00020161574,0.00009664528,0.07658509],"genre_scores_gemma":[0.64595646,0.0064160344,0.00081283937,0.31586146,0.012675201,0.000031003907,0.00011384134,0.000062058956,0.018071132],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99946564,0.00021596669,0.000042210675,0.0000610516,0.00013851598,0.00007654833],"domain_scores_gemma":[0.9988551,0.0007190685,0.00008773399,0.000040475446,0.00014233043,0.00015527563],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007089113,0.00013827927,0.00029833394,0.00015189726,0.00077724044,0.0007378538,0.00023471854,0.002468294,0.009973174],"category_scores_gemma":[0.0037445326,0.000082626044,0.00027654285,0.00019107698,0.00044059052,0.00054005097,0.0002351302,0.0037258517,0.002081666],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013918934,0.00025936787,0.02432069,0.00035479706,0.00008979024,0.10156507,0.0012183787,0.0002391701,0.0057161395,0.007894488,0.7095669,0.14738333],"study_design_scores_gemma":[0.00061744644,0.0007787308,0.024307843,0.00075412256,0.00012337156,0.3301064,0.0036678344,0.00118486,0.0026477354,0.011925593,0.62374693,0.00013907277],"about_ca_topic_score_codex":0.0008840486,"about_ca_topic_score_gemma":0.0015012866,"teacher_disagreement_score":0.009973174,"about_ca_system_score_codex":0.00062771223,"about_ca_system_score_gemma":0.00034133898,"threshold_uncertainty_score":0.03336358},"labels":[],"label_agreement":null},{"id":"W2798001650","doi":"10.1111/jdv.14985","title":"Response to ‘Psoriasis patients’ preference for an aerosol foam topical formulation’ by Vender R <i>et al</i>.","year":2018,"lang":"en","type":"letter","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; University of British Columbia","funders":"","keywords":"Medicine; Psoriasis; Dermatology; Preference","score_opus":0.03894838788157808,"score_gpt":0.2748958025533598,"score_spread":0.23594741467178174,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2798001650","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0076871435,0.0023278063,0.00025505445,0.96183836,0.019244215,0.000032762713,0.000089286616,0.00007852465,0.008446759],"genre_scores_gemma":[0.09375181,0.0023145496,0.00045600487,0.8638229,0.027059272,0.000051494997,0.00009827238,0.00006619464,0.012379526],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990828,0.00031238384,0.00009024668,0.00017793223,0.00017015838,0.000166457],"domain_scores_gemma":[0.9982369,0.0010029707,0.00015849754,0.000063345,0.00033924787,0.00019904839],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009934817,0.00051138364,0.0006038032,0.0003138282,0.001395608,0.0011652353,0.000615329,0.010653611,0.005913633],"category_scores_gemma":[0.008787482,0.00025982154,0.0005552687,0.00033396704,0.0009035299,0.0011581739,0.00045588784,0.010692906,0.0030095994],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020192318,0.0000734284,0.0030333141,0.000103694714,0.00002753885,0.058467068,0.0006341476,0.00012402232,0.0007756398,0.001871277,0.9183936,0.01629436],"study_design_scores_gemma":[0.00044780906,0.00049563736,0.009973369,0.0007640308,0.000066669694,0.21868412,0.0024680605,0.0018921669,0.0011835465,0.0075095454,0.7563232,0.00019177236],"about_ca_topic_score_codex":0.0028720105,"about_ca_topic_score_gemma":0.0030476786,"teacher_disagreement_score":0.010653611,"about_ca_system_score_codex":0.00183629,"about_ca_system_score_gemma":0.0007694909,"threshold_uncertainty_score":0.01978314},"labels":[],"label_agreement":null},{"id":"W2801142924","doi":"10.1111/jdv.15016","title":"The role of interleukins in vitiligo: a systematic review","year":2018,"lang":"en","type":"review","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"melanin and skin pigmentation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Conselho Nacional de Desenvolvimento Científico e Tecnológico","keywords":"Vitiligo; Medicine; Interleukin; Immunology; Depigmentation; Disease; Asymptomatic; Cytokine; Dermatology; Pathology","score_opus":0.015157007044452194,"score_gpt":0.30501872985716333,"score_spread":0.2898617228127111,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2801142924","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00012752305,0.9995503,0.000023997049,0.000103977705,0.000039931878,0.000011132038,0.000052246738,0.0000014144433,0.000089638146],"genre_scores_gemma":[0.0016395645,0.99796957,0.00009245671,0.00013723048,0.000046835077,0.000021542584,0.00004905181,7.4206434e-7,0.00004294174],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99897707,0.00027596002,0.00037991937,0.00012100469,0.00019841503,0.000047672864],"domain_scores_gemma":[0.99384236,0.0045618983,0.0009171849,0.00006404952,0.00052116724,0.000093283255],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020731308,0.0010033585,0.0034317183,0.0065733073,0.00033125022,0.0014477093,0.0011466886,0.0013314253,0.0045741857],"category_scores_gemma":[0.007974818,0.00045983004,0.0030540265,0.006482791,0.0004231292,0.0014133905,0.00078564987,0.00081251754,0.00034701216],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021872715,0.000029576306,0.00088235363,0.8094698,0.0033044366,0.0002161923,0.00014870943,0.00018222866,0.00031804122,0.00066249736,0.0058857775,0.17868164],"study_design_scores_gemma":[0.00022646521,0.00032845393,0.00781974,0.7706099,0.039799802,0.0021214234,0.00033400673,0.00014022188,0.00037240895,0.0012062932,0.17697585,0.00006551554],"about_ca_topic_score_codex":0.003317631,"about_ca_topic_score_gemma":0.008389037,"teacher_disagreement_score":0.0065733073,"about_ca_system_score_codex":0.0011548756,"about_ca_system_score_gemma":0.005015414,"threshold_uncertainty_score":0.015302181},"labels":[],"label_agreement":null},{"id":"W2802919678","doi":"10.1111/jdv.15057","title":"Beta‐adrenoceptor expression in pemphigus foliaceus","year":2018,"lang":"en","type":"letter","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Pain Mechanisms and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Pemphigus foliaceus; Medicine; BETA (programming language); Dermatology; Pemphigus; Desmoglein 1; Adrenergic receptor; Immunology; Internal medicine; Receptor; Autoantibody; Antibody; Programming language","score_opus":0.024353150556012056,"score_gpt":0.2831459466822575,"score_spread":0.25879279612624545,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2802919678","genre_codex":"commentary","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.14581113,0.076136224,0.0012534509,0.6793803,0.027175259,0.00010834949,0.00024533257,0.00016875965,0.06972125],"genre_scores_gemma":[0.7927583,0.01870372,0.00069308863,0.11014043,0.064764865,0.000046833436,0.000115811876,0.000029139086,0.012747949],"study_design_codex":"case_report","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995735,0.00012040678,0.00004078426,0.000062152394,0.00010926963,0.00009393275],"domain_scores_gemma":[0.9992975,0.0004622114,0.000064693166,0.00002410933,0.00008761103,0.000063890766],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007269678,0.0003362675,0.0005486941,0.00054833235,0.00091681024,0.0007959532,0.00043418494,0.005633411,0.0026143803],"category_scores_gemma":[0.0036747712,0.00018196554,0.00029939733,0.00032831967,0.0009560457,0.00084228907,0.00045670863,0.0040352787,0.0008230128],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045779723,0.00010048624,0.018700432,0.00047608127,0.000053966134,0.62214136,0.00087093987,0.00028858555,0.0056465436,0.005250278,0.29173082,0.054282684],"study_design_scores_gemma":[0.00025706325,0.00026310765,0.031004068,0.0012183575,0.00010806518,0.74405336,0.0012229092,0.0015723997,0.0017421454,0.010247187,0.20825034,0.000061017414],"about_ca_topic_score_codex":0.001290061,"about_ca_topic_score_gemma":0.0011130102,"teacher_disagreement_score":0.005633411,"about_ca_system_score_codex":0.0012577447,"about_ca_system_score_gemma":0.00025584296,"threshold_uncertainty_score":0.00912565},"labels":[],"label_agreement":null},{"id":"W2803335705","doi":"10.1111/jdv.15081","title":"Efficacy of non‐surgical treatments for androgenetic alopecia: a systematic review and network meta‐analysis","year":2018,"lang":"en","type":"review","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Hair Growth and Disorders","field":"Medicine","cited_by":107,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; Mediprobe Research (Canada); Women's College Hospital; University of Toronto","funders":"","keywords":"Finasteride; Minoxidil; Medicine; Dutasteride; Placebo; Male-pattern baldness; Hair loss; Adverse effect; Urology; Randomized controlled trial; Dermatology; Internal medicine; Scalp; Pathology","score_opus":0.06398085349448426,"score_gpt":0.36476405646930876,"score_spread":0.3007832029748245,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2803335705","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.010033529,0.9877627,0.0004905454,0.00022079649,0.00013767871,0.00028061957,0.0007306892,0.000024981644,0.00031859102],"genre_scores_gemma":[0.35590875,0.6377668,0.002188173,0.0009986387,0.00026546785,0.0010995428,0.0012887451,0.00003417517,0.00044972805],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9932794,0.0036101625,0.0014837706,0.0007469239,0.0006547674,0.0002249515],"domain_scores_gemma":[0.9854977,0.010785772,0.0021442892,0.00039097934,0.00096004776,0.00022117812],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009559291,0.0022547655,0.014607858,0.005103442,0.0005656376,0.0023332736,0.0018216036,0.001811704,0.0038188614],"category_scores_gemma":[0.019810693,0.0011612518,0.030831939,0.0052049565,0.00055596617,0.0014070716,0.0012463013,0.0016587165,0.00027464028],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028534783,0.00003767229,0.0042875656,0.2412295,0.7415792,0.0001267307,0.00005956658,0.0004853872,0.00021805702,0.00008817251,0.00045385264,0.008580808],"study_design_scores_gemma":[0.0007580157,0.00019003647,0.0037582915,0.010414461,0.9834999,0.000069012,0.000028763927,0.00017530972,0.00007129393,0.00011413171,0.0009061171,0.000014713316],"about_ca_topic_score_codex":0.0066743703,"about_ca_topic_score_gemma":0.015520281,"teacher_disagreement_score":0.014607858,"about_ca_system_score_codex":0.0021187428,"about_ca_system_score_gemma":0.0023930022,"threshold_uncertainty_score":0.05055493},"labels":[],"label_agreement":null},{"id":"W2803749964","doi":"10.1111/jdv.15088","title":"Tinea capitis in children: a systematic review of management","year":2018,"lang":"en","type":"review","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Nail Diseases and Treatments","field":"Medicine","cited_by":141,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; Mediprobe Research (Canada); Women's College Hospital; University of Toronto","funders":"","keywords":"Tinea capitis; Terbinafine; Medicine; Griseofulvin; Itraconazole; Dermatology; Trichophyton tonsurans; Adverse effect; Dosing; Microsporum; Dermatophyte; Antifungal; Trichophyton; Internal medicine","score_opus":0.02032123706487033,"score_gpt":0.3193218781669557,"score_spread":0.29900064110208535,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2803749964","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00048578426,0.9988397,0.000035150686,0.000120594195,0.000046465855,0.00011852353,0.00019608805,0.0000034263978,0.00015428748],"genre_scores_gemma":[0.0065536276,0.9925243,0.00032705805,0.00020736939,0.000040540577,0.00018127177,0.0001285961,0.000002140565,0.000035116613],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9946398,0.0017779992,0.0020906308,0.00035989808,0.00094557594,0.00018610228],"domain_scores_gemma":[0.98179597,0.012489683,0.0037400662,0.00019987741,0.0015187236,0.0002556522],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005720491,0.0013052219,0.0071253306,0.009865917,0.0006185728,0.0020320197,0.0017387228,0.0013414805,0.004161373],"category_scores_gemma":[0.02523039,0.0008594741,0.0060896,0.010685568,0.0007534656,0.0019281398,0.0012624165,0.0011545011,0.00021847419],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016341946,0.00001639104,0.000820063,0.94477624,0.0047859293,0.00010727422,0.00016526919,0.00006829646,0.00008623574,0.00014420465,0.001713715,0.04715303],"study_design_scores_gemma":[0.0002655184,0.00026523546,0.005598099,0.9218209,0.044499017,0.0006365618,0.00038578172,0.000060041246,0.0001293224,0.00018179591,0.026125664,0.00003212719],"about_ca_topic_score_codex":0.009531746,"about_ca_topic_score_gemma":0.026527563,"teacher_disagreement_score":0.009865917,"about_ca_system_score_codex":0.0039566285,"about_ca_system_score_gemma":0.012077907,"threshold_uncertainty_score":0.030253232},"labels":[],"label_agreement":null},{"id":"W2884804561","doi":"10.1111/jdv.15181","title":"A practical application of onychomycosis cure – combining patient, physician and regulatory body perspectives","year":2018,"lang":"en","type":"review","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Nail Diseases and Treatments","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Mediprobe Research (Canada); University of Toronto","funders":"","keywords":"Medicine; Cure rate; Quality of life (healthcare); Intensive care medicine; Surgery; Nursing","score_opus":0.03385927652698154,"score_gpt":0.3585449813794023,"score_spread":0.32468570485242076,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2884804561","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00029084698,0.98134816,0.0011424478,0.009865216,0.00084377883,0.000038224316,0.000016464346,0.000014728624,0.0064400984],"genre_scores_gemma":[0.011279853,0.97665286,0.0036830413,0.0050885645,0.0013368542,0.0000777056,0.00003730475,0.000006025455,0.0018378267],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99610245,0.0020973256,0.00046054466,0.0002220034,0.0009940453,0.00012367182],"domain_scores_gemma":[0.9956559,0.0029013793,0.00039833027,0.00013261155,0.00077320915,0.00013866393],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0062696645,0.0007104832,0.0013595504,0.0023950601,0.00059475395,0.0029462245,0.0009981557,0.0035321182,0.0045440514],"category_scores_gemma":[0.006675527,0.00030630527,0.0008827717,0.0014130708,0.0017752547,0.0034145843,0.0019786279,0.0031768386,0.0012001706],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000044402663,0.00009167662,0.000417161,0.030541241,0.000112553695,0.0004736372,0.00065815763,0.00023535399,0.0009597358,0.028155297,0.02848259,0.9098281],"study_design_scores_gemma":[0.00002989777,0.00015271096,0.0015648649,0.031094413,0.00016331267,0.0036445337,0.0013108521,0.00015800212,0.00049742684,0.015242841,0.9461031,0.000037911934],"about_ca_topic_score_codex":0.00097361056,"about_ca_topic_score_gemma":0.0020106407,"teacher_disagreement_score":0.0062696645,"about_ca_system_score_codex":0.0011351845,"about_ca_system_score_gemma":0.003979532,"threshold_uncertainty_score":0.033157527},"labels":[],"label_agreement":null},{"id":"W2887110542","doi":"10.1111/jdv.15203","title":"Systematic review of the real‐world evidence of adalimumab safety in psoriasis registries","year":2018,"lang":"en","type":"review","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; Probity Medical Research","funders":"AbbVie","keywords":"Medicine; Adalimumab; Psoriasis; Adverse effect; Incidence (geometry); MEDLINE; Internal medicine; Dermatology; Disease","score_opus":0.047650653023145736,"score_gpt":0.31506376057707347,"score_spread":0.2674131075539277,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2887110542","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0044511985,0.99037206,0.0005068525,0.0005256909,0.00022669534,0.0013500609,0.0019269711,0.000023497743,0.0006169786],"genre_scores_gemma":[0.050217025,0.94165295,0.002212841,0.0012190676,0.00028272747,0.002535251,0.0016429194,0.000024637538,0.00021260297],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9429634,0.023546636,0.024249244,0.0022877895,0.006311827,0.0006412028],"domain_scores_gemma":[0.8011869,0.1272654,0.048792273,0.0046596033,0.017006826,0.0010890992],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.037054833,0.0017211919,0.011608069,0.017414223,0.0007315372,0.003852903,0.002194995,0.0019911495,0.0052683386],"category_scores_gemma":[0.13754697,0.0016116627,0.008978201,0.016201435,0.0013542623,0.0029189708,0.0021626325,0.0012139151,0.00057478703],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003746849,0.000016478276,0.0016071679,0.9570804,0.020602604,0.00008387982,0.00014306167,0.000060605937,0.00013059922,0.00011146203,0.0010148875,0.018774068],"study_design_scores_gemma":[0.00092650985,0.0004317311,0.009227522,0.809506,0.16024837,0.00045513935,0.00030016573,0.00009146286,0.0002784921,0.00025480337,0.018220335,0.000059437516],"about_ca_topic_score_codex":0.004104632,"about_ca_topic_score_gemma":0.012430152,"teacher_disagreement_score":0.037054833,"about_ca_system_score_codex":0.003522044,"about_ca_system_score_gemma":0.01437016,"threshold_uncertainty_score":0.19596708},"labels":[],"label_agreement":null},{"id":"W2890730116","doi":"10.1111/jdv.15233","title":"Hidradenitis suppurativa/acne inversa: a practical framework for treatment optimization – systematic review and recommendations from the HS ALLIANCE working group","year":2018,"lang":"en","type":"review","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Hidradenitis Suppurativa and Treatments","field":"Medicine","cited_by":251,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"Allergan; LEO Pharma; Cilag; Astellas Pharma; Bayer HealthCare; AbbVie; InflaRx; Les Laboratories Pierre Fabre; Celgene; Biogen; UCB Pharma; Regeneron Pharmaceuticals; Novartis; Amgen; LEO Pharma Research Foundation; Pfizer; Galderma; Eli Lilly and Company","keywords":"Hidradenitis suppurativa; Medicine; Acne; Alliance; Dermatology; MEDLINE; Internal medicine","score_opus":0.09580992379422286,"score_gpt":0.38634731173368964,"score_spread":0.29053738793946676,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2890730116","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0007808576,0.94530296,0.005000613,0.040432606,0.0025304807,0.0038149892,0.0008211387,0.00008654094,0.0012299395],"genre_scores_gemma":[0.011321384,0.92793095,0.0344476,0.015226564,0.00092288223,0.00850143,0.00090152,0.0000384263,0.0007093057],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.947428,0.025076367,0.018331157,0.0022459303,0.005759806,0.0011586446],"domain_scores_gemma":[0.8631123,0.09079604,0.016972357,0.0028179835,0.02425269,0.0020487022],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.094433814,0.0030663991,0.010447486,0.023183942,0.0015500461,0.006991708,0.006309101,0.0064090597,0.0044433484],"category_scores_gemma":[0.16607748,0.0020275444,0.01102596,0.013845863,0.0022745566,0.00874913,0.0056208917,0.0055230176,0.0012034338],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024846088,0.00006536924,0.00085135153,0.7570523,0.0051352694,0.00034107626,0.001785794,0.0012029908,0.00043902552,0.005314454,0.035281412,0.1922825],"study_design_scores_gemma":[0.00019224333,0.0000671078,0.0007002824,0.9296929,0.009668459,0.00012180148,0.0006832525,0.00038923748,0.00013730812,0.0041312664,0.054140743,0.00007533924],"about_ca_topic_score_codex":0.014246693,"about_ca_topic_score_gemma":0.028494656,"teacher_disagreement_score":0.094433814,"about_ca_system_score_codex":0.011282339,"about_ca_system_score_gemma":0.05772736,"threshold_uncertainty_score":0.4994197},"labels":[],"label_agreement":null},{"id":"W2890837529","doi":"10.1111/jdv.15242","title":"Long‐term safety profile of ixekizumab in patients with moderate‐to‐severe plaque psoriasis: an integrated analysis from 11 clinical trials","year":2018,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":62,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"Eli Lilly and Company","keywords":"Medicine; Ixekizumab; Plaque psoriasis; Psoriasis; Clinical trial; Term (time); Safety profile; Dermatology; Internal medicine; Adverse effect; Psoriatic arthritis; Secukinumab","score_opus":0.03878062737402969,"score_gpt":0.3123729353849405,"score_spread":0.2735923080109108,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2890837529","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.75895965,0.23086329,0.00153303,0.00047298367,0.00007004169,0.001690463,0.0040992573,0.000055268105,0.0022560982],"genre_scores_gemma":[0.95948464,0.033181246,0.0013892788,0.00048300534,0.00012373339,0.0008519987,0.0041936887,0.000019640376,0.0002728002],"study_design_codex":"observational","study_design_gemma":"meta_analysis","domain_scores_codex":[0.98982924,0.0049752775,0.0018511735,0.001104082,0.0018307648,0.00040946677],"domain_scores_gemma":[0.97955745,0.008942077,0.008214367,0.0010317578,0.0014474232,0.00080694497],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.021007733,0.00077758793,0.0038673219,0.0013307368,0.00033397408,0.0023228065,0.0006208349,0.0009449076,0.0012817236],"category_scores_gemma":[0.012612164,0.0004394653,0.0061220964,0.0021331944,0.0005002083,0.0009416514,0.0007815843,0.0011567688,0.00017942392],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.20628747,0.0019382476,0.33389434,0.02344471,0.22046421,0.00055366504,0.00040059537,0.00406925,0.007932994,0.0002704803,0.0024762175,0.19826789],"study_design_scores_gemma":[0.055153023,0.052368592,0.6818042,0.0037251571,0.18902422,0.0017742096,0.0002455753,0.0018264102,0.0021005208,0.00051218027,0.011296776,0.00016918965],"about_ca_topic_score_codex":0.0002743626,"about_ca_topic_score_gemma":0.00089046854,"teacher_disagreement_score":0.021007733,"about_ca_system_score_codex":0.00087830896,"about_ca_system_score_gemma":0.0012082314,"threshold_uncertainty_score":0.11110085},"labels":[],"label_agreement":null},{"id":"W2900581149","doi":"10.1111/jdv.15369","title":"Calcipotriol plus betamethasone dipropionate aerosol foam vs. apremilast, methotrexate, acitretin or fumaric acid esters for the treatment of plaque psoriasis: a matching‐adjusted indirect comparison","year":2018,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"LEO Pharma","keywords":"Medicine; Psoriasis; Apremilast; Betamethasone dipropionate; Acitretin; Calcipotriol; Methotrexate; Dermatology; Internal medicine; Population; Psoriatic arthritis","score_opus":0.05021722530616508,"score_gpt":0.2970588162189813,"score_spread":0.2468415909128162,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2900581149","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.56889784,0.38986173,0.006189492,0.0015000436,0.0035644367,0.010413831,0.008233415,0.00027483428,0.011064424],"genre_scores_gemma":[0.9578514,0.026290411,0.0038834414,0.0010002546,0.00042878816,0.0061019706,0.0020345827,0.000035664038,0.002373563],"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","domain_scores_codex":[0.98774326,0.0084159775,0.0017147533,0.00090386096,0.0008403265,0.00038173664],"domain_scores_gemma":[0.9913448,0.005873853,0.0017146706,0.0003704494,0.00045435852,0.0002419209],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00994935,0.0025913971,0.0083572045,0.002040133,0.00038026425,0.0022558437,0.0017311333,0.0026815354,0.010987881],"category_scores_gemma":[0.01732004,0.00093775993,0.017914593,0.0017277687,0.00069657277,0.001449123,0.0016387883,0.0021527603,0.00075915275],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.54926074,0.0006890087,0.005871085,0.05273648,0.35802636,0.00015626519,0.00023504291,0.0013969628,0.0011482716,0.00065970136,0.0010575413,0.028762517],"study_design_scores_gemma":[0.33164823,0.040629737,0.018620713,0.0051089404,0.5919934,0.0002682945,0.00028261804,0.002718479,0.0011867431,0.0022311911,0.005182181,0.00012948646],"about_ca_topic_score_codex":0.00212107,"about_ca_topic_score_gemma":0.0024071157,"teacher_disagreement_score":0.010987881,"about_ca_system_score_codex":0.0013911156,"about_ca_system_score_gemma":0.0011580421,"threshold_uncertainty_score":0.052617848},"labels":[],"label_agreement":null},{"id":"W2901821809","doi":"10.1111/jdv.15360","title":"Diagnosis validation and clinical characterization of atopic dermatitis in Nurses’ Health Study 2","year":2018,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; University of Toronto","funders":"National Cancer Institute","keywords":"Medicine; Atopic dermatitis; Cohort; Asthma; Disease; Cohort study; Family medicine; Internal medicine; Dermatology","score_opus":0.030960346723171214,"score_gpt":0.35634206980842104,"score_spread":0.3253817230852498,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2901821809","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99702877,0.00027928216,0.00044915348,0.0000932794,0.000045017023,0.00017905365,0.00088811066,0.000004995713,0.0010323862],"genre_scores_gemma":[0.9971276,0.00009886754,0.0005933076,0.00006992223,0.000022062244,0.00019784796,0.0015743893,0.00000376532,0.0003123171],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99442977,0.002582678,0.00085056125,0.00072445674,0.0011685311,0.00024401788],"domain_scores_gemma":[0.9926259,0.0014682956,0.0027298091,0.00084380264,0.0018650492,0.00046723319],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0073326146,0.0004217144,0.0004500461,0.0008655739,0.0005881795,0.0008393951,0.000953024,0.0006100362,0.0009147958],"category_scores_gemma":[0.014944403,0.00028678845,0.00054123154,0.00074984826,0.00042967452,0.000491615,0.0010727467,0.00066363,0.00041571268],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000061003168,0.000036736412,0.9989404,0.000012405937,0.000029070345,0.000017975412,0.000088274704,0.000013570233,0.00006675886,0.000008702817,0.000111995876,0.00061319006],"study_design_scores_gemma":[0.000027146263,0.00010675296,0.99892455,0.000017146262,0.000024128802,0.00012861032,0.00017221423,0.00013073161,0.00007993323,0.000023763081,0.0003621425,0.0000028750655],"about_ca_topic_score_codex":0.0067019393,"about_ca_topic_score_gemma":0.0070888563,"teacher_disagreement_score":0.0073326146,"about_ca_system_score_codex":0.00053250865,"about_ca_system_score_gemma":0.00067905325,"threshold_uncertainty_score":0.03877902},"labels":[],"label_agreement":null},{"id":"W2911530371","doi":"10.1111/jdv.15490","title":"Algorithms for ascertaining keratinocyte carcinomas using health insurance claims and prescription records","year":2019,"lang":"en","type":"letter","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Nonmelanoma Skin Cancer Studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Coastal Health Research Institute; University of British Columbia","funders":"Canadian Institutes of Health Research; University of British Columbia; Canadian Dermatology Foundation","keywords":"Medicine; Library science; Medical prescription; Family medicine; Nursing","score_opus":0.06979027728207951,"score_gpt":0.3308491421694968,"score_spread":0.26105886488741725,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2911530371","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.64609104,0.0102917785,0.21122958,0.0569567,0.002284154,0.01013595,0.033918444,0.0025511133,0.026541173],"genre_scores_gemma":[0.65735924,0.0024072619,0.31145406,0.005343507,0.000580142,0.0019149132,0.016667163,0.00013381126,0.004139899],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99215674,0.0042791013,0.0015407631,0.0006312422,0.0010012016,0.00039099576],"domain_scores_gemma":[0.9692694,0.020355843,0.0025896032,0.0024065778,0.004856877,0.00052170455],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.013497736,0.00045784633,0.00093602104,0.0034085617,0.00058961636,0.0025854635,0.0021037313,0.0020711047,0.0037308624],"category_scores_gemma":[0.05357241,0.00059141574,0.001400527,0.0026828619,0.00030938134,0.0014585714,0.0010497626,0.0013633255,0.0012565958],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020045994,0.00058377185,0.7435012,0.0003781244,0.00045724874,0.000368191,0.0002116426,0.0055921176,0.0013313456,0.005965167,0.041771833,0.19783476],"study_design_scores_gemma":[0.0029489647,0.0014078044,0.639407,0.0015749673,0.0019537741,0.0035730435,0.0008386513,0.2404944,0.0060532917,0.040052608,0.061476897,0.00021862135],"about_ca_topic_score_codex":0.007904868,"about_ca_topic_score_gemma":0.011999619,"teacher_disagreement_score":0.013497736,"about_ca_system_score_codex":0.0011108392,"about_ca_system_score_gemma":0.0019622254,"threshold_uncertainty_score":0.071383715},"labels":[],"label_agreement":null},{"id":"W2913092006","doi":"10.1111/jdv.15443","title":"Utilization of the validated Psoriasis Epidemiology Screening Tool to identify signs and symptoms of psoriatic arthritis among those with psoriasis: a cross‐sectional analysis from the <scp>US</scp>‐based Corrona Psoriasis Registry","year":2019,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research","funders":"Janssen Biotech; Genentech; Valeant Pharmaceuticals International; UCB; Roche; Novartis; AbbVie; Merck; GlaxoSmithKline; Boehringer Ingelheim; Amgen; Pfizer; Bristol-Myers Squibb; Eli Lilly and Company; Momenta Pharmaceuticals; Gilead Sciences","keywords":"Medicine; Psoriatic arthritis; Psoriasis; Epidemiology; Enthesitis; Quality of life (healthcare); Disease; Physical therapy; Internal medicine; Dermatology","score_opus":0.0385938888709923,"score_gpt":0.3152920402258842,"score_spread":0.2766981513548919,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2913092006","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99921894,0.00008334275,0.00005338037,0.000019183919,0.000002740031,0.000016108188,0.0003582994,0.0000021827043,0.00024590312],"genre_scores_gemma":[0.9994092,0.000056969813,0.0000557133,0.000025470725,0.000004467032,0.000015952965,0.0003815186,0.0000013947737,0.00004932706],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989323,0.00033695283,0.00015935252,0.00020740065,0.00026275695,0.00010123558],"domain_scores_gemma":[0.9975204,0.0005224036,0.0011284284,0.00022552945,0.0003224847,0.00028075732],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014587367,0.00017800939,0.00035101987,0.0006919918,0.0002728829,0.0005013819,0.0003346826,0.00033890884,0.0010287444],"category_scores_gemma":[0.0030703652,0.00032671195,0.00046894053,0.0007728055,0.00019478676,0.0004942818,0.00045489272,0.00049568096,0.00029087684],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000034615132,0.000032139244,0.9993875,0.000004751972,0.000024481602,0.00002410504,0.000038422957,0.000014860092,0.000060332386,0.0000040082764,0.00006209445,0.0003127158],"study_design_scores_gemma":[0.000008160979,0.00008863201,0.99934417,0.0000042249862,0.000017845916,0.00018802893,0.00011930119,0.0001181755,0.000026902262,0.0000033260133,0.00007910861,0.0000022251802],"about_ca_topic_score_codex":0.004692246,"about_ca_topic_score_gemma":0.004504585,"teacher_disagreement_score":0.004692246,"about_ca_system_score_codex":0.00024942125,"about_ca_system_score_gemma":0.00029283072,"threshold_uncertainty_score":0.009329915},"labels":[],"label_agreement":null},{"id":"W2920975913","doi":"10.1111/jdv.15480","title":"Optimization of placebo use in clinical trials with systemic treatments for atopic dermatitis: an International Eczema Council survey‐based position statement","year":2019,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Innovaderm (Canada)","funders":"Chugai Pharmaceutical; LEO Pharma; LEO Fondet; Les Laboratories Pierre Fabre; Celgene; Valeant Pharmaceuticals International; Genzyme; AbbVie; Sanofi; Novartis; Amgen; LEO Pharma Research Foundation; Pfizer; Galderma; Eli Lilly and Company; MedImmune; GlaxoSmithKline","keywords":"Medicine; Atopic dermatitis; Position statement; Dermatology; Placebo; Position paper; Statement (logic); Clinical trial; Alternative medicine; Family medicine; Internal medicine; Pathology","score_opus":0.1299320467437381,"score_gpt":0.38191664785881935,"score_spread":0.25198460111508125,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2920975913","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":"methods","domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"methods","domain_consensus":"methods","prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.040253904,0.027676078,0.21848288,0.49483663,0.013029178,0.1542878,0.0039944844,0.0015615439,0.04587754],"genre_scores_gemma":[0.1646159,0.010244983,0.5114904,0.1464539,0.0043151216,0.15552206,0.0026157952,0.00035787534,0.004383938],"study_design_codex":"design_other","study_design_gemma":"qualitative","domain_scores_codex":[0.2624079,0.5801239,0.10650478,0.0056253914,0.03945981,0.005878234],"domain_scores_gemma":[0.16986619,0.5192593,0.1095437,0.03784158,0.14656581,0.016923398],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.73387617,0.002654555,0.0027750824,0.0044193203,0.003369167,0.009200381,0.005127055,0.014251737,0.0035615715],"category_scores_gemma":[0.63113946,0.0019232661,0.004534644,0.0057691424,0.0051439605,0.0060078255,0.008561941,0.010131454,0.0023218775],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0121797025,0.0018745061,0.041323088,0.02640136,0.0028726791,0.0004382247,0.009319494,0.0061334805,0.0070246398,0.0252199,0.1883887,0.6788242],"study_design_scores_gemma":[0.01190169,0.014130957,0.09573475,0.048065085,0.0033455999,0.0008550995,0.004608501,0.013445594,0.010029757,0.028353635,0.7686904,0.00083883875],"about_ca_topic_score_codex":0.0022147726,"about_ca_topic_score_gemma":0.0042690816,"teacher_disagreement_score":0.26612383,"about_ca_system_score_codex":0.008355522,"about_ca_system_score_gemma":0.064582475,"threshold_uncertainty_score":0.3281781},"labels":[],"label_agreement":null},{"id":"W2921008494","doi":"10.1111/jdv.15548","title":"Finasteride for androgenetic alopecia is not associated with sexual dysfunction: a survey‐based, single‐centre, controlled study","year":2019,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Hair Growth and Disorders","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mediprobe Research (Canada); University of Toronto","funders":"","keywords":"Finasteride; Sexual dysfunction; Medicine; Libido; Population; Decreased Libido; Urology; Gynecology; Clinical psychology; Internal medicine; Prostate","score_opus":0.02924285478860018,"score_gpt":0.25895179102645066,"score_spread":0.2297089362378505,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2921008494","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972621,0.0011852406,0.0001780394,0.000031395713,0.0000475848,0.00065216084,0.00028982275,0.000012358878,0.0003412651],"genre_scores_gemma":[0.9982235,0.00051265385,0.000173215,0.000091565424,0.000096929914,0.0003706606,0.00035171353,0.000004020512,0.00017575258],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9954881,0.0026023346,0.0004970459,0.0005574816,0.00059292896,0.00026220334],"domain_scores_gemma":[0.99125075,0.004049559,0.0022479491,0.0009482355,0.00077561854,0.00072778104],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0055258493,0.0009707526,0.0017566453,0.0006700053,0.00092481455,0.0010532702,0.00073442305,0.0011327125,0.0037298698],"category_scores_gemma":[0.008547062,0.0007034785,0.0017858155,0.0012464373,0.0017137569,0.0006366786,0.0003907292,0.000857794,0.0003531153],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.21952924,0.037516825,0.70425326,0.0025185542,0.01253603,0.0007148427,0.000928391,0.00022414887,0.0040336237,0.00011816694,0.001104763,0.016522152],"study_design_scores_gemma":[0.054544438,0.13879973,0.79786235,0.00013354939,0.0052057174,0.00074986933,0.00043455928,0.00045436653,0.0006508879,0.00006136997,0.001036302,0.00006684366],"about_ca_topic_score_codex":0.004781998,"about_ca_topic_score_gemma":0.0058110077,"teacher_disagreement_score":0.0055258493,"about_ca_system_score_codex":0.000686523,"about_ca_system_score_gemma":0.0011145402,"threshold_uncertainty_score":0.0292238},"labels":[],"label_agreement":null},{"id":"W2922099376","doi":"10.1111/jdv.15400","title":"Efficacy of tildrakizumab for moderate‐to‐severe plaque psoriasis: pooled analysis of three randomized controlled trials at weeks 12 and 28","year":2019,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; Probity Medical Research","funders":"Merck","keywords":"Medicine; Placebo; Psoriasis; Internal medicine; Psoriasis Area and Severity Index; Randomized controlled trial; Gastroenterology; Dermatology; Pathology","score_opus":0.02369100495985317,"score_gpt":0.26942692635877286,"score_spread":0.2457359213989197,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2922099376","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.120811485,0.8612053,0.005644392,0.0008643285,0.0012421932,0.004379343,0.0036683513,0.00041199624,0.0017726136],"genre_scores_gemma":[0.80696857,0.17090823,0.0070943157,0.0015380288,0.000740608,0.007974008,0.0035940968,0.00014947707,0.0010326925],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.97106445,0.018045988,0.005440257,0.002635711,0.0022076357,0.0006059303],"domain_scores_gemma":[0.97926486,0.010565096,0.006830377,0.0013719145,0.0014181593,0.00054961344],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.03360318,0.0030090127,0.019775221,0.0034689775,0.00043258036,0.0036178178,0.0014781569,0.0024173993,0.0037044415],"category_scores_gemma":[0.034682285,0.0014986021,0.029862287,0.0038334373,0.0008858214,0.0015182145,0.0013846232,0.0018105626,0.0003725775],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.20067659,0.00022914802,0.003863237,0.05405724,0.7159211,0.000077449535,0.00009417319,0.00074527215,0.0009495181,0.0001084574,0.0010103685,0.022267465],"study_design_scores_gemma":[0.13118969,0.005567553,0.014245079,0.003339565,0.8413801,0.00012775887,0.000066728644,0.000590182,0.00053251476,0.00039322642,0.002481186,0.00008632817],"about_ca_topic_score_codex":0.0017545235,"about_ca_topic_score_gemma":0.0031565155,"teacher_disagreement_score":0.03360318,"about_ca_system_score_codex":0.0014664667,"about_ca_system_score_gemma":0.0019983307,"threshold_uncertainty_score":0.17771268},"labels":[],"label_agreement":null},{"id":"W2940671601","doi":"10.1111/jdv.15637","title":"Secukinumab, a fully human anti‐interleukin‐17A monoclonal antibody, exhibits low immunogenicity in psoriasis patients treated up to 5 years","year":2019,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"Novartis Pharma","keywords":"Secukinumab; Medicine; Immunogenicity; Psoriasis; Psoriatic arthritis; Psoriasis Area and Severity Index; Monoclonal antibody; Pharmacokinetics; Monoclonal; Immunology; Internal medicine; Antibody; Gastroenterology","score_opus":0.010880054229883123,"score_gpt":0.24964591105737083,"score_spread":0.23876585682748772,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2940671601","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988825,0.00064409,0.000071428636,0.0000109521925,0.000002632806,0.000011261887,0.00004531486,0.0000034820587,0.000328375],"genre_scores_gemma":[0.9996278,0.00012251455,0.000053532545,0.000013653982,0.000004011221,0.000006787595,0.000082700404,7.5886027e-7,0.000088135595],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996966,0.00009712945,0.000033165405,0.00005443041,0.00007945579,0.00003919836],"domain_scores_gemma":[0.9992901,0.0001640686,0.00036286318,0.000041477855,0.00006438022,0.00007717533],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00078586733,0.00015629575,0.00030487013,0.00018945421,0.00018958865,0.0002736121,0.00008900383,0.00021884532,0.0011117777],"category_scores_gemma":[0.0009921296,0.00011354816,0.00023991047,0.00021435588,0.00014078908,0.00022601527,0.00012239147,0.0002872257,0.00016629991],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010262436,0.0007174584,0.8855173,0.00019194068,0.00025816125,0.00058677356,0.00023222229,0.00045821426,0.049662486,0.000050797946,0.00041113957,0.05165107],"study_design_scores_gemma":[0.00025034198,0.009037875,0.9835037,0.000018907916,0.00014396565,0.0019080283,0.000079341095,0.00048653418,0.0034674867,0.00002540442,0.0010711544,0.000007246767],"about_ca_topic_score_codex":0.0002783933,"about_ca_topic_score_gemma":0.00037654833,"teacher_disagreement_score":0.0011117777,"about_ca_system_score_codex":0.00016668886,"about_ca_system_score_gemma":0.0001480289,"threshold_uncertainty_score":0.0041561127},"labels":[],"label_agreement":null},{"id":"W2944233838","doi":"10.1111/jdv.15608","title":"Conjunctivitis in atopic dermatitis patients with and without dupilumab therapy – international eczema council survey and opinion","year":2019,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":72,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; University of Toronto","funders":"Sanofi Genzyme; LEO Pharma; Regeneron Pharmaceuticals; Celgene; Sanofi; Pfizer; Eli Lilly and Company","keywords":"Dupilumab; Medicine; Atopic dermatitis; Dermatology; MEDLINE; Family medicine","score_opus":0.023281146616513215,"score_gpt":0.25937562896826133,"score_spread":0.23609448235174813,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2944233838","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99479973,0.0004984677,0.00006206984,0.00038308726,0.00001577235,0.00007388543,0.0017100866,0.000007475141,0.0024493057],"genre_scores_gemma":[0.99748,0.00045323514,0.00016144224,0.0002619779,0.000026650916,0.000054318476,0.0012491586,0.000002394247,0.00031087451],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979686,0.00062736607,0.0003971172,0.00022676201,0.000510126,0.00026998442],"domain_scores_gemma":[0.99311596,0.00095205137,0.0040684785,0.00015751265,0.00094983,0.0007562388],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019611649,0.00015231554,0.0002968645,0.001250921,0.0003868271,0.00056750793,0.00032132163,0.0005245481,0.0020295214],"category_scores_gemma":[0.004848441,0.00018169578,0.0004968641,0.0014021952,0.00027493763,0.0006557835,0.00067836663,0.0005112601,0.0003154745],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000054820775,0.00006096337,0.9961642,0.000055412842,0.000038252823,0.00010816393,0.00034516733,0.000026638283,0.00007654188,0.000010467797,0.00073360646,0.0023257614],"study_design_scores_gemma":[0.000006963989,0.00008904637,0.9981133,0.00002553217,0.000013610042,0.00026238133,0.0007100228,0.00006322667,0.00002793987,0.000004982761,0.0006787916,0.0000042692263],"about_ca_topic_score_codex":0.010292492,"about_ca_topic_score_gemma":0.009549346,"teacher_disagreement_score":0.010292492,"about_ca_system_score_codex":0.0007454697,"about_ca_system_score_gemma":0.00046598577,"threshold_uncertainty_score":0.020465195},"labels":[],"label_agreement":null},{"id":"W2944356468","doi":"10.1111/jdv.15661","title":"Bexarotene as maintenance treatment after therapies other than skin‐directed therapy in advanced‐stage mycosis fungoides: a pilot study","year":2019,"lang":"en","type":"letter","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Cutaneous lymphoproliferative disorders research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Mycosis fungoides; Bexarotene; Medicine; Stage (stratigraphy); Dermatology; Internal medicine; Lymphoma","score_opus":0.03330412918896731,"score_gpt":0.3129605620578447,"score_spread":0.2796564328688774,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2944356468","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968232,0.0012889475,0.00015234986,0.0002556317,0.00012253884,0.00034311425,0.000105990286,0.000011671431,0.00089662283],"genre_scores_gemma":[0.996902,0.0011449637,0.00027660705,0.00025253638,0.00033293662,0.0002582484,0.00014935441,0.000004564151,0.0006788219],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9992706,0.0004155281,0.000046259476,0.00007761476,0.00006283691,0.00012728243],"domain_scores_gemma":[0.99882394,0.00050868036,0.00009932933,0.0001286517,0.000053429132,0.0003859042],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016370347,0.00070885895,0.0018777935,0.00031657994,0.0007054779,0.0007748116,0.0006379885,0.001563464,0.002684263],"category_scores_gemma":[0.0013831208,0.00027606366,0.000911227,0.0004072715,0.0010175142,0.0008692171,0.00023295189,0.0018681703,0.0006072532],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.54226893,0.22875744,0.012205621,0.000813726,0.0006387009,0.0078165615,0.0010400774,0.0007658649,0.085291445,0.0004854946,0.0016940134,0.118222155],"study_design_scores_gemma":[0.072466955,0.9033581,0.01745782,0.00003168001,0.00027731867,0.0011702819,0.00012559273,0.0004474841,0.0029406552,0.00012876876,0.0015739088,0.00002138191],"about_ca_topic_score_codex":0.0009299563,"about_ca_topic_score_gemma":0.00067490665,"teacher_disagreement_score":0.002684263,"about_ca_system_score_codex":0.00045159744,"about_ca_system_score_gemma":0.00061063893,"threshold_uncertainty_score":0.008979738},"labels":[],"label_agreement":null},{"id":"W2944669799","doi":"10.1111/jdv.15668","title":"Use of dose–exposure–response relationships in Phase 2 and Phase 3 guselkumab studies to optimize dose selection in psoriasis","year":2019,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"Janssen Research and Development","keywords":"Medicine; Psoriasis; Selection (genetic algorithm); Phase (matter); Dermatology; Machine learning","score_opus":0.06422691084866118,"score_gpt":0.31386034106018246,"score_spread":0.2496334302115213,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2944669799","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.84872526,0.022423536,0.062069356,0.0013446211,0.00047831886,0.046361145,0.0032370416,0.0014146201,0.013946011],"genre_scores_gemma":[0.93545496,0.0014342818,0.037669286,0.0011621385,0.00018547794,0.021343164,0.001173326,0.0002569349,0.001320503],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9290249,0.058533892,0.0037461964,0.0020740812,0.005409009,0.0012118679],"domain_scores_gemma":[0.9378754,0.032319225,0.019161142,0.004688346,0.0044677453,0.0014881658],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.10064786,0.0015810054,0.002073058,0.0014709136,0.0006431398,0.0021361115,0.0014442921,0.0016475541,0.0026463768],"category_scores_gemma":[0.049764786,0.00077646796,0.003398818,0.0015965641,0.0005734562,0.0016191662,0.0011190136,0.0027048897,0.00077670737],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.36460257,0.02249143,0.16470806,0.0026319476,0.009837372,0.0002833099,0.0014040635,0.019101217,0.07098465,0.001766851,0.005847236,0.33634126],"study_design_scores_gemma":[0.056424804,0.4371555,0.37722096,0.00054470747,0.0066836225,0.0007111005,0.00025793753,0.026166802,0.05196777,0.0022268554,0.0403343,0.00030563236],"about_ca_topic_score_codex":0.00028925488,"about_ca_topic_score_gemma":0.00063378894,"teacher_disagreement_score":0.10064786,"about_ca_system_score_codex":0.0017484848,"about_ca_system_score_gemma":0.0025900814,"threshold_uncertainty_score":0.5322831},"labels":[],"label_agreement":null},{"id":"W2955396608","doi":"10.1111/jdv.15736","title":"Skin, eye and other problems","year":2019,"lang":"en","type":"letter","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Dermatology; Hyperaemia; Internal medicine","score_opus":0.019772213992097085,"score_gpt":0.27046376326212346,"score_spread":0.25069154927002635,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2955396608","genre_codex":"other","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.06347296,0.15857798,0.0030399144,0.036022432,0.00763043,0.00052407355,0.0025661231,0.0007905188,0.72737557],"genre_scores_gemma":[0.5134989,0.07442307,0.0028674838,0.06654857,0.0055435584,0.0001821833,0.001854619,0.00026534576,0.33481628],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987218,0.00017640667,0.00008415799,0.00017030451,0.00051620323,0.0003310756],"domain_scores_gemma":[0.9988939,0.00017192031,0.00020095515,0.00017768629,0.00034965307,0.00020586119],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005708949,0.0006595096,0.000683261,0.0011405369,0.0019960762,0.0017872228,0.00062845985,0.0018423129,0.062038105],"category_scores_gemma":[0.0044599585,0.00021011257,0.0009187161,0.0011635802,0.0007898675,0.0016542414,0.0013705486,0.0028086277,0.01334996],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026504148,0.00066061236,0.041332792,0.0018194193,0.00022560635,0.051270176,0.00138063,0.00017452722,0.0022466904,0.012232878,0.3659436,0.522448],"study_design_scores_gemma":[0.0000731852,0.00022600469,0.039427064,0.0029505591,0.00011695575,0.19185106,0.001567981,0.00017705998,0.00060866954,0.004299914,0.75862473,0.0000768635],"about_ca_topic_score_codex":0.0066154744,"about_ca_topic_score_gemma":0.007923876,"teacher_disagreement_score":0.062038105,"about_ca_system_score_codex":0.0013203035,"about_ca_system_score_gemma":0.001411383,"threshold_uncertainty_score":0.20753813},"labels":[],"label_agreement":null},{"id":"W2956922241","doi":"10.1111/jdv.15793","title":"Adalimumab for nail psoriasis: efficacy and safety over 52 weeks from a phase‐3, randomized, placebo‐controlled trial","year":2019,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre de Recherche Dermatologique du Québec Métropolitain","funders":"AbbVie","keywords":"Medicine; Adalimumab; Placebo; Psoriasis; Dermatology; Nail (fastener); Randomized controlled trial; Internal medicine; Alternative medicine; Pathology","score_opus":0.013741175539809372,"score_gpt":0.2626512666596356,"score_spread":0.24891009111982626,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2956922241","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.934949,0.030211773,0.002283792,0.0016374463,0.0013072796,0.020894535,0.003277825,0.00037765424,0.0050608623],"genre_scores_gemma":[0.954262,0.012693508,0.0032153537,0.0029983716,0.0012997636,0.01947736,0.0020378032,0.000059955455,0.003955858],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9976483,0.0012656221,0.00021206187,0.0004061937,0.00023322004,0.00023457043],"domain_scores_gemma":[0.99785703,0.00059545564,0.0006016918,0.00019696011,0.0001974647,0.00055139477],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0059893727,0.0017333605,0.0034119745,0.0005192326,0.000947857,0.0014077774,0.001011874,0.0022434902,0.009401384],"category_scores_gemma":[0.003485441,0.00072014285,0.002784936,0.000631706,0.0009674822,0.0010585997,0.00047485108,0.0023331116,0.0013544455],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9652344,0.005895415,0.00064995646,0.0013778376,0.0013144573,0.000044448116,0.00004154157,0.00015067351,0.0020609677,0.00006566312,0.0010718679,0.022092778],"study_design_scores_gemma":[0.9708955,0.026709836,0.0012315406,0.000063114676,0.00037472494,0.00002216721,0.00000639917,0.0000782276,0.00014224563,0.00004851665,0.0004206004,0.0000070600363],"about_ca_topic_score_codex":0.0006071606,"about_ca_topic_score_gemma":0.0015206373,"teacher_disagreement_score":0.009401384,"about_ca_system_score_codex":0.0007647859,"about_ca_system_score_gemma":0.0018106677,"threshold_uncertainty_score":0.03167522},"labels":[],"label_agreement":null},{"id":"W2967066402","doi":"10.1111/jdv.15862","title":"Tildrakizumab efficacy and impact on quality of life up to 52 weeks in patients with moderate‐to‐severe psoriasis: a pooled analysis of two randomized controlled trials","year":2019,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":57,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health; Probity Medical Research","funders":"","keywords":"Medicine; Psoriasis Area and Severity Index; Dermatology Life Quality Index; Psoriasis; Internal medicine; Randomized controlled trial; Quality of life (healthcare); Plaque psoriasis; Gastroenterology; Dermatology","score_opus":0.021058167939606725,"score_gpt":0.30064712035991437,"score_spread":0.2795889524203076,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2967066402","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.39626992,0.59107333,0.0029874926,0.00064831774,0.00090712163,0.0027559772,0.0033677376,0.00021383901,0.001776273],"genre_scores_gemma":[0.93185925,0.060605835,0.0018653693,0.00067948335,0.0005533868,0.0023772945,0.0015507306,0.000036927988,0.0004716853],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9865345,0.008063454,0.0022675146,0.0016172897,0.0010987894,0.00041856093],"domain_scores_gemma":[0.98686826,0.006811043,0.0045075943,0.00075601065,0.0006330884,0.0004240637],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.015321375,0.0021249359,0.012959371,0.0023541802,0.00043518358,0.0023123976,0.0009914398,0.0020216934,0.0028070922],"category_scores_gemma":[0.015393443,0.0010811378,0.024542034,0.0026950534,0.0008094569,0.0010465703,0.0009231424,0.0014663341,0.00022953033],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.42446727,0.0005371602,0.011173379,0.030821962,0.50387365,0.00010333983,0.000078855286,0.0011033022,0.0010418297,0.00009715659,0.0007476816,0.025954498],"study_design_scores_gemma":[0.2837025,0.017482704,0.04591204,0.0023407016,0.6463579,0.0001921441,0.00008869309,0.0010755722,0.0005085353,0.00034185278,0.0018965715,0.00010079836],"about_ca_topic_score_codex":0.0012936391,"about_ca_topic_score_gemma":0.0023432607,"teacher_disagreement_score":0.015321375,"about_ca_system_score_codex":0.0011133739,"about_ca_system_score_gemma":0.0010996981,"threshold_uncertainty_score":0.08102816},"labels":[],"label_agreement":null},{"id":"W2973062927","doi":"10.1111/jdv.15931","title":"Lymphomatoid papulosis: an update and review","year":2019,"lang":"en","type":"review","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Cutaneous lymphoproliferative disorders research","field":"Medicine","cited_by":89,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Lymphomatoid papulosis; Medicine; Mycosis fungoides; Anaplastic large-cell lymphoma; Lymphoproliferative disorders; Differential diagnosis; Lymphoma; Pathology; Dermatology; Immunophenotyping; Histology; Biopsy; Immunology; Antigen","score_opus":0.06616972778289887,"score_gpt":0.3862789712384459,"score_spread":0.32010924345554703,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2973062927","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00022020326,0.9983506,0.000065031156,0.0002749495,0.00035007432,0.0000045429397,0.000030660798,0.000007633896,0.0006963464],"genre_scores_gemma":[0.0010051792,0.99770194,0.00018882401,0.00026776866,0.00044671478,0.0000051932766,0.000058447273,0.0000015432838,0.00032435378],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99982005,0.000025858411,0.000051057476,0.000033493314,0.000051837826,0.000017781516],"domain_scores_gemma":[0.9993667,0.00031199557,0.00012649402,0.000014511681,0.00012382852,0.000056480956],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035403902,0.0007732589,0.0011834347,0.0049374816,0.00039442178,0.0012013803,0.0008237216,0.00089560926,0.0048643234],"category_scores_gemma":[0.0011147021,0.00029490623,0.00055722514,0.0040639015,0.00043591784,0.0015525749,0.0005884377,0.0013427115,0.0016005054],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000076110446,0.000088989764,0.0009032562,0.034828365,0.00014043381,0.0015220399,0.00015508683,0.00031547956,0.0010559519,0.0015627495,0.06505701,0.8942946],"study_design_scores_gemma":[0.000017806713,0.000103234655,0.0028813304,0.016221745,0.00043167028,0.020252354,0.0002125861,0.00011800781,0.00026050222,0.0013416469,0.9581232,0.000035884343],"about_ca_topic_score_codex":0.0013425798,"about_ca_topic_score_gemma":0.0028286467,"teacher_disagreement_score":0.0049374816,"about_ca_system_score_codex":0.00051920686,"about_ca_system_score_gemma":0.0011280295,"threshold_uncertainty_score":0.016272843},"labels":[],"label_agreement":null},{"id":"W2978453992","doi":"10.1111/jdv.16003","title":"The patient‐reported disease burden in adults with atopic dermatitis: a cross‐sectional study in Europe and Canada","year":2019,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":76,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Probity Medical Research","funders":"Regeneron Pharmaceuticals; Sanofi","keywords":"Medicine; Atopic dermatitis; Quality of life (healthcare); Cross-sectional study; Contraindication; Depression (economics); Anxiety; SCORAD; Hospital Anxiety and Depression Scale; Dermatology Life Quality Index; Visual analogue scale; Severity of illness; Young adult; Internal medicine; Disease; Physical therapy; Pediatrics; Dermatology; Psychiatry; Alternative medicine","score_opus":0.008203211006526014,"score_gpt":0.24476031788504926,"score_spread":0.23655710687852324,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2978453992","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995478,0.0007190622,0.00005588551,0.00014974535,0.000007831375,0.00003876437,0.0023087242,0.000003772612,0.0012381977],"genre_scores_gemma":[0.9984902,0.00040666072,0.00006979284,0.00008084739,0.000004193097,0.000012613173,0.0007629781,0.000001442348,0.00017127769],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99909115,0.00009056834,0.00008401836,0.00014526375,0.00035312853,0.0002359778],"domain_scores_gemma":[0.99833614,0.000097763615,0.00035229878,0.00004848811,0.0007074231,0.00045798192],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007778906,0.00024494732,0.0004050991,0.0010837049,0.001638665,0.0010756467,0.00066165486,0.00038630987,0.0012555675],"category_scores_gemma":[0.0016626314,0.00026308728,0.0004820769,0.0032862192,0.00049263414,0.00035851385,0.00073096785,0.0005469366,0.00015241897],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000031184696,0.000013450387,0.9986473,0.000012219091,0.00003416943,0.000026853035,0.00019360203,0.000018964578,0.000033721073,0.000016323374,0.00018516707,0.0007871713],"study_design_scores_gemma":[0.000003556275,0.000013482268,0.9991202,0.0000129457785,0.000014162562,0.000046966365,0.0004946302,0.00006326981,0.00001340515,0.0000046222544,0.00020976263,0.0000030996234],"about_ca_topic_score_codex":0.96153563,"about_ca_topic_score_gemma":0.96562773,"teacher_disagreement_score":0.038464367,"about_ca_system_score_codex":0.008572787,"about_ca_system_score_gemma":0.008368618,"threshold_uncertainty_score":0.07738173},"labels":[],"label_agreement":null},{"id":"W2988810667","doi":"10.1111/jdv.16077","title":"Safety and efficacy of topical, fixed‐dose combination calcipotriene (0.005%) and betamethasone (0.064% as dipropionate) gel in adolescent patients with scalp and body psoriasis: a phase II trial","year":2019,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Medicine; Psoriasis; Betamethasone dipropionate; Adverse effect; Scalp; Internal medicine; Vitamin D and neurology; Dermatology","score_opus":0.012726363187107353,"score_gpt":0.25744918661802746,"score_spread":0.2447228234309201,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2988810667","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99297357,0.003459847,0.00028038528,0.0002183347,0.000083555446,0.0014302253,0.00043180518,0.00003268563,0.0010895419],"genre_scores_gemma":[0.9919408,0.0025363995,0.00090494443,0.0005758154,0.00016239048,0.0016827133,0.00073211634,0.000012785955,0.0014520857],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.999627,0.00017260113,0.000026685264,0.00006768962,0.000056367095,0.00004964318],"domain_scores_gemma":[0.99918467,0.00019939229,0.00020854703,0.00004839792,0.00007229586,0.00028668463],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013606171,0.0009599161,0.0015820068,0.00030998868,0.00029194064,0.0008191664,0.0006850361,0.0010728734,0.0032460312],"category_scores_gemma":[0.0009133144,0.00045587288,0.001177767,0.0002902577,0.0005580293,0.0005493006,0.00020948505,0.0022033532,0.00066911674],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7738576,0.06913787,0.0077013136,0.0021271168,0.002029775,0.00027478873,0.00039510694,0.0012121889,0.039626047,0.0002151772,0.0025467996,0.10087618],"study_design_scores_gemma":[0.6226309,0.3623277,0.009571196,0.00007671625,0.0005872743,0.00031566666,0.00005963959,0.00059339026,0.0018468669,0.000071415474,0.0019019987,0.00001729633],"about_ca_topic_score_codex":0.0005385982,"about_ca_topic_score_gemma":0.0010886961,"teacher_disagreement_score":0.0032460312,"about_ca_system_score_codex":0.00051535235,"about_ca_system_score_gemma":0.00095267856,"threshold_uncertainty_score":0.010859072},"labels":[],"label_agreement":null},{"id":"W2990215547","doi":"10.1111/jdv.16101","title":"The efficacy and safety of pulse vs. continuous therapy for dermatophyte toenail onychomycosis","year":2019,"lang":"en","type":"review","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Nail Diseases and Treatments","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; Mediprobe Research (Canada); Women's College Hospital; University of Toronto","funders":"","keywords":"Terbinafine; Itraconazole; Fluconazole; Medicine; Dermatophyte; Adverse effect; Dermatology; Placebo; Nail (fastener); Internal medicine; Pharmacology; Antifungal; Pathology","score_opus":0.03876348225410053,"score_gpt":0.33639176154871486,"score_spread":0.29762827929461433,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2990215547","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.03559872,0.96170473,0.00046964706,0.00038527916,0.0002655777,0.00021499507,0.0003916384,0.000019185543,0.0009502688],"genre_scores_gemma":[0.6796315,0.31673905,0.0015061853,0.0007338465,0.00037710386,0.0003316203,0.0003387521,0.000016594833,0.00032540274],"study_design_codex":"meta_analysis","study_design_gemma":"systematic_review","domain_scores_codex":[0.99333304,0.0037912691,0.0013087277,0.0006528342,0.00078022183,0.00013397152],"domain_scores_gemma":[0.9816855,0.013815772,0.0032372363,0.0003358627,0.000692317,0.00023316282],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008732125,0.0009794114,0.0059682415,0.002018595,0.00027836728,0.002055471,0.0010405603,0.0018044619,0.0023198316],"category_scores_gemma":[0.02344365,0.00067952386,0.015579984,0.0017174573,0.0006211714,0.0012864494,0.00068019156,0.0018175789,0.00016881977],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04206607,0.00029012555,0.007510683,0.30361325,0.5513637,0.00019185392,0.00014683214,0.0015393844,0.0012779422,0.0004571,0.000916463,0.0906267],"study_design_scores_gemma":[0.016247444,0.008071484,0.017166596,0.035618454,0.916131,0.00038697477,0.00014748641,0.0011348338,0.000977786,0.0010124405,0.0030419177,0.0000635324],"about_ca_topic_score_codex":0.0021647061,"about_ca_topic_score_gemma":0.0033970934,"teacher_disagreement_score":0.008732125,"about_ca_system_score_codex":0.0016470538,"about_ca_system_score_gemma":0.0011738306,"threshold_uncertainty_score":0.046180427},"labels":[],"label_agreement":null},{"id":"W2993611775","doi":"10.1111/jdv.16132","title":"Baseline patient‐reported outcomes from <scp>UNITE</scp>: an observational, international, multicentre registry to evaluate hidradenitis suppurativa in clinical practice","year":2019,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Hidradenitis Suppurativa and Treatments","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research","funders":"","keywords":"Hidradenitis suppurativa; Medicine; Observational study; Quality of life (healthcare); Depression (economics); Anxiety; Dermatology Life Quality Index; Young adult; Disease; Internal medicine; Psychiatry","score_opus":0.08867471654139757,"score_gpt":0.38932388405907165,"score_spread":0.30064916751767407,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2993611775","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99307185,0.00038644,0.00025957494,0.000055303448,0.0000061546157,0.0003338251,0.005170451,0.000011165303,0.0007052592],"genre_scores_gemma":[0.98975766,0.00022794172,0.0005412351,0.00009869844,0.000029142611,0.0005772896,0.008674114,0.000007195507,0.00008669102],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.995884,0.001575929,0.00077182794,0.0006567689,0.0008256163,0.0002859508],"domain_scores_gemma":[0.98410416,0.0031322502,0.00823759,0.0013544115,0.0017212917,0.0014504243],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0042232494,0.0003961439,0.00080396875,0.001954491,0.0005599545,0.0010517957,0.0006811649,0.0006412434,0.0015543901],"category_scores_gemma":[0.011081547,0.00029063318,0.0005930312,0.0035495614,0.000513355,0.0011923431,0.0012476881,0.0007622953,0.0003962079],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025089577,0.00009921336,0.99749786,0.00005534043,0.000072712755,0.00005572359,0.00010928623,0.000031966763,0.00006844308,0.000014719688,0.00042417855,0.0013197267],"study_design_scores_gemma":[0.0001284537,0.0005292908,0.99796885,0.00003697671,0.000051707513,0.000328239,0.0001982889,0.00017374715,0.00007401689,0.000011145846,0.00049209327,0.000007069011],"about_ca_topic_score_codex":0.004224569,"about_ca_topic_score_gemma":0.0040706675,"teacher_disagreement_score":0.004224569,"about_ca_system_score_codex":0.00067007204,"about_ca_system_score_gemma":0.0013063735,"threshold_uncertainty_score":0.022334933},"labels":[],"label_agreement":null},{"id":"W2999032467","doi":"10.1111/jdv.16187","title":"Efficacy of tildrakizumab by patient demographic and disease characteristics across a phase 2b and 2 phase 3 trials in patients with moderate‐to‐severe chronic plaque psoriasis","year":2020,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Innovation Initiatives Ontario North; Université Laval; Centre de Recherche Dermatologique du Québec Métropolitain; Hôtel-Dieu de Québec","funders":"","keywords":"Medicine; Internal medicine; Psoriasis; Psoriasis Area and Severity Index; Psoriatic arthritis; Placebo; Arthritis; Gastroenterology; Dermatology; Pathology","score_opus":0.018723276707812878,"score_gpt":0.2714211060891499,"score_spread":0.252697829381337,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2999032467","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9885529,0.0070675705,0.00039681653,0.00026814587,0.000052935924,0.0012815224,0.0010636897,0.000039202954,0.0012772703],"genre_scores_gemma":[0.9940352,0.0011832692,0.00072361634,0.000391603,0.0000730729,0.0017509221,0.0013967325,0.000014022813,0.00043150262],"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9965664,0.0021229333,0.00031388702,0.00039521855,0.00039466115,0.00020684928],"domain_scores_gemma":[0.99752444,0.0008254036,0.0008617401,0.00019793483,0.00017187349,0.0004185647],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00796713,0.0005889421,0.001629706,0.00041223064,0.00048286104,0.0010235553,0.0004278343,0.0006945381,0.0031551279],"category_scores_gemma":[0.0035299608,0.00037275316,0.0017960867,0.0006959739,0.00040976252,0.0008358928,0.00041635477,0.0013171372,0.00034416004],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.85756636,0.006824864,0.055800945,0.0007801891,0.0055731977,0.00006497184,0.00022546937,0.00096382765,0.009803816,0.00013774438,0.0018142941,0.060444225],"study_design_scores_gemma":[0.5485833,0.16871099,0.26825234,0.00015774753,0.0052113268,0.00033104728,0.00012002219,0.0019026633,0.0019993982,0.00046416384,0.0041811997,0.000085728396],"about_ca_topic_score_codex":0.0003955808,"about_ca_topic_score_gemma":0.0014200873,"teacher_disagreement_score":0.00796713,"about_ca_system_score_codex":0.00052215165,"about_ca_system_score_gemma":0.001028181,"threshold_uncertainty_score":0.042134702},"labels":[],"label_agreement":null},{"id":"W2999046456","doi":"10.1111/jdv.16183","title":"Defining hidradenitis suppurativa phenotypes based on the elementary lesion pattern: results of a prospective study","year":2020,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Hidradenitis Suppurativa and Treatments","field":"Medicine","cited_by":79,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Hidradenitis suppurativa; Medicine; Internal medicine; Follicular phase; Phenotype; Prospective cohort study; Epidemiology; Observational study; Gastroenterology; Dermatology; Pathology; Disease","score_opus":0.030539890601822543,"score_gpt":0.28468058090203846,"score_spread":0.2541406903002159,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2999046456","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9993338,0.0001608237,0.00012066939,0.00000871519,0.000004694405,0.00005426473,0.00012688688,0.0000013870628,0.00018886302],"genre_scores_gemma":[0.9991417,0.00010217435,0.00020966976,0.000027259397,0.000011201069,0.00005617808,0.0003529388,0.0000023036348,0.00009644546],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99829966,0.0006881405,0.00024313071,0.0003467131,0.00021946541,0.00020297173],"domain_scores_gemma":[0.99523795,0.001618279,0.0012687538,0.0005321937,0.00059878273,0.00074399594],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0032310407,0.0007321858,0.00054846983,0.00095847395,0.0007115375,0.00096371403,0.00033568504,0.00066256104,0.0017351924],"category_scores_gemma":[0.0050823004,0.0005914053,0.0008660713,0.0010898878,0.00065878785,0.00096975284,0.0008406562,0.0006659809,0.00050780666],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00075402664,0.0003064052,0.99748814,0.000016687463,0.00007759707,0.0001038829,0.00020881632,0.000017682141,0.00020712335,0.000010740022,0.000029411656,0.00077950454],"study_design_scores_gemma":[0.000117773714,0.0019762672,0.99629706,0.000018448154,0.00013173537,0.0004290732,0.0006111296,0.00010062025,0.00008446467,0.000022485849,0.0002006787,0.000010168907],"about_ca_topic_score_codex":0.0014703039,"about_ca_topic_score_gemma":0.0016518492,"teacher_disagreement_score":0.0032310407,"about_ca_system_score_codex":0.00029779968,"about_ca_system_score_gemma":0.0005244566,"threshold_uncertainty_score":0.01708752},"labels":[],"label_agreement":null},{"id":"W2999397029","doi":"10.1111/jdv.16190","title":"Hornstein–Knickenberg syndrome vs. Birt–Hogg–Dubé syndrome: a critical review of an unjustified designation","year":2020,"lang":"en","type":"review","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Cancer and Skin Lesions","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Birt–Hogg–Dubé syndrome; Cancer; Trait; Medicine; Computer science; Surgery; Internal medicine","score_opus":0.06403692011258323,"score_gpt":0.365731604161595,"score_spread":0.3016946840490118,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2999397029","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00021301572,0.9844035,0.00014142001,0.010776454,0.004102398,0.000003790819,0.0000115565235,0.0000059439913,0.0003420353],"genre_scores_gemma":[0.0047616847,0.94537526,0.00045211823,0.017946295,0.030997688,0.00002871815,0.000067222216,0.000021293174,0.00034965907],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9963366,0.001041899,0.0010830199,0.00061119057,0.000664139,0.0002632329],"domain_scores_gemma":[0.9796116,0.01592193,0.0011594226,0.0003373684,0.0024652325,0.0005044774],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008871758,0.0016233464,0.0048081097,0.0093403505,0.0015694735,0.0036297457,0.0042300927,0.0069168657,0.0014964011],"category_scores_gemma":[0.022787012,0.00078056974,0.0017769149,0.006283938,0.008613394,0.007314565,0.0027905724,0.012530669,0.0007529057],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006296952,0.00013699474,0.0045586745,0.016913876,0.000509147,0.008938988,0.002037845,0.0005273819,0.0011650284,0.05816792,0.28733215,0.61908233],"study_design_scores_gemma":[0.00007799786,0.00019041357,0.004890233,0.021358008,0.0004615259,0.028597193,0.0016765274,0.00030213446,0.00027828227,0.023892852,0.91809434,0.00018049173],"about_ca_topic_score_codex":0.0042301933,"about_ca_topic_score_gemma":0.0039183376,"teacher_disagreement_score":0.0093403505,"about_ca_system_score_codex":0.0047996496,"about_ca_system_score_gemma":0.0040564854,"threshold_uncertainty_score":0.04691893},"labels":[],"label_agreement":null},{"id":"W3001357839","doi":"10.1111/jdv.16224","title":"Reduced risk of suicidal behaviours associated with the treatment of hidradenitis suppurativa with tumour necrosis factor alpha antagonists: results from the <scp>US FDA</scp> Adverse Events Reporting System pharmacovigilance database","year":2020,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Hidradenitis Suppurativa and Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Western University","funders":"","keywords":"Hidradenitis suppurativa; Medicine; Pharmacovigilance; Isotretinoin; Adalimumab; Adverse effect; Odds ratio; Tumor necrosis factor alpha; Internal medicine; Acne; Database; Etanercept; Gastroenterology; Dermatology; Pharmacology","score_opus":0.034488618079278555,"score_gpt":0.2811125559813605,"score_spread":0.24662393790208192,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3001357839","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9654008,0.010171737,0.0011391087,0.00065311405,0.00006504825,0.00012513221,0.020595945,0.000057978723,0.0017911767],"genre_scores_gemma":[0.99261403,0.0009631769,0.0004759115,0.00025105983,0.000042479587,0.000045494344,0.0054190615,0.000013506017,0.00017518595],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9891328,0.004366333,0.0023538545,0.0017436058,0.0020276145,0.00037577],"domain_scores_gemma":[0.9527676,0.01985089,0.022568693,0.0017208951,0.0023555653,0.0007364536],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008123906,0.00037796874,0.001144021,0.0014832866,0.00017930678,0.0011757369,0.00067795237,0.0007507814,0.001982631],"category_scores_gemma":[0.032266058,0.00029390334,0.005131876,0.002210829,0.00022538991,0.00069620117,0.00069694634,0.0010364031,0.00024017046],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00563189,0.00005342876,0.97735196,0.0006540322,0.007775248,0.00009844903,0.0000664287,0.00034480757,0.0002042816,0.000062496845,0.0009006264,0.0068563307],"study_design_scores_gemma":[0.00034531398,0.0005589767,0.9895579,0.000113140006,0.00665873,0.00051629735,0.000076880155,0.00093886215,0.00018228561,0.00006976991,0.00096202764,0.000019913457],"about_ca_topic_score_codex":0.004180243,"about_ca_topic_score_gemma":0.0031164007,"teacher_disagreement_score":0.008123906,"about_ca_system_score_codex":0.0004367387,"about_ca_system_score_gemma":0.00057556684,"threshold_uncertainty_score":0.042963803},"labels":[],"label_agreement":null},{"id":"W3004913099","doi":"10.1111/jdv.16274","title":"The National Psoriasis Foundation psoriasis treatment targets in real‐world patients: prevalence and association with patient‐reported outcomes in the Corrona Psoriasis Registry","year":2020,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Valeant Pharmaceuticals International; Merck; AbbVie; Celgene; Eli Lilly and Company; Boehringer Ingelheim","keywords":"Psoriasis; Medicine; Cohort; Odds ratio; Odds; Body surface area; Cohort study; Internal medicine; Cross-sectional study; Quality of life (healthcare); Physical therapy; Dermatology; Logistic regression; Pathology","score_opus":0.024279181702368313,"score_gpt":0.25957366323252823,"score_spread":0.23529448153015992,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3004913099","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.989652,0.0012173221,0.00038461885,0.000336406,0.000014216934,0.000029060102,0.005736614,0.00002946612,0.002600169],"genre_scores_gemma":[0.99660647,0.00033247878,0.00022228822,0.00005299699,0.000019953084,0.000048662878,0.002573984,0.000008514525,0.00013465268],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99677354,0.001201156,0.00047502448,0.00070350245,0.00067100953,0.00017569958],"domain_scores_gemma":[0.9862071,0.0024318113,0.008886297,0.0011680049,0.0008376917,0.00046912287],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034466789,0.00014508521,0.0004817707,0.0010303687,0.0002900726,0.00092991116,0.00064661604,0.00040341867,0.002070812],"category_scores_gemma":[0.010453754,0.00021913908,0.00041436747,0.0019316595,0.00033129187,0.00083626044,0.00084585656,0.00047614222,0.00052148267],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015956214,0.000017778075,0.99652255,0.00003417085,0.000077313525,0.000027944414,0.000068985755,0.00009378716,0.000056202978,0.000045585322,0.0007376425,0.0021585638],"study_design_scores_gemma":[0.000016475471,0.00003535246,0.99863017,0.000029209079,0.00003787637,0.00027492055,0.00011223327,0.00013724157,0.000043022443,0.000027651517,0.0006497202,0.0000060890743],"about_ca_topic_score_codex":0.005470307,"about_ca_topic_score_gemma":0.004509157,"teacher_disagreement_score":0.005470307,"about_ca_system_score_codex":0.00037344638,"about_ca_system_score_gemma":0.00047786525,"threshold_uncertainty_score":0.018227994},"labels":[],"label_agreement":null},{"id":"W3011658364","doi":"10.1111/jdv.16378","title":"Response to Raschi E <i>et al</i>. 'Reduced reporting of neuropsychiatric adverse events with tumor necrosis factor alpha inhibitors for hidradenitis suppurativa: caution before concluding for risk reduction'","year":2020,"lang":"en","type":"letter","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Hidradenitis Suppurativa and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Western University","funders":"","keywords":"Hidradenitis suppurativa; Medicine; Adverse effect; Dermatology; Tumor necrosis factor alpha; Reduction (mathematics); Alpha (finance); Internal medicine; Surgery; Disease","score_opus":0.027738111119787776,"score_gpt":0.3029163683982548,"score_spread":0.275178257278467,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3011658364","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00062979467,0.0011916655,0.00006212656,0.97804457,0.016959231,0.000021274205,0.000118644304,0.000055118402,0.0029176325],"genre_scores_gemma":[0.0053280755,0.0013776053,0.00017770831,0.9599418,0.027365824,0.000041371233,0.000076293174,0.000027988428,0.0056632725],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9980464,0.00046801873,0.00026595587,0.0002658836,0.00058710197,0.00036663952],"domain_scores_gemma":[0.99497944,0.0017716258,0.00052098493,0.00012715666,0.0015755534,0.0010253232],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019862016,0.00076330756,0.0011662224,0.0008624956,0.00223533,0.0022899944,0.0014968108,0.025705447,0.008759711],"category_scores_gemma":[0.019183842,0.0004997813,0.00096829643,0.0007506537,0.0013525906,0.0022002638,0.0008815776,0.02354158,0.0072534974],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000758822,0.000036483685,0.0008839988,0.00006839804,0.000011185753,0.0031127164,0.00007760602,0.000044280947,0.00013046584,0.000425239,0.989234,0.005899739],"study_design_scores_gemma":[0.00043309075,0.00033582267,0.006646652,0.001361048,0.0000674078,0.019885961,0.0009909468,0.00082163844,0.0005819498,0.005740821,0.9629533,0.00018140842],"about_ca_topic_score_codex":0.0072238734,"about_ca_topic_score_gemma":0.009241076,"teacher_disagreement_score":0.025705447,"about_ca_system_score_codex":0.0039119483,"about_ca_system_score_gemma":0.0028070002,"threshold_uncertainty_score":0.029304147},"labels":[],"label_agreement":null},{"id":"W3012480276","doi":"10.1111/jdv.16366","title":"Comparative 12‐week effectiveness and safety outcomes of biologic agents ustekinumab, secukinumab and ixekizumab for the treatment of plaque psoriasis: a real‐world multicenter retrospective study","year":2020,"lang":"en","type":"letter","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; Health Sciences Centre; Sunnybrook Health Science Centre; Women's College Hospital; University of Toronto","funders":"","keywords":"Secukinumab; Ixekizumab; Medicine; Family medicine; Library science; Ustekinumab; Psoriasis; Dermatology; Adalimumab; Psoriatic arthritis; Internal medicine","score_opus":0.046634290625239945,"score_gpt":0.29616185914182785,"score_spread":0.24952756851658792,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3012480276","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969608,0.0018067058,0.00010725274,0.000110756555,0.000032290696,0.000039539664,0.00044640596,0.0000027037236,0.0004934821],"genre_scores_gemma":[0.9981908,0.00033269404,0.00012263069,0.00024867945,0.0000843154,0.000037274873,0.0007318191,0.0000032423923,0.000248422],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99776566,0.0010170493,0.00031893436,0.00040818242,0.00029110536,0.00019918471],"domain_scores_gemma":[0.99420184,0.0022562104,0.0019083484,0.00054619234,0.00059937855,0.000487957],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029258858,0.0004750449,0.0011243413,0.00042684542,0.0003676083,0.0011160467,0.00053049385,0.0013459316,0.0016436074],"category_scores_gemma":[0.0053524836,0.00035760246,0.0018246286,0.0007962366,0.0006032688,0.0009880193,0.000314587,0.0009500853,0.00042496968],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.1821477,0.0024952726,0.779027,0.00048474345,0.006907122,0.0015521687,0.0003975195,0.000686766,0.0033961947,0.0001665489,0.0012922176,0.021446606],"study_design_scores_gemma":[0.0139829535,0.03776494,0.93165576,0.00010144825,0.0060486225,0.0032534353,0.00051166007,0.0016530472,0.0015246196,0.00026209536,0.003112375,0.00012904988],"about_ca_topic_score_codex":0.0008005377,"about_ca_topic_score_gemma":0.00063641137,"teacher_disagreement_score":0.0029258858,"about_ca_system_score_codex":0.0008404195,"about_ca_system_score_gemma":0.00035973903,"threshold_uncertainty_score":0.015473783},"labels":[],"label_agreement":null},{"id":"W3014004008","doi":"10.1111/jdv.16338","title":"Pioneers in dermatology and venereology: an interview with Prof. Marcia Ramos‐e‐Silva","year":2020,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Medicine and Dermatology Studies History","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Venereology; Medicine; Family medicine; Medical school; Dermatology; Library science; Medical education","score_opus":0.036617852732135664,"score_gpt":0.2727672513135978,"score_spread":0.23614939858146214,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3014004008","genre_codex":"commentary","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.03992512,0.048443995,0.0012625222,0.88186705,0.01542109,0.00021729713,0.00009317098,0.00009059173,0.012679098],"genre_scores_gemma":[0.3123731,0.09263411,0.005476331,0.54154634,0.01118374,0.0007697853,0.00014165399,0.00022535867,0.035649534],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99093103,0.005680515,0.00021087081,0.0005718056,0.0013923382,0.0012133458],"domain_scores_gemma":[0.9864166,0.0044570337,0.0008310425,0.00013526696,0.0020844988,0.0060756314],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011360236,0.0008769071,0.0013935454,0.001230035,0.009335512,0.0054812217,0.0018679029,0.005106711,0.003330299],"category_scores_gemma":[0.019217208,0.001034485,0.0007080525,0.001199313,0.005869519,0.007523972,0.0047149197,0.018357629,0.0010411682],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000081857565,0.00038726375,0.0050373375,0.00083020737,0.000027835658,0.005770205,0.43058562,0.00017428042,0.0012776183,0.008691451,0.5136076,0.033528715],"study_design_scores_gemma":[0.000026957197,0.00022291396,0.0028102011,0.0014353937,0.000010596159,0.007944897,0.44577035,0.00017648177,0.00015019425,0.0014499528,0.5398961,0.0001060314],"about_ca_topic_score_codex":0.00889505,"about_ca_topic_score_gemma":0.017319212,"teacher_disagreement_score":0.011360236,"about_ca_system_score_codex":0.0047657616,"about_ca_system_score_gemma":0.007829153,"threshold_uncertainty_score":0.060079396},"labels":[],"label_agreement":null},{"id":"W3015004082","doi":"10.1111/jdv.16394","title":"Onychomycosis: a review","year":2020,"lang":"en","type":"review","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Nail Diseases and Treatments","field":"Medicine","cited_by":278,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; Health Sciences Centre; Sunnybrook Health Science Centre; University of Toronto; Mediprobe Research (Canada); Public Health Ontario","funders":"","keywords":"Medicine; Dermatology; Terbinafine; Itraconazole; Dermatophyte; Fluconazole; Nail (fastener); Adverse effect; Cure rate; Antifungal drug; Antifungal; Surgery; Internal medicine","score_opus":0.05165707969153019,"score_gpt":0.36230613841726156,"score_spread":0.31064905872573134,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3015004082","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00022137805,0.99831474,0.00007824197,0.00024177502,0.00027470427,0.000008569968,0.000046252968,0.000008484022,0.0008059117],"genre_scores_gemma":[0.0012013273,0.99766374,0.00018226636,0.00022965012,0.0002995942,0.000008750212,0.00008429097,0.0000024238218,0.0003279878],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995472,0.000064832435,0.00014175693,0.00008225939,0.00012795195,0.00003597916],"domain_scores_gemma":[0.9989197,0.0005324216,0.00021081783,0.000028604652,0.00023133923,0.00007711495],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005460576,0.0009961695,0.0016125967,0.0060816314,0.00048279404,0.0019338774,0.0010362279,0.0011628069,0.007454184],"category_scores_gemma":[0.0018627297,0.00030727134,0.001073721,0.005463673,0.00047825783,0.0020042574,0.0007579015,0.001248415,0.0019928566],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001365562,0.00013180563,0.0009300069,0.07734132,0.00022350636,0.0010029122,0.00018120978,0.00031407314,0.0010328877,0.0017743121,0.054289516,0.86264193],"study_design_scores_gemma":[0.000026348453,0.00014212332,0.003481753,0.04325075,0.0006984389,0.01273429,0.00024984035,0.00012645943,0.00036678303,0.0016706821,0.93721074,0.000041828396],"about_ca_topic_score_codex":0.0017254798,"about_ca_topic_score_gemma":0.0020338595,"teacher_disagreement_score":0.007454184,"about_ca_system_score_codex":0.00065333344,"about_ca_system_score_gemma":0.0019230683,"threshold_uncertainty_score":0.024936736},"labels":[],"label_agreement":null},{"id":"W3015551664","doi":"10.1111/jdv.16433","title":"Tofacitinib in psoriatic arthritis patients: skin signs and symptoms and health‐related quality of life from two randomized phase 3 studies","year":2020,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research","funders":"","keywords":"Medicine; Tofacitinib; Psoriatic arthritis; Dermatology Life Quality Index; Janus kinase inhibitor; Psoriasis; Psoriasis Area and Severity Index; Placebo; Dermatology; Adalimumab; Internal medicine; Randomized controlled trial; Arthritis; Quality of life (healthcare); Rheumatoid arthritis; Pathology","score_opus":0.055036348459078406,"score_gpt":0.34932812880001923,"score_spread":0.29429178034094083,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3015551664","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9035462,0.055928513,0.002831516,0.0019595858,0.00084279245,0.021492556,0.008067463,0.00023992432,0.0050913584],"genre_scores_gemma":[0.95569575,0.01304079,0.0030201618,0.0026557988,0.0006991875,0.018742321,0.004799382,0.000042895255,0.0013036744],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99375075,0.00394305,0.00074327254,0.0005255328,0.0006140218,0.00042341815],"domain_scores_gemma":[0.9934958,0.0022755323,0.0022375993,0.00048328022,0.0005763068,0.00093147234],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.012285605,0.0019524605,0.00494646,0.000895262,0.0009989172,0.0021970398,0.0010956482,0.0025453314,0.007173091],"category_scores_gemma":[0.008312704,0.0009306764,0.009209871,0.0013357213,0.0012440681,0.0015727833,0.00093661604,0.0026941784,0.0005602396],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9552788,0.004174384,0.0027491918,0.0027171345,0.013049779,0.000049077626,0.00007866583,0.00034764546,0.0015593878,0.00008527628,0.00092368334,0.018987099],"study_design_scores_gemma":[0.95022005,0.03365655,0.0073142503,0.0001938027,0.0069376645,0.00005490416,0.00003137505,0.00020368617,0.00023505028,0.00016803156,0.0009570813,0.000027584545],"about_ca_topic_score_codex":0.0010230215,"about_ca_topic_score_gemma":0.0028943154,"teacher_disagreement_score":0.012285605,"about_ca_system_score_codex":0.001500277,"about_ca_system_score_gemma":0.0024145446,"threshold_uncertainty_score":0.064973295},"labels":[],"label_agreement":null},{"id":"W3015837428","doi":"10.1111/jdv.16446","title":"Quality‐of‐life analysis with intermittent vismodegib regimens in patients with multiple basal cell carcinomas: patient‐reported outcomes from the MIKIE study","year":2020,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Hedgehog Signaling Pathway Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Roche","keywords":"Medicine; Vismodegib; University hospital; SAINT; Library science; Family medicine; Basal cell; Basal cell carcinoma; Internal medicine; Art history; History","score_opus":0.02742846975996751,"score_gpt":0.24763552323106702,"score_spread":0.2202070534710995,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3015837428","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99691087,0.0016846389,0.00007008679,0.00009024005,0.000007516394,0.00001468802,0.00081475195,0.0000027303204,0.0004045015],"genre_scores_gemma":[0.99831223,0.0003965845,0.000063261046,0.00007060551,0.000016352014,0.000015721966,0.0010124684,0.0000016024875,0.000111312525],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996581,0.0001052654,0.000035808123,0.000071293005,0.00006322906,0.00006628604],"domain_scores_gemma":[0.99912745,0.00019904479,0.0004142168,0.00005275656,0.00005069887,0.00015583131],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009938907,0.00031723376,0.0005952771,0.0003463028,0.00020099824,0.0008001671,0.00028686805,0.00034807675,0.0011242717],"category_scores_gemma":[0.001162101,0.00010537872,0.0017529515,0.0006154704,0.00022658923,0.00053516065,0.00054568605,0.0006296569,0.00011378445],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.021760255,0.0007881019,0.93111014,0.00029106584,0.0055481954,0.00012923779,0.000110231646,0.0012120348,0.0016708074,0.00010993381,0.00096705457,0.036302943],"study_design_scores_gemma":[0.00085199566,0.0026960096,0.9927449,0.00003949728,0.0017439412,0.00019512736,0.00011329761,0.00060579483,0.00025749713,0.00009987862,0.000632124,0.000020005122],"about_ca_topic_score_codex":0.00093712984,"about_ca_topic_score_gemma":0.0019182303,"teacher_disagreement_score":0.0011242717,"about_ca_system_score_codex":0.00056226866,"about_ca_system_score_gemma":0.00026506497,"threshold_uncertainty_score":0.005256295},"labels":[],"label_agreement":null},{"id":"W3015886911","doi":"10.1111/jdv.16460","title":"Safety in moderate‐to‐severe plaque psoriasis patients with latent tuberculosis treated with guselkumab and anti‐tuberculosis treatments concomitantly: results from pooled phase 3 VOYAGE 1 &amp; VOYAGE 2 trials","year":2020,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health","funders":"Janssen Research and Development","keywords":"Medicine; Latent tuberculosis; Internal medicine; Concomitant; Adalimumab; Adverse effect; Psoriasis; Tuberculosis; Placebo; Isoniazid; Gastroenterology; Dermatology; Mycobacterium tuberculosis; Tumor necrosis factor alpha; Pathology","score_opus":0.028320329105978818,"score_gpt":0.2563176746490313,"score_spread":0.2279973455430525,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3015886911","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90057826,0.09226764,0.0010392686,0.00062957813,0.00036773045,0.0012994291,0.0015573043,0.00011327375,0.002147537],"genre_scores_gemma":[0.97839487,0.016983751,0.00078218704,0.00085565075,0.00027521315,0.0009588077,0.0010453999,0.000020411719,0.00068366167],"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9977507,0.0014833697,0.00019808416,0.0002606137,0.00017705117,0.00013016521],"domain_scores_gemma":[0.99782085,0.0007129271,0.00083791825,0.0001824551,0.00015027137,0.00029562475],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0045452313,0.0009610751,0.0039039613,0.0005226765,0.00033064946,0.0015844603,0.0006611613,0.0014683581,0.0024255267],"category_scores_gemma":[0.0035044842,0.0006751788,0.0057741744,0.0006773876,0.00076649326,0.0010410958,0.00051767915,0.0023571453,0.0003871918],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9149409,0.0017251329,0.0047228243,0.004926534,0.022914708,0.00005624425,0.00011135596,0.00052153063,0.0040754722,0.000107151594,0.0011390124,0.044759106],"study_design_scores_gemma":[0.8896363,0.067153506,0.019674733,0.0007498989,0.018674554,0.0002248654,0.000081262726,0.0004655371,0.000972047,0.00041782385,0.0019027762,0.00004672226],"about_ca_topic_score_codex":0.0005024907,"about_ca_topic_score_gemma":0.0013692041,"teacher_disagreement_score":0.0045452313,"about_ca_system_score_codex":0.00058951497,"about_ca_system_score_gemma":0.00090241135,"threshold_uncertainty_score":0.024037719},"labels":[],"label_agreement":null},{"id":"W3020819830","doi":"10.1111/jdv.16557","title":"European Task Force on Contact Dermatitis statement on coronavirus disease‐19 (COVID‐19) outbreak and the risk of adverse cutaneous reactions","year":2020,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Contact Dermatitis and Allergies","field":"Medicine","cited_by":68,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"","keywords":"Medicine; Outbreak; Coronavirus disease 2019 (COVID-19); Task force; 2019-20 coronavirus outbreak; Statement (logic); Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Coronavirus; Contact dermatitis; Adverse effect; Disease; Dermatology; Intensive care medicine; Virology; Infectious disease (medical specialty); Immunology; Internal medicine; Allergy","score_opus":0.03516493040799747,"score_gpt":0.2946229852089531,"score_spread":0.25945805480095563,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3020819830","genre_codex":"review","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.1662376,0.23510009,0.019984085,0.18105556,0.033119395,0.009161199,0.14918292,0.0014889803,0.20467024],"genre_scores_gemma":[0.63071954,0.16086847,0.017820884,0.032090176,0.013141499,0.008486425,0.09393546,0.0005026973,0.042434935],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99684095,0.0010104305,0.00055176526,0.00020148991,0.0010478696,0.00034755518],"domain_scores_gemma":[0.9885848,0.002104776,0.003668546,0.00034313224,0.0042239125,0.0010748749],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007233058,0.00085855083,0.001009927,0.0017196531,0.00060298253,0.00086911436,0.0010227277,0.001784123,0.0070887716],"category_scores_gemma":[0.009347015,0.00033184636,0.00095997774,0.0015157517,0.0003993189,0.0006391329,0.0010597964,0.0013460603,0.001183428],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006988667,0.00039836328,0.374717,0.0044688857,0.0004943474,0.001177092,0.0007514674,0.0006387397,0.0018175987,0.0014187901,0.43041503,0.18300392],"study_design_scores_gemma":[0.0001785309,0.0003115137,0.63927585,0.010308933,0.00048423928,0.0015297224,0.0008578199,0.0010277223,0.0007155477,0.0013216705,0.34388533,0.000103173516],"about_ca_topic_score_codex":0.02334837,"about_ca_topic_score_gemma":0.013203928,"teacher_disagreement_score":0.02334837,"about_ca_system_score_codex":0.0006971466,"about_ca_system_score_gemma":0.002794043,"threshold_uncertainty_score":0.046424925},"labels":[],"label_agreement":null},{"id":"W3027804939","doi":"10.1111/j.1346-8138.2008.00462.x-i1","title":"Sexually transmitted infections and human immunodeficiency virus infection in Europe: the way ahead?","year":2001,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Reproductive tract infections research","field":"Immunology and Microbiology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Medicine; Human immunodeficiency virus (HIV); Transmission (telecommunications); Psychological intervention; Incidence (geometry); Health care; Environmental health; Immunology; Family medicine; Intensive care medicine; Nursing; Telecommunications; Economic growth","score_opus":0.023437856927139848,"score_gpt":0.29967884812382645,"score_spread":0.2762409911966866,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3027804939","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0054080877,0.5201863,0.00043377612,0.4562207,0.011317106,0.000011947384,0.00031013743,0.000046346337,0.00606556],"genre_scores_gemma":[0.14241803,0.7013092,0.0023381596,0.11880796,0.025758358,0.00006992781,0.00075519516,0.000031057454,0.0085121095],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9977418,0.00095365883,0.00030431245,0.00015644984,0.0004127439,0.00043099828],"domain_scores_gemma":[0.99166673,0.0026757703,0.0009793262,0.00021595017,0.0025433155,0.0019189438],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005560377,0.00055015547,0.0015063207,0.0015878342,0.00083724037,0.0041522905,0.0010661036,0.009235063,0.018107383],"category_scores_gemma":[0.00856562,0.00027497456,0.0010152603,0.0028724624,0.0013030904,0.008664305,0.002141066,0.0034174253,0.0018884031],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008091729,0.0004850902,0.03325816,0.0049642855,0.00056171237,0.0012466378,0.0006672701,0.0005436821,0.0004286654,0.017559377,0.3449555,0.5945205],"study_design_scores_gemma":[0.000244145,0.0007416686,0.17536673,0.027198901,0.000880681,0.0036135444,0.014777819,0.0012606081,0.00034927324,0.039046664,0.7362666,0.00025336392],"about_ca_topic_score_codex":0.010493967,"about_ca_topic_score_gemma":0.0089221215,"teacher_disagreement_score":0.018107383,"about_ca_system_score_codex":0.0010619679,"about_ca_system_score_gemma":0.0060725324,"threshold_uncertainty_score":0.060575247},"labels":[],"label_agreement":null},{"id":"W3036751310","doi":"10.1111/jdv.16767","title":"Genomic profiling of late‐onset basal cell carcinomas from two brothers with nevoid basal cell carcinoma syndrome","year":2020,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Hedgehog Signaling Pathway Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cytodiagnostics (Canada)","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases; Institut Gustave-Roussy; National Institute of Environmental Health Sciences; National Cancer Institute; Swiss Cancer Research Foundation; Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung","keywords":"Nevoid basal-cell carcinoma syndrome; PTCH1; Loss of heterozygosity; Germline mutation; Biology; Germline; Genetics; Exome; Mutation; Basal cell carcinoma; Exome sequencing; Cancer research; Pathology; Medicine; Allele; Basal cell; Hedgehog; Gene","score_opus":0.014765561990416638,"score_gpt":0.21748920695275378,"score_spread":0.20272364496233714,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3036751310","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988017,0.00014505586,0.0003620486,0.00003211051,0.0000074338855,0.000011493323,0.00018961082,0.000010686853,0.00043991988],"genre_scores_gemma":[0.99830073,0.000108961496,0.0006216076,0.000045347897,0.000006665604,0.000006769152,0.00040645603,0.00001409188,0.0004892993],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9996444,0.000026646134,0.000032816683,0.00010341597,0.00015341704,0.00003940624],"domain_scores_gemma":[0.9995209,0.000108238986,0.00008289337,0.000049392547,0.000106161046,0.0001323579],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015605376,0.00029158374,0.0003529958,0.0012112303,0.0005554789,0.0004827929,0.00022424418,0.0005991862,0.0014239853],"category_scores_gemma":[0.00089318777,0.00027609314,0.00029155513,0.00036375492,0.00022063097,0.00013333022,0.00040648703,0.00038734946,0.00049779296],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00054795307,0.00018445049,0.42088708,0.0001304407,0.00011061369,0.1299324,0.0034061295,0.00023527678,0.4329308,0.00014748638,0.0005505902,0.01093683],"study_design_scores_gemma":[0.000020722495,0.00034281696,0.7789877,0.000026059686,0.00011529213,0.17973189,0.0015177589,0.0009757191,0.03539281,0.00010698848,0.0027583907,0.000023814739],"about_ca_topic_score_codex":0.001547698,"about_ca_topic_score_gemma":0.002117486,"teacher_disagreement_score":0.001547698,"about_ca_system_score_codex":0.00026085434,"about_ca_system_score_gemma":0.00014002701,"threshold_uncertainty_score":0.0047637224},"labels":[],"label_agreement":null},{"id":"W3048440237","doi":"10.1111/jdv.16868","title":"Demographic and clinical characteristics of extramammary Paget's disease patients in Japan from 2000 to 2019","year":2020,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Cancer and Skin Lesions","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University; University of Ottawa","funders":"Canadian Dermatology Foundation","keywords":"Medicine; Dermatology; Family medicine","score_opus":0.02129663902420617,"score_gpt":0.28905027580350773,"score_spread":0.26775363677930153,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3048440237","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99842715,0.00018973829,0.000022982375,0.000056084817,0.00001348626,0.0000054861607,0.000635794,0.0000022852278,0.00064694765],"genre_scores_gemma":[0.9984049,0.00016864469,0.000023806484,0.0000711344,0.000020842572,0.00001243492,0.0008923665,0.000001857237,0.00040398585],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99973315,0.000026849619,0.000049593695,0.000060897302,0.000036967445,0.00009253958],"domain_scores_gemma":[0.9993093,0.000064097556,0.00023371083,0.000021704396,0.00009436848,0.00027681686],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022985382,0.0002542027,0.00030929787,0.0013253139,0.00060976914,0.00063378044,0.00030928667,0.0004895483,0.002026983],"category_scores_gemma":[0.0008152595,0.00030851978,0.00046663385,0.0016499544,0.00031614894,0.0007092823,0.0004512577,0.00062090677,0.0003511474],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007904636,0.000046931826,0.99850345,0.000009813307,0.000029015373,0.00027440058,0.00013547498,0.000024287843,0.0001726971,0.000013041835,0.00017403698,0.0005377713],"study_design_scores_gemma":[0.0000043369505,0.000044653338,0.9985039,0.0000052706714,0.000018557685,0.0004811081,0.0005315231,0.00005805643,0.000020386236,0.000009289968,0.00031850536,0.000004425527],"about_ca_topic_score_codex":0.012267542,"about_ca_topic_score_gemma":0.013950188,"teacher_disagreement_score":0.012267542,"about_ca_system_score_codex":0.00053325196,"about_ca_system_score_gemma":0.00048757053,"threshold_uncertainty_score":0.024392247},"labels":[],"label_agreement":null},{"id":"W3048542426","doi":"10.1111/jdv.16869","title":"<i>MC1R</i> variants in relation to naevi in melanoma cases and controls: a pooled analysis from the M‐SKIP project","year":2020,"lang":"en","type":"letter","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"melanin and skin pigmentation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"National Cancer Institute; Instituto de Salud Carlos III; Fundació la Marató de TV3; Agència de Gestió d'Ajuts Universitaris i de Recerca; Associazione Italiana per la Ricerca sul Cancro; Ministero della Salute; European Regional Development Fund; European Commission; National Institutes of Health; Fundación Científica Asociación Española Contra el Cáncer; Generalitat de Catalunya; Cancer Research UK; Centres de Recerca de Catalunya","keywords":"Biostatistics; Medicine; Epidemiology; Family medicine; Medical school; Library science; Dermatology; Pathology; Medical education","score_opus":0.018964198554976844,"score_gpt":0.2665146066703497,"score_spread":0.24755040811537288,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3048542426","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8086834,0.0064456207,0.0018835884,0.14937502,0.00533775,0.000093236114,0.010761318,0.00016229512,0.017257825],"genre_scores_gemma":[0.9225873,0.0011456762,0.0008971037,0.058224194,0.006891014,0.00009551722,0.0019422534,0.000077407625,0.008139587],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99879396,0.0005633834,0.000109817134,0.0002393579,0.00017618705,0.00011728074],"domain_scores_gemma":[0.99706143,0.0017290763,0.00031679048,0.00033204677,0.000354054,0.00020654447],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015702881,0.00036016025,0.0007768373,0.00052979775,0.00065520784,0.0006884653,0.00047540525,0.0027946318,0.0019841713],"category_scores_gemma":[0.006519929,0.00025938195,0.0005313238,0.00065603794,0.00033970783,0.00033915948,0.00035519354,0.0009831678,0.00067948306],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0054360637,0.00012394843,0.7228878,0.00023155226,0.00175792,0.035347346,0.0011115368,0.0002813438,0.0059021446,0.0011007254,0.1910807,0.03473887],"study_design_scores_gemma":[0.00082382455,0.0007894488,0.8055959,0.0003383282,0.0024352418,0.08752041,0.0017526619,0.0023765813,0.0023770505,0.006393713,0.08945059,0.00014629918],"about_ca_topic_score_codex":0.0041430653,"about_ca_topic_score_gemma":0.004657709,"teacher_disagreement_score":0.0041430653,"about_ca_system_score_codex":0.00028362637,"about_ca_system_score_gemma":0.0002557054,"threshold_uncertainty_score":0.008304536},"labels":[],"label_agreement":null},{"id":"W3082748021","doi":"10.1111/jdv.16895","title":"Atopic dermatitis and bone health: a systematic review","year":2020,"lang":"en","type":"review","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; Women's College Hospital; University of Ottawa; University of British Columbia","funders":"","keywords":"Medicine; Atopic dermatitis; Osteoporosis; Cross-sectional study; Cohort study; Checklist; Cohort; MEDLINE; Bone health; Systematic review; Bone mineral; Internal medicine; Physical therapy; Pathology; Dermatology","score_opus":0.03882822304125718,"score_gpt":0.33654123636695044,"score_spread":0.2977130133256933,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3082748021","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0008120335,0.998298,0.00006461884,0.0001597405,0.00006796589,0.00019409454,0.00023136397,0.0000054779593,0.00016676637],"genre_scores_gemma":[0.012762743,0.9856399,0.0003684407,0.0004798119,0.00007474754,0.00038715496,0.00016687112,0.000003525913,0.00011672702],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9953661,0.0016513633,0.0015472787,0.00036684907,0.0008948286,0.00017360167],"domain_scores_gemma":[0.98276293,0.012163099,0.0034136777,0.00022135518,0.0012216656,0.00021724775],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0048459545,0.0013767895,0.0081311865,0.0066644694,0.00060008926,0.0023779166,0.0015680977,0.0019606033,0.0058969697],"category_scores_gemma":[0.023231596,0.0010054815,0.0072079482,0.008007235,0.0006784374,0.0017368781,0.0013414705,0.0011262461,0.00037355893],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015861932,0.000014148498,0.00070663204,0.9705931,0.00888969,0.000108410546,0.000087825436,0.00006455302,0.000074475305,0.00010624832,0.001164289,0.018031953],"study_design_scores_gemma":[0.00032847605,0.00020237283,0.005585948,0.88944554,0.08975365,0.0006072033,0.0002054929,0.00009501229,0.000105088315,0.00025627424,0.013380296,0.00003464328],"about_ca_topic_score_codex":0.010945547,"about_ca_topic_score_gemma":0.031126216,"teacher_disagreement_score":0.010945547,"about_ca_system_score_codex":0.0031460957,"about_ca_system_score_gemma":0.008393679,"threshold_uncertainty_score":0.02562821},"labels":[],"label_agreement":null},{"id":"W3083911803","doi":"10.1111/jdv.16927","title":"Patients’ perspective on current treatments and demand for novel treatments in vitiligo","year":2020,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"melanin and skin pigmentation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"","keywords":"Medicine; Vitiligo; Quality of life (healthcare); Patient satisfaction; Clinical trial; Prospective cohort study; Physical therapy; Dermatology; Surgery; Internal medicine; Nursing","score_opus":0.023482372479040753,"score_gpt":0.2942980184791727,"score_spread":0.27081564600013197,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3083911803","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9846464,0.0022556032,0.0001437343,0.007436991,0.00005105063,0.000014285416,0.00015809687,0.000004608674,0.005289324],"genre_scores_gemma":[0.9979214,0.0008173801,0.00012434713,0.0007989394,0.00003682687,0.0000050816984,0.000052933174,0.0000014665917,0.00024161384],"study_design_codex":"observational","study_design_gemma":"qualitative","domain_scores_codex":[0.99789786,0.00122653,0.00011691175,0.00008199282,0.00041687224,0.00025986065],"domain_scores_gemma":[0.99370724,0.0021997434,0.0021400372,0.0000877139,0.0005600217,0.0013051169],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023389773,0.000109193265,0.00025186545,0.00034764278,0.00072438037,0.0012911366,0.00022555608,0.00082489394,0.0037464544],"category_scores_gemma":[0.006300951,0.00012535078,0.00046791846,0.00034314508,0.0005605085,0.00088007195,0.00059706613,0.0011238931,0.00027643502],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00059847964,0.00035216223,0.9098306,0.000390097,0.00023560009,0.0016549329,0.019653533,0.0004105554,0.0018642774,0.0009974785,0.006634948,0.05737736],"study_design_scores_gemma":[0.00012893484,0.0015429936,0.8958517,0.00053079904,0.0001840113,0.008324322,0.07030717,0.0012574081,0.000501478,0.0011158519,0.020141296,0.00011401489],"about_ca_topic_score_codex":0.0014122187,"about_ca_topic_score_gemma":0.0018687202,"teacher_disagreement_score":0.0037464544,"about_ca_system_score_codex":0.0006777388,"about_ca_system_score_gemma":0.0005968482,"threshold_uncertainty_score":0.012533128},"labels":[],"label_agreement":null},{"id":"W3087665791","doi":"10.1111/jdv.16948","title":"Pooled safety analysis of baricitinib in adult patients with atopic dermatitis from 8 randomized clinical trials","year":2020,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":147,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health; Innovaderm (Canada)","funders":"Sanofi Genzyme; Galderma; Incyte; Les Laboratories Pierre Fabre; Regeneron Pharmaceuticals; Sanofi; Pfizer; Eli Lilly and Company","keywords":"Medicine; Atopic dermatitis; Placebo; Adverse effect; Context (archaeology); Internal medicine; Incidence (geometry); Randomized controlled trial; Cellulitis; Dermatology","score_opus":0.03293357512864343,"score_gpt":0.32780115854623215,"score_spread":0.29486758341758873,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3087665791","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6227119,0.3151211,0.016119566,0.0013239107,0.0014074985,0.01894091,0.01669808,0.0005954548,0.007081506],"genre_scores_gemma":[0.95278233,0.022495486,0.0049904343,0.0012799694,0.0005409094,0.0098356735,0.007117634,0.00007712091,0.0008805977],"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","domain_scores_codex":[0.956077,0.028054418,0.008617071,0.0032304327,0.0033542672,0.0006668387],"domain_scores_gemma":[0.95434636,0.025703456,0.014009191,0.0026570198,0.002669717,0.00061421853],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.038983572,0.001977617,0.008438934,0.0023554685,0.00038994144,0.0023489736,0.00088641193,0.0018058693,0.0040514315],"category_scores_gemma":[0.058650292,0.001025567,0.01586781,0.0022420688,0.000729657,0.0013712465,0.0011832217,0.0014848022,0.00036644645],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.46341947,0.00049623736,0.022149242,0.025881985,0.4355896,0.00020061496,0.00011085928,0.0029022344,0.0017378625,0.00020420615,0.0024630027,0.044844724],"study_design_scores_gemma":[0.3710452,0.030086104,0.07145816,0.0027754938,0.5114615,0.00054915826,0.00011368638,0.0032616954,0.00136923,0.0013137672,0.0064209714,0.00014505931],"about_ca_topic_score_codex":0.00042416045,"about_ca_topic_score_gemma":0.0008193455,"teacher_disagreement_score":0.038983572,"about_ca_system_score_codex":0.00089904753,"about_ca_system_score_gemma":0.0013724086,"threshold_uncertainty_score":0.20616728},"labels":[],"label_agreement":null},{"id":"W3088197465","doi":"10.1111/jdv.16958","title":"Patients’, family members’ and healthcare practitioners’ experiences of Stevens–Johnson syndrome and toxic epidermal necrolysis: a qualitative descriptive study using emotional touchpoints","year":2020,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Drug-Induced Adverse Reactions","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Health Research Institute, University of Limerick; University of Limerick","keywords":"Toxic epidermal necrolysis; Medicine; Mucocutaneous zone; Qualitative research; Health professionals; Perception; Health care; Family medicine; Nursing; Psychiatry; Disease; Dermatology; Psychology; Internal medicine","score_opus":0.07986683687651158,"score_gpt":0.34415887856402977,"score_spread":0.2642920416875182,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3088197465","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99048597,0.0015629119,0.0012156558,0.002374157,0.00009499898,0.00022347651,0.00018488234,0.000011523991,0.0038463804],"genre_scores_gemma":[0.9946515,0.0013571087,0.00077947765,0.0010221621,0.00002491922,0.00034361857,0.000075930184,0.000019246718,0.001726114],"study_design_codex":"qualitative","study_design_gemma":"qualitative","domain_scores_codex":[0.99087816,0.006637222,0.00030882144,0.00044855243,0.0006031346,0.0011241988],"domain_scores_gemma":[0.98308563,0.013115121,0.0010443166,0.0003071956,0.0010315394,0.0014161299],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010524343,0.0007628244,0.0010539889,0.0017582865,0.009668933,0.0048409877,0.0019701049,0.0022868316,0.003617209],"category_scores_gemma":[0.015501362,0.0009425639,0.00059348467,0.0016907944,0.01040013,0.0062544486,0.0063218935,0.0040974338,0.0004083842],"study_design_candidate":"qualitative","study_design_consensus":"qualitative","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000020464613,0.000026463913,0.0010534732,0.00011922096,0.0000028455402,0.0005141188,0.9963348,0.00001671323,0.00018046657,0.00047635657,0.00023322926,0.0010218527],"study_design_scores_gemma":[0.0000019912225,0.000025167294,0.0005242352,0.00011073568,0.000001719082,0.00017044359,0.9972065,0.000018890967,0.000050431387,0.00010221413,0.0017816637,0.000006149093],"about_ca_topic_score_codex":0.009024018,"about_ca_topic_score_gemma":0.015313829,"teacher_disagreement_score":0.010524343,"about_ca_system_score_codex":0.005425657,"about_ca_system_score_gemma":0.0046227337,"threshold_uncertainty_score":0.055658758},"labels":[],"label_agreement":null},{"id":"W3088766896","doi":"10.1111/jdv.16889","title":"European dermatology forum: Updated guidelines on the use of extracorporeal photopheresis 2020 – Part 2","year":2020,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Cutaneous lymphoproliferative disorders research","field":"Medicine","cited_by":60,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Celgene; Eli Lilly and Company","keywords":"Medicine; Extracorporeal Photopheresis; Photopheresis; Dermatology; Intensive care medicine; Graft-versus-host disease; Expert opinion; Cutaneous T-cell lymphoma; Disease; Transplantation; Surgery; Mycosis fungoides; Lymphoma; Pathology","score_opus":0.13020137616497382,"score_gpt":0.32808022898665257,"score_spread":0.19787885282167875,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3088766896","genre_codex":"review","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004827213,0.5489997,0.026082417,0.18344884,0.041726954,0.0033522155,0.010151696,0.0018832884,0.1795277],"genre_scores_gemma":[0.040090293,0.44682115,0.13081244,0.21935381,0.021453908,0.006501586,0.035289627,0.00094676996,0.09873039],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9912537,0.0031381086,0.0021855861,0.00027555757,0.002617149,0.0005298862],"domain_scores_gemma":[0.9846198,0.0040067392,0.002353302,0.00039249423,0.007937314,0.00069040555],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00964623,0.001016613,0.0012829395,0.005168908,0.00075521995,0.0026308293,0.0025388554,0.005932914,0.008613406],"category_scores_gemma":[0.016977653,0.00057327887,0.0021575997,0.0021695069,0.0010002437,0.0021157537,0.0018235486,0.004748115,0.006582082],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000084786116,0.00014706672,0.00075131457,0.0028232085,0.000050551393,0.00038179837,0.00017911484,0.00047262534,0.0010676485,0.0039299577,0.7101646,0.27994725],"study_design_scores_gemma":[0.000037075748,0.00004060786,0.0012545405,0.0053641866,0.000048348145,0.0009991074,0.000069968046,0.00015061285,0.0002667263,0.0013583789,0.99038833,0.000022025117],"about_ca_topic_score_codex":0.0051524052,"about_ca_topic_score_gemma":0.007237658,"teacher_disagreement_score":0.00964623,"about_ca_system_score_codex":0.0022542463,"about_ca_system_score_gemma":0.006628621,"threshold_uncertainty_score":0.05101478},"labels":[],"label_agreement":null},{"id":"W3091930030","doi":"10.1111/jdv.16916","title":"A position paper on the management of itch and pain in atopic dermatitis from the International Society of Atopic Dermatitis (ISAD)/Oriented Patient‐Education Network in Dermatology (OPENED) task force","year":2020,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Atopic dermatitis; Medicine; Dermatology; Task force; Position paper; Disease; Pathology","score_opus":0.011294981541079772,"score_gpt":0.24217726365464326,"score_spread":0.2308822821135635,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3091930030","genre_codex":"editorial","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0014258111,0.13599834,0.0022472653,0.4015952,0.4044087,0.000685795,0.00054693455,0.000078350015,0.053013597],"genre_scores_gemma":[0.01168501,0.33779743,0.008718388,0.15936989,0.35847893,0.00069086655,0.0016466307,0.00014836871,0.12146444],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99793386,0.00043412467,0.00024995388,0.00016384124,0.0009903618,0.00022785056],"domain_scores_gemma":[0.9919184,0.0020116894,0.0007133673,0.00010560978,0.0031764987,0.002074428],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004622334,0.0010617347,0.0008978529,0.0014010846,0.0012924562,0.002356949,0.0014766558,0.005462797,0.012812261],"category_scores_gemma":[0.008119254,0.00033949575,0.0010502753,0.000911481,0.0008313908,0.0021701502,0.0012570083,0.006076387,0.005841362],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000042517677,0.00009317924,0.00029649035,0.0006128174,0.000011047304,0.00020448753,0.000052923086,0.000089375826,0.0002538664,0.0007988176,0.9017224,0.09582217],"study_design_scores_gemma":[0.00008797511,0.00023792275,0.0016918521,0.0022935306,0.00003862819,0.00068602664,0.00012516131,0.00009430613,0.00019201808,0.0010845986,0.9934503,0.000017696038],"about_ca_topic_score_codex":0.004543911,"about_ca_topic_score_gemma":0.012702349,"teacher_disagreement_score":0.012812261,"about_ca_system_score_codex":0.0017968606,"about_ca_system_score_gemma":0.007096251,"threshold_uncertainty_score":0.042861283},"labels":[],"label_agreement":null},{"id":"W3092554446","doi":"10.1111/jdv.16890","title":"European dermatology forum – updated guidelines on the use of extracorporeal photopheresis 2020 – part 1","year":2020,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Cutaneous lymphoproliferative disorders research","field":"Medicine","cited_by":92,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Cilag; LEO Pharma; Celgene; Sanofi; Amgen; Pfizer; Eli Lilly and Company","keywords":"Medicine; Extracorporeal Photopheresis; Photopheresis; Intensive care medicine; Dermatology; Graft-versus-host disease; Disease; Extracorporeal; Expert opinion; Cutaneous T-cell lymphoma; Transplantation; Surgery; Lymphoma; Mycosis fungoides; Pathology","score_opus":0.12992317454448676,"score_gpt":0.3270150961100168,"score_spread":0.19709192156553001,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3092554446","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0040824274,0.5791846,0.02187104,0.14601138,0.03340238,0.0031530703,0.010204016,0.0018158039,0.20027529],"genre_scores_gemma":[0.0344334,0.51791865,0.10709459,0.17860498,0.019477742,0.0059100823,0.038002107,0.0008773472,0.09768105],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99229264,0.0027786808,0.001857105,0.0002431447,0.0023797275,0.00044860924],"domain_scores_gemma":[0.98661894,0.0037522558,0.0020756447,0.0003397603,0.0066592675,0.0005540965],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0074939183,0.0009593556,0.0012733223,0.0050908504,0.0007128847,0.0025231433,0.0023041384,0.0051808385,0.011040908],"category_scores_gemma":[0.015732605,0.00052819686,0.0019866875,0.0020795895,0.00091767096,0.0020166237,0.0016731062,0.0042304085,0.0081956275],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000075462056,0.00013534653,0.0006703709,0.0030401754,0.0000493308,0.00037512058,0.0001638057,0.0004483515,0.000940793,0.003887806,0.7054785,0.2847349],"study_design_scores_gemma":[0.000031478285,0.000033070704,0.0010487144,0.0054479693,0.000040726412,0.0009269235,0.000056894016,0.0001171097,0.00021064996,0.001330001,0.99073845,0.000018084545],"about_ca_topic_score_codex":0.0047497326,"about_ca_topic_score_gemma":0.0070410627,"teacher_disagreement_score":0.011040908,"about_ca_system_score_codex":0.0020352064,"about_ca_system_score_gemma":0.0054365853,"threshold_uncertainty_score":0.039632082},"labels":[],"label_agreement":null},{"id":"W3111099322","doi":"10.1111/jdv.17072","title":"Spontaneous resolution of multidrug‐resistant <i>Mycobacterium abscessus</i> infection in tattoo","year":2020,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Mycobacterium research and diagnosis","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"","keywords":"Medicine; Library science; Dermatology; Computer science","score_opus":0.023441487409902453,"score_gpt":0.2760546798667502,"score_spread":0.25261319245684777,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111099322","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97579545,0.0051219226,0.0045024054,0.001508965,0.0006173854,0.00022801862,0.00019366405,0.00026531442,0.011766853],"genre_scores_gemma":[0.99760157,0.000400043,0.0002836573,0.00045154153,0.00016980973,0.00001649497,0.00005977026,0.000012350887,0.0010047825],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99963975,0.000068161826,0.000027323256,0.000065398846,0.000055688535,0.00014374904],"domain_scores_gemma":[0.99869436,0.000294485,0.0003309674,0.00028448686,0.00006537153,0.0003303364],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002740465,0.00073677005,0.00076121994,0.0004966392,0.0010632044,0.00088944373,0.0007166396,0.0021957543,0.0011769914],"category_scores_gemma":[0.003108868,0.0005013723,0.0007686902,0.000539071,0.0008913526,0.0009346286,0.0007987052,0.0022491908,0.00071345805],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034062524,0.00017840159,0.012927555,0.00008641265,0.000031033498,0.9762299,0.0004348751,0.00016397456,0.0032390873,0.0003571075,0.000544314,0.005466677],"study_design_scores_gemma":[0.00011741295,0.0006901447,0.022594523,0.000044566845,0.000027911781,0.9692777,0.00021717836,0.0007969429,0.0026129244,0.00034745358,0.0032508262,0.000022395687],"about_ca_topic_score_codex":0.00049489964,"about_ca_topic_score_gemma":0.0005454401,"teacher_disagreement_score":0.0021957543,"about_ca_system_score_codex":0.0004660513,"about_ca_system_score_gemma":0.0003457682,"threshold_uncertainty_score":0.003937423},"labels":[],"label_agreement":null},{"id":"W3115852192","doi":"10.1111/jdv.17092","title":"Effectiveness and safety of guselkumab in 50 patients with moderate to severe plaque psoriasis who had previously been treated with other biologics: a retrospective real‐world evidence study","year":2020,"lang":"en","type":"letter","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Plaque psoriasis; Psoriasis; Dermatology; Retrospective cohort study; Ustekinumab; Real world evidence; Internal medicine; Adalimumab; Disease","score_opus":0.01754378247948413,"score_gpt":0.2423139302186115,"score_spread":0.22477014773912737,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3115852192","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9820718,0.016011305,0.00016515826,0.0003974939,0.000042611286,0.000077500226,0.00035006876,0.0000039215674,0.00088011555],"genre_scores_gemma":[0.9963109,0.002576339,0.00013986969,0.0005093612,0.00009272044,0.000028244742,0.00022622757,0.0000015117996,0.000114855466],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99818426,0.00091950234,0.00036150744,0.00019744057,0.00023321585,0.00010401132],"domain_scores_gemma":[0.9962308,0.0022494937,0.0010433831,0.00015853284,0.0001372151,0.00018055188],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021376957,0.00038511836,0.0013705421,0.00050339365,0.00035118926,0.0010039476,0.00031086203,0.0013517843,0.00090175215],"category_scores_gemma":[0.00460735,0.0004434805,0.0020620164,0.0008399284,0.0006419625,0.0006000764,0.00023970149,0.0008178081,0.00016652205],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.1669541,0.0028082961,0.72476774,0.0029323054,0.015970215,0.005270396,0.00043743275,0.00080588664,0.0052626566,0.00025951906,0.0014204376,0.07311109],"study_design_scores_gemma":[0.047026943,0.05214753,0.8566717,0.0006608386,0.020777225,0.0121998,0.00056260434,0.0016099744,0.001996012,0.00041857138,0.0057698195,0.00015892785],"about_ca_topic_score_codex":0.0007226494,"about_ca_topic_score_gemma":0.0010778799,"teacher_disagreement_score":0.0021376957,"about_ca_system_score_codex":0.0006304326,"about_ca_system_score_gemma":0.00036572406,"threshold_uncertainty_score":0.011305332},"labels":[],"label_agreement":null},{"id":"W3118633569","doi":"10.1111/jdv.17113","title":"Long‐term safety and efficacy of a fixed‐combination halobetasol propionate 0.01%/tazarotene 0.045% lotion in moderate‐to‐severe plaque psoriasis: phase 3 open‐label study","year":2021,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research","funders":"Ortho Dermatologics","keywords":"Medicine; Lotion; Tolerability; Tazarotene; Psoriasis; Adverse effect; Dermatology; Irritation; Itching; Body surface area; Erythema; Internal medicine; Pharmacology; Immunology","score_opus":0.032725368470184174,"score_gpt":0.30031655855357614,"score_spread":0.26759119008339194,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3118633569","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978034,0.0009801864,0.00021890491,0.00006408421,0.000030317668,0.00038389122,0.00024203406,0.000029684637,0.00024747712],"genre_scores_gemma":[0.9969374,0.0005875001,0.00044417707,0.00023949516,0.00009386585,0.00056137674,0.0005223422,0.000011777408,0.0006020879],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9993137,0.00029336356,0.000040632716,0.000121955294,0.00012657252,0.000103855986],"domain_scores_gemma":[0.999022,0.00020858289,0.00029460576,0.00009712799,0.000076288336,0.00030127738],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020627377,0.0010792825,0.0021104629,0.00037668098,0.00049108925,0.00083006447,0.0009736133,0.0013247739,0.0025766972],"category_scores_gemma":[0.0010243712,0.0005273278,0.0014286083,0.00030198254,0.00085568655,0.00079425646,0.0002459084,0.0020281572,0.00070554914],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.71241474,0.107224956,0.010075624,0.00095340563,0.0018922205,0.00023443981,0.00033244057,0.0011284616,0.09486452,0.00007568889,0.0015588141,0.069244675],"study_design_scores_gemma":[0.24562064,0.71085405,0.035574973,0.000033164888,0.00071827497,0.00025389352,0.00005981368,0.00083555863,0.0050652036,0.00005785444,0.00089094805,0.000035620556],"about_ca_topic_score_codex":0.00072826416,"about_ca_topic_score_gemma":0.00115556,"teacher_disagreement_score":0.0025766972,"about_ca_system_score_codex":0.0006354059,"about_ca_system_score_gemma":0.0006981053,"threshold_uncertainty_score":0.010908902},"labels":[],"label_agreement":null},{"id":"W3119170264","doi":"10.1111/jdv.17108","title":"Donor to recipient ratios in the surgical treatment of vitiligo and piebaldism: a systematic review","year":2021,"lang":"en","type":"review","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"melanin and skin pigmentation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"Amsterdam University Medical Centers","keywords":"Medicine; Vitiligo; Transplantation; Grafting; Tissue expansion; Dermatology; Surgery","score_opus":0.03355242457704115,"score_gpt":0.3392292751334489,"score_spread":0.30567685055640775,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3119170264","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010596858,0.9981647,0.0000748838,0.00008204651,0.000048249993,0.000119285454,0.0002642005,0.0000038705803,0.00018311774],"genre_scores_gemma":[0.017875805,0.9806851,0.00032513027,0.00036185735,0.00006892365,0.00033372617,0.00025788593,0.000005720625,0.00008582268],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9945644,0.001783198,0.0022487347,0.0004439664,0.00081487594,0.00014479742],"domain_scores_gemma":[0.9741122,0.020622445,0.0033625027,0.00022756669,0.0014728017,0.00020257504],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0059333104,0.0011627183,0.008052179,0.007979814,0.00049624447,0.0023838219,0.0016237119,0.0017931586,0.005452033],"category_scores_gemma":[0.026229264,0.0007913969,0.0071292655,0.009397742,0.00074664527,0.0021100703,0.0011658514,0.0009816029,0.00037446828],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028689048,0.000017853905,0.0007106505,0.9667558,0.0078280475,0.0000629524,0.000102902944,0.00004622223,0.00010260514,0.00010856338,0.0007483301,0.023229107],"study_design_scores_gemma":[0.00044334176,0.00034856488,0.0058335676,0.8675822,0.109674044,0.00045071158,0.00031037812,0.00007930478,0.00019191895,0.0002615729,0.014781606,0.000042777963],"about_ca_topic_score_codex":0.0051459637,"about_ca_topic_score_gemma":0.012305445,"teacher_disagreement_score":0.008052179,"about_ca_system_score_codex":0.002076139,"about_ca_system_score_gemma":0.00544874,"threshold_uncertainty_score":0.031378746},"labels":[],"label_agreement":null},{"id":"W3126748472","doi":"10.1111/jdv.17148","title":"Convergent Validity of Suffering and Quality of Life as Measured by The Hidradenitis Suppurativa Quality of Life","year":2021,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Hidradenitis Suppurativa and Treatments","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"LEO Fondet","keywords":"Hidradenitis suppurativa; Medicine; Quality of life (healthcare); Quality (philosophy); Dermatology; Pathology; Epistemology; Disease; Nursing","score_opus":0.09153471850980774,"score_gpt":0.3360936874400628,"score_spread":0.24455896893025506,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3126748472","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9923915,0.0007252694,0.001708121,0.00017822036,0.000043068212,0.00012704649,0.00079075526,0.000011124473,0.0040248674],"genre_scores_gemma":[0.99840456,0.00012875049,0.0008266689,0.00004511157,0.0000111651825,0.00008688345,0.00039024747,0.0000036369372,0.000102951766],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.993725,0.0023749098,0.00081489974,0.00076634553,0.0020340802,0.00028474073],"domain_scores_gemma":[0.9772915,0.0121691665,0.004336138,0.0015125957,0.0038325447,0.00085803226],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010006831,0.0003741764,0.00073994265,0.0015169631,0.00040255734,0.0010473577,0.0006129024,0.00044476986,0.0015666852],"category_scores_gemma":[0.03044708,0.00023492338,0.0012975662,0.0009289206,0.00085391256,0.00070948614,0.0018500533,0.00066630275,0.00020579615],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012316697,0.00007485859,0.9869846,0.000121846795,0.0004997686,0.000040039693,0.00097208394,0.0003195168,0.0003317415,0.00038952465,0.00019252404,0.009950427],"study_design_scores_gemma":[0.000025128102,0.00017194703,0.995589,0.00011678874,0.00009361597,0.00011271594,0.00084336055,0.001495683,0.00029447753,0.00065610366,0.0005828385,0.000018267716],"about_ca_topic_score_codex":0.0014652635,"about_ca_topic_score_gemma":0.0014399985,"teacher_disagreement_score":0.010006831,"about_ca_system_score_codex":0.0005533089,"about_ca_system_score_gemma":0.00050786353,"threshold_uncertainty_score":0.05292183},"labels":[],"label_agreement":null},{"id":"W3127185312","doi":"10.1111/jdv.17075","title":"Position statement for a pragmatic approach to immunotherapeutics in patients with inflammatory skin diseases during the coronavirus disease 2019 pandemic and beyond","year":2021,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre de Recherche Dermatologique du Québec Métropolitain; Hôtel-Dieu de Québec; Innovaderm (Canada); Lynde Centre for Dermatology; University of Alberta; SKiN Health; McMaster University; Université Laval; BC Children's Hospital; Probity Medical Research; Surrey Memorial Hospital; University of British Columbia; Ottawa Hospital; Dermatrials Research; University of Ottawa","funders":"Bausch Health; Celgene; Amgen; Pfizer; BC Children's Hospital; Eli Lilly and Company","keywords":"Medicine; Pandemic; Coronavirus disease 2019 (COVID-19); Position statement; Disease; Coronavirus; 2019-20 coronavirus outbreak; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Position (finance); Statement (logic); Intensive care medicine; Virology; Pathology; Family medicine; Infectious disease (medical specialty); Epistemology; Outbreak","score_opus":0.011426869718740122,"score_gpt":0.2686697970676748,"score_spread":0.25724292734893467,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3127185312","genre_codex":"commentary","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00027558443,0.0040663127,0.0009330257,0.92586076,0.0631863,0.00012243992,0.00007569117,0.000053199044,0.0054266257],"genre_scores_gemma":[0.0069964128,0.008193087,0.008125332,0.8539613,0.096321546,0.0005475435,0.00018302834,0.00013512664,0.025536595],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9877743,0.0038350255,0.0017176567,0.0012861796,0.0037842274,0.0016027004],"domain_scores_gemma":[0.94759005,0.017787995,0.0025370892,0.0018598863,0.013693646,0.016531298],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.018514885,0.0011702608,0.0014762459,0.0007623814,0.0045582554,0.009300685,0.0033108457,0.04892441,0.022645172],"category_scores_gemma":[0.046199456,0.00070175563,0.002789933,0.0005867341,0.0043426957,0.0066014566,0.0066958857,0.049207196,0.015260162],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007907044,0.00010263007,0.00021427938,0.00038628082,0.000032883818,0.0005087361,0.000221741,0.00014250526,0.0004886373,0.011335801,0.95277995,0.033707496],"study_design_scores_gemma":[0.00012002004,0.00008770618,0.00023090297,0.0011511561,0.00003722131,0.00038669872,0.0002632276,0.00016128267,0.00020607938,0.009799778,0.98750955,0.00004650672],"about_ca_topic_score_codex":0.0021233966,"about_ca_topic_score_gemma":0.005017899,"teacher_disagreement_score":0.04892441,"about_ca_system_score_codex":0.0043610693,"about_ca_system_score_gemma":0.026494108,"threshold_uncertainty_score":0.09791726},"labels":[],"label_agreement":null},{"id":"W3133906725","doi":"10.1111/jdv.17196","title":"Global publication productivity in dermatology: a bibliometric description of the past and estimation of the future","year":2021,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"scientometrics and bibliometrics research","field":"Decision Sciences","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Atopic dermatitis; Scopus; Dermatology; Bibliometrics; Family medicine; MEDLINE; Library science; Political science","score_opus":0.18854739366658751,"score_gpt":0.4408241137055947,"score_spread":0.2522767200390072,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3133906725","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"evaluation","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"evaluation","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4462183,0.23013884,0.018952599,0.009483824,0.0010920843,0.0011518715,0.22546925,0.0018299589,0.06566325],"genre_scores_gemma":[0.8564267,0.06961936,0.01735134,0.00030166173,0.001311556,0.0010859414,0.051061973,0.00029668087,0.0025447179],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9701937,0.0059699025,0.0069361706,0.0024543179,0.013586561,0.000859384],"domain_scores_gemma":[0.88009024,0.06579805,0.027683316,0.0063837017,0.018369192,0.0016755495],"candidate_categories":["metaresearch","bibliometrics"],"consensus_categories":[],"category_scores_codex":[0.02261675,0.00095074804,0.0023228053,0.1438906,0.0007930449,0.007943549,0.0012032005,0.00069904036,0.004153306],"category_scores_gemma":[0.092689484,0.0003545504,0.0033362554,0.26954278,0.0014430996,0.0069252197,0.003343091,0.0008637065,0.0012954576],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045045052,0.00008917772,0.6260672,0.023929507,0.006788931,0.00048123996,0.004131074,0.005414683,0.00094651035,0.011168359,0.025059434,0.2954734],"study_design_scores_gemma":[0.00008861774,0.00023634033,0.8506201,0.0054475926,0.0028314372,0.0017867403,0.0048068026,0.006609515,0.0008780104,0.014350201,0.112123385,0.00022106091],"about_ca_topic_score_codex":0.0033419,"about_ca_topic_score_gemma":0.003016964,"teacher_disagreement_score":0.97738326,"about_ca_system_score_codex":0.0025325504,"about_ca_system_score_gemma":0.0030470614,"threshold_uncertainty_score":0.11961019},"labels":[{"model":"gemma","categories":["bibliometrics"],"domain":null,"study_design":"observational","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"high"},{"model":"gpt","categories":["bibliometrics"],"domain":null,"study_design":"observational","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"medium"}],"label_agreement":"agree"},{"id":"W3134278412","doi":"10.1111/jdv.17218","title":"Nemolizumab is associated with a rapid improvement in atopic dermatitis signs and symptoms: subpopulation (EASI ≥ 16) analysis of randomized phase 2B study","year":2021,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Galderma","keywords":"Eczema Area and Severity Index; Medicine; Atopic dermatitis; Placebo; Post-hoc analysis; Clinical endpoint; Internal medicine; Randomized controlled trial; Adverse effect; Gastroenterology; Dermatology; Pathology","score_opus":0.015132827379515289,"score_gpt":0.2887306334420211,"score_spread":0.27359780606250583,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3134278412","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99469984,0.0019292238,0.0003101284,0.00020494482,0.00008017279,0.0010993292,0.0007744956,0.00005726752,0.00084462506],"genre_scores_gemma":[0.99184483,0.0010460508,0.0010221105,0.0004979407,0.00019894021,0.0017542371,0.0016038328,0.000032568525,0.001999505],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9990878,0.00054202473,0.000059916307,0.00012431119,0.00009598177,0.00008991963],"domain_scores_gemma":[0.99902856,0.00020676713,0.00029469904,0.00013936935,0.000075819924,0.000254734],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002831602,0.0010363306,0.0022062873,0.00027502805,0.00025099982,0.0008304303,0.00047999012,0.00088825467,0.0037852756],"category_scores_gemma":[0.0014815199,0.00047574862,0.0018279628,0.00024872308,0.0004027825,0.0005401992,0.00034202953,0.0015693511,0.000682247],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9376972,0.008341995,0.007494176,0.000473093,0.0026662834,0.00010466204,0.00006597232,0.00036503616,0.01781368,0.000053308857,0.0012065924,0.023717983],"study_design_scores_gemma":[0.7141525,0.21795568,0.060595833,0.00005504476,0.0020416058,0.00026081013,0.000041797168,0.0005781102,0.0021335073,0.000117353244,0.0020344483,0.00003340487],"about_ca_topic_score_codex":0.00026245145,"about_ca_topic_score_gemma":0.00082330295,"teacher_disagreement_score":0.0037852756,"about_ca_system_score_codex":0.0003930263,"about_ca_system_score_gemma":0.0006683242,"threshold_uncertainty_score":0.014975131},"labels":[],"label_agreement":null},{"id":"W3138957728","doi":"10.1111/jdv.17240","title":"Nondermatophyte mould onychomycosis","year":2021,"lang":"en","type":"review","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Nail Diseases and Treatments","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mediprobe Research (Canada); Public Health Ontario; University of Toronto","funders":"","keywords":"Posaconazole; Itraconazole; Voriconazole; Terbinafine; Dermatology; Medicine; Fluconazole; Antifungal; Amphotericin B","score_opus":0.05524000403766112,"score_gpt":0.35959467950382157,"score_spread":0.30435467546616046,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3138957728","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.762995,0.08157629,0.024601372,0.002772264,0.00081969774,0.00066995097,0.0017000525,0.0011370932,0.12372831],"genre_scores_gemma":[0.97589135,0.011875258,0.002846179,0.0005512358,0.000082821694,0.000027505386,0.0003842164,0.00003710613,0.008304201],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995432,0.00006146851,0.000054722816,0.00007217869,0.00018392388,0.00008449561],"domain_scores_gemma":[0.9997391,0.00004854838,0.00008941301,0.000024526023,0.000055081713,0.000043314816],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018533351,0.00047788207,0.0005390864,0.0010521284,0.00046314497,0.000720847,0.00020924032,0.00055030076,0.003600743],"category_scores_gemma":[0.0011191464,0.00020941134,0.0002808213,0.00071797817,0.0004627959,0.00061264454,0.00054765044,0.0006482858,0.001246819],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00054898614,0.0004089215,0.1262704,0.0025730045,0.00016069351,0.31380886,0.0006921992,0.00052582903,0.07487221,0.0034384439,0.016548922,0.46015155],"study_design_scores_gemma":[0.00005129037,0.00041178224,0.15411827,0.0011749339,0.000117930125,0.75578433,0.00085404597,0.0012334002,0.02317227,0.0024104272,0.06060974,0.000061674014],"about_ca_topic_score_codex":0.0024403424,"about_ca_topic_score_gemma":0.0021855377,"teacher_disagreement_score":0.003600743,"about_ca_system_score_codex":0.00030874458,"about_ca_system_score_gemma":0.0002829579,"threshold_uncertainty_score":0.0120456815},"labels":[],"label_agreement":null},{"id":"W3149413846","doi":"10.1111/jdv.17278","title":"Impact of baricitinib in combination with topical steroids on atopic dermatitis symptoms, quality of life and functioning in adult patients with moderate‐to‐severe atopic dermatitis from the BREEZE‐AD7 Phase 3 randomized trial","year":2021,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Innovaderm (Canada)","funders":"Cilag; LEO Pharma; Galderma; Incyte; Les Laboratories Pierre Fabre; Regeneron Pharmaceuticals; Sanofi; Eli Lilly and Company","keywords":"Medicine; Atopic dermatitis; Dermatology Life Quality Index; Placebo; Quality of life (healthcare); Eczema Area and Severity Index; Janus kinase inhibitor; Presenteeism; Internal medicine; Physical therapy; Dermatology; Absenteeism; Janus kinase","score_opus":0.01579163501841914,"score_gpt":0.2885635648316334,"score_spread":0.2727719298132143,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3149413846","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.989442,0.005648099,0.00017712523,0.00045342866,0.00026866642,0.001988487,0.000798476,0.000051384606,0.0011723178],"genre_scores_gemma":[0.9918029,0.0021506096,0.00049593113,0.0005475879,0.00024972134,0.0022949802,0.0011229983,0.000009976895,0.00132543],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99946874,0.00028009596,0.000040612358,0.00007669486,0.000046743917,0.00008710431],"domain_scores_gemma":[0.9992849,0.00019188855,0.00018793676,0.000043681004,0.000064480286,0.00022710052],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014209084,0.001258438,0.0033818653,0.0003238055,0.00041263463,0.001108735,0.0008326553,0.0015181069,0.0051863827],"category_scores_gemma":[0.0012771806,0.0005054484,0.0024898814,0.00043034722,0.0006951394,0.00061306916,0.0003586566,0.0020090023,0.00070877624],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9881054,0.0014043907,0.00086707197,0.0005927427,0.0010790308,0.000029446514,0.000024552151,0.00017362555,0.0011797623,0.000028065013,0.00044652453,0.006069315],"study_design_scores_gemma":[0.96473885,0.030698795,0.003043587,0.00003533496,0.00072877633,0.000038320086,0.000016226828,0.0002408421,0.00013810072,0.000041425636,0.00027010823,0.000009629659],"about_ca_topic_score_codex":0.0015427339,"about_ca_topic_score_gemma":0.0033991782,"teacher_disagreement_score":0.0051863827,"about_ca_system_score_codex":0.00086092605,"about_ca_system_score_gemma":0.001093169,"threshold_uncertainty_score":0.017350137},"labels":[],"label_agreement":null},{"id":"W3158553282","doi":"10.1111/jdv.17311","title":"Clinical manifestations and treatment outcomes in degos disease: a systematic review","year":2021,"lang":"en","type":"review","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Parvovirus B19 Infection Studies","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; Brock University; Memorial University of Newfoundland; University of Toronto; McMaster University","funders":"","keywords":"Medicine; Disease; Dermatology; Asymptomatic; Trunk; CINAHL; MEDLINE; Internal medicine","score_opus":0.12710267029456404,"score_gpt":0.45171693489945497,"score_spread":0.32461426460489096,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3158553282","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0017394334,0.9972095,0.000054216864,0.00011135479,0.000038987793,0.00010732974,0.0004963707,0.0000045044785,0.00023821682],"genre_scores_gemma":[0.017653402,0.9811441,0.00024843533,0.00024581348,0.000046552555,0.00021936868,0.00036822032,0.0000033774247,0.000070653376],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9964779,0.00090803,0.0016903294,0.00028268356,0.0005333031,0.00010782706],"domain_scores_gemma":[0.9863775,0.009334586,0.0029841189,0.00013385453,0.001004429,0.00016553783],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031467136,0.0009878037,0.0059541757,0.00789023,0.00041978594,0.0017286532,0.0013103512,0.0011442957,0.0036333844],"category_scores_gemma":[0.017164784,0.0006140756,0.005461582,0.010264212,0.00052754453,0.0015761685,0.0009113282,0.000725781,0.00021669484],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025086486,0.000018885929,0.0017618871,0.9569314,0.006871784,0.00010260559,0.00016868277,0.0000892895,0.00011043124,0.00011339373,0.0013934387,0.032187358],"study_design_scores_gemma":[0.00037397942,0.00034708314,0.013573111,0.87813973,0.08794271,0.0009625865,0.00042970138,0.00011867955,0.00017761928,0.00023965357,0.017651718,0.000043434513],"about_ca_topic_score_codex":0.0068537253,"about_ca_topic_score_gemma":0.017808776,"teacher_disagreement_score":0.00789023,"about_ca_system_score_codex":0.0023153487,"about_ca_system_score_gemma":0.0054885666,"threshold_uncertainty_score":0.016799092},"labels":[],"label_agreement":null},{"id":"W3162599840","doi":"10.1111/jdv.17345","title":"Interobserver variability in the classification of childhood maculopapular cutaneous mastocytosis","year":2021,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Mast cells and histamine","field":"Immunology and Microbiology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health; Quest University Canada; University of British Columbia","funders":"","keywords":"Medicine; Confidence interval; Cohen's kappa; Kappa; Dermatology; Pediatrics; Statistics; Internal medicine; Mathematics","score_opus":0.015825039208142454,"score_gpt":0.23129840404143603,"score_spread":0.21547336483329357,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3162599840","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9814998,0.001407448,0.013505773,0.000071629394,0.00016007992,0.00014217666,0.00014611114,0.000100195044,0.0029667113],"genre_scores_gemma":[0.9968953,0.00008169574,0.0026051314,0.00001979435,0.000027138905,0.000049441933,0.00013104375,0.000025142963,0.00016528463],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9543198,0.023937609,0.0052861907,0.004770552,0.010616908,0.0010690731],"domain_scores_gemma":[0.85813004,0.10177497,0.012872262,0.009718944,0.016233787,0.0012699954],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.041849285,0.00053610926,0.00063948514,0.0028932116,0.00065219187,0.0012281248,0.0009585087,0.0007693017,0.0006960877],"category_scores_gemma":[0.0855151,0.00035944182,0.00080818526,0.0011060048,0.0013874387,0.0009130073,0.0020574508,0.00064664596,0.00032401178],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00118561,0.00006260707,0.95706785,0.0001759236,0.00053831236,0.00023477282,0.0039333813,0.0012924412,0.0035392076,0.00022353436,0.000578026,0.031168295],"study_design_scores_gemma":[0.000037545375,0.00044010952,0.9792043,0.00013534748,0.0003234927,0.001356053,0.0019253303,0.009738446,0.0043940414,0.00080026366,0.001573963,0.000071056566],"about_ca_topic_score_codex":0.0015291163,"about_ca_topic_score_gemma":0.0023800328,"teacher_disagreement_score":0.041849285,"about_ca_system_score_codex":0.0007102055,"about_ca_system_score_gemma":0.0003653275,"threshold_uncertainty_score":0.22132283},"labels":[],"label_agreement":null},{"id":"W3165311349","doi":"10.1111/jdv.17432","title":"Adult skin acute stress responses to short‐term environmental and internal aggression from exposome factors","year":2021,"lang":"en","type":"review","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Skin Protection and Aging","field":"Medicine","cited_by":106,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Windsor Clinical Research; Western University","funders":"","keywords":"Medicine; Immune system; Integumentary system; Exposome; Acne; Stressor; Skin Aging; Dermatology; Immunology; Physiology; Pathology","score_opus":0.03345377109606145,"score_gpt":0.3299414986517157,"score_spread":0.2964877275556542,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3165311349","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.40753385,0.51795626,0.017297385,0.0031646932,0.002471013,0.00051224855,0.0031676237,0.0005723555,0.047324527],"genre_scores_gemma":[0.7020532,0.2597874,0.0061443993,0.0021946044,0.0010738063,0.00036325044,0.0024666153,0.000069217596,0.025847519],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9996057,0.000093714945,0.000037811213,0.00007063816,0.0001171981,0.000074889984],"domain_scores_gemma":[0.99960095,0.00007633109,0.00012985767,0.000025940246,0.00010543499,0.0000613983],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038316776,0.0005846897,0.00052474835,0.00071350596,0.00046743365,0.0010489069,0.00030901906,0.00083826337,0.0051573575],"category_scores_gemma":[0.0004323872,0.00020703847,0.00079983857,0.00039582865,0.0005067084,0.00064338505,0.001042515,0.001067287,0.0010189406],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023895022,0.0004228943,0.038608696,0.017144233,0.00091357366,0.007316166,0.0023734113,0.001028831,0.47587872,0.006757165,0.018002205,0.42916465],"study_design_scores_gemma":[0.0000955747,0.0046002143,0.37605226,0.005548626,0.00096543645,0.029175812,0.0044002933,0.00097314897,0.14580707,0.0071436516,0.424954,0.00028384497],"about_ca_topic_score_codex":0.000721306,"about_ca_topic_score_gemma":0.0010460404,"teacher_disagreement_score":0.0051573575,"about_ca_system_score_codex":0.0004270294,"about_ca_system_score_gemma":0.00033750865,"threshold_uncertainty_score":0.017253041},"labels":[],"label_agreement":null},{"id":"W3165612536","doi":"10.1111/jdv.17269","title":"2021 European Guideline on the management of proctitis, proctocolitis and enteritis caused by sexually transmissible pathogens","year":2021,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Reproductive tract infections research","field":"Immunology and Microbiology","cited_by":81,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"Nabriva Therapeutics; National Institute for Health and Care Research; Gilead Sciences; Amsterdam University Medical Centers; Health Technology Assessment Programme; AstraZeneca","keywords":"Medicine; Proctitis; Guideline; Enteritis; Dermatology; Intensive care medicine; Internal medicine; Pathology; Disease; Ulcerative colitis","score_opus":0.01976258311921531,"score_gpt":0.28126053684441005,"score_spread":0.26149795372519474,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3165612536","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0020026485,0.4015117,0.010151576,0.13757038,0.020455476,0.005227114,0.027695598,0.0017568553,0.3936287],"genre_scores_gemma":[0.01758659,0.4285531,0.057955608,0.20268372,0.008580158,0.010232212,0.076732524,0.0009166665,0.19675949],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99681133,0.00088528567,0.00058928557,0.00015222025,0.0013047763,0.00025717207],"domain_scores_gemma":[0.99487525,0.0012710862,0.0005560346,0.00008717933,0.0029569385,0.00025363796],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022199461,0.00093542464,0.0017930238,0.0023863553,0.000577718,0.0018530849,0.0027210007,0.0058722296,0.025158625],"category_scores_gemma":[0.009497849,0.0005786463,0.0026628166,0.0015772779,0.00052275,0.0012107926,0.0012013768,0.0036958277,0.017863229],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000053078777,0.000079343095,0.00021465706,0.00267423,0.000028783286,0.00024738113,0.00006643844,0.00021885904,0.00025258336,0.0020603393,0.8680643,0.12604004],"study_design_scores_gemma":[0.00013756126,0.00006738758,0.0010092147,0.010858449,0.00006635093,0.0006876168,0.000039408653,0.00016997989,0.000092025264,0.0010824242,0.98576874,0.00002089683],"about_ca_topic_score_codex":0.023161082,"about_ca_topic_score_gemma":0.030970927,"teacher_disagreement_score":0.025158625,"about_ca_system_score_codex":0.0028008523,"about_ca_system_score_gemma":0.0073134187,"threshold_uncertainty_score":0.084163964},"labels":[],"label_agreement":null},{"id":"W3174239144","doi":"10.1111/jdv.17486","title":"Three‐year efficacy and safety of certolizumab pegol for the treatment of plaque psoriasis: results from the randomized phase 3 CIMPACT trial","year":2021,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; University of Toronto","funders":"","keywords":"Certolizumab pegol; Medicine; Placebo; Randomized controlled trial; Etanercept; Internal medicine; Plaque psoriasis; Open label; Surgery; Psoriasis; Dermatology; Tumor necrosis factor alpha","score_opus":0.033942147230820445,"score_gpt":0.2879030609756602,"score_spread":0.25396091374483976,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3174239144","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9798733,0.010250108,0.0007919208,0.0011314786,0.000455369,0.0025215095,0.0023551497,0.00011385735,0.002507352],"genre_scores_gemma":[0.98575735,0.0036288388,0.0009775149,0.001362484,0.0005625228,0.0033285634,0.0029018337,0.000040424307,0.0014403062],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9982534,0.0010106722,0.00011681017,0.00021834984,0.00019709811,0.0002036116],"domain_scores_gemma":[0.9973911,0.0007173955,0.00087839866,0.00029873528,0.00017233631,0.0005420179],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005637494,0.0014870033,0.0022991989,0.0003202424,0.00056449336,0.001608448,0.0008822175,0.0018621907,0.004373636],"category_scores_gemma":[0.004105718,0.0005360071,0.0033961397,0.00046527403,0.0009910672,0.0010393783,0.0004718301,0.0038232887,0.00077099376],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9798448,0.0026764404,0.0017645961,0.00039882818,0.0017744963,0.000040767078,0.000047869446,0.00029732555,0.0011918944,0.00007094116,0.0011142214,0.010777834],"study_design_scores_gemma":[0.95609725,0.032985296,0.00776729,0.00005551119,0.0015027983,0.000064497726,0.000022566677,0.00030009236,0.0003741865,0.00016215965,0.0006496269,0.000018758885],"about_ca_topic_score_codex":0.0009854584,"about_ca_topic_score_gemma":0.0014081689,"teacher_disagreement_score":0.005637494,"about_ca_system_score_codex":0.0009430916,"about_ca_system_score_gemma":0.0015140293,"threshold_uncertainty_score":0.029814303},"labels":[],"label_agreement":null},{"id":"W3184565124","doi":"10.1111/jdv.17545","title":"Skin conditions among 20th century politicians and world leaders","year":2021,"lang":"en","type":"letter","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Diversity and Career in Medicine","field":"Social Sciences","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Population; Power (physics); Medicine; Politics; Skin cancer; Public health; Passions; Mandate; Political science; History; Law; Cancer; Pathology; Environmental health; Art","score_opus":0.03153895287660562,"score_gpt":0.2883141085767513,"score_spread":0.2567751557001457,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3184565124","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7658106,0.16167054,0.000639352,0.03301444,0.019797524,0.0001948772,0.001123238,0.0000671656,0.017682338],"genre_scores_gemma":[0.9118574,0.0542486,0.00053770473,0.0080932705,0.021934386,0.00007299012,0.00043873084,0.000019588808,0.002797244],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995328,0.00014261484,0.00006890211,0.00007402113,0.00009251424,0.00008920048],"domain_scores_gemma":[0.9970188,0.0014234069,0.00090971496,0.00006849338,0.00027964107,0.00029998217],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00064192765,0.0003865348,0.00038837307,0.0024564373,0.0009227471,0.00094549876,0.00042392436,0.0012879738,0.0041327197],"category_scores_gemma":[0.0051216367,0.00021299091,0.00021675765,0.0018588506,0.0007141594,0.0012211977,0.00048530224,0.0007196513,0.0005321509],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00053365354,0.00032809642,0.51448816,0.0023764584,0.0002213329,0.15479486,0.0062383814,0.00017600451,0.0013332688,0.0015375582,0.20394933,0.11402279],"study_design_scores_gemma":[0.00008844148,0.00041214406,0.48604494,0.0028151104,0.0002602431,0.346398,0.011376904,0.00069797557,0.00083420944,0.000870594,0.15010302,0.00009841634],"about_ca_topic_score_codex":0.0010311439,"about_ca_topic_score_gemma":0.0018961807,"teacher_disagreement_score":0.0041327197,"about_ca_system_score_codex":0.0003003929,"about_ca_system_score_gemma":0.00025104362,"threshold_uncertainty_score":0.013825297},"labels":[],"label_agreement":null},{"id":"W3186228135","doi":"10.1111/jdv.17446","title":"Pioneers in Dermatology and Venereology: an interview with Professor Ricardo Luis Galimberti","year":2021,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Medicine and Dermatology Studies History","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Venereology; Dermatology; Medicine; Family medicine","score_opus":0.02883490683493317,"score_gpt":0.2879425491683935,"score_spread":0.25910764233346034,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3186228135","genre_codex":"commentary","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.01002955,0.09518701,0.00031496328,0.8684867,0.016165303,0.00007805946,0.000046697794,0.000043688615,0.009647969],"genre_scores_gemma":[0.12113779,0.20167452,0.001806249,0.6124114,0.026413802,0.00048188417,0.00014646357,0.0001511872,0.035776757],"study_design_codex":"not_applicable","study_design_gemma":"qualitative","domain_scores_codex":[0.9944171,0.0033197924,0.00013273195,0.00037636442,0.00086070155,0.00089321274],"domain_scores_gemma":[0.99287206,0.0023565867,0.000428819,0.000068909474,0.0008413222,0.003432319],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00821066,0.00090069417,0.0012866625,0.0013131158,0.0058028894,0.0048391894,0.001614544,0.005184548,0.003655384],"category_scores_gemma":[0.01143853,0.00066016364,0.0005639247,0.0014505258,0.0045882175,0.0055354377,0.0041966527,0.016206717,0.0014187268],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005079996,0.00023326723,0.0022058608,0.00061848667,0.000014208523,0.002358547,0.06990874,0.0000906607,0.0003852813,0.0068239854,0.88368464,0.03362553],"study_design_scores_gemma":[0.000030214098,0.00011776169,0.0024582192,0.0014390283,0.000008379652,0.004564064,0.09486339,0.000097901146,0.00008779711,0.0010734115,0.89520234,0.00005746432],"about_ca_topic_score_codex":0.008576212,"about_ca_topic_score_gemma":0.012797801,"teacher_disagreement_score":0.008576212,"about_ca_system_score_codex":0.005735231,"about_ca_system_score_gemma":0.0078189885,"threshold_uncertainty_score":0.04342264},"labels":[],"label_agreement":null},{"id":"W3189309485","doi":"10.1111/jdv.17586","title":"Air pollution and meteorological factors are associated with dermographism: a population‐based study in college students","year":2021,"lang":"en","type":"letter","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Urticaria and Related Conditions","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health","funders":"Project 211","keywords":"Psoriasis; Medicine; Skin cancer; Research center; Health science; Population; Dermatology; Dermatological diseases; University hospital; Center (category theory); Cancer; Family medicine; Medical education; Pathology; Environmental health; Internal medicine","score_opus":0.02409483357222376,"score_gpt":0.27426616454754504,"score_spread":0.2501713309753213,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3189309485","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99686205,0.00017823276,0.00006519722,0.0012299344,0.00008596551,0.0000127933135,0.00022900365,0.000004875013,0.0013319908],"genre_scores_gemma":[0.997849,0.0001441987,0.0000446006,0.0006824566,0.00013113409,0.000010354006,0.00009705484,0.0000023975483,0.0010388114],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996877,0.000089191664,0.000043353626,0.000059192254,0.000058080375,0.00006249373],"domain_scores_gemma":[0.99897826,0.000269731,0.0002430615,0.00007297292,0.0001533214,0.00028273417],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002787569,0.00027719722,0.00041191504,0.0005991745,0.000900197,0.00075179874,0.0002953297,0.0016904274,0.0039025855],"category_scores_gemma":[0.0017320234,0.00045863367,0.0005209402,0.001064379,0.00029754257,0.0005187849,0.00029168135,0.001442361,0.00056919263],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008530519,0.00018682577,0.9968815,0.000011515246,0.00003867498,0.0007581971,0.00022665999,0.0000070418537,0.00030613563,0.000010762662,0.0003896915,0.0010978654],"study_design_scores_gemma":[0.000011462126,0.00015445711,0.9976146,0.000007358491,0.00003740248,0.0010948953,0.0005933416,0.00007719384,0.000042910833,0.000020225074,0.0003408116,0.0000052553364],"about_ca_topic_score_codex":0.0100422,"about_ca_topic_score_gemma":0.011177542,"teacher_disagreement_score":0.0100422,"about_ca_system_score_codex":0.00024394515,"about_ca_system_score_gemma":0.0003342875,"threshold_uncertainty_score":0.019967496},"labels":[],"label_agreement":null},{"id":"W3192610156","doi":"10.1111/jdv.17598","title":"Real‐world effectiveness of adalimumab in patients with moderate‐to‐severe hidradenitis suppurativa: the 1‐year SOLACE study","year":2021,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Hidradenitis Suppurativa and Treatments","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"ABB (Canada); Barrie Urology Group; University of Alberta; SKiN Health; University of Manitoba; Memorial University of Newfoundland; Guenther Dermatology Research Centre; Probity Medical Research; Nexus Clinical Research (Canada)","funders":"AbbVie","keywords":"Hidradenitis suppurativa; Medicine; Adalimumab; Post-hoc analysis; Dermatology; Severity of illness; Odds ratio; Internal medicine; Abscess; Disease; Surgery","score_opus":0.011227927289668323,"score_gpt":0.2647186675176494,"score_spread":0.25349074022798107,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3192610156","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99591666,0.0019194247,0.00008921405,0.00015292002,0.000029656663,0.00035739076,0.0007413728,0.000009070894,0.0007842598],"genre_scores_gemma":[0.9962148,0.0007128094,0.00039700154,0.00025483157,0.000086269385,0.00033277372,0.0014430309,0.000004291534,0.0005542932],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9981179,0.0009027822,0.0001255325,0.0002407792,0.00042397596,0.00018910118],"domain_scores_gemma":[0.99577147,0.00089818524,0.0011825077,0.0003974466,0.00047610587,0.0012742761],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0051248935,0.00085378485,0.0017662309,0.00036550846,0.00063996523,0.0010380297,0.0007259872,0.0010410254,0.00204914],"category_scores_gemma":[0.0034724937,0.0002867625,0.0025380203,0.0005627737,0.0007211507,0.00081454474,0.000687229,0.0013316225,0.00029796074],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7088769,0.024567662,0.15044169,0.0017092747,0.0048089055,0.0004111773,0.0013344346,0.0026765375,0.006083254,0.00026630558,0.003421072,0.09540279],"study_design_scores_gemma":[0.20557722,0.4019158,0.3765227,0.00036606396,0.0023940415,0.0006039367,0.0007669306,0.0029905648,0.0023827248,0.0002055631,0.0060948352,0.00017967104],"about_ca_topic_score_codex":0.008967007,"about_ca_topic_score_gemma":0.017380476,"teacher_disagreement_score":0.008967007,"about_ca_system_score_codex":0.0027509308,"about_ca_system_score_gemma":0.002986828,"threshold_uncertainty_score":0.027103364},"labels":[],"label_agreement":null},{"id":"W3199135985","doi":"10.1111/jdv.17704","title":"Improvement in symptoms of anxiety and depression in patients with atopic dermatitis after treatment with baricitinib","year":2021,"lang":"en","type":"letter","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Windsor Clinical Research; Western University","funders":"Lundbeckfonden; Eli Lilly and Company","keywords":"Medicine; Atopic dermatitis; Depression (economics); Anxiety; Dermatology; Psychiatry","score_opus":0.006498637606879758,"score_gpt":0.22140261698297303,"score_spread":0.21490397937609326,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3199135985","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.42939213,0.02756771,0.001127492,0.420646,0.0073726214,0.00020702796,0.0012088169,0.00030896332,0.112169236],"genre_scores_gemma":[0.9222803,0.0049149566,0.00040758427,0.057994165,0.005007576,0.000050677758,0.00026235156,0.000021313446,0.0090611745],"study_design_codex":"not_applicable","study_design_gemma":"case_report","domain_scores_codex":[0.9995402,0.00017626607,0.000037019363,0.00003925709,0.00011538951,0.00009190455],"domain_scores_gemma":[0.99895537,0.0005849668,0.00013011572,0.000047281177,0.00014576188,0.00013644909],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00063000317,0.00013216645,0.00036017637,0.00023548491,0.0004908644,0.00045703244,0.00021306891,0.0017076383,0.003027701],"category_scores_gemma":[0.0040822574,0.00006969861,0.0002846197,0.00039397518,0.0002826753,0.00035040133,0.000136805,0.0014159583,0.0008490669],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036554134,0.0004948399,0.17290895,0.00052009546,0.00020015615,0.15440412,0.00095910166,0.0003689394,0.004799546,0.0027856561,0.38734147,0.27156165],"study_design_scores_gemma":[0.0010990502,0.0015575208,0.4932051,0.0011502272,0.00032961945,0.31695932,0.001861678,0.0026665248,0.0017129512,0.0066501996,0.17268027,0.00012741468],"about_ca_topic_score_codex":0.0020182242,"about_ca_topic_score_gemma":0.004300619,"teacher_disagreement_score":0.003027701,"about_ca_system_score_codex":0.0006880669,"about_ca_system_score_gemma":0.00037800908,"threshold_uncertainty_score":0.010128677},"labels":[],"label_agreement":null},{"id":"W3199392290","doi":"10.1111/jdv.17600","title":"An integrated approach is recommended in bullous pemphigoid","year":2021,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Autoimmune Bullous Skin Diseases","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Neurocognitive; Bullous pemphigoid; Montreal Cognitive Assessment; Comorbidity; Cognitive impairment; Disease; Dermatology; Cognition; Psychiatry; Internal medicine; Immunology","score_opus":0.019831910700109315,"score_gpt":0.2837422320570245,"score_spread":0.26391032135691517,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3199392290","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0006638767,0.012538392,0.00055456045,0.89795035,0.08517133,0.00005881902,0.00007353556,0.00015219537,0.002836917],"genre_scores_gemma":[0.0073093763,0.008559522,0.0015026528,0.7849385,0.19287172,0.00013527113,0.000069605514,0.000052078547,0.00456118],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9937046,0.0027642113,0.0011932155,0.0006336572,0.001218922,0.00048533521],"domain_scores_gemma":[0.9686404,0.015506817,0.0013288272,0.0011865413,0.010165609,0.0031718477],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0050015226,0.0010192037,0.0021523025,0.0015984282,0.0023433685,0.0031956865,0.0050906427,0.0476557,0.008875909],"category_scores_gemma":[0.03985939,0.0008205773,0.0028039159,0.00074346515,0.0030352194,0.008105189,0.0022466967,0.03809001,0.0062162024],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013473282,0.00006605231,0.00072958507,0.00075056794,0.000049131802,0.0031995366,0.00035284096,0.00009126743,0.0003303831,0.0014257851,0.9648888,0.02798124],"study_design_scores_gemma":[0.00016303458,0.000107675456,0.0030217688,0.003874642,0.000092309245,0.00731425,0.001174616,0.0004353231,0.00030464417,0.0062387884,0.97711915,0.00015378882],"about_ca_topic_score_codex":0.006242853,"about_ca_topic_score_gemma":0.009952658,"teacher_disagreement_score":0.0476557,"about_ca_system_score_codex":0.002518932,"about_ca_system_score_gemma":0.0034644424,"threshold_uncertainty_score":0.029692888},"labels":[],"label_agreement":null},{"id":"W3201090734","doi":"10.1111/jdv.17673","title":"Quality of life and patient‐perceived symptoms in patients with psoriasis undergoing proactive or reactive management with the fixed‐dose combination Cal/BD foam: A <i>post‐hoc</i> analysis of PSO‐LONG","year":2021,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"LEO Pharma","keywords":"Medicine; Dermatology Life Quality Index; Betamethasone dipropionate; Psoriasis; Post-hoc analysis; Quality of life (healthcare); Psychosocial; Post hoc; Randomized controlled trial; Physical therapy; Fixed-dose combination; Internal medicine; Dermatology","score_opus":0.013484148588341011,"score_gpt":0.23798337783838674,"score_spread":0.22449922925004573,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3201090734","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9987627,0.0005324815,0.00013254615,0.00003012671,0.000018092247,0.00015472987,0.00012585653,0.0000058577557,0.00023761511],"genre_scores_gemma":[0.99883324,0.00014857214,0.00021135053,0.00005795419,0.00003621966,0.0003168103,0.00022125278,0.0000020343862,0.00017262468],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9987984,0.0006733377,0.00009913838,0.00016108005,0.00012468403,0.00014337282],"domain_scores_gemma":[0.99710935,0.0015058046,0.0006564188,0.00016283081,0.00017161481,0.000394053],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0032111653,0.00058170594,0.001546114,0.00027572276,0.00021149419,0.0006102613,0.0004169301,0.0006527776,0.0026797939],"category_scores_gemma":[0.0026316664,0.00032871868,0.0025354861,0.0002829239,0.0004947586,0.0007366173,0.00036378563,0.0013599603,0.00019066622],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.93105304,0.007159012,0.033462077,0.00045140382,0.0032720019,0.00004043821,0.00011603661,0.0008590609,0.003187225,0.0000457707,0.00033381657,0.020020206],"study_design_scores_gemma":[0.22299077,0.5566554,0.20791756,0.00006295279,0.005433382,0.00012314631,0.00017370936,0.003238453,0.002395113,0.00015307474,0.0007884608,0.0000679379],"about_ca_topic_score_codex":0.00034848682,"about_ca_topic_score_gemma":0.00042775538,"teacher_disagreement_score":0.0032111653,"about_ca_system_score_codex":0.00040830555,"about_ca_system_score_gemma":0.00042448015,"threshold_uncertainty_score":0.016982496},"labels":[],"label_agreement":null},{"id":"W3203894372","doi":"10.1111/jdv.17719","title":"Pfizer/BioNTech‐associated perniosis in two young adults with re‐challenge evidence","year":2021,"lang":"en","type":"letter","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Dermatological and COVID-19 studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; Sunnybrook Hospital; University of Toronto","funders":"","keywords":"Medicine; Erythema; Dermatology; Natural history; Surgery; Internal medicine","score_opus":0.050713411604871736,"score_gpt":0.3046223948186244,"score_spread":0.25390898321375266,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3203894372","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9706072,0.0025785328,0.00073160115,0.005177237,0.00034016563,0.00018515908,0.00020653564,0.000059858645,0.020113632],"genre_scores_gemma":[0.9946243,0.0008827202,0.00029353783,0.0018058344,0.000314903,0.000020125566,0.00010035576,0.0000123185255,0.0019458248],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9995796,0.000054952045,0.00004432642,0.000071012524,0.000090846246,0.00015934407],"domain_scores_gemma":[0.9989079,0.00020068603,0.00023223151,0.000047047295,0.00012467391,0.00048749478],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038937628,0.0005561284,0.00038019867,0.0013157543,0.0014796681,0.0009846663,0.0003722716,0.0020649012,0.0045731394],"category_scores_gemma":[0.0021356104,0.0003881266,0.00043223434,0.0005325622,0.00048975373,0.0012981342,0.000783519,0.001691362,0.0010148654],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013433791,0.00043790345,0.21741037,0.00006655583,0.00001784,0.7677601,0.0013585775,0.000039620936,0.00078036747,0.0005784586,0.0033957881,0.008020069],"study_design_scores_gemma":[0.000023025845,0.0003664834,0.070815,0.00009989113,0.000018697008,0.92262614,0.0012966635,0.00025515148,0.00021879675,0.00022447207,0.0040373295,0.000018388257],"about_ca_topic_score_codex":0.0038669012,"about_ca_topic_score_gemma":0.003778959,"teacher_disagreement_score":0.0045731394,"about_ca_system_score_codex":0.0006497168,"about_ca_system_score_gemma":0.0006911607,"threshold_uncertainty_score":0.015298665},"labels":[],"label_agreement":null},{"id":"W3207234169","doi":"10.1111/jdv.17743","title":"Sensitivity of clinician‐assessed efficacy outcome measurement instruments in trials of topical therapies for atopic dermatitis: a systematic review and meta‐analysis","year":2021,"lang":"en","type":"review","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Innovaderm (Canada)","funders":"","keywords":"Medicine; Atopic dermatitis; Meta-analysis; SCORAD; Confidence interval; Clinical trial; Internal medicine; Dermatology; Disease; Dermatology Life Quality Index","score_opus":0.22747187320261705,"score_gpt":0.4322029028719589,"score_spread":0.20473102966934184,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3207234169","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008913095,0.98564744,0.0025553873,0.00040372164,0.00040335528,0.0007261444,0.00080527895,0.00006316467,0.0004823368],"genre_scores_gemma":[0.598538,0.3829977,0.008036644,0.002259662,0.0007412899,0.0050061652,0.0016945186,0.00017265668,0.00055334275],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.8397766,0.098608576,0.03989359,0.00962265,0.010731833,0.0013667697],"domain_scores_gemma":[0.7061736,0.2535841,0.02500305,0.0069214017,0.007432441,0.0008854431],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.12937826,0.0047587827,0.029893586,0.009244618,0.000963055,0.0066949218,0.0034960269,0.0040051695,0.0022614498],"category_scores_gemma":[0.23754035,0.0030811876,0.07442144,0.009722616,0.0023453427,0.003978128,0.0033500143,0.0037043865,0.00031293518],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002555398,0.0000116760575,0.0043000896,0.10571235,0.882062,0.00007939053,0.000064685955,0.00047914378,0.0001067184,0.00010177985,0.00021740321,0.004309359],"study_design_scores_gemma":[0.0008974049,0.00018958634,0.0038487206,0.008379665,0.9850133,0.000085660664,0.00003620731,0.0002468836,0.0001475703,0.00034919282,0.00077559304,0.00003021967],"about_ca_topic_score_codex":0.004560874,"about_ca_topic_score_gemma":0.007420726,"teacher_disagreement_score":0.12937826,"about_ca_system_score_codex":0.004311469,"about_ca_system_score_gemma":0.003524527,"threshold_uncertainty_score":0.6842258},"labels":[],"label_agreement":null},{"id":"W3212919949","doi":"10.1111/jdv.17815","title":"Association of vitiligo with high‐frequency sensorineural hearing loss: a systematic review and meta‐analysis","year":2021,"lang":"en","type":"review","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"melanin and skin pigmentation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Vitiligo; Meta-analysis; Audiology; Sensorineural hearing loss; Hearing loss; Cohort study; Systematic review; MEDLINE; Cohort; Internal medicine; Dermatology","score_opus":0.03120085035554712,"score_gpt":0.30687392168274674,"score_spread":0.27567307132719965,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3212919949","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.005297722,0.99304503,0.00046286674,0.00018364273,0.00010629206,0.00021959252,0.00047198244,0.000019590272,0.00019319405],"genre_scores_gemma":[0.16459101,0.8295426,0.00220752,0.0008532405,0.0002372798,0.0011334852,0.0009859421,0.00002805218,0.00042094025],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99517137,0.0019283077,0.001533581,0.0005867678,0.0005640029,0.00021594713],"domain_scores_gemma":[0.98922044,0.007642178,0.0017049758,0.00036321912,0.0009177424,0.00015154255],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008092267,0.0020790545,0.012209829,0.0046584895,0.0005726836,0.0025885196,0.0015900672,0.0018138161,0.0032629503],"category_scores_gemma":[0.019770201,0.0011871855,0.025253331,0.0063054156,0.00052975083,0.001268507,0.001205523,0.0013789698,0.00027160998],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012276038,0.00003090906,0.0064686784,0.4805645,0.49789253,0.00019815014,0.00010277634,0.00044929062,0.00029213016,0.00013676571,0.00078999926,0.011846589],"study_design_scores_gemma":[0.00031573488,0.0001446796,0.006069034,0.027491419,0.9634249,0.00014498857,0.000048547543,0.00015915849,0.00013059947,0.00017484976,0.0018729174,0.000023162094],"about_ca_topic_score_codex":0.0053914855,"about_ca_topic_score_gemma":0.012189589,"teacher_disagreement_score":0.012209829,"about_ca_system_score_codex":0.0018199128,"about_ca_system_score_gemma":0.0028945107,"threshold_uncertainty_score":0.042796493},"labels":[],"label_agreement":null},{"id":"W3215006483","doi":"10.1111/jdv.17836","title":"Ixekizumab provides persistent improvements in health‐related quality of life and the sexual impact associated with moderate‐to‐severe genital psoriasis in adult patients during a 52‐week, randomised, placebo‐controlled, phase 3 clinical trial","year":2021,"lang":"en","type":"letter","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Guenther Dermatology Research Centre","funders":"Eli Lilly and Company","keywords":"Ixekizumab; Medicine; Psoriasis; Placebo; Sex organ; Quality of life (healthcare); Dosing; Internal medicine; Dermatology Life Quality Index; Secukinumab; Dermatology; Alternative medicine; Psoriatic arthritis","score_opus":0.03883039974010785,"score_gpt":0.3024456140539665,"score_spread":0.2636152143138587,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3215006483","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97434324,0.013154052,0.00051697396,0.0015225149,0.0009899035,0.0034128923,0.0022464572,0.00015469725,0.0036592474],"genre_scores_gemma":[0.9864389,0.0042357896,0.00075609045,0.0015455165,0.00085852895,0.0019417943,0.0011206719,0.00002252237,0.0030801997],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99942017,0.00027979215,0.000055263474,0.000073203686,0.00006617364,0.00010544589],"domain_scores_gemma":[0.99909925,0.00028262878,0.0002194266,0.00006124377,0.00007384846,0.00026364182],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022890782,0.0009890081,0.0021126021,0.00023770053,0.00036737885,0.0011642044,0.00068126654,0.0012882556,0.008173065],"category_scores_gemma":[0.0017882533,0.00043985195,0.0019223756,0.0003207866,0.00065612013,0.0007963686,0.0002824568,0.0029311392,0.0008923524],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.949396,0.00892828,0.0014916356,0.0012118916,0.0014808049,0.00008241983,0.00008121969,0.00025145223,0.004697415,0.00008637211,0.0024938672,0.029798701],"study_design_scores_gemma":[0.8866833,0.1019601,0.007799836,0.00008390737,0.00060996396,0.00009634304,0.00003263135,0.00035719122,0.0006983481,0.00009665363,0.0015636147,0.00001808472],"about_ca_topic_score_codex":0.00035002688,"about_ca_topic_score_gemma":0.00085830054,"teacher_disagreement_score":0.008173065,"about_ca_system_score_codex":0.0003676097,"about_ca_system_score_gemma":0.0005531689,"threshold_uncertainty_score":0.027341664},"labels":[],"label_agreement":null},{"id":"W4205482295","doi":"10.1111/jdv.17931","title":"Effects of risankizumab on nail psoriasis in patients with active psoriatic arthritis: results from KEEPsAKE 1","year":2022,"lang":"en","type":"letter","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research","funders":"AbbVie; Pfizer; Eli Lilly and Company","keywords":"Medicine; Clinical trial; Data sharing; Psoriasis; Medical physics; Alternative medicine; Dermatology; Pathology","score_opus":0.007843113539990695,"score_gpt":0.2210223989424718,"score_spread":0.2131792854024811,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205482295","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.20855181,0.05136306,0.0006257792,0.6479064,0.01491946,0.00060940435,0.0073064254,0.00013848006,0.06857907],"genre_scores_gemma":[0.60702443,0.028185656,0.002854012,0.30722967,0.019571071,0.0006559264,0.005297318,0.00009856209,0.029083427],"study_design_codex":"not_applicable","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99872667,0.00066376885,0.00015359886,0.000075694865,0.00026511066,0.00011516668],"domain_scores_gemma":[0.9953976,0.0030896142,0.00029988107,0.00017156397,0.00068194553,0.00035942855],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021876644,0.000229663,0.0007675345,0.00024974465,0.0004647357,0.0008558766,0.0002683559,0.0020796997,0.0038993226],"category_scores_gemma":[0.007950384,0.00013760923,0.0007760412,0.00049663393,0.00025692486,0.0004550289,0.00022293058,0.0019105269,0.0015001326],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.030503476,0.0011732902,0.029883673,0.001367697,0.0007866133,0.007277687,0.0005418431,0.00035415427,0.0029848746,0.0012496726,0.5779035,0.34597352],"study_design_scores_gemma":[0.026368607,0.021179795,0.20730844,0.003625214,0.0029760494,0.01729584,0.0014234318,0.0016614693,0.004869555,0.0062276507,0.7068755,0.00018840266],"about_ca_topic_score_codex":0.0024012874,"about_ca_topic_score_gemma":0.004502627,"teacher_disagreement_score":0.0038993226,"about_ca_system_score_codex":0.0009644447,"about_ca_system_score_gemma":0.0010739911,"threshold_uncertainty_score":0.013044596},"labels":[],"label_agreement":null},{"id":"W4205966205","doi":"10.1111/jdv.17932","title":"Skin cancer risk among testicular germ‐cell cancer survivors: a systematic review and meta‐analysis","year":2022,"lang":"en","type":"review","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Testicular diseases and treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Cancer Institute","keywords":"Medicine; Meta-analysis; Cancer; Testicular cancer; Skin cancer; Population; Incidence (geometry); Oncology; Relative risk; Internal medicine; Gynecology; Confidence interval; Environmental health","score_opus":0.04424716704243978,"score_gpt":0.3411296734601831,"score_spread":0.2968825064177433,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205966205","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.002115686,0.99695075,0.00019276618,0.000088281384,0.00005969152,0.00014414145,0.0002930083,0.000010270048,0.0001453845],"genre_scores_gemma":[0.047562495,0.95008045,0.00080618006,0.0003351105,0.00009518323,0.00049105904,0.0004438022,0.000009842309,0.00017577475],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99661714,0.0013681051,0.0010521978,0.0003616333,0.00045613025,0.00014484643],"domain_scores_gemma":[0.9916932,0.0061439946,0.0011049781,0.00018577653,0.0007539871,0.00011807031],"candidate_categories":["metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.005727435,0.0019695996,0.012261997,0.0053508435,0.0005551602,0.0022760862,0.0014622123,0.0016031937,0.0037759908],"category_scores_gemma":[0.016203487,0.0010812655,0.019229421,0.0065351804,0.0004176423,0.0012402266,0.0010839206,0.001270487,0.00028303315],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008442325,0.00002426857,0.0026915427,0.7405695,0.23538817,0.00015096091,0.00009689188,0.00031193512,0.00021892847,0.00012647646,0.0008826542,0.01869456],"study_design_scores_gemma":[0.0003878495,0.00022254148,0.005309719,0.09321976,0.8958469,0.00021697352,0.00008212383,0.00016436166,0.00017495173,0.00020233396,0.004141881,0.000030675375],"about_ca_topic_score_codex":0.006348898,"about_ca_topic_score_gemma":0.016062016,"teacher_disagreement_score":0.987738,"about_ca_system_score_codex":0.0019185425,"about_ca_system_score_gemma":0.0032928216,"threshold_uncertainty_score":0.030289948},"labels":[],"label_agreement":null},{"id":"W4211089583","doi":"10.1111/j.1468-3083.2004.00693.x","title":"Seborrheic dermatitis","year":2003,"lang":"en","type":"review","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Nail Diseases and Treatments","field":"Medicine","cited_by":235,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mediprobe Research (Canada); Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Seborrheic dermatitis; Dermatology","score_opus":0.042133043299886534,"score_gpt":0.3401090581758407,"score_spread":0.29797601487595415,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4211089583","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0006330837,0.9876044,0.00017863805,0.00050303416,0.0015236671,0.000012717936,0.000037902504,0.00003728631,0.009469294],"genre_scores_gemma":[0.0106098745,0.9728378,0.00027005543,0.0010904594,0.0016394091,0.000018157249,0.00015122394,0.00000878152,0.013374107],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99980885,0.000027940077,0.000027048472,0.000037759004,0.00006562123,0.000032703785],"domain_scores_gemma":[0.99983597,0.000044500244,0.000039174076,0.000008064176,0.000050263105,0.000021978753],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018159999,0.001191065,0.0012046989,0.0011745911,0.00034385832,0.00080387405,0.00061017723,0.0010474804,0.014395618],"category_scores_gemma":[0.0004561037,0.00013553383,0.00031266382,0.0011512421,0.00028598052,0.0007929221,0.00046512485,0.00082332996,0.0123424865],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010848899,0.000060089493,0.00050491624,0.008045799,0.000031886695,0.0016477332,0.000065264045,0.00011216884,0.002167053,0.0009252779,0.049375623,0.93695575],"study_design_scores_gemma":[0.000032636817,0.000098634104,0.00194267,0.0028481283,0.000051295632,0.0174131,0.00011859526,0.00004025645,0.0012538233,0.0008234906,0.975367,0.00001030651],"about_ca_topic_score_codex":0.0008411286,"about_ca_topic_score_gemma":0.0014166652,"teacher_disagreement_score":0.014395618,"about_ca_system_score_codex":0.0002658574,"about_ca_system_score_gemma":0.00045077447,"threshold_uncertainty_score":0.04815817},"labels":[],"label_agreement":null},{"id":"W4211144429","doi":"10.1046/j.1468-3083.2002.00378.x","title":"Pityriasis versicolor","year":2002,"lang":"en","type":"review","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Nail Diseases and Treatments","field":"Medicine","cited_by":170,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Western University; Mediprobe Research (Canada); Sunnybrook Health Science Centre","funders":"","keywords":"Pityriasis; Medicine; Dermatology; Tinea versicolor","score_opus":0.06552862642545489,"score_gpt":0.3389828850178928,"score_spread":0.27345425859243794,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4211144429","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004886786,0.9767983,0.00039833848,0.00094773347,0.0012928026,0.000029129602,0.0001534559,0.0000635757,0.015429853],"genre_scores_gemma":[0.06980475,0.9073723,0.00046330207,0.0013917271,0.0020349831,0.000038593964,0.00047467736,0.0000115864605,0.018408015],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99988925,0.000019512487,0.000012995913,0.000025121019,0.000030206953,0.00002290628],"domain_scores_gemma":[0.99989724,0.000030894767,0.000033598888,0.0000044429507,0.000018418397,0.000015297037],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012814582,0.00071110873,0.00072516326,0.00047199544,0.0002204125,0.00036480682,0.0003897933,0.0006226683,0.009674076],"category_scores_gemma":[0.00039155773,0.00008875381,0.00016842551,0.0006136195,0.00020607814,0.00059988163,0.00020356725,0.00039977484,0.0045336196],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031910295,0.00007049974,0.001668872,0.01242276,0.000053834403,0.010317947,0.0000965502,0.00023128938,0.0045272717,0.001137685,0.049703486,0.91945064],"study_design_scores_gemma":[0.00009647446,0.0002938913,0.008121893,0.003420648,0.0001158112,0.113831654,0.00027186776,0.00015423194,0.002964299,0.0007329294,0.8699749,0.000021432259],"about_ca_topic_score_codex":0.0013637533,"about_ca_topic_score_gemma":0.0015183171,"teacher_disagreement_score":0.009674076,"about_ca_system_score_codex":0.00017205598,"about_ca_system_score_gemma":0.00029337927,"threshold_uncertainty_score":0.032362998},"labels":[],"label_agreement":null},{"id":"W4212866886","doi":"10.1111/jdv.18013","title":"A case of psoriatic spondyloarthritis exacerbation triggered by COVID‐19 messenger RNA vaccine","year":2022,"lang":"en","type":"letter","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"SARS-CoV-2 and COVID-19 Research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Vaccination; Exacerbation; Psoriasis; Medical history; Disease; Dermatology; Psoriatic arthritis; Fibromyalgia; Internal medicine; Pediatrics; Immunology","score_opus":0.03436503166754282,"score_gpt":0.32208907145540067,"score_spread":0.2877240397878579,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4212866886","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.877292,0.038666185,0.008574963,0.033459876,0.011260381,0.0008033598,0.0006226967,0.0006537937,0.028666772],"genre_scores_gemma":[0.97122586,0.0043993383,0.0018691465,0.007854821,0.011015372,0.00008258988,0.00017340507,0.00004846295,0.0033309576],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99878913,0.0002092738,0.0001459716,0.00024890754,0.00019709503,0.00040967492],"domain_scores_gemma":[0.99811745,0.0006631211,0.00034098077,0.0001640415,0.00018168236,0.0005327616],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006179167,0.0019552044,0.0025366142,0.0018699985,0.0021469991,0.0014341316,0.0015685621,0.007885857,0.0030084047],"category_scores_gemma":[0.002995005,0.0012194024,0.0019679104,0.0012454333,0.0012793324,0.002289895,0.0011955252,0.005043799,0.0011020115],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000079878504,0.000041245294,0.0014358117,0.000073088086,0.000014231879,0.995948,0.00009541397,0.000040211005,0.0004362518,0.00012813542,0.0008514062,0.0008563961],"study_design_scores_gemma":[0.00007181486,0.00012383859,0.0028660449,0.00004528166,0.000043894892,0.99317306,0.000098112476,0.00076608866,0.00036770344,0.00018298089,0.0022451798,0.000015981237],"about_ca_topic_score_codex":0.0012233718,"about_ca_topic_score_gemma":0.0015353046,"teacher_disagreement_score":0.007885857,"about_ca_system_score_codex":0.0014280697,"about_ca_system_score_gemma":0.000585878,"threshold_uncertainty_score":0.010361433},"labels":[],"label_agreement":null},{"id":"W4213058992","doi":"10.1111/jdv.18010","title":"Long‐term, durable, absolute Psoriasis Area and Severity Index and health‐related quality of life improvements with risankizumab treatment: a <i>post hoc</i> integrated analysis of patients with moderate‐to‐severe plaque psoriasis","year":2022,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; Queen's University","funders":"AbbVie","keywords":"Dermatology Life Quality Index; Medicine; Psoriasis Area and Severity Index; Ustekinumab; Post-hoc analysis; Psoriasis; Severity of illness; Internal medicine; Quality of life (healthcare); Dermatology; Disease; Adalimumab","score_opus":0.01953885691421686,"score_gpt":0.2453142887681741,"score_spread":0.22577543185395724,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4213058992","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997783,0.0007086861,0.00036562368,0.000038729235,0.00002405152,0.0003009089,0.00045329114,0.000014522493,0.00031116031],"genre_scores_gemma":[0.99749917,0.00014758944,0.0005887892,0.000057079396,0.000059513415,0.00037882224,0.0008354338,0.000008933335,0.00042472314],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99611306,0.0024542494,0.0002169534,0.0004957179,0.0003584179,0.00036161006],"domain_scores_gemma":[0.9946293,0.002802961,0.0010852161,0.00054684025,0.00037161773,0.00056410284],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005967382,0.0009562889,0.002729605,0.00046044413,0.0002537956,0.0010545071,0.0006678133,0.0006090373,0.003572537],"category_scores_gemma":[0.0040879957,0.00044565176,0.0057735695,0.00046464513,0.00078612193,0.0007400344,0.00061304844,0.0014145836,0.00029037034],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.91099703,0.003487718,0.054269332,0.00054494117,0.008470093,0.00007150823,0.00014213166,0.0012730828,0.004366628,0.000054240627,0.00048462363,0.015838679],"study_design_scores_gemma":[0.16973267,0.33133388,0.46599165,0.0000830144,0.019542145,0.0002569652,0.00022032559,0.005572337,0.005301493,0.00017997171,0.0016747898,0.00011076596],"about_ca_topic_score_codex":0.0008115736,"about_ca_topic_score_gemma":0.0012275712,"teacher_disagreement_score":0.005967382,"about_ca_system_score_codex":0.0007847108,"about_ca_system_score_gemma":0.0013069486,"threshold_uncertainty_score":0.03155887},"labels":[],"label_agreement":null},{"id":"W4214731596","doi":"10.1111/jdv.18033","title":"Treatment of severe hidradenitis Suppurativa and Fistulizing Crohn’s disease with Guselkumab","year":2022,"lang":"en","type":"letter","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Hidradenitis Suppurativa and Treatments","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hospital for Sick Children; Mount Sinai Hospital; Women's College Hospital; University of Toronto","funders":"","keywords":"Medicine; Hidradenitis suppurativa; Dermatology; Crohn's disease; Adalimumab; Disease; Surgery; Internal medicine","score_opus":0.021331948048761824,"score_gpt":0.26003582482336207,"score_spread":0.23870387677460025,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4214731596","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.13908084,0.027020754,0.0035589114,0.7005845,0.028695744,0.0003320801,0.0002555586,0.00031301338,0.10015863],"genre_scores_gemma":[0.6693124,0.01403266,0.0025645338,0.23928079,0.041726965,0.00014499991,0.00018598589,0.00008311213,0.03266843],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99918574,0.0002767723,0.00007929773,0.00007217483,0.0002068166,0.00017917683],"domain_scores_gemma":[0.99886405,0.00056936324,0.000104180086,0.000062258565,0.00011652981,0.00028354832],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00078635383,0.0005940277,0.0007103992,0.00061890716,0.001757336,0.00088969636,0.0005046971,0.00717715,0.0021061692],"category_scores_gemma":[0.0050532664,0.0003200605,0.0009796881,0.000582418,0.0011137918,0.0012414308,0.0004553806,0.005307015,0.0014313495],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039141215,0.00024792485,0.009975577,0.00023459246,0.000052218253,0.82806236,0.00037815128,0.00053057674,0.0015316851,0.00367049,0.12613119,0.028793817],"study_design_scores_gemma":[0.00041939516,0.00050756213,0.011283236,0.00046365958,0.000043713564,0.85215473,0.00037336655,0.002651219,0.00082056836,0.006931653,0.12430388,0.000046938792],"about_ca_topic_score_codex":0.0019847155,"about_ca_topic_score_gemma":0.0033676238,"teacher_disagreement_score":0.00717715,"about_ca_system_score_codex":0.0017009977,"about_ca_system_score_gemma":0.0010041365,"threshold_uncertainty_score":0.012341678},"labels":[],"label_agreement":null},{"id":"W4214807866","doi":"10.1111/jdv.18044","title":"Psoriasis and metabolic syndrome: implications for the management and treatment of psoriasis","year":2022,"lang":"en","type":"review","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":189,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta Hospital; University of Alberta","funders":"","keywords":"Psoriasis; Medicine; Metabolic syndrome; Disease; Comorbidity; Inflammation; Systemic inflammation; Dermatology; Bioinformatics; Intensive care medicine; Immunology; Internal medicine; Obesity","score_opus":0.05756281154694331,"score_gpt":0.3043400099104051,"score_spread":0.2467771983634618,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4214807866","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00005526704,0.9983187,0.000075002776,0.0008091742,0.00031150554,0.0000021005098,0.00000738207,0.0000047170156,0.00041613565],"genre_scores_gemma":[0.0004375629,0.9983726,0.00015214072,0.0003784968,0.00038610704,0.0000043181067,0.000015667218,0.0000010703038,0.00025212916],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99973816,0.00006481484,0.0000405166,0.000037054637,0.00009617944,0.00002331048],"domain_scores_gemma":[0.99951375,0.00025300443,0.00005175379,0.0000122249,0.0001195473,0.00004977199],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006875539,0.0005999926,0.0013119027,0.001576173,0.0002677211,0.0009608416,0.0006208751,0.001268519,0.0034118954],"category_scores_gemma":[0.0010262604,0.00017910497,0.00060337776,0.001203317,0.00043814583,0.0010958242,0.0005951869,0.0029056643,0.0014875244],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007536535,0.00009033429,0.0001702328,0.009313793,0.00008862679,0.00019608144,0.000045433157,0.00026711565,0.0006326747,0.0032646928,0.040657658,0.94519794],"study_design_scores_gemma":[0.000039174014,0.00013300765,0.0013294083,0.007557217,0.00013101201,0.0020262336,0.00009322759,0.00014462112,0.00019619761,0.004843928,0.9834795,0.000026590875],"about_ca_topic_score_codex":0.0009110143,"about_ca_topic_score_gemma":0.0016878817,"teacher_disagreement_score":0.0034118954,"about_ca_system_score_codex":0.0005967183,"about_ca_system_score_gemma":0.0010046713,"threshold_uncertainty_score":0.011413932},"labels":[],"label_agreement":null},{"id":"W4220947258","doi":"10.1111/jdv.18053","title":"Impact of fixed‐dose combination Cal/BD foam on the work productivity of patients with psoriasis: results from the 52‐week randomized, double‐blind, PSO‐LONG trial","year":2022,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Guenther Dermatology Research Centre; Western University","funders":"LEO Pharma","keywords":"Medicine; Psoriasis; Presenteeism; Work productivity; Productivity; Randomized controlled trial; Physical therapy; Dermatology Life Quality Index; Placebo; Quality of life (healthcare); Surgery; Dermatology; Nursing","score_opus":0.03014265511376589,"score_gpt":0.25739756277781395,"score_spread":0.22725490766404804,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220947258","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98200536,0.01105141,0.00076015847,0.00064073416,0.00041050595,0.0021166564,0.0010351562,0.00018596464,0.0017940468],"genre_scores_gemma":[0.98954237,0.0035625524,0.00104019,0.0006739994,0.0003408756,0.0021322968,0.00072815537,0.000028929499,0.0019504706],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9991345,0.0004557786,0.000071914175,0.00014300313,0.0000741459,0.00012061507],"domain_scores_gemma":[0.99870694,0.0004522003,0.0003320471,0.00012820006,0.000102561695,0.00027807357],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020222014,0.0015304047,0.0031074171,0.0004383938,0.00039893118,0.0011447787,0.0008109899,0.002012286,0.0059142024],"category_scores_gemma":[0.0020894294,0.000599521,0.002667227,0.00041431948,0.0008924693,0.0009846198,0.00036367588,0.0022198819,0.000880259],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.97676784,0.004296723,0.0002814364,0.0007699368,0.0009189518,0.000023212702,0.000033138465,0.00020532227,0.0020727334,0.000029492185,0.000412674,0.014188552],"study_design_scores_gemma":[0.9546068,0.04286324,0.0013535761,0.000034018984,0.0004608698,0.000018074807,0.000013973165,0.00017641539,0.00021159432,0.00003482718,0.00021585243,0.0000108139375],"about_ca_topic_score_codex":0.0009401261,"about_ca_topic_score_gemma":0.001604682,"teacher_disagreement_score":0.0059142024,"about_ca_system_score_codex":0.0006364232,"about_ca_system_score_gemma":0.0007381935,"threshold_uncertainty_score":0.019784987},"labels":[],"label_agreement":null},{"id":"W4220977774","doi":"10.1111/jdv.18054","title":"Maskne prevalence and associated factors in Irish healthcare workers during the COVID‐19 pandemic","year":2022,"lang":"en","type":"letter","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Infection Control and Ventilation","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Irish; Personal protective equipment; Pandemic; Health care; Quarter (Canadian coin); Family medicine; Coronavirus disease 2019 (COVID-19); Health professionals; Disease; Infectious disease (medical specialty)","score_opus":0.04003163696569984,"score_gpt":0.3035173376773125,"score_spread":0.26348570071161265,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220977774","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982039,0.0002484781,0.000025055726,0.00016040704,0.000013989502,0.00002481609,0.00039412064,0.0000029163898,0.0009262149],"genre_scores_gemma":[0.99879456,0.00030012263,0.00006549828,0.000098829216,0.000018017407,0.00002389141,0.00034828,0.000002278966,0.00034860816],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994417,0.00009477694,0.00006170618,0.0000928196,0.00011984036,0.00018910006],"domain_scores_gemma":[0.99897826,0.000110791065,0.0004827949,0.00004270562,0.00016294382,0.0002226231],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006546133,0.000205446,0.00028697719,0.00068953267,0.00054509996,0.00065761764,0.00040878286,0.00052383856,0.0019013635],"category_scores_gemma":[0.0018948313,0.0002910674,0.0002858118,0.00071723986,0.0004054843,0.0005047289,0.0008113563,0.00063176523,0.00031603323],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000928256,0.00004154233,0.9949242,0.000039540708,0.000008483858,0.00016890188,0.0011019113,0.000026287567,0.00045545446,0.000012623203,0.00045364417,0.0026745708],"study_design_scores_gemma":[0.0000016451415,0.000062113264,0.99706334,0.000023279437,0.000001971389,0.00014101519,0.0023933887,0.00003473691,0.000021197666,0.000004420461,0.00024911264,0.0000038110281],"about_ca_topic_score_codex":0.051404923,"about_ca_topic_score_gemma":0.04970441,"teacher_disagreement_score":0.051404923,"about_ca_system_score_codex":0.0009904522,"about_ca_system_score_gemma":0.00064442924,"threshold_uncertainty_score":0.102211416},"labels":[],"label_agreement":null},{"id":"W4223573355","doi":"10.1111/jdv.18134","title":"Assessing the dynamic changes in vitiligo: reliability and validity of the Vitiligo Disease Activity Score (<scp>VDAS</scp>) and Vitiligo Disease Improvement Score (<scp>VDIS</scp>)","year":2022,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"melanin and skin pigmentation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"Vlaamse regering; Fonds Wetenschappelijk Onderzoek; Incyte","keywords":"Vitiligo; Medicine; Intraclass correlation; Depigmentation; Intra-rater reliability; Construct validity; Reliability (semiconductor); Dermatology; Surgery; Internal medicine; Psychometrics; Confidence interval; Patient satisfaction; Clinical psychology","score_opus":0.019494443581417897,"score_gpt":0.2811838886241469,"score_spread":0.261689445042729,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4223573355","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99468225,0.0007711929,0.0020202065,0.00004663742,0.000038551956,0.00017069657,0.00022167376,0.000026976177,0.0020218447],"genre_scores_gemma":[0.99845743,0.000090269015,0.0010258155,0.000014952832,0.0000114448085,0.000055385903,0.00016836575,0.0000058864975,0.00017046316],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9935341,0.0026637036,0.0008041783,0.0009048636,0.0018651844,0.0002279796],"domain_scores_gemma":[0.9852114,0.0076348586,0.002389043,0.0009773517,0.0033175005,0.0004698295],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011236447,0.00041941856,0.00073106115,0.0013235322,0.00028462784,0.0007562368,0.00045503865,0.000407991,0.0010180537],"category_scores_gemma":[0.017121904,0.00022611764,0.0007635364,0.00084840244,0.00069300714,0.00052982906,0.0011772744,0.00051304756,0.00035456003],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00052391214,0.00013295305,0.9723012,0.00009665099,0.00032708977,0.000020685575,0.0006034642,0.0004353505,0.0010381838,0.000070626185,0.0001884301,0.024261478],"study_design_scores_gemma":[0.00007419303,0.0010190558,0.99343866,0.00005711827,0.00013363242,0.00021025057,0.00039473522,0.0028087182,0.0009980822,0.00011742295,0.0007307552,0.000017282151],"about_ca_topic_score_codex":0.0012264409,"about_ca_topic_score_gemma":0.0012034717,"teacher_disagreement_score":0.011236447,"about_ca_system_score_codex":0.00032943586,"about_ca_system_score_gemma":0.00034779627,"threshold_uncertainty_score":0.0594247},"labels":[],"label_agreement":null},{"id":"W4224326447","doi":"10.1111/jdv.18170","title":"High threshold efficacy responses in moderate‐to‐severe atopic dermatitis are associated with additional quality of life benefits: pooled analyses of abrocitinib monotherapy studies in adults and adolescents","year":2022,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; SKiN Health; Queen's University","funders":"Lundbeckfonden; Regeneron Pharmaceuticals; Sanofi; Pfizer","keywords":"Medicine; Atopic dermatitis; Quality of life (healthcare); Pooled analysis; MEDLINE; Dermatology; Meta-analysis; Internal medicine","score_opus":0.06114919787321532,"score_gpt":0.3422434632500999,"score_spread":0.2810942653768846,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4224326447","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.25978473,0.72065204,0.005206826,0.00059609005,0.00037104738,0.0009752517,0.009256059,0.000113714465,0.0030442763],"genre_scores_gemma":[0.9492996,0.04295415,0.002119869,0.0006796356,0.00036156861,0.0009479623,0.003243353,0.000052028277,0.00034184966],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.96753937,0.018747734,0.007358667,0.0031771772,0.0027710393,0.0004060499],"domain_scores_gemma":[0.9428195,0.03985918,0.012514626,0.002655088,0.0017438026,0.00040790997],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.03454145,0.0013032554,0.006608474,0.0034252342,0.0002667018,0.0023894066,0.0008316352,0.0010976311,0.0023248296],"category_scores_gemma":[0.035845898,0.0007419067,0.02122864,0.0037697428,0.0005561745,0.0010419125,0.0010641331,0.000996611,0.00022158049],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02981694,0.00008521516,0.109810896,0.026158268,0.80313236,0.000147891,0.00014234263,0.0008784002,0.0010824649,0.0001363265,0.0010362621,0.027572736],"study_design_scores_gemma":[0.005228306,0.0024023936,0.22170544,0.003035409,0.76141495,0.0004921202,0.00014274623,0.00072795537,0.00064228906,0.00047371397,0.0036682836,0.0000663629],"about_ca_topic_score_codex":0.0007780055,"about_ca_topic_score_gemma":0.0016185804,"teacher_disagreement_score":0.03454145,"about_ca_system_score_codex":0.0005126113,"about_ca_system_score_gemma":0.00067382376,"threshold_uncertainty_score":0.18267477},"labels":[],"label_agreement":null},{"id":"W4224327048","doi":"10.1111/jdv.18167","title":"Tildrakizumab efficacy and safety in patients with psoriasis and concomitant metabolic syndrome: <i>post hoc</i> analysis of 5‐year data from <scp>reSURFACE</scp> 1 and <scp>reSURFACE</scp> 2","year":2022,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; SKiN Health; Queen's University","funders":"National Institutes of Health; LEO Pharma; Eli Lilly and Company; AstraZeneca; Galderma; Cilag; Mylan; Alexion Pharmaceuticals; Merck; Simon Spies Fonden; Celgene; Pfizer; Samsung; National Psoriasis Foundation; Amgen","keywords":"Medicine; Post-hoc analysis; Concomitant; Post hoc; Psoriasis; Metabolic syndrome; Internal medicine; Oncology; Dermatology; Obesity","score_opus":0.013614150035106548,"score_gpt":0.22559881992687966,"score_spread":0.21198466989177311,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4224327048","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99463165,0.0022873392,0.00043361014,0.00008326394,0.000034722983,0.0005529649,0.0009915988,0.00003187205,0.0009529249],"genre_scores_gemma":[0.9967019,0.00040478678,0.00050896837,0.00012818034,0.00008052131,0.00040722554,0.0012206448,0.000011261107,0.0005364763],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.997054,0.0016291474,0.00027058672,0.00045027223,0.00032120376,0.00027474458],"domain_scores_gemma":[0.99568594,0.0014751961,0.0015121769,0.00056164927,0.000388011,0.00037700374],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006532655,0.00092356466,0.0022202418,0.0004771511,0.00037977952,0.0009689872,0.0005209608,0.0005345346,0.0029669278],"category_scores_gemma":[0.0029245522,0.0004058157,0.0052356026,0.00046686523,0.00048457418,0.000915955,0.00048000363,0.0015157646,0.000315249],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.87083876,0.005524376,0.05852323,0.0009056044,0.01496064,0.00011409138,0.00015737991,0.0014114516,0.011301794,0.00009329112,0.0011257968,0.035043478],"study_design_scores_gemma":[0.23632438,0.36092794,0.35879678,0.00012340677,0.02540632,0.00049668,0.00016588849,0.0032738375,0.009489918,0.00024980272,0.0046320152,0.0001129976],"about_ca_topic_score_codex":0.0005983682,"about_ca_topic_score_gemma":0.0015999211,"teacher_disagreement_score":0.006532655,"about_ca_system_score_codex":0.00074831565,"about_ca_system_score_gemma":0.0011168475,"threshold_uncertainty_score":0.0345484},"labels":[],"label_agreement":null},{"id":"W4255763756","doi":"10.1111/jdv.12837","title":"Erratum","year":2014,"lang":"en","type":"erratum","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Antifungal resistance and susceptibility","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine","score_opus":0.018999085648673083,"score_gpt":0.28217887059944186,"score_spread":0.26317978495076877,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4255763756","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00074769,0.012047108,0.001469369,0.06313751,0.80494416,0.00025392088,0.0070011355,0.0009542238,0.10944489],"genre_scores_gemma":[0.010394891,0.032906592,0.004679647,0.07044341,0.20324506,0.0003551472,0.016898554,0.0018105886,0.6592661],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99569976,0.000583806,0.0007177465,0.00058803085,0.0021061106,0.00030456638],"domain_scores_gemma":[0.98337966,0.0025603638,0.0011092135,0.0012342791,0.010547843,0.0011686616],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0022736087,0.0014691869,0.001347345,0.003791263,0.0024181583,0.0062723625,0.0017867305,0.0030658657,0.40679055],"category_scores_gemma":[0.024621258,0.000668725,0.0012170341,0.0022382662,0.0011107123,0.0037495096,0.0020677594,0.005708473,0.276135],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000030014138,0.0000107456935,0.000115173854,0.0001427993,0.0000056756826,0.00009755662,0.000017501901,0.000012098023,0.00004524015,0.0005509041,0.97955745,0.019414885],"study_design_scores_gemma":[0.000010412169,0.0000124565195,0.00024222635,0.00031131026,0.000008245066,0.0003617025,0.00006401059,0.000019787281,0.00009835699,0.0005432543,0.9983191,0.000009196256],"about_ca_topic_score_codex":0.003007867,"about_ca_topic_score_gemma":0.0037278947,"teacher_disagreement_score":0.59320945,"about_ca_system_score_codex":0.001995928,"about_ca_system_score_gemma":0.0043449164,"threshold_uncertainty_score":0},"labels":[],"label_agreement":null},{"id":"W4281991880","doi":"10.1111/jdv.18311","title":"Real‐life experience of upadacitinib for the treatment of adult patients with moderate‐to‐severe atopic dermatitis – a case series","year":2022,"lang":"en","type":"letter","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Rappaport; Tel aviv; Medicine; Atopic dermatitis; Center (category theory); Family medicine; Library science; Dermatology; Theology; Philosophy","score_opus":0.018303773555178728,"score_gpt":0.2676243734966456,"score_spread":0.24932059994146685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281991880","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9621241,0.0071803126,0.0015333558,0.01177242,0.0007190039,0.00008660655,0.00024059096,0.00005164111,0.016292006],"genre_scores_gemma":[0.99174,0.0019903942,0.0005588963,0.0023928515,0.0006948704,0.000014426584,0.00011278984,0.00001857758,0.0024771185],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99968123,0.0000872924,0.000043284475,0.000046849105,0.00005379581,0.00008763539],"domain_scores_gemma":[0.99920875,0.00031100996,0.00011872573,0.0000403597,0.000053657324,0.00026760052],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026174297,0.000531688,0.0004260937,0.0003276702,0.0014134437,0.0010803235,0.00038962334,0.0026235676,0.0024143758],"category_scores_gemma":[0.0021499372,0.0002741406,0.00065001653,0.00036898867,0.0005197136,0.00095418334,0.00053180614,0.0015732199,0.0007654837],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001355089,0.0002238974,0.014386547,0.00005297705,0.000035042387,0.97310096,0.0006142976,0.00020531015,0.0008036332,0.00031664124,0.0033824188,0.0067427484],"study_design_scores_gemma":[0.000024718138,0.00017256281,0.0049461103,0.000022518057,0.000018382945,0.9898437,0.00049776305,0.0003013877,0.00022203382,0.000208676,0.0037290012,0.000013148904],"about_ca_topic_score_codex":0.0008634116,"about_ca_topic_score_gemma":0.0017837749,"teacher_disagreement_score":0.0026235676,"about_ca_system_score_codex":0.0007436412,"about_ca_system_score_gemma":0.00041860092,"threshold_uncertainty_score":0.008076906},"labels":[],"label_agreement":null},{"id":"W4282563647","doi":"10.1111/jdv.18323","title":"Clinical, epidemiological, trichoscopic and histopathological features of linear morphea on the scalp","year":2022,"lang":"en","type":"letter","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Autoimmune Bullous Skin Diseases","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Guelph General Hospital","funders":"","keywords":"Medicine; Morphea; Scalp; Dermatology; Epidemiology; Dermatopathology; Pathology","score_opus":0.05860861197188383,"score_gpt":0.3345494955536169,"score_spread":0.2759408835817331,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282563647","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9602633,0.0023875216,0.00055277563,0.010783477,0.0003672227,0.00006405364,0.00027097363,0.000037157657,0.025273455],"genre_scores_gemma":[0.9973642,0.00043082694,0.00013807626,0.0007325367,0.0004374648,0.0000051197007,0.000036432844,0.0000023632438,0.00085292436],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99970907,0.00006873697,0.00002340282,0.000050479463,0.00005969722,0.00008859658],"domain_scores_gemma":[0.9993254,0.0002527002,0.000081703925,0.000039765877,0.0001156724,0.00018477699],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022617803,0.00046747617,0.00025202424,0.00077380845,0.00065861305,0.0005000782,0.0003404894,0.0017530425,0.0013162394],"category_scores_gemma":[0.0017525585,0.00022170518,0.00022825148,0.00056171935,0.00057343487,0.0005816524,0.0002468852,0.00090939034,0.00029085632],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021319868,0.00006906528,0.1336864,0.00004595933,0.000018349076,0.8548196,0.0003130677,0.00012773386,0.003708014,0.00032361218,0.0025752087,0.0040999185],"study_design_scores_gemma":[0.000019823652,0.00011947328,0.12449311,0.000036599235,0.000020685906,0.8701315,0.00070813566,0.000752893,0.0005442446,0.00036397303,0.0027932927,0.000016309541],"about_ca_topic_score_codex":0.004000835,"about_ca_topic_score_gemma":0.0033852905,"teacher_disagreement_score":0.004000835,"about_ca_system_score_codex":0.0005596808,"about_ca_system_score_gemma":0.00024529838,"threshold_uncertainty_score":0.007955134},"labels":[],"label_agreement":null},{"id":"W4282945318","doi":"10.1111/jdv.18296","title":"Global prevalence of metabolic syndrome in patients with psoriasis in the past two decades: current evidence","year":2022,"lang":"en","type":"review","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Key Research and Development Program of China; Science and Technology Commission of Shanghai Municipality; National Natural Science Foundation of China","keywords":"Medicine; Psoriasis; Observational study; Metabolic syndrome; Confidence interval; Population; Internal medicine; Meta-analysis; Publication bias; Subgroup analysis; Environmental health; Dermatology; Obesity","score_opus":0.04439570488320536,"score_gpt":0.31075612483327153,"score_spread":0.26636041995006615,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282945318","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0065006376,0.9922505,0.00014180916,0.0003664481,0.00009382591,0.000014874169,0.00039706897,0.000007562228,0.0002271994],"genre_scores_gemma":[0.17250459,0.8243392,0.0006704009,0.0010800768,0.0004223319,0.00008483661,0.0007931433,0.000010073593,0.000095272175],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.995619,0.0013281908,0.0013732302,0.0008661003,0.00067992083,0.0001334737],"domain_scores_gemma":[0.98921645,0.0056389947,0.003813723,0.0002887008,0.00087492773,0.00016716516],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006327345,0.00083658885,0.0046734065,0.0036352386,0.00027311454,0.0021275706,0.0010109917,0.0014163723,0.0016706095],"category_scores_gemma":[0.01328921,0.00073658046,0.010367076,0.0054002036,0.00052737683,0.0011901746,0.0008460121,0.0012687498,0.0001574121],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037761866,0.00008754737,0.20568639,0.3276384,0.32079723,0.00032139255,0.00034201698,0.0008504425,0.00048406317,0.00057416473,0.0050742743,0.13436791],"study_design_scores_gemma":[0.0009149109,0.0005796337,0.29763007,0.09917238,0.5783933,0.0015787061,0.00042174457,0.0007236154,0.00032552617,0.0010391382,0.019089837,0.0001311992],"about_ca_topic_score_codex":0.0053298185,"about_ca_topic_score_gemma":0.009370663,"teacher_disagreement_score":0.006327345,"about_ca_system_score_codex":0.0008199704,"about_ca_system_score_gemma":0.0011878912,"threshold_uncertainty_score":0.033462584},"labels":[],"label_agreement":null},{"id":"W4283713497","doi":"10.1111/jdv.18376","title":"Comparative effectiveness of biologics in clinical practice: week 12 primary outcomes from an international observational <i>psoriasis study of health outcomes</i> (<scp>PSoHO</scp>)","year":2022,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"UCB Pharma; Sanofi Genzyme; LEO Pharma; Biogen; Celgene; Sanofi; Pfizer; Eli Lilly and Company","keywords":"Medicine; Secukinumab; Ustekinumab; Psoriasis; Ixekizumab; Psoriatic arthritis; Psoriasis Area and Severity Index; Observational study; Cohort; Clinical endpoint; Internal medicine; Dermatology Life Quality Index; Cohort study; Clinical trial; Physical therapy; Adalimumab; Dermatology; Disease","score_opus":0.1047750623908989,"score_gpt":0.3722308858027155,"score_spread":0.2674558234118166,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283713497","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9882267,0.0033208712,0.00131489,0.00027908696,0.00007204058,0.00066245266,0.0040366226,0.000025636104,0.0020615677],"genre_scores_gemma":[0.99501544,0.0003998017,0.00093267113,0.00016197814,0.000059117436,0.0005940728,0.0025782988,0.000010141917,0.00024848766],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.96962893,0.02232901,0.0022364205,0.0025170783,0.0026724108,0.00061609846],"domain_scores_gemma":[0.94983333,0.025907371,0.016231282,0.0042077485,0.0017848922,0.0020353193],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.024140125,0.00071537937,0.0016436082,0.0013281318,0.00041574775,0.0012608735,0.0009350788,0.0014456331,0.0030989808],"category_scores_gemma":[0.044410866,0.0003559917,0.0035084311,0.0013728975,0.00070588104,0.001035288,0.0014074048,0.0018080762,0.00035438873],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.49518704,0.0069817575,0.39784738,0.0021777165,0.041650478,0.00011431679,0.00060581,0.005259382,0.0014342176,0.000704636,0.0026411759,0.04539608],"study_design_scores_gemma":[0.059817046,0.08452039,0.8146493,0.0005248183,0.022997573,0.0004658816,0.00047244865,0.00856499,0.0020354432,0.0012764322,0.0045107193,0.00016503467],"about_ca_topic_score_codex":0.0012337851,"about_ca_topic_score_gemma":0.001095379,"teacher_disagreement_score":0.024140125,"about_ca_system_score_codex":0.0008114258,"about_ca_system_score_gemma":0.0009672444,"threshold_uncertainty_score":0.12766665},"labels":[],"label_agreement":null},{"id":"W4285587538","doi":"10.1111/jdv.18425","title":"Prenatal exposure to nickel and atopic dermatitis at age 3 years: a birth cohort study with cytokine profiles","year":2022,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Heavy Metal Exposure and Toxicity","field":"Environmental Science","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"National Defence Medical Centre","funders":"National Health Research Institutes; Ministry of Science and Technology","keywords":"Medicine; Nickel allergy; Urinary system; Atopic dermatitis; Immunology; Allergy; Cohort; Urine; Physiology; Internal medicine; Obstetrics; Contact dermatitis","score_opus":0.009635570850865272,"score_gpt":0.22486135797891246,"score_spread":0.21522578712804719,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4285587538","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99926764,0.00024055569,0.00006833141,0.00002190014,0.0000049689666,0.000009520624,0.00022283885,0.0000018664873,0.00016235806],"genre_scores_gemma":[0.9993666,0.00013925016,0.00010750406,0.000015608422,0.000003993621,0.000012570961,0.00018801917,0.0000014299175,0.00016497551],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995666,0.00009759088,0.000038552927,0.00013576003,0.00008112348,0.00008028632],"domain_scores_gemma":[0.9992186,0.00012118941,0.00029991634,0.00009348266,0.00010436625,0.000162408],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00064988405,0.00035316125,0.00034626498,0.00060262287,0.00054303184,0.00056070456,0.0003344418,0.0005793317,0.0011025853],"category_scores_gemma":[0.0013037515,0.00044487586,0.0006877879,0.00096093776,0.00020976027,0.0003509498,0.0003673384,0.0006477035,0.00017822541],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007758042,0.000027576494,0.99899143,0.0000048072957,0.00004716093,0.00014005609,0.00009293887,0.000010200015,0.0002491798,0.000008073294,0.000028503577,0.0003225269],"study_design_scores_gemma":[0.0000035191142,0.00008693149,0.99932444,0.0000049693676,0.000041232663,0.00024338029,0.000120847915,0.000059412192,0.00003957441,0.0000068585246,0.000067005254,0.0000018857635],"about_ca_topic_score_codex":0.01447392,"about_ca_topic_score_gemma":0.011156974,"teacher_disagreement_score":0.01447392,"about_ca_system_score_codex":0.00029449209,"about_ca_system_score_gemma":0.000370651,"threshold_uncertainty_score":0.028779328},"labels":[],"label_agreement":null},{"id":"W4289593609","doi":"10.1111/jdv.18475","title":"The effect of risankizumab on achieving minimal clinically important differences in patient‐reported outcomes in patients with psoriatic arthritis: results from KEEPsAKE 1 and 2","year":2022,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research","funders":"Janssen Pharmaceuticals; AbbVie; Eli Lilly and Company","keywords":"Medicine; Psoriatic arthritis; Dermatology; Physical therapy; Psoriasis","score_opus":0.010373481311936387,"score_gpt":0.25154943822867776,"score_spread":0.24117595691674137,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4289593609","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99240065,0.005683606,0.00018743491,0.000341442,0.000057959063,0.00022957822,0.00036066113,0.000013958267,0.0007246705],"genre_scores_gemma":[0.9971781,0.001240915,0.0004081115,0.00022970495,0.00009626105,0.00019163378,0.0003869745,0.0000038349035,0.00026435906],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99773186,0.0014190739,0.00022099407,0.00017761673,0.00030156772,0.000148991],"domain_scores_gemma":[0.9946273,0.0026102199,0.0015127661,0.00034243285,0.00029262895,0.00061456044],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0060132924,0.0006198883,0.0017583627,0.00020646796,0.00024263201,0.0006608076,0.00035863474,0.0006314122,0.0016448661],"category_scores_gemma":[0.005070721,0.00024921258,0.0028757204,0.0002423927,0.00039009665,0.00054134405,0.00044136166,0.0014197079,0.0001692146],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.84572965,0.005653483,0.029676719,0.00128579,0.004733165,0.000060195187,0.00017931331,0.001250823,0.0037282181,0.0001345207,0.00108786,0.10648025],"study_design_scores_gemma":[0.25806963,0.45586842,0.26943377,0.00026551122,0.007977418,0.00029405422,0.00017093327,0.0022896556,0.0030102725,0.00029616867,0.0022145158,0.00010971836],"about_ca_topic_score_codex":0.0005536872,"about_ca_topic_score_gemma":0.0015374727,"teacher_disagreement_score":0.0060132924,"about_ca_system_score_codex":0.0004045777,"about_ca_system_score_gemma":0.0008262864,"threshold_uncertainty_score":0.0318017},"labels":[],"label_agreement":null},{"id":"W4289594701","doi":"10.1111/jdv.18474","title":"Super‐response to guselkumab treatment in patients with moderate‐to‐severe psoriasis: age, body weight, baseline Psoriasis Area and Severity Index, and baseline Investigator's Global Assessment scores predict complete skin clearance","year":2022,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"Janssen Research and Development","keywords":"Medicine; Psoriasis Area and Severity Index; Psoriasis; Internal medicine; Logistic regression; Dermatology Life Quality Index; Odds ratio; Body mass index; Severity of illness; Confidence interval; Gastroenterology; Dermatology","score_opus":0.014595092351164303,"score_gpt":0.24012915341881164,"score_spread":0.22553406106764734,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4289594701","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99768674,0.0018314668,0.00013377565,0.00003810999,0.0000081966045,0.0000278883,0.000073331124,0.0000037820394,0.00019675172],"genre_scores_gemma":[0.99961334,0.00015607207,0.000075295604,0.000018848097,0.000013771138,0.000011632693,0.00007514424,9.508376e-7,0.000034897865],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985701,0.0009296123,0.00012171424,0.00016898994,0.00012429796,0.000085342836],"domain_scores_gemma":[0.99602133,0.002191559,0.0012205049,0.00016665302,0.00009855688,0.0003014256],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00359939,0.0002563672,0.0010937789,0.0003467223,0.00014642737,0.00047087803,0.00024367597,0.00035939558,0.0011755147],"category_scores_gemma":[0.002903068,0.00021713701,0.0022112601,0.0004258326,0.00020888887,0.00031552804,0.000305268,0.0005462921,0.00009760915],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.056660302,0.0003668932,0.9198361,0.00028798284,0.0039841095,0.000102207356,0.00007824188,0.00047836287,0.0018897481,0.00004067913,0.0002371088,0.016038284],"study_design_scores_gemma":[0.0024541442,0.011448749,0.9794392,0.00006850875,0.0032527028,0.00044186285,0.000102809696,0.0015876956,0.000613944,0.000114990835,0.0004584022,0.000016858618],"about_ca_topic_score_codex":0.00022670117,"about_ca_topic_score_gemma":0.0004969555,"teacher_disagreement_score":0.00359939,"about_ca_system_score_codex":0.00014570869,"about_ca_system_score_gemma":0.00028145895,"threshold_uncertainty_score":0.019035637},"labels":[],"label_agreement":null},{"id":"W4289839526","doi":"10.1111/jdv.18478","title":"The global prevalence of primary psychodermatologic disorders: a systematic review","year":2022,"lang":"en","type":"review","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Body Image and Dysmorphia Studies","field":"Psychology","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of Alberta","funders":"","keywords":"Medicine; Body dysmorphic disorder; Population; Prevalence; Psychiatry; Psychological intervention; Systematic review; Outpatient clinic; Pediatrics; Dermatology; MEDLINE; Internal medicine; Environmental health","score_opus":0.05447063169056728,"score_gpt":0.35682959457006674,"score_spread":0.3023589628794995,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4289839526","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00151205,0.99732816,0.00011400666,0.0001656318,0.00005864655,0.00013991534,0.0005213335,0.0000061325422,0.00015405608],"genre_scores_gemma":[0.02654205,0.9716622,0.00054243405,0.00042686827,0.000061551385,0.0003314464,0.00035877962,0.0000062841173,0.00006829348],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9916431,0.002406739,0.0035038837,0.0007963588,0.0014026928,0.00024733346],"domain_scores_gemma":[0.9717496,0.0203443,0.004758102,0.00045845364,0.00244611,0.0002434057],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0087468065,0.0013576392,0.008735114,0.009691839,0.0005686621,0.0026969996,0.0014428488,0.0016898174,0.003237868],"category_scores_gemma":[0.032416943,0.0011523986,0.009248589,0.011597378,0.00084906234,0.0020681955,0.0014971808,0.0009726871,0.0002535037],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001628453,0.000009427573,0.0025054913,0.9559454,0.021524861,0.00013090044,0.00015898762,0.00007841419,0.00014108927,0.0001295889,0.000993031,0.018219987],"study_design_scores_gemma":[0.00023839452,0.00023229454,0.015203885,0.7513948,0.21713337,0.0009544643,0.00044568066,0.00010892722,0.00022018934,0.00036077746,0.013659592,0.00004757026],"about_ca_topic_score_codex":0.0076503074,"about_ca_topic_score_gemma":0.022009287,"teacher_disagreement_score":0.009691839,"about_ca_system_score_codex":0.0026135808,"about_ca_system_score_gemma":0.007505653,"threshold_uncertainty_score":0.046258092},"labels":[],"label_agreement":null},{"id":"W4292116273","doi":"10.1111/j.1468-3083.2007.02245.x","title":"Abstracts of Invited Speakers","year":2007,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Citation; Library science; Information retrieval; Computer science","score_opus":0.018751402987448543,"score_gpt":0.24921331421339607,"score_spread":0.23046191122594753,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4292116273","genre_codex":"editorial","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004628084,0.024663782,0.0019861585,0.091896996,0.6398553,0.0013051345,0.0037474753,0.0006079009,0.23130916],"genre_scores_gemma":[0.011783949,0.0070536532,0.0008104842,0.014309561,0.121736765,0.0007974434,0.0018929268,0.00031071997,0.8413045],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99859256,0.00022961786,0.000077734854,0.0002143673,0.0006076026,0.00027810855],"domain_scores_gemma":[0.993486,0.0008483232,0.00035399917,0.00016842259,0.0030582875,0.0020850387],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.002381034,0.001495268,0.00083734526,0.0020068276,0.0017368325,0.0037027767,0.0011669408,0.0036960628,0.30529156],"category_scores_gemma":[0.008094814,0.0003598126,0.00081187673,0.0009197714,0.00029675558,0.0014181837,0.0024703166,0.0024957743,0.15112609],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009834505,0.0000322084,0.00014160134,0.00014128016,0.000004703863,0.00011677661,0.000039328508,0.000024566692,0.0003892407,0.0003557444,0.9770471,0.021609023],"study_design_scores_gemma":[0.000039888448,0.00004441326,0.0015176723,0.00015617463,0.000011286969,0.00016103168,0.00018505863,0.000094910625,0.00018941645,0.0005780086,0.9970112,0.000011030071],"about_ca_topic_score_codex":0.0012563033,"about_ca_topic_score_gemma":0.00239179,"teacher_disagreement_score":0.69470847,"about_ca_system_score_codex":0.0011621442,"about_ca_system_score_gemma":0.0023440565,"threshold_uncertainty_score":0.99091727},"labels":[],"label_agreement":null},{"id":"W4294754906","doi":"10.1111/jdv.18571","title":"Rapid pruritus reduction with ruxolitinib cream treatment in patients with atopic dermatitis","year":2022,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research","funders":"Cilag; Galderma; Incyte; Kiniksa Pharmaceuticals; Regeneron Pharmaceuticals; Pfizer; Eli Lilly and Company","keywords":"Ruxolitinib; Medicine; Atopic dermatitis; Janus kinase inhibitor; Internal medicine; Dermatology; Janus kinase; Myelofibrosis","score_opus":0.01098673088197736,"score_gpt":0.23534679485071644,"score_spread":0.2243600639687391,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4294754906","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99009085,0.0076276823,0.00021561049,0.00016606439,0.00004831791,0.00021931563,0.0001263778,0.000032748794,0.0014729751],"genre_scores_gemma":[0.99774003,0.0012289596,0.00036693912,0.00015250583,0.00005416532,0.00009631191,0.00011978599,0.0000025421166,0.00023878357],"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99966824,0.00015498613,0.000037549886,0.000052965435,0.000046727524,0.00003955768],"domain_scores_gemma":[0.999658,0.00014702512,0.00010097124,0.000015902793,0.000022169419,0.00005603402],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00080619234,0.0002822856,0.0010774338,0.00014834583,0.0001641676,0.0002921233,0.0001815297,0.00025544784,0.0018437605],"category_scores_gemma":[0.0009046372,0.00012630982,0.000726866,0.00017296165,0.00013167471,0.00026128048,0.000144853,0.0005647999,0.00027379917],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.21542606,0.01046976,0.08889162,0.0035803998,0.0021047895,0.0010794017,0.0004173485,0.0020907694,0.065812275,0.00016425847,0.005089791,0.6048735],"study_design_scores_gemma":[0.10991778,0.32941136,0.5283196,0.0004262838,0.0024032174,0.0045627113,0.00030877985,0.0036510027,0.011343772,0.00027143813,0.009327822,0.000056352008],"about_ca_topic_score_codex":0.00026564128,"about_ca_topic_score_gemma":0.0006710121,"teacher_disagreement_score":0.0018437605,"about_ca_system_score_codex":0.00027859907,"about_ca_system_score_gemma":0.00021789255,"threshold_uncertainty_score":0.0061679482},"labels":[],"label_agreement":null},{"id":"W4297460252","doi":"10.1111/jdv.18613","title":"The effects of systemic immunomodulatory treatments on <scp>COVID</scp>‐19 outcomes in patients with atopic dermatitis: Results from the global <scp>SECURE‐AD</scp> registry","year":2022,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; University of Toronto","funders":"Universiteit van Amsterdam; NIHR Biomedical Research Centre, Royal Marsden NHS Foundation Trust/Institute of Cancer Research","keywords":"Medicine; Atopic dermatitis; Coronavirus disease 2019 (COVID-19); Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); 2019-20 coronavirus outbreak; Dermatology; Virology; Internal medicine; Disease","score_opus":0.006999999538581242,"score_gpt":0.23569494688694717,"score_spread":0.22869494734836593,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4297460252","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99306244,0.0020344576,0.000097254044,0.00008174396,0.000010484082,0.000017767443,0.0038891155,0.0000050452304,0.0008015162],"genre_scores_gemma":[0.9947014,0.0006874598,0.00009468975,0.0000387827,0.000020460018,0.0000218052,0.004343734,0.000004332433,0.000087325505],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99832636,0.00057794777,0.0003077716,0.00029047922,0.00032699254,0.00017040438],"domain_scores_gemma":[0.99384815,0.0012033127,0.0040020724,0.00028462723,0.00039465245,0.00026712054],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020168205,0.0002434739,0.00043418104,0.00073296804,0.00020673704,0.0005648892,0.00029291643,0.00019099191,0.0012565497],"category_scores_gemma":[0.003987543,0.00013176653,0.0011421319,0.0016160914,0.00020775075,0.00058703223,0.0006747279,0.00044903776,0.00019659572],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030846635,0.0000127832445,0.99772125,0.00004851577,0.00013487622,0.000018334269,0.000018506551,0.000034957393,0.000027209118,0.000010056004,0.00017620389,0.0014888069],"study_design_scores_gemma":[0.000028356932,0.00015593116,0.9988803,0.000037892176,0.0001433478,0.0001522833,0.0000831161,0.00011147171,0.000064605076,0.000016740487,0.00032293604,0.0000028897462],"about_ca_topic_score_codex":0.0017219366,"about_ca_topic_score_gemma":0.002834137,"teacher_disagreement_score":0.0020168205,"about_ca_system_score_codex":0.00034283003,"about_ca_system_score_gemma":0.00037509087,"threshold_uncertainty_score":0.010666132},"labels":[],"label_agreement":null},{"id":"W4298088553","doi":"10.1111/jdv.18622","title":"Monkeypox vaccine: Special considerations for dermatologic patients","year":2022,"lang":"en","type":"letter","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Poxvirus research and outbreaks","field":"Immunology and Microbiology","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Monkeypox; Vaccinia; Smallpox; Virology; Medicine; Virus; Smallpox vaccine; Herd immunity; Vaccination; Immunity; Attenuated vaccine; Smallpox virus; Immune system; Immunology; Biology; Gene","score_opus":0.027140189996464833,"score_gpt":0.2650258607964269,"score_spread":0.2378856707999621,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4298088553","genre_codex":"review","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.050463308,0.4684127,0.011397648,0.3491203,0.021457687,0.0006560553,0.00036494885,0.0006219557,0.09750541],"genre_scores_gemma":[0.3659826,0.2970542,0.028614141,0.15294595,0.099996895,0.0011326716,0.0007649785,0.00026373568,0.053244878],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996871,0.00011539996,0.000033802833,0.000032161846,0.00007825096,0.000053245087],"domain_scores_gemma":[0.99900573,0.0003554168,0.00008372603,0.000040333263,0.00013634018,0.0003784458],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00075290824,0.000370984,0.00062057195,0.00027622795,0.0007663928,0.001218256,0.00043900433,0.003570353,0.012818294],"category_scores_gemma":[0.0023484242,0.00014206726,0.0004970133,0.00016652077,0.0003282959,0.0013638216,0.00065601355,0.0024473113,0.0032896851],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006148224,0.0004771096,0.008778251,0.0014897587,0.000045143228,0.053543475,0.00042116476,0.00047716437,0.0057925214,0.0046216683,0.30197003,0.62176883],"study_design_scores_gemma":[0.00022194139,0.00065029715,0.010454751,0.0019502153,0.000066083485,0.22622877,0.00078678154,0.00052510307,0.0011084694,0.005692859,0.75226706,0.000047731428],"about_ca_topic_score_codex":0.0003659108,"about_ca_topic_score_gemma":0.00072154176,"teacher_disagreement_score":0.012818294,"about_ca_system_score_codex":0.0003168369,"about_ca_system_score_gemma":0.00057101384,"threshold_uncertainty_score":0.04288149},"labels":[],"label_agreement":null},{"id":"W4300166872","doi":"10.1111/jdv.18632","title":"Development and validation of <scp>IHS4</scp>‐55, an <scp>IHS4</scp> dichotomous outcome to assess treatment effect for hidradenitis suppurativa","year":2022,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Hidradenitis Suppurativa and Treatments","field":"Medicine","cited_by":60,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"","keywords":"Hidradenitis suppurativa; Medicine; Outcome (game theory); Internal medicine","score_opus":0.05331564288036937,"score_gpt":0.3282484388344554,"score_spread":0.27493279595408604,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4300166872","genre_codex":"empirical","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7629078,0.015638258,0.10151685,0.002990075,0.0008878668,0.0361657,0.047981746,0.0010304127,0.030881265],"genre_scores_gemma":[0.796265,0.0022394587,0.14126228,0.0009972762,0.0002930615,0.032146893,0.02440055,0.00018408376,0.002211362],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9671016,0.01900552,0.0036831407,0.0015896797,0.008036858,0.00058338477],"domain_scores_gemma":[0.91744995,0.03858113,0.024592549,0.0043543302,0.013250588,0.001771578],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.06606474,0.0007732346,0.0012165803,0.0024776973,0.0004613584,0.0018497383,0.0015420947,0.0009996644,0.0033872358],"category_scores_gemma":[0.076794475,0.00035122407,0.0032712314,0.0015036473,0.0009614899,0.00095211464,0.001512538,0.0016156574,0.000892645],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05628604,0.002094954,0.4805401,0.0130458595,0.009300015,0.00025639444,0.0015114663,0.007231852,0.01777868,0.0064419094,0.019334236,0.38617846],"study_design_scores_gemma":[0.012937273,0.033940442,0.8491194,0.004444389,0.006345028,0.00085722154,0.0004944065,0.013708541,0.018790493,0.003723265,0.055349138,0.00029045044],"about_ca_topic_score_codex":0.00090064574,"about_ca_topic_score_gemma":0.0013395961,"teacher_disagreement_score":0.06606474,"about_ca_system_score_codex":0.0012906147,"about_ca_system_score_gemma":0.0042597353,"threshold_uncertainty_score":0.34938788},"labels":[],"label_agreement":null},{"id":"W4301401132","doi":"10.1111/jdv.18638","title":"Strategies for the enhancement of nail plate permeation of drugs to treat onychomycosis","year":2022,"lang":"en","type":"review","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Nail Diseases and Treatments","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mediprobe Research (Canada); University of Toronto","funders":"","keywords":"Medicine; Permeation; Drug; Nail plate; Nail (fastener); Dermatology; Adverse effect; Lipophilicity; Pharmacology; Nail disease; Antifungal; Chemistry; Materials science; Membrane","score_opus":0.06149874479573477,"score_gpt":0.3607334551112631,"score_spread":0.29923471031552834,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4301401132","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00059298077,0.9972494,0.0003342076,0.00016289127,0.00016704715,0.000013390505,0.000020836167,0.000013619677,0.0014455363],"genre_scores_gemma":[0.003030817,0.9951662,0.00045072733,0.00017635188,0.000079048805,0.000016601403,0.00003630893,0.000002884836,0.0010410077],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998585,0.000023061617,0.000016085836,0.000022584161,0.000059963382,0.000019759442],"domain_scores_gemma":[0.9998989,0.000044914712,0.000019683128,0.000003243106,0.00002522846,0.00000798054],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003073956,0.0006040389,0.00082493835,0.0017289625,0.00020933211,0.00067494716,0.00048643758,0.0009694111,0.0029594558],"category_scores_gemma":[0.0003161673,0.00023668332,0.00066814176,0.0008346308,0.00024918263,0.0008957769,0.00038990835,0.0014240633,0.0013342934],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010614424,0.00021985755,0.00013721055,0.04162862,0.00015285266,0.00045054778,0.00010369381,0.00069806044,0.019007597,0.0060594636,0.018433942,0.91300195],"study_design_scores_gemma":[0.00004037561,0.00035116108,0.0008584143,0.0034109254,0.00018074122,0.001988845,0.00006686201,0.00029853376,0.006595285,0.001188756,0.9849916,0.00002860257],"about_ca_topic_score_codex":0.00066211284,"about_ca_topic_score_gemma":0.0012549021,"teacher_disagreement_score":0.0029594558,"about_ca_system_score_codex":0.00036705518,"about_ca_system_score_gemma":0.00049886457,"threshold_uncertainty_score":0.009900391},"labels":[],"label_agreement":null},{"id":"W4307036499","doi":"10.1111/jdv.18687","title":"Further insights into the wider impact of childhood atopic dermatitis – Comment on “Burden of childhood atopic dermatitis on parents: Fathers' and mothers' respective feelings” by Mahé et al.","year":2022,"lang":"en","type":"letter","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"","keywords":"Venereology; Atopic dermatitis; Medicine; Feeling; Family medicine; Dermatology; Psychology","score_opus":0.009628545221443718,"score_gpt":0.26683937376847067,"score_spread":0.2572108285470269,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4307036499","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0004583324,0.00072717684,0.00002590555,0.98943233,0.00865441,0.0000033209262,0.00003173064,0.000012001526,0.0006547744],"genre_scores_gemma":[0.0042090365,0.00070584426,0.000056369154,0.9771239,0.016258122,0.000016607544,0.000015534773,0.000013163887,0.0016014682],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99727696,0.0011084626,0.00031632633,0.00034379988,0.0005630325,0.00039143168],"domain_scores_gemma":[0.9889247,0.0067900377,0.00071556476,0.00029337633,0.0018448454,0.0014314973],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0039453395,0.0007028707,0.0010207769,0.0004715884,0.004123655,0.0025726366,0.0018741257,0.03397458,0.0055860667],"category_scores_gemma":[0.022656366,0.0006509,0.0010488024,0.00066681445,0.0029570297,0.004119177,0.0017186392,0.033206947,0.0039752405],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000045940913,0.000019104778,0.00086228235,0.000063019834,0.000013542021,0.0027373983,0.0010266772,0.000036909423,0.00016526233,0.000858196,0.99076277,0.00340884],"study_design_scores_gemma":[0.00015707627,0.00012492853,0.0049102698,0.000727788,0.000063383435,0.010723869,0.0069813505,0.00030914563,0.00055741554,0.0069199563,0.96836245,0.0001624426],"about_ca_topic_score_codex":0.010896827,"about_ca_topic_score_gemma":0.01329631,"teacher_disagreement_score":0.03397458,"about_ca_system_score_codex":0.0034175047,"about_ca_system_score_gemma":0.0035680737,"threshold_uncertainty_score":0.02479589},"labels":[],"label_agreement":null},{"id":"W4307580685","doi":"10.1111/jdv.18698","title":"Effectiveness of a standardized skin care regimen to prevent atopic dermatitis in infants at risk for atopy: A randomized, pragmatic, parallel‐group study","year":2022,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Klohn Crippen Berger (Canada)","funders":"","keywords":"Atopic dermatitis; Medicine; Regimen; Atopy; Randomized controlled trial; Incidence (geometry); Cumulative incidence; Eczema Area and Severity Index; Sensitive skin; Pediatrics; Dermatology; Allergy; Internal medicine; Cohort; Immunology","score_opus":0.007823724954158845,"score_gpt":0.2830232630184037,"score_spread":0.27519953806424485,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4307580685","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9762006,0.0018708616,0.001012837,0.0002625275,0.00050057855,0.019153187,0.00035108862,0.000062930216,0.00058533775],"genre_scores_gemma":[0.96048564,0.0017125795,0.0058282926,0.0005642363,0.0005227223,0.029632417,0.0004071579,0.000015281292,0.00083160517],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9930735,0.0045474065,0.0006568569,0.000728606,0.0006114569,0.00038213836],"domain_scores_gemma":[0.9958106,0.0013059606,0.0009725723,0.00050924334,0.00040373116,0.0009979028],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0056385365,0.0020099166,0.0049309167,0.0011068739,0.0009541316,0.0009605367,0.0013077753,0.0027312045,0.0044899657],"category_scores_gemma":[0.007741473,0.0010322286,0.0026063307,0.00080178515,0.0015281505,0.0008922367,0.0009524952,0.0018631474,0.00048425235],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9366413,0.043084383,0.0006950685,0.0012665117,0.00078484224,0.000052305528,0.00009826761,0.00027120602,0.0016901991,0.000084865525,0.00019278728,0.015138255],"study_design_scores_gemma":[0.80780935,0.18924502,0.0018290856,0.000056022316,0.00036186824,0.000018082146,0.000023749524,0.00016750842,0.00023538279,0.00005549482,0.00018531787,0.000013121537],"about_ca_topic_score_codex":0.0015922793,"about_ca_topic_score_gemma":0.0015639233,"teacher_disagreement_score":0.0056385365,"about_ca_system_score_codex":0.0012408764,"about_ca_system_score_gemma":0.002550278,"threshold_uncertainty_score":0.029819787},"labels":[],"label_agreement":null},{"id":"W4308772283","doi":"10.1111/jdv.18726","title":"An open source pipeline for quantitative immunohistochemistry image analysis of inflammatory skin disease using artificial intelligence","year":2022,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Cutaneous Melanoma Detection and Management","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"UCB Pharma; Sanofi Genzyme; Medical Research Council Canada; Rosetrees Trust; Newcastle University; Psoriasis Association; National Institute for Health and Care Research; Regeneron Pharmaceuticals; Medical Research Council; Sanofi; Amgen","keywords":"Computer science; Segmentation; Artificial intelligence; Ground truth; Digital pathology; Dermis; Pipeline (software); Pattern recognition (psychology); Epidermis (zoology); Papillary dermis; Pathology; Computer vision; Medicine; Anatomy","score_opus":0.03975647994070301,"score_gpt":0.3485434769949706,"score_spread":0.3087869970542676,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308772283","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0048732823,0.0008331877,0.71827716,0.00028474358,0.00017603117,0.0004768028,0.010574107,0.2617388,0.0027658779],"genre_scores_gemma":[0.050900314,0.00084239664,0.88192344,0.0006269517,0.00008756043,0.0020514592,0.03759575,0.017208442,0.0087637],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9990976,0.00009489624,0.00008856916,0.00028227948,0.00033264395,0.00010401599],"domain_scores_gemma":[0.9992442,0.00021537673,0.0000934061,0.00013531471,0.0002528916,0.00005887915],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018288053,0.002202894,0.0010432587,0.0022923474,0.0006336814,0.002075184,0.0028562448,0.0016270183,0.022344502],"category_scores_gemma":[0.0027865137,0.0012029886,0.0023679244,0.0010409257,0.0004318702,0.001131641,0.00211143,0.0017579282,0.015410887],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011215964,0.0003447143,0.0049065393,0.0032934505,0.0010044015,0.0011455289,0.00044035207,0.029490735,0.13393858,0.0059220265,0.2024834,0.6159088],"study_design_scores_gemma":[0.00035212954,0.00036392512,0.010813478,0.00038071285,0.0002820297,0.0016929166,0.00014577642,0.628833,0.13549142,0.02221902,0.19911703,0.00030863014],"about_ca_topic_score_codex":0.003120216,"about_ca_topic_score_gemma":0.0051029017,"teacher_disagreement_score":0.022344502,"about_ca_system_score_codex":0.0010132104,"about_ca_system_score_gemma":0.001765335,"threshold_uncertainty_score":0.07474983},"labels":[],"label_agreement":null},{"id":"W4309095504","doi":"10.1111/jdv.18727","title":"Spesolimab, an anti‐interleukin‐36 receptor antibody, in patients with moderate‐to‐severe atopic dermatitis: Results from a multicentre, randomized, double‐blind, placebo‐controlled, phase <scp>IIa</scp> study","year":2022,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Boehringer Ingelheim (Canada); Innovaderm (Canada)","funders":"Boehringer Ingelheim","keywords":"Eczema Area and Severity Index; Medicine; Atopic dermatitis; Placebo; Clinical endpoint; Internal medicine; Dermatology Life Quality Index; Randomized controlled trial; Adverse effect; Gastroenterology; Interleukin; Minimal clinically important difference; Immunology; Cytokine; Disease; Pathology","score_opus":0.015783586907225238,"score_gpt":0.28983117463656743,"score_spread":0.2740475877293422,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309095504","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9862366,0.009888527,0.0005948759,0.00037029374,0.00018897573,0.0012502648,0.0005544068,0.000053961005,0.0008621838],"genre_scores_gemma":[0.99209446,0.0034575982,0.0010540716,0.0007399925,0.00024359023,0.00086396554,0.0008403995,0.0000114460345,0.000694345],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99897325,0.00058900553,0.00009803521,0.00013814097,0.00010458231,0.0000970862],"domain_scores_gemma":[0.9986362,0.0004298516,0.00037232784,0.00011245068,0.00012416604,0.00032495923],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0038088034,0.0012108992,0.002454578,0.0002809,0.000285793,0.0007614506,0.0005652571,0.0013622437,0.002341717],"category_scores_gemma":[0.002054246,0.00047222181,0.00305206,0.00035345915,0.0006510972,0.00065533706,0.00026326114,0.0013954273,0.00038931743],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9335796,0.007423834,0.004162009,0.0014552936,0.003703231,0.00011133743,0.00010632528,0.0006010828,0.013712669,0.000068950045,0.00091290195,0.03416267],"study_design_scores_gemma":[0.84621865,0.1346842,0.014586985,0.00007383637,0.0021570455,0.00015745388,0.000025203675,0.00034303762,0.00084152375,0.00007928877,0.00080970634,0.000023086895],"about_ca_topic_score_codex":0.00037240775,"about_ca_topic_score_gemma":0.00080592115,"teacher_disagreement_score":0.0038088034,"about_ca_system_score_codex":0.00044881075,"about_ca_system_score_gemma":0.00084247574,"threshold_uncertainty_score":0.020143092},"labels":[],"label_agreement":null},{"id":"W4309176875","doi":"10.1111/jdv.18760","title":"Chronic dermatoses exacerbation after <scp>COVID</scp>‐19 vaccination—A systematic review","year":2022,"lang":"en","type":"review","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Dermatological and COVID-19 studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Venereology; Tel aviv; Rappaport; Medicine; Family medicine; Library science; Dermatology; Theology","score_opus":0.05205354138350329,"score_gpt":0.3392483392063504,"score_spread":0.28719479782284707,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309176875","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0014163544,0.9979261,0.000030330651,0.000082670624,0.00006324393,0.00009472668,0.00025380048,0.0000031042623,0.00012971691],"genre_scores_gemma":[0.022465236,0.9763738,0.0002080407,0.00047025137,0.0000607857,0.0001314026,0.00019052712,0.000002390443,0.00009761576],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9980185,0.0005562185,0.00078317686,0.00023230615,0.000279444,0.00013025728],"domain_scores_gemma":[0.9956682,0.0025853312,0.0013067923,0.000061651444,0.000273492,0.00010455139],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023819879,0.0010698508,0.005266862,0.0039212327,0.00037667484,0.0017424729,0.0009204368,0.0015032543,0.0054891547],"category_scores_gemma":[0.008289043,0.0007930902,0.0068026655,0.004259076,0.0005140753,0.0012772937,0.0012921429,0.0010713193,0.00027992445],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006857167,0.000039945844,0.00236547,0.93553036,0.023229547,0.00013101062,0.00011468632,0.00007872817,0.00018778167,0.000120182085,0.0021425737,0.035373908],"study_design_scores_gemma":[0.0015670755,0.0005262955,0.020360213,0.69661057,0.25152925,0.00083408225,0.0004589054,0.00010493495,0.00021118305,0.00029357272,0.027428797,0.00007512627],"about_ca_topic_score_codex":0.008753515,"about_ca_topic_score_gemma":0.031981353,"teacher_disagreement_score":0.008753515,"about_ca_system_score_codex":0.0017274471,"about_ca_system_score_gemma":0.0041691554,"threshold_uncertainty_score":0.018362999},"labels":[],"label_agreement":null},{"id":"W4310957487","doi":"10.1111/jdv.18810","title":"Systematic review of newer agents for the management of alopecia areata in adults: Janus kinase inhibitors, biologics and phosphodiesterase‐4 inhibitors","year":2022,"lang":"en","type":"review","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Hair Growth and Disorders","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mediprobe Research (Canada); Women's College Hospital; University of Toronto","funders":"","keywords":"Medicine; Apremilast; Alopecia areata; Adverse effect; Secukinumab; Janus kinase; Dermatology; Tofacitinib; Randomized controlled trial; Clinical trial; Regimen; Dupilumab; Atopic dermatitis; Pharmacology; Internal medicine; Psoriasis","score_opus":0.03465199132448457,"score_gpt":0.3132057574868744,"score_spread":0.2785537661623898,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310957487","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0009258802,0.99699235,0.00016762911,0.00016635412,0.00010868253,0.00041329733,0.0007869036,0.000011247449,0.0004277458],"genre_scores_gemma":[0.007484145,0.990257,0.0004817952,0.00052844454,0.00007935763,0.00054816855,0.00039487673,0.0000066107746,0.0002194627],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9963941,0.0009324229,0.0016557085,0.00028547287,0.00062755804,0.00010481508],"domain_scores_gemma":[0.9907114,0.005872427,0.002268958,0.0001279791,0.00088853505,0.00013079433],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0038996965,0.001294214,0.008374135,0.0077059004,0.00056435965,0.0017968486,0.0015225867,0.0014303466,0.0070106434],"category_scores_gemma":[0.013567471,0.00066567597,0.007302194,0.009061217,0.0006015062,0.0016899663,0.0009793773,0.00085893954,0.00051159307],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016122662,0.000009772797,0.00018395459,0.97607976,0.0045859977,0.000068413,0.00005784321,0.00005023186,0.00017080127,0.00009638591,0.0012489732,0.01728672],"study_design_scores_gemma":[0.00050734374,0.00037040847,0.0028518985,0.86918765,0.09329127,0.00047388554,0.00016847566,0.00007974865,0.00026597644,0.0002667459,0.032501087,0.000035432422],"about_ca_topic_score_codex":0.0059023863,"about_ca_topic_score_gemma":0.017797595,"teacher_disagreement_score":0.008374135,"about_ca_system_score_codex":0.0022836244,"about_ca_system_score_gemma":0.007021178,"threshold_uncertainty_score":0.023452938},"labels":[],"label_agreement":null},{"id":"W4313575311","doi":"10.1111/jdv.18851","title":"Generalized pustular psoriasis: A global Delphi consensus on clinical course, diagnosis, treatment goals and disease management","year":2023,"lang":"en","type":"review","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":77,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; Queen's University","funders":"Boehringer Ingelheim","keywords":"Medicine; Psoriasis; Delphi method; Disease; Generalized pustular psoriasis; Intensive care medicine; Disease management; Delphi; MEDLINE; Dermatology; Pathology; Artificial intelligence","score_opus":0.09660565050261666,"score_gpt":0.3754584025731065,"score_spread":0.2788527520704898,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4313575311","genre_codex":"commentary","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.19279385,0.12739098,0.124511115,0.41534597,0.017006373,0.051816594,0.0035650702,0.00062897056,0.06694106],"genre_scores_gemma":[0.57650846,0.069349766,0.23601605,0.062700324,0.0023247183,0.04383267,0.003617478,0.00031174487,0.005338825],"study_design_codex":"design_other","study_design_gemma":"qualitative","domain_scores_codex":[0.8425925,0.11577541,0.022472767,0.003214246,0.010711594,0.0052335165],"domain_scores_gemma":[0.87707543,0.060006965,0.0069533396,0.0033123575,0.045201756,0.007450125],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.21195774,0.0015202326,0.0022556505,0.00593148,0.003729209,0.0037357572,0.0036061087,0.005031421,0.0030163901],"category_scores_gemma":[0.13490406,0.0012874808,0.004013586,0.0029562705,0.004600999,0.004854104,0.014301448,0.0072252317,0.0011898278],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001519776,0.0005056262,0.021033486,0.0523081,0.0012419492,0.0028762182,0.17014563,0.0034988967,0.010554494,0.03311541,0.17242931,0.5307711],"study_design_scores_gemma":[0.00089496677,0.0012888209,0.025642151,0.17446566,0.001285162,0.0068402467,0.17268606,0.0056142807,0.0035626674,0.0786446,0.528134,0.0009413133],"about_ca_topic_score_codex":0.003485388,"about_ca_topic_score_gemma":0.0032079678,"teacher_disagreement_score":0.21195774,"about_ca_system_score_codex":0.009114529,"about_ca_system_score_gemma":0.043652218,"threshold_uncertainty_score":0.9717964},"labels":[],"label_agreement":null},{"id":"W4313575980","doi":"10.1111/jdv.18852","title":"Identifying unmet needs and challenges in the definition of a plaque in mycosis fungoides: An EORTC‐CLTG/ISCL survey","year":2023,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Cutaneous lymphoproliferative disorders research","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Mycosis fungoides; Medicine; Dermatology; Family medicine; Pathology; Lymphoma","score_opus":0.21740497982629503,"score_gpt":0.36398013582561156,"score_spread":0.14657515599931653,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4313575980","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98902965,0.0014042151,0.00023938339,0.0049310713,0.000039245166,0.0001196137,0.0012706252,0.000012189117,0.0029540204],"genre_scores_gemma":[0.9966271,0.0007601982,0.000336783,0.0009757044,0.000033760094,0.000115492825,0.0008868749,0.000008613459,0.0002553845],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9945239,0.002115586,0.00085626426,0.00033374043,0.0011804344,0.0009901576],"domain_scores_gemma":[0.9910143,0.0030991558,0.002581044,0.00019246979,0.0016505707,0.0014623831],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010416489,0.00015744887,0.00037348733,0.0011964793,0.0006054112,0.0010335078,0.00046931035,0.0010180455,0.0017152628],"category_scores_gemma":[0.014540272,0.00016398833,0.00037467649,0.0012896077,0.00051629124,0.0013453548,0.001846248,0.00078339473,0.00030707192],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014418998,0.00007108413,0.97369766,0.00033350062,0.000031285148,0.00021788054,0.004892042,0.00015143096,0.00032042252,0.00013345548,0.0030218244,0.01698515],"study_design_scores_gemma":[0.000007637652,0.00010613943,0.9842626,0.00024418923,0.000012282407,0.00029677653,0.010228855,0.00024020932,0.000059649134,0.00007697132,0.0044532362,0.000011401446],"about_ca_topic_score_codex":0.007335618,"about_ca_topic_score_gemma":0.008710717,"teacher_disagreement_score":0.010416489,"about_ca_system_score_codex":0.0015379266,"about_ca_system_score_gemma":0.0016978856,"threshold_uncertainty_score":0.05508834},"labels":[],"label_agreement":null},{"id":"W4317233295","doi":"10.1111/jdv.18881","title":"Estimands for atopic dermatitis clinical trials: Expert opinion on the importance of intercurrent events","year":2023,"lang":"en","type":"review","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Innovaderm (Canada)","funders":"Syddansk Universitet; Novartis Pharma; Regeneron Pharmaceuticals; Sanofi; Pfizer","keywords":"Medicine; Atopic dermatitis; Clinical trial; Harmonization; Intensive care medicine; Expert opinion; Clinical Practice; Family medicine; Dermatology; Pathology","score_opus":0.32747608371670206,"score_gpt":0.5098488525936481,"score_spread":0.18237276887694603,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4317233295","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001564476,0.9643285,0.009799642,0.019317115,0.0028494403,0.0003329864,0.00043563766,0.00010306608,0.002677168],"genre_scores_gemma":[0.017669942,0.898373,0.036942557,0.03499584,0.00654523,0.0026861145,0.0007389218,0.00018989212,0.0018584481],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.86363965,0.100214615,0.016694393,0.0037274284,0.015060647,0.00066328264],"domain_scores_gemma":[0.4864738,0.48401234,0.013383777,0.0058639487,0.009452259,0.0008139702],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.1301429,0.001577676,0.007837747,0.002783652,0.00045987082,0.0062785563,0.005531772,0.006888976,0.008802701],"category_scores_gemma":[0.32960972,0.001148611,0.00832166,0.003143341,0.0027171643,0.0048898356,0.0025255734,0.010819408,0.0023747764],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010306467,0.00005811113,0.0008587265,0.1562139,0.008691721,0.00018916195,0.0003816824,0.0026047912,0.00024943557,0.057785634,0.085381,0.68655527],"study_design_scores_gemma":[0.0016933949,0.0002928943,0.001735252,0.31183764,0.0107407905,0.00062322244,0.00015670387,0.002620766,0.0005955587,0.10652968,0.5629952,0.00017895769],"about_ca_topic_score_codex":0.002000282,"about_ca_topic_score_gemma":0.0023346504,"teacher_disagreement_score":0.8698571,"about_ca_system_score_codex":0.0035314234,"about_ca_system_score_gemma":0.006949841,"threshold_uncertainty_score":0.6882696},"labels":[],"label_agreement":null},{"id":"W4317233319","doi":"10.1111/jdv.18880","title":"Lentigo maligna (melanoma): A systematic review and meta‐analysis on surgical techniques and presurgical mapping by reflectance confocal microscopy","year":2023,"lang":"en","type":"review","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Cutaneous Melanoma Detection and Management","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"","keywords":"Medicine; Lentigo maligna; Lentigo maligna melanoma; Confocal; Dermatology; Confocal microscopy; Melanoma; Optics","score_opus":0.06035888434127823,"score_gpt":0.3608536105608194,"score_spread":0.30049472621954115,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4317233319","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.005502181,0.9935946,0.00019301729,0.00011527941,0.000058087764,0.000097327415,0.0002946369,0.000007414599,0.00013738722],"genre_scores_gemma":[0.16401087,0.8324977,0.0012756736,0.0006309122,0.00017815571,0.0005706841,0.00058391446,0.000014680812,0.00023755169],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.994639,0.002321296,0.0016734464,0.0006318873,0.0005494905,0.00018490128],"domain_scores_gemma":[0.9873585,0.009245409,0.0022476716,0.00030933364,0.00067596906,0.00016315449],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007929857,0.0017950071,0.011877283,0.004862512,0.000508814,0.002283282,0.00149487,0.0016241581,0.002657454],"category_scores_gemma":[0.016969696,0.0009758003,0.022731217,0.006708533,0.00051819603,0.0011647008,0.0009929821,0.0012267716,0.00018676386],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002039405,0.000042656313,0.010011076,0.47138655,0.49894175,0.00018253573,0.00011863426,0.00033105112,0.00029930563,0.00012637104,0.0006288717,0.01589187],"study_design_scores_gemma":[0.0004997938,0.00022416224,0.010570937,0.029423816,0.95664185,0.00015918344,0.00007023418,0.00013573273,0.00010456712,0.00014513804,0.0019999188,0.000024560251],"about_ca_topic_score_codex":0.005706581,"about_ca_topic_score_gemma":0.01358831,"teacher_disagreement_score":0.011877283,"about_ca_system_score_codex":0.0013708834,"about_ca_system_score_gemma":0.0021499924,"threshold_uncertainty_score":0.04193759},"labels":[],"label_agreement":null},{"id":"W4317930699","doi":"10.1111/jdv.18922","title":"Expert consensus on the systemic treatment of atopic dermatitis in special populations","year":2023,"lang":"en","type":"review","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":83,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Government of New Brunswick; Dalhousie University; University of New Brunswick; University of Calgary; Lynde Centre for Dermatology; Women's College Hospital; Sunnybrook Health Science Centre; SKiN Health; McMaster University; University of Ottawa; McGill University; McGill University Health Centre; Health Sciences Centre; Ottawa Hospital; McMaster University Medical Centre; Surrey Memorial Hospital; University of British Columbia; Probity Medical Research; University of Toronto","funders":"AbbVie","keywords":"Medicine; Atopic dermatitis; Systemic therapy; Dupilumab; Intensive care medicine; MEDLINE; Dermatology; Cancer; Internal medicine; Breast cancer","score_opus":0.12251869145812352,"score_gpt":0.370735321670961,"score_spread":0.2482166302128375,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4317930699","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00035994357,0.9775954,0.0016020974,0.012196964,0.0028065739,0.00016904996,0.00012451132,0.000019838335,0.0051255315],"genre_scores_gemma":[0.0047360514,0.9816388,0.0041849287,0.0061595566,0.0011668425,0.00018408112,0.00031642444,0.00000978688,0.001603594],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9934689,0.0024001782,0.0015522661,0.00045983502,0.0018109457,0.00030789978],"domain_scores_gemma":[0.9883946,0.005883147,0.0012128814,0.00022818988,0.0038362406,0.00044483412],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.015704969,0.0010654128,0.0021978219,0.0054536546,0.00056548906,0.0018017972,0.0025564192,0.003507998,0.004273154],"category_scores_gemma":[0.015751068,0.00045908202,0.0021646516,0.0038050348,0.0009908425,0.0027176335,0.001897627,0.002905949,0.0014858922],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011005866,0.00008261002,0.00030149857,0.08443278,0.00028878558,0.0008091148,0.00068306254,0.00066294405,0.0014318785,0.008567887,0.11674365,0.7858858],"study_design_scores_gemma":[0.0000720811,0.000111691006,0.0013095696,0.13263868,0.00070697407,0.0025334898,0.00051609875,0.00023783144,0.0007038093,0.0071084043,0.8540046,0.000056869212],"about_ca_topic_score_codex":0.0020856287,"about_ca_topic_score_gemma":0.0030819438,"teacher_disagreement_score":0.015704969,"about_ca_system_score_codex":0.0021194397,"about_ca_system_score_gemma":0.008297302,"threshold_uncertainty_score":0.08305681},"labels":[],"label_agreement":null},{"id":"W4318027083","doi":"10.1111/jdv.18914","title":"Efficacy and safety of etrasimod, a sphingosine 1‐phosphate receptor modulator, in adults with moderate‐to‐severe atopic dermatitis (<scp>ADVISE</scp>)","year":2023,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Innovaderm (Canada)","funders":"","keywords":"Medicine; Eczema Area and Severity Index; Placebo; Atopic dermatitis; Randomized controlled trial; Clinical endpoint; Internal medicine; Adverse effect; Placebo-controlled study; Double blind; Dermatology","score_opus":0.010371647252086395,"score_gpt":0.24787866381549073,"score_spread":0.23750701656340434,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4318027083","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9901896,0.0070344936,0.00020543436,0.0002805792,0.00009701941,0.0007791154,0.00039769596,0.000026244841,0.0009897612],"genre_scores_gemma":[0.9940501,0.0027654453,0.0006749632,0.0004778033,0.00021113991,0.00083234394,0.00031673163,0.0000041391377,0.0006673258],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9995746,0.00020367005,0.00005860927,0.000067327484,0.000052987958,0.000042696767],"domain_scores_gemma":[0.99927574,0.00024313042,0.00022769197,0.000034785942,0.000057444344,0.00016133772],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013170068,0.0006372565,0.0012014152,0.00018475004,0.00024994212,0.00041808048,0.00029994216,0.0008481075,0.0037831925],"category_scores_gemma":[0.0013275607,0.00030934712,0.00090918335,0.0001294821,0.00033153172,0.0004785378,0.000196048,0.0011220189,0.0004814787],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.86997575,0.01310199,0.009106959,0.0015542172,0.0014620388,0.00014458189,0.00012637915,0.00028533672,0.025072794,0.000088038,0.0013835595,0.07769832],"study_design_scores_gemma":[0.60727525,0.34181425,0.044058412,0.0001687424,0.0014854545,0.00033943748,0.000066020446,0.00048370849,0.0025622805,0.00010951488,0.0016167084,0.000020286267],"about_ca_topic_score_codex":0.00022084353,"about_ca_topic_score_gemma":0.00068099034,"teacher_disagreement_score":0.0037831925,"about_ca_system_score_codex":0.0002480924,"about_ca_system_score_gemma":0.00045039714,"threshold_uncertainty_score":0.012656033},"labels":[],"label_agreement":null},{"id":"W4318391618","doi":"10.1111/jdv.18926","title":"The burden of alopecia areata: A scoping review focusing on quality of life, mental health and work productivity","year":2023,"lang":"en","type":"review","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Hair Growth and Disorders","field":"Medicine","cited_by":108,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Lynde Centre for Dermatology; Holland Bloorview Kids Rehabilitation Hospital; Guenther Dermatology Research Centre; Probity Medical Research; University of British Columbia; SKiN Health; Western University; Queen's University; University of Calgary; McGill University","funders":"AbbVie; Valeant Pharmaceuticals International; Amgen; Pfizer; Allergan; Bristol-Myers Squibb","keywords":"Presenteeism; Absenteeism; Quality of life (healthcare); Medicine; Depression (economics); Mental health; Anxiety; Alopecia areata; Observational study; Productivity; Cross-sectional study; Cohort; Gerontology; Indirect costs; Disease burden; Disease; Psychiatry; Psychology; Internal medicine; Nursing; Dermatology","score_opus":0.11970512713029498,"score_gpt":0.41291695415087437,"score_spread":0.2932118270205794,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4318391618","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00073533045,0.99840957,0.00006373211,0.00024316629,0.00009638159,0.000058798112,0.00013026755,0.0000034013592,0.00025937156],"genre_scores_gemma":[0.0051728557,0.9940796,0.0001647169,0.000228204,0.0000643142,0.00009596414,0.00011936168,0.0000021700785,0.00007284676],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99600595,0.0011466603,0.0015154794,0.00029397782,0.0008734665,0.0001644267],"domain_scores_gemma":[0.9790236,0.016065603,0.0030856351,0.00021907919,0.0014427546,0.00016335405],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004879023,0.0012481314,0.0044656126,0.0115557425,0.0007099816,0.0033964233,0.0011832126,0.0021124412,0.002783751],"category_scores_gemma":[0.021270644,0.0007711664,0.0055366084,0.010920061,0.0007506969,0.0019079645,0.0014998813,0.0012397092,0.00027122573],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014300733,0.000030036259,0.0012795639,0.85223806,0.0040315,0.00023014306,0.0005526429,0.00024860087,0.00027927977,0.0005114612,0.0036082808,0.1368474],"study_design_scores_gemma":[0.00004780953,0.0001306759,0.0057309535,0.9328082,0.01954908,0.0008902976,0.000544695,0.00011102794,0.0001336136,0.000446435,0.03957313,0.000034114437],"about_ca_topic_score_codex":0.007894576,"about_ca_topic_score_gemma":0.014389576,"teacher_disagreement_score":0.0115557425,"about_ca_system_score_codex":0.0023545811,"about_ca_system_score_gemma":0.0073038563,"threshold_uncertainty_score":0.02580309},"labels":[],"label_agreement":null},{"id":"W4318393743","doi":"10.1111/jdv.18925","title":"Tapinarof for psoriasis and atopic dermatitis: 15 years of clinical research","year":2023,"lang":"en","type":"review","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Innovaderm (Canada)","funders":"","keywords":"Medicine; Psoriasis; Atopic dermatitis; Dermatology; Discontinuation; Clinical trial; Drug; Hand dermatitis; Contact dermatitis; Allergy; Surgery; Internal medicine; Pharmacology; Immunology","score_opus":0.23641071883897655,"score_gpt":0.4869919387398765,"score_spread":0.2505812199009,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4318393743","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006604399,0.9991862,0.000041830248,0.00018428618,0.00011329627,0.0000040293357,0.000006958748,0.0000037412506,0.00039352308],"genre_scores_gemma":[0.00041311615,0.99890745,0.000103037026,0.0002298395,0.00010801566,0.0000050695658,0.000017551885,0.0000014385566,0.0002144302],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99960786,0.000077833196,0.000072371746,0.000059554768,0.00014951178,0.00003289507],"domain_scores_gemma":[0.9990783,0.00054170797,0.000104042556,0.000027502094,0.00018849144,0.000059866215],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001695549,0.0009026367,0.0018413354,0.002756833,0.00032295243,0.0013081316,0.0009375142,0.0012453983,0.004679972],"category_scores_gemma":[0.0013653979,0.0003138315,0.00086616917,0.002981322,0.0006663304,0.0018468255,0.0009255899,0.0022406464,0.0018136563],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010283891,0.000079569225,0.00010818152,0.02481294,0.000115641546,0.00011996903,0.00010290974,0.0001740051,0.0009016214,0.0028818462,0.01859021,0.9520103],"study_design_scores_gemma":[0.000046503275,0.00024084169,0.0006474258,0.015096145,0.00028048328,0.0011456329,0.000092711605,0.00006686606,0.0003005455,0.001639755,0.98042136,0.000021831467],"about_ca_topic_score_codex":0.00096521503,"about_ca_topic_score_gemma":0.0020901044,"teacher_disagreement_score":0.004679972,"about_ca_system_score_codex":0.0005608048,"about_ca_system_score_gemma":0.0013902672,"threshold_uncertainty_score":0.015656114},"labels":[],"label_agreement":null},{"id":"W4319062980","doi":"10.1111/jdv.18933","title":"Distinct presentations of scalp dissecting cellulitis manifesting with furrows and gyri","year":2023,"lang":"en","type":"letter","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Autoimmune and Inflammatory Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Activation Laboratories","funders":"","keywords":"Garcia; Humanities; Boulevard; Medicine; Library science; Cartography; Art; Geography; Archaeology","score_opus":0.021993411725704154,"score_gpt":0.2640290214093405,"score_spread":0.24203560968363633,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4319062980","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.59180063,0.010592106,0.003895295,0.15906085,0.0115792705,0.00039122324,0.0012567674,0.00030721963,0.22111657],"genre_scores_gemma":[0.9630435,0.002432642,0.0010951953,0.015816346,0.007265891,0.000049633676,0.00015714392,0.000032756554,0.010106776],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9994604,0.00011837548,0.00005496473,0.000109652254,0.00009366594,0.00016297118],"domain_scores_gemma":[0.9987791,0.0006296097,0.00013828652,0.00010166217,0.000096581076,0.00025480377],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043518707,0.0010428325,0.0006845849,0.0010239596,0.0015231777,0.0012631243,0.00073621765,0.006659774,0.006119471],"category_scores_gemma":[0.0041222945,0.00052744726,0.0005414072,0.001120996,0.001487431,0.0014600549,0.0007230796,0.0037049642,0.0015883688],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000110750574,0.000029003262,0.008054416,0.000024784369,0.000008415097,0.9822183,0.00019251723,0.00007793339,0.00053146156,0.0010385799,0.005938449,0.0017753035],"study_design_scores_gemma":[0.00006346968,0.00005582051,0.00836145,0.000058849455,0.000011227524,0.98133767,0.0003328943,0.00040443728,0.0002560393,0.0016699147,0.007429534,0.000018701792],"about_ca_topic_score_codex":0.00338323,"about_ca_topic_score_gemma":0.0036773994,"teacher_disagreement_score":0.006659774,"about_ca_system_score_codex":0.0014955584,"about_ca_system_score_gemma":0.0007960146,"threshold_uncertainty_score":0.020471632},"labels":[],"label_agreement":null},{"id":"W4322620768","doi":"10.1111/jdv.18999","title":"Psychometric validation of the generalized pustular psoriasis physician global assessment (<scp>GPPGA</scp>) and generalized pustular psoriasis area and severity index (<scp>GPPASI</scp>)","year":2023,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Innovaderm (Canada)","funders":"LEO Pharma; Pfizer; Bristol-Myers Squibb; Boehringer Ingelheim","keywords":"Medicine; Intraclass correlation; Convergent validity; Confirmatory factor analysis; Generalized pustular psoriasis; Psoriasis; Reliability (semiconductor); Severity of illness; Correlation; Internal medicine; Psychometrics; Physical therapy; Dermatology; Clinical psychology; Internal consistency; Statistics; Structural equation modeling","score_opus":0.02415150028357699,"score_gpt":0.27141775719606487,"score_spread":0.24726625691248788,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4322620768","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99545044,0.00035697364,0.0021653103,0.00012603536,0.0000389116,0.0003159163,0.00021285277,0.00001845121,0.001315053],"genre_scores_gemma":[0.99643385,0.00011360165,0.0024863968,0.000057514542,0.00002051427,0.00029830914,0.00040617635,0.000009536383,0.00017397213],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9928827,0.0035229675,0.00066021533,0.0005000208,0.0022100478,0.000224057],"domain_scores_gemma":[0.98217463,0.008331132,0.0033729777,0.0013255385,0.0041468674,0.0006488116],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.017923243,0.00041518157,0.00049426674,0.0005732354,0.00026198142,0.00063421216,0.0004677456,0.00048275903,0.00098082],"category_scores_gemma":[0.030831708,0.00020846666,0.0009975011,0.00050263316,0.0006764702,0.0005780168,0.0011241314,0.00093855686,0.00031175418],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00191007,0.0011073977,0.9087788,0.0002576011,0.0006012784,0.000081096834,0.0028371478,0.0011140531,0.0031411895,0.00030220655,0.0011544357,0.07871465],"study_design_scores_gemma":[0.00035147238,0.004634346,0.98743093,0.0001369161,0.00027170524,0.00037479485,0.0007226337,0.0029036668,0.0013344185,0.0002423518,0.001567524,0.000029169807],"about_ca_topic_score_codex":0.00057580444,"about_ca_topic_score_gemma":0.0006552238,"teacher_disagreement_score":0.017923243,"about_ca_system_score_codex":0.00035731727,"about_ca_system_score_gemma":0.00078947464,"threshold_uncertainty_score":0.09478837},"labels":[],"label_agreement":null},{"id":"W4360599495","doi":"10.1111/jdv.19059","title":"Cross‐sectional quantitative validation of the paediatric Localized Scleroderma Quality of Life Instrument (<scp>LoSQI</scp>): A disease‐specific patient‐reported outcome measure","year":2023,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Probity Medical Research; SKiN Health; Alberta Children's Hospital; University of Calgary","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","keywords":"Medicine; Quality of life (healthcare); Patient-reported outcome; Reliability (semiconductor); Confirmatory factor analysis; Psychometrics; Physical therapy; Localized Scleroderma; Convergent validity; Cross-sectional study; Exploratory factor analysis; Clinical psychology; Structural equation modeling; Pathology","score_opus":0.11456972198933654,"score_gpt":0.3267230305984744,"score_spread":0.21215330860913786,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4360599495","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99655175,0.000088046996,0.0012026479,0.00004518413,0.000010648511,0.0005027147,0.00056368916,0.0000076396045,0.001027734],"genre_scores_gemma":[0.99495995,0.00007247017,0.00256256,0.00005962626,0.000010105736,0.0009773372,0.0011261734,0.0000068090876,0.00022502693],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9951794,0.0023585947,0.00054152356,0.00040287408,0.0013254298,0.00019213228],"domain_scores_gemma":[0.9864007,0.0044653,0.0030834808,0.00077983766,0.004533158,0.00073748495],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01195823,0.00031340812,0.00028757096,0.0008439722,0.00056096737,0.00051651546,0.00042724455,0.0003880665,0.0013284341],"category_scores_gemma":[0.013855601,0.00020344558,0.0004324239,0.0007610552,0.0006473742,0.0005079623,0.00071166025,0.0006906843,0.00033165814],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015608298,0.00047300555,0.99096656,0.000048925478,0.00008905307,0.00002467703,0.0006800463,0.00013459378,0.0006002089,0.000068194626,0.00023904974,0.0065194946],"study_design_scores_gemma":[0.00004865146,0.00095074094,0.9970835,0.000020628653,0.000038027207,0.00013172548,0.00042419301,0.00032929413,0.0004001662,0.000030124198,0.00053614436,0.0000067217843],"about_ca_topic_score_codex":0.0028264108,"about_ca_topic_score_gemma":0.0046477076,"teacher_disagreement_score":0.01195823,"about_ca_system_score_codex":0.0006880665,"about_ca_system_score_gemma":0.0013014271,"threshold_uncertainty_score":0.0632419},"labels":[],"label_agreement":null},{"id":"W4362520762","doi":"10.1111/jdv.19089","title":"Adalimumab combined with methotrexate versus adalimumab monotherapy in psoriasis: Three‐year follow‐up data of a single‐blind randomized controlled trial","year":2023,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"","keywords":"Medicine; Adalimumab; Methotrexate; Activities of daily living; Randomization; Randomized controlled trial; Internal medicine; Psoriasis; Clinical trial; Physical therapy; Surgery; Rheumatoid arthritis; Dermatology","score_opus":0.06056539793169732,"score_gpt":0.29344964174290106,"score_spread":0.23288424381120373,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362520762","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9658053,0.019655362,0.0015071282,0.00081927,0.0010368391,0.0069801114,0.0021038589,0.00013251015,0.0019595108],"genre_scores_gemma":[0.97999156,0.0055069188,0.0016709402,0.0009137482,0.0006502141,0.007862615,0.0016061093,0.00003754347,0.0017603276],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.98934036,0.007230716,0.0010981405,0.00092767715,0.0008167601,0.00058635],"domain_scores_gemma":[0.98969287,0.003945274,0.0030214135,0.0011991069,0.00090393133,0.0012374026],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01130767,0.0016807538,0.007640507,0.0007973797,0.0009648325,0.0024095743,0.0012495772,0.003363264,0.006029677],"category_scores_gemma":[0.011808919,0.0009282752,0.006803957,0.0012148301,0.0018634773,0.0016874366,0.0007662818,0.0027770957,0.0009978603],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.98996514,0.0018834104,0.0006261012,0.00064650766,0.0027458945,0.000026582362,0.000030664058,0.00009377082,0.0005083755,0.000024891953,0.00017920478,0.0032693592],"study_design_scores_gemma":[0.95873564,0.033266697,0.0036196655,0.00011271537,0.0033313292,0.000036586865,0.000024224637,0.00023752793,0.00019806514,0.00008872377,0.00032755543,0.000021260143],"about_ca_topic_score_codex":0.0012180464,"about_ca_topic_score_gemma":0.0015765572,"teacher_disagreement_score":0.01130767,"about_ca_system_score_codex":0.0012135254,"about_ca_system_score_gemma":0.0019012865,"threshold_uncertainty_score":0.0598014},"labels":[],"label_agreement":null},{"id":"W4362602289","doi":"10.1111/jdv.19093","title":"Frontal fibrosing alopecia associated with lichen planus pigmentosus: A multicentre retrospective descriptive analytical study of 104 patients","year":2023,"lang":"en","type":"letter","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Genetic and rare skin diseases.","field":"Biochemistry, Genetics and Molecular Biology","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Activation Laboratories","funders":"","keywords":"Medicine; Dermatology; Retrospective cohort study; Pathology","score_opus":0.012956314150070548,"score_gpt":0.2299971964498437,"score_spread":0.21704088229977317,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362602289","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9991254,0.00011691021,0.00007038565,0.000018973693,0.0000025822499,0.000013982935,0.00013043259,0.0000025498596,0.00051867805],"genre_scores_gemma":[0.99953175,0.00006498495,0.00005306994,0.000040819403,0.000009986411,0.000009812543,0.00014098866,0.0000015425428,0.00014701622],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995703,0.000111612026,0.000044027434,0.00012136071,0.00006332688,0.000089524015],"domain_scores_gemma":[0.9991448,0.00026656408,0.00027284827,0.00010777253,0.000082433005,0.00012553348],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035020028,0.00033449472,0.00037044362,0.0011202369,0.0010003158,0.0005593717,0.00036660006,0.0005893144,0.0025172923],"category_scores_gemma":[0.0015432922,0.0005679032,0.00028692794,0.0009856584,0.0005056727,0.0004569721,0.00042211355,0.00035305522,0.000531284],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002133491,0.00009462886,0.99176073,0.000007896841,0.000022816823,0.0058991173,0.00018936252,0.000024777255,0.000530205,0.000028406883,0.00009463933,0.0011341394],"study_design_scores_gemma":[0.000039093753,0.00049180223,0.9753259,0.000007904738,0.00003354646,0.022813005,0.0005629438,0.00013675401,0.00016195182,0.000046025714,0.0003697161,0.000011275892],"about_ca_topic_score_codex":0.0034430039,"about_ca_topic_score_gemma":0.0023134053,"teacher_disagreement_score":0.0034430039,"about_ca_system_score_codex":0.00039074037,"about_ca_system_score_gemma":0.00023398272,"threshold_uncertainty_score":0.008421123},"labels":[],"label_agreement":null},{"id":"W4367317123","doi":"10.1111/jdv.19132","title":"Vitiligo induced by dupilumab treatment: A case series","year":2023,"lang":"en","type":"letter","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"melanin and skin pigmentation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Dupilumab; Vitiligo; Dermatology; Series (stratigraphy); Medicine; Atopic dermatitis; Biology; Paleontology","score_opus":0.021947270970467562,"score_gpt":0.269082531134224,"score_spread":0.24713526016375642,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4367317123","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8893286,0.024033394,0.008376675,0.02311507,0.0034825061,0.0004918,0.00077655277,0.00058540935,0.049809925],"genre_scores_gemma":[0.9867444,0.0029679965,0.0012462189,0.0026432937,0.0024895633,0.000046163208,0.0001312335,0.000050786264,0.0036803258],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9989511,0.0001653627,0.000104132734,0.00021531295,0.00017305088,0.00039112562],"domain_scores_gemma":[0.9976793,0.00090120896,0.0003785775,0.000281391,0.000117189076,0.00064246263],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00057146,0.0018980841,0.0016513207,0.0025448387,0.0037296414,0.0024900471,0.0011479077,0.00682181,0.004581702],"category_scores_gemma":[0.0041148583,0.0010459463,0.0015311218,0.0020870732,0.0016684183,0.0021948174,0.0019399981,0.0046733376,0.0014780309],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000015764135,0.000022452241,0.001689471,0.000016367005,0.000007399178,0.99654096,0.000068981106,0.00003586216,0.00014858825,0.00015543606,0.00044573055,0.0008529923],"study_design_scores_gemma":[0.00000862028,0.000013441919,0.0009843763,0.000010869457,0.000008569215,0.99806994,0.000059929458,0.00012305245,0.000080075646,0.00014466138,0.0004915207,0.0000049466425],"about_ca_topic_score_codex":0.0019917286,"about_ca_topic_score_gemma":0.0024697727,"teacher_disagreement_score":0.00682181,"about_ca_system_score_codex":0.0018881758,"about_ca_system_score_gemma":0.0009623523,"threshold_uncertainty_score":0.015327275},"labels":[],"label_agreement":null},{"id":"W4372323139","doi":"10.1111/jdv.19136","title":"Association of hidradenitis suppurativa and malignancy: A systematic review and meta‐analysis","year":2023,"lang":"en","type":"review","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Hidradenitis Suppurativa and Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Hidradenitis suppurativa; Medicine; Meta-analysis; Malignancy; Association (psychology); Dermatology; MEDLINE; Internal medicine; Disease; Psychotherapist","score_opus":0.06791551958265173,"score_gpt":0.35138110063959715,"score_spread":0.2834655810569454,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4372323139","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0032342793,0.9956318,0.00019277495,0.00012323074,0.00009607486,0.00011918742,0.00042135708,0.000010001915,0.00017132815],"genre_scores_gemma":[0.092197545,0.90473825,0.0010221074,0.00051520515,0.00017496722,0.00046151082,0.0005742319,0.000012426329,0.00030384326],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9965849,0.0015665932,0.000905543,0.00036545968,0.000397622,0.0001798968],"domain_scores_gemma":[0.99059033,0.007237001,0.0011883194,0.00026571602,0.0005972126,0.0001214874],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0058491537,0.0017015402,0.009236084,0.0040465514,0.0005058185,0.0018770206,0.0011463107,0.001407063,0.004635831],"category_scores_gemma":[0.01713894,0.00089997106,0.019132657,0.005504743,0.00042935702,0.0012192009,0.0010719079,0.0014202677,0.00033246542],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016243465,0.00003696727,0.006989683,0.54743105,0.42006147,0.00018776092,0.00009635267,0.00032646614,0.00025003758,0.00018035829,0.0017858673,0.021029707],"study_design_scores_gemma":[0.0005002009,0.00021392132,0.008641065,0.0474593,0.9385806,0.00018539371,0.00007413404,0.00016098762,0.00012045498,0.00022426652,0.0038091457,0.000030613293],"about_ca_topic_score_codex":0.0057361177,"about_ca_topic_score_gemma":0.01868964,"teacher_disagreement_score":0.009236084,"about_ca_system_score_codex":0.0014917438,"about_ca_system_score_gemma":0.0021664875,"threshold_uncertainty_score":0.030933619},"labels":[],"label_agreement":null},{"id":"W4372336289","doi":"10.1111/jdv.19161","title":"Speed of clinical improvement in the real‐world setting from patient‐reported Psoriasis Symptoms and Signs Diary: Secondary outcomes from the Psoriasis Study of Health Outcomes through 12 weeks","year":2023,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Dermatrials Research","funders":"Eli Lilly and Company","keywords":"Medicine; Psoriasis; Dermatology","score_opus":0.060568958796291525,"score_gpt":0.3297519327588512,"score_spread":0.26918297396255964,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4372336289","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95490146,0.0026777152,0.0022585695,0.0002626969,0.0001486565,0.0031923037,0.030394135,0.0001550172,0.0060094693],"genre_scores_gemma":[0.97143036,0.00058899546,0.0022352198,0.00019075192,0.0001178958,0.00383467,0.01991864,0.000038501334,0.0016450463],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99358326,0.00277485,0.001194731,0.00075985945,0.0013878186,0.00029950577],"domain_scores_gemma":[0.98136204,0.003924057,0.009448589,0.0012002226,0.00297431,0.0010908388],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009148954,0.0007814253,0.0016305681,0.0013715808,0.00055577996,0.0010845502,0.00089324726,0.0007706647,0.0030943588],"category_scores_gemma":[0.013507779,0.00034330063,0.0024872157,0.0016533338,0.0002869167,0.001041519,0.0010922004,0.0016277846,0.00091020996],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07789228,0.0047218157,0.81501955,0.0030396755,0.008051532,0.00010245901,0.00062395644,0.0019820845,0.001458722,0.00025043005,0.009287464,0.07757008],"study_design_scores_gemma":[0.0037670545,0.010655859,0.9774334,0.00011212463,0.0017308621,0.00021777838,0.00012656818,0.0010584288,0.00095902215,0.00016082294,0.0037036892,0.00007445244],"about_ca_topic_score_codex":0.0011535913,"about_ca_topic_score_gemma":0.0013995096,"teacher_disagreement_score":0.009148954,"about_ca_system_score_codex":0.0005807545,"about_ca_system_score_gemma":0.00064178114,"threshold_uncertainty_score":0.048384905},"labels":[],"label_agreement":null},{"id":"W4376611740","doi":"10.1111/jdv.19194","title":"Effect of upadacitinib on atopic hand eczema in patients with moderate‐to‐severe atopic dermatitis: Results from two randomized phase 3 trials","year":2023,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; Lynde Centre for Dermatology","funders":"Sanofi Genzyme; LEO Pharma; Galderma; Incyte; Kiniksa Pharmaceuticals; Sanofi; AbbVie; Regeneron Pharmaceuticals; Pfizer; Eli Lilly and Company","keywords":"Medicine; Placebo; Atopic dermatitis; Eczema Area and Severity Index; Post-hoc analysis; Internal medicine; Randomized controlled trial; Hand eczema; Dermatology Life Quality Index; Severity of illness; Gastroenterology; Allergy; Dermatology; Immunology; Disease; Contact dermatitis","score_opus":0.021092730408223327,"score_gpt":0.31901537388768125,"score_spread":0.2979226434794579,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4376611740","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88738906,0.1005106,0.00085278216,0.001317196,0.0006120583,0.0039687282,0.001717622,0.00013236841,0.0034995957],"genre_scores_gemma":[0.9763383,0.017992936,0.00079534284,0.0009309285,0.00025216176,0.0017845808,0.00089902506,0.000014960984,0.000991683],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9988772,0.00059733907,0.00013776959,0.00013110971,0.00013230107,0.00012423769],"domain_scores_gemma":[0.998133,0.00071165164,0.00060808763,0.00012591113,0.00017072058,0.00025061247],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0032852292,0.0010393056,0.0030454278,0.0003762514,0.000373108,0.0013607292,0.0006667696,0.0013264177,0.0032086829],"category_scores_gemma":[0.0029934566,0.0004200245,0.004099569,0.0005271291,0.0005559368,0.0008414504,0.0003358132,0.0018697325,0.00030369696],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.88749516,0.0038660076,0.0035243968,0.007849475,0.014775138,0.00012315174,0.00012764044,0.0007004322,0.004197935,0.0001449041,0.0018977606,0.07529791],"study_design_scores_gemma":[0.90120596,0.067929745,0.015026279,0.0006748712,0.010804501,0.00022558084,0.00007050847,0.00046127476,0.0009685965,0.00023629396,0.0023520954,0.00004427389],"about_ca_topic_score_codex":0.00077178696,"about_ca_topic_score_gemma":0.003382854,"teacher_disagreement_score":0.0032852292,"about_ca_system_score_codex":0.00082910794,"about_ca_system_score_gemma":0.0009528251,"threshold_uncertainty_score":0.017374158},"labels":[],"label_agreement":null},{"id":"W4377151439","doi":"10.1111/jdv.19217","title":"Combatting antifungal resistance: Paradigm shift in the diagnosis and management of onychomycosis and dermatomycosis","year":2023,"lang":"en","type":"review","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Nail Diseases and Treatments","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mediprobe Research (Canada); Women's College Hospital; University of Toronto","funders":"","keywords":"Dermatomycosis; Antifungal; Medicine; Terbinafine; Stewardship (theology); Intensive care medicine; Resistance (ecology); Itraconazole; Dermatology; Biology","score_opus":0.07412945007808655,"score_gpt":0.3630191518815363,"score_spread":0.28888970180344975,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4377151439","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000089381414,0.9989361,0.0000777665,0.00045166916,0.00013061897,0.0000022673587,0.000005314071,0.0000039117194,0.00030294232],"genre_scores_gemma":[0.0007095437,0.9985709,0.00018474406,0.00024255631,0.0001564497,0.0000030944175,0.000010866038,9.150762e-7,0.00012092032],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996612,0.00007242933,0.00006657654,0.00005186272,0.00012124148,0.000026703437],"domain_scores_gemma":[0.99920446,0.00041003918,0.00010255526,0.000018442077,0.00021634992,0.00004815689],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009497667,0.0005831851,0.0012389071,0.0025616481,0.0002742917,0.0010704303,0.0007700525,0.0013386691,0.0020439005],"category_scores_gemma":[0.0013965307,0.00018692188,0.00061127765,0.0020196962,0.0006037048,0.0014987884,0.00058207,0.0020140402,0.000790781],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000480658,0.000070714224,0.00026652197,0.024609648,0.00008754939,0.00025971417,0.000081132275,0.00033061695,0.00075338467,0.0036029862,0.01631242,0.9535773],"study_design_scores_gemma":[0.000024058463,0.00018788652,0.0020582643,0.01655121,0.000245125,0.0039704987,0.00020672643,0.0002198215,0.00046484533,0.0036315457,0.9724047,0.000035320412],"about_ca_topic_score_codex":0.0013254036,"about_ca_topic_score_gemma":0.0021539745,"teacher_disagreement_score":0.0025616481,"about_ca_system_score_codex":0.00065121765,"about_ca_system_score_gemma":0.0015173943,"threshold_uncertainty_score":0.006837547},"labels":[],"label_agreement":null},{"id":"W4377219938","doi":"10.1111/jdv.19223","title":"Characteristics of mpox positive, versus mpox negative, and mpox unsuspected clients from the Centre of Sexual Health, Public Health Service of Amsterdam, 20 May to 15 September 2022","year":2023,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Poxvirus research and outbreaks","field":"Immunology and Microbiology","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"","keywords":"Medicine; Men who have sex with men; Malaise; Outbreak; Anal sex; Transmission (telecommunications); Proctitis; Public health; Condom; Reproductive health; Chills; Demography; Gynecology; Human immunodeficiency virus (HIV); Syphilis; Internal medicine; Family medicine; Environmental health; Population; Virology; Pathology; Disease","score_opus":0.04063822112835325,"score_gpt":0.3022324717189667,"score_spread":0.2615942505906135,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4377219938","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985066,0.00011296436,0.000018986932,0.000062387524,0.0000051328047,0.000018923249,0.00041925145,0.0000043716864,0.00085126644],"genre_scores_gemma":[0.9986702,0.00011293633,0.000030699466,0.00006251341,0.000010566014,0.000021829928,0.00037997696,0.0000031906002,0.00070797396],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99946886,0.0000780181,0.000060322567,0.00011080616,0.000120952325,0.00016116207],"domain_scores_gemma":[0.99891055,0.00015257412,0.00037768294,0.000019899257,0.00010832775,0.00043092656],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038211446,0.00028834847,0.00028250233,0.0008802871,0.000753449,0.00078296487,0.00064266194,0.00057167385,0.0038810591],"category_scores_gemma":[0.0019325267,0.00034678265,0.0002018036,0.0007437709,0.00046505302,0.0005343054,0.00070912926,0.0004262408,0.0005783866],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008054044,0.0000669915,0.9974361,0.000010019649,0.0000077753575,0.00065056595,0.00046048145,0.000025268553,0.0001935113,0.000011889383,0.00030043905,0.0007564538],"study_design_scores_gemma":[0.0000066634693,0.00014005645,0.99640226,0.000012456516,0.000007159106,0.0013878006,0.001499019,0.00011006805,0.00008390298,0.000006129549,0.00034040213,0.0000040253117],"about_ca_topic_score_codex":0.025892533,"about_ca_topic_score_gemma":0.023115685,"teacher_disagreement_score":0.025892533,"about_ca_system_score_codex":0.0011085707,"about_ca_system_score_gemma":0.00075159245,"threshold_uncertainty_score":0.05148363},"labels":[],"label_agreement":null},{"id":"W4378640342","doi":"10.1111/jdv.19232","title":"Upadacitinib for moderate‐to‐severe atopic dermatitis: Stratified analysis from three randomized phase 3 trials by key baseline characteristics","year":2023,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; SKiN Health; Queen's University","funders":"Cilag; LEO Pharma; Galderma; Regeneron Pharmaceuticals; AbbVie; L'Oreal USA; Sanofi; Amgen; Pfizer; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Atopic dermatitis; Randomized controlled trial; Key (lock); Baseline (sea); Dermatology; Internal medicine","score_opus":0.04383005266787829,"score_gpt":0.3365443378977821,"score_spread":0.29271428522990384,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4378640342","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97620505,0.013081535,0.0019202842,0.0002959147,0.00014485249,0.0035491537,0.0030801843,0.00010819152,0.0016149365],"genre_scores_gemma":[0.9912209,0.0018478605,0.00095633673,0.00042528912,0.00006472654,0.0026776528,0.002344373,0.000029102423,0.00043381617],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99402195,0.0034133415,0.0006500708,0.0008293451,0.0005436546,0.00054156967],"domain_scores_gemma":[0.9941618,0.0026462919,0.0017589749,0.00063647586,0.00030958193,0.00048684658],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009764921,0.0012585956,0.004021334,0.0007205688,0.0004384481,0.001756574,0.0007791158,0.0011528768,0.0041549155],"category_scores_gemma":[0.008252013,0.00053242565,0.009281284,0.0011458697,0.00069041614,0.0010396556,0.000703617,0.0016311388,0.00035425866],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9157391,0.0015403877,0.016957918,0.0019874203,0.039338436,0.00010426955,0.00009414886,0.0013375498,0.0029370233,0.00014168533,0.0009519722,0.018869972],"study_design_scores_gemma":[0.7111109,0.07678845,0.11843697,0.0004103683,0.08426244,0.00035746547,0.00013528089,0.0027779038,0.0015767687,0.0011510056,0.0028603089,0.00013223095],"about_ca_topic_score_codex":0.00040522442,"about_ca_topic_score_gemma":0.0013410527,"teacher_disagreement_score":0.009764921,"about_ca_system_score_codex":0.0007033082,"about_ca_system_score_gemma":0.0015433516,"threshold_uncertainty_score":0.051642478},"labels":[],"label_agreement":null},{"id":"W4380606537","doi":"10.1111/jdv.19252","title":"Guselkumab for the treatment of patients with moderate‐to‐severe hidradenitis suppurativa: A phase 2 randomized study","year":2023,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Hidradenitis Suppurativa and Treatments","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research","funders":"Janssen Research and Development; InflaRx; Gemeinsame Bundesausschuss; Yale University; Sanofi","keywords":"Medicine; Psoriatic arthritis; Placebo; Randomization; Internal medicine; Psoriasis; Randomized controlled trial; Dermatology; Pathology","score_opus":0.02548360220270296,"score_gpt":0.31274471956868166,"score_spread":0.2872611173659787,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380606537","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9572616,0.016117249,0.0014732309,0.0016625687,0.0011613314,0.016568942,0.0025048028,0.00019895445,0.0030513192],"genre_scores_gemma":[0.9608981,0.0094244275,0.0035548497,0.0029706794,0.00084546563,0.01641566,0.001745907,0.000039795057,0.004105197],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9989753,0.0006044805,0.000061769686,0.00013387972,0.00008079384,0.00014378328],"domain_scores_gemma":[0.9988764,0.00035083137,0.0002511838,0.000091975686,0.0000982121,0.00033136443],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034522256,0.0016039838,0.003058529,0.00057382387,0.0004464111,0.0011380553,0.0010705808,0.0020409322,0.008888335],"category_scores_gemma":[0.0019901954,0.0009371767,0.0029141328,0.000598935,0.0009034352,0.0010990158,0.00046758694,0.0025543226,0.0010557416],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.97039175,0.010978715,0.0004498129,0.0011819028,0.0011600147,0.000041495114,0.00004250589,0.00018703111,0.0025332156,0.00007501051,0.0006581379,0.012300332],"study_design_scores_gemma":[0.9662131,0.032094173,0.0007567001,0.000026921112,0.00030713447,0.000016451368,0.000008460931,0.00009172118,0.00009577106,0.0000346701,0.0003486621,0.0000062428476],"about_ca_topic_score_codex":0.00079531525,"about_ca_topic_score_gemma":0.002388443,"teacher_disagreement_score":0.008888335,"about_ca_system_score_codex":0.0007728342,"about_ca_system_score_gemma":0.0015664689,"threshold_uncertainty_score":0.029734433},"labels":[],"label_agreement":null},{"id":"W4380785503","doi":"10.1111/jdv.19254","title":"Abrocitinib effect on patient‐reported outcomes in patients with moderate‐to‐severe atopic dermatitis: Results from phase 3 studies, including the long‐term extension <scp>JADE EXTEND</scp> study","year":2023,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; University of Toronto","funders":"Dermira; Ribon Therapeutics; LEO Pharma; Eli Lilly and Company; Galderma; Sanofi Genzyme; Incyte; Regeneron Pharmaceuticals; Sanofi; Amgen; Pfizer; GlaxoSmithKline","keywords":"Medicine; Atopic dermatitis; JADE (particle detector); Term (time); Extension (predicate logic); Dermatology; Pediatrics","score_opus":0.03790619327836579,"score_gpt":0.3323025249461746,"score_spread":0.2943963316678088,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380785503","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9278933,0.06183182,0.00045293738,0.0007839435,0.00017928644,0.00084857154,0.0036455698,0.000066364395,0.0042980653],"genre_scores_gemma":[0.98636913,0.008336899,0.0005364334,0.00090625597,0.0002159519,0.00052724243,0.0025585596,0.0000120672485,0.0005374901],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9979426,0.0011060094,0.0002517287,0.00021817947,0.00034062366,0.00014087155],"domain_scores_gemma":[0.9957482,0.0014326271,0.0017363381,0.00023174277,0.00044086063,0.0004102409],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0062730582,0.00071106805,0.0014797442,0.00030678103,0.0003172501,0.0009900951,0.00048991945,0.000719594,0.002248795],"category_scores_gemma":[0.003681967,0.00017882716,0.003604721,0.00054663746,0.00032864534,0.00071438914,0.0004116426,0.0017519973,0.00030446987],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5654151,0.012977075,0.10487168,0.008627718,0.027683806,0.00026028216,0.00044536658,0.0018541781,0.016826013,0.0002620868,0.009120102,0.25165662],"study_design_scores_gemma":[0.22518188,0.20401753,0.5333307,0.0011196234,0.0189779,0.001195022,0.0002144975,0.0016001047,0.0037008815,0.00048488134,0.010040217,0.00013671412],"about_ca_topic_score_codex":0.00049851404,"about_ca_topic_score_gemma":0.0015828339,"teacher_disagreement_score":0.0062730582,"about_ca_system_score_codex":0.00055079797,"about_ca_system_score_gemma":0.0005903634,"threshold_uncertainty_score":0.033175528},"labels":[],"label_agreement":null},{"id":"W4381189146","doi":"10.1111/jdv.19280","title":"Abrocitinib efficacy and safety in patients with moderate‐to‐severe atopic dermatitis: Results from phase 3 studies, including the long‐term extension JADE EXTEND study","year":2023,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; University of Toronto","funders":"Pfizer","keywords":"Medicine; Atopic dermatitis; JADE (particle detector); Dermatology; Term (time); Extension (predicate logic); Pediatrics","score_opus":0.042920761079305605,"score_gpt":0.3362677017214416,"score_spread":0.293346940642136,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4381189146","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8391623,0.13666323,0.0014485089,0.0016796845,0.00027186598,0.0025346049,0.0065180045,0.00018578817,0.011535983],"genre_scores_gemma":[0.9665578,0.021129105,0.0015383299,0.002598929,0.0003659269,0.0011648203,0.005345258,0.00003753583,0.0012622847],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99825305,0.0007972801,0.00020967175,0.00021769937,0.00036859282,0.0001536996],"domain_scores_gemma":[0.99632996,0.0010613267,0.0013200338,0.00030079868,0.00054278754,0.00044514387],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0076934663,0.00075125054,0.0015985477,0.0003551177,0.00048350648,0.0013665707,0.00055754784,0.0008572159,0.0024916811],"category_scores_gemma":[0.0033474902,0.00024292507,0.0033716047,0.0005317813,0.00039707002,0.00088220066,0.00043534805,0.0019947896,0.0005218499],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.330402,0.015304635,0.09711148,0.013163677,0.029724644,0.00059952075,0.0006861341,0.0028173043,0.04750395,0.0006139039,0.024387902,0.43768492],"study_design_scores_gemma":[0.25104612,0.24931355,0.40771705,0.0021301769,0.026910828,0.0039219484,0.00031712372,0.0018502225,0.010114083,0.0011364016,0.045344077,0.00019842909],"about_ca_topic_score_codex":0.00052266306,"about_ca_topic_score_gemma":0.002651169,"teacher_disagreement_score":0.0076934663,"about_ca_system_score_codex":0.0006768252,"about_ca_system_score_gemma":0.000991968,"threshold_uncertainty_score":0.04068744},"labels":[],"label_agreement":null},{"id":"W4383668374","doi":"10.1111/jdv.19324","title":"Racial representation in dermatology clinical trials, a Canadian perspective","year":2023,"lang":"en","type":"letter","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Diversity and Career in Medicine","field":"Social Sciences","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Women's College Hospital; University of Toronto","funders":"","keywords":"Medicine; Perspective (graphical); Dermatology; Representation (politics); MEDLINE; Artificial intelligence","score_opus":0.19026137157773593,"score_gpt":0.44980962966968024,"score_spread":0.2595482580919443,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4383668374","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.002002231,0.0076976945,0.00012217031,0.97351056,0.0040675197,0.000030370658,0.00026287488,0.000013156573,0.012293386],"genre_scores_gemma":[0.085423276,0.016626367,0.0011859139,0.8595061,0.030955687,0.000113468624,0.00028836212,0.000055448112,0.005845507],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.96252304,0.014972347,0.004486943,0.0019403198,0.01198147,0.0040958202],"domain_scores_gemma":[0.83159786,0.08076919,0.01116516,0.0031640227,0.043486755,0.029816944],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.043348733,0.0004334391,0.001640857,0.0027254724,0.007888416,0.008164685,0.0031304623,0.011599008,0.011207257],"category_scores_gemma":[0.12850717,0.00072577683,0.0013411465,0.0052908543,0.0064395024,0.0032182594,0.0019669263,0.011244719,0.0012769147],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005836953,0.00009043938,0.017228508,0.0006911078,0.00022226802,0.0011249284,0.0012411175,0.00047213782,0.0003986666,0.023655241,0.8881287,0.06616313],"study_design_scores_gemma":[0.0012706404,0.00033663004,0.06858796,0.005737095,0.000670475,0.0021987804,0.0043624174,0.00192312,0.00041493104,0.03994474,0.8741414,0.00041183436],"about_ca_topic_score_codex":0.7918793,"about_ca_topic_score_gemma":0.8876693,"teacher_disagreement_score":0.9566513,"about_ca_system_score_codex":0.04979813,"about_ca_system_score_gemma":0.12583676,"threshold_uncertainty_score":0.4186927},"labels":[],"label_agreement":null},{"id":"W4384484767","doi":"10.1111/jdv.19349","title":"A call for action to tackle the increasing global burden and challenges of acne","year":2023,"lang":"en","type":"letter","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Acne and Rosacea Treatments and Effects","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Acne; Call to action; Action (physics); Dermatology; Advertising","score_opus":0.06319549597392886,"score_gpt":0.3263127585567409,"score_spread":0.26311726258281204,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4384484767","genre_codex":"commentary","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00018085244,0.001050344,0.000095266114,0.98559684,0.011559423,0.0000067325755,0.000030288369,0.000032188465,0.0014479867],"genre_scores_gemma":[0.0024923007,0.0019851231,0.0010826901,0.9546307,0.03287957,0.000034197765,0.000053474083,0.00002911975,0.006812827],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99498296,0.002073932,0.0005691764,0.00042996704,0.0013521968,0.0005917493],"domain_scores_gemma":[0.9690015,0.014879963,0.0010834333,0.0013128096,0.0069365352,0.006785806],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0055866526,0.0006890594,0.0018278342,0.0007761373,0.0040166443,0.0050906185,0.0018962033,0.048750274,0.02706343],"category_scores_gemma":[0.031049598,0.00066232966,0.0019882217,0.00082481303,0.0040705916,0.008723112,0.0028947804,0.051202644,0.019803569],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000031690422,0.00006190935,0.0005337632,0.00006886723,0.000010644198,0.0012492635,0.000121281184,0.00004125783,0.00013766691,0.0015177974,0.98486,0.011365988],"study_design_scores_gemma":[0.00008454612,0.000083722414,0.001260404,0.00052087626,0.000025875763,0.004817704,0.001621677,0.00029128868,0.00013803362,0.014498034,0.9765673,0.00009053337],"about_ca_topic_score_codex":0.0046013137,"about_ca_topic_score_gemma":0.008466712,"teacher_disagreement_score":0.048750274,"about_ca_system_score_codex":0.0031251279,"about_ca_system_score_gemma":0.008498223,"threshold_uncertainty_score":0.09053618},"labels":[],"label_agreement":null},{"id":"W4385475958","doi":"10.1111/jdv.19391","title":"Upadacitinib treatment withdrawal and retreatment in patients with moderate‐to‐severe atopic dermatitis: Results from a phase 2b, randomized, controlled trial","year":2023,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research","funders":"AbbVie","keywords":"Medicine; Atopic dermatitis; Dermatology; Randomized controlled trial; Internal medicine","score_opus":0.013095769606776986,"score_gpt":0.273459544002194,"score_spread":0.260363774395417,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385475958","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9585581,0.028926874,0.0006335545,0.0014133048,0.0009185878,0.0049803513,0.0021013515,0.00013097572,0.0023369645],"genre_scores_gemma":[0.9784685,0.009546594,0.0010598097,0.0017399264,0.0006120407,0.0042875907,0.002204615,0.000025096142,0.0020558336],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99909973,0.0004609487,0.00008343475,0.00015071874,0.00009285468,0.00011223519],"domain_scores_gemma":[0.9989421,0.0003092797,0.00027702327,0.00008579219,0.00011662708,0.00026928767],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024376486,0.0012535851,0.0031139336,0.0003259432,0.0003658651,0.0012495922,0.00089032686,0.0015628776,0.005305608],"category_scores_gemma":[0.0023964527,0.00048928615,0.0030358068,0.00046435776,0.0007395251,0.0009752556,0.0003698432,0.002277556,0.000634506],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9678799,0.003883628,0.0010023465,0.0019390058,0.0030223073,0.000061335355,0.000044440738,0.00019654456,0.0020293647,0.00005266804,0.0013273199,0.018561305],"study_design_scores_gemma":[0.96858025,0.02581988,0.0030277225,0.00008832261,0.0013561426,0.000057959962,0.00001814051,0.00017859465,0.00016333188,0.00006344118,0.00063330436,0.000012979432],"about_ca_topic_score_codex":0.0007492433,"about_ca_topic_score_gemma":0.0021265806,"teacher_disagreement_score":0.005305608,"about_ca_system_score_codex":0.0006657258,"about_ca_system_score_gemma":0.0010304183,"threshold_uncertainty_score":0.017749071},"labels":[],"label_agreement":null},{"id":"W4385968952","doi":"10.1111/jdv.19434","title":"Folliculitis decalvans in women: A retrospective multicentre study of 150 patients","year":2023,"lang":"en","type":"letter","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Dermatological and Skeletal Disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences","funders":"","keywords":"Medicine; Retrospective cohort study; Dermatology; Folliculitis; Surgery","score_opus":0.009287268636345877,"score_gpt":0.23686144187686392,"score_spread":0.22757417324051804,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385968952","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99849415,0.0004984658,0.00007494731,0.000055727247,0.000007342368,0.000015195759,0.00020942878,0.0000028534807,0.00064181106],"genre_scores_gemma":[0.9994056,0.00019349587,0.000042743282,0.0000929595,0.000012144761,0.0000093249355,0.0001191541,0.0000017447434,0.00012284481],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995789,0.00011417332,0.000046465757,0.00012268931,0.000062866544,0.00007481773],"domain_scores_gemma":[0.9992861,0.00021615639,0.0002676958,0.00009173619,0.000048464175,0.00008982366],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040546493,0.00021706373,0.00048460052,0.00060561637,0.00056844775,0.00057698804,0.00028933515,0.0006579389,0.0016301281],"category_scores_gemma":[0.0014118099,0.00049485837,0.0003555623,0.0010872356,0.0004035496,0.0005106769,0.00033085537,0.00034197007,0.00041072225],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024934698,0.000033390268,0.99545586,0.000013397127,0.000043554603,0.0021429588,0.00017009763,0.00001889543,0.00038718435,0.000027697852,0.0001406051,0.0013170759],"study_design_scores_gemma":[0.000046216326,0.00036194298,0.9855564,0.000021403448,0.00006052658,0.012431361,0.0005417484,0.00010545107,0.00009655817,0.000058460028,0.00070969184,0.000010187742],"about_ca_topic_score_codex":0.0022678,"about_ca_topic_score_gemma":0.001866282,"teacher_disagreement_score":0.0022678,"about_ca_system_score_codex":0.00032644512,"about_ca_system_score_gemma":0.00018110355,"threshold_uncertainty_score":0.005453348},"labels":[],"label_agreement":null},{"id":"W4385969629","doi":"10.1111/jdv.19421","title":"Sun exposure behaviours as a compromise to paradoxical injunctions: Insight from a worldwide survey","year":2023,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Skin Protection and Aging","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Sunburn; Sun protection; Dark skin; Sun exposure; Sensitive skin; Demographics; Population; Psychological intervention; Environmental health; Demography; Dermatology; Psychiatry","score_opus":0.040336496905505455,"score_gpt":0.310198601899237,"score_spread":0.26986210499373153,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385969629","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99744177,0.00027780898,0.00014250269,0.00022708734,0.0000064560927,0.000017169124,0.00014462617,0.0000022379768,0.0017404568],"genre_scores_gemma":[0.9994783,0.00016207667,0.000062845524,0.00006686664,0.0000025733314,0.000011144492,0.00008108135,0.0000017279332,0.00013335216],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986773,0.0006680366,0.00010537153,0.000121535915,0.00021046419,0.00021722539],"domain_scores_gemma":[0.99509996,0.001601817,0.0020074279,0.00025872682,0.00064358854,0.00038856207],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029253394,0.00016953454,0.00019261886,0.00081361464,0.0004327053,0.00090163405,0.000323891,0.00038794294,0.0013825801],"category_scores_gemma":[0.007334875,0.00019316841,0.00039359153,0.00096296315,0.0004865718,0.0009083403,0.0013645678,0.0008228806,0.00019773119],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002969461,0.000073702904,0.9806717,0.00007253334,0.00003322069,0.000113003196,0.009074713,0.000031958818,0.00012624344,0.00009613111,0.00036046983,0.009316659],"study_design_scores_gemma":[0.0000022465256,0.00007390621,0.9824572,0.00008587893,0.000016848942,0.0002009851,0.015670182,0.0001289734,0.000045593082,0.00006801959,0.0012433861,0.0000067861847],"about_ca_topic_score_codex":0.009000009,"about_ca_topic_score_gemma":0.010905023,"teacher_disagreement_score":0.009000009,"about_ca_system_score_codex":0.0005273316,"about_ca_system_score_gemma":0.0006460949,"threshold_uncertainty_score":0.017895222},"labels":[],"label_agreement":null},{"id":"W4386253844","doi":"10.1111/jdv.19478","title":"Risk factors for malignancy in adult‐onset dermatomyositis","year":2023,"lang":"en","type":"letter","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Inflammatory Myopathies and Dermatomyositis","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; University of Toronto","funders":"","keywords":"Medicine; Malignancy; Dermatomyositis; Internal medicine; Retrospective cohort study; Myositis","score_opus":0.017653243165688802,"score_gpt":0.2652864781114795,"score_spread":0.24763323494579068,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386253844","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.71893036,0.02073603,0.0008961728,0.17154197,0.002774987,0.0000641471,0.0013733107,0.000115240466,0.08356777],"genre_scores_gemma":[0.97343713,0.004276019,0.00042177003,0.010913591,0.004452588,0.000030975243,0.00025394987,0.000012179252,0.0062017674],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99977785,0.00007178529,0.000027033477,0.000023991091,0.000059588303,0.000039698833],"domain_scores_gemma":[0.99911374,0.00041330475,0.0001773602,0.00004309548,0.00010466996,0.00014784865],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023333599,0.00015811792,0.0002912395,0.0005689852,0.0005136915,0.0003511099,0.00019790114,0.0018249864,0.0039981185],"category_scores_gemma":[0.0027234398,0.00013121736,0.00018885957,0.00081197306,0.00021704884,0.00037807395,0.00016485325,0.0011267881,0.0005788576],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047939827,0.00027054996,0.8215834,0.00014131659,0.000054046915,0.08280571,0.0004748954,0.0002713999,0.0021234385,0.0021777877,0.05640171,0.03321631],"study_design_scores_gemma":[0.000109576016,0.00035774292,0.7716397,0.00044977156,0.00007871717,0.18076079,0.0011414604,0.0016201383,0.0005089253,0.0036786771,0.039609957,0.000044445947],"about_ca_topic_score_codex":0.0028407883,"about_ca_topic_score_gemma":0.0039340933,"teacher_disagreement_score":0.0039981185,"about_ca_system_score_codex":0.00031006406,"about_ca_system_score_gemma":0.00038360505,"threshold_uncertainty_score":0.0133751035},"labels":[],"label_agreement":null},{"id":"W4386449417","doi":"10.1111/jdv.19500","title":"<scp>Real‐world</scp> clinical, psychosocial and economic burden of atopic dermatitis: Results from a multicountry study","year":2023,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; SKiN Health; Queen's University","funders":"AbbVie","keywords":"Medicine; Psychosocial; Atopic dermatitis; Dermatology Life Quality Index; Quality of life (healthcare); Population; Disease; Disease burden; Eczema Area and Severity Index; Internal medicine; Pediatrics; Dermatology; Psychiatry; Environmental health","score_opus":0.03431813049675671,"score_gpt":0.34176282764781984,"score_spread":0.30744469715106315,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386449417","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968256,0.00041256964,0.0000903765,0.00011465623,0.0000068178942,0.000043397664,0.0020364113,0.000005132512,0.00046513806],"genre_scores_gemma":[0.9980153,0.00014371211,0.00014243933,0.000067407986,0.000016842918,0.000057548885,0.001439477,0.000004870981,0.0001124688],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982805,0.0008183677,0.00028527103,0.00022096191,0.0002578052,0.00013719039],"domain_scores_gemma":[0.9942601,0.0012354716,0.0028546818,0.00067003723,0.0005977444,0.000382011],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029928486,0.00032485864,0.00035614954,0.00096325035,0.0004571287,0.0009481758,0.0005621931,0.00040087715,0.0018026781],"category_scores_gemma":[0.00659039,0.00027599419,0.0011782494,0.001840081,0.00027305493,0.0006935344,0.0012748204,0.00039836948,0.00036202362],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008847433,0.00002858358,0.9973018,0.000031050982,0.00025806238,0.000055105018,0.00016699414,0.000031621767,0.000056648354,0.000008704856,0.00038536533,0.0015876072],"study_design_scores_gemma":[0.000010373589,0.00004217285,0.9993007,0.000014026528,0.000053825872,0.00014353676,0.00017596118,0.000067801375,0.000013728443,0.0000049646164,0.00016996032,0.0000029592738],"about_ca_topic_score_codex":0.006652438,"about_ca_topic_score_gemma":0.011354904,"teacher_disagreement_score":0.006652438,"about_ca_system_score_codex":0.0004548383,"about_ca_system_score_gemma":0.00044090036,"threshold_uncertainty_score":0.015827894},"labels":[],"label_agreement":null},{"id":"W4386695447","doi":"10.1111/jdv.19506","title":"Treat‐to‐target in dermatology: A scoping review and International Eczema Council survey on the approach in atopic dermatitis","year":2023,"lang":"en","type":"review","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; University of Toronto; Innovaderm (Canada)","funders":"National Center for Advancing Translational Sciences; National Institutes of Health","keywords":"Medicine; Atopic dermatitis; Dermatology; Psoriasis; Disease; Family medicine; MEDLINE; Pathology","score_opus":0.15839582544056,"score_gpt":0.37253965776684833,"score_spread":0.21414383232628834,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386695447","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0027171131,0.99032366,0.00039096212,0.0015558839,0.00029677746,0.0008403672,0.002006955,0.00002347189,0.0018448493],"genre_scores_gemma":[0.00939307,0.98619425,0.0010081884,0.0010411716,0.00008930677,0.0009584636,0.0011309207,0.000013631384,0.00017095068],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9830967,0.0035215563,0.009173921,0.0007965236,0.003034532,0.00037668983],"domain_scores_gemma":[0.9057042,0.06600669,0.01662472,0.001281109,0.0094553195,0.0009278486],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.018674217,0.0009659579,0.00361779,0.03037661,0.0011208438,0.003094241,0.0016942371,0.0019749366,0.004322258],"category_scores_gemma":[0.0711169,0.0009966348,0.0056469077,0.035919033,0.0011484147,0.0038042811,0.0029191915,0.0017350966,0.00062860694],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013734945,0.000037592854,0.0037421198,0.8676669,0.002336951,0.0002159679,0.0012884188,0.00013062851,0.00022178843,0.00069937337,0.007980867,0.11554201],"study_design_scores_gemma":[0.000040986866,0.00006413451,0.0069579794,0.94476587,0.007947686,0.00037190635,0.00075116445,0.000046515393,0.000084166175,0.00019171751,0.038753193,0.000024636709],"about_ca_topic_score_codex":0.012601386,"about_ca_topic_score_gemma":0.030839853,"teacher_disagreement_score":0.03037661,"about_ca_system_score_codex":0.0037262307,"about_ca_system_score_gemma":0.014129572,"threshold_uncertainty_score":0.09875983},"labels":[],"label_agreement":null},{"id":"W4386795930","doi":"10.1111/jdv.19450","title":"Worldwide expert recommendations for the diagnosis and management of vitiligo: Position statement from the international Vitiligo Task Force—Part 2: Specific treatment recommendations","year":2023,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"melanin and skin pigmentation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":138,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity; University of British Columbia","funders":"EMD Serono; Incyte; Dermira; Galderma; Eli Lilly and Company; CSL Behring; Celgene; LEO Pharma; Immune Tolerance Network; Sanofi; Amgen; Pfizer; Sun Pharma; Regeneron Pharmaceuticals; Teva Pharmaceutical Industries","keywords":"Vitiligo; Medicine; Position paper; Position statement; Modalities; Pimecrolimus; Alternative medicine; Depigmentation; Dermatology; Intensive care medicine; Family medicine; Calcineurin; Surgery; Pathology; Transplantation","score_opus":0.04546761642194368,"score_gpt":0.32229550635713444,"score_spread":0.27682788993519075,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386795930","genre_codex":"commentary","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004126748,0.24466859,0.059312306,0.5587907,0.04125059,0.009282257,0.007573725,0.0011461314,0.073848955],"genre_scores_gemma":[0.043043546,0.3467308,0.36089605,0.1497157,0.012831616,0.015745508,0.026133923,0.00086489326,0.044037912],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.96700555,0.013265117,0.007367127,0.0012929187,0.008938004,0.0021312153],"domain_scores_gemma":[0.9221737,0.019775156,0.008737644,0.0017107289,0.043532632,0.0040701767],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.046077054,0.0022836113,0.0031299936,0.009338273,0.0023839432,0.0051969336,0.007185177,0.013070932,0.010727934],"category_scores_gemma":[0.08414771,0.0014029571,0.0066541703,0.004778843,0.0021479812,0.0042048707,0.005590193,0.012859848,0.007991906],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014969123,0.00030635908,0.0016734041,0.012683033,0.0003061723,0.00039369412,0.0010496733,0.0012581588,0.001092978,0.007918839,0.6360877,0.3370803],"study_design_scores_gemma":[0.0003230197,0.00015781038,0.0034292461,0.061124887,0.0008023014,0.0007045192,0.0012288804,0.0010046208,0.00078508427,0.010498027,0.91978574,0.00015580578],"about_ca_topic_score_codex":0.017045397,"about_ca_topic_score_gemma":0.0138626,"teacher_disagreement_score":0.046077054,"about_ca_system_score_codex":0.0072862217,"about_ca_system_score_gemma":0.034800418,"threshold_uncertainty_score":0.24368167},"labels":[],"label_agreement":null},{"id":"W4387002827","doi":"10.1111/jdv.19451","title":"Worldwide expert recommendations for the diagnosis and management of vitiligo: Position statement from the International Vitiligo Task Force Part 1: towards a new management algorithm","year":2023,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"melanin and skin pigmentation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":121,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Institute of Infection and Immunity","funders":"Sun Pharma; Incyte; Pfizer","keywords":"Vitiligo; Medicine; Disease; Position statement; Disease management; Clinical Practice; Algorithm; Family medicine; Dermatology; Computer science; Pathology; Parkinson's disease","score_opus":0.031770435288790845,"score_gpt":0.31163571308814836,"score_spread":0.2798652777993575,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387002827","genre_codex":"commentary","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0034991014,0.09945074,0.076117784,0.7226926,0.042760864,0.006335009,0.0036009492,0.0012126263,0.04433042],"genre_scores_gemma":[0.038317632,0.14518979,0.6100631,0.13083243,0.01496026,0.01113362,0.016690278,0.0010358699,0.031777024],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9529841,0.019402454,0.00979807,0.0019805664,0.013311607,0.0025232157],"domain_scores_gemma":[0.87725556,0.025715113,0.012284373,0.0028195444,0.07381907,0.008106387],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.07064932,0.0026870703,0.0031856496,0.010489359,0.0038723734,0.007598599,0.009495108,0.014183935,0.007363472],"category_scores_gemma":[0.11475898,0.001476942,0.006335867,0.005509303,0.0031311454,0.006761103,0.0074403887,0.017499175,0.007841351],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000113982744,0.00032180262,0.0028708584,0.0057387226,0.00021747673,0.00039412445,0.0013919286,0.0014746574,0.000659148,0.012767033,0.68391454,0.2901357],"study_design_scores_gemma":[0.00034398993,0.00020404554,0.004986054,0.04773091,0.00074930943,0.0010129072,0.0019766656,0.0025402766,0.000742276,0.026929088,0.9125561,0.00022851405],"about_ca_topic_score_codex":0.016663868,"about_ca_topic_score_gemma":0.015760947,"teacher_disagreement_score":0.07064932,"about_ca_system_score_codex":0.01014945,"about_ca_system_score_gemma":0.049053747,"threshold_uncertainty_score":0.3736338},"labels":[],"label_agreement":null},{"id":"W4387002830","doi":"10.1111/jdv.19358","title":"Climate change and air pollution: Twin threats of burning fossil fuels with implications for the practice of dermatology","year":2023,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Climate Change and Health Impacts","field":"Environmental Science","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Atopic dermatitis; Medicine; Environmental health; Air pollution; Climate change; Global warming; Air quality index; Natural resource economics; Dermatology; Ecology","score_opus":0.08572407246333662,"score_gpt":0.34731017456116964,"score_spread":0.261586102097833,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387002830","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0022781831,0.9124069,0.0007711015,0.07386229,0.005684199,0.00004775618,0.00012578166,0.000013169862,0.004810619],"genre_scores_gemma":[0.050149664,0.8764089,0.0031398635,0.05418174,0.014643872,0.00008443562,0.00013224785,0.00003662394,0.0012226454],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9847207,0.007465228,0.0027408758,0.00085671945,0.0038126982,0.0004038151],"domain_scores_gemma":[0.92233944,0.059153635,0.0070404154,0.0015101628,0.008702047,0.0012543974],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010117439,0.00031553645,0.0007587926,0.0049326085,0.00121544,0.004194045,0.0008276516,0.002618681,0.0047504855],"category_scores_gemma":[0.063148916,0.00032815037,0.0012736522,0.0052123214,0.0030042273,0.006392269,0.0027469571,0.0039574085,0.00051512645],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026725026,0.000085709704,0.026045172,0.043299425,0.00077545445,0.0009114902,0.0045918776,0.00059651193,0.0005258567,0.02500597,0.13764706,0.7602482],"study_design_scores_gemma":[0.00006173361,0.00012071845,0.027273646,0.12710786,0.0007712262,0.0060583707,0.008317127,0.00025222634,0.00033120904,0.035593543,0.79401237,0.000100010424],"about_ca_topic_score_codex":0.0031593898,"about_ca_topic_score_gemma":0.012085967,"teacher_disagreement_score":0.010117439,"about_ca_system_score_codex":0.0028671587,"about_ca_system_score_gemma":0.007328361,"threshold_uncertainty_score":0.05350679},"labels":[],"label_agreement":null},{"id":"W4387439333","doi":"10.1111/jdv.19266","title":"Patient prioritisation of impact items to develop the <scp>patient‐reported</scp> impact of dermatological diseases (<scp>PRIDD</scp>) measure: European Delphi data","year":2023,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Arthritis Patient Alliance","funders":"","keywords":"Medicine; Delphi method; Dermatological diseases; Family medicine; Descriptive statistics; Disease; Qualitative research; Dermatology; Pathology","score_opus":0.048175646124691995,"score_gpt":0.29129264488163537,"score_spread":0.24311699875694337,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387439333","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8195684,0.00054027786,0.06585129,0.0031178643,0.00021394595,0.06487729,0.008509396,0.00031905618,0.037002515],"genre_scores_gemma":[0.76105815,0.0006593387,0.10684209,0.0012175106,0.00005176085,0.123928286,0.0038458612,0.00010252256,0.0022944098],"study_design_codex":"design_other","study_design_gemma":"qualitative","domain_scores_codex":[0.94634366,0.036874253,0.0073226406,0.0012588585,0.0059177787,0.0022827354],"domain_scores_gemma":[0.9354035,0.037942056,0.0048070378,0.0033959663,0.0170948,0.0013565287],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.078864805,0.001000217,0.00082160824,0.0045767287,0.0013511877,0.0015425796,0.0013408898,0.0010313729,0.0078083086],"category_scores_gemma":[0.082313955,0.00051888777,0.0016793685,0.0032458662,0.0015036538,0.0020806943,0.0053413757,0.0019610762,0.0014221951],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031124388,0.0015427223,0.13807806,0.012881182,0.0005779813,0.0009944926,0.26130036,0.007662012,0.016190726,0.01824508,0.038367555,0.50104743],"study_design_scores_gemma":[0.0020409408,0.006729587,0.3483681,0.008603428,0.0005029213,0.0024428938,0.25471416,0.029945593,0.03621567,0.03499101,0.2743803,0.0010654669],"about_ca_topic_score_codex":0.0013729224,"about_ca_topic_score_gemma":0.0013607356,"teacher_disagreement_score":0.078864805,"about_ca_system_score_codex":0.002967382,"about_ca_system_score_gemma":0.0048275245,"threshold_uncertainty_score":0.41708195},"labels":[],"label_agreement":null},{"id":"W4387563402","doi":"10.1111/jdv.19565","title":"Ethnic endotypes in paediatric atopic dermatitis depend on immunotype, lipid composition and microbiota of the skin","year":2023,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"LEO Pharma; Olga Mayenfisch Stiftung; Cilag; LEO Fondet; Christine Kühne – Center for Allergy Research and Education; Novo Nordisk Fonden; Vontobel-Stiftung; EMDO Stiftung; Universität Zürich; Novo Nordisk; National Science Foundation; Les Laboratories Pierre Fabre; Stavros Niarchos Foundation; Eli Lilly and Company; AstraZeneca; LEO Pharma Research Foundation; Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung; Region Hovedstaden","keywords":"Medicine; Atopic dermatitis; Ethnic group; Dermatology","score_opus":0.016007250378363633,"score_gpt":0.2686763365369132,"score_spread":0.25266908615854955,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387563402","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9995061,0.00020848066,0.0000309476,0.000006065927,0.0000015865334,0.000002360463,0.000053238648,7.118222e-7,0.00019051715],"genre_scores_gemma":[0.99966943,0.000095917276,0.00005290411,0.000004290756,9.844064e-7,0.0000020690447,0.00008374052,0.0000010104069,0.00008966448],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99977845,0.000038917948,0.000021618172,0.00007112691,0.00004673388,0.00004319145],"domain_scores_gemma":[0.9997198,0.000037184687,0.00013764891,0.000013268627,0.000032102776,0.000060037284],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017065884,0.00024598528,0.00019045873,0.00045053154,0.00035296535,0.00045264326,0.0001506046,0.00021986719,0.0014476782],"category_scores_gemma":[0.00049337826,0.0001604546,0.00024297998,0.00049207377,0.00026247595,0.0002342354,0.00034881986,0.00022076901,0.0001599008],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020084913,0.000026149202,0.9924604,0.000019825102,0.000026491753,0.00034156925,0.00040938306,0.00002910671,0.0045758635,0.000024789037,0.000032804735,0.0018528235],"study_design_scores_gemma":[0.0000011903327,0.00004472377,0.9986731,0.0000054744132,0.000010016006,0.000553704,0.00036703507,0.000030704006,0.00020235733,0.000009377562,0.00010101067,0.0000013702476],"about_ca_topic_score_codex":0.007255647,"about_ca_topic_score_gemma":0.008193189,"teacher_disagreement_score":0.007255647,"about_ca_system_score_codex":0.0002778444,"about_ca_system_score_gemma":0.0001742907,"threshold_uncertainty_score":0.014426827},"labels":[],"label_agreement":null},{"id":"W4387661948","doi":"10.1111/jdv.19566","title":"Post‐inflammatory hyperpigmentation: A systematic review of treatment outcomes","year":2023,"lang":"en","type":"review","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Dermatologic Treatments and Research","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland; University of British Columbia","funders":"","keywords":"Medicine; Hyperpigmentation; Dermatology; MEDLINE; Internal medicine","score_opus":0.08372735065471885,"score_gpt":0.4003348708293048,"score_spread":0.31660752017458593,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387661948","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0015894263,0.99694073,0.00010660601,0.0001570903,0.00006525021,0.0002721654,0.00059622485,0.000007240115,0.00026523668],"genre_scores_gemma":[0.02429092,0.97341305,0.0005679327,0.00043414702,0.00006833248,0.0006249279,0.00046833986,0.000009165552,0.00012322847],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99064714,0.0032742897,0.0039971303,0.000607363,0.0012306359,0.00024341588],"domain_scores_gemma":[0.9726576,0.018607737,0.0058216946,0.00042790358,0.0021979513,0.0002870826],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008036571,0.001469825,0.009385241,0.008566881,0.00061148364,0.0025954256,0.0016183533,0.0013959244,0.005077589],"category_scores_gemma":[0.035072204,0.00083129335,0.009609103,0.011424073,0.0008045596,0.0020461816,0.0014722736,0.0011990024,0.00037917378],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024785218,0.000013443598,0.000650019,0.9697483,0.013482148,0.00005683961,0.00011532893,0.000049877617,0.000096584394,0.000073279494,0.0007552013,0.014711221],"study_design_scores_gemma":[0.0004620525,0.0003534393,0.0062564877,0.82670283,0.15250438,0.00032428477,0.00031348603,0.000069010115,0.00019827159,0.00019372851,0.012584006,0.0000380855],"about_ca_topic_score_codex":0.0058690067,"about_ca_topic_score_gemma":0.019599428,"teacher_disagreement_score":0.009385241,"about_ca_system_score_codex":0.0030177727,"about_ca_system_score_gemma":0.0069024493,"threshold_uncertainty_score":0.042501926},"labels":[],"label_agreement":null},{"id":"W4387931455","doi":"10.1111/jdv.19570","title":"Quality of life measurement in teledermatology. Position statement of the European Academy of Dermatology and Venereology Task Forces on Quality of Life and Patient Oriented Outcomes and Teledermatology","year":2023,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Cutaneous Melanoma Detection and Management","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"","keywords":"Venereology; Teledermatology; Medicine; Task (project management); Quality of life (healthcare); Quality (philosophy); Dermatology; Position statement; Task force; Medical physics; Family medicine; Telemedicine; Health care; Nursing","score_opus":0.04738278634548345,"score_gpt":0.3130732004812124,"score_spread":0.26569041413572897,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387931455","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.43013227,0.22827303,0.056983612,0.10926082,0.011593731,0.012642062,0.030380283,0.0006109075,0.12012327],"genre_scores_gemma":[0.87595695,0.030907148,0.051386945,0.01141516,0.0013538488,0.013668897,0.008961828,0.000083934174,0.0062653474],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9875893,0.007761033,0.0013413846,0.00034564806,0.002640143,0.00032253648],"domain_scores_gemma":[0.98420966,0.006523334,0.003975762,0.00056335784,0.0035213693,0.0012065867],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.015924877,0.0003180508,0.00050439866,0.0018119825,0.0004374303,0.0012632904,0.0007819873,0.0010099439,0.0028101585],"category_scores_gemma":[0.021115877,0.00018168469,0.0010690454,0.0020714172,0.0005492648,0.0012069299,0.0013764715,0.0015691193,0.000648372],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007307525,0.0010832971,0.32075813,0.0021837254,0.00027489662,0.00029403373,0.0013762178,0.0011269009,0.0010149685,0.003613186,0.06470165,0.6028422],"study_design_scores_gemma":[0.00022699955,0.0020651983,0.9088955,0.0031728647,0.00014579338,0.0009694643,0.0013187901,0.0014954149,0.0008735757,0.003165223,0.07759989,0.0000713579],"about_ca_topic_score_codex":0.0028370696,"about_ca_topic_score_gemma":0.0033364205,"teacher_disagreement_score":0.015924877,"about_ca_system_score_codex":0.0017019146,"about_ca_system_score_gemma":0.0018866549,"threshold_uncertainty_score":0.084219754},"labels":[],"label_agreement":null},{"id":"W4388539835","doi":"10.1111/jdv.19627","title":"The <scp>vIGA‐AD</scp> scale for atopic dermatitis: Uptake in the past 5 years and position of the International Eczema Council","year":2023,"lang":"en","type":"letter","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Innovaderm (Canada)","funders":"National Institute of Allergy and Infectious Diseases; LEO Pharma; Pfizer","keywords":"Atopic dermatitis; Medicine; Position paper; Scale (ratio); Dermatology; Family medicine; Pathology; Cartography","score_opus":0.02726660054493898,"score_gpt":0.2627826286530366,"score_spread":0.2355160281080976,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388539835","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00756139,0.0041588536,0.0001512624,0.9583152,0.0057845623,0.00004195993,0.0010096724,0.000045613237,0.022931583],"genre_scores_gemma":[0.21513416,0.016325118,0.0012939222,0.7040173,0.02952027,0.00033738755,0.0018663408,0.00011166179,0.031393982],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99812037,0.0006742682,0.0002789533,0.00015925414,0.00053661305,0.00023057067],"domain_scores_gemma":[0.99300414,0.003474741,0.0006700147,0.00015686727,0.0019503048,0.0007438636],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015403683,0.00021985735,0.0005628046,0.0008422494,0.0010319606,0.0009809013,0.00043422755,0.003910971,0.010515642],"category_scores_gemma":[0.0133552365,0.00014311147,0.0004135049,0.0010561479,0.0005891956,0.0013482504,0.00044926404,0.0041986196,0.004924139],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013903997,0.0000809067,0.01598475,0.00012112786,0.0000126190325,0.0025577596,0.00018270516,0.000044423192,0.00020176054,0.0010217559,0.9325441,0.04710902],"study_design_scores_gemma":[0.0005100848,0.0004476688,0.09726963,0.0038732223,0.000117489624,0.031827718,0.0031246853,0.0020060474,0.00074245175,0.012633988,0.84729034,0.00015669789],"about_ca_topic_score_codex":0.009639077,"about_ca_topic_score_gemma":0.0150019545,"teacher_disagreement_score":0.010515642,"about_ca_system_score_codex":0.002176345,"about_ca_system_score_gemma":0.0013382636,"threshold_uncertainty_score":0.035178304},"labels":[],"label_agreement":null},{"id":"W4389069855","doi":"10.1111/jdv.19644","title":"A comprehensive review of nondermatophyte mould onychomycosis: Epidemiology, diagnosis and management","year":2023,"lang":"en","type":"review","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Nail Diseases and Treatments","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mediprobe Research (Canada); Women's College Hospital; Public Health Ontario; University of Toronto","funders":"","keywords":"Dermatophyte; Itraconazole; Fusarium; Aspergillus; Nail disease; Terbinafine; Dermatology; Nail (fastener); Biology; Natamycin; Antifungal; Medicine; Microbiology; Pathology; Paronychia; Botany","score_opus":0.1536914493497326,"score_gpt":0.4161412184917021,"score_spread":0.2624497691419695,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389069855","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002680919,0.99820924,0.00012865987,0.0004428229,0.00022680759,0.000008276781,0.00007846944,0.000014482589,0.00062313647],"genre_scores_gemma":[0.0012336189,0.9972704,0.00033609197,0.00028722957,0.000380304,0.000011793731,0.00019200185,0.0000036156694,0.00028500168],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99934655,0.00013659536,0.00024723043,0.000084507985,0.00014713261,0.000037979342],"domain_scores_gemma":[0.99824786,0.00089128,0.0003780154,0.000029495146,0.00031598093,0.0001374119],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008448473,0.00091471866,0.0015692179,0.006557387,0.00033323813,0.0011847758,0.0009930658,0.0011324713,0.0064035845],"category_scores_gemma":[0.00289241,0.00042598933,0.00090088823,0.0055239787,0.0003511819,0.0017035713,0.000732577,0.0011923687,0.0017872738],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000098026256,0.00007836187,0.0015839522,0.056868907,0.0002595532,0.0008197312,0.00020001247,0.0003725543,0.0010073178,0.0011067032,0.08597033,0.85163456],"study_design_scores_gemma":[0.000031937932,0.00018249311,0.008208471,0.05409445,0.00076404505,0.012843405,0.00025457083,0.00020606162,0.0002635563,0.0010284679,0.9220579,0.00006472396],"about_ca_topic_score_codex":0.0027122202,"about_ca_topic_score_gemma":0.004596265,"teacher_disagreement_score":0.006557387,"about_ca_system_score_codex":0.0008265427,"about_ca_system_score_gemma":0.0021357334,"threshold_uncertainty_score":0.021422148},"labels":[],"label_agreement":null},{"id":"W4389180536","doi":"10.1111/jdv.19643","title":"Real‐world reported adverse events related to systemic immunomodulating therapy in patients with atopic dermatitis: Results from the <scp>TREAT NL</scp> (<scp>TREatment</scp> of <scp>ATopic</scp> eczema, the Netherlands) registry","year":2023,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"","keywords":"Medicine; Atopic dermatitis; Adverse effect; Incidence (geometry); Cohort; Dermatology; Dupilumab; Internal medicine","score_opus":0.01628472200443285,"score_gpt":0.260076606564794,"score_spread":0.24379188456036113,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389180536","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99425346,0.0010351458,0.00021939579,0.00003325919,0.000004995452,0.00006756877,0.0039974074,0.000004891781,0.00038372897],"genre_scores_gemma":[0.99528545,0.0003951919,0.0002277466,0.0000253717,0.000011169645,0.000064970445,0.0038904278,0.0000033195035,0.00009645614],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971027,0.0010463621,0.0007296603,0.00041849472,0.00058654044,0.000116178984],"domain_scores_gemma":[0.98620206,0.0025890141,0.00959593,0.0006039747,0.0007094819,0.00029952725],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0032497114,0.00018060586,0.0003650307,0.0008494553,0.00012877495,0.00056200963,0.00026307875,0.00023713485,0.0009475888],"category_scores_gemma":[0.0062800534,0.0001524501,0.0008704022,0.0013722021,0.00016622429,0.0004217475,0.0004613001,0.00026918386,0.0001589654],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048698206,0.000033822358,0.9964306,0.00009542097,0.00026143913,0.000041700052,0.00004394715,0.00010431233,0.00010461609,0.000010030601,0.00016110482,0.0022261948],"study_design_scores_gemma":[0.00006424538,0.00020980221,0.998558,0.00002028525,0.00012709854,0.00022420034,0.000058973204,0.00017664253,0.00010020703,0.000008492752,0.00044701668,0.000005148011],"about_ca_topic_score_codex":0.0015102137,"about_ca_topic_score_gemma":0.0022991048,"teacher_disagreement_score":0.0032497114,"about_ca_system_score_codex":0.000359288,"about_ca_system_score_gemma":0.00034469558,"threshold_uncertainty_score":0.017186284},"labels":[],"label_agreement":null},{"id":"W4389225095","doi":"10.1111/jdv.19640","title":"Genetic mutations and phenotype characteristics in peripheral vascular malformations: A systematic review","year":2023,"lang":"en","type":"review","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Vascular Malformations and Hemangiomas","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Phenotype; Medicine; Germline mutation; Gene; Disease; Mutation; Genetics; Germline; Candidate gene; Somatic cell; Bioinformatics; Biology; Pathology","score_opus":0.038463179885042935,"score_gpt":0.3197480153356369,"score_spread":0.28128483545059396,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389225095","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0029605925,0.99540436,0.00012211263,0.0001476698,0.00006125884,0.0000994553,0.00093586295,0.0000059990484,0.00026276728],"genre_scores_gemma":[0.021447241,0.9768529,0.0004832952,0.0002636489,0.000060071252,0.00017830616,0.0006082945,0.0000052519817,0.00010104897],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99684346,0.0006242636,0.0016857657,0.00032322065,0.00043531437,0.00008803548],"domain_scores_gemma":[0.98618156,0.010210253,0.0023949426,0.00019202664,0.00089471304,0.00012645563],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028773574,0.0009620196,0.004890346,0.010266305,0.00037073385,0.0013875815,0.0010868789,0.0011052653,0.0033507547],"category_scores_gemma":[0.013874925,0.00052968034,0.0045826063,0.012098465,0.00055915694,0.0013202432,0.00075125735,0.0004738297,0.00028281249],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025391192,0.000015409385,0.004906611,0.9324833,0.008837751,0.00041286746,0.00021239062,0.00014860678,0.00043413465,0.00026998486,0.0022269038,0.04979801],"study_design_scores_gemma":[0.00027879875,0.00031979923,0.034065176,0.82140964,0.10148591,0.0034940944,0.00052450143,0.00015492483,0.0004947194,0.0004978137,0.037200797,0.00007388474],"about_ca_topic_score_codex":0.0044961725,"about_ca_topic_score_gemma":0.011578438,"teacher_disagreement_score":0.010266305,"about_ca_system_score_codex":0.0013929298,"about_ca_system_score_gemma":0.0044098035,"threshold_uncertainty_score":0.015217066},"labels":[],"label_agreement":null},{"id":"W4389521645","doi":"10.1111/jdv.19652","title":"An international Delphi consensus to define a clinically appropriate definition of disease modification for plaque psoriasis","year":2023,"lang":"en","type":"letter","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Janssen Pharmaceuticals","keywords":"Medicine; Delphi method; Facilitator; Psoriasis; Delphi; MEDLINE; Disease; Family medicine; Intensive care medicine; Pathology; Dermatology; Artificial intelligence","score_opus":0.06629232433920085,"score_gpt":0.3118911905439097,"score_spread":0.24559886620470883,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389521645","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.050037265,0.086277165,0.18274193,0.5453694,0.0337385,0.05962171,0.0020237851,0.00039524055,0.0397951],"genre_scores_gemma":[0.30155036,0.044817343,0.48299262,0.08494636,0.0062577897,0.07409919,0.0014494227,0.00037089383,0.0035160899],"study_design_codex":"design_other","study_design_gemma":"qualitative","domain_scores_codex":[0.55951875,0.37177983,0.039330058,0.003602437,0.020999799,0.0047691595],"domain_scores_gemma":[0.6762453,0.22908989,0.014143602,0.0074611194,0.06760434,0.005455812],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.3687623,0.0018730075,0.0023833683,0.008748787,0.0047724405,0.0068302467,0.0043996135,0.0056252303,0.0047024256],"category_scores_gemma":[0.32218522,0.0013712635,0.0039722696,0.006325597,0.00963095,0.010525351,0.018441826,0.011653099,0.0012446614],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00057086,0.00033606915,0.0049311323,0.044554625,0.0004966704,0.0015935326,0.26027822,0.001682504,0.0032481055,0.078299,0.17115399,0.43285537],"study_design_scores_gemma":[0.0004351966,0.001138899,0.006746335,0.13056768,0.0003727697,0.0026475727,0.18547736,0.0046125236,0.001976409,0.08034227,0.58504784,0.00063517684],"about_ca_topic_score_codex":0.0019999612,"about_ca_topic_score_gemma":0.0020092146,"teacher_disagreement_score":0.3687623,"about_ca_system_score_codex":0.00794673,"about_ca_system_score_gemma":0.032175343,"threshold_uncertainty_score":0.77842844},"labels":[],"label_agreement":null},{"id":"W4389560802","doi":"10.1111/jdv.19732","title":"Biomarkers in rosacea: A systematic review","year":2023,"lang":"en","type":"review","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Acne and Rosacea Treatments and Effects","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; Queen's University; Public Health Ontario; University of Toronto","funders":"","keywords":"Medicine; Rosacea; Dermatology; MEDLINE; Acne","score_opus":0.053890417437903355,"score_gpt":0.36180229024044797,"score_spread":0.3079118728025446,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389560802","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0007267104,0.9979894,0.00012213833,0.0001863071,0.00009039396,0.00032952105,0.0003804309,0.0000071393333,0.00016796791],"genre_scores_gemma":[0.015840381,0.98166955,0.00052268733,0.0005404534,0.00010867893,0.00086012046,0.00032438445,0.000005293242,0.00012838119],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9933751,0.0020603407,0.0023702402,0.0005279111,0.0014402616,0.00022615178],"domain_scores_gemma":[0.98087835,0.012033868,0.0044214847,0.00027274407,0.0021699776,0.00022353837],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007717541,0.0019024886,0.010683204,0.010928258,0.00072327664,0.0032774298,0.0019894189,0.002125502,0.007083777],"category_scores_gemma":[0.028164325,0.0010592625,0.010430395,0.011459039,0.00079789694,0.0027283474,0.0016330386,0.0012620228,0.00047214908],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016230313,0.000011595173,0.00059086113,0.97484905,0.010226672,0.000071610164,0.00006543584,0.00006066173,0.00008943259,0.000102060054,0.00089526334,0.012875174],"study_design_scores_gemma":[0.00034365844,0.00022221946,0.004514028,0.8537556,0.1270328,0.0003561031,0.00019034215,0.0001098543,0.000154055,0.0003210344,0.012957839,0.000042532436],"about_ca_topic_score_codex":0.006117508,"about_ca_topic_score_gemma":0.013026239,"teacher_disagreement_score":0.010928258,"about_ca_system_score_codex":0.003551878,"about_ca_system_score_gemma":0.00965457,"threshold_uncertainty_score":0.040814698},"labels":[],"label_agreement":null},{"id":"W4389564602","doi":"10.1111/jdv.19686","title":"Epidemiology of mental health comorbidity in patients with atopic dermatitis: An analysis of global trends from 1998 to 2022","year":2023,"lang":"en","type":"review","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Anxiety; Suicidal ideation; Comorbidity; Depression (economics); Psychiatry; Epidemiology; Population; Mental health; Atopic dermatitis; Observational study; Strengthening the reporting of observational studies in epidemiology; Clinical psychology; Poison control; Suicide prevention; Internal medicine; Environmental health","score_opus":0.053825760446114,"score_gpt":0.3756292961325643,"score_spread":0.3218035356864503,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389564602","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9163373,0.061425056,0.00022029487,0.0007208086,0.0000735849,0.000050554198,0.01988425,0.00002781238,0.0012602912],"genre_scores_gemma":[0.9794855,0.013287581,0.0002879963,0.00024239905,0.00006685245,0.000063491956,0.0063983463,0.000006133108,0.00016154359],"study_design_codex":"observational","study_design_gemma":"systematic_review","domain_scores_codex":[0.99898344,0.00019609196,0.00031444852,0.00020841,0.00020253647,0.00009505512],"domain_scores_gemma":[0.99647635,0.00052021304,0.0022809794,0.000096350406,0.00043060107,0.0001954749],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009912777,0.0002450424,0.00061214814,0.0037065186,0.00019858996,0.0007478469,0.0003271673,0.00039383813,0.000716416],"category_scores_gemma":[0.0032428175,0.00019640125,0.0012953584,0.006401067,0.00021324266,0.00066470384,0.000513515,0.00049580407,0.000121455465],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012354067,0.000012696176,0.9921321,0.00052296417,0.00055878813,0.00012559677,0.00010786089,0.00008011667,0.00008118484,0.00003547789,0.0006527368,0.005566821],"study_design_scores_gemma":[0.0000058128776,0.00002364904,0.99841475,0.00016012725,0.00017017098,0.00029353937,0.00015916822,0.000103880186,0.000019758249,0.000015388781,0.000629797,0.000003897114],"about_ca_topic_score_codex":0.014343939,"about_ca_topic_score_gemma":0.014440691,"teacher_disagreement_score":0.014343939,"about_ca_system_score_codex":0.0006315166,"about_ca_system_score_gemma":0.00050160056,"threshold_uncertainty_score":0.028520942},"labels":[],"label_agreement":null},{"id":"W4389608052","doi":"10.1111/jdv.19727","title":"The perception of lip aesthetics in the context of facial proportions—An eye‐tracking‐based analysis","year":2023,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Facial Rejuvenation and Surgery Techniques","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Institute of Mining, Metallurgy and Petroleum","funders":"","keywords":"Chin; Vermilion; Medicine; Upper lip; Nose; Lower lip; Contouring; Context (archaeology); Forehead; Orthodontics; Philtrum; Eye tracking; Anatomy; Artificial intelligence; Surgery","score_opus":0.03396602155399783,"score_gpt":0.3411585463651999,"score_spread":0.3071925248112021,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389608052","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9989266,0.0000303621,0.00042285406,0.000005715968,0.0000016141214,0.000015823802,0.000050099046,0.0000038795797,0.00054303097],"genre_scores_gemma":[0.99944323,0.000020904221,0.00030961377,0.000007184737,0.00000226735,0.000010477224,0.000046676752,0.0000012132583,0.00015849185],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998123,0.000060593804,0.000014677047,0.000034417906,0.00005845277,0.000019617934],"domain_scores_gemma":[0.99897206,0.00043651692,0.00025742172,0.000052238927,0.00021644568,0.00006523654],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006476772,0.00013521616,0.00012063515,0.0006000518,0.00013550051,0.00031094474,0.000090448506,0.00021087662,0.001425964],"category_scores_gemma":[0.001904508,0.000067714565,0.00018384714,0.00026364322,0.00013800067,0.00022965885,0.00023288037,0.00017290376,0.00022283707],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019069605,0.00024089108,0.8917895,0.0000985674,0.00008415445,0.00024055774,0.0018578812,0.00051222456,0.06762207,0.000082725324,0.0002160553,0.03534847],"study_design_scores_gemma":[0.00000685816,0.0003397633,0.9962767,0.0000049546557,0.000021477961,0.00035923033,0.0004912525,0.0008576973,0.0015076804,0.000018640365,0.00010869952,0.0000071149448],"about_ca_topic_score_codex":0.0012671406,"about_ca_topic_score_gemma":0.0012842489,"teacher_disagreement_score":0.001425964,"about_ca_system_score_codex":0.00013543385,"about_ca_system_score_gemma":0.000077626064,"threshold_uncertainty_score":0.004770279},"labels":[],"label_agreement":null},{"id":"W4390614285","doi":"10.1111/jdv.19748","title":"Efficacy of long‐term risankizumab treatment for moderate‐to‐severe plaque psoriasis: Subgroup analyses by baseline characteristics and psoriatic disease manifestations through 256 weeks (<scp>LIMMitless</scp> trial)","year":2024,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health","funders":"","keywords":"Medicine; Psoriasis; Psoriasis Area and Severity Index; Internal medicine; Dermatology; Body mass index; Severity of illness; Randomized controlled trial; Subgroup analysis; Gastroenterology; Surgery; Meta-analysis","score_opus":0.041608995851492636,"score_gpt":0.3131399310294778,"score_spread":0.27153093517798516,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390614285","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9773203,0.01721824,0.00089127035,0.00032095064,0.00026894035,0.00071031746,0.002029053,0.00006330619,0.0011776331],"genre_scores_gemma":[0.99446565,0.0014620993,0.00054696616,0.00031250744,0.00016843632,0.0006521776,0.0016647215,0.00002145755,0.00070590456],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9975375,0.0011678658,0.0004002669,0.00042299923,0.00024982315,0.00022149448],"domain_scores_gemma":[0.99806136,0.00074742595,0.00047412378,0.00034970033,0.00015143823,0.00021593181],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0056893453,0.00094766874,0.00393571,0.00043015214,0.00025998906,0.0012126715,0.00071623066,0.0010572008,0.0019173694],"category_scores_gemma":[0.0037605837,0.00038744454,0.009180559,0.0004959719,0.00030697504,0.00074094924,0.00050937856,0.0013266791,0.0002367228],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8792974,0.0007023334,0.026220955,0.002072348,0.05670146,0.0001302932,0.00013674209,0.0010145736,0.0046768403,0.0001107441,0.0015583433,0.027377883],"study_design_scores_gemma":[0.42644358,0.10092172,0.29478082,0.00068983715,0.1605645,0.0006246288,0.00039926232,0.0051122345,0.0035338528,0.0016528948,0.005055871,0.00022078607],"about_ca_topic_score_codex":0.00084478804,"about_ca_topic_score_gemma":0.0021663515,"teacher_disagreement_score":0.0056893453,"about_ca_system_score_codex":0.00048854493,"about_ca_system_score_gemma":0.0007436727,"threshold_uncertainty_score":0.030088425},"labels":[],"label_agreement":null},{"id":"W4390790402","doi":"10.1111/jdv.19701","title":"Tofacitinib efficacy, patient‐reported outcomes and safety in patients with psoriasis and a medical history of psoriatic arthritis: Pooled analysis of two Phase <scp>III</scp> studies","year":2024,"lang":"en","type":"letter","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland; Pfizer (Canada); Probity Medical Research; University of Toronto","funders":"Medical Research Council; Manchester Biomedical Research Centre; LEO Pharma; Sun Pharma; Bausch Health; Astellas Pharma; National Institute for Health and Care Research; Valeant Pharmaceuticals International; Amgen; Pfizer; Ono Pharmaceutical; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Tofacitinib; Discontinuation; Internal medicine; Psoriatic arthritis; Janus kinase inhibitor; Placebo; Adverse effect; Psoriasis; Randomized controlled trial; Physical therapy; Rheumatoid arthritis; Dermatology; Alternative medicine","score_opus":0.018156013562432686,"score_gpt":0.2660924596037756,"score_spread":0.2479364460413429,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390790402","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.12982196,0.85141027,0.0020618238,0.00061232934,0.00048124336,0.001042543,0.012204567,0.000108726825,0.0022565234],"genre_scores_gemma":[0.84251285,0.13905226,0.0025047755,0.001194117,0.0009139303,0.0021059706,0.010950682,0.00006755185,0.00069784134],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.98742956,0.0062964503,0.003142304,0.0013173674,0.0015136598,0.0003006466],"domain_scores_gemma":[0.98315686,0.009468745,0.004596641,0.0009673076,0.0014918228,0.00031860961],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.019945825,0.0019689454,0.009770114,0.0029966973,0.00033216603,0.0025258907,0.00089354353,0.0014325032,0.0023862044],"category_scores_gemma":[0.022474378,0.0008427335,0.02390114,0.0040952787,0.00042058402,0.0011616582,0.0011521549,0.001340577,0.00024129904],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04869567,0.00007264618,0.018717997,0.028728854,0.87930745,0.00010211141,0.0000571875,0.00074072677,0.0005540818,0.00009570503,0.0015669765,0.021360613],"study_design_scores_gemma":[0.019990316,0.0026281963,0.06307136,0.002610304,0.9057698,0.00031502175,0.0000718782,0.0006734383,0.00037180068,0.00040584314,0.0040075476,0.0000843512],"about_ca_topic_score_codex":0.0016881621,"about_ca_topic_score_gemma":0.0037209962,"teacher_disagreement_score":0.019945825,"about_ca_system_score_codex":0.0008646642,"about_ca_system_score_gemma":0.0010168323,"threshold_uncertainty_score":0.1054849},"labels":[],"label_agreement":null},{"id":"W4391281248","doi":"10.1111/jdv.19811","title":"Efficacy and safety of piclidenoson in plaque psoriasis: Results from a randomized phase 3 clinical trial (<scp>COMFORT</scp>‐1)","year":2024,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; University of Toronto","funders":"","keywords":"Apremilast; Placebo; Medicine; Psoriasis Area and Severity Index; Population; Clinical endpoint; Randomized controlled trial; Psoriasis; Placebo-controlled study; Internal medicine; Anesthesia; Gastroenterology; Dermatology; Double blind; Psoriatic arthritis; Pathology","score_opus":0.03853453511229285,"score_gpt":0.3225671857400922,"score_spread":0.28403265062779937,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391281248","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9844284,0.0074906354,0.0005313072,0.00063214236,0.0002408529,0.0033217184,0.001228754,0.00012673889,0.0019994427],"genre_scores_gemma":[0.98538566,0.0048734434,0.0013965513,0.0012183138,0.0004382568,0.0035375485,0.001715758,0.000029429777,0.0014049914],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99944717,0.00031168462,0.00003559372,0.00007528431,0.000061296196,0.00006901226],"domain_scores_gemma":[0.9991831,0.00018621533,0.00026419753,0.0000612544,0.000066899695,0.00023830596],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018188546,0.0011070527,0.0018228985,0.00027572617,0.0003762419,0.0007988623,0.00053158746,0.001101864,0.005690152],"category_scores_gemma":[0.0012355526,0.0004323064,0.0014536468,0.00033819117,0.0006388132,0.0005638682,0.0002567155,0.0020220263,0.00064029836],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9514713,0.00839686,0.0010628472,0.000875255,0.0011655495,0.00005477722,0.00005743073,0.0003238998,0.007740246,0.00008385468,0.00138925,0.027378626],"study_design_scores_gemma":[0.9238613,0.07066739,0.0035455907,0.000040648472,0.00044899544,0.00005886414,0.00001581478,0.00021290337,0.0005616714,0.00007137023,0.00050461385,0.00001087835],"about_ca_topic_score_codex":0.0005569267,"about_ca_topic_score_gemma":0.0012369556,"teacher_disagreement_score":0.005690152,"about_ca_system_score_codex":0.00047191783,"about_ca_system_score_gemma":0.0010071803,"threshold_uncertainty_score":0.019035459},"labels":[],"label_agreement":null},{"id":"W4391612018","doi":"10.1111/jdv.19818","title":"Global study reveals almost half of patients with skin disease suffer from sleep disturbances and identifies predictive factors","year":2024,"lang":"en","type":"letter","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Circadian rhythm and melatonin","field":"Neuroscience","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Disease; Pediatrics; Intensive care medicine; Internal medicine","score_opus":0.013908787146087138,"score_gpt":0.24192785026644564,"score_spread":0.2280190631203585,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391612018","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97422284,0.011128435,0.00044445228,0.0008739853,0.00008038475,0.000057632333,0.005239346,0.00005335953,0.007899595],"genre_scores_gemma":[0.99217963,0.003998632,0.00027411155,0.00039416165,0.00008548163,0.000031677228,0.0021082296,0.00001072922,0.00091733295],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99966955,0.00008515527,0.00003390361,0.00007802602,0.00008289431,0.000050484065],"domain_scores_gemma":[0.9993698,0.000099474746,0.0002788282,0.000040604198,0.00009855399,0.00011284485],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000343604,0.0002689058,0.00053087325,0.0010043225,0.00028471602,0.0004374316,0.00018619344,0.00036576693,0.005123848],"category_scores_gemma":[0.0007692464,0.000112908965,0.0004091107,0.0020942618,0.00022366637,0.0005829528,0.00040985824,0.00047854558,0.0009758594],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000049926366,0.000032470984,0.9855311,0.00011867179,0.000046829882,0.00013839672,0.00016264532,0.000022371763,0.00032437016,0.000050045637,0.001545611,0.011977582],"study_design_scores_gemma":[0.0000023708023,0.000043519296,0.9972951,0.00003792734,0.000020938414,0.00060138525,0.00031692,0.00003138795,0.000029624503,0.00002980172,0.0015883727,0.000002668454],"about_ca_topic_score_codex":0.003175898,"about_ca_topic_score_gemma":0.0031932585,"teacher_disagreement_score":0.005123848,"about_ca_system_score_codex":0.00014007548,"about_ca_system_score_gemma":0.00018969065,"threshold_uncertainty_score":0.017140985},"labels":[],"label_agreement":null},{"id":"W4391680495","doi":"10.1111/jdv.19830","title":"Psychometric validation of the Psoriasis Symptom Scale, Functional Assessment of Chronic Illness Therapy–Fatigue and <scp>pain‐Visual</scp> Analogue Scale in patients with generalized pustular psoriasis","year":2024,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Innovaderm (Canada)","funders":"Boehringer Ingelheim","keywords":"Visual analogue scale; Cronbach's alpha; Medicine; Intraclass correlation; Convergent validity; Physical therapy; Population; Psychometrics; Clinical psychology; Internal consistency","score_opus":0.015881056557061346,"score_gpt":0.25699040019336483,"score_spread":0.24110934363630349,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391680495","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960731,0.00055060914,0.00095249066,0.000114041635,0.000045963847,0.00040566645,0.0003437433,0.000013524885,0.0015008944],"genre_scores_gemma":[0.99804074,0.00010721717,0.0008949907,0.00006765676,0.000020949576,0.00028135016,0.00047052468,0.0000052717496,0.00011141105],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99393517,0.00280741,0.0007479771,0.0004364531,0.0018333106,0.0002395896],"domain_scores_gemma":[0.98964757,0.004875554,0.0022812078,0.00079470023,0.0019233333,0.00047767055],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.014327377,0.0004549157,0.0005063598,0.0008122714,0.0003388179,0.00063826673,0.0004942321,0.00077980326,0.0009596052],"category_scores_gemma":[0.023372082,0.00023943446,0.0010642349,0.00072418986,0.0007401018,0.000700621,0.0009006265,0.0009324734,0.000500172],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020472133,0.0008727378,0.96322334,0.00014862102,0.00031378868,0.000081200684,0.00094931363,0.0005493237,0.0015007043,0.00006973823,0.0006263872,0.02961775],"study_design_scores_gemma":[0.0003828661,0.0045756917,0.99227035,0.000049864935,0.000083313884,0.0002851932,0.00028700955,0.0009570343,0.00029106037,0.000083323175,0.00071955734,0.000014749369],"about_ca_topic_score_codex":0.00047491948,"about_ca_topic_score_gemma":0.00062735187,"teacher_disagreement_score":0.014327377,"about_ca_system_score_codex":0.00032039144,"about_ca_system_score_gemma":0.000475354,"threshold_uncertainty_score":0.07577133},"labels":[],"label_agreement":null},{"id":"W4391927285","doi":"10.1111/jdv.19848","title":"Temporal and external validation of the multidimensional scale—uremic pruritus in dialysis patients (<scp>UP‐Dial</scp>): A psychometric evaluation","year":2024,"lang":"en","type":"letter","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Clinical Evaluative Sciences; Ottawa Hospital; University of Ottawa","funders":"Genentech; LEO Pharma; National Research Council of Thailand; Chiang Mai University; Incyte; Regeneron Pharmaceuticals; Teva Pharmaceutical Industries; Health Systems Research Institute; Sanofi; Cilag; Celldex Therapeutics; Amgen; Pfizer; Galderma; AstraZeneca; Eli Lilly and Company; GlaxoSmithKline","keywords":"Pharmacy; Chiang mai; Medicine; Family medicine; Public health; Epidemiology; Research center; Library science; Nursing; Internal medicine; History","score_opus":0.021930033995658987,"score_gpt":0.2875814229949667,"score_spread":0.26565138899930774,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391927285","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930721,0.00017707625,0.0008181756,0.0007976023,0.000103780556,0.00032436606,0.0004443294,0.0000064803185,0.004255987],"genre_scores_gemma":[0.99694014,0.00009670869,0.0012135407,0.00036032283,0.000043488584,0.0003721722,0.00040313663,0.000004745301,0.00056580984],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9918031,0.005165313,0.0011378535,0.00030353913,0.0013530152,0.00023712266],"domain_scores_gemma":[0.9550575,0.026618477,0.0038029104,0.003537145,0.009953497,0.0010305343],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.018923322,0.00022876261,0.00029701256,0.0007050783,0.00056285155,0.000854607,0.00045288383,0.00073469995,0.0015617901],"category_scores_gemma":[0.05569149,0.00016759791,0.0006109084,0.00095100317,0.000751044,0.00077873137,0.0010903645,0.001073716,0.0005292928],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008965978,0.00088409754,0.9523465,0.00007299532,0.00009144678,0.0002400916,0.0036472334,0.00029971093,0.0008094519,0.00041264508,0.0016974008,0.03860189],"study_design_scores_gemma":[0.00015995032,0.0017662313,0.98621154,0.000104085826,0.0000551291,0.0007630691,0.0032095034,0.0018960176,0.00075086165,0.00033827915,0.004717577,0.000027696053],"about_ca_topic_score_codex":0.002066891,"about_ca_topic_score_gemma":0.0017792223,"teacher_disagreement_score":0.018923322,"about_ca_system_score_codex":0.00085399597,"about_ca_system_score_gemma":0.0009153447,"threshold_uncertainty_score":0.10007733},"labels":[],"label_agreement":null},{"id":"W4392045360","doi":"10.1111/jdv.19886","title":"Harmonizing body surface area assessments between the Eczema Area and Severity Index, <scp>SCORing</scp> Atopic Dermatitis, and handprint methods utilizing one shared <scp>measurement—A</scp> proposal to improve efficiency and reduce error in atopic dermatitis trials","year":2024,"lang":"en","type":"letter","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Innovaderm (Canada)","funders":"","keywords":"Atopic dermatitis; Medicine; Dermatology; Family medicine; Library science; Computer science","score_opus":0.11641342890996287,"score_gpt":0.36303155352233824,"score_spread":0.24661812461237537,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392045360","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.20836504,0.017863115,0.03840841,0.6031245,0.031740293,0.005708623,0.0014338992,0.0004148543,0.09294131],"genre_scores_gemma":[0.63280946,0.006280705,0.0622773,0.24772929,0.03055472,0.0034717713,0.00097577804,0.00021012912,0.015690826],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.99064356,0.006223439,0.0011294847,0.00039116788,0.0013742065,0.00023810712],"domain_scores_gemma":[0.9902096,0.0056442763,0.0005305848,0.0006224121,0.0027236994,0.0002694221],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.012732384,0.00026070717,0.0006031799,0.00062754354,0.0004859978,0.0011328441,0.00081581244,0.0024862778,0.0023458202],"category_scores_gemma":[0.03751468,0.00021284715,0.0003031511,0.00071749726,0.0007572287,0.0010405881,0.00070430496,0.002626519,0.0019815303],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022450928,0.00058291556,0.06648866,0.0005173379,0.00009738497,0.0039956407,0.00079461734,0.0004925372,0.0028231565,0.0031255262,0.4330016,0.48583558],"study_design_scores_gemma":[0.0029978445,0.0064216787,0.18301605,0.002581802,0.0002260077,0.025375554,0.0028855996,0.007791138,0.0078073936,0.015995191,0.7446821,0.00021973754],"about_ca_topic_score_codex":0.0014706174,"about_ca_topic_score_gemma":0.0032752668,"teacher_disagreement_score":0.9872676,"about_ca_system_score_codex":0.0010306578,"about_ca_system_score_gemma":0.0007895213,"threshold_uncertainty_score":0.06733608},"labels":[],"label_agreement":null},{"id":"W4392110966","doi":"10.1111/jdv.19788","title":"Commentary on Epidemiology of mental health comorbidity in patients with atopic dermatitis: An analysis of global trends from 1998 to 2022","year":2024,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Atopic dermatitis; Comorbidity; Epidemiology; Observational study; Medicine; Distress; Anxiety; Disease; Psychiatry; Mental health; Quality of life (healthcare); Clinical psychology; Dermatology; Pathology","score_opus":0.019185569053805016,"score_gpt":0.3206528726987867,"score_spread":0.30146730364498164,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392110966","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005076672,0.018068565,0.00025372955,0.7999748,0.17842935,0.00005215164,0.0016947921,0.000073248324,0.00094572356],"genre_scores_gemma":[0.005385623,0.013574763,0.00046509222,0.74931663,0.22849068,0.00014725431,0.0004693371,0.00007703461,0.0020736246],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9862179,0.0054603787,0.0020687946,0.002041316,0.003681624,0.000529984],"domain_scores_gemma":[0.8875803,0.07910965,0.005329487,0.0017899909,0.023485038,0.0027055521],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.012885394,0.0016462934,0.0033893855,0.0028848534,0.0022803608,0.0028016157,0.00810847,0.02111108,0.007728222],"category_scores_gemma":[0.09151858,0.0012530915,0.0035819414,0.00377109,0.0025202432,0.0038242475,0.0016305067,0.018880036,0.0037158222],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007873788,0.000010887273,0.0005167505,0.0011657136,0.00018046843,0.00017178706,0.000089339206,0.000058049704,0.000054730266,0.00039913855,0.99313956,0.0041347183],"study_design_scores_gemma":[0.00059730693,0.00021626671,0.007745903,0.015702898,0.0012863026,0.0011809096,0.0008046337,0.00073396263,0.0005011275,0.0064021423,0.96459055,0.00023790586],"about_ca_topic_score_codex":0.017310815,"about_ca_topic_score_gemma":0.017897923,"teacher_disagreement_score":0.02111108,"about_ca_system_score_codex":0.00473221,"about_ca_system_score_gemma":0.0063624703,"threshold_uncertainty_score":0.068145275},"labels":[],"label_agreement":null},{"id":"W4392117491","doi":"10.1111/jdv.19908","title":"Prevalence of dermatitis including allergic contact dermatitis from medical devices used by children and adults with Type 1 diabetes mellitus: A systematic review and questionnaire study","year":2024,"lang":"en","type":"review","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Diabetes Management and Research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Referral; Incidence (geometry); CINAHL; Cochrane Library; Atopic dermatitis; MEDLINE; Diabetes mellitus; Pediatrics; Contact dermatitis; Family medicine; Dermatology; Allergy; Internal medicine; Meta-analysis; Psychological intervention; Immunology; Psychiatry","score_opus":0.021252312818836605,"score_gpt":0.318816986140365,"score_spread":0.2975646733215284,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392117491","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0067828554,0.99139047,0.000096324635,0.00013813627,0.00004935571,0.0003821902,0.00090222317,0.0000054449188,0.00025292652],"genre_scores_gemma":[0.054900575,0.9422655,0.0007464396,0.00048449874,0.000056151697,0.00087675767,0.0005422869,0.000005290942,0.00012261361],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9898816,0.0021946935,0.005470457,0.00080127915,0.0014102708,0.00024172329],"domain_scores_gemma":[0.96380913,0.02420546,0.0088115875,0.0004926569,0.0023512135,0.00032992536],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0065445085,0.0010081413,0.006883223,0.013316851,0.0005851851,0.0023182174,0.0012844121,0.0015294476,0.0027829714],"category_scores_gemma":[0.029311052,0.0008639165,0.007856045,0.015409157,0.00094236946,0.0021456163,0.0015543803,0.0008187465,0.00017161424],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019764311,0.000015438674,0.00442462,0.97038513,0.008637436,0.00017240284,0.0004260684,0.00004080452,0.00013045869,0.00007226917,0.0005145761,0.0149831055],"study_design_scores_gemma":[0.0002682056,0.0003627617,0.028149514,0.87599933,0.082543224,0.0016300863,0.0010709608,0.00006881293,0.00016853439,0.00013159864,0.009552513,0.00005442025],"about_ca_topic_score_codex":0.008442313,"about_ca_topic_score_gemma":0.023447152,"teacher_disagreement_score":0.013316851,"about_ca_system_score_codex":0.0032033192,"about_ca_system_score_gemma":0.005774809,"threshold_uncertainty_score":0.034611106},"labels":[],"label_agreement":null},{"id":"W4392139316","doi":"10.1111/jdv.19903","title":"Patient prioritisation of items to develop the Patient‐Reported Impact of Dermatological Diseases measure: A global Delphi study","year":2024,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Delphi Technique in Research","field":"Social Sciences","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Occupational and Environmental Medical Association of Canada","funders":"","keywords":"Delphi method; Likert scale; Medicine; Delphi; Patient-reported outcome; Dermatological diseases; Family medicine; Psychology; Quality of life (healthcare); Nursing; Computer science; Dermatology","score_opus":0.07932169567629054,"score_gpt":0.4191088325306131,"score_spread":0.33978713685432255,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392139316","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9411569,0.00021843538,0.030527249,0.0019335931,0.0001291786,0.019667607,0.0003057819,0.00007951346,0.0059817685],"genre_scores_gemma":[0.9123822,0.00037725543,0.04752878,0.0012657843,0.000042460062,0.03709691,0.00024839127,0.000046339857,0.0010119134],"study_design_codex":"qualitative","study_design_gemma":"qualitative","domain_scores_codex":[0.9226244,0.06359157,0.0041036406,0.0017025647,0.0045036618,0.0034741045],"domain_scores_gemma":[0.92804325,0.050917547,0.002629538,0.0027530622,0.013679854,0.001976732],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.131156,0.0009294279,0.000839946,0.0030300266,0.002859616,0.0018007373,0.0014378431,0.001514813,0.003602946],"category_scores_gemma":[0.10187209,0.00080975087,0.0013379743,0.001927717,0.0026983004,0.0027816498,0.008339244,0.0026227979,0.00066592917],"study_design_candidate":"qualitative","study_design_consensus":"qualitative","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018170456,0.0018511617,0.06135288,0.0034472737,0.00024894666,0.0010130086,0.66489536,0.0035727615,0.013913313,0.009905937,0.010263069,0.22771925],"study_design_scores_gemma":[0.001207347,0.009285862,0.07912483,0.0026969062,0.00023592611,0.0020256331,0.7998626,0.017232226,0.01174358,0.012381161,0.06360198,0.0006019129],"about_ca_topic_score_codex":0.0008805261,"about_ca_topic_score_gemma":0.00100726,"teacher_disagreement_score":0.131156,"about_ca_system_score_codex":0.0036506876,"about_ca_system_score_gemma":0.0071712616,"threshold_uncertainty_score":0.6936275},"labels":[],"label_agreement":null},{"id":"W4392287099","doi":"10.1111/jdv.19857","title":"Expert consensus on perioperative integrated skincare for noninvasive energy‐based device aesthetic procedures in clinical practice in China","year":2024,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Body Contouring and Surgery","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health","funders":"National Key Research and Development Program of China; L'Oreal USA","keywords":"Perioperative; Medicine; Clinical Practice; Intensive care medicine; Medical physics; Surgery; Physical therapy","score_opus":0.027100720116002845,"score_gpt":0.35201724571190796,"score_spread":0.3249165255959051,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392287099","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.050711654,0.46106225,0.053645995,0.32177332,0.03685772,0.0027690085,0.0016893115,0.000455184,0.07103554],"genre_scores_gemma":[0.4402709,0.30947745,0.13050938,0.08904855,0.006731414,0.0030569364,0.002798149,0.00016744847,0.017939826],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.97738683,0.006767887,0.007664397,0.0012544383,0.005761453,0.0011650481],"domain_scores_gemma":[0.9621511,0.009251671,0.0026916608,0.0008632816,0.022578374,0.002463845],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0333832,0.0006443178,0.001071769,0.003212634,0.0013988786,0.0018534872,0.0027664984,0.0045280834,0.002820536],"category_scores_gemma":[0.039554548,0.00036204985,0.001994387,0.0020555416,0.0016642585,0.0019519792,0.0026871113,0.0025978116,0.0007145389],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022213443,0.00014086837,0.010611473,0.02006868,0.0003827392,0.00170578,0.0060137296,0.0012925478,0.0037190744,0.013475094,0.2331292,0.70923865],"study_design_scores_gemma":[0.00021499116,0.00031793638,0.019535642,0.048513457,0.0012241857,0.0038419033,0.010596744,0.0021291028,0.0038876187,0.014259606,0.8951353,0.00034351868],"about_ca_topic_score_codex":0.00706098,"about_ca_topic_score_gemma":0.0075134644,"teacher_disagreement_score":0.0333832,"about_ca_system_score_codex":0.0035391538,"about_ca_system_score_gemma":0.027725613,"threshold_uncertainty_score":0.17654938},"labels":[],"label_agreement":null},{"id":"W4392551856","doi":"10.1111/jdv.19925","title":"Deucravacitinib in moderate‐to‐severe plaque psoriasis: Pooled safety and tolerability over 52 weeks from two phase 3 trials (<scp>POETYK PSO</scp>‐1 and <scp>PSO</scp>‐2)","year":2024,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; University of Toronto","funders":"","keywords":"Medicine; Placebo; Tolerability; Adverse effect; Discontinuation; Internal medicine; Apremilast; Psoriasis; Incidence (geometry); Population; Gastroenterology; Dermatology; Psoriatic arthritis; Pathology","score_opus":0.02740083357130022,"score_gpt":0.29529768643913734,"score_spread":0.2678968528678371,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392551856","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.882144,0.09732712,0.0051871864,0.00068876654,0.0002709209,0.0037278724,0.007410529,0.00035009618,0.0028935985],"genre_scores_gemma":[0.9795416,0.010839305,0.001750934,0.00047689004,0.0002362331,0.001504679,0.005001804,0.000055169872,0.00059336994],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9946608,0.0027900364,0.0007562719,0.0007553032,0.00081818283,0.00021951563],"domain_scores_gemma":[0.994703,0.0020095725,0.0019976893,0.00042957332,0.0004955958,0.000364603],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.013314777,0.0017844943,0.0044091796,0.00092158467,0.00039685032,0.0014869381,0.000625747,0.0013764007,0.0024791192],"category_scores_gemma":[0.009051119,0.00084884354,0.010471849,0.0010629117,0.0004115461,0.0009156583,0.0007130393,0.0015487153,0.0003466369],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.64223707,0.0018937356,0.029463232,0.01207629,0.19357269,0.00032005896,0.000299974,0.0051037986,0.017070327,0.000116715404,0.0046598976,0.093186215],"study_design_scores_gemma":[0.387082,0.102233924,0.21292342,0.00093559775,0.275404,0.0016229138,0.0001540833,0.0029043318,0.007933591,0.0006314575,0.007933686,0.00024096234],"about_ca_topic_score_codex":0.00082994933,"about_ca_topic_score_gemma":0.0023374867,"teacher_disagreement_score":0.013314777,"about_ca_system_score_codex":0.00084696914,"about_ca_system_score_gemma":0.0014428728,"threshold_uncertainty_score":0.07041615},"labels":[],"label_agreement":null},{"id":"W4392587390","doi":"10.1111/jdv.19937","title":"Consensus statement on the diagnosis and treatment of sclerosing diseases of the skin, Part 2: Scleromyxoedema and scleroedema","year":2024,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Skin Diseases and Diabetes","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Mallinckrodt Pharmaceuticals","keywords":"Medicine; Statement (logic); Dermatology; Intensive care medicine; Epistemology","score_opus":0.048201867663706675,"score_gpt":0.29154758667972885,"score_spread":0.24334571901602217,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392587390","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0028259098,0.44917282,0.016731696,0.40448314,0.081824355,0.0014339442,0.0038655808,0.000534482,0.03912806],"genre_scores_gemma":[0.030500567,0.5616788,0.08219354,0.21635172,0.05922753,0.0035206894,0.017036637,0.00051704515,0.028973512],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98443377,0.004815824,0.004402779,0.0007370385,0.004754521,0.0008561178],"domain_scores_gemma":[0.96122944,0.009240847,0.004074252,0.0008517688,0.021996526,0.0026070888],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.018968256,0.0014119779,0.0033559194,0.0039967005,0.0015811357,0.0024811989,0.005579084,0.010188438,0.004806725],"category_scores_gemma":[0.03590028,0.00082666986,0.0048419572,0.0022679113,0.0017001963,0.0020463667,0.0030855995,0.010973795,0.005162316],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020850453,0.00015629051,0.0010346317,0.0065950286,0.00023786453,0.0005720829,0.00032303148,0.00076114107,0.0012481725,0.0041604065,0.74793327,0.23676962],"study_design_scores_gemma":[0.00016989581,0.00014286973,0.0026885446,0.020829642,0.00045439124,0.0015879268,0.00027320697,0.00033578376,0.0007155647,0.00392105,0.9688103,0.000070754715],"about_ca_topic_score_codex":0.007877203,"about_ca_topic_score_gemma":0.0074368645,"teacher_disagreement_score":0.018968256,"about_ca_system_score_codex":0.003195943,"about_ca_system_score_gemma":0.013851098,"threshold_uncertainty_score":0.100314915},"labels":[],"label_agreement":null},{"id":"W4392597580","doi":"10.1111/jdv.19912","title":"Consensus statement on the diagnosis and treatment of sclerosing diseases of the skin, Part 1: Localized scleroderma, systemic sclerosis and overlap syndromes","year":2024,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Mallinckrodt Pharmaceuticals","keywords":"Medicine; Scleroderma (fungus); Statement (logic); Dermatology; Systemic scleroderma; Intensive care medicine; Pathology; Epistemology","score_opus":0.05851737823717363,"score_gpt":0.2821338745900391,"score_spread":0.22361649635286546,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392597580","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0028966093,0.48932272,0.017297924,0.3839005,0.06358566,0.0013154614,0.0033278603,0.0005290761,0.03782426],"genre_scores_gemma":[0.031360522,0.59124035,0.07987916,0.20157789,0.051959243,0.0031212054,0.015840897,0.00045557824,0.024565145],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98347867,0.005609725,0.004575236,0.0007389766,0.004721158,0.0008761511],"domain_scores_gemma":[0.96366674,0.009184459,0.0038780933,0.0007643551,0.020117125,0.0023893584],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.019001674,0.0012930828,0.003203727,0.0038364138,0.001559138,0.0025606456,0.00516793,0.009059222,0.0044049723],"category_scores_gemma":[0.034256708,0.00074972364,0.0042019566,0.0022444937,0.0016991809,0.0021127155,0.0032340798,0.010189756,0.0047404254],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021656403,0.00015099514,0.001133348,0.0070143538,0.00024678104,0.0006562425,0.00041325015,0.00077296194,0.0013865571,0.0053115203,0.71985257,0.2628449],"study_design_scores_gemma":[0.0001643288,0.00013919351,0.0026099682,0.020873323,0.00043804175,0.0017407422,0.00030011972,0.00030862,0.0006668315,0.0041992934,0.9684913,0.000068333706],"about_ca_topic_score_codex":0.006533456,"about_ca_topic_score_gemma":0.006845833,"teacher_disagreement_score":0.019001674,"about_ca_system_score_codex":0.0030271166,"about_ca_system_score_gemma":0.014157556,"threshold_uncertainty_score":0.1004917},"labels":[],"label_agreement":null},{"id":"W4392711217","doi":"10.1111/jdv.19913","title":"Dermatological patients with itch report more stress, stigmatization experience, anxiety and depression compared to patients without itch: Results from a European multi‐centre study","year":2024,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"UCB Pharma; Genentech; LEO Pharma; Medac; Bausch Health; Argenx; Bristol-Myers Squibb; Eli Lilly and Company; Galderma; Sanofi Genzyme; Incyte; InflaRx; Les Laboratories Pierre Fabre; Celgene; Celltrion; Sanofi; Amgen; Pfizer","keywords":"Medicine; Depression (economics); Anxiety; Dermatology; Psychiatry; Clinical psychology; Physical therapy","score_opus":0.017929244287169934,"score_gpt":0.28793390142545594,"score_spread":0.27000465713828603,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392711217","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9996062,0.00013686939,0.000026735042,0.000015117866,0.0000035991459,0.000007867092,0.00007239619,7.976176e-7,0.00013053294],"genre_scores_gemma":[0.99970835,0.00007878525,0.000030218887,0.000023551693,0.0000059332933,0.000007824601,0.000099361925,7.0322216e-7,0.000045303786],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994753,0.00017277272,0.000075857664,0.00010420209,0.0000975239,0.000074284806],"domain_scores_gemma":[0.99830306,0.00038957974,0.0007124721,0.00012264577,0.00016471761,0.00030745787],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009287799,0.0002798057,0.0004163476,0.0007050884,0.00047811744,0.0008424918,0.00023840256,0.0004509077,0.0020650348],"category_scores_gemma":[0.0021349113,0.0002521557,0.00072971225,0.0009690956,0.000310556,0.0004371027,0.00058011356,0.00037876336,0.00027103417],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022408638,0.000117940945,0.99736255,0.000026254065,0.00011787539,0.00012322736,0.00041693123,0.000014410469,0.00022869445,0.00000842666,0.000091375725,0.0012681376],"study_design_scores_gemma":[0.000017012539,0.00012144934,0.999141,0.000007249688,0.000028821447,0.0002233367,0.00033108128,0.000028441718,0.0000204636,0.0000050999324,0.00007261179,0.0000033309773],"about_ca_topic_score_codex":0.0018743004,"about_ca_topic_score_gemma":0.0020170233,"teacher_disagreement_score":0.0020650348,"about_ca_system_score_codex":0.00020159822,"about_ca_system_score_gemma":0.00016532377,"threshold_uncertainty_score":0.006908238},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"observational","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":[],"domain":null,"study_design":"observational","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"}],"label_agreement":"agree"},{"id":"W4392805342","doi":"10.1111/jdv.19958","title":"Maternal tobacco exposure during pregnancy and atopic dermatitis in offspring: A systematic review and meta‐analysis","year":2024,"lang":"en","type":"review","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Henan Provincial Science and Technology Research Project","keywords":"Offspring; Medicine; Pregnancy; Checklist; Atopic dermatitis; Population; Meta-analysis; Systematic review; Observational study; Cohort study; Cotinine; Critical appraisal; Environmental health; Obstetrics; Nicotine; MEDLINE; Internal medicine; Immunology; Pathology; Alternative medicine; Psychology; Biology","score_opus":0.037257836549789196,"score_gpt":0.3177652176259097,"score_spread":0.2805073810761205,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392805342","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0024947356,0.99626654,0.0003273817,0.00013874276,0.00013020966,0.00024256036,0.00026092882,0.0000129632335,0.00012609405],"genre_scores_gemma":[0.100054465,0.8948846,0.0018137421,0.00080860755,0.00027253016,0.001290234,0.0005440131,0.000018883005,0.0003129054],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9922191,0.0034449187,0.0024573433,0.00073074433,0.0008961887,0.00025173562],"domain_scores_gemma":[0.9838309,0.011778322,0.0025435765,0.00049758627,0.0011796824,0.0001697791],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0106338225,0.0023417037,0.016678533,0.0053381035,0.00059515913,0.003455098,0.0019016259,0.0022869261,0.003537024],"category_scores_gemma":[0.029322978,0.0014274734,0.029019516,0.0062433444,0.000606113,0.0015941572,0.0014549133,0.0018467341,0.00026347433],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008381027,0.000028348255,0.0032830562,0.58294135,0.4017208,0.00015390904,0.000087277396,0.00031896168,0.00019078887,0.00013338288,0.00050285493,0.009801152],"study_design_scores_gemma":[0.00027791952,0.00018811146,0.004056426,0.05436999,0.93843,0.00012917447,0.00004774244,0.00015681695,0.000108124324,0.00017023782,0.0020430088,0.000022387532],"about_ca_topic_score_codex":0.0054430603,"about_ca_topic_score_gemma":0.012255945,"teacher_disagreement_score":0.016678533,"about_ca_system_score_codex":0.0022529627,"about_ca_system_score_gemma":0.003946222,"threshold_uncertainty_score":0.056237698},"labels":[],"label_agreement":null},{"id":"W4394808579","doi":"10.1111/jdv.19978","title":"Dysregulation of epigenetic, biological and mitotic age in the context of biologic drug treatment and phototherapy in plaque psoriasis patients","year":2024,"lang":"en","type":"letter","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health; Centre for Addiction and Mental Health; Women's College Hospital; University of Toronto; McGill University Health Centre","funders":"","keywords":"Context (archaeology); Excellence; Library science; Medicine; Center of excellence; Gerontology; Family medicine; History; Political science; Archaeology","score_opus":0.02479109202086943,"score_gpt":0.24426489398196366,"score_spread":0.21947380196109423,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394808579","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.11944246,0.0095654065,0.0009653672,0.83731276,0.008919405,0.000042578868,0.0027303454,0.00015298695,0.020868644],"genre_scores_gemma":[0.6845048,0.0063158832,0.0012799267,0.2672665,0.024920842,0.000095220224,0.0010344745,0.00005979427,0.014522569],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9994659,0.00022512827,0.00005418218,0.000080221136,0.00010881697,0.0000657415],"domain_scores_gemma":[0.9981585,0.0010682364,0.00013993758,0.00014887073,0.0003183642,0.0001659725],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006772113,0.00012729538,0.00038332064,0.0003002895,0.0005960543,0.0006212164,0.00026156713,0.002637449,0.0020814806],"category_scores_gemma":[0.0057480116,0.00011095959,0.00021200824,0.000479173,0.00030647792,0.0004747454,0.0002470618,0.0021039885,0.001073335],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001990939,0.00014377614,0.15201238,0.00024273394,0.0001251863,0.027463648,0.0010119384,0.0003953137,0.0035280667,0.0030393668,0.6592567,0.15078986],"study_design_scores_gemma":[0.00041122138,0.0005848456,0.16042243,0.0005208006,0.00024921104,0.08028821,0.0025444701,0.0027181446,0.003716016,0.022640705,0.725786,0.000117918506],"about_ca_topic_score_codex":0.0022200085,"about_ca_topic_score_gemma":0.0031023503,"teacher_disagreement_score":0.002637449,"about_ca_system_score_codex":0.0007026822,"about_ca_system_score_gemma":0.0005016527,"threshold_uncertainty_score":0.006963253},"labels":[],"label_agreement":null},{"id":"W4394808583","doi":"10.1111/jdv.20030","title":"Adaptive designs in dermatology clinical trials: Current status and future perspectives","year":2024,"lang":"en","type":"review","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Statistical Methods in Clinical Trials","field":"Mathematics","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Innovaderm (Canada)","funders":"","keywords":"Adaptive design; Clinical trial; Risk analysis (engineering); Clinical study design; Limiting; Drug development; Computer science; Medicine; Intensive care medicine; Field (mathematics); Medical physics; Management science; Drug; Engineering; Pathology; Pharmacology","score_opus":0.7608716892957742,"score_gpt":0.6425289689462116,"score_spread":0.11834272034956261,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394808583","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00029034403,0.96830606,0.0249693,0.0041595553,0.00053499185,0.00011511655,0.000028328204,0.000053191576,0.0015430668],"genre_scores_gemma":[0.011133164,0.94508624,0.03850233,0.0025220015,0.0015812195,0.00052974926,0.000050204104,0.00004350226,0.00055165746],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9632189,0.029820187,0.0021828127,0.0011425962,0.0033446087,0.00029084747],"domain_scores_gemma":[0.7779354,0.2096469,0.0050013424,0.0024251766,0.0042979084,0.0006932868],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0548491,0.0011297787,0.0037243562,0.002764514,0.00030810066,0.0029366799,0.0028194888,0.0029017006,0.0055963458],"category_scores_gemma":[0.0901917,0.0007702084,0.0022605343,0.0036568828,0.0044535776,0.0031544636,0.0016724732,0.0056924857,0.0011149007],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030909583,0.00013146385,0.00053442095,0.031735394,0.00057471043,0.00007644342,0.00021434632,0.0058781826,0.00017327316,0.106141746,0.0072863847,0.8469446],"study_design_scores_gemma":[0.0011130046,0.0013754957,0.0023994574,0.07742187,0.0011152354,0.0012353575,0.00034136744,0.011451718,0.00073460303,0.3914615,0.5111387,0.00021174148],"about_ca_topic_score_codex":0.0011809107,"about_ca_topic_score_gemma":0.0010402491,"teacher_disagreement_score":0.9451509,"about_ca_system_score_codex":0.002401949,"about_ca_system_score_gemma":0.0062004747,"threshold_uncertainty_score":0.29007328},"labels":[],"label_agreement":null},{"id":"W4396579742","doi":"10.1111/jdv.20061","title":"Acne lesions cycle","year":2024,"lang":"en","type":"letter","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Acne and Rosacea Treatments and Effects","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Acne; Dermatology; Medicine","score_opus":0.02033979225353014,"score_gpt":0.2850872460513451,"score_spread":0.26474745379781495,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396579742","genre_codex":"other","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.032634966,0.016414404,0.0019044849,0.3032668,0.024898032,0.0002903248,0.00086350314,0.00043725627,0.61929023],"genre_scores_gemma":[0.2870115,0.008299071,0.0014382104,0.20967351,0.013623314,0.0001145114,0.00053269893,0.00008463253,0.4792225],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996891,0.000061790015,0.000030729116,0.000052574207,0.000095725794,0.000070136884],"domain_scores_gemma":[0.9995771,0.00009206585,0.000029665656,0.000051548403,0.00016043743,0.00008922537],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025138038,0.00023120314,0.00029272493,0.00037893653,0.0012819621,0.000801178,0.00035199622,0.0035866138,0.0190549],"category_scores_gemma":[0.0019437845,0.000094622366,0.0003749802,0.00022427368,0.00032826676,0.00055502425,0.00032927573,0.00263136,0.011531209],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043258414,0.00021249743,0.009951869,0.00030378444,0.000031736527,0.09530659,0.00042300142,0.0000846138,0.0072968304,0.007486744,0.70720685,0.171263],"study_design_scores_gemma":[0.00004677868,0.00015565527,0.005847171,0.00019593585,0.000010536697,0.10573292,0.00027847328,0.00016383157,0.0011887942,0.0031024418,0.88326174,0.000015690084],"about_ca_topic_score_codex":0.001527589,"about_ca_topic_score_gemma":0.0037035262,"teacher_disagreement_score":0.0190549,"about_ca_system_score_codex":0.00059339195,"about_ca_system_score_gemma":0.0004536912,"threshold_uncertainty_score":0.06374496},"labels":[],"label_agreement":null},{"id":"W4396871371","doi":"10.1111/jdv.20102","title":"EADV Task Force Pruritus White Paper on chronic pruritus and chronic prurigo: Current challenges and future solutions","year":2024,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Cilag; Genentech; LEO Pharma; Medac; European Academy of Dermatology and Venereology; Bausch Health; Deutsche Forschungsgemeinschaft; Argenx; Celltrion; InflaRx; Pfizer; Incyte; Sun Pharma; Deutsche Gesetzliche Unfallversicherung; Regeneron Pharmaceuticals; Les Laboratories Pierre Fabre; Teva Pharmaceutical Industries; Sanofi; Celldex Therapeutics; Amgen; Kiniksa Pharmaceuticals; Celgene; Galderma; AstraZeneca; Eli Lilly and Company","keywords":"Medicine; Disease; Population; Etiology; Quality of life (healthcare); Complaint; Prurigo; Psychogenic disease; Intensive care medicine; Dermatology; Psychiatry; Pathology; Nursing","score_opus":0.01970382962617013,"score_gpt":0.27885995278232356,"score_spread":0.25915612315615344,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396871371","genre_codex":"commentary","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00079603033,0.09584083,0.002501047,0.6586863,0.17860006,0.0010634245,0.005617332,0.00036294066,0.0565321],"genre_scores_gemma":[0.016672995,0.236568,0.016129259,0.39477304,0.15405989,0.0035607398,0.02632795,0.0010228886,0.15088525],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.97622,0.0056066755,0.003663203,0.0018751072,0.009420879,0.0032141237],"domain_scores_gemma":[0.90349823,0.021004928,0.007433737,0.0030907237,0.05177163,0.013200757],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.028711852,0.0016400159,0.0026145496,0.004028437,0.0029120427,0.009082282,0.0059824763,0.017875884,0.022952579],"category_scores_gemma":[0.057569623,0.0010864519,0.0034700506,0.0027899304,0.0025953972,0.0058303704,0.0060854773,0.016665602,0.020062167],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005846613,0.000062909276,0.00051673764,0.0013627772,0.00002811208,0.00011089802,0.00009448647,0.000070513524,0.00016279188,0.0018988672,0.93563,0.060003433],"study_design_scores_gemma":[0.000046107616,0.000046911573,0.0011082916,0.0045016906,0.000037341968,0.00017710609,0.00013944754,0.000040311657,0.000104536055,0.0014244051,0.99235326,0.000020567279],"about_ca_topic_score_codex":0.018151471,"about_ca_topic_score_gemma":0.014575448,"teacher_disagreement_score":0.028711852,"about_ca_system_score_codex":0.0061880206,"about_ca_system_score_gemma":0.03657796,"threshold_uncertainty_score":0.15184462},"labels":[],"label_agreement":null},{"id":"W4398138598","doi":"10.1111/jdv.20049","title":"Predictors of selfie‐phobia in individuals with visible skin or hair diseases: A large‐scale international study","year":2024,"lang":"en","type":"letter","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Body Image and Dysmorphia Studies","field":"Psychology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Selfie; Demography; Social media; Stigma (botany); Feeling; Population; Demographics; Psychology; Logistic regression; China; Medicine; Geography; Psychiatry; Social psychology; Political science; Sociology","score_opus":0.015247657021372402,"score_gpt":0.29555437508194293,"score_spread":0.2803067180605705,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4398138598","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9990262,0.00019452587,0.000030904495,0.000033705954,0.000004935065,0.000020702637,0.00020215109,9.867966e-7,0.0004858766],"genre_scores_gemma":[0.9993388,0.00018531154,0.00007785611,0.00004189333,0.00001027123,0.000018771572,0.00021266974,0.0000011955829,0.00011313379],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997135,0.00007978143,0.000041269017,0.00005979201,0.000055964767,0.00004962523],"domain_scores_gemma":[0.99894756,0.00018144924,0.00047258337,0.00007330094,0.000107887085,0.00021726677],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00069075346,0.00024416856,0.0002711378,0.0007732935,0.0004533127,0.0005913664,0.0003190384,0.000541391,0.0017269546],"category_scores_gemma":[0.0015273963,0.0002536923,0.00045625327,0.0011146229,0.00034448697,0.00059487106,0.00060485175,0.00071941095,0.0002843208],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003937557,0.0001335084,0.99770015,0.000023107166,0.000025990767,0.00004991838,0.00056025735,0.000010191951,0.00008371188,0.000017551867,0.00010951792,0.0012467515],"study_design_scores_gemma":[0.0000025089707,0.000078585756,0.9988931,0.000009593886,0.000011319917,0.000101874386,0.00073804316,0.00003375689,0.000009470754,0.0000058949995,0.00011359426,0.0000023095984],"about_ca_topic_score_codex":0.0049153734,"about_ca_topic_score_gemma":0.0058503654,"teacher_disagreement_score":0.0049153734,"about_ca_system_score_codex":0.00024697065,"about_ca_system_score_gemma":0.0002355332,"threshold_uncertainty_score":0.009773552},"labels":[],"label_agreement":null},{"id":"W4399527455","doi":"10.1111/jdv.20143","title":"Age affects drug survival rates of interleukin (<scp>IL</scp>)‐17 and <scp>IL</scp>‐23 inhibitors in patients with plaque psoriasis: Results from a retrospective, multicentric, multi‐country, cohort study","year":2024,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; Lynde Centre for Dermatology; University of Toronto; McMaster University","funders":"","keywords":"Psoriasis; Medicine; Plaque psoriasis; Drug; Pharmacology; Immunology","score_opus":0.010134738420319046,"score_gpt":0.2337633874384789,"score_spread":0.22362864901815988,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399527455","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99939656,0.00027096033,0.000046643643,0.000010387257,0.0000024065923,0.0000030754552,0.00016111013,0.0000010171133,0.000107821994],"genre_scores_gemma":[0.999648,0.00008989081,0.000025842179,0.0000093143435,0.0000050910976,0.0000030957704,0.00016793846,0.0000011411687,0.000049695285],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992318,0.00022731771,0.00010432324,0.00018700925,0.00011506878,0.00013441015],"domain_scores_gemma":[0.9964451,0.0006666162,0.001868166,0.00035914377,0.00024438842,0.0004166093],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015440675,0.00020627433,0.00042169366,0.00050985435,0.00026610593,0.00053348026,0.00020427303,0.00029776536,0.001203901],"category_scores_gemma":[0.00312032,0.00021233798,0.00074873934,0.0007262965,0.0001944036,0.00048039245,0.00034649848,0.00042404843,0.00017496508],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003926898,0.000017672499,0.9983474,0.0000045306033,0.00006553799,0.000041954034,0.000040820643,0.00004571146,0.000116944124,0.0000078653575,0.000033556596,0.00088526093],"study_design_scores_gemma":[0.000017772296,0.00022657473,0.9989795,0.000003455778,0.000063657666,0.00027014094,0.000076065335,0.00015044442,0.000054505603,0.000011503704,0.00014262278,0.0000036451552],"about_ca_topic_score_codex":0.0018142634,"about_ca_topic_score_gemma":0.0018077812,"teacher_disagreement_score":0.0018142634,"about_ca_system_score_codex":0.00021744736,"about_ca_system_score_gemma":0.00020565218,"threshold_uncertainty_score":0.008165956},"labels":[],"label_agreement":null},{"id":"W4400248035","doi":"10.1111/jdv.20221","title":"Dupilumab and joint‐related adverse effects: A systematic review","year":2024,"lang":"en","type":"review","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Dupilumab; Adverse effect; Medicine; Joint (building); Psychology; Dermatology; Internal medicine; Engineering; Atopic dermatitis","score_opus":0.02345678332346928,"score_gpt":0.3163510630326448,"score_spread":0.29289427970917553,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400248035","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005580682,0.9984524,0.00005967975,0.00031195136,0.00012212602,0.00012934887,0.0002355507,0.0000046180157,0.00012616083],"genre_scores_gemma":[0.011155295,0.98658305,0.00030766966,0.0010449187,0.0002503432,0.00033367058,0.00018925697,0.000005177702,0.00013055175],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9942761,0.0018478844,0.0019276812,0.00044891518,0.0013147937,0.00018452913],"domain_scores_gemma":[0.9669737,0.022145636,0.0072067045,0.00032264652,0.0030164642,0.00033482484],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0072858143,0.0011964685,0.007990379,0.0076179975,0.0005125202,0.0020676197,0.001588312,0.0018414397,0.0062745777],"category_scores_gemma":[0.031473774,0.00077585777,0.0058769914,0.008511025,0.0007277656,0.0020000355,0.0012915314,0.0012269708,0.0003147361],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019411556,0.000014277676,0.0005044228,0.9688408,0.0059323134,0.000063811676,0.00009175939,0.000057643607,0.00009211931,0.00012881994,0.0023008473,0.021779116],"study_design_scores_gemma":[0.00040099252,0.00029165996,0.00482839,0.9025707,0.06765364,0.00043707876,0.00018163215,0.00010794889,0.00013453534,0.00031394462,0.02303052,0.00004894833],"about_ca_topic_score_codex":0.004811501,"about_ca_topic_score_gemma":0.017056834,"teacher_disagreement_score":0.007990379,"about_ca_system_score_codex":0.00244186,"about_ca_system_score_gemma":0.0076187225,"threshold_uncertainty_score":0.03853154},"labels":[],"label_agreement":null},{"id":"W4400300887","doi":"10.1111/jdv.20194","title":"Large‐scale international study on scalp seborrheic dermatitis: Prevalence, demographics, healthcare trends and quality of life","year":2024,"lang":"en","type":"letter","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Nail Diseases and Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Dandruff; Scalp; Seborrheic dermatitis; Demographics; Demography; Quality of life (healthcare); Population; Dermatology; Environmental health; Pathology; Shampoo","score_opus":0.035796266356320154,"score_gpt":0.3406849192496692,"score_spread":0.30488865289334904,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400300887","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955805,0.0007923013,0.0002703879,0.00010073947,0.000015259391,0.00006948587,0.0015772919,0.000005555496,0.0015885003],"genre_scores_gemma":[0.99699366,0.0006130232,0.00035303485,0.000117550175,0.00003317825,0.00008504306,0.001389372,0.0000046797154,0.00041051823],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99936956,0.00023018717,0.000084209605,0.00013294455,0.000102413076,0.00008069818],"domain_scores_gemma":[0.9988018,0.00021155522,0.0004253183,0.00009423766,0.0002548708,0.00021211563],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009464298,0.00028330935,0.00030449833,0.0009533128,0.00045348346,0.00051796495,0.00022698882,0.00043948813,0.0022556398],"category_scores_gemma":[0.0013202614,0.0002098963,0.00033408808,0.0017508193,0.0002593419,0.00088749285,0.00052848115,0.0004764886,0.00070283253],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000069688926,0.00013635638,0.9959032,0.00003769215,0.00005822839,0.00008110189,0.00036358507,0.000017240882,0.00028369797,0.000017972838,0.0003228348,0.0027084053],"study_design_scores_gemma":[0.000004918492,0.000109938934,0.99868375,0.000010240327,0.000014123945,0.00025850255,0.00039614702,0.000023662476,0.000025188743,0.000008705635,0.00046076733,0.0000039690563],"about_ca_topic_score_codex":0.0024164014,"about_ca_topic_score_gemma":0.0025434992,"teacher_disagreement_score":0.0024164014,"about_ca_system_score_codex":0.00017975202,"about_ca_system_score_gemma":0.00024006219,"threshold_uncertainty_score":0.0075458884},"labels":[],"label_agreement":null},{"id":"W4400547319","doi":"10.1111/jdv.20229","title":"Combining treat‐to‐target principles and shared decision‐making: International expert consensus‐based recommendations with a novel concept for minimal disease activity criteria in atopic dermatitis","year":2024,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":84,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; SKiN Health; Ottawa Hospital; Queen's University","funders":"Eli Lilly Japan; Bausch Health; Chugai Pharmaceutical; Mitsubishi Tanabe Pharma Corporation; Eisai; Boehringer Ingelheim Japan; LEO Pharma; Torii Pharmaceutical; Dermira; Incyte; Taiho Pharmaceutical; Sun Pharma; Regeneron Pharmaceuticals; Les Laboratories Pierre Fabre; Celgene; L'Oreal USA; Sanofi; Amgen; Pfizer; Galderma; Eli Lilly and Company; Bristol-Myers Squibb; GlaxoSmithKline","keywords":"Voting; Atopic dermatitis; Medicine; MEDLINE; Disease; Nominal group technique; Computer science; Knowledge management; Dermatology; Pathology; Political science","score_opus":0.045163055013329706,"score_gpt":0.35187403439948484,"score_spread":0.3067109793861551,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400547319","genre_codex":"methods","genre_gemma":"empirical","domain_codex":"methods","domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.030285865,0.007718028,0.72452474,0.17936645,0.003932712,0.019594602,0.00040264707,0.0005800291,0.033594966],"genre_scores_gemma":[0.17773548,0.0017129327,0.7976536,0.012497115,0.0005939866,0.008487391,0.00029435277,0.00007658444,0.0009485264],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.32986253,0.5692072,0.045131896,0.00965846,0.04206282,0.0040770825],"domain_scores_gemma":[0.5150268,0.37266588,0.023409693,0.017882362,0.06354899,0.007466291],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.49505663,0.00240933,0.0032662754,0.008925984,0.0044728513,0.012811736,0.008597198,0.011798735,0.0027125953],"category_scores_gemma":[0.44864777,0.002403148,0.006734979,0.0039659473,0.011054119,0.010252801,0.017753396,0.015607841,0.0010317075],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010027193,0.0010193222,0.0091801,0.019898724,0.0038623651,0.0013936115,0.084642984,0.02181577,0.0025523,0.15827243,0.06332946,0.63303024],"study_design_scores_gemma":[0.002842211,0.0018770869,0.00937703,0.061460167,0.004008072,0.0015593076,0.033590145,0.071957745,0.004035819,0.62446326,0.18348712,0.0013420405],"about_ca_topic_score_codex":0.0048782662,"about_ca_topic_score_gemma":0.007222591,"teacher_disagreement_score":0.49505663,"about_ca_system_score_codex":0.015969174,"about_ca_system_score_gemma":0.044248167,"threshold_uncertainty_score":0.6226851},"labels":[],"label_agreement":null},{"id":"W4400960097","doi":"10.1111/jdv.20249","title":"Beyond the classic players: Mas‐related G protein‐coupled receptor member <scp>X2</scp> role in pruritus and skin diseases","year":2024,"lang":"en","type":"review","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Urticaria and Related Conditions","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Receptor; Dermatology; Computational biology; Internal medicine","score_opus":0.017160230402249444,"score_gpt":0.2867188853229643,"score_spread":0.26955865492071485,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400960097","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.002370197,0.98912674,0.00069322094,0.0030399966,0.0016034413,0.000009969675,0.0000546208,0.000029900399,0.0030718532],"genre_scores_gemma":[0.018321166,0.9688552,0.001119857,0.0020961396,0.004132053,0.000015228942,0.00015085498,0.000011433351,0.005297986],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99982905,0.00003647373,0.000029289473,0.000027523838,0.000053533113,0.000024084065],"domain_scores_gemma":[0.99982315,0.00005198859,0.00002943713,0.0000043871714,0.00006712442,0.000023985272],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031872737,0.00034616716,0.00045676413,0.0008928576,0.00025580198,0.0007259221,0.00024789188,0.0006792811,0.0025774133],"category_scores_gemma":[0.00042070536,0.00008786706,0.00036863761,0.00059119397,0.00041349858,0.0009598438,0.00041924027,0.0011782527,0.0008865779],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038439955,0.000087540255,0.0039458973,0.013230702,0.00020889516,0.0044108857,0.00050876074,0.00035516397,0.021635544,0.013118366,0.09273435,0.8493794],"study_design_scores_gemma":[0.000023508508,0.00019434236,0.0058242,0.0018765816,0.00019497391,0.015355387,0.00029753058,0.00022085286,0.003045378,0.0037682585,0.9691646,0.00003450097],"about_ca_topic_score_codex":0.00058302615,"about_ca_topic_score_gemma":0.00088973704,"teacher_disagreement_score":0.0025774133,"about_ca_system_score_codex":0.0003610723,"about_ca_system_score_gemma":0.00066811155,"threshold_uncertainty_score":0.008622348},"labels":[],"label_agreement":null},{"id":"W4400988134","doi":"10.1111/jdv.19876","title":"A dermocosmetic product containing the sap of oat plantlets and <i>Garcinia mangostana</i> extract improves the clinical signs of acne","year":2024,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Acne and Rosacea Treatments and Effects","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Windsor; Western University","funders":"","keywords":"Garcinia mangostana; Medicine; Acne; Dermatology; Traditional medicine","score_opus":0.032508512662787016,"score_gpt":0.32925384605681324,"score_spread":0.2967453333940262,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400988134","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99738187,0.0013461385,0.00022250105,0.000048701113,0.000026159525,0.000027885522,0.00004899497,0.000042601765,0.0008552258],"genre_scores_gemma":[0.99785787,0.0006522372,0.0004801631,0.00004612096,0.000034931025,0.000011640948,0.00008959866,0.0000052052355,0.00082218164],"study_design_codex":"bench_or_experimental","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9999647,0.000007524077,0.000002608057,0.000006769296,0.00000994139,0.000008430424],"domain_scores_gemma":[0.9999511,0.000010027704,0.00001414013,0.0000041556877,0.0000052557675,0.000015209852],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007107096,0.00023039554,0.00022587308,0.00014698302,0.00009657921,0.00011548145,0.000083939594,0.00011840696,0.0020742863],"category_scores_gemma":[0.00009966157,0.000044878405,0.00014906147,0.00005680002,0.000079028236,0.000109896784,0.000070831506,0.0003041722,0.00018908012],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0054891566,0.0023936322,0.0018441831,0.0002565399,0.000047726382,0.0002061818,0.000046142468,0.00009330249,0.94155073,0.000035598205,0.00031605363,0.047720797],"study_design_scores_gemma":[0.0026139067,0.119881645,0.20101705,0.0001328045,0.0004565212,0.0038790703,0.00025806107,0.0010957491,0.6573474,0.00007625223,0.013219707,0.000021812259],"about_ca_topic_score_codex":0.00018805062,"about_ca_topic_score_gemma":0.00028868485,"teacher_disagreement_score":0.0020742863,"about_ca_system_score_codex":0.000058804915,"about_ca_system_score_gemma":0.0000561817,"threshold_uncertainty_score":0.006939113},"labels":[],"label_agreement":null},{"id":"W4401219177","doi":"10.1111/jdv.20271","title":"International consensus on methotrexate dosing for patients with atopic dermatitis: An <scp>eDelphi</scp> study","year":2024,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital","funders":"European Academy of Dermatology and Venereology; Amsterdam University Medical Centers","keywords":"Medicine; Atopic dermatitis; Methotrexate; Dosing; Dermatology; MEDLINE; Dermatologic agents; Pharmacology; Internal medicine; Microbiology","score_opus":0.024007717148668072,"score_gpt":0.3105486911741494,"score_spread":0.28654097402548134,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401219177","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7659339,0.0244021,0.02820537,0.013190815,0.0017826258,0.09027539,0.008669748,0.00016944225,0.06737062],"genre_scores_gemma":[0.89128107,0.0049335435,0.02792391,0.0056894827,0.00025030653,0.06505294,0.003505852,0.000055530367,0.0013074034],"study_design_codex":"design_other","study_design_gemma":"qualitative","domain_scores_codex":[0.83494407,0.1268619,0.019781422,0.0043343385,0.011568965,0.0025093255],"domain_scores_gemma":[0.8177646,0.10683485,0.01917499,0.0076053105,0.045159187,0.0034609851],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.16321088,0.00062801706,0.0012402802,0.003397881,0.0017754254,0.0017435033,0.0015699712,0.002171562,0.004693449],"category_scores_gemma":[0.17668818,0.00077904604,0.003291684,0.003189695,0.001443193,0.002127209,0.0064119757,0.0019942436,0.00089228986],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01517051,0.003260956,0.25371137,0.06623187,0.0076953936,0.0010284105,0.1073273,0.001955043,0.0022678247,0.005879211,0.053893346,0.48157883],"study_design_scores_gemma":[0.017740969,0.011755905,0.46141025,0.09932038,0.010795677,0.0021547652,0.12283935,0.008916426,0.005564109,0.0075529777,0.2509576,0.000991676],"about_ca_topic_score_codex":0.0025308006,"about_ca_topic_score_gemma":0.003815808,"teacher_disagreement_score":0.16321088,"about_ca_system_score_codex":0.0036025671,"about_ca_system_score_gemma":0.0141965635,"threshold_uncertainty_score":0.86315197},"labels":[],"label_agreement":null},{"id":"W4401365966","doi":"10.1111/jdv.20279","title":"Interactions between dupilumab and vitiligo: A scoping review","year":2024,"lang":"en","type":"review","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"melanin and skin pigmentation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Women's College Hospital; McMaster University; University of Toronto","funders":"","keywords":"Dupilumab; Medicine; Atopic dermatitis; Exacerbation; Vitiligo; Dermatology; Adverse effect; Cohort; MEDLINE; Retrospective cohort study; Critical appraisal; Internal medicine; Alternative medicine; Pathology","score_opus":0.05213042352244577,"score_gpt":0.39225569452921155,"score_spread":0.34012527100676576,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401365966","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00035739838,0.9985738,0.00009566616,0.0002631413,0.00007977663,0.00012371245,0.00012891459,0.000004962567,0.00037274224],"genre_scores_gemma":[0.0035324907,0.99520123,0.0003710903,0.00032366673,0.00007313804,0.00020433875,0.00014948787,0.000004197928,0.00014031184],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9942297,0.0016553937,0.0024485455,0.00041522796,0.00107721,0.00017397926],"domain_scores_gemma":[0.9670036,0.025416829,0.0045527965,0.0004001863,0.0023890838,0.0002375345],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008854328,0.0013797362,0.0054086926,0.019963188,0.0010728539,0.0031251602,0.0018794863,0.0025447009,0.0059620524],"category_scores_gemma":[0.030473243,0.0010514787,0.004426524,0.020722773,0.0012034682,0.0029545047,0.002224952,0.0013558683,0.0006600973],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014070624,0.000031731433,0.0007295112,0.8507848,0.0021202804,0.00042702386,0.00060471223,0.00015028824,0.0002863809,0.00056727655,0.0046678637,0.1394894],"study_design_scores_gemma":[0.000033421977,0.000079564656,0.001918898,0.9364287,0.009858338,0.0006786319,0.0003700988,0.000072827024,0.00015961485,0.00036495912,0.0500108,0.000024256988],"about_ca_topic_score_codex":0.0069372486,"about_ca_topic_score_gemma":0.016659625,"teacher_disagreement_score":0.019963188,"about_ca_system_score_codex":0.0035011685,"about_ca_system_score_gemma":0.01059251,"threshold_uncertainty_score":0.04682672},"labels":[],"label_agreement":null},{"id":"W4401646838","doi":"10.1111/jdv.20287","title":"Treatment of psoriasis with biologic and non‐biologic targeted therapies in patients with latent tuberculosis infection or at risk for tuberculosis disease progression: Recommendations from a <scp>SPIN</scp>‐<scp>FRT</scp> expert consensus","year":2024,"lang":"en","type":"review","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Tuberculosis Research and Epidemiology","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"Fondation René Touraine","keywords":"Medicine; Latent tuberculosis; Tuberculosis; Mycobacterium tuberculosis; Disease; Psoriasis; Immunology; Immunosuppression; Intensive care medicine; Internal medicine; Pathology","score_opus":0.0464925179729168,"score_gpt":0.3523073234817891,"score_spread":0.3058148055088723,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401646838","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010003322,0.85742754,0.0036690552,0.12126944,0.0066401046,0.00087343354,0.00089068804,0.00015345734,0.008075992],"genre_scores_gemma":[0.0072320476,0.89927936,0.020479528,0.061221123,0.004359998,0.0015525835,0.0013115462,0.000071943636,0.0044918614],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99517953,0.0017062377,0.0014705182,0.00028327154,0.0011147942,0.00024568566],"domain_scores_gemma":[0.9861016,0.0057674707,0.0016578798,0.00028643257,0.005350227,0.0008362891],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.012422726,0.0009250552,0.0033333425,0.0027854485,0.00088008284,0.0025818779,0.004657178,0.006224775,0.0037056506],"category_scores_gemma":[0.015714856,0.00068101886,0.004772492,0.0017011994,0.0009145645,0.0023936622,0.00183397,0.007015518,0.0027554582],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040365895,0.00021787256,0.0006319894,0.03273444,0.0006189304,0.00025732888,0.00032571948,0.0005755621,0.00088543317,0.0036319036,0.23515116,0.72456604],"study_design_scores_gemma":[0.0005393765,0.00022614005,0.0022790947,0.10923524,0.0016776398,0.00046272,0.00028591088,0.0003986538,0.0003740931,0.006458768,0.8779905,0.00007192492],"about_ca_topic_score_codex":0.005394035,"about_ca_topic_score_gemma":0.00900368,"teacher_disagreement_score":0.012422726,"about_ca_system_score_codex":0.0019058762,"about_ca_system_score_gemma":0.008546282,"threshold_uncertainty_score":0.065698445},"labels":[],"label_agreement":null},{"id":"W4401913772","doi":"10.1111/jdv.20308","title":"Familial Mediterranean fever and <i>MEFV</i> gene variants in hidradenitis suppurativa: A systematic review","year":2024,"lang":"en","type":"review","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Hidradenitis Suppurativa and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Women's College Hospital; University of Toronto; Hospital for Sick Children; University of Ottawa","funders":"","keywords":"Hidradenitis suppurativa; Familial Mediterranean fever; MEFV; Medicine; Dermatology; Pyrin domain; Genetics; Gene; Gene mutation; Internal medicine; Mutation; Disease; Inflammation; Inflammasome","score_opus":0.04313927256110273,"score_gpt":0.3353079825342032,"score_spread":0.29216870997310046,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401913772","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00082571065,0.9986162,0.000030470099,0.000102178674,0.000047914484,0.000051671723,0.00020453976,0.0000027744834,0.00011849837],"genre_scores_gemma":[0.011033979,0.9881406,0.00018974041,0.00023583193,0.000051915096,0.00010794157,0.00015651905,0.0000014151337,0.00008207541],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99866664,0.00044921157,0.00043811277,0.00014410987,0.00022313,0.00007878944],"domain_scores_gemma":[0.99471045,0.0038779336,0.00089095166,0.000068650224,0.00038439519,0.00006752231],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021581233,0.000836211,0.0046829446,0.0042297556,0.00035558027,0.0011754322,0.000842178,0.0011549009,0.004434803],"category_scores_gemma":[0.009653735,0.0004904479,0.0052130315,0.0049209013,0.00037760174,0.0009759747,0.00072768,0.00071357226,0.00021604086],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039156902,0.00002540968,0.0017640269,0.917573,0.01576919,0.00012319721,0.00012604336,0.00010547167,0.00018028467,0.00024413598,0.0035683091,0.060129344],"study_design_scores_gemma":[0.00057055755,0.00030730764,0.016790442,0.78725135,0.1600371,0.00078281644,0.00031223096,0.00014063531,0.00015456422,0.00045310264,0.033139188,0.000060659506],"about_ca_topic_score_codex":0.008032436,"about_ca_topic_score_gemma":0.025054576,"teacher_disagreement_score":0.008032436,"about_ca_system_score_codex":0.0014156564,"about_ca_system_score_gemma":0.0032351022,"threshold_uncertainty_score":0.015971363},"labels":[],"label_agreement":null},{"id":"W4402002513","doi":"10.1111/jdv.20300","title":"Mobile teledermoscopy for patients at high risk of cutaneous melanoma: A single‐arm, feasibility study of a clinical intervention at two tertiary centres (<scp>MOBILEMEL</scp>)","year":2024,"lang":"en","type":"letter","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Cutaneous Melanoma Detection and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Password; Intranet; Teledermatology; Mucosal melanoma; Intervention (counseling); Transmission (telecommunications); Melanoma; Telemedicine; World Wide Web; The Internet; Operating system; Telecommunications; Nursing; Health care; Computer science","score_opus":0.025632226488479428,"score_gpt":0.31782056252688884,"score_spread":0.29218833603840944,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402002513","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985524,0.000040411003,0.000089458095,0.00001880577,0.0000072240155,0.0010354371,0.000054221367,0.0000036158317,0.0001984883],"genre_scores_gemma":[0.99714607,0.00009172858,0.0006940389,0.00011412486,0.000050571653,0.0014941854,0.00018470314,0.0000030509923,0.00022151486],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99565387,0.002547391,0.00022325278,0.0006135387,0.00046088902,0.0005010342],"domain_scores_gemma":[0.9952055,0.0016510411,0.0010040929,0.00044574455,0.00042236468,0.0012712777],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0058284444,0.0014577666,0.0011223257,0.0007783793,0.001237437,0.0010442258,0.0010873377,0.0013374151,0.0027805602],"category_scores_gemma":[0.007859978,0.00091936,0.0013260146,0.0006450711,0.0012987179,0.0013247253,0.00088983204,0.001221289,0.0007479449],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.22957708,0.24698989,0.47879007,0.00036181932,0.0007426635,0.0007295563,0.0032925638,0.00050309434,0.0069314856,0.0001206007,0.0004434171,0.031517796],"study_design_scores_gemma":[0.032206576,0.66340923,0.30085433,0.00002802356,0.00034360983,0.00021989498,0.00101345,0.00078483135,0.00070414454,0.00004385552,0.0003382049,0.000053723892],"about_ca_topic_score_codex":0.0071317363,"about_ca_topic_score_gemma":0.0079289,"teacher_disagreement_score":0.0071317363,"about_ca_system_score_codex":0.0016846139,"about_ca_system_score_gemma":0.002811507,"threshold_uncertainty_score":0.030824125},"labels":[],"label_agreement":null},{"id":"W4402311632","doi":"10.1111/jdv.20310","title":"Considerations for defining and diagnosing generalized pustular psoriasis","year":2024,"lang":"en","type":"review","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; Centre de Recherche Dermatologique du Québec Métropolitain; Sunnybrook Health Science Centre; Dermatrials Research; Health Sciences Centre; Ottawa Hospital; University of Ottawa; Women's College Hospital; Queen's University; University of British Columbia; Probity Medical Research; University of Toronto; Hospital for Sick Children; McMaster University; SKiN Health; University of Calgary","funders":"Boehringer Ingelheim","keywords":"Medicine; Generalized pustular psoriasis; Dermatology; Psoriasis; Erythema; Pustular psoriasis; Disease; Pathology","score_opus":0.06326976682797841,"score_gpt":0.32032572746090765,"score_spread":0.25705596063292924,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402311632","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001305386,0.98918825,0.00092060916,0.0065099807,0.0015968271,0.000010802298,0.000018027446,0.000021266127,0.0016036986],"genre_scores_gemma":[0.001830748,0.9897956,0.0025165884,0.0026321083,0.002523029,0.000019676088,0.00005758771,0.0000062603185,0.00061844994],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99819607,0.00063659775,0.0003173573,0.0001925938,0.00055727805,0.00010012563],"domain_scores_gemma":[0.9963941,0.0017568899,0.00029307549,0.000091495735,0.001271253,0.0001932096],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004009358,0.0009932423,0.0018586399,0.0034194267,0.0005678391,0.0022506122,0.0016316544,0.002770386,0.0021002097],"category_scores_gemma":[0.0056496877,0.00039769887,0.00085452717,0.0015492514,0.0019205157,0.003799569,0.0011046533,0.00626616,0.0023462444],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006834678,0.0000831098,0.00085550686,0.014020153,0.00007969438,0.0012917449,0.0004230993,0.00032736137,0.0016886906,0.013445132,0.10318213,0.8645351],"study_design_scores_gemma":[0.000014024491,0.0000500941,0.0012754184,0.011729111,0.00009234035,0.008092611,0.00038699404,0.00011976894,0.0004386116,0.009095627,0.9686642,0.000041310945],"about_ca_topic_score_codex":0.0022692247,"about_ca_topic_score_gemma":0.003070371,"teacher_disagreement_score":0.004009358,"about_ca_system_score_codex":0.001359131,"about_ca_system_score_gemma":0.002566652,"threshold_uncertainty_score":0.021203756},"labels":[],"label_agreement":null},{"id":"W4402311674","doi":"10.1111/jdv.20315","title":"Low‐dose isotretinoin for the management of rosacea: A systematic review and meta‐analysis","year":2024,"lang":"en","type":"review","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Acne and Rosacea Treatments and Effects","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Rosacea; Medicine; Isotretinoin; Tolerability; Dermatology; Erythema; Adverse effect; Papulopustular; Lesion; Meta-analysis; Randomized controlled trial; Target lesion; Internal medicine; Surgery; Acne","score_opus":0.054734905315046684,"score_gpt":0.3621742366742561,"score_spread":0.3074393313592094,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402311674","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.003647766,0.99509925,0.00022743465,0.000148858,0.00008149297,0.00022936976,0.0003282066,0.000012675394,0.000224863],"genre_scores_gemma":[0.11786627,0.8779105,0.001318579,0.00089571875,0.00019191111,0.00093082554,0.00059491815,0.000016684384,0.00027461883],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99453825,0.0023717836,0.0016915516,0.0005327413,0.0006644654,0.00020110386],"domain_scores_gemma":[0.9889277,0.0071983384,0.0022749335,0.0002793057,0.0011197807,0.0001998851],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007387567,0.0018753962,0.013602219,0.0043204483,0.0005610037,0.0023782186,0.0018744344,0.0018990708,0.0042781904],"category_scores_gemma":[0.01790566,0.0009649649,0.02132189,0.0051022577,0.00053594704,0.001433649,0.0010426015,0.001369452,0.00027694125],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002338011,0.000048133214,0.00277521,0.65694267,0.31843194,0.0001473479,0.00009484055,0.00032938158,0.00031858167,0.000118307296,0.00080676033,0.017648784],"study_design_scores_gemma":[0.0010660231,0.00039209207,0.0050041657,0.06762289,0.92206407,0.00014107233,0.000076496915,0.00016495702,0.00015603985,0.000168071,0.0031142666,0.000029784933],"about_ca_topic_score_codex":0.0055358866,"about_ca_topic_score_gemma":0.014049657,"teacher_disagreement_score":0.013602219,"about_ca_system_score_codex":0.001927307,"about_ca_system_score_gemma":0.0033715407,"threshold_uncertainty_score":0.039069653},"labels":[],"label_agreement":null},{"id":"W4402680236","doi":"10.1111/jdv.20338","title":"B‐type natriuretic peptide levels are associated with chronic itch: A case–control study","year":2024,"lang":"en","type":"letter","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"","keywords":"Medicine; Natriuretic peptide; Dermatology; Internal medicine; Heart failure","score_opus":0.026565318576369127,"score_gpt":0.280742375474335,"score_spread":0.2541770568979659,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402680236","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944352,0.0008871188,0.0004226391,0.0015426013,0.00020594524,0.000083667175,0.0003949733,0.000014079333,0.00201372],"genre_scores_gemma":[0.9973435,0.0003483388,0.00028489754,0.0007542089,0.00035683686,0.00004163668,0.00013037366,0.000003951542,0.00073629344],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99859995,0.00060481986,0.00017227423,0.0002698218,0.00022289158,0.00013033328],"domain_scores_gemma":[0.99622464,0.0018343207,0.00055555213,0.0005346918,0.00047525667,0.000375563],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018250109,0.00054830336,0.0006349546,0.0010452669,0.0011704374,0.0008093432,0.000585821,0.0023262426,0.003991435],"category_scores_gemma":[0.006307768,0.0008405361,0.0005216621,0.0012999318,0.000772321,0.0007585135,0.00037357118,0.0012472549,0.00046341168],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018938481,0.0008087407,0.9668561,0.000093800576,0.0004844904,0.019867262,0.0006508483,0.000052562933,0.0019450837,0.00023657529,0.0023753247,0.0047352775],"study_design_scores_gemma":[0.0005969975,0.0012841658,0.9556545,0.00006417134,0.0003320761,0.03802242,0.0005147174,0.0007915667,0.00019829076,0.00025700135,0.002247397,0.00003669539],"about_ca_topic_score_codex":0.005555367,"about_ca_topic_score_gemma":0.004341951,"teacher_disagreement_score":0.005555367,"about_ca_system_score_codex":0.00045148793,"about_ca_system_score_gemma":0.00031576937,"threshold_uncertainty_score":0.0133526325},"labels":[],"label_agreement":null},{"id":"W4403567788","doi":"10.1111/jdv.20380","title":"Association of <i>MC1R</i> variants with melanoma risk and interaction with sun exposure: An M‐SKIP project","year":2024,"lang":"en","type":"letter","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"melanin and skin pigmentation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"National Cancer Institute; Associazione Italiana per la Ricerca sul Cancro; Division of Cancer Prevention, National Cancer Institute; Verein fur Krebsforschung; Ospedale Policlinico San Martino, Istituto di Ricovero e Cura a Carattere Scientifico","keywords":"Medicine; Melanoma; Association (psychology); Cancer research","score_opus":0.010316835756823689,"score_gpt":0.24816952194267536,"score_spread":0.23785268618585167,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403567788","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.15089425,0.0026391824,0.0010748683,0.80037534,0.0129345665,0.00006798016,0.0031961729,0.00011490907,0.028702851],"genre_scores_gemma":[0.62637365,0.0021811656,0.0014305183,0.28001174,0.041832767,0.00012720047,0.0010087132,0.00011144421,0.04692282],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9996159,0.0001427896,0.000035539684,0.000076347664,0.00007245478,0.000056926085],"domain_scores_gemma":[0.9982405,0.0010344959,0.00010748836,0.00012264265,0.00025184205,0.0002430982],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00073357567,0.0002772046,0.00043406987,0.0002953815,0.0008221309,0.0004740226,0.00035406605,0.004206396,0.004985724],"category_scores_gemma":[0.0037954778,0.0001517875,0.00034356193,0.00030219796,0.00031929705,0.00032213907,0.00022595517,0.0024222685,0.0014768034],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001966923,0.0002480125,0.15840574,0.0001283149,0.00022452243,0.055782296,0.00050929404,0.00027350907,0.0050883405,0.0027105524,0.7293865,0.045276],"study_design_scores_gemma":[0.00091986265,0.00097016635,0.31291682,0.0004867115,0.00049430423,0.14178649,0.0012083459,0.0064334576,0.00340132,0.017247096,0.5139922,0.00014326347],"about_ca_topic_score_codex":0.0042404975,"about_ca_topic_score_gemma":0.0047474746,"teacher_disagreement_score":0.004985724,"about_ca_system_score_codex":0.00041612124,"about_ca_system_score_gemma":0.00040368448,"threshold_uncertainty_score":0.01667887},"labels":[],"label_agreement":null},{"id":"W4403768580","doi":"10.1111/jdv.20356","title":"Fears for tears? Targeted therapies for atopic dermatitis and ocular surface health","year":2024,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; Women's College Hospital; McGill University Health Centre; McGill University","funders":"","keywords":"Medicine; Atopic dermatitis; Tears; Dermatology; Ophthalmology; Surgery","score_opus":0.019742479257530345,"score_gpt":0.3042529917384084,"score_spread":0.28451051248087805,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403768580","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.011236209,0.77183867,0.0008926622,0.17951822,0.003239173,0.000073627154,0.00022592371,0.00008838065,0.032887243],"genre_scores_gemma":[0.15455881,0.69845223,0.0025802073,0.11263566,0.010558826,0.00018494038,0.00029695468,0.000044068554,0.020688418],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99917126,0.00031581896,0.000053952765,0.00005397412,0.00030018485,0.00010481833],"domain_scores_gemma":[0.9990903,0.00043753977,0.00018993838,0.000027600458,0.00015506074,0.00009957285],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013764729,0.00033581673,0.0006384182,0.00047171567,0.0005966841,0.0013910043,0.00036125892,0.0012464159,0.010834309],"category_scores_gemma":[0.0024023855,0.00010340321,0.00078469067,0.0003778628,0.00066986034,0.0016173789,0.00087052834,0.0026390236,0.0015284648],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005364482,0.000325552,0.0054241805,0.0029314414,0.0002322678,0.00071973697,0.00053506816,0.00013137255,0.0017116524,0.014110312,0.21518497,0.7581569],"study_design_scores_gemma":[0.00029061874,0.0007736933,0.016507257,0.00877997,0.00036730088,0.0058766655,0.0012500824,0.00038784754,0.0009638644,0.024167296,0.94057065,0.00006480699],"about_ca_topic_score_codex":0.0018328113,"about_ca_topic_score_gemma":0.0054058847,"teacher_disagreement_score":0.010834309,"about_ca_system_score_codex":0.001344754,"about_ca_system_score_gemma":0.0011029673,"threshold_uncertainty_score":0.036244392},"labels":[],"label_agreement":null},{"id":"W4403790478","doi":"10.1111/jdv.20391","title":"Management of human epidermal growth factor receptor inhibitors‐related acneiform rash: A position paper based on the first Europe/<scp>USA</scp> Delphi consensus process","year":2024,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"EMD Serono; European Academy of Dermatology and Venereology; Astellas Pharma; Les Laboratories Pierre Fabre; Sanofi; Amgen; Pfizer; National Cancer Institute; Incyte","keywords":"Medicine; Rash; Dermatology; Epidermal growth factor receptor; Position paper; Receptor; Internal medicine; Pathology","score_opus":0.01918575740880833,"score_gpt":0.28006768490745926,"score_spread":0.2608819274986509,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403790478","genre_codex":"commentary","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.12501381,0.014105109,0.1451699,0.5484682,0.037422094,0.08300986,0.0009931151,0.00038300507,0.045434903],"genre_scores_gemma":[0.48468935,0.01848796,0.29929128,0.09372736,0.0070959576,0.066316314,0.0017867533,0.00038551458,0.028219499],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.86158085,0.103719145,0.010527801,0.003659009,0.014024135,0.0064890925],"domain_scores_gemma":[0.8921182,0.05174995,0.004816767,0.0032995185,0.03845085,0.009564734],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.18810871,0.0019850507,0.0011700691,0.0018624228,0.0055986047,0.006097545,0.0034655388,0.0126447035,0.007289588],"category_scores_gemma":[0.117995925,0.0013742659,0.002341186,0.0015934927,0.004627124,0.005962238,0.012983561,0.009891766,0.0022995018],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010969731,0.0015987509,0.0049779834,0.014993584,0.0004951391,0.0049945368,0.1369699,0.0050236434,0.01966951,0.032298505,0.36095294,0.41692853],"study_design_scores_gemma":[0.0010237654,0.0026952887,0.008284773,0.030010682,0.00029816234,0.0035674188,0.122789234,0.007859287,0.0072338227,0.04235271,0.77322733,0.0006575271],"about_ca_topic_score_codex":0.0021787249,"about_ca_topic_score_gemma":0.0027691848,"teacher_disagreement_score":0.18810871,"about_ca_system_score_codex":0.010412647,"about_ca_system_score_gemma":0.04804016,"threshold_uncertainty_score":0.99482584},"labels":[],"label_agreement":null},{"id":"W4404187814","doi":"10.1111/jdv.20417","title":"Reply to: Oral dutasteride is a first‐line treatment for frontal fibrosing alopecia – There is insufficient evidence to recommend dutasteride as first‐line treatment in frontal fibrosing alopecia","year":2024,"lang":"en","type":"letter","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Hair Growth and Disorders","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"Manchester Biomedical Research Centre; Medical Research Council; National Institute for Health and Care Research","keywords":"Medicine; Dutasteride; Dermatology; Internal medicine","score_opus":0.05310590662582493,"score_gpt":0.32459869690269616,"score_spread":0.27149279027687123,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404187814","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0011158714,0.0010180919,0.00007978409,0.9851092,0.010866335,0.000014374146,0.00013273548,0.00004083317,0.0016227149],"genre_scores_gemma":[0.010783177,0.0014578147,0.0002605495,0.95571524,0.02685415,0.00004259597,0.00008704325,0.000032085736,0.0047672163],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99904436,0.00032088536,0.00016095156,0.000116223186,0.00021478359,0.00014284712],"domain_scores_gemma":[0.99681973,0.0017257178,0.0002289103,0.00008254142,0.000701414,0.00044164195],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012355262,0.0005400026,0.000975049,0.000625095,0.0018724396,0.0014263327,0.0008801701,0.022075644,0.0074840826],"category_scores_gemma":[0.013051502,0.00036940223,0.0008613713,0.000541623,0.0013677666,0.0021078587,0.00078619836,0.015851669,0.006031607],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015907057,0.000044780456,0.0022166334,0.000103770624,0.00002508329,0.009681706,0.00022626799,0.00011346977,0.00028379282,0.001409761,0.9761523,0.009583422],"study_design_scores_gemma":[0.00033504947,0.00023788481,0.004919003,0.00067762553,0.0000966763,0.036541745,0.0010819238,0.0010884261,0.0006814101,0.009971361,0.94421417,0.0001547757],"about_ca_topic_score_codex":0.004220645,"about_ca_topic_score_gemma":0.0036450827,"teacher_disagreement_score":0.022075644,"about_ca_system_score_codex":0.0021565598,"about_ca_system_score_gemma":0.0017112993,"threshold_uncertainty_score":0.025036752},"labels":[],"label_agreement":null},{"id":"W4404826455","doi":"10.1111/jdv.20456","title":"AI versus dermatologist performance in psoriasis body surface area assessment: A ground truth‐validated, anatomical segment‐based comparative study (AI <scp>PASS</scp>)","year":2024,"lang":"en","type":"letter","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Psoriasis; Body surface area; Dermatology; Ground truth; Artificial intelligence; Surgery","score_opus":0.04213087454373087,"score_gpt":0.3059883763534948,"score_spread":0.2638575018097639,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404826455","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9812352,0.0009900812,0.0011742183,0.0055153063,0.00041507927,0.000068660374,0.0014323471,0.000028069588,0.009140937],"genre_scores_gemma":[0.9965071,0.00011738317,0.0007333458,0.0010238772,0.00021088247,0.000028300272,0.00049061386,0.000008329466,0.0008801963],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975877,0.0013628657,0.00018702375,0.00029484593,0.00042182847,0.00014572551],"domain_scores_gemma":[0.9795594,0.013874761,0.0011984563,0.0010870143,0.0037802288,0.0005001021],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0059641916,0.00015320904,0.00034504,0.00039187944,0.00025959424,0.0007430189,0.00030193417,0.001081585,0.0027478377],"category_scores_gemma":[0.025587268,0.00009089267,0.00018703564,0.00045353075,0.00027667472,0.0006575969,0.00029084357,0.00044783103,0.0009522376],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007880682,0.00034538662,0.88764626,0.00012638586,0.00018868972,0.0008823117,0.0008026181,0.00063147116,0.0015913602,0.0004187926,0.017061368,0.08242459],"study_design_scores_gemma":[0.0003163697,0.0036485551,0.9700548,0.000103208025,0.00016879487,0.0041689593,0.0015672082,0.0053199334,0.0013300951,0.0010489292,0.0122235725,0.000049435665],"about_ca_topic_score_codex":0.002728018,"about_ca_topic_score_gemma":0.0033373511,"teacher_disagreement_score":0.0059641916,"about_ca_system_score_codex":0.0005124093,"about_ca_system_score_gemma":0.00025516425,"threshold_uncertainty_score":0.031542003},"labels":[],"label_agreement":null},{"id":"W4404999079","doi":"10.1111/jdv.20458","title":"Bimatoprost for the management of vitiligo: A systematic review and meta‐analysis","year":2024,"lang":"en","type":"review","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"melanin and skin pigmentation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia; University of Toronto; University of Ottawa","funders":"","keywords":"Medicine; Vitiligo; Bimatoprost; Meta-analysis; Dermatology; MEDLINE; Systematic review; Ophthalmology; Internal medicine; Glaucoma","score_opus":0.04761384563884568,"score_gpt":0.35300190216432176,"score_spread":0.30538805652547607,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404999079","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0027901249,0.9960569,0.00022341369,0.00012261116,0.00007896059,0.0002555463,0.00026931977,0.000012895076,0.00019025536],"genre_scores_gemma":[0.082262315,0.9140452,0.0012258127,0.0005893104,0.0001726308,0.0008691534,0.0005252289,0.0000145248805,0.00029567705],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9955117,0.002051042,0.0012607479,0.00040113932,0.00059705233,0.00017822352],"domain_scores_gemma":[0.99267066,0.004983192,0.0012758954,0.00019939963,0.00072678115,0.00014403147],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0077427924,0.0021808054,0.015211062,0.005617689,0.0005674182,0.002396342,0.0018625505,0.0018261829,0.005017385],"category_scores_gemma":[0.014214185,0.0010287302,0.027535528,0.006580735,0.00048363002,0.0015747622,0.0011695013,0.0016347381,0.0002963569],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002617055,0.00005880806,0.0018969711,0.58105534,0.393504,0.00012647614,0.000092260256,0.00036396598,0.0002423272,0.00014633089,0.00079642417,0.019100023],"study_design_scores_gemma":[0.0009629466,0.0003558227,0.0034115775,0.04750546,0.9445014,0.00011946858,0.00006665389,0.00019792677,0.00011679573,0.00017308783,0.002559911,0.000028896098],"about_ca_topic_score_codex":0.0054714535,"about_ca_topic_score_gemma":0.014041389,"teacher_disagreement_score":0.015211062,"about_ca_system_score_codex":0.0022704492,"about_ca_system_score_gemma":0.003206817,"threshold_uncertainty_score":0.04094827},"labels":[],"label_agreement":null},{"id":"W4405199851","doi":"10.1111/jdv.20481","title":"Merkel cell carcinoma after solid organ transplant","year":2024,"lang":"en","type":"letter","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Polyomavirus and related diseases","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Merkel cell carcinoma; Incidence (geometry); Internal medicine; Surgery; Carcinoma","score_opus":0.011526206337907054,"score_gpt":0.24617843788106097,"score_spread":0.23465223154315393,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405199851","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.010398136,0.98636067,0.00011055239,0.00037048376,0.00012570838,0.000108402535,0.0008476019,0.000004999597,0.0016734308],"genre_scores_gemma":[0.23583947,0.7591541,0.00067370106,0.001603145,0.00046181233,0.00026952167,0.0015553025,0.0000071453933,0.00043575797],"study_design_codex":"systematic_review","study_design_gemma":"case_report","domain_scores_codex":[0.997259,0.0009797227,0.0010202029,0.00021510881,0.0004396421,0.00008627552],"domain_scores_gemma":[0.9891298,0.007206902,0.0027134917,0.00021498768,0.0005914178,0.00014330448],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0033902745,0.00020424578,0.0016922534,0.0030201008,0.00031490147,0.0011340692,0.00037440725,0.0005271173,0.0037984631],"category_scores_gemma":[0.013285734,0.00014797202,0.0016385979,0.0048795277,0.00041354154,0.0011137711,0.00063380104,0.0005134964,0.0002962219],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019712884,0.00009032074,0.026957003,0.5860247,0.009089485,0.0016434597,0.0006340765,0.00024161865,0.0008698135,0.0010486646,0.006771637,0.364658],"study_design_scores_gemma":[0.0012317792,0.0024810212,0.15982166,0.6474845,0.031783413,0.013488474,0.0024444591,0.00020711831,0.0014852383,0.003841131,0.13560037,0.00013087828],"about_ca_topic_score_codex":0.0012281243,"about_ca_topic_score_gemma":0.0028468596,"teacher_disagreement_score":0.0037984631,"about_ca_system_score_codex":0.0006952563,"about_ca_system_score_gemma":0.0019519671,"threshold_uncertainty_score":0.017929673},"labels":[],"label_agreement":null},{"id":"W4405614747","doi":"10.1111/jdv.20516","title":"Certolizumab pegol for plaque psoriasis in women of childbearing potential, pregnant or breastfeeding in clinical settings: One‐year outcomes from the international noninterventional CIMREAL study","year":2024,"lang":"en","type":"letter","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Pregnancy and Medication Impact","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Western University","funders":"LEO Pharma; UCB Pharma; Bausch Health; Celgene; Biogen; Sanofi; Amgen; Pfizer; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Certolizumab pegol; Breastfeeding; Plaque psoriasis; Obstetrics; Psoriasis; Family medicine; Pediatrics; Internal medicine; Dermatology; Adalimumab","score_opus":0.05052788682321108,"score_gpt":0.347544725732191,"score_spread":0.2970168389089799,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405614747","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9844081,0.0075558918,0.00017809859,0.00047323506,0.000059742444,0.0006300998,0.0044319252,0.000010836146,0.0022521203],"genre_scores_gemma":[0.9846346,0.0054518795,0.00043454778,0.00055705395,0.00024947518,0.00063958595,0.007522668,0.000010005402,0.00050030096],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99830794,0.0006529606,0.00021605233,0.00018484148,0.00045852532,0.00017970036],"domain_scores_gemma":[0.99582857,0.00077702815,0.0018231886,0.00027087034,0.00046963064,0.00083074026],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004796712,0.00059022533,0.00086227286,0.0007017015,0.0005104722,0.0009734701,0.0004963176,0.00065854925,0.0009796922],"category_scores_gemma":[0.0055916347,0.0002977063,0.0014291159,0.0010742745,0.0003662989,0.0007092026,0.001068494,0.0014381887,0.0002846821],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07348086,0.0073733884,0.8410535,0.0015908296,0.004874707,0.00049519585,0.001268848,0.00046028075,0.0008314708,0.00019817046,0.005680793,0.062691994],"study_design_scores_gemma":[0.0067837005,0.010957378,0.97489023,0.00032638301,0.0017799535,0.00052540214,0.00060554466,0.00025804056,0.00020372355,0.00009670386,0.0035254813,0.00004732043],"about_ca_topic_score_codex":0.004845966,"about_ca_topic_score_gemma":0.004571761,"teacher_disagreement_score":0.004845966,"about_ca_system_score_codex":0.00083804847,"about_ca_system_score_gemma":0.0011765788,"threshold_uncertainty_score":0.025367737},"labels":[],"label_agreement":null},{"id":"W4406796342","doi":"10.1111/jdv.20490","title":"Alitretinoin is not a suitable treatment for the majority of chronic hand eczema patients","year":2025,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Contact Dermatitis and Allergies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Dermatology; Tolerability; Etiology; Atopic dermatitis; Discontinuation; Clinical trial; Adverse effect; Hand eczema; Contact dermatitis; Internal medicine; Allergy; Immunology","score_opus":0.01963299387706939,"score_gpt":0.2890791713942849,"score_spread":0.2694461775172155,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406796342","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8348061,0.10916921,0.0009838486,0.013409562,0.0005015133,0.00014521016,0.0015848882,0.0001033602,0.039296407],"genre_scores_gemma":[0.9715649,0.016472083,0.00086923095,0.005661107,0.00041945325,0.0000548245,0.0009185559,0.000024208846,0.004015586],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9996395,0.00007095118,0.00006047256,0.00005990013,0.00011002946,0.000059223505],"domain_scores_gemma":[0.99926287,0.00019653104,0.0002556393,0.000045466557,0.00009240858,0.00014705044],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026456808,0.00009790875,0.00047344455,0.0001679774,0.00047749074,0.0004969209,0.00020756402,0.00044238503,0.0054225903],"category_scores_gemma":[0.0015324951,0.00006626634,0.0004251131,0.00034482722,0.00016821735,0.00035977538,0.00021664216,0.00055738713,0.0012090879],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0039745877,0.0006288594,0.38795575,0.0019543513,0.00082570134,0.0064628213,0.00076929893,0.00022300954,0.014512484,0.0013767374,0.038181573,0.54313487],"study_design_scores_gemma":[0.00046027434,0.0017434062,0.81481755,0.0013460178,0.00056412205,0.028979585,0.000995455,0.00034983736,0.0016877349,0.00090361974,0.14811532,0.000037074842],"about_ca_topic_score_codex":0.002541551,"about_ca_topic_score_gemma":0.0052977046,"teacher_disagreement_score":0.0054225903,"about_ca_system_score_codex":0.00036365804,"about_ca_system_score_gemma":0.00040385866,"threshold_uncertainty_score":0.018140376},"labels":[],"label_agreement":null},{"id":"W4407190067","doi":"10.1111/jdv.20578","title":"Expanding <i>PIGM</i>‐related disorders to coding mutations","year":2025,"lang":"en","type":"letter","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; Université de Montréal; Université de Sherbrooke; McGill University","funders":"","keywords":"Medicine; Genetics; Computational biology","score_opus":0.015018869646095168,"score_gpt":0.27097407117358513,"score_spread":0.25595520152748996,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407190067","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9666467,0.0026248912,0.0030371172,0.00061354873,0.00015914858,0.000107834945,0.0006265168,0.00026723684,0.025917066],"genre_scores_gemma":[0.99498534,0.0008445115,0.0011863265,0.00036453837,0.00022990236,0.000041542706,0.00036246586,0.00004113962,0.001944338],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9998363,0.000017452381,0.00001622225,0.000049182665,0.00003038448,0.00005046004],"domain_scores_gemma":[0.9996942,0.00012153397,0.00007011016,0.000015266129,0.000026335301,0.000072547504],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013297852,0.0013213878,0.00039835414,0.0008331338,0.00068377244,0.00035232573,0.0005123404,0.00077950757,0.00626364],"category_scores_gemma":[0.0006917468,0.00015082778,0.00042708375,0.0006505675,0.0006688843,0.00023313629,0.00067660684,0.00053171307,0.00071689446],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017250511,0.00010625431,0.041499104,0.00013245449,0.000032970023,0.89897645,0.0005406447,0.0002552467,0.035140805,0.001096562,0.0023336923,0.019713277],"study_design_scores_gemma":[0.00004411725,0.00012617398,0.05476256,0.00009388238,0.0000888219,0.9253872,0.00012883518,0.0003382834,0.008960618,0.00047492364,0.009577866,0.000016706146],"about_ca_topic_score_codex":0.00091551826,"about_ca_topic_score_gemma":0.0008996414,"teacher_disagreement_score":0.00626364,"about_ca_system_score_codex":0.0003019434,"about_ca_system_score_gemma":0.00031372948,"threshold_uncertainty_score":0.020953953},"labels":[],"label_agreement":null},{"id":"W4407224567","doi":"10.1111/jdv.20581","title":"Drug survival of dupilumab, tralokinumab and upadacitinib in patients with atopic dermatitis: An international, real‐world comparative study","year":2025,"lang":"en","type":"letter","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health; University of Calgary; Probity Medical Research; Health Sciences Centre; Women's College Hospital; University of Toronto; Sunnybrook Health Science Centre","funders":"LEO Pharma; Bristol-Myers Squibb; Eli Lilly and Company; Galderma; Sanofi Genzyme; Incyte; Les Laboratories Pierre Fabre; Regeneron Pharmaceuticals; Sun Pharma; Biogen; Sanofi; Amgen; Pfizer","keywords":"Dupilumab; Medicine; Atopic dermatitis; Dermatology; Drug; Pharmacology","score_opus":0.02247603674056011,"score_gpt":0.30038160355270077,"score_spread":0.2779055668121407,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407224567","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98880005,0.0075290534,0.00007269486,0.0016719768,0.00019344552,0.00003404495,0.00035645728,0.0000026193677,0.0013396431],"genre_scores_gemma":[0.996398,0.0014576344,0.00012236925,0.0011233137,0.0002637623,0.00003176837,0.0003111177,0.0000012426236,0.00029083085],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99882,0.00061364006,0.00013567414,0.00015554317,0.000130961,0.00014416223],"domain_scores_gemma":[0.9956527,0.0025004349,0.0007263303,0.00017830876,0.00040660912,0.000535559],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017288078,0.00024605918,0.00082865654,0.0004167147,0.00034402174,0.0008976759,0.00032107666,0.0010853589,0.0014943421],"category_scores_gemma":[0.0045848517,0.0001409406,0.0007927253,0.0009041801,0.0003487417,0.00073468103,0.0002143242,0.0009953344,0.00026558075],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.21918201,0.003588439,0.6268767,0.0010613567,0.004069454,0.005214744,0.0006931401,0.0006755221,0.002986735,0.0006221895,0.0070093554,0.12802038],"study_design_scores_gemma":[0.019050883,0.052067082,0.8901239,0.00039050198,0.0060953186,0.011637792,0.001769597,0.0021755083,0.0012281031,0.00075918547,0.014561571,0.00014047859],"about_ca_topic_score_codex":0.0011204157,"about_ca_topic_score_gemma":0.0016901714,"teacher_disagreement_score":0.0017288078,"about_ca_system_score_codex":0.0013411791,"about_ca_system_score_gemma":0.00046151213,"threshold_uncertainty_score":0.009730995},"labels":[],"label_agreement":null},{"id":"W4407710220","doi":"10.1111/jdv.20600","title":"International consensus statement on the use of ultrasound in hidradenitis suppurativa","year":2025,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Hidradenitis Suppurativa and Treatments","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"LEO Pharma; Eli Lilly and Company","keywords":"Medicine; Delphi method; Statement (logic); Evidence-based medicine; International Classification of Functioning, Disability and Health; Medical physics; Hidradenitis suppurativa; Delphi; MEDLINE; Task force; Family medicine; Alternative medicine; Physical therapy; Pathology; Rehabilitation; Statistics; Law","score_opus":0.046959211548189383,"score_gpt":0.3107673430895779,"score_spread":0.2638081315413885,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407710220","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.012106225,0.10703899,0.18209198,0.49304596,0.08478788,0.025914589,0.005337487,0.0012837447,0.08839323],"genre_scores_gemma":[0.14798744,0.11431495,0.55175215,0.08627435,0.013756309,0.04567121,0.014665047,0.0009377016,0.024640799],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.70855236,0.17009433,0.0645496,0.005200643,0.04497466,0.006628436],"domain_scores_gemma":[0.6325224,0.13826832,0.020559782,0.01202655,0.18194014,0.014682775],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.22754163,0.0025365057,0.0038924557,0.009207804,0.003459307,0.006771361,0.0089629525,0.01455222,0.0064151445],"category_scores_gemma":[0.25659364,0.001584873,0.0077761784,0.004876338,0.0052555343,0.0048825596,0.010802342,0.015943335,0.004753988],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008163731,0.0006145133,0.005190247,0.03666616,0.0008370266,0.0018335667,0.013177821,0.003661184,0.004514933,0.037052784,0.4321633,0.46347213],"study_design_scores_gemma":[0.00037886633,0.00046017554,0.005965104,0.07545936,0.00073566084,0.0020990428,0.006670007,0.0021894192,0.0021435374,0.028691499,0.87489253,0.00031480973],"about_ca_topic_score_codex":0.006024498,"about_ca_topic_score_gemma":0.0028737192,"teacher_disagreement_score":0.22754163,"about_ca_system_score_codex":0.009384541,"about_ca_system_score_gemma":0.06550663,"threshold_uncertainty_score":0.9525787},"labels":[],"label_agreement":null},{"id":"W4407859111","doi":"10.1111/jdv.20555","title":"Mission impossible? Caveats in interpreting and comparing long‐term efficacy in biologic studies for moderate‐to‐severe plaque psoriasis","year":2025,"lang":"en","type":"letter","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada); University of British Columbia; Probity Medical Research; Centre de Recherche Dermatologique du Québec Métropolitain; Innovaderm (Canada); Queen's University; Dalhousie University","funders":"Janssen Canada","keywords":"Medicine; Plaque psoriasis; Psoriasis; Term (time); Dermatology; Dermatologic agents; Intensive care medicine; Astronomy","score_opus":0.049031501153527966,"score_gpt":0.3131835518266548,"score_spread":0.26415205067312686,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407859111","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.009567731,0.018074723,0.0092505915,0.89359856,0.05672417,0.00053969386,0.0013706351,0.00018517853,0.010688738],"genre_scores_gemma":[0.10477358,0.0048500667,0.029131383,0.7756886,0.08044553,0.0016512809,0.00029946852,0.00019266465,0.0029674047],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.5005375,0.37858337,0.08231235,0.009807614,0.026414564,0.0023446297],"domain_scores_gemma":[0.2600474,0.6650668,0.016750952,0.02258684,0.03197842,0.003569529],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.37581375,0.0010018579,0.0036600986,0.0033643558,0.00244972,0.008191648,0.0061348407,0.010684262,0.0035262087],"category_scores_gemma":[0.66116935,0.0013320943,0.0039300425,0.0043862495,0.009649074,0.006088668,0.0036101595,0.017424425,0.0021825389],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006232155,0.00037922026,0.04106374,0.0059044794,0.005535814,0.0038709622,0.006483921,0.0015899809,0.0013594005,0.05562074,0.59822136,0.2737382],"study_design_scores_gemma":[0.003765696,0.0018598902,0.040003557,0.010154002,0.0038872627,0.010298341,0.004759305,0.0070833075,0.0033972068,0.2549959,0.6592212,0.00057433476],"about_ca_topic_score_codex":0.005548796,"about_ca_topic_score_gemma":0.00798305,"teacher_disagreement_score":0.6241863,"about_ca_system_score_codex":0.004629281,"about_ca_system_score_gemma":0.0058548157,"threshold_uncertainty_score":0.7697328},"labels":[],"label_agreement":null},{"id":"W4408243988","doi":"10.1111/jdv.20586","title":"Regulating sunbed use: Skin cancer risks linked to tanning beds","year":2025,"lang":"en","type":"editorial","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Skin Protection and Aging","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Skin cancer; Dermatology; Environmental health; Cancer; Internal medicine","score_opus":0.037186897267698873,"score_gpt":0.35593170864482276,"score_spread":0.3187448113771239,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408243988","genre_codex":"commentary","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.10967877,0.24578206,0.0038379808,0.4273847,0.007925532,0.00023157467,0.0030389025,0.00026184163,0.20185861],"genre_scores_gemma":[0.6626419,0.19321416,0.0028224464,0.06982925,0.006315319,0.00022626012,0.0016745965,0.00014974675,0.063126385],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990651,0.00033366666,0.000028854047,0.00010595631,0.0003651731,0.00010131829],"domain_scores_gemma":[0.99695253,0.001186678,0.00061227166,0.00017152973,0.00067412056,0.00040283264],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014171583,0.00019502427,0.00020846547,0.00081849535,0.0007810151,0.00142288,0.00053211284,0.0011167699,0.008020844],"category_scores_gemma":[0.0067177694,0.000163291,0.00031271242,0.00063036446,0.00063630583,0.0005095029,0.0014971915,0.0019612378,0.0014129492],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004172583,0.00028890444,0.11590584,0.0012078014,0.000116916126,0.0002948516,0.0009400762,0.00048900116,0.001427478,0.014407271,0.45502213,0.4094824],"study_design_scores_gemma":[0.00006680762,0.00041545354,0.34674102,0.004844785,0.0001514386,0.0007888737,0.0012159612,0.00073940086,0.0016393894,0.015084385,0.62824154,0.00007101854],"about_ca_topic_score_codex":0.01637046,"about_ca_topic_score_gemma":0.025872923,"teacher_disagreement_score":0.01637046,"about_ca_system_score_codex":0.0009303223,"about_ca_system_score_gemma":0.001530536,"threshold_uncertainty_score":0.032550395},"labels":[],"label_agreement":null},{"id":"W4408245591","doi":"10.1111/jdv.20553","title":"Deucravacitinib in plaque psoriasis: Four‐year safety and efficacy results from the Phase 3 <scp>POETYK PSO</scp>‐1, <scp>PSO</scp>‐2 and long‐term extension trials","year":2025,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; University of Toronto","funders":"","keywords":"Medicine; Adverse effect; Discontinuation; Psoriasis; Placebo; Clinical trial; Internal medicine; Incidence (geometry); Cumulative incidence; Randomized controlled trial; Dosing; Dermatology; Cohort","score_opus":0.03773991648713579,"score_gpt":0.2932539044022475,"score_spread":0.2555139879151117,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408245591","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9827999,0.012971275,0.0004000138,0.00028906067,0.000052746836,0.00038434594,0.0011499115,0.000054862423,0.0018979828],"genre_scores_gemma":[0.99272716,0.003515615,0.0004091882,0.00027619992,0.000083861974,0.00020065113,0.0020637973,0.000013730898,0.0007097505],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9983152,0.00078528124,0.00012473692,0.00021661281,0.00034294656,0.00021515352],"domain_scores_gemma":[0.99741864,0.0005648314,0.0009022779,0.00023138073,0.00031334488,0.0005696693],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005788226,0.00072428514,0.0012542981,0.00037568063,0.0004026261,0.001104179,0.0005184584,0.0008253024,0.0014243617],"category_scores_gemma":[0.0025847761,0.0002933379,0.001767984,0.0003853365,0.00040510023,0.0007227806,0.00038059612,0.0018663236,0.0004252055],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5524288,0.021647071,0.048236515,0.0018730334,0.007255035,0.00032238572,0.0005281866,0.006962436,0.034070965,0.00026981995,0.00847296,0.3179329],"study_design_scores_gemma":[0.3079056,0.3530828,0.30008328,0.00034183316,0.007350752,0.0014561568,0.0002093943,0.0043210774,0.012128348,0.000623026,0.01234439,0.00015327652],"about_ca_topic_score_codex":0.0010810934,"about_ca_topic_score_gemma":0.002216242,"teacher_disagreement_score":0.005788226,"about_ca_system_score_codex":0.0008407367,"about_ca_system_score_gemma":0.0009087031,"threshold_uncertainty_score":0.030611396},"labels":[],"label_agreement":null},{"id":"W4409813498","doi":"10.1111/jdv.20704","title":"Surgical outcomes in patients treated with deroofing for hidradenitis suppurativa","year":2025,"lang":"en","type":"letter","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Hidradenitis Suppurativa and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; University of Toronto","funders":"","keywords":"Medicine; Hidradenitis suppurativa; Surgery; Dermatology; Disease; Internal medicine","score_opus":0.015112798690857333,"score_gpt":0.27025229017128954,"score_spread":0.2551394914804322,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409813498","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98058885,0.002066243,0.00009830184,0.005270907,0.00028782812,0.00001949158,0.0003476293,0.0000057573716,0.0113149425],"genre_scores_gemma":[0.9976017,0.000574149,0.000049240007,0.00093402225,0.00014345665,0.0000100707775,0.00019573225,0.00000177429,0.0004899341],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996538,0.00008659239,0.000032364245,0.000025230527,0.000076424796,0.00012557098],"domain_scores_gemma":[0.99884963,0.00035908117,0.0002729282,0.00002978644,0.000094010386,0.00039445027],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002607283,0.00008099745,0.00021604786,0.00038898224,0.00070475513,0.00054343237,0.00016027753,0.00053645,0.0024636397],"category_scores_gemma":[0.0022243434,0.00006367011,0.0003011996,0.0005765373,0.00029280642,0.00029148953,0.00029081528,0.0005703668,0.00021616943],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004941019,0.00020427998,0.95831996,0.00006667093,0.00006973966,0.020977171,0.00040412272,0.00020231714,0.00046188326,0.00044626978,0.0043805675,0.013972909],"study_design_scores_gemma":[0.000076260134,0.00071756775,0.9465096,0.00012736008,0.000052915922,0.044300016,0.0027608217,0.000447717,0.0002191759,0.00093485846,0.0038214584,0.000032306256],"about_ca_topic_score_codex":0.0021190906,"about_ca_topic_score_gemma":0.003888314,"teacher_disagreement_score":0.0024636397,"about_ca_system_score_codex":0.00053553877,"about_ca_system_score_gemma":0.00047253832,"threshold_uncertainty_score":0.008241713},"labels":[],"label_agreement":null},{"id":"W4409814547","doi":"10.1111/jdv.20671","title":"Consensus on core domains for hand eczema trials: Signs, symptoms, control and quality of life","year":2025,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Contact Dermatitis and Allergies","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"Faculty of Medicine Siriraj Hospital, Mahidol University; Genentech; Bispebjerg Hospital; Universität Osnabrück; Sun Pharma; Mitsubishi Tanabe Pharma Corporation; LEO Pharma; Servier; Galderma; University of Cape Town; Universität zu Köln; Universidad de Las Palmas de Gran Canaria; Universitair Medisch Centrum Groningen; Universidade de Coimbra; University of Toronto; State University of New York; Eli Lilly and Company; Cardiff University; Rijksuniversiteit Groningen; NYU Grossman School of Medicine; Kepler Universitätsklinikum; Inselspital, Universitätsspital Bern; Friedrich-Alexander-Universität Erlangen-Nürnberg; Odense Universitetshospital; Pfizer; York University; Incyte; Les Laboratories Pierre Fabre; Medical University Sofia; Regeneron Pharmaceuticals; Islamic Azad University; AstraZeneca; European Academy of Dermatology and Venereology; Uniwersytet Jagielloński Collegium Medicum; Sanofi; Irving Medical Center, Columbia University; University of Bern; Gentofte Hospital; Celldex Therapeutics; Mahidol University; Amgen","keywords":"Medicine; Delphi method; Quality of life (healthcare); Set (abstract data type); Clinical trial; Delphi; Randomized controlled trial; Nursing; Pathology; Artificial intelligence","score_opus":0.06961865841119953,"score_gpt":0.3562349808628293,"score_spread":0.28661632245162977,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409814547","genre_codex":"commentary","genre_gemma":"methods","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.086553395,0.05718958,0.23428078,0.32310328,0.019574927,0.19497693,0.006559947,0.0012344756,0.07652676],"genre_scores_gemma":[0.34444526,0.017531184,0.41202185,0.040588472,0.003047251,0.17077762,0.0063353055,0.0003568709,0.004896238],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.52098185,0.3322347,0.09621535,0.006554145,0.036594123,0.007419757],"domain_scores_gemma":[0.48389092,0.26003006,0.036055807,0.02562264,0.16489454,0.02950607],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.47780815,0.0016391448,0.004304799,0.008978646,0.004668888,0.007409965,0.008132598,0.011439247,0.008009834],"category_scores_gemma":[0.44434962,0.0019498132,0.0061437436,0.004867914,0.005893546,0.0077569643,0.018342702,0.011303385,0.0035559102],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0052119927,0.001024429,0.023058197,0.11657971,0.00188522,0.0015722007,0.08186659,0.0073365746,0.011959095,0.041654523,0.17638841,0.5314631],"study_design_scores_gemma":[0.0057779993,0.0033846297,0.063915454,0.15766217,0.0016978978,0.0035487874,0.045565557,0.014748512,0.007025768,0.15201148,0.5432131,0.0014485661],"about_ca_topic_score_codex":0.0027542715,"about_ca_topic_score_gemma":0.0021403295,"teacher_disagreement_score":0.5221919,"about_ca_system_score_codex":0.011862077,"about_ca_system_score_gemma":0.06834693,"threshold_uncertainty_score":0.6439555},"labels":[],"label_agreement":null},{"id":"W4410701422","doi":"10.1111/jdv.20759","title":"Skin's molecular signature may help guide treatment of complex inflammatory skin diseases","year":2025,"lang":"en","type":"letter","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Hôtel-Dieu de Québec","funders":"Sanofi; Eli Lilly and Company","keywords":"Medicine; Signature (topology); Dermatology","score_opus":0.014286749174730657,"score_gpt":0.2809294782694476,"score_spread":0.2666427290947169,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410701422","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.007073732,0.007733659,0.0016465297,0.93113,0.016854635,0.000052191615,0.00015962242,0.00014330052,0.035206344],"genre_scores_gemma":[0.14986867,0.020144727,0.0063032787,0.6529381,0.12408832,0.000104964165,0.0003501676,0.00011432086,0.046087503],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99941015,0.0002183724,0.000081855454,0.00006810647,0.00012845214,0.000093151604],"domain_scores_gemma":[0.9978193,0.0012236851,0.00009057934,0.00012361955,0.0004436839,0.00029914893],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008863339,0.00036815103,0.0006838197,0.00075686834,0.001138483,0.0015604798,0.0005319691,0.0071972865,0.009172491],"category_scores_gemma":[0.0076294695,0.00017546344,0.0006942548,0.0002673844,0.0011251636,0.0023332727,0.00056456146,0.0099996915,0.0053600413],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024430896,0.0002789274,0.013729039,0.00020044993,0.00004804782,0.046787165,0.00026243745,0.000646142,0.0023094153,0.014109744,0.7861015,0.13528271],"study_design_scores_gemma":[0.00021966739,0.00035570457,0.013345138,0.0010500333,0.00008450465,0.11516344,0.0010810365,0.0032671774,0.0014330555,0.060613833,0.80326754,0.00011894142],"about_ca_topic_score_codex":0.0015424385,"about_ca_topic_score_gemma":0.002693913,"teacher_disagreement_score":0.009172491,"about_ca_system_score_codex":0.0011487079,"about_ca_system_score_gemma":0.0009777457,"threshold_uncertainty_score":0.030685067},"labels":[],"label_agreement":null},{"id":"W4411377735","doi":"10.1111/jdv.20777","title":"Systemic exposure and bioavailability of delgocitinib cream in adults with moderate to severe Chronic Hand Eczema","year":2025,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Innovaderm (Canada); Probity Medical Research; Queen's University","funders":"LEO Pharma","keywords":"Medicine; Bioavailability; Pharmacokinetics; Oral administration; Drug; Area under the curve; Pharmacology; Dermatology; Gastroenterology; Internal medicine","score_opus":0.00836640342736458,"score_gpt":0.25221715405287515,"score_spread":0.24385075062551057,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411377735","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998264,0.0010855792,0.00011535808,0.000031419015,0.000004793759,0.00007161919,0.000094574214,0.0000057801167,0.0003268923],"genre_scores_gemma":[0.9993038,0.00018539574,0.00017049121,0.00004900996,0.000010069975,0.000040032934,0.00008951508,0.0000011788268,0.00015033118],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9996314,0.000118873184,0.00003710814,0.00007918208,0.00008740234,0.000046083584],"domain_scores_gemma":[0.99952567,0.00015030318,0.0001776353,0.000020506064,0.000053413667,0.00007254282],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008284217,0.00021080647,0.0005658145,0.00012863235,0.00014686631,0.0003078264,0.00012057488,0.00035287166,0.0012953442],"category_scores_gemma":[0.00090918073,0.0001204262,0.00026058938,0.000120914774,0.00013669324,0.00020997839,0.0001641723,0.00040880564,0.00021891398],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.18714644,0.009412218,0.27540678,0.0016551468,0.0010330152,0.0012105723,0.00071588793,0.0017072611,0.30351847,0.00009386252,0.0019758309,0.21612456],"study_design_scores_gemma":[0.012716231,0.28938192,0.64628875,0.00010549965,0.0010532247,0.0038444193,0.00032703858,0.002410769,0.039028358,0.00008636083,0.004719312,0.000038111724],"about_ca_topic_score_codex":0.00044819276,"about_ca_topic_score_gemma":0.0009258303,"teacher_disagreement_score":0.0012953442,"about_ca_system_score_codex":0.00027718875,"about_ca_system_score_gemma":0.0002092018,"threshold_uncertainty_score":0.00438112},"labels":[],"label_agreement":null},{"id":"W4411492673","doi":"10.1111/jdv.20799","title":"Severity strata and minimally important differences of <scp>CompAQ</scp> and Skindex‐16 for patients with acne","year":2025,"lang":"en","type":"letter","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Acne and Rosacea Treatments and Effects","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Windsor Clinical Research; Brock University; Western University","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases; Yale School of Medicine; Australian College of Perioperative Nurses","keywords":"Medicine; Acne; Dermatology","score_opus":0.01198514553851698,"score_gpt":0.24590247365300894,"score_spread":0.23391732811449195,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411492673","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.31686798,0.0036798487,0.0012534367,0.413355,0.005180836,0.0002852965,0.18929382,0.000173807,0.06991015],"genre_scores_gemma":[0.85882723,0.0011219118,0.00159811,0.076260746,0.0050274413,0.0005097557,0.037858605,0.00006508524,0.018731087],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99915457,0.0002967039,0.00016766087,0.00012089952,0.00011681042,0.00014323082],"domain_scores_gemma":[0.9962733,0.0020383978,0.0005421462,0.0002645931,0.00046825595,0.0004132508],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000939459,0.000118855954,0.00030929758,0.0005547971,0.0004284812,0.00039949443,0.0002898788,0.0014516625,0.009894602],"category_scores_gemma":[0.008768447,0.00011622793,0.00038120485,0.00086459506,0.00014995117,0.00050110096,0.00030472453,0.0014971644,0.0023054804],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002006231,0.00011075351,0.3906793,0.00010487521,0.00008510981,0.0014273167,0.00018680398,0.0003277124,0.0003399341,0.0022738283,0.57151425,0.030943885],"study_design_scores_gemma":[0.0010393276,0.00039487102,0.7548727,0.00047099107,0.00013431939,0.0048966194,0.0011454404,0.0035821088,0.0006347553,0.013834095,0.21887833,0.00011649179],"about_ca_topic_score_codex":0.00770601,"about_ca_topic_score_gemma":0.015560804,"teacher_disagreement_score":0.009894602,"about_ca_system_score_codex":0.0007335942,"about_ca_system_score_gemma":0.0008122896,"threshold_uncertainty_score":0.033100784},"labels":[],"label_agreement":null},{"id":"W4411666769","doi":"10.1111/jdv.20802","title":"Type I interferon and type I interferon induced biomarkers in dermatomyositis: A systematic review","year":2025,"lang":"en","type":"review","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Inflammatory Myopathies and Dermatomyositis","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Women's College Hospital; University of Toronto","funders":"","keywords":"Medicine; Dermatomyositis; Interferon; Interferon type I; Immunology; Dermatology","score_opus":0.02871328869256829,"score_gpt":0.3310547196073589,"score_spread":0.3023414309147906,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411666769","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00036042635,0.99933726,0.000021397764,0.000066229135,0.000032858858,0.000021272934,0.000093576906,0.0000013118371,0.000065557186],"genre_scores_gemma":[0.004413741,0.9951255,0.00010991359,0.00014694435,0.000035198602,0.000044717734,0.000079182595,6.9512754e-7,0.00004409075],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9983317,0.000576934,0.0005198196,0.00017282784,0.00032023477,0.00007842849],"domain_scores_gemma":[0.99222374,0.005717312,0.0013578983,0.00008064567,0.0005334871,0.00008695461],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026845515,0.0009837137,0.004738847,0.004331691,0.0002994627,0.0012994058,0.00089726335,0.0012226356,0.0034249397],"category_scores_gemma":[0.010206568,0.00049477984,0.0043470436,0.005858772,0.0003643102,0.0011068222,0.0008457481,0.000730691,0.00023809569],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038566723,0.000029699882,0.0015316005,0.8902955,0.01171866,0.00010529533,0.000100374564,0.00015929139,0.00024087449,0.00027699274,0.0036035632,0.09155245],"study_design_scores_gemma":[0.0005008556,0.00042071793,0.017409684,0.795902,0.13421838,0.0009895083,0.00029457556,0.00018805993,0.0003013452,0.00060063135,0.049091585,0.000082706654],"about_ca_topic_score_codex":0.004226058,"about_ca_topic_score_gemma":0.013314064,"teacher_disagreement_score":0.004738847,"about_ca_system_score_codex":0.001268687,"about_ca_system_score_gemma":0.0038110693,"threshold_uncertainty_score":0.014197409},"labels":[],"label_agreement":null},{"id":"W4411884862","doi":"10.1111/jdv.20815","title":"<scp>TikTok</scp> and benzoyl peroxide safety: Balancing public concerns with expert guidance","year":2025,"lang":"en","type":"letter","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Chemical Safety and Risk Management","field":"Chemical Engineering","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Centre Hospitalier de l’Université de Montréal; University of Alberta","funders":"","keywords":"Medicine; Benzoyl peroxide; Peroxide; Organic chemistry","score_opus":0.0142275897837611,"score_gpt":0.23548434590700495,"score_spread":0.22125675612324386,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411884862","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00035778814,0.0006565867,0.00009003834,0.978746,0.0072875894,0.000013482593,0.00006953669,0.000038799346,0.012740077],"genre_scores_gemma":[0.003920697,0.0006326426,0.0003155528,0.958459,0.008664394,0.000029294302,0.000035271634,0.00003056313,0.027912615],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9963973,0.000882384,0.00041587005,0.00040469316,0.0014077049,0.0004921484],"domain_scores_gemma":[0.9887378,0.0061034583,0.0005599908,0.00040062476,0.0030162274,0.0011819232],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0036458776,0.00057395163,0.0008343939,0.00060157094,0.0050050477,0.003959766,0.00175955,0.064380415,0.019857846],"category_scores_gemma":[0.02127608,0.00060161715,0.0011578806,0.0007079068,0.0023515106,0.003056507,0.0014660228,0.031105349,0.015847526],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000026028703,0.000025619545,0.00024873018,0.000032270094,0.000003943927,0.0010021642,0.00007673929,0.000036672976,0.00020377441,0.0029480015,0.99035,0.005046008],"study_design_scores_gemma":[0.000035636425,0.00003303401,0.0007126653,0.00018220399,0.000009538116,0.0014016707,0.00033666153,0.00027295048,0.0003490748,0.0067959237,0.9898414,0.000029174555],"about_ca_topic_score_codex":0.014590695,"about_ca_topic_score_gemma":0.030787535,"teacher_disagreement_score":0.064380415,"about_ca_system_score_codex":0.0043790257,"about_ca_system_score_gemma":0.008608773,"threshold_uncertainty_score":0.066431165},"labels":[],"label_agreement":null},{"id":"W4412037714","doi":"10.1111/jdv.20810","title":"<i>Trichophyton indotineae</i> : Epidemiology, antifungal resistance and antifungal stewardship strategies","year":2025,"lang":"en","type":"review","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Nail Diseases and Treatments","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mediprobe Research (Canada); Women's College Hospital; University of Toronto","funders":"","keywords":"Posaconazole; Terbinafine; Itraconazole; Medicine; Voriconazole; Griseofulvin; Fluconazole; Dermatophyte; Dermatology; Trichophyton; Drug resistance; Intensive care medicine; Antifungal; Microbiology; Biology","score_opus":0.045655757404892805,"score_gpt":0.36319694706429173,"score_spread":0.3175411896593989,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412037714","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.007696837,0.95047444,0.001011583,0.023936836,0.0010465103,0.000113268,0.0023060825,0.000098767916,0.013315651],"genre_scores_gemma":[0.05022024,0.9324477,0.0022766634,0.00814515,0.0018360806,0.00014608225,0.0022686,0.000042560798,0.0026170108],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99897623,0.00031020513,0.00026670858,0.00014073613,0.00021165109,0.0000945357],"domain_scores_gemma":[0.9973425,0.0010469975,0.0008475251,0.00004788661,0.00058695656,0.00012811845],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012056791,0.0003681805,0.0005568476,0.002325657,0.00028537153,0.0015768231,0.00046561766,0.00093755446,0.0073833656],"category_scores_gemma":[0.005230236,0.00015533553,0.0008553764,0.0031224892,0.00039185066,0.0017529147,0.0007589774,0.00085016707,0.0012714589],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027854048,0.000062691724,0.033140708,0.052051954,0.0005208285,0.0011658842,0.0009313607,0.0005449017,0.0015134865,0.006286499,0.19028269,0.7132205],"study_design_scores_gemma":[0.000043080337,0.00024602155,0.07767103,0.10474036,0.00087336247,0.008767966,0.0024009831,0.00053403,0.0009764252,0.0037171307,0.79993945,0.00009015548],"about_ca_topic_score_codex":0.008805855,"about_ca_topic_score_gemma":0.008262172,"teacher_disagreement_score":0.008805855,"about_ca_system_score_codex":0.0011042851,"about_ca_system_score_gemma":0.0021074915,"threshold_uncertainty_score":0.024699867},"labels":[],"label_agreement":null},{"id":"W4412115968","doi":"10.1111/jdv.20839","title":"Efficacy and safety of dual biologic therapy in inflammatory skin diseases: A systematic review","year":2025,"lang":"en","type":"review","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo; Memorial University of Newfoundland; University of Ottawa; Dermatrials Research; Hospital for Sick Children; Toronto Western Hospital; SickKids Foundation; University of Toronto; University Health Network; McMaster University; Women's College Hospital","funders":"","keywords":"Medicine; Dermatology; Intensive care medicine; Dual (grammatical number)","score_opus":0.02320978548925014,"score_gpt":0.32276813528934467,"score_spread":0.29955834980009455,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412115968","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0014580917,0.9979656,0.000052419535,0.00007933289,0.000045581815,0.000072171235,0.00019285643,0.0000030157964,0.00013093598],"genre_scores_gemma":[0.027814014,0.9710618,0.00031282823,0.0002959963,0.0000743103,0.00014731652,0.00020703794,0.0000025670706,0.000084098836],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99660933,0.0013376998,0.0011230505,0.0003076032,0.00051839545,0.00010394868],"domain_scores_gemma":[0.98772347,0.009443177,0.0018729105,0.00015649328,0.0006755389,0.00012849849],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004411931,0.00086545513,0.006657219,0.0034034098,0.00034236215,0.0014941983,0.0009987948,0.0012230922,0.0038903465],"category_scores_gemma":[0.018136019,0.00057161285,0.0070846886,0.0037747626,0.00051317643,0.0012791003,0.0008494201,0.001086233,0.00021630882],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010459163,0.000028786473,0.0013467711,0.9176951,0.03636467,0.000059734688,0.000088061504,0.00011377392,0.00018413199,0.0001713017,0.0014049499,0.04149672],"study_design_scores_gemma":[0.0019500989,0.0008677291,0.013135676,0.59084105,0.37352985,0.0005115943,0.00029349967,0.0002273241,0.0002908397,0.0005380325,0.017751582,0.00006268822],"about_ca_topic_score_codex":0.0040149735,"about_ca_topic_score_gemma":0.014570503,"teacher_disagreement_score":0.006657219,"about_ca_system_score_codex":0.0016055087,"about_ca_system_score_gemma":0.0028211905,"threshold_uncertainty_score":0.023332834},"labels":[],"label_agreement":null},{"id":"W4412509907","doi":"10.1111/jdv.20809","title":"Systemic treatment of immune checkpoint inhibitor‐induced psoriasis: Inference‐based guidance","year":2025,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; McMaster University; Juravinski Cancer Centre; BC Children's Hospital; Vancouver General Hospital; Probity Medical Research; University of British Columbia; BC Cancer Agency; Hôtel-Dieu de Québec; Krembil Foundation; Research Canada; Ottawa Hospital; University Health Network; University of Toronto; Blackberry (Canada); University of Ottawa","funders":"Janssen Pharmaceuticals; Eli Lilly Canada; Sanofi Genzyme; Amgen Canada; Janssen Canada; University of Texas MD Anderson Cancer Center; Sun Pharma; EMD Serono; Galderma; Seagen; Novartis Pharmaceuticals Canada; MacroGenics; Pfizer; Incyte; BeiGene; Melanoma Research Alliance; Queen Mary University of London; Clovis Oncology; BC Children's Hospital; Astellas Pharma; Eisai; Jazz Pharmaceuticals; National Institutes of Health; Regeneron Pharmaceuticals; National Center for Advancing Translational Sciences; Les Laboratories Pierre Fabre; Therakos; Amgen; Ariad Pharmaceuticals; Daiichi Sankyo Europe; LEO Pharma; Servier; Gilead Sciences; Bausch Health; L'Oreal USA; National Institute of Arthritis and Musculoskeletal and Skin Diseases; Sanofi; Celgene; AstraZeneca; Eli Lilly and Company; Samsung; Bristol-Myers Squibb","keywords":"Medicine; Psoriasis; Inference; Dermatology; Artificial intelligence","score_opus":0.025928135575957047,"score_gpt":0.2768369650984526,"score_spread":0.2509088295224956,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412509907","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.016318547,0.16311882,0.5844056,0.13985546,0.0019153935,0.0120291235,0.010258339,0.0016629447,0.070435725],"genre_scores_gemma":[0.26755062,0.05965555,0.63808787,0.017226376,0.0013151726,0.009022682,0.0048740515,0.00016927785,0.00209845],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.93925565,0.046932276,0.0059426357,0.0021488445,0.005145093,0.0005756189],"domain_scores_gemma":[0.6904005,0.2896996,0.0062233736,0.0025574798,0.010063993,0.0010551058],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.06752492,0.002068919,0.0035737155,0.00732757,0.0011071154,0.005029867,0.005045948,0.0057477555,0.011875633],"category_scores_gemma":[0.19202624,0.0014137843,0.006160435,0.0028642116,0.0020638038,0.0031203034,0.003702865,0.0060325726,0.0016606798],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023878291,0.00051657174,0.0067011737,0.08047416,0.0057217604,0.0011875135,0.0028800606,0.16714267,0.0010690374,0.09203241,0.07673772,0.56314903],"study_design_scores_gemma":[0.0033266146,0.0011793975,0.0043928847,0.13500781,0.009467165,0.00090246444,0.0011185315,0.18688263,0.0028572385,0.4120701,0.2423736,0.00042158156],"about_ca_topic_score_codex":0.012120597,"about_ca_topic_score_gemma":0.01487806,"teacher_disagreement_score":0.06752492,"about_ca_system_score_codex":0.007063274,"about_ca_system_score_gemma":0.018555384,"threshold_uncertainty_score":0.35711014},"labels":[],"label_agreement":null},{"id":"W4412597033","doi":"10.1111/jdv.20833","title":"Statement from the frontal fibrosing alopecia international expert alliance: <scp>SOFFIA</scp> 2024","year":2025,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Hair Growth and Disorders","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Noda Institute for Scientific Research","keywords":"Medicine; Statement (logic); Alliance; Modalities; Delphi method; Family medicine; Artificial intelligence","score_opus":0.01381184159948344,"score_gpt":0.28761026627163033,"score_spread":0.2737984246721469,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412597033","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.04491493,0.01566646,0.039167646,0.6714238,0.052830756,0.015405837,0.010704351,0.0004956879,0.1493905],"genre_scores_gemma":[0.42522073,0.025185565,0.16666073,0.17492072,0.03409865,0.032681264,0.03379163,0.0006902352,0.10675061],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98456097,0.0069876267,0.0037492975,0.00048711392,0.0031231723,0.001091771],"domain_scores_gemma":[0.94495463,0.014860897,0.0041358173,0.0016327389,0.028698806,0.005717016],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.033325836,0.0007119848,0.0007040969,0.0016120248,0.0017252227,0.0015647002,0.0015333667,0.0034907167,0.013521931],"category_scores_gemma":[0.053108543,0.00035669425,0.0013541359,0.00083784445,0.0009759774,0.0013074034,0.003173304,0.003971185,0.0053929277],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031169827,0.00014391237,0.007874336,0.0015636216,0.00006545275,0.0006475921,0.0018572157,0.00052713027,0.0022137703,0.0049602133,0.80638134,0.17345366],"study_design_scores_gemma":[0.00023016141,0.00031160563,0.017225115,0.006058353,0.00008590511,0.0027097394,0.0031156717,0.0012264369,0.0010118394,0.00697119,0.96095747,0.00009650027],"about_ca_topic_score_codex":0.002712608,"about_ca_topic_score_gemma":0.0026449198,"teacher_disagreement_score":0.033325836,"about_ca_system_score_codex":0.0017874185,"about_ca_system_score_gemma":0.013606551,"threshold_uncertainty_score":0.17624599},"labels":[],"label_agreement":null},{"id":"W4412666256","doi":"10.1111/jdv.20863","title":"Efficacy and safety of <scp>ME3183</scp> , an oral phosphodiesterase 4 inhibitor, in patients with plaque psoriasis","year":2025,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Phosphodiesterase function and regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; University of Toronto","funders":"","keywords":"Medicine; Placebo; Psoriasis; Nausea; Adverse effect; Plaque psoriasis; Internal medicine; Psoriasis Area and Severity Index; Clinical endpoint; Tolerability; Vomiting; Gastroenterology; Randomized controlled trial; Dermatology","score_opus":0.006026239801996486,"score_gpt":0.23015115103380993,"score_spread":0.22412491123181344,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412666256","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99367464,0.0049549295,0.00015661553,0.00014799155,0.000030166027,0.00025950896,0.000115362825,0.000026550762,0.0006342234],"genre_scores_gemma":[0.9971758,0.0016000065,0.00040554293,0.00018783024,0.00010183707,0.00016337847,0.00012201082,0.0000032811356,0.00024023831],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9995202,0.0002371571,0.00005811984,0.000047426263,0.000089305926,0.000047780228],"domain_scores_gemma":[0.9990883,0.00032656683,0.00033983882,0.000039288247,0.000051242074,0.00015481013],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013012252,0.00045666684,0.0013346411,0.00020261433,0.00024525603,0.0003529275,0.00027770537,0.0006302903,0.002239345],"category_scores_gemma":[0.0012812128,0.00030041466,0.00069621875,0.00022736182,0.0004524802,0.00036052678,0.00017056496,0.0012812769,0.0003352213],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7071629,0.016658925,0.016742818,0.0022935008,0.0013327559,0.0002779077,0.00017335282,0.0010842149,0.061653715,0.000084504034,0.0012448742,0.19129044],"study_design_scores_gemma":[0.32424363,0.5869603,0.075851366,0.000144354,0.001179851,0.00078330055,0.00006839392,0.0011449476,0.007867469,0.0001289809,0.0015937805,0.0000336548],"about_ca_topic_score_codex":0.0003132495,"about_ca_topic_score_gemma":0.0005555784,"teacher_disagreement_score":0.002239345,"about_ca_system_score_codex":0.00029693672,"about_ca_system_score_gemma":0.0005324305,"threshold_uncertainty_score":0.00749135},"labels":[],"label_agreement":null},{"id":"W4412755233","doi":"10.1111/jdv.20883","title":"Analysis of global skin cancer epidemiology in 2022 and correlation with dermatologist density","year":2025,"lang":"en","type":"letter","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Nonmelanoma Skin Cancer Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Future Earth","funders":"","keywords":"Medicine; Dermatology; Epidemiology; Skin cancer; Cancer; Pathology; Internal medicine","score_opus":0.022302001422026287,"score_gpt":0.31452520744235807,"score_spread":0.2922232060203318,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412755233","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.938092,0.0056679565,0.0014967644,0.0012060718,0.00009858571,0.00007888639,0.04792745,0.00011615969,0.0053160912],"genre_scores_gemma":[0.9732632,0.0016808701,0.0008971375,0.00019694232,0.00009088088,0.00009128784,0.023033835,0.000024448269,0.00072159694],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99933016,0.0001837278,0.000096311145,0.00011988837,0.00016489731,0.00010516044],"domain_scores_gemma":[0.99728775,0.00037058993,0.001345962,0.00016873109,0.0005653862,0.00026164955],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013455187,0.00031859434,0.00025820945,0.0033496975,0.00023202974,0.0009366517,0.00038178547,0.00037252705,0.0022908212],"category_scores_gemma":[0.004635646,0.00018622399,0.00091717707,0.0053905086,0.00019560364,0.000797727,0.0008580184,0.00048604386,0.00055662025],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000031531512,0.00000917251,0.99523526,0.000047435493,0.00009942721,0.000029265131,0.00005021265,0.00030181743,0.000034026227,0.000082328996,0.0010083278,0.0030711656],"study_design_scores_gemma":[0.0000018787944,0.000023864262,0.9972363,0.000026687587,0.000023186842,0.00012319519,0.00017939862,0.0005199506,0.000037036465,0.000048654972,0.0017751397,0.0000047771837],"about_ca_topic_score_codex":0.022280363,"about_ca_topic_score_gemma":0.019062633,"teacher_disagreement_score":0.022280363,"about_ca_system_score_codex":0.00080450665,"about_ca_system_score_gemma":0.0006899915,"threshold_uncertainty_score":0.04430133},"labels":[],"label_agreement":null},{"id":"W4413102018","doi":"10.1111/jdv.20881","title":"Management of Tinea Capitis in children under 10 kg : Results from a French multicentre study","year":2025,"lang":"en","type":"letter","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Nail Diseases and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"","keywords":"Medicine; Tinea capitis; Dermatology","score_opus":0.01337245685823232,"score_gpt":0.2711511362280069,"score_spread":0.2577786793697746,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413102018","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962203,0.0025202627,0.000097878205,0.00008317604,0.000007211613,0.00004653617,0.00046500703,0.000004714298,0.00055481854],"genre_scores_gemma":[0.9978629,0.0011490539,0.00020331718,0.00010975809,0.000021573092,0.000034080393,0.0005543354,0.0000039312704,0.00006115551],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986921,0.0005724991,0.0001695236,0.0002054854,0.00019451404,0.00016588141],"domain_scores_gemma":[0.99683243,0.0008307466,0.0012654086,0.00018200093,0.00054804026,0.00034136767],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020481932,0.00049868727,0.00065220334,0.0007551767,0.0004890486,0.0005774007,0.0003296118,0.00045561176,0.0009228473],"category_scores_gemma":[0.0035975745,0.00020084075,0.00081172434,0.0011217736,0.00040112162,0.0004673871,0.0003566577,0.00030292314,0.00017556436],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005608347,0.00020113042,0.987849,0.00013194897,0.00018604734,0.0007810329,0.000870368,0.000084785286,0.00029821033,0.00002680307,0.00046743738,0.008542395],"study_design_scores_gemma":[0.00004423109,0.0009208604,0.9963811,0.000055524848,0.00009705635,0.0011241316,0.0004655123,0.00004915711,0.0000351234,0.000005170386,0.0008111489,0.00001110212],"about_ca_topic_score_codex":0.017442532,"about_ca_topic_score_gemma":0.01852747,"teacher_disagreement_score":0.017442532,"about_ca_system_score_codex":0.0012409419,"about_ca_system_score_gemma":0.0007800906,"threshold_uncertainty_score":0.034681976},"labels":[],"label_agreement":null},{"id":"W4413783518","doi":"10.1111/jdv.70016","title":"Reply to ‘Delayed absorption and systemic variability of topical delgocitinib in Chronic Hand Eczema’","year":2025,"lang":"en","type":"letter","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Contact Dermatitis and Allergies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Innovaderm (Canada); Probity Medical Research; Queen's University","funders":"LEO Pharma","keywords":"Cmax; Medicine; Bioavailability; Pharmacokinetics; Absorption (acoustics); Drug; Pharmacology; Dermatology","score_opus":0.014971232471978388,"score_gpt":0.2696815139289235,"score_spread":0.2547102814569451,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413783518","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00071166595,0.0028381033,0.0004966848,0.9172081,0.07772005,0.000036291967,0.0001791087,0.00014090158,0.0006690809],"genre_scores_gemma":[0.004141313,0.0011454783,0.0004113859,0.9246436,0.068111256,0.00007057195,0.000043810553,0.000045564895,0.0013871344],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9946795,0.001625731,0.0011654287,0.00085857057,0.0012542685,0.00041637252],"domain_scores_gemma":[0.97283506,0.01644275,0.0019770616,0.00087846874,0.0064940173,0.0013726335],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009061843,0.0011647935,0.002185748,0.000889123,0.0018280438,0.0026000475,0.0029445118,0.032453366,0.0041367253],"category_scores_gemma":[0.05886166,0.00093455066,0.001633624,0.0009357731,0.0031169709,0.003328024,0.0015119215,0.034532435,0.0046207285],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015443735,0.000030446532,0.00059416826,0.00017174661,0.000045081328,0.00094495784,0.00016598236,0.00007390866,0.0002370083,0.0006443838,0.9893678,0.0075701345],"study_design_scores_gemma":[0.00028654817,0.00029246634,0.0027939493,0.0006163177,0.00013941768,0.0039579244,0.0004972231,0.0008308787,0.0011621382,0.004054633,0.9851355,0.00023305201],"about_ca_topic_score_codex":0.0033410457,"about_ca_topic_score_gemma":0.002998058,"teacher_disagreement_score":0.032453366,"about_ca_system_score_codex":0.0027021796,"about_ca_system_score_gemma":0.0027699051,"threshold_uncertainty_score":0.04792416},"labels":[],"label_agreement":null},{"id":"W4414125639","doi":"10.1111/jdv.70057","title":"Bacteriophage therapy in dermatology: A systematic review","year":2025,"lang":"en","type":"review","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Bacteriophages and microbial interactions","field":"Environmental Science","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dermatrials Research; University of Saskatchewan; Women's College Hospital; University of Toronto; McMaster University","funders":"","keywords":"Bacteriophage; MEDLINE; Phage therapy; Clinical trial","score_opus":0.020777169839236595,"score_gpt":0.304654462250278,"score_spread":0.28387729241104137,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414125639","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000301358,0.99924076,0.00004093779,0.00008917314,0.000053890897,0.000051653475,0.0001248373,0.0000027223894,0.000094687246],"genre_scores_gemma":[0.003120464,0.9963271,0.00014653942,0.00017748255,0.000034026834,0.00006816763,0.0000756149,0.0000012021675,0.000049469156],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9976398,0.0008102492,0.0007384283,0.00021976882,0.00047589003,0.00011599218],"domain_scores_gemma":[0.9903804,0.006771061,0.001697391,0.0001359139,0.00087270944,0.0001424917],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0037194781,0.0011911886,0.005815696,0.0054299915,0.0004235053,0.0017401328,0.0012353155,0.0015419533,0.0046732044],"category_scores_gemma":[0.013015492,0.0006430434,0.005826058,0.0064035025,0.0004690324,0.0013850775,0.0011211204,0.00095142913,0.00036592843],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003236521,0.000026204447,0.00048335333,0.9234177,0.008292284,0.00007614029,0.000081339356,0.00012141486,0.0002087053,0.00020646569,0.0029386645,0.06382416],"study_design_scores_gemma":[0.00046397946,0.00039762,0.004795172,0.8511969,0.09553689,0.0004995757,0.00025496178,0.00012606125,0.00023308415,0.00042602554,0.046014283,0.00005562303],"about_ca_topic_score_codex":0.0056890785,"about_ca_topic_score_gemma":0.019560928,"teacher_disagreement_score":0.005815696,"about_ca_system_score_codex":0.0018925591,"about_ca_system_score_gemma":0.0059270365,"threshold_uncertainty_score":0.019670725},"labels":[],"label_agreement":null},{"id":"W4414337418","doi":"10.1111/jdv.20886","title":"Reporting of skin colour in randomized controlled trials on vitiligo: A systematic review","year":2025,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"melanin and skin pigmentation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of Toronto; Western University","funders":"","keywords":"Randomized controlled trial; MEDLINE; Research design; Skin color; Skin colour","score_opus":0.02073489772706239,"score_gpt":0.33616799610957143,"score_spread":0.31543309838250905,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414337418","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"reporting","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"reporting","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00792742,0.9704342,0.0043971757,0.0020545607,0.0012787649,0.008654495,0.004143287,0.00015509162,0.0009549147],"genre_scores_gemma":[0.27679917,0.6473674,0.020295322,0.0053084036,0.0009598125,0.04531646,0.0030487129,0.00016021394,0.0007444216],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.8040558,0.109241545,0.06667353,0.008122615,0.010385505,0.0015210264],"domain_scores_gemma":[0.58777195,0.31021166,0.077584155,0.010137643,0.01301855,0.0012760692],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.09436148,0.0024181802,0.022732614,0.006987617,0.0011976389,0.0055037667,0.0037121733,0.0041462695,0.009434818],"category_scores_gemma":[0.38043243,0.0024575898,0.022950174,0.0074286647,0.0027730865,0.0056778365,0.0032430105,0.0032658267,0.00059254054],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019551346,0.000022210363,0.0011338845,0.92055994,0.06024688,0.000040447285,0.00018962118,0.00016795468,0.00010925998,0.00040658392,0.0015149678,0.013653148],"study_design_scores_gemma":[0.011155963,0.00064438296,0.0056324867,0.6995553,0.2718237,0.00018072236,0.00037964666,0.0004307018,0.00039594396,0.002061872,0.0076044956,0.00013475743],"about_ca_topic_score_codex":0.004550948,"about_ca_topic_score_gemma":0.0070212474,"teacher_disagreement_score":0.9056385,"about_ca_system_score_codex":0.0062336926,"about_ca_system_score_gemma":0.009706208,"threshold_uncertainty_score":0.49903715},"labels":[],"label_agreement":null},{"id":"W4414376204","doi":"10.1111/jdv.70070","title":"Petrolatum versus saline vehicle for drug testing","year":2025,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Drug-Induced Adverse Reactions","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"","keywords":"Saline; Drug; MEDLINE; Drug injection","score_opus":0.03728423196508998,"score_gpt":0.3201119366958014,"score_spread":0.2828277047307114,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414376204","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9345496,0.0070673386,0.003156387,0.0015248006,0.0048964717,0.0045651896,0.004226662,0.00062208093,0.0393915],"genre_scores_gemma":[0.9510644,0.0043780254,0.004786659,0.0005678563,0.0008032522,0.0026299036,0.0015437864,0.00011672124,0.034109253],"study_design_codex":"randomized_trial","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999076,0.00028006762,0.00008340739,0.0001227268,0.00020239748,0.00023543744],"domain_scores_gemma":[0.9986058,0.0006841626,0.00016336236,0.00014089944,0.0001483551,0.00025751514],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00086989073,0.0008780567,0.0012683361,0.0008248739,0.00036922286,0.00054962875,0.00070142566,0.0007701442,0.04316101],"category_scores_gemma":[0.0023394658,0.00023690503,0.00040533626,0.0005294053,0.00049944984,0.0008036769,0.00035708345,0.0020548315,0.0034938413],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.55015385,0.046987012,0.00096025004,0.0015577398,0.00032134252,0.0005538234,0.00019204065,0.00065843994,0.26159826,0.0026550258,0.013010687,0.12135151],"study_design_scores_gemma":[0.042596497,0.51953274,0.0076923333,0.00028302977,0.001032528,0.0011257476,0.00047955138,0.0038276166,0.3744152,0.002222534,0.04665725,0.00013500449],"about_ca_topic_score_codex":0.0007647728,"about_ca_topic_score_gemma":0.0015373308,"teacher_disagreement_score":0.04316101,"about_ca_system_score_codex":0.00031177586,"about_ca_system_score_gemma":0.00095132896,"threshold_uncertainty_score":0.14438796},"labels":[],"label_agreement":null},{"id":"W4414511807","doi":"10.1111/jdv.70066","title":"Delphi consensus on melasma management by international experts and pigmentary disorders society","year":2025,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Dermatologic Treatments and Research","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health","funders":"","keywords":"Melasma; Delphi method; Expert opinion; Delphi; MEDLINE; Alternative medicine","score_opus":0.011009728974684076,"score_gpt":0.3015106188915515,"score_spread":0.29050088991686746,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414511807","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.20936716,0.055655796,0.22082415,0.18072058,0.020864444,0.11752083,0.0034428812,0.0006578302,0.1909463],"genre_scores_gemma":[0.5532683,0.026333213,0.30237454,0.022645866,0.0022485552,0.081353694,0.0017199018,0.00018958474,0.009866366],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.7927509,0.15334855,0.024860641,0.0042361366,0.018622437,0.006181402],"domain_scores_gemma":[0.85176986,0.06718858,0.0068661477,0.004531733,0.06543101,0.004212605],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.22042614,0.0016238858,0.0015177072,0.007902093,0.003384639,0.003805678,0.003355148,0.004083545,0.006523726],"category_scores_gemma":[0.18684207,0.0011394211,0.0031127986,0.0040344913,0.004145586,0.003986238,0.012088961,0.004940725,0.0014253658],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015800394,0.00047526634,0.010746307,0.033437006,0.0008731067,0.0021645178,0.2072346,0.0025646081,0.01456116,0.04940821,0.1463221,0.53063303],"study_design_scores_gemma":[0.0007796887,0.0014476485,0.017522747,0.06603619,0.00090055703,0.0031188123,0.13554463,0.005600208,0.0077755637,0.06604885,0.6945249,0.0007001486],"about_ca_topic_score_codex":0.0020672234,"about_ca_topic_score_gemma":0.001992248,"teacher_disagreement_score":0.22042614,"about_ca_system_score_codex":0.007461827,"about_ca_system_score_gemma":0.03180081,"threshold_uncertainty_score":0.96135336},"labels":[],"label_agreement":null},{"id":"W4414816688","doi":"10.1111/jdv.70081","title":"Dupilumab improves quality of life assessed by the Quality of Life in Hand Eczema Questionnaire","year":2025,"lang":"en","type":"letter","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Contact Dermatitis and Allergies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"Regeneron Pharmaceuticals; Sanofi","keywords":"Dupilumab; Quality of life (healthcare); Protocol (science); Hand eczema; Clinical trial; MEDLINE; Quality (philosophy); Statistical analysis","score_opus":0.03143609960767745,"score_gpt":0.31924069311336695,"score_spread":0.2878045935056895,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414816688","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.013690933,0.0017726629,0.0004669237,0.8772168,0.00833096,0.00016040649,0.0009099532,0.00019954918,0.09725181],"genre_scores_gemma":[0.15099996,0.0028803928,0.0015721268,0.6944307,0.014245088,0.0002850765,0.0007592766,0.0001062696,0.13472106],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990094,0.00041452012,0.00009168061,0.00006518599,0.00027187137,0.00014730419],"domain_scores_gemma":[0.9961617,0.0022916521,0.00026386353,0.000110165805,0.00082919665,0.00034342328],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017667522,0.00019005509,0.00042718774,0.00037042613,0.0010943187,0.00080841826,0.00031599615,0.0053953016,0.017447397],"category_scores_gemma":[0.010226246,0.000113665476,0.0002978071,0.00027828768,0.00044143555,0.0005110255,0.00036868645,0.0034373493,0.008104763],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022616559,0.00018359203,0.0054066502,0.00006969989,0.0000119345295,0.0034941917,0.00012665923,0.00004168028,0.0005026322,0.00238622,0.9380543,0.049496245],"study_design_scores_gemma":[0.00047791345,0.0005530675,0.018837044,0.00061990554,0.000042157757,0.010570932,0.00044206405,0.0010194009,0.0009322176,0.006903666,0.95955706,0.000044531793],"about_ca_topic_score_codex":0.0026123743,"about_ca_topic_score_gemma":0.0050995545,"teacher_disagreement_score":0.017447397,"about_ca_system_score_codex":0.0011965567,"about_ca_system_score_gemma":0.0011707736,"threshold_uncertainty_score":0.058367312},"labels":[],"label_agreement":null},{"id":"W4414982287","doi":"10.1111/jdv.70103","title":"Long‐term outcomes of juvenile dermatomyositis","year":2025,"lang":"en","type":"letter","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Inflammatory Myopathies and Dermatomyositis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Juvenile dermatomyositis; Dermatomyositis; MEDLINE; Juvenile; Connective tissue disease","score_opus":0.016882763833831773,"score_gpt":0.27638892445850755,"score_spread":0.2595061606246758,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414982287","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9218298,0.013504015,0.00025468072,0.033094134,0.000688576,0.00002214914,0.0018477888,0.000026430993,0.028732482],"genre_scores_gemma":[0.9945306,0.0012734919,0.000038072634,0.0016859109,0.0004378138,0.000011297457,0.00049841584,0.0000032221155,0.0015211513],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993766,0.00017649456,0.000058763533,0.000039512965,0.00011994758,0.00022867773],"domain_scores_gemma":[0.99585223,0.0009859053,0.0012174683,0.00016893518,0.0005556506,0.0012198718],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00070395065,0.00009551914,0.000275738,0.00032854447,0.00087833824,0.0006708468,0.00028560506,0.00080150476,0.0025271706],"category_scores_gemma":[0.005171689,0.00005184991,0.0002593911,0.0006424512,0.00026602196,0.0004928892,0.00041642264,0.0010327366,0.00042940388],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001404981,0.0003252471,0.8685122,0.00014567522,0.00014232863,0.035719175,0.00061994715,0.00042480783,0.0008794762,0.0017940784,0.018050347,0.07198172],"study_design_scores_gemma":[0.00007588272,0.000602308,0.9579313,0.0002367398,0.00010315828,0.027458409,0.0009879716,0.00037633788,0.00017046442,0.0023565036,0.009659149,0.000041714946],"about_ca_topic_score_codex":0.004267541,"about_ca_topic_score_gemma":0.007782179,"teacher_disagreement_score":0.004267541,"about_ca_system_score_codex":0.0011222605,"about_ca_system_score_gemma":0.0005883987,"threshold_uncertainty_score":0.008485436},"labels":[],"label_agreement":null},{"id":"W4415147299","doi":"10.1111/jdv.70080","title":"Safety and efficacy of nemolizumab for atopic dermatitis up to 2 years in open‐label extension study","year":2025,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Merck Canada Inc. (Canada); Probity Medical Research; Alberta Barley; University of Toronto","funders":"Galderma","keywords":"Atopic dermatitis; Extension (predicate logic); MEDLINE; Dupilumab; Clinical trial","score_opus":0.02983851589985237,"score_gpt":0.34350516520124563,"score_spread":0.31366664930139326,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415147299","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942603,0.001614885,0.00033173087,0.00014375767,0.00006427108,0.0012096926,0.0011422477,0.000054109747,0.0011790674],"genre_scores_gemma":[0.99127495,0.00092619687,0.0005739121,0.00042921727,0.00018646978,0.0017575509,0.0026415107,0.000013663353,0.002196529],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99933124,0.00029321006,0.00005180201,0.000114609495,0.00010445439,0.00010464094],"domain_scores_gemma":[0.99844736,0.00019553941,0.00043300143,0.00019941643,0.00014864169,0.00057604036],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002768216,0.0009157507,0.0018189438,0.00033282538,0.00049480196,0.0008040564,0.0006141376,0.0010957087,0.004078593],"category_scores_gemma":[0.0012124066,0.00031147286,0.0015711728,0.00025269022,0.00045255758,0.0009220449,0.0004139734,0.0020857558,0.0012188961],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.84112823,0.04351007,0.023068376,0.0006175975,0.0018033781,0.0003740599,0.00021262393,0.00067833986,0.018209416,0.00010788479,0.0025107542,0.06777931],"study_design_scores_gemma":[0.44806135,0.40852162,0.13008216,0.00012588163,0.0015064485,0.0005988588,0.00008016876,0.0013207968,0.003265596,0.00020137227,0.0061881565,0.000047603353],"about_ca_topic_score_codex":0.00038811754,"about_ca_topic_score_gemma":0.00079968723,"teacher_disagreement_score":0.004078593,"about_ca_system_score_codex":0.0005802786,"about_ca_system_score_gemma":0.000815387,"threshold_uncertainty_score":0.014639914},"labels":[],"label_agreement":null},{"id":"W4415280763","doi":"10.1111/jdv.70108","title":"Drug survival of systemic treatments for severe paediatric psoriasis: An international retrospective study","year":2025,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Retrospective cohort study; Methotrexate; Drug; Acitretin; Survival analysis; Cohort; Cohort study","score_opus":0.016116479903800333,"score_gpt":0.2724736230258559,"score_spread":0.2563571431220556,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415280763","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99796957,0.0008343815,0.00010628628,0.000019235087,0.0000038462395,0.000023314245,0.0006230424,0.000002843083,0.00041742955],"genre_scores_gemma":[0.9985455,0.00041372195,0.00011229828,0.000025555848,0.00001054035,0.000026737178,0.0008119545,0.0000026547416,0.00005110119],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988004,0.00026909725,0.00019973135,0.00037080338,0.00022653649,0.00013340985],"domain_scores_gemma":[0.99575055,0.000605258,0.002752956,0.0003121122,0.00027617166,0.0003028614],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012444212,0.00024664286,0.00045736737,0.001369036,0.00034422812,0.000654999,0.0003245401,0.0003692547,0.0012455988],"category_scores_gemma":[0.0026374804,0.000255862,0.0005965036,0.001961484,0.00035864464,0.00065401004,0.00050480996,0.00055132527,0.00023766677],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015125184,0.000022404034,0.9979582,0.000022975612,0.00005032123,0.00012786334,0.00008273749,0.00003233703,0.00006570497,0.00001541698,0.00008008913,0.0013907612],"study_design_scores_gemma":[0.000017474134,0.00026272633,0.997486,0.000015097833,0.000045634486,0.0013236315,0.00018734313,0.00007626197,0.00006029195,0.00001216035,0.00050774665,0.000005535146],"about_ca_topic_score_codex":0.0022605506,"about_ca_topic_score_gemma":0.0015103942,"teacher_disagreement_score":0.0022605506,"about_ca_system_score_codex":0.00044797384,"about_ca_system_score_gemma":0.00040607032,"threshold_uncertainty_score":0.006581247},"labels":[],"label_agreement":null},{"id":"W4415281107","doi":"10.1111/jdv.70115","title":"Deep and disseminated dermatophytosis in immunocompromised populations—A systematic review","year":2025,"lang":"en","type":"review","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Nail Diseases and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mediprobe Research (Canada); Women's College Hospital; University of Toronto","funders":"Bausch Health; LEO Pharma; Incyte; Celgene; Sanofi; Pfizer; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"MEDLINE; Mycosis; Health care; Healthcare system; Immunosuppression","score_opus":0.027797901772806183,"score_gpt":0.3495348666804501,"score_spread":0.3217369649076439,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415281107","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0019822633,0.9972031,0.000037044912,0.00009255467,0.000034251694,0.00006781552,0.0003820763,0.000002436926,0.00019848379],"genre_scores_gemma":[0.021365985,0.9777194,0.00017009627,0.00023881462,0.000047909958,0.00013359364,0.00025331488,0.0000019812328,0.00006883563],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9981785,0.00043035913,0.0008196219,0.00019546495,0.0003016621,0.0000743885],"domain_scores_gemma":[0.9912985,0.0059644356,0.0019237457,0.000098549936,0.0005836552,0.00013115797],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016946702,0.0007188404,0.0037739505,0.007962489,0.00034696868,0.0012671099,0.0009706023,0.0010593432,0.0037808083],"category_scores_gemma":[0.00857665,0.0005030171,0.0030527068,0.010201853,0.00048035607,0.0012507448,0.00077916635,0.00053694565,0.00019868597],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018572016,0.000019106128,0.0041399323,0.94830453,0.004686414,0.00044344686,0.00022323581,0.00008580339,0.00019739363,0.00017739227,0.001985738,0.03955127],"study_design_scores_gemma":[0.00025512828,0.0003195348,0.02825558,0.88583577,0.04903647,0.0035515195,0.0007128558,0.00011422248,0.00018972132,0.0003120155,0.031369552,0.00004759295],"about_ca_topic_score_codex":0.005257093,"about_ca_topic_score_gemma":0.014641809,"teacher_disagreement_score":0.007962489,"about_ca_system_score_codex":0.0011691399,"about_ca_system_score_gemma":0.0039874595,"threshold_uncertainty_score":0.012648106},"labels":[],"label_agreement":null},{"id":"W4415431846","doi":"10.1111/jdv.70139","title":"International insights into bullying in patients with atopic dermatitis: Global trends and key predictors","year":2025,"lang":"en","type":"letter","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Windsor Clinical Research; Western University; University of Toronto","funders":"","keywords":"Atopic dermatitis; Observational study; Representativeness heuristic; Telephone interview; Human factors and ergonomics; Occupational safety and health; Population; Injury prevention; Suicide prevention; Poison control","score_opus":0.006874026360541119,"score_gpt":0.24207695313506383,"score_spread":0.2352029267745227,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415431846","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95646733,0.027743543,0.00022348999,0.0032402014,0.00009020955,0.00006083271,0.0058614947,0.000026243037,0.006286643],"genre_scores_gemma":[0.9844646,0.011921573,0.00024205782,0.00026969708,0.00015616478,0.000045177323,0.00248989,0.000008089103,0.00040260275],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996264,0.000097962155,0.000068858564,0.000062426814,0.00005825343,0.00008599895],"domain_scores_gemma":[0.99883217,0.00012883707,0.0006209716,0.000041401043,0.00014239151,0.00023419014],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006792652,0.00023286593,0.00032166738,0.0026980592,0.00036553285,0.00087382173,0.0002788744,0.0003585299,0.002694706],"category_scores_gemma":[0.0014078987,0.00014573244,0.00043555893,0.0056233923,0.0002832321,0.0011676424,0.0007992496,0.0007502432,0.00036884818],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005607628,0.00003431753,0.9883796,0.0001243708,0.00005129919,0.00007893315,0.00056702533,0.000028268383,0.00008005552,0.000095145115,0.0007018368,0.0098031005],"study_design_scores_gemma":[0.0000018068878,0.00003205009,0.99723345,0.00008114805,0.000021316257,0.00016959579,0.0013023422,0.00004251576,0.000013343774,0.000043850298,0.0010550909,0.0000035565092],"about_ca_topic_score_codex":0.007941931,"about_ca_topic_score_gemma":0.0069591077,"teacher_disagreement_score":0.007941931,"about_ca_system_score_codex":0.000378574,"about_ca_system_score_gemma":0.00041439768,"threshold_uncertainty_score":0.015791416},"labels":[],"label_agreement":null},{"id":"W4415619026","doi":"10.1111/jdv.70138","title":"Suicidal ideation in patients with atopic dermatitis: A case‐control study on 23,191 adults","year":2025,"lang":"en","type":"letter","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Windsor Clinical Research; Western University","funders":"","keywords":"Suicidal ideation; Psychosocial; Population; Poison control; Young adult; Injury prevention; Suicide prevention; Depression (economics)","score_opus":0.0088933446079244,"score_gpt":0.25039353530806346,"score_spread":0.24150019070013906,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415619026","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9989256,0.00032286785,0.00010632198,0.0000185128,0.000008142327,0.00007344542,0.0002370626,0.0000029498415,0.00030505902],"genre_scores_gemma":[0.99883944,0.00030055718,0.00014860563,0.0000547561,0.000024860892,0.00006450031,0.00040336172,0.0000026652071,0.00016116582],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99885607,0.0003028213,0.00014693085,0.00033711447,0.00025292594,0.00010410973],"domain_scores_gemma":[0.998899,0.00025712076,0.00034341324,0.00016019055,0.00013631977,0.00020392152],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014000722,0.0005643653,0.0007126969,0.0012519802,0.0010136033,0.0009326431,0.000661888,0.0008421439,0.002015184],"category_scores_gemma":[0.0023596652,0.0009881435,0.0007084899,0.0014840849,0.00061136886,0.00079001015,0.00054393534,0.00073615595,0.00045561118],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002781967,0.00029022055,0.99713874,0.00003068327,0.00013890503,0.0004470346,0.00041611955,0.000018622668,0.00022308287,0.0000210912,0.00012632353,0.0008708422],"study_design_scores_gemma":[0.000110945795,0.0007121869,0.99671185,0.000018681883,0.00011610099,0.0011624969,0.0006100972,0.00016597679,0.00005131542,0.000015970914,0.0003144326,0.000009943083],"about_ca_topic_score_codex":0.010445382,"about_ca_topic_score_gemma":0.008790237,"teacher_disagreement_score":0.010445382,"about_ca_system_score_codex":0.0005583482,"about_ca_system_score_gemma":0.0003637742,"threshold_uncertainty_score":0.020769179},"labels":[],"label_agreement":null},{"id":"W4415809316","doi":"10.1111/jdv.70176","title":"Efficacy and tolerability of hydroxychloroquine in dermatomyositis","year":2025,"lang":"en","type":"letter","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Inflammatory Myopathies and Dermatomyositis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Hydroxychloroquine; Tolerability; Adverse effect; Dermatomyositis; Observational study; Juvenile dermatomyositis; Cohort study; Meta-analysis","score_opus":0.011454688790498116,"score_gpt":0.25995747222187904,"score_spread":0.24850278343138094,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415809316","genre_codex":"review","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0134801455,0.9851016,0.0002019341,0.00019947211,0.00007897912,0.00019911422,0.00031451051,0.000005496482,0.00041874696],"genre_scores_gemma":[0.4755729,0.5199665,0.0013696892,0.0010072802,0.0005714007,0.0005666432,0.0006319994,0.000016066017,0.00029748052],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.9878066,0.005743999,0.0039413483,0.00072156894,0.001592186,0.00019421303],"domain_scores_gemma":[0.98375523,0.009473745,0.005120437,0.0003288701,0.0011472254,0.00017439728],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01594089,0.0007282059,0.0059524686,0.0021858113,0.00024255614,0.001257879,0.00079480803,0.001090231,0.002873726],"category_scores_gemma":[0.022962254,0.00049607543,0.00877501,0.0020591747,0.00048552844,0.0010242683,0.000711725,0.0010926615,0.00018349147],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.021728514,0.0003267079,0.013428066,0.6622357,0.13435204,0.00034810437,0.00038614194,0.0007034294,0.0022087574,0.00031418755,0.0016233632,0.16234505],"study_design_scores_gemma":[0.021991985,0.026569324,0.14962156,0.2890567,0.4784273,0.0031507267,0.00074810773,0.0011627134,0.0031015407,0.0019902128,0.02392328,0.0002565516],"about_ca_topic_score_codex":0.0010616696,"about_ca_topic_score_gemma":0.0028498878,"teacher_disagreement_score":0.01594089,"about_ca_system_score_codex":0.0009997493,"about_ca_system_score_gemma":0.0009814089,"threshold_uncertainty_score":0.08430451},"labels":[],"label_agreement":null},{"id":"W4416028666","doi":"10.1111/jdv.70171","title":"The <scp>SWITCH</scp> algorithm: An expert consensus on treat‐to‐target criteria for chronic prurigo","year":2025,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Innovaderm (Canada)","funders":"Galderma; Deutsche Forschungsgemeinschaft","keywords":"MEDLINE; Alternative medicine; Systematic review; Chronic disease","score_opus":0.021099980204629328,"score_gpt":0.3324636463383322,"score_spread":0.31136366613370287,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416028666","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.079380974,0.009980326,0.671989,0.063638896,0.0053182784,0.08820316,0.0041573266,0.0025613124,0.07477077],"genre_scores_gemma":[0.13935143,0.0014068717,0.82888883,0.003672789,0.0005918791,0.020020934,0.0032609769,0.00028335192,0.00252297],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.89442277,0.07120527,0.016410701,0.0029958491,0.012973221,0.0019921442],"domain_scores_gemma":[0.8530105,0.050744355,0.016225588,0.0068032956,0.06593752,0.007278796],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.14202054,0.0012142378,0.0023151822,0.007476316,0.0032878234,0.0040086005,0.0059258617,0.0037446306,0.004835907],"category_scores_gemma":[0.14603704,0.00084319053,0.0051766494,0.0033669453,0.002273878,0.0033930938,0.007881743,0.00467328,0.0025305264],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028675091,0.0011942926,0.035896394,0.015894914,0.0018726053,0.0010433994,0.011670429,0.011583459,0.0042017573,0.023864131,0.22602238,0.6638887],"study_design_scores_gemma":[0.009064301,0.004693349,0.07349789,0.036531705,0.004560004,0.0052120057,0.015423933,0.14930758,0.010812541,0.13094103,0.5585351,0.0014205616],"about_ca_topic_score_codex":0.0037711707,"about_ca_topic_score_gemma":0.005847468,"teacher_disagreement_score":0.14202054,"about_ca_system_score_codex":0.005247897,"about_ca_system_score_gemma":0.029143477,"threshold_uncertainty_score":0.7510854},"labels":[],"label_agreement":null},{"id":"W4416127362","doi":"10.1111/jdv.70165","title":"Efficacy of up to 4 years of tralokinumab in adults with moderate‐to‐severe atopic dermatitis","year":2025,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; Surrey Memorial Hospital; SKiN Health; University of British Columbia; Queen's University","funders":"LEO Pharma","keywords":"Atopic dermatitis; Young adult; Clinical trial; Disease; MEDLINE","score_opus":0.009522154342859154,"score_gpt":0.26561321623030176,"score_spread":0.25609106188744263,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416127362","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98253286,0.013004544,0.00013107326,0.000411397,0.00014550502,0.00038964645,0.0009719535,0.000034784993,0.0023784311],"genre_scores_gemma":[0.9944231,0.0020431709,0.00026774753,0.0005800072,0.00012888035,0.0004745579,0.0011524693,0.0000040565196,0.0009261079],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99918073,0.00025013258,0.00009599591,0.00016539251,0.00011727101,0.00019045168],"domain_scores_gemma":[0.9985623,0.00031958494,0.00048393084,0.000107836735,0.0001411576,0.00038520616],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023998783,0.0005046047,0.0015279497,0.00027260336,0.00054854824,0.0006652349,0.00044958215,0.00082788785,0.002736073],"category_scores_gemma":[0.0024542194,0.00023828098,0.0028918777,0.00024491746,0.00018480026,0.0007687012,0.0005219899,0.001526696,0.0004318826],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5410731,0.012449284,0.15053195,0.0022069556,0.006715318,0.00042481194,0.00045701367,0.0018507924,0.0064853383,0.00029894756,0.006021338,0.27148518],"study_design_scores_gemma":[0.087741286,0.26825082,0.6158308,0.0008717527,0.010200105,0.00078197004,0.0003001591,0.0013496993,0.0023343598,0.0003984728,0.011862726,0.00007792999],"about_ca_topic_score_codex":0.0010097297,"about_ca_topic_score_gemma":0.003198142,"teacher_disagreement_score":0.002736073,"about_ca_system_score_codex":0.00060512533,"about_ca_system_score_gemma":0.0009636103,"threshold_uncertainty_score":0.012691915},"labels":[],"label_agreement":null},{"id":"W4416228555","doi":"10.1111/jdv.70147","title":"From reactive to predictive: Advancing biologic dosing in dermatology","year":2025,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"Fonds Wetenschappelijk Onderzoek; British Skin Foundation","keywords":"Dosing; Therapeutic drug monitoring; Pharmacogenomics; Drug; Population; Adverse effect; Precision medicine; Pharmacokinetics","score_opus":0.012088244179375979,"score_gpt":0.2627130128702634,"score_spread":0.2506247686908874,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416228555","genre_codex":"methods","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.011756659,0.13592346,0.7880503,0.038697373,0.0027763066,0.00019427462,0.0006907647,0.0038878499,0.01802295],"genre_scores_gemma":[0.32048914,0.1254997,0.526255,0.013821761,0.0055696354,0.00024041648,0.0010961338,0.0010454715,0.005982785],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99401146,0.0024576103,0.00042187318,0.0008397519,0.0020857996,0.0001835058],"domain_scores_gemma":[0.98968655,0.0060786586,0.00092112384,0.0011145908,0.0016926274,0.00050650846],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008247701,0.0011458708,0.0013582219,0.0017959388,0.00044612118,0.006002588,0.0027340516,0.002549434,0.0044033877],"category_scores_gemma":[0.03031958,0.0008656671,0.0012738348,0.0016532252,0.0017130784,0.005590402,0.0034921833,0.005694416,0.0025097213],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029934372,0.00022025898,0.006164966,0.0011825874,0.00017320308,0.00016232346,0.0003482264,0.071711175,0.0038043282,0.05017528,0.018570796,0.8471876],"study_design_scores_gemma":[0.0001483208,0.00070121785,0.0034805601,0.0022946375,0.00030236214,0.0008814946,0.00047074934,0.3046482,0.007505649,0.35129008,0.32795733,0.00031935074],"about_ca_topic_score_codex":0.0033012142,"about_ca_topic_score_gemma":0.0028153386,"teacher_disagreement_score":0.008247701,"about_ca_system_score_codex":0.0022491233,"about_ca_system_score_gemma":0.0028031187,"threshold_uncertainty_score":0.04361856},"labels":[],"label_agreement":null},{"id":"W4416276818","doi":"10.1111/jdv.70202","title":"The risk and prevalence of hepatic diseases in psoriasis: A systematic review and meta‐analysis","year":2025,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Alberta Health Services; Memorial University of Newfoundland","funders":"","keywords":"Psoriasis; Observational study; Odds ratio; Epidemiology; Fatty liver; Liver disease; Meta-analysis; Confidence interval; Hepatitis C","score_opus":0.01393929777026235,"score_gpt":0.25878505994304346,"score_spread":0.24484576217278112,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416276818","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.02005458,0.97538924,0.00089877367,0.00035448166,0.00021366961,0.00017223398,0.0024291608,0.0000480464,0.00043986435],"genre_scores_gemma":[0.4224949,0.56972367,0.0026347092,0.0007931995,0.0004377286,0.00076085964,0.0025237175,0.000056877023,0.0005743735],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99555236,0.001943069,0.0011332448,0.0006771779,0.00045333014,0.00024074735],"domain_scores_gemma":[0.9910411,0.006322494,0.0012323505,0.00053073996,0.0007146115,0.00015870383],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0062058633,0.0016570978,0.0091670845,0.0037524637,0.0005663705,0.001879911,0.001145658,0.0014272648,0.0036026717],"category_scores_gemma":[0.016612213,0.0010308586,0.02687251,0.006367585,0.00043336683,0.001120389,0.001133838,0.0015119733,0.00034920016],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0040947055,0.00003802862,0.020322189,0.19709899,0.7597646,0.00023411412,0.00009291586,0.0005990238,0.0004431914,0.0001843628,0.0021377099,0.014990199],"study_design_scores_gemma":[0.0004952024,0.00013995619,0.012608281,0.008402908,0.9760191,0.00014314745,0.00003899359,0.00021818848,0.000117796946,0.00018807605,0.0016029301,0.000025449152],"about_ca_topic_score_codex":0.0048730536,"about_ca_topic_score_gemma":0.011691869,"teacher_disagreement_score":0.0091670845,"about_ca_system_score_codex":0.00091275503,"about_ca_system_score_gemma":0.0014549715,"threshold_uncertainty_score":0.032820106},"labels":[],"label_agreement":null},{"id":"W4416456850","doi":"10.1111/jdv.70142","title":"Characterizing global dermatologic engagement and needs: A cross‐sectional study from 83 countries","year":2025,"lang":"en","type":"letter","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Cutaneous Melanoma Detection and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital","funders":"","keywords":"Outreach; Psychological intervention; Context (archaeology); Incentive; Health care; Global health; Poverty; MEDLINE","score_opus":0.027413471330857198,"score_gpt":0.289998450774376,"score_spread":0.26258497944351883,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416456850","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9987943,0.00013729189,0.00004828614,0.000048324557,0.000002431716,0.000054290344,0.0004038215,0.0000017704731,0.0005094292],"genre_scores_gemma":[0.9986828,0.00028133873,0.00018834855,0.00015452241,0.0000048717434,0.000114480965,0.0004462053,0.0000032162907,0.00012415311],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988851,0.00041475522,0.00015627773,0.00013072394,0.00020130727,0.00021178847],"domain_scores_gemma":[0.99782515,0.0004870016,0.00078687357,0.00014823856,0.00031656303,0.0004362462],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002685065,0.0003401207,0.0004701362,0.0012984984,0.00095727295,0.0010946519,0.0004964276,0.0008194755,0.0016274329],"category_scores_gemma":[0.0028437101,0.00076700764,0.0006108039,0.002296325,0.0005780036,0.0014262552,0.0015910706,0.0009835633,0.00058300473],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000029408537,0.00011325772,0.9952141,0.00004644286,0.000031499825,0.00012162907,0.0028085797,0.000023523397,0.00011006962,0.000016966325,0.00018339486,0.0013011633],"study_design_scores_gemma":[0.0000060158336,0.0001885363,0.9920719,0.000039516188,0.000015860043,0.0002438378,0.006900359,0.00005920542,0.000031389653,0.000009470581,0.00042736076,0.0000065226004],"about_ca_topic_score_codex":0.008044146,"about_ca_topic_score_gemma":0.01056026,"teacher_disagreement_score":0.008044146,"about_ca_system_score_codex":0.0006573284,"about_ca_system_score_gemma":0.0006094057,"threshold_uncertainty_score":0.015994668},"labels":[],"label_agreement":null},{"id":"W4416773282","doi":"10.1111/jdv.70166","title":"Apremilast in Japanese patients with palmoplantar pustulosis: A randomized, Phase 3 trial","year":2025,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health","funders":"Amgen","keywords":"Apremilast; Palmoplantar pustulosis; Phase (matter); MEDLINE; Clinical trial","score_opus":0.00941797863843805,"score_gpt":0.24421294682497138,"score_spread":0.23479496818653334,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416773282","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97097385,0.014704022,0.0007631118,0.0015683647,0.00063694624,0.007185991,0.0011510322,0.000157993,0.002858617],"genre_scores_gemma":[0.97661555,0.0069733346,0.0019546328,0.0024098728,0.00056597916,0.008129735,0.00097056257,0.000022625913,0.0023577306],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9995035,0.0002797381,0.000037947466,0.00006677401,0.00004592143,0.00006616616],"domain_scores_gemma":[0.9994111,0.00012019838,0.00018072745,0.000041508956,0.000054973236,0.00019153138],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002143445,0.0011292412,0.0022411495,0.0002851542,0.0005660734,0.00082159525,0.0005303424,0.001251772,0.00470529],"category_scores_gemma":[0.0013223642,0.0005659644,0.0018885325,0.0004057422,0.00074584276,0.0006187768,0.00028811928,0.0016703368,0.0006194214],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9502568,0.006756185,0.0017275203,0.0024862096,0.0019249498,0.00016886782,0.00014971494,0.0002958851,0.0059758206,0.00015226271,0.002204393,0.02790122],"study_design_scores_gemma":[0.95376813,0.04133522,0.002846631,0.000052858457,0.0006135145,0.00007768719,0.000027483398,0.00018834676,0.00017875391,0.000068656525,0.0008312445,0.000011609712],"about_ca_topic_score_codex":0.00085855246,"about_ca_topic_score_gemma":0.0027246226,"teacher_disagreement_score":0.00470529,"about_ca_system_score_codex":0.00051811675,"about_ca_system_score_gemma":0.0015662316,"threshold_uncertainty_score":0.015740752},"labels":[],"label_agreement":null},{"id":"W4416816656","doi":"10.1111/jdv.70222","title":"Efficacy and safety of treatments for notalgia paresthetica: A systematic review","year":2025,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Peripheral Nerve Disorders","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; University of Toronto; University of Ottawa","funders":"","keywords":"MEDLINE; Systematic review; Clinical trial; Alternative medicine; Evidence-based medicine","score_opus":0.013908242206201425,"score_gpt":0.30567934091682686,"score_spread":0.29177109871062545,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416816656","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.003965695,0.99456465,0.00010775754,0.00022255495,0.0000876743,0.00017386336,0.000618796,0.000005696515,0.00025334558],"genre_scores_gemma":[0.09440489,0.9025093,0.0005966262,0.0009227346,0.00017312159,0.0005457536,0.00070476363,0.000007794875,0.0001350402],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9928235,0.002691524,0.0026353076,0.00063192873,0.0010249091,0.00019282318],"domain_scores_gemma":[0.9713846,0.02111213,0.005143588,0.00044945817,0.001691944,0.0002183267],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0067302184,0.0008889845,0.0072914413,0.0031707967,0.00045631587,0.0014914151,0.0011676663,0.0016632773,0.0035454452],"category_scores_gemma":[0.032273486,0.00068710395,0.010060776,0.0034430316,0.00070426875,0.001387255,0.00084001,0.0011998004,0.00023582779],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002164182,0.000046558445,0.003197132,0.8877473,0.07206179,0.00006814478,0.00013690136,0.00012302226,0.00019727169,0.0001875386,0.001687363,0.03238285],"study_design_scores_gemma":[0.0033675898,0.0010687975,0.021657651,0.5226237,0.43780264,0.00049016014,0.0003392992,0.00018330722,0.00031180997,0.0005027602,0.0115766395,0.00007565647],"about_ca_topic_score_codex":0.0053909584,"about_ca_topic_score_gemma":0.0154171735,"teacher_disagreement_score":0.0072914413,"about_ca_system_score_codex":0.0018139784,"about_ca_system_score_gemma":0.003453581,"threshold_uncertainty_score":0.03559321},"labels":[],"label_agreement":null},{"id":"W4416992163","doi":"10.1111/jdv.70240","title":"Novel treatment approaches for keloids and hypertrophic scars in skin of colour","year":2025,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Dermatologic Treatments and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Hospital for Sick Children; University of Alberta; University of Toronto","funders":"","keywords":"Cryosurgery; Keloid; Hypertrophic scar; Hypertrophic scars; Scars; Acne; MEDLINE; Adverse effect; Ethnic group","score_opus":0.061071765259162324,"score_gpt":0.3227205302466932,"score_spread":0.2616487649875309,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416992163","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0012830951,0.99418926,0.00035929293,0.0011135101,0.00029499608,0.00016720375,0.00023854701,0.000009002378,0.0023451655],"genre_scores_gemma":[0.019866923,0.97296983,0.0028273505,0.0020408658,0.00065774395,0.00041637887,0.0003719856,0.000010996381,0.0008379963],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.997759,0.00085200724,0.0006771708,0.00020928656,0.00042161872,0.0000809499],"domain_scores_gemma":[0.9944458,0.003741204,0.0011495812,0.00013156408,0.00043614607,0.00009568662],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004118901,0.00050540233,0.002200978,0.004546742,0.00041125217,0.0015012716,0.0009719529,0.0014193247,0.017873162],"category_scores_gemma":[0.009399758,0.0002434066,0.0030855718,0.0025353911,0.0005016627,0.0023825625,0.00083984755,0.0012156281,0.0013846391],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000978966,0.00021109822,0.0009278122,0.39569408,0.0018535578,0.0004341077,0.00026965956,0.00019197132,0.00091435603,0.002518575,0.009996125,0.58600974],"study_design_scores_gemma":[0.0024884064,0.0018515075,0.011400896,0.65727687,0.011670666,0.0040850844,0.0010311463,0.00031900697,0.0013426095,0.0061985804,0.30223048,0.000104841776],"about_ca_topic_score_codex":0.0013184224,"about_ca_topic_score_gemma":0.0054359823,"teacher_disagreement_score":0.017873162,"about_ca_system_score_codex":0.0011287584,"about_ca_system_score_gemma":0.002251469,"threshold_uncertainty_score":0.059791684},"labels":[],"label_agreement":null},{"id":"W4417114041","doi":"10.1111/jdv.70228","title":"Global burden of major depressive disorder attributable to psoriasis, 2000–2021","year":2025,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; McGill University","funders":"","keywords":"Major depressive disorder; MEDLINE; Depression (economics); Comorbidity; Young adult","score_opus":0.010423259482284007,"score_gpt":0.25494764604090075,"score_spread":0.24452438655861675,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417114041","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7307797,0.011836627,0.0010365533,0.002134871,0.00045983115,0.00009691224,0.24065396,0.00027843422,0.012723163],"genre_scores_gemma":[0.8841835,0.0059495186,0.00064037513,0.00048285574,0.00019978543,0.00007764306,0.1049767,0.000021022113,0.0034685468],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998387,0.000038367936,0.000023983952,0.00003372401,0.00003101937,0.000034177778],"domain_scores_gemma":[0.9996245,0.000023753577,0.00018186559,0.000016935102,0.000081882456,0.000071075134],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003275412,0.0002900903,0.00020907438,0.00093060115,0.00013028017,0.00041910418,0.00024352685,0.00037445506,0.0018954653],"category_scores_gemma":[0.0007644781,0.0001630189,0.00052727456,0.0014596435,0.00012231423,0.00033544863,0.00031765745,0.0006307443,0.0006535613],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017607093,0.00009496195,0.93643194,0.00061329996,0.0010901202,0.00026715006,0.000083607,0.0016678313,0.0018628195,0.00043668624,0.031071274,0.024619574],"study_design_scores_gemma":[0.000033640383,0.00006609837,0.9955462,0.000050308976,0.00009802535,0.00026157653,0.00005860757,0.00038294154,0.000060906033,0.00006207425,0.0033733838,0.000006067544],"about_ca_topic_score_codex":0.032674167,"about_ca_topic_score_gemma":0.03832201,"teacher_disagreement_score":0.032674167,"about_ca_system_score_codex":0.00061014114,"about_ca_system_score_gemma":0.00043935454,"threshold_uncertainty_score":0.06496793},"labels":[],"label_agreement":null},{"id":"W4417196083","doi":"10.1111/jdv.70110","title":"Results from the 32‐week, phase 3 <scp>DISCREET</scp> study of apremilast in patients with moderate to severe genital psoriasis","year":2025,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Lynde Centre for Dermatology; Probity Medical Research; Guenther Dermatology Research Centre","funders":"Amgen","keywords":"Apremilast; Psoriasis; Sex organ; MEDLINE; Severity of illness; Plaque psoriasis","score_opus":0.01513872788205899,"score_gpt":0.24218543233240727,"score_spread":0.22704670445034827,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417196083","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9826434,0.0070342137,0.0008526681,0.0007708579,0.00020314989,0.0035753425,0.0022270314,0.00010118381,0.002592087],"genre_scores_gemma":[0.9872843,0.0024101147,0.0018143363,0.0011853484,0.0002273669,0.0025481181,0.0024665701,0.000024590354,0.0020392323],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9989906,0.00059142435,0.00007526205,0.000121940044,0.00012680993,0.000093994786],"domain_scores_gemma":[0.9980282,0.0005892458,0.0005407089,0.0001804605,0.00016241049,0.000498975],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0042071175,0.0011053897,0.0023130653,0.00029469628,0.000458663,0.0009798178,0.0005460282,0.0010576874,0.004679614],"category_scores_gemma":[0.0021906965,0.00051966956,0.0024086242,0.00034497486,0.0006275573,0.00070991897,0.00036467437,0.0027809858,0.0006098142],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.91030264,0.019110525,0.0042059477,0.001197176,0.0025612612,0.00013853345,0.0001584995,0.0008958652,0.0117013585,0.00011903805,0.0033850025,0.04622426],"study_design_scores_gemma":[0.8212069,0.15796429,0.017044662,0.000061734674,0.00072555547,0.00023530674,0.00003055327,0.0003489508,0.00081575883,0.00012181083,0.0014176697,0.000026786218],"about_ca_topic_score_codex":0.00050522893,"about_ca_topic_score_gemma":0.0011907734,"teacher_disagreement_score":0.004679614,"about_ca_system_score_codex":0.000494014,"about_ca_system_score_gemma":0.0012315735,"threshold_uncertainty_score":0.022249639},"labels":[],"label_agreement":null},{"id":"W4417427330","doi":"10.1111/jdv.70249","title":"Recommendations for the diagnostic work‐up of cutaneous small vessel vasculitis – Position Statement of the European Academy of Dermatology and Venereology Vasculitis and Vasculopathy Task Force","year":2025,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Vasculitis and related conditions","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Venereology; Task force; Statement (logic); Position statement; Position paper; Task (project management)","score_opus":0.01674028836298033,"score_gpt":0.2690196958717759,"score_spread":0.2522794075087956,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417427330","genre_codex":"commentary","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.006840033,0.050419744,0.04636247,0.78274816,0.041638948,0.01888194,0.0053823604,0.0008473155,0.04687898],"genre_scores_gemma":[0.049959127,0.09210228,0.5046994,0.2151275,0.016354566,0.046420306,0.028996827,0.00086951104,0.045470584],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9463017,0.027270015,0.011051739,0.0014774995,0.01018195,0.0037171815],"domain_scores_gemma":[0.840521,0.046071492,0.011605096,0.0035732593,0.08847437,0.009754807],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.07544968,0.0026945048,0.002265558,0.007894553,0.0032567268,0.004459088,0.009960493,0.017429749,0.007479958],"category_scores_gemma":[0.09569058,0.0017853796,0.006969793,0.0036421467,0.0034185802,0.0041254647,0.0054928106,0.017244942,0.010321024],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015143874,0.00049268856,0.003259544,0.003979811,0.0001073885,0.0008223385,0.0020502778,0.0010372595,0.0019352114,0.0060498803,0.82078296,0.15933122],"study_design_scores_gemma":[0.0003402887,0.00031425102,0.0130539825,0.036421634,0.0003294414,0.0018611052,0.0037764595,0.0016750379,0.0011027962,0.016189428,0.92466074,0.0002747976],"about_ca_topic_score_codex":0.019873204,"about_ca_topic_score_gemma":0.012799125,"teacher_disagreement_score":0.07544968,"about_ca_system_score_codex":0.0065134983,"about_ca_system_score_gemma":0.040058322,"threshold_uncertainty_score":0.39902085},"labels":[],"label_agreement":null},{"id":"W4417429226","doi":"10.1111/jdv.70266","title":"Nemolizumab in prurigo nodularis up to 100 weeks: <scp>OLYMPIA LTE</scp> interim analysis","year":2025,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; University of Toronto","funders":"Samsung; LEO Pharma; InflaRx; Horizon Therapeutics; Argenx; Incyte; Kiniksa Pharmaceuticals; Fresenius Medical Care North America; UCB Pharma; Regeneron Pharmaceuticals; Teva Pharmaceutical Industries; Celgene; Biogen; Sanofi; Celldex Therapeutics; Amgen; Pfizer; Galderma; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Prurigo nodularis; Interim analysis; Interim; MEDLINE; Clinical trial","score_opus":0.015003837092929424,"score_gpt":0.30491407832226974,"score_spread":0.28991024122934034,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417429226","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.763346,0.030890679,0.015330507,0.0064647463,0.0033410154,0.020506527,0.09103296,0.001637973,0.06744956],"genre_scores_gemma":[0.9010925,0.0033208444,0.0085021965,0.005199524,0.00081668264,0.021334853,0.036012497,0.00033503005,0.023385897],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9936407,0.0035542054,0.0003217388,0.0006121268,0.00071838667,0.0011528141],"domain_scores_gemma":[0.9937696,0.0023583584,0.0011444605,0.0013000459,0.0008041219,0.00062330376],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0141986795,0.0015438573,0.004040669,0.0006070076,0.0006245816,0.0025183714,0.0012456848,0.001465385,0.013328459],"category_scores_gemma":[0.009990255,0.0006109125,0.00992588,0.0007390125,0.00055656215,0.00170786,0.0010768628,0.004501635,0.0022708045],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8474648,0.003251235,0.011795868,0.0028847575,0.027875703,0.00020360528,0.00011914182,0.0071397377,0.003098679,0.0010422274,0.031361952,0.063762344],"study_design_scores_gemma":[0.5628192,0.17333424,0.11559365,0.0020062986,0.059097573,0.0005719605,0.00025825168,0.013765658,0.0063533606,0.005498899,0.060476348,0.00022469928],"about_ca_topic_score_codex":0.0016640186,"about_ca_topic_score_gemma":0.0025801838,"teacher_disagreement_score":0.0141986795,"about_ca_system_score_codex":0.0012638386,"about_ca_system_score_gemma":0.0024242476,"threshold_uncertainty_score":0.07509065},"labels":[],"label_agreement":null},{"id":"W7116862287","doi":"10.1111/jdv.70131","title":"Beyond surface: Rethinking prognostic boundaries in early mycosis fungoides","year":2025,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Cutaneous lymphoproliferative disorders research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital du Saint-Sacrement","funders":"","keywords":"Mycosis fungoides; Disease; Stage (stratigraphy); Body surface area; Identification (biology); Adverse effect; Predictive value; Value (mathematics)","score_opus":0.017607655125253814,"score_gpt":0.30228956679534713,"score_spread":0.2846819116700933,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7116862287","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.81772906,0.06406387,0.03588364,0.057003375,0.005864205,0.00016806829,0.0008574357,0.00047903866,0.017951434],"genre_scores_gemma":[0.97831637,0.004217953,0.010148557,0.0029514276,0.0033319849,0.0000612224,0.0003695031,0.00013393081,0.00046918754],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9963695,0.0016980093,0.0004586661,0.0004068392,0.00070965517,0.00035732196],"domain_scores_gemma":[0.9858153,0.007423231,0.0015934559,0.0010500944,0.0030201217,0.0010977972],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008515907,0.00062169734,0.0011044913,0.0022062107,0.0007785948,0.00391287,0.0015476149,0.0012476803,0.0016057281],"category_scores_gemma":[0.035611395,0.00021613152,0.00039340882,0.0013030643,0.0014297285,0.005248166,0.0025040146,0.0041148136,0.00096997],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002959656,0.00010802024,0.515663,0.00069361285,0.00011150446,0.003285203,0.0036360084,0.0013130632,0.0037323395,0.0060639596,0.020483742,0.4419498],"study_design_scores_gemma":[0.00034632653,0.0027374877,0.658109,0.007219511,0.00073927955,0.03552017,0.014939992,0.02794354,0.0062696417,0.11099233,0.1346683,0.00051443453],"about_ca_topic_score_codex":0.0015238546,"about_ca_topic_score_gemma":0.001949804,"teacher_disagreement_score":0.008515907,"about_ca_system_score_codex":0.0007719601,"about_ca_system_score_gemma":0.00073178957,"threshold_uncertainty_score":0.04503697},"labels":[],"label_agreement":null},{"id":"W7117457106","doi":"10.1111/jdv.70265","title":"Short‐term efficacy of biologics in moderate‐to‐severe hidradenitis suppurativa: A systematic review and <scp>NMA</scp>","year":2025,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Hidradenitis Suppurativa and Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; University of Toronto","funders":"UCB Pharma","keywords":"MEDLINE; Clinical efficacy; Hidradenitis suppurativa; Adalimumab; Severity of illness","score_opus":0.019193852300876356,"score_gpt":0.2971473239697167,"score_spread":0.2779534716688404,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7117457106","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.003931579,0.9933508,0.00029862864,0.0004054979,0.00011379191,0.0004990015,0.000985741,0.000011383852,0.00040368328],"genre_scores_gemma":[0.15053333,0.84197366,0.0021509263,0.0015210756,0.00028200712,0.0019709202,0.0012574415,0.000016048394,0.0002946468],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.98756623,0.0056405207,0.004081441,0.0010317285,0.0014112348,0.00026881002],"domain_scores_gemma":[0.9573006,0.031623863,0.007605998,0.0006979812,0.0023986618,0.00037279734],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01685173,0.0013227018,0.008777752,0.007741898,0.00046090348,0.0022617178,0.0013173065,0.0015206359,0.0035479292],"category_scores_gemma":[0.04505107,0.0007835948,0.01700603,0.0071571614,0.0006794348,0.0016174759,0.0011338271,0.0010195058,0.00025800665],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001151087,0.000028587381,0.003753208,0.80787337,0.16034739,0.000109849476,0.000117507414,0.00036238215,0.00027031644,0.00025203425,0.0010747437,0.024659492],"study_design_scores_gemma":[0.0012533182,0.0005085127,0.012291324,0.32666683,0.6478853,0.0003120178,0.00015192399,0.00040877724,0.00023442178,0.0006837161,0.00955798,0.000045784393],"about_ca_topic_score_codex":0.0059872842,"about_ca_topic_score_gemma":0.017643059,"teacher_disagreement_score":0.01685173,"about_ca_system_score_codex":0.0028748494,"about_ca_system_score_gemma":0.0070952163,"threshold_uncertainty_score":0.08912158},"labels":[],"label_agreement":null}]}